10-K

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

WASHINGTON, DC 20549

FORM 10-K

☒ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

For the fiscal year ended December 31, 2021

or
☐	TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

Commission file number 1-15319

DIVERSIFIED HEALTHCARE TRUST

(Exact Name of Registrant as Specified in Its Charter)

Maryland	04-3445278
(State of Organization)	(IRS Employer Identification No.)

Two Newton Place, 255 Washington Street, Suite 300, Newton, MA 02458-1634

(Address of Principal Executive Offices) (Zip Code)

617-796-8350

(Registrant's Telephone Number, Including Area Code)

Securities registered pursuant to Section 12(b) of the Act:

Title Of Each Class	Trading Symbol(s)	Name Of Each Exchange On Which Registered
Common Shares of Beneficial Interest	DHC	The Nasdaq Stock Market LLC
5.625% Senior Notes due 2042	DHCNI	The Nasdaq Stock Market LLC
6.25% Senior Notes due 2046	DHCNL	The Nasdaq Stock Market LLC

    Securities registered pursuant to Section 12(g) of the Act: None

    Indicate by check mark if the registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act. Yes x  No ¨

    Indicate by check mark if the registrant is not required to file reports pursuant to Section 13 or Section 15(d) of the Act. Yes ¨  No x

    Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. Yes x  No ¨

    Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit such files). Yes x  No ¨    

    Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company or an emerging growth company. See the definitions of “large accelerated filer,” “accelerated filer,” “smaller reporting company” and “emerging growth company” in Rule 12b-2 of the Exchange Act.

Large accelerated filer x Accelerated filer ☐ Non-Accelerated filer ☐
Smaller reporting company ☐ Emerging growth company ☐

    If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ¨

    Indicate by check mark whether the registrant has filed a report on and attestation to its management's assessment of the effectiveness of its internal control over financial reporting under Section 404(b) of the Sarbanes-Oxley Act (15 U.S.C. 7262(b)) by the registered public accounting firm that prepared or issued its audit report. ☒

    Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act). Yes ☐ No x

    The aggregate market value of the voting common shares of beneficial interest, $.01 par value, or common shares, of the registrant held by non-affiliates was approximately $1.0 billion based on the $4.18 closing price per common share on The Nasdaq Stock Market LLC on June 30, 2021. For purposes of this calculation, an aggregate of 3,153,232 common shares held directly by, or by affiliates of, the trustees and the executive officers of the registrant have been included in the number of common shares held by affiliates.

    Number of the registrant's common shares outstanding as of February 21, 2022: 238,994,894.

    References in this Annual Report on Form 10-K to the Company, DHC, we, us or our mean Diversified Healthcare Trust and its consolidated subsidiaries unless otherwise expressly stated or the context indicates otherwise.

DOCUMENTS INCORPORATED BY REFERENCE

    Certain information required by Items 10, 11, 12, 13 and 14 of Part III of this Annual Report on Form 10-K is incorporated by reference to our definitive Proxy Statement for the 2022 Annual Meeting of Shareholders, to be filed with the Securities and Exchange Commission within 120 days after the fiscal year ended December 31, 2021.

Warning Concerning Forward-Looking Statements

This Annual Report on Form 10-K contains statements that constitute forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995 and other securities laws. Also, whenever we use words such as “believe”, “expect”, “anticipate”, “intend”, “plan”, “estimate”, “will”, “may” and negatives or derivatives of these or similar expressions, we are making forward-looking statements. These forward-looking statements are based upon our present intent, beliefs or expectations, but forward-looking statements are not guaranteed to occur and may not occur. Forward-looking statements in this Annual Report on Form 10-K relate to various aspects of our business, including:    

•The duration and severity of the COVID-19 pandemic and its impact on us and our managers' and other operators' and tenants' businesses,

•The ability of our senior living community managers to minimize the negative economic impact resulting from the COVID-19 pandemic on our senior living communities and to manage them profitably and increase our returns,

•Our belief that we are well positioned to weather the present disruptions facing the real estate industry and, in particular, the real estate healthcare industry, including the senior living industry,

•Our belief that the healthcare sector and many of our tenants and managers and other operators provide essential services across the United States and the implication that our and our tenants' and managers' and other operators' businesses will remain open to provide such essential services,

•Our expectations regarding the quality and future performance of the new third party managers of the senior living communities we transitioned from Five Star Senior Living, or Five Star, which is an operating division of AlerisLife Inc. (f/k/a Five Star Senior Living Inc.), or AlerisLife, during 2021,

•Whether the aging U.S. population and increasing life spans of seniors will increase the demand for senior living communities and other medical and healthcare related properties and healthcare services,

•Our ability to retain our existing tenants, attract new tenants and maintain or increase current rental rates on terms as favorable to us as our prior leases,

•The credit qualities of our tenants,

•Our ability to compete for tenancies and acquisitions effectively,

•Our potential receipt of any additional funding under the Coronavirus Aid, Relief, and Economic Security Act, or the CARES Act,

•Our expectation that our redevelopment projects will be completed on budget and by the estimated completion dates,

•Our acquisitions and sales of properties,

•Our closures and repositioning of senior living communities,

•Our ability to raise debt or equity capital,

•Our ability to complete dispositions,

•The future availability of borrowings under our revolving credit facility,

•Our policies and plans regarding investments, financings and dispositions,

•Our ability to pay distributions to our shareholders and to sustain the amount of such distributions,

•Whether we may contribute additional properties to our joint ventures and receive proceeds from the other investors in our joint ventures in connection with any such contributions or enter into new joint venture arrangements,

•Our ability to pay interest on and principal of our debt,

i

•Our ability to appropriately balance our use of debt and equity capital,

•Our credit ratings,

•Our expectation that we benefit from our relationships with The RMR Group LLC, or RMR LLC,

•Our qualification for taxation as a real estate investment trust, or REIT, and

•Other matters.

Our actual results may differ materially from those contained in or implied by our forward-looking statements. Forward-looking statements involve known and unknown risks, uncertainties and other factors, some of which are beyond our control. Risks, uncertainties and other factors that could have a material adverse effect on our forward-looking statements and upon our business, results of operations, financial condition, funds from operations attributable to common shareholders, or FFO attributable to common shareholders, normalized funds from operations attributable to common shareholders, or Normalized FFO attributable to common shareholders, net operating income, or NOI, cash flows, liquidity and prospects include, but are not limited to:

•The impacts of the COVID-19 pandemic on us and our managers and other operators and tenants,

•The impacts of economic conditions and the capital markets on us and our managers and other operators and tenants,

•Compliance with, and changes to, federal, state and local laws and regulations, accounting rules, tax laws and similar matters,

•Limitations imposed on our business and our ability to satisfy complex rules in order for us to maintain our qualification for taxation as a REIT for U.S. federal income tax purposes,

•Competition within the healthcare and real estate industries, particularly in those markets in which our properties are located,

•Actual and potential conflicts of interest with our related parties, including our Managing Trustees, AlerisLife (including Five Star), RMR LLC and others affiliated with them, and

•Acts of terrorism, outbreaks of pandemics, including the COVID-19 pandemic, or other manmade or natural disasters beyond our control.

For example:

•Under the current economic conditions for the industries in which our properties and businesses operate, our managers and other operators and tenants may not be able to profitably operate their businesses at our properties, our tenants may become unable or unwilling to pay their rent obligations to us, or our senior living community managers may be unable to generate our minimum returns for sustained periods as a result of the COVID-19 pandemic or otherwise. Additionally, if we default under our credit facility or other debt obligations due to the impacts of the COVID-19 pandemic or otherwise, we may be required to repay our outstanding borrowings and other debt. Further, although we have taken steps to enhance our ability to maintain sufficient liquidity, unanticipated events may require us to expend amounts not currently planned,

•Our senior living community managers and other operators may experience operating and financial challenges resulting from a number of factors, some of which are beyond their control, and which challenges impact our operating results, including, but not limited to:

◦Fluctuations in occupancy,

◦Competition within the senior living and other health and wellness related service businesses,

◦Older adults delaying or forgoing moving into senior living communities or purchasing health and wellness services,

ii

◦Increased labor costs, decreased labor availability and staffing turnover at our senior living communities or increases in costs paid for goods and services, due in part to supply chain constraints and commodity price inflation,

◦The availability and increases in cost of general and professional liability insurance coverage,

◦Medicare or Medicaid policies and regulations, as well as federal, state, local, and industry-regulated licensure, certification and inspection laws, regulations and standards that could affect our senior living community managers' services or impose requirements, costs and administrative burdens that may reduce our managers' ability to profitably operate their businesses,

◦Imposition of civil, criminal and administrative penalties resulting from any noncompliance with healthcare laws and regulations at our senior living communities, including suspension of or non-payment for new admission or the loss or suspension of accreditation, licenses or certificates of need, or CONs, among other things, and

◦Exposure to litigation and regulatory and government proceedings due to the nature of the senior living and other health and wellness related service businesses.

•We own a significant number of AlerisLife common shares and we expect to own these shares for the foreseeable future. However, we may sell some or all of our AlerisLife common shares, or our ownership interest in AlerisLife may otherwise be diluted in the future,

•Our current cash distribution rate to common shareholders is $0.01 per share per quarter, or $0.04 per share per year, due to the operating challenges and other economic impacts resulting from the COVID-19 pandemic. Our distribution rate may be set and reset from time to time by our Board of Trustees. Our Board of Trustees will consider many factors when setting or resetting our distribution rate, including our historical and projected net income, Normalized FFO, requirements to maintain our qualification for taxation as a REIT, limitations in the agreements governing our debt, the availability to us of debt and equity capital, our expectation of our future capital requirements and operating performance, our expected needs for and availability of cash to pay our obligations and other factors deemed relevant by our Board of Trustees in its discretion. Further, our projected cash available for distribution may change and may vary from our expectations. Accordingly, future distributions to our shareholders may be increased or decreased and we cannot be sure as to the rate at which future distributions will be paid,

•Our ability to make future distributions to our shareholders and to make payments of principal and interest on our debt depends upon a number of factors, including our future earnings, the capital costs we incur to lease and operate our properties and our working capital requirements. We may be unable to pay our debt obligations when they become due or to maintain our current rate of distributions on our common shares and future distributions may be reduced or eliminated,

•We intend to conduct our business activities in a manner that will afford us reasonable access to capital for investment and financing activities. However, we may not succeed in this regard and we may not have reasonable access to capital,

•Subject to limitations on acquisitions in agreements governing our debt, we plan to selectively sell certain properties from time to time to fund future acquisitions, manage leverage and strategically update, rebalance and reposition our investment portfolio, which we refer to as our capital recycling program. We cannot be sure we will sell any of these properties or what the terms or timing of any such sales may be. In addition, any updating, rebalancing or repositioning of our portfolio may not result in the benefits we expect, and properties we may sell may be at prices that are less than expected and less than their carrying values,

•Contingencies in our acquisition and sale agreements that we may enter may not be satisfied and any acquisitions and sales pursuant to such agreements and any related management arrangements we may expect to enter may not occur, may be delayed or the terms of such transactions or arrangements may change,

•The capital investments we are making at our senior living communities and our plan to invest significant additional capital in our senior living communities to better position them in their respective markets in order to increase our future returns may not be successful and may not achieve our expected results. Our senior living communities may not

iii

be competitive, despite these capital investments, or these capital investments may be delayed or may cost more than expected due to supply chain disruptions, labor shortages or other conditions,

•Our redevelopment projects may not be successful and may cost more or take longer to complete than we currently expect. In addition, we may not realize the returns we expect from these projects and we may incur losses from these projects, and potential leasing arrangements related to our redevelopment projects may not materialize,

•We may spend more for capital expenditures or redevelopment projects than we currently expect,

•Our existing joint ventures and any additional joint ventures we may enter into in the future may not be successful,

•Our tenants may experience losses and default on their rent obligations to us,

•Some of our tenants may not renew expiring leases, and we may be unable to obtain new tenants to maintain or increase the historical occupancy rates of, or rents from, our properties. In addition, we may incur significant costs to reposition or relet a vacant property for a new operator and vacancies may reduce the value of the property,

•Our ability to grow our business and maintain or increase our distributions to shareholders depends in large part upon our ability to buy properties and arrange for their profitable operation or lease them for rents, less their property operating expenses, that exceed our capital costs. We are currently generally limited in making acquisitions pursuant to the agreement governing our revolving credit facility, or our credit agreement. In addition, even after these restrictions expire, we may be unable to identify properties that we want to acquire, and we may fail to reach agreement with the sellers and complete the purchase of any properties we do want to acquire. In addition, we may not realize the returns we expect on any properties we acquire,

•Rents that we receive from our properties may decline upon renewals or expirations of our leases because of changing market conditions or otherwise,

•Although we have obtained a waiver from compliance with the fixed charge coverage ratio covenant included in our credit agreement through December 2022, if our operating results and financial condition are further adversely impacted by current economic conditions or otherwise, we may fail to comply with the terms of the waiver and other requirements under our credit agreement, and we may also fail to satisfy certain financial requirements under the agreements governing our public debt. For example, our ratio of consolidated income available for debt service to debt service was below the 1.5x incurrence requirement under our credit agreement and our public debt covenants as of December 31, 2021, and we cannot be certain how long this ratio will remain below 1.5x. We are currently unable to incur additional debt because this ratio is below 1.5x on a pro forma basis, but we are not required to repay outstanding debt as a result of failure to comply with this financial requirement. We are currently fully drawn under our revolving credit facility and could also be required to repay our outstanding debt in the event of non-compliance with certain other requirements of our credit agreement or the agreements governing our public debt. We may therefore experience future liquidity constraints, as we are currently unable to incur additional debt under our credit agreement or otherwise for failure to comply with the requirements of our credit agreement and the agreements governing our public debt, and we will be limited to our cash on hand or be forced to raise additional sources of capital or take other measures to maintain adequate liquidity,

•Actual costs under our revolving credit facility or other floating rate debt will be higher than the stated rates because of fees and expenses associated with such debt,

•The premiums used to determine the interest rate payable on our revolving credit facility and the facility fee payable on our revolving credit facility are based on our credit ratings, which are subject to change,

•For the year ended December 31, 2021, substantially all of our NOI was generated from properties where a majority of the revenues are derived from our tenants', residents' and patients' private resources. This may imply that we will maintain or increase the percentage of our NOI generated from private resources at our senior living communities. However, our residents and patients may become unable to fund our charges with private resources and we may be required or may elect for business reasons to accept or pursue revenues from government sources, which could result in an increased part of our NOI and revenue being generated from government payments and our becoming more dependent on government payments. If the government fails to pay us or our managers or other operators amounts due to us or them because of government defaults, shutdowns, budgetary constraints or otherwise, we and they may be significantly negatively impacted,

iv

•Circumstances that adversely affect the ability of seniors or their families to pay for our managers' or other operators' services, such as economic downturns, weak housing market conditions, higher levels of unemployment among our residents' family members, lower levels of consumer confidence, stock market volatility and/or changes in demographics generally could affect the profitability of our senior living communities,

•It is difficult to accurately estimate tenant space preparation costs. Our unspent leasing related obligations may cost more or less and may take longer to complete than we currently expect, and we may incur increasing amounts for these and similar purposes in the future,

•We expect that we will benefit from RMR LLC's Environmental, Social and Governance, or ESG, program and initiatives. However, we may not realize the benefits we expect from such program and initiatives and we or RMR LLC may not succeed in meeting existing or future standards regarding ESG,

•We believe that our relationships with our related parties, including AlerisLife (including Five Star) and RMR LLC and others affiliated with them may benefit us and provide us with competitive advantages in operating and growing our business. However, the advantages we believe we may realize from these relationships may not materialize, and

•The business and property management agreements between us and RMR LLC have continuing 20 year terms. However, those agreements permit early termination in certain circumstances. Accordingly, we cannot be sure that these agreements will remain in effect for continuing 20 year terms.

Currently unexpected results could occur due to many different circumstances, some of which are beyond our control, such as the COVID-19 pandemic and its aftermath, new legislation or regulations affecting our business or the businesses of our managers or other operators or tenants, changes in our managers' or other operators' or tenants' revenues or costs, worsening or lack of improvement of the financial condition or changes in our managers' or other operators' or tenants' financial conditions, deficiencies in operations by a manager or other operator of one or more of our senior living communities, acts of terrorism, pandemics, natural disasters, climate change and climate related events or changes in capital markets or the economy generally.

The information contained elsewhere in this Annual Report on Form 10-K or in our other filings with the Securities and Exchange Commission, or SEC, including under the caption “Risk Factors”, or incorporated herein or therein, identifies other important factors that could cause differences from our forward-looking statements. Our other filings with the SEC are available on the SEC's website at www.sec.gov.

You should not place undue reliance upon our forward-looking statements.

Except as required by law, we do not intend to update or change any forward-looking statements as a result of new information, future events or otherwise.

v

Statement Concerning Limited Liability

The Amended and Restated Declaration of Trust establishing Diversified Healthcare Trust, dated September 20, 1999, as amended and supplemented, as filed with the State Department of Assessments and Taxation of Maryland, provides that no trustee, officer, shareholder, employee or agent of Diversified Healthcare Trust shall be held to any personal liability, jointly or severally, for any obligation of, or claim against, Diversified Healthcare Trust. All persons dealing with Diversified Healthcare Trust in any way shall look only to the assets of Diversified Healthcare Trust for the payment of any sum or the performance of any obligation.

vi

DIVERSIFIED HEALTHCARE TRUST

2021 FORM 10-K ANNUAL REPORT

Table of Contents

		Page
	Part I
Item 1.	Business	1
Item 1A.	Risk Factors	36
Item 1B.	Unresolved Staff Comments	59
Item 2.	Properties	59
Item 3.	Legal Proceedings	61
Item 4.	Mine Safety Disclosures	61
	Part II
Item 5.	Market for Registrant's Common Equity, Related Stockholder Matters and Issuer Purchases of Equity Securities	61
Item 6.	[Reserved]	61
Item 7.	Management's Discussion and Analysis of Financial Condition and Results of Operations	62
Item 7A.	Quantitative and Qualitative Disclosures About Market Risk	86
Item 8.	Financial Statements and Supplementary Data	87
Item 9.	Changes in and Disagreements With Accountants on Accounting and Financial Disclosure	87
Item 9A.	Controls and Procedures	87
Item 9B.	Other Information	88
Item 9C.	Disclosure Regarding Foreign Jurisdictions that Prevent Inspections	88
	Part III
Item 10.	Directors, Executive Officers and Corporate Governance	88
Item 11.	Executive Compensation	88
Item 12.	Security Ownership of Certain Beneficial Owners and Management and Related Stockholder Matters	88
Item 13.	Certain Relationships and Related Transactions, and Director Independence	89
Item 14.	Principal Accountant Fees and Services	89
	Part IV
Item 15.	Exhibits and Financial Statement Schedules	90
Item 16.	Form 10-K Summary	94
	Signatures

vii

PART I

Item 1.  Business.

Our Company

We are a real estate investment trust, or REIT, that was organized under Maryland law in 1998. We own medical office and life science properties, senior living communities and other healthcare related properties throughout the United States. As of December 31, 2021, we wholly owned 390 properties located in 36 states and Washington, D.C. On that date, the gross book value of our real estate assets at cost plus certain acquisition costs, before depreciation and purchase price allocations and less impairment write downs, was $7.2 billion.

As of December 31, 2021, we owned a 20% equity interest in an unconsolidated joint venture that owns a life science property located in Boston, Massachusetts with approximately 1.1 million rentable square feet that was 100% leased with an average (by annualized rental revenues) remaining lease term of 7.0 years. Additionally, in January 2022, we entered into a joint venture for 10 medical office and life science properties we owned with two unrelated third party global institutional investors, and we retained a 20% equity interest in the joint venture.

Our principal executive offices are located at Two Newton Place, 255 Washington Street, Suite 300, Newton, Massachusetts 02458-1634, and our telephone number is (617) 796-8350.

Our Business Strategy

We believe that the aging of the U.S. population benefits our portfolio of healthcare real estate. According to U.S. Census data, between now and 2030, more than 20% of the total U.S. population will be age 65 or older, with that demographic projected to grow thereafter by the equivalent of 10,000 people per day. We believe that this will increase demand for healthcare services and products supplied by the tenants in our medical office and life science properties. The primary market for senior living services is individuals age 80 and older. According to U.S. Census data, the age 75+ demographic is projected to be among the fastest growing age cohorts in the United States over the next 20 years, and according to the Centers for Medicare & Medicaid Services, or CMS, the age 85+ demographic is projected to grow over 30% over the next five years. Also, as a result of medical advances, seniors are living longer, and CMS reports that healthcare spending is projected to grow at an average rate of 5.7% per year and reach $6.0 trillion by 2027.

In light of these demographic trends, we believe that the aging of the U.S. population will increase demand for existing medical office and life science properties, senior living communities (including active adult rental properties) and other medical and healthcare related properties. Although we are currently limited in making acquisitions or other capital investments pursuant to the terms of the agreement governing our revolving credit facility, or our credit agreement, described below, we plan to seek to profit from this demand in the future by, over time, acquiring additional properties and entering into leases and management arrangements with qualified tenants and managers which generate returns to us that exceed our operating and capital costs, including structuring leases that provide for or permit periodic rent increases. Despite this trend, future economic downturns, softness in the U.S. housing market, higher levels of unemployment among our potential residents' family members, lower levels of consumer confidence, stock market volatility and/or changes in demographics could adversely affect the ability of seniors to afford the resident fees at our senior living communities. Further, as discussed elsewhere in this Annual Report on Form 10-K, the COVID-19 pandemic and its resulting economic impact have materially adversely affected the senior living industry, including us and our senior living community managers.

We seek to selectively sell properties from time to time when we determine our continued ownership or ongoing required capital expenditures will not achieve desired returns or when we believe we can successfully pursue more desirable opportunities than retaining these properties. We also expect to use future sales proceeds, at such time as we are able to do so under our credit agreement or otherwise, to acquire new properties that we believe will help us reduce the average age of our properties, increase our weighted average lease term, reduce our ongoing capital requirements and/or increase our distributions to shareholders. We refer to this as our capital recycling program.

Office Portfolio

Our portfolio of medical office and life science properties, or our Office Portfolio, consists of commercial properties constructed for use or operated as medical office space for physicians and other healthcare personnel, and other businesses in medical related fields, including clinics and life science or laboratory uses. Some of our medical office properties are occupied as administrative facilities for healthcare companies, such as hospitals and healthcare insurance companies.

1

Senior Living Communities

Independent Living Communities.  Independent living communities provide high levels of privacy to residents and require residents to be capable of relatively high degrees of independence. An independent living community usually bundles several services as part of a regular monthly charge. For example, an independent living community may include one or two meals per day in a central dining room, daily or weekly maid service or a social director in the base charge. Additional services are generally available from staff employees on a fee for service basis. In some of our independent living communities, separate parts of the property are dedicated to assisted living and/or nursing services. We also own an active adult rental property, which we have classified as an independent living community.

Assisted Living Communities.  Assisted living communities typically have one bedroom or studio units which include private bathrooms and efficiency kitchens. Services bundled within one charge usually include three meals per day in a central dining room, daily housekeeping, laundry, medical reminders and 24 hour availability of assistance with the activities of daily living, such as dressing and bathing. Professional nursing and healthcare services are usually available at the property on call or at regularly scheduled times. In some of our assisted living communities, separate parts of the property are dedicated to independent living and/or nursing services.

Skilled Nursing Facilities.  Skilled nursing facilities, or SNFs, generally provide extensive nursing and healthcare services similar to those available in hospitals, without the high costs associated with operating rooms, emergency rooms or intensive care units. A typical purpose built SNF includes mostly rooms with one or two beds, a separate bathroom and shared dining facilities. Licensed nursing professionals staff SNFs 24 hours per day. During 2021, we closed approximately 1,500 skilled nursing units, and we have approximately 1,900 skilled nursing units remaining in our portfolio.

Wellness Centers

Wellness centers typically have exercise classes, strength and cardiovascular equipment areas, tennis and racquet sports facilities, pools, spas and children's centers. Professional sports training and therapist services are often available. Wellness centers often market themselves as clubs for which members may pay monthly fees plus additional fees for specific services.

Other Types of Real Estate

In the past, we have considered investing in real estate different from our existing property types and some properties located outside the United States. For example, in 2019 we acquired an age restricted active adult rental property, which we have classified as an independent living community, to diversify our portfolio of senior living communities. We may explore these or other alternative investments in the future.

Lease Terms

Our medical office and life science property leases include both “triple net” leases, as described below, and “net” and “modified gross” leases, where we are responsible for operating and maintaining the properties and we charge the tenants for some or all of the property operating expenses. A small percentage of our medical office and life science property leases are “full service” leases where we receive fixed rent from the tenants and do not charge the tenants for any property operating expenses. The leases for some of our senior living communities and all of our wellness centers are “triple net” leases.

Triple net leases generally require the tenants to pay rent and all property operating expenses, to indemnify us from liability which may arise by reason of our ownership of the properties, to maintain the properties at their expense, to remove and dispose of hazardous substances on the properties in compliance with applicable law and to maintain insurance on the properties for their and our benefit. In the event of any damage, or immaterial condemnation, of a leased property, the tenants are generally required to rebuild with insurance or condemnation proceeds or, if such proceeds are insufficient, other amounts made available by us, if any, but if other amounts are made available by us, the rent will be increased accordingly. In the event of any material or total condemnation of a leased property, generally the lease will terminate with respect to that leased property, in which event we will be entitled to the condemnation proceeds and the rent will be reduced accordingly. In the event of any material or total destruction of a leased property, in certain cases the applicable tenant may terminate the lease with respect to that leased property, in which event the tenant will be required to pay us any shortfall in the amount of proceeds we receive from insurance compared to the replacement cost of that leased property.

2

Senior Housing Operating Portfolio Management Agreements

Because we are a REIT for U.S. federal income tax purposes, we generally may not operate our senior living communities. For nearly all of our senior living communities, we use a taxable REIT subsidiary, or TRS, structure authorized by the REIT Investment Diversification and Empowerment Act. Under this structure, we lease certain of our communities to our TRSs and our TRSs enter into management agreements with third parties for the operation of such communities. These management agreements generally provide the managers with a management fee, which is a percentage of the gross revenues realized at the communities, plus reimbursement for the managers' direct costs and expenses related to the communities. The managers may also receive an annual incentive fee equal to a percentage of the amount by which the annual earnings before interest, taxes, depreciation and amortization, or EBITDA, of the applicable communities exceeds the target EBITDA for the applicable communities.

Effective January 1, 2020, we completed a restructuring of our business arrangements, or the 2020 Restructuring Transaction, with Five Star Senior Living, or Five Star, which is an operating division of AlerisLife Inc. (f/k/a Five Star Senior Living Inc.), or AlerisLife, pursuant to which, among other things, our previously existing master leases with Five Star for 166 of our senior living communities and our previously existing management and pooling agreements for 78 of our senior living communities were terminated and replaced with new management agreements and a related omnibus agreement, which agreements were subsequently replaced in June 2021, as described below.

2021 Amendments to our Management Arrangements with Five Star. In June 2021, we amended our then existing management arrangements with Five Star. The principal changes to the management arrangements included:

•that Five Star agreed to cooperate with us in transitioning 108 of our senior living communities with approximately 7,500 living units to other third party managers without our payment of any termination fee to Five Star;

•that we no longer had the right to sell up to an additional $682.0 million of senior living communities then managed by Five Star and terminate Five Star's management of those communities without our payment of a fee to Five Star;

•that Five Star is continuing to manage 120 of our senior living communities, and that the skilled nursing units in all of our continuing care retirement communities that Five Star is continuing to manage, which then included approximately 1,500 living units, were closed and are being evaluated and repositioned;

•that beginning in 2025, we will have the right to terminate up to 10% of the senior living communities that Five Star is continuing to manage, based on total revenues per year, for failure to meet 80% of a target EBITDA for the applicable period;

•that the incentive fee that Five Star may earn in any calendar year for the senior living communities that Five Star is continuing to manage is no longer subject to a cap and that any senior living communities that are undergoing a major renovation or repositioning are excluded from the calculation of the incentive fee;

•that The RMR Group LLC, or RMR LLC, will oversee any major renovation or repositioning activities at the senior living communities that Five Star is continuing to manage; and

•that the term of our management agreements with Five Star for our senior living communities that Five Star is continuing to manage was extended by two years to December 31, 2036.

Pursuant to these changes, we and Five Star entered into an amended and restated master management agreement, or the Master Management Agreement, for the senior living communities that Five Star is continuing to manage. In addition, Five Star delivered to us a related amended and restated guaranty agreement pursuant to which Five Star is continuing to guarantee the payment and performance of each of its applicable subsidiary's obligations under the applicable management agreements.

As of December 31, 2021, we had transitioned 107 of the 108 senior living communities from Five Star to new third party managers. The remaining senior living community was closed and we are assessing opportunities to redevelop that community. We lease nearly all of our senior living communities, including those managed by Five Star and by the new third party managers, to our TRSs.

3

Although we have various rights as owner under our senior living management agreements, we rely on the managers' personnel, good faith, expertise, performance, technical resources, operating efficiencies, information systems, proprietary information and judgment to manage our managed senior living communities efficiently and effectively. We also rely on the managers to set resident fees and otherwise operate our managed senior living communities in compliance with the applicable management agreements.

Under our senior living management agreements, we assume the operational risks and fund the operations and capital and maintenance requirements for our senior living communities. As a result, we are required to maintain sufficient funding for these purposes. Further, any funding we maintain for these purposes will not be available for other business purposes, which may limit our ability to pursue other business opportunities and could limit the amount of distributions we can pay to our shareholders. As a result of the 2020 Restructuring Transaction, effective January 1, 2020, the operating results of our senior living communities that were previously leased from us and operated by Five Star and are now managed by new third party managers for our account are included in our operating results. The operating results of our other pre-existing and subsequently acquired or transitioned senior living communities managed by Five Star for our account are similarly included in our operating results. The change in our historical arrangements with Five Star from mostly leased to now managed has resulted, and likely will continue to result in future periods, in our realizing significantly increased variability in our operating results from our senior living communities from what we experienced in the past.

For more information about the 2020 Restructuring Transaction and the terms of the Master Management Agreement and of the management agreements with the new third party managers, see Note 6 to our Consolidated Financial Statements included in Part IV, Item 15 of this Annual Report on Form 10-K.

COVID-19 Pandemic

The COVID-19 pandemic and the various governmental and market responses intended to contain and mitigate the spread of the virus and its detrimental public health impact have had a significant impact on the global economy, including the U.S. economy. Many of the restrictions that had been imposed in the United States during the pandemic have since been lifted and commercial activity in the United States generally has increasingly returned to pre-pandemic practices and operations, although recent variants of the virus have caused increased infections and resulted in governments and businesses implementing or adopting certain requirements, including proof of vaccinations and mask wearing. We are continuing to closely monitor the impact of the COVID-19 pandemic on all aspects of our business. It is unclear whether the number of COVID-19 infections will further increase or amplify in the United States or elsewhere and, if so, what the impact of that would be on human health and safety, the economy, or our managers', operators' and tenants' businesses.

Our business is focused on healthcare related properties, including medical office and life science properties, senior living communities, wellness centers and other medical and healthcare related properties. We believe that the healthcare sector and many of our tenants, managers and operators provide essential services across the United States. Due to restrictions intended to prevent the spread of the virus that causes COVID-19, certain of our medical office and wellness center tenants, which include physician practices that had discontinued non-essential surgeries and procedures and fitness centers, that had been ordered closed by state executive orders experienced disruptions to their businesses. Our senior living community operators also experienced disruptions, including limitations on in-person tours and new admissions, and experienced challenges in attracting new residents to their communities in addition to experiencing increased expenses due to increased labor costs, including higher health benefits costs, and increased costs and consumption of supplies, including personal protective equipment. There will be lasting impacts of the COVID-19 pandemic, even as states and municipalities have eased and may further ease restrictions. Our tenants and their businesses may become increasingly negatively impacted, which may result in our tenants seeking assistance from us regarding their rent obligations owed to us, their being unable or unwilling to pay us rent, their ceasing to pay us rent and their ceasing to continue as going concerns.

We are closely monitoring the impacts of the COVID-19 pandemic on all aspects of our business, including, but not limited to, labor availability and costs and other cost pressures from supply chain disruptions and commodity price inflation in our senior housing operating portfolio, or SHOP segment.

With respect to our SHOP segment, we expect that our senior living community managers will be operating our communities at lower average occupancy with higher operating expenses per resident as a result of the COVID-19 pandemic, which will likely lead to decreased returns to us. Our managers continue to follow federal, state and local health department guidelines and their own infection prevention protocols but we expect to see additional cases of COVID-19 in our senior living communities.

4

In December 2020, the United States Food and Drug Administration, or FDA, issued emergency use authorizations, or EUAs, for vaccines for the prevention of COVID-19, to Pfizer Inc. / BioNTech SE and Moderna, Inc. This was followed by the FDA issuing an EUA for the Johnson & Johnson vaccine in February 2021. Throughout 2021, COVID-19 variants became of increasing concern. The variants have caused COVID-19 surges in different parts of the country at different times, which has caused the Federal and state governments to re-impose certain restrictions in certain geographies at different times. In response to the variants, and scientific findings that the protection from COVID-19 vaccines waned over time, the Federal government began emphasizing the importance of COVID-19 vaccine booster shots.

Throughout the first quarter of 2021, Five Star coordinated multiple COVID-19 vaccination clinics at all senior living communities in our SHOP segment for residents and staff. As previously disclosed, all of the communities in our SHOP segment completed vaccination clinics and are accepting new residents. On September 13, 2021, Five Star reported full compliance with its previously announced requirement that all of its team members at our communities managed by Five Star be fully vaccinated.

We may be subject to claims by residents and staff related to vaccines our managers administer or the care our managers provide following administration of the vaccine. However, any such potential liability will be limited by the Public Readiness and Emergency Preparedness Act, or PREP Act, which provides immunity protections under federal and state law for individuals and entities, or Covered Persons, against claims of loss relating to certain COVID-19 countermeasures, or Covered Countermeasures. We and our managers' personnel that administer Covered Countermeasures such as the COVID-19 vaccine are classified as Covered Persons immune to claims arising from COVID-19 vaccine administration with the exception of death or serious physical injury caused by willful misconduct.

We also believe that we and our managers, operators and impacted tenants have and may continue to benefit from provisions of the Coronavirus Aid, Relief, and Economic Security Act, or the CARES Act, signed into law in March 2020 and further supplemented by the Consolidated Appropriations Act, 2021, or other federal or state relief programs allowing them to continue or resume business activity. During the year ended December 31, 2021, we recognized $19.6 million in interest and other income in our consolidated statement of comprehensive income (loss) related to funds received under the CARES Act.

We believe that our current financial position and recent financing activities will enable us to withstand the COVID-19 pandemic and its aftermath due in part to the following:

•In June 2020, we issued $1.0 billion aggregate principal amount of 9.75% senior notes due 2025. We used the net proceeds from this offering to prepay in full our $250.0 million term loan that was scheduled to mature on June 12, 2020 and to reduce amounts outstanding under our revolving credit facility;

•Beginning in the second quarter of 2020, we reduced our quarterly cash distribution rate on our common shares to $0.01 per share, conserving approximately $33.3 million of cash per calendar quarter compared to our prior quarterly distribution rate;

•In January 2021, we and our lenders amended our credit agreement and the agreement governing our previously existing $200.0 million term loan to, among other things, obtain waivers from compliance with certain financial covenants through June 2022, or the Amendment Period;

•In February 2021, we issued $500.0 million aggregate principal amount of 4.375% senior notes due 2031. We used the net proceeds from this offering to prepay our $200.0 million term loan. In June 2021, we used the remaining net proceeds to redeem all of our outstanding 6.75% senior notes due 2021, when those notes were redeemable with no prepayment premium;

•In March 2021, we borrowed $800.0 million under our revolving credit facility as a precautionary measure to increase our cash position and preserve financial flexibility. In February 2022, we repaid $100.0 million of this borrowing to reduce the borrowing capacity under our revolving credit facility to $700.0 million pursuant to the February 2022 amendment to our credit agreement;

•In December 2021 and January 2022, we raised aggregate net proceeds of approximately $1.0 billion from the sale of equity interests in an existing joint venture that owns a life science property located in Boston, Massachusetts and in a new joint venture for 10 medical office and life science properties we owned. We retained a 20% equity interest in each of these joint ventures. We expect to use these proceeds to fund capital expenditures and to reduce leverage; and

5

•In February 2022, we amended our credit agreement to, among other things, extend the waiver of the fixed charge coverage ratio covenant through December 31, 2022, and we also exercised our option to extend the maturity date of our revolving credit facility to January 2024.

As a result of these uncertainties, we are unable to determine what the ultimate impacts will be on our, our tenants', our managers', our operators' and other stakeholders' businesses, operations, financial results and financial position. For further information and risks relating to the COVID-19 pandemic and its aftermath on us and our business, see elsewhere in this Annual Report on Form 10-K, including “Warning Concerning Forward-Looking Statements”, Part I, Item 1A, “Risk Factors” and Part II, Item 7, "Management's Discussion and Analysis of Financial Condition and Results of Operations".

Our Investment and Operating Policies

Our investment objectives include increasing cash flows from operations from dependable and diverse sources in order to make distributions to our shareholders. To seek to achieve these objectives, we seek to: maintain a strong capital base of shareholders' equity; invest in strong credit quality properties with strong credit quality tenants and managers; use debt leverage to fund additional investments which increase cash flow from operations because of positive spreads between our cost of investment capital and investment yields; structured investments, including joint venture arrangements, which generate a minimum return and provide an opportunity to participate in operating growth at our properties; when market conditions permit, refinance debt with additional equity or long term debt; and pursue diversification so that our cash flow from operations comes from diverse properties and tenants.

Our Board of Trustees may change our investment and operating policies at any time without a vote of, or notice to, our shareholders.

Acquisition Policies

Subject to the current limitations on acquisitions imposed by our credit agreement discussed elsewhere in this Annual Report on Form 10-K, including "Management's Discussion and Analysis of Financial Condition and Results of Operations" in Part II, Item 7 and Note 9 to our Consolidated Financial Statements included in Part IV, Item 15 of this Annual Report on Form 10-K, our acquisition strategy is to seek to acquire additional properties primarily for income and secondarily for appreciation potential. We may purchase individual properties or multiple properties in one portfolio. In implementing this acquisition strategy, we consider a range of factors relating to each proposed acquisition, including, but not limited to:

•the use and size of the property;

•the location of the property;

•the price at which the property may be acquired as compared to the estimated replacement cost of the property;

•the existing or proposed lease or management terms;

•the availability and reputation of experienced and financially qualified tenants, managers or guarantors;

•the historical and projected cash flows from the operations of the property;

•the construction quality, physical condition and design of the property, including various environmental sustainability factors;

•the expected capital expenditures that may be needed at the property;

•the competitive market environment of the property;

•the growth, tax and regulatory environments of the market in which the property is located;

•the price segment and payment sources in which the property is operated;

•the strategic fit of the property with the rest of our portfolio;

•our cost of capital compared to projected returns we may realize by owning the property;

6

•the level of permitted services and regulatory history of the property and its historical tenants and managers; and

•the existence of alternative sources, uses or needs for capital.

An important part of our acquisition strategy is to identify and select qualified, experienced and financially stable tenants and managers.

Disposition Policies

We plan to selectively sell certain properties from time to time to fund future acquisitions and to strategically update, rebalance and reposition our investment portfolio, and to achieve and maintain leverage at levels we believe are appropriate with a goal of (1) improving the asset quality of our portfolio by reducing the average age, lengthening the weighted average term of our leases and increasing the likelihood of retaining our tenants, (2) reducing our leverage and (3) increasing our distributions to shareholders. We expect further disruptions to future disposition activity due to uncertain market conditions as a result of the COVID-19 pandemic and its resulting economic conditions.

Other than as described, we generally consider ourselves to be a long term owner of properties and are more interested in the long term earnings potential of our properties and stability of our portfolio than selling properties for short term gains. However, from time to time, we may consider the sale of all or a stake in one or more of our properties or other investments. We make disposition decisions based on a number of factors, including, but not limited to, the following:

•our ability to lease or operate the affected property on terms acceptable to us or have the affected property managed with our realizing acceptable returns;

•the manager's or tenant's desire to operate the affected property;

•the manager's or tenant's desire to dispose of or cease operating the affected property;

•the proposed sale price;

•the remaining length of the lease relating to the property and its other terms;

•our evaluation of future cash flows which may be achieved from the property;

•the strategic fit of the property or investment with the rest of our portfolio;

•the capital required to maintain the property;

•the estimated value we may receive by selling the property;

•our intended use of the proceeds we may realize from the sale of a property;

•the expected benefits that can be achieved from contributing additional properties to our existing or any new joint ventures;

•the existence of alternative sources, uses or needs for capital; and

•the tax implications to us and our shareholders for any proposed disposition.    

Other Investments

We have no policies which specifically limit the percentage of our assets that may be invested in any individual property, in any one type of property, in properties leased to any one tenant or to an affiliated group of tenants or in properties operated by any one tenant or manager or by an affiliated group of tenants or managers or in securities of one or more persons.

We own a significant number of common shares of AlerisLife, and we expect to own these shares for the foreseeable future. However, we may sell some or all of our AlerisLife common shares, or our ownership interest in AlerisLife may otherwise be diluted in the future. We may also in the future acquire additional common shares or securities of other entities, including entities engaged in real estate activities. We may invest in the securities of other entities for the purpose of exercising

7

control, or otherwise, make loans to other persons or entities, engage in the sale of investments, offer securities in exchange for property or repurchase or reacquire our securities. As of December 31, 2021, Five Star, an operating division of AlerisLife, managed 120 senior living communities for our account.

Historically, we have primarily owned wholly owned investments in fee interests. However, circumstances may arise in which we may invest in leaseholds, joint ventures, mortgages and other real estate interests. We may invest or enter into additional real estate joint ventures if we conclude that by doing so we may benefit from the participation of joint venture partners or that our opportunity to participate in the investment is contingent on the use of a joint venture structure. As of December 31, 2021, we owned a 20% equity interest in an unconsolidated joint venture for a life science property located in Boston, Massachusetts. Additionally, in January 2022, we entered into a joint venture for 10 medical office and life science properties we owned with two unrelated third party global institutional investors. We retained a 20% equity interest in this joint venture. Further, we may acquire interests in joint ventures as part of an acquisition of properties or entities or we may contribute wholly owned properties into our existing or new joint ventures. We also may invest in participating, convertible or other types of mortgages if we conclude that by doing so, we may benefit from the cash flow or appreciation in the value of a property which is not available for purchase.

Mergers and Strategic Combinations

In the past, we have considered the possibility of entering into mergers or strategic combinations with other companies and we may explore such possibilities in the future, subject to the current limitations on acquisitions imposed by our credit agreement discussed further elsewhere in this Annual Report on Form 10-K, including "Management's Discussion and Analysis of Financial Condition and Results of Operations" in Part II, Item 7 and Note 9 to our Consolidated Financial Statements included in Part IV, Item 15 of this Annual Report on Form 10-K.

Our Financing Policies

Although there are no limitations in our organizational documents on the amount of indebtedness we may incur, our credit agreement and our senior unsecured notes indentures and their supplements contain financial covenants which, among other things, restrict our ability to incur indebtedness and require us to maintain certain financial ratios. As of December 31, 2021, our ratio of consolidated income available for debt service to debt service was below the 1.5x incurrence requirement under our credit agreement and our public debt covenants, as the effects of the COVID-19 pandemic continued to adversely impact our operations. We are currently unable to incur additional debt because this ratio is below 1.5x on a pro forma basis, and as such, prior to falling below the 1.5x incurrence requirement, we borrowed $800.0 million under our revolving credit facility as a precautionary measure to increase our cash position and preserve financial flexibility. For further information relating to our indebtedness, see elsewhere in this Annual Report on Form 10-K, including Note 9 to our Consolidated Financial Statements included in Part IV, Item 15 of this Annual Report on Form 10-K.

We may seek additional capital through equity offerings, debt financings, retention of cash flows in excess of distributions to shareholders, sales of properties, or equity interests in properties, or a combination of these methods or other transactions. To the extent we obtain additional debt financing, we may do so on an unsecured basis or a secured basis. We may seek to obtain lines of credit or to issue securities senior to our common shares, including preferred shares or debt securities, some of which may be convertible into our common shares or be accompanied by warrants to purchase our common shares. We may also finance acquisitions by assuming debt, through an exchange of properties or through the issuance of equity or other securities. The proceeds from any of our financings may be used to pay distributions, to provide working capital, to refinance existing indebtedness or to finance acquisitions and improvements of existing or new properties, subject to limitations in agreements governing our debt.

As of December 31, 2021, we had a $800.0 million revolving credit facility. As a result of the February 2022 amendment to our credit agreement, our revolving credit facility was reduced to $700.0 million. We use our revolving credit facility for working capital and general business purposes and for funding investments on an interim basis until we are able to refinance them with equity or long term debt. In some instances, we may assume debt in connection with our acquisition of properties or place new mortgages on properties we own. For more information regarding our financing sources and activities, see “Management's Discussion and Analysis of Financial Condition and Results of Operations—Liquidity and Capital Resources—Our Investment and Financing Liquidity and Resources” in Part II, Item 7 of this Annual Report on Form 10-K.

Our Board of Trustees may change our financing policies at any time without a vote of, or notice to, our shareholders.

8

Our Manager

The RMR Group Inc., or RMR Inc., is a holding company and substantially all of its business is conducted by its majority owned subsidiary, RMR LLC. The Chair of our Board of Trustees and one of our Managing Trustees, Adam D. Portnoy, as the sole trustee of ABP Trust, is the controlling shareholder of RMR Inc., is a managing director and the president and chief executive officer of RMR Inc. and an officer and employee of RMR LLC. Jennifer F. Francis, our other Managing Trustee and our President and Chief Executive Officer, also serves as an officer and employee of RMR LLC. Jennifer B. Clark, our Secretary and former Managing Trustee, also serves as a managing director and as executive vice president, general counsel and secretary of RMR Inc., an officer of ABP Trust and an officer and employee of RMR LLC. Our day to day operations are conducted by RMR LLC. RMR LLC originates and presents investment and divestment opportunities to our Board of Trustees and provides management and administrative services to us. RMR LLC has a principal place of business at Two Newton Place, 255 Washington Street, Suite 300, Newton, Massachusetts, 02458-1634, and its telephone number is (617) 796-8390. RMR LLC is an alternative asset management company that is focused on commercial real estate and related businesses. RMR LLC or its subsidiaries also act as a manager to other publicly traded real estate companies, privately held real estate funds and real estate related operating businesses. In addition, RMR LLC provides management services to our existing joint ventures. As of the date of this Annual Report on Form 10-K, the executive officers of RMR LLC are: Adam D. Portnoy, President and Chief Executive Officer; Jennifer B. Clark, Executive Vice President, General Counsel and Secretary; Jennifer F. Francis, Executive Vice President; Matthew P. Jordan, Executive Vice President, Chief Financial Officer and Treasurer; John G. Murray, Executive Vice President; and Jonathan M. Pertchik, Executive Vice President. In addition, our Chief Financial Officer and Treasurer, Richard W. Siedel, Jr., is a Senior Vice President of RMR LLC. Mr. Siedel and other officers of RMR LLC also serve as officers of other companies to which RMR LLC or its subsidiaries provide management services.

Employees

We have no employees. Services which would otherwise be provided to us by employees are provided by RMR LLC and by our Managing Trustees and officers. As of December 31, 2021, RMR LLC had approximately 600 full time employees in its headquarters and regional offices located throughout the United States.

Government Regulation and Reimbursement

The senior living and healthcare industries are subject to extensive, frequently changing federal, state and local laws and regulations. Although most of these laws and regulations affect the manner in which our tenants and managers operate our properties, some of them also impact us and the values of our properties. Some of the laws that impact or may impact us or our tenants or managers include: state and local licensure laws; laws protecting consumers against deceptive practices; laws relating to the operation of our properties and how our tenants and managers conduct their operations, such as health and safety, fire and privacy laws; federal and state laws affecting assisted living communities that participate in Medicaid and federal and state laws affecting SNFs, clinics and other healthcare facilities that participate in both Medicaid and Medicare that mandate allowable costs, pricing, reimbursement procedures and limitations, quality of services and care, food service and physical plants; resident rights laws (including abuse and neglect laws) and fraud laws; anti-kickback and physician referral laws; the Americans with Disabilities Act and similar state and local laws; and safety and health standards set by the federal Occupational Safety and Health Administration, or OSHA. Medicaid funding is available in some, but not all, states for assisted living services. State licensure standards for assisted living communities, SNFs, clinics and other healthcare facilities typically address facility policies, staffing, quality of services and care, resident rights, fire safety and physical plant matters, and related matters. In addition, the spread of COVID-19 has brought increased government regulation, including additional compliance obligations. We are unable to predict the future course of federal, state and local legislation or regulation. Changes in the regulatory framework could have a material adverse effect on the ability of our tenants to pay us rent, the profitability of our managed senior living communities and the values of our properties.

State and local health and social service agencies and other regulatory authorities regulate and license many senior living communities. State health authorities regulate and license clinics and other healthcare facilities. In most states in which we own properties, we and our tenants and managers are prohibited from providing certain services without first obtaining appropriate licenses. In addition, most states require a certificate of need, or CON, before an entity may open an assisted living facility or expand services at an existing community. In addition, some states (such as California and Texas) that have eliminated CON laws have retained other means of limiting development of facilities, including moratoria, licensing laws and limitations upon participation in the state Medicaid program. Senior living communities and certain other healthcare facilities must also comply with applicable state and local building, zoning, fire and food service codes before licensing or Medicare and Medicaid certification are granted. These laws and regulatory requirements could affect our ability and that of our tenants and managers to expand into new markets or to expand communities in existing markets.

9

In addition, government authorities have been subjecting healthcare facilities such as those that we own to increasing numbers of inspections, surveys, investigations, audits and other potential enforcement actions. We and our tenants and managers expend considerable resources to respond to such actions. Unannounced inspections or surveys may occur annually or biannually, or even more regularly, such as following a regulatory body's receipt of a complaint about a facility. From time to time in the ordinary course of business, we and our tenants and managers receive deficiency reports from state regulatory bodies resulting from those inspections and surveys. We and our tenants and managers seek to resolve most inspection deficiencies through a plan of corrective action relating to the affected facility's operations. If we or our tenants or managers fail to comply with any applicable legal requirements, or are unable to cure deficiencies, certain sanctions may be imposed and, if imposed, may adversely affect the ability of our tenants to pay their rent to us, the profitability of our managed senior living communities and the values of our properties. In addition, government agencies typically have the authority to take or seek further action against a licensed or certified facility, including the ability to impose civil money penalties or fines; suspend, modify, or revoke a license or Medicare or Medicaid participation; suspend or deny admissions of residents; deny payments in full or in part; institute state oversight, temporary management or receivership; and impose criminal penalties. Loss, suspension or modification of a license or certification or the imposition of other sanctions or penalties could adversely affect the values of our properties, the ability of our tenants to pay their rents and the profitability of our managed senior living communities.

The Centers for Medicare and Medicaid Services, or CMS, of the U.S. Department of Health and Human Services, or HHS, has increased its oversight of state survey agencies in recent years, focusing its enforcement efforts on SNFs and chains of SNF operators with findings of substandard care or repeat and continuing deficiencies and violations. Moreover, state Attorneys General typically enforce consumer protection laws relating to senior living services, clinics and other healthcare facilities. In addition, state Medicaid fraud control agencies may investigate and prosecute assisted living communities and SNFs, clinics and other healthcare facilities under fraud and patient abuse and neglect laws.

Current state laws and regulations allow enforcement officials to make determinations as to whether the care provided by or on behalf of our tenants or by our managers at our facilities exceeds the level of care for which a particular facility is licensed, which could result in closure of the community and the immediate discharge and transfer of residents, which could adversely affect the ability of that tenant to pay rent to us, the profitability of our managed senior living communities and the values of our properties. Citations or revocation of a license could impact the ability for us or our managers to obtain new licenses or certifications or maintain or renew existing licenses and certifications which would trigger defaults under management agreements and leases with us and adversely affect our ability to operate. Furthermore, some states and the federal government allow certain citations of one facility to impact other facilities owned or operated by the same entity or a related entity, including facilities in other states. Revocation of a license or certification at one facility could therefore impact our or a tenant's or manager's ability to obtain new licenses or certifications or to maintain or renew existing licenses at other facilities, which could adversely affect the ability of that tenant to pay rent to us, the profitability of that manager, the profitability and values of our properties and trigger defaults under our tenants' leases and managers' management agreements and our or our tenants' or managers' credit arrangements, or adversely affect our or our tenants' or managers' ability to obtain financing in the future. In addition, an adverse finding by state officials could serve as the basis for lawsuits by private plaintiffs and lead to investigations under federal and state laws, which could result in civil and/or criminal penalties against the facility as well as a related entity.

For the year ended December 31, 2021, substantially all of our net operating income, or NOI, was generated from properties where a majority of the revenues are derived from our tenants' and residents' private resources, and a small amount of our NOI was generated from properties where a majority of the revenue is dependent upon Medicare and Medicaid programs. Our tenants and managers operate facilities in many states and they and we participate in federal and state healthcare payment programs, including the federal Medicare and state Medicaid benefit programs for services in SNFs and other similar facilities and state Medicaid programs for services in assisted living communities. In 2021, we closed approximately 1,500 skilled nursing units, reducing the overall impact of government regulation in this sector on our operations, and we have approximately 1,900 skilled nursing units remaining in our portfolio.

In addition, the Federal government took several measures to address the financial impact of the pandemic. The CARES Act was signed into law on March 27, 2020. The CARES Act, among other things, provides billions of dollars of relief to certain individuals and businesses suffering from the COVID-19 pandemic, including as follows:

•It temporarily suspended the 2% Medicare sequestration payment reductions from May 1, 2020 through December 31, 2020. This suspension was extended to March 31, 2021 as part of the Consolidated Appropriations Act, 2021, and in April 2021, was further extended until December 31, 2021.

•It established a Provider Relief Fund for allocation by HHS. On April 10, 2020, HHS began to distribute these funds, or the General Distribution, to healthcare providers who received Medicare fee-for-service reimbursement

10

in 2018 and 2019. On May 22, 2020, HHS announced that Provider Relief Funds would be available to SNFs with six or more certified beds that have been impacted by the COVID-19 pandemic. On June 9, 2020, HHS announced Phase 2 General Distributions, including the Medicaid and Children's Health Insurance Program programs. On September 3, 2020, HHS announced details of a $2 billion incentive-payment distribution to nursing homes, of which approximately $333 million was distributed in the first round and $523 million in the second round. On October 1, 2020, HHS announced Phase 3 General Distributions, intended to balance payments of 2% of annual revenue from patient care for all applicants plus a possible add-on payment to account for revenue losses and expenses attributable to COVID-19. On December 16, 2020, HHS announced that Phase 3 funds would be distributed in amounts up to 88% of reported losses.

•On September 1, 2020, HHS announced that assisted living providers could apply for COVID-19 relief funding as provided by the CARES Act and the Paycheck Protection Program and Health Care Enhancement Act. On October 28, 2020, CMS published an interim final rule that, among other items, clarified its interpretation that the CARES Act provided Medicare Part B coverage and the payment for COVID-19 vaccine and administration.

•It created the employee retention credit calculated at 50% of qualifying wages up to $10,000 in total per employee, resulting in a maximum credit of $5,000 per employee for employers with 100 or fewer employees.

Further, the Consolidated Appropriations Act, 2021 was signed into law on December 27, 2020. Among other things, this Act further supplemented the Provider Relief Fund with an additional $3 billion. The statute required that no less than 85% of unobligated balances of the fund and funds recovered from providers after the enactment date be allocated based on financial losses and changes in operating expenses occurring in the third or fourth quarter of calendar year 2020. The Consolidated Appropriations Act, 2021 also extended the credits and modified the calculation to 70% of qualifying wages up to $10,000 per quarter per employee for employers with up to 500 employees.

On March 11, 2021, the American Rescue Plan Act of 2021, or ARPA, was signed into law. In addition to broad-based public and private financial relief, ARPA included a number of measures intended to assist the health care industry, including funding to support COVID-19 research, testing, and vaccination efforts. The ARPA temporarily increased the Federal Medical Assistance Percentage specifically for the provision of home- and community- based services, or HCBS, which include home health care services and rehabilitative services, by ten points from April 1, 2021 through March 31, 2022, provided states maintain state spending levels as of April 1, 2021. ARPA further specified that states must use the enhanced funds to “implement, or supplement the implementation of, one or more activities to enhance, expand, or strengthen” Medicaid HCBS.

Further, on September 10, 2021, HHS, through the Health Resources and Services Administration, made $25.5 billion in new funding in COVID-19 relief available to healthcare providers. Under this plan, Provider Relief Fund Phase 4 payments were based on lost revenues and expenditures between July 1, 2020, and March 31, 2021.

We have received funds as part of certain relief programs provided under the CARES Act. The terms and conditions of the Provider Relief Fund require that the funds are utilized to compensate for lost revenues that are attributable to the COVID-19 pandemic and for eligible costs to prevent, prepare for and respond to the COVID-19 pandemic that are not covered by other sources. In addition, Provider Relief Fund recipients are subject to other terms and conditions, including certain reporting requirements. Any funds not used in accordance with the terms and conditions, must be returned to HHS. Receipt of additional government funds and other benefits from the CARES Act is subject to, in certain circumstances, a detailed application and approval process and it is too soon to accurately predict whether we will meet any eligibility requirements. We have received funds related to certain programs under the CARES Act and various state programs in which certain of our communities in our SHOP segment are located. We recognized $19.6 million of these funds in interest and other income in our consolidated statement of comprehensive income (loss) for which we have met the required terms and conditions for the year ended December 31, 2021.

In addition to federal measures, many states have taken actions to waive or modify healthcare laws or regulations and Medicaid reimbursement rules. Both state and federal waivers and other temporary actions in response to the COVID-19 pandemic are expected to last throughout the national emergency, the duration of which is currently unknown. Additional measures may be taken prior to and after the conclusion of the national emergency to alleviate the economic impact of the COVID-19 pandemic. Governmental responses to COVID-19 are rapidly evolving, and it is not yet known what the duration or impact of such responses will be.

Government Payers. In light of the current and projected federal budget deficit and challenging state fiscal conditions, there have been numerous recent legislative and regulatory actions or proposed actions with respect to federal Medicare rates and state Medicaid rates and federal payments to states for Medicaid programs, each of which, or in any combination, could

11

have a material adverse effect on the ability of our tenants to pay us rent, the profitability of our managed senior living communities and the values of our properties.

Our tenants' and managers' Medicare Part B outpatient therapy revenue rates are tied to the Medicare Physician Fee Schedule, or MPFS, which has been subject to separate limitations on rate growth.

It is unclear whether any adjustments in Medicare rates will compensate for the increased costs our tenants and managers may incur for services to residents whose services are paid for by Medicare.

Medicaid Reimbursement. Current and future programmatic changes to Medicaid eligibility and rates may also impact us.

Enforcement. Federal and state efforts to target false claims, fraud and abuse and violations of anti-kickback, physician referral and privacy laws by providers under Medicare, Medicaid and other public and private programs have increased in recent years, as have civil monetary penalties, treble damages, repayment requirements and criminal sanctions for noncompliance. The federal False Claims Act, as amended and expanded by the Fraud Enforcement and Recovery Act of 2009 and the Patient Protection and Affordable Care Act of 2010, or the ACA, provides significant civil monetary penalties and treble damages for false claims and authorizes individuals to bring claims on behalf of the federal government for false claims and earn a percentage of the government's recovery should the government intervene. These incentives have led to a steady increase in whistleblower actions. The federal Civil Monetary Penalties Law authorizes the Secretary of HHS to impose substantial civil penalties, treble damages and program exclusions administratively for false claims or violations of the federal anti-kickback statute. In addition, the ACA increased penalties under federal sentencing guidelines between 20% and 50% for healthcare fraud offenses involving more than $1.0 million.

Government authorities are devoting increasing attention and resources to the prevention, detection and prosecution of healthcare fraud and abuse. CMS contractors are also expanding the retroactive audits of Medicare claims submitted by SNFs and other providers, and recouping alleged overpayments for services determined by auditors not to have been medically necessary or not to meet Medicare coverage criteria as billed. State Medicaid programs and other third party payers are conducting similar medical necessity and compliance audits. The ACA facilitates the Department of Justice's, or the DOJ's, ability to investigate allegations of wrongdoing or fraud at healthcare facilities, in part because of increased cooperation and data sharing among CMS, the United States Department of Health and Human Services, Office of the Inspector General, or the OIG, the DOJ and the states.

In addition, the ACA requires all states to terminate the Medicaid participation of any provider that has been terminated under Medicare or any Medicaid state plan. We and our tenants and managers expend significant resources to comply with these laws and regulations.

Other Matters. Federal and state laws designed to protect the confidentiality and security of individually identifiable information apply to us, our tenants and our managers. Under the federal Health Insurance Portability and Accountability Act of 1996, or HIPAA, and the Health Information Technology for Economic and Clinical Health Act, or the HITECH Act, we, our managers and our tenants that are covered entities or business associates within the meaning of HIPAA must comply with rules adopted by HHS governing the privacy, security, use and disclosure of individually identifiable information, including financial information and protected health information, or PHI, and also with security rules for electronic PHI. There may be both civil monetary penalties and criminal sanctions for noncompliance with such federal laws. In January 2013, HHS released the HIPAA Omnibus Rule, or the Omnibus Rule, which modified various requirements, including the standard for providing breach notices, which previously required an analysis of the harm of any disclosure, to a more objective analysis relating to whether any PHI was actually acquired or viewed as a result of the breach. On December 10, 2020, HHS issued a proposed rule that would modify certain standards, definitions and patient rights under the previously-promulgated Standards for Privacy of Individually Identifiable Health Information, or the HIPAA Privacy Rule, to address barriers to coordinated care and case management. The effect of this proposed rule, if finalized, upon our operations is unknown at this time. In addition to HIPAA, many states have enacted their own security and privacy laws relating to individually identifiable information. For example, the California Consumer Privacy Act became effective in 2020, and was further modified by the California Privacy Rights Act. We expect additional federal and state legislative and regulatory efforts to regulate consumer privacy in the future. In some states, these laws are more stringent than HIPAA, and we, our tenants and our managers must comply with both the applicable federal and state standards. HIPAA enforcement efforts have increased considerably over the past few years, with HHS, through its Office for Civil Rights, or OCR, entering into several multi-million dollar HIPAA settlements in 2021 alone. OCR has also demonstrated a continuing commitment to enforce the obligation to provide individuals with timely access to their health information upon request. Finally, OCR and other regulatory bodies have become increasingly focused on cybersecurity risks,

12

including the emerging threat of ransomware and similar cyberattacks. The increasing sophistication of cybersecurity threats presents challenges to the entire healthcare industry.

We require our tenants and managers to comply with all laws that regulate the operation of our senior living communities. The costs to comply with these laws may adversely affect the profitability of our managed senior living communities and the ability of our tenants to pay their rent to us. If we, our managers, or any of our tenants were subject to an action alleging violations of such laws or to any adverse determination concerning any of our or our tenants' or managers' licenses or eligibility for Medicare or Medicaid reimbursement or any substantial penalties, repayments or sanctions, these actions could materially and adversely affect the ability of our tenants to pay rent to us, the profitability of our managed senior living communities and the values of our properties. If our managers or any of our tenants becomes unable to operate our properties, or if any of our tenants becomes unable to pay its rent because it has violated government regulations or payment laws, we may experience difficulty in finding a substitute tenant or managers or selling the affected property at a price that provides us with a desirable return, and the value of the affected property may decline materially.

Federal, state and local agencies regulate our medical office and life science property tenants that provide healthcare services. Many states require medical clinics, ambulatory surgery centers, clinical laboratories and other outpatient healthcare facilities to be licensed and inspected for compliance with licensure regulations concerning professional staffing, services, patient rights and physical plant requirements, among other matters. Our tenants must comply with the Americans with Disabilities Act and similar state and local laws to the extent that such facilities are “public accommodations” as defined in those statutes. The obligation to comply with the Americans with Disabilities Act and similar laws is an ongoing obligation, and our tenants expend significant resources to comply with such laws.

Healthcare providers and suppliers, including physicians and other licensed medical practitioners, that receive federal or state reimbursement under Medicare, Medicaid or other federal or state programs must comply with the requirements for their participation in those programs. Our tenants that are healthcare providers or suppliers are subject to reimbursement rates that are increasingly subject to cost control pressures and may be reduced or may not be increased sufficiently to cover their increasing costs, including our rents.

The FDA and other federal, state and local authorities extensively regulate our biotechnology laboratory tenants that develop, manufacture, market or distribute new drugs, biologicals or medical devices for human use. The FDA and such other authorities regulate the clinical development, testing, manufacture, quality control, safety, effectiveness, labeling, storage, record keeping, advertising and promotion of those products. Before a new pharmaceutical product or medical device may be marketed and distributed in the United States, the FDA must approve it as safe and effective for human use. Preclinical and clinical studies and documentation in connection with FDA approval of new pharmaceuticals or medical devices involve significant time, expense and risks of failure. Once a product is approved, the FDA maintains oversight of the product and its developer and can withdraw its approval, recall products or suspend their production, impose or seek to impose civil or criminal penalties on the developer or take other actions for the developer's failure to comply with regulatory requirements, including anti-fraud, false claims, anti-kickback or physician referral laws. Other concerns affecting our biotechnology laboratory tenants include the potential for subsequent discovery of safety concerns and related litigation, ensuring that the product qualifies for reimbursement under Medicare, Medicaid or other federal or state programs, cost control initiatives of payment programs, the potential for litigation over the validity or infringement of intellectual property rights related to the product, the eventual expiration of relevant patents and the need to raise additional capital. The cost of compliance with these regulations and the risks described in this paragraph, among others, could adversely affect the ability of our biotechnology laboratory tenants to pay rent to us. In addition, if these laws and regulations are altered, additional regulatory risks may arise. Depending upon what aspects of the laws and regulations are altered, the ability of our biotechnology laboratory tenants to pay rent to us could be adversely and materially affected.

Competition

Investing in medical office and life science properties, senior living communities and other healthcare related properties, and their operations, are highly competitive businesses. We compete against other REITs, numerous financial institutions, individuals and other public and private companies who are actively engaged in this business. Also, we compete for tenants and residents and for investments based on a number of factors including location, rents, rates, financings offered, underwriting criteria and reputation. Our ability to successfully compete is also impacted by economic and population trends, availability of acceptable investment opportunities, our ability to negotiate beneficial investment terms, availability and cost of capital, limitations in agreements governing our debt and new and existing laws and regulations. Some of our competitors are dominant in selected geographic or property markets, including in markets we operate. Some of our competitors may have greater financial and other resources than we have. We believe the quality and diversity of our investments, the financial

13

strength of many of our tenants and the experience and capabilities of our managers may afford us some competitive advantages and allow us to operate our business successfully despite the competitive nature of our business.

Our tenants and managers compete on a local and regional basis with operators of facilities that provide comparable services. Operators compete for residents and patients based on quality of care, reputation, physical appearance of properties, services offered, family preferences, physicians, staff, price and location. We and our tenants and managers also face competition from other healthcare facilities for qualified personnel, such as physicians and other healthcare providers that provide comparable facilities and services.

For additional information on competition and the risks associated with our business, see “Risk Factors” in Part I, Item 1A of this Annual Report on Form 10-K.

Corporate Sustainability

We are guided by Environmental, Social and Governance, or ESG, principles, and believe corporate sustainability must be a strategic focus alongside our focus on economic performance. Our sustainability practices which align with those of our manager, RMR LLC — minimizing our impact on the environment, embracing the communities where we operate and attracting top professionals — are critical elements supporting our long-term success.

We recognize our responsibility to minimize the impact of our business on the environment and seek to preserve natural resources and maximize efficiencies in order to reduce the impact the properties we own have on the planet. Our environmental sustainability strategies and best practices help to mitigate our properties’ environmental footprint, optimize operational efficiency and enhance our competitiveness in the marketplace. We seek to obtain certifications that measure progress in environmental sustainability, which helps to benchmark performance and mitigate risk.

We and our manager, RMR LLC, drive value, manage risk and benchmark the performance of our properties by effectively capturing and managing data through real-time energy monitoring, or RTM. RTM facilitates advanced data analytics and access to detect faults and inefficiencies in equipment operations faster meanwhile enhancing building system control in a cost-effective and scalable way.

Our energy performance programs drive down energy consumption and reduce carbon emissions of our properties. Lower energy use and emissions reduce our properties' potential exposure to policies that call for a carbon tax or other emissions-based penalties. Our existing business practices are intended to align with the Task Force on Climate-related Financial Disclosures framework across both physical and transition risks and opportunities.

In an effort to reduce the effects of any increased energy costs in the future, we continuously study ways to improve the energy efficiency at all of our properties. Our property manager, RMR LLC, is a member of the ENERGY STAR program, a joint program of the U.S. Environmental Protection Agency and the U.S. Department of Energy that is focused on promoting energy efficiency at commercial properties through its “ENERGY STAR” partner program, and a member of the U.S. Green Building Council, a nonprofit organization focused on promoting energy efficiency at commercial properties through its Leadership in Energy and Environmental Design, or LEED®, green building program. Properties that reach a specified level of energy efficiency may receive the ENERGY STAR recognition for a period of 12 months before the requirement that they be recertified. Furthermore, certain properties are not eligible for ENERGY STAR certification. For example, lab uses, medical office properties and properties less than 50% occupied cannot be ENERGY STAR certified.

We believe our effort to obtain additional ENERGY STAR labels and/or LEED® designations and manage our properties in a sustainable manner benefits our business while also bettering the environment. Additionally, RMR Inc. releases an annual Sustainability Report, which summarizes the ESG initiatives RMR Inc. and its clients, including us, employ. RMR Inc.'s Sustainability Report may be accessed on RMR Inc.'s website at www.rmrgroup.com/corporate-sustainability/default.aspx. The information on or accessible through RMR Inc.'s website is not incorporated by reference into this Annual Report on Form 10-K.

For more information, see “Risk Factors—Risks Related to Our Business—Ownership of real estate is subject to environmental risks and liabilities,” “Risk Factors—Risks Related to Our Business—We are subject to risks from adverse weather, natural disasters and climate change and climate related events, and we incur significant costs and invest significant amounts with respect to these matters” and “Management's Discussion and Analysis of Financial Condition and Results of Operations—Impact of Climate Change”.

14

Environmental Matters

Ownership of real estate is subject to risks associated with environmental hazards. Under various laws, owners as well as tenants and operators of real estate may be required to investigate and clean up or remove hazardous substances present at or migrating from properties they own, lease or operate and may be held liable for property damage or personal injuries that result from hazardous substances. These laws also expose us to the possibility that we may become liable to government agencies or third parties for costs and damages they incur in connection with hazardous substances. In addition, these laws also impose various requirements regarding the operation and maintenance of properties and recordkeeping and reporting requirements relating to environmental matters that require us or the tenants or managers of our properties to incur costs to comply with.

We reviewed environmental surveys of the properties we own prior to their purchase. Based upon those surveys, other studies we may have since reviewed and our understanding of the operations of these properties by our tenants and managers, we do not believe that there are environmental conditions at any of our properties that have had or will have a material adverse effect on us. However, we cannot be sure that conditions are not present at our properties or that costs we may be required to incur in the future to remediate contamination will not have a material adverse effect on our business or financial condition or results of operations.

When major weather or climate-related events, such as hurricanes, floods or wildfires, occur near our properties, we, our tenants or our managers may relocate the residents at our senior living properties to alternative locations for their safety and we, our tenants or our managers may close or limit the operations of the impacted senior living community or office property until the event has ended and the property is then ready for operation. We or the tenants or managers of our properties may incur significant costs and losses as a result of these activities, both in terms of operating, preparing and repairing our properties in anticipation of, during and after a severe weather or climate-related event and in terms of potential lost business due to the interruption in operating our properties. Our insurance and our tenants' and managers' insurance may not adequately compensate us or them for these costs and losses.

Concerns about climate change have resulted in various treaties, laws and regulations that are intended to limit carbon emissions and address other environmental concerns. These and other laws may cause energy or other costs at our properties to increase. We do not expect the direct impact of these increases to be material to our results of operations, because the increased costs either would be the responsibility of our tenants directly or in the longer term, passed through and paid by tenants of our leased properties and residents at our managed senior living communities. Although we do not believe it is likely in the foreseeable future, laws enacted to mitigate climate change may make some of our buildings obsolete or cause us to make material investments in our properties, which could materially and adversely affect our financial condition or the financial condition of our tenants or managers and their ability to pay rent or returns to us. For more information regarding climate change and other environmental matters and their possible adverse impact on us, see “Risk Factors—Risks Related to Our Business—Ownership of real estate is subject to environmental risks,” “Risk Factors—Risks Related to Our Business—Ownership of real estate is subject to risks from adverse weather and climate events” and “Management's Discussion and Analysis of Financial Condition and Results of Operations—Impact of Climate Change”.

Board Diversity

As of December 31, 2021, our Board of Trustees was comprised of six Trustees, of which four were independent trustees. Our Board of Trustees is comprised of approximately 33% women and approximately 17% members of underrepresented minorities.

Insurance

We or our tenants are generally responsible for the costs of insurance coverage for our properties and the operations conducted on them, including for casualty, liability, fire, extended coverage and rental or business interruption losses. Either we purchase the insurance ourselves and, except in the case of our managed senior living communities, our tenants are required to reimburse us, or the tenants buy the insurance directly and are required to list us as an insured party.

Internet Website

Our internet website address is www.dhcreit.com. Copies of our governance guidelines, our code of business conduct and ethics, or our Code of Conduct, and the charters of our audit, compensation and nominating and governance committees are posted on our website and also may be obtained free of charge by writing to our Secretary, Diversified Healthcare Trust, Two Newton Place, 255 Washington Street, Suite 300, Newton, Massachusetts 02458-1634. We also have a policy outlining procedures for handling concerns or complaints about accounting, internal accounting controls or auditing matters and a

15

governance hotline accessible on our website that shareholders can use to report concerns or complaints about accounting, internal accounting controls or auditing matters or violations or possible violations of our Code of Conduct. We make available, free of charge, through the "Investors" section of our website, our Annual Reports on Form 10-K, Quarterly Reports on Form 10-Q, Current Reports on Form 8-K and amendments to these reports filed or furnished pursuant to Section 13(a) or 15(d) of the Securities Exchange Act of 1934, as amended, or the Exchange Act, as soon as reasonably practicable after these forms are filed with, or furnished to, the Securities and Exchange Commission, or SEC. Any material we file with or furnish to the SEC is also maintained on the SEC website, www.sec.gov. Security holders may send communications to our Board of Trustees or individual Trustees by writing to the party for whom the communication is intended at c/o Secretary, Diversified Healthcare Trust, Two Newton Place, 255 Washington Street, Suite 300, Newton, Massachusetts 02458-1634 or by email at secretary@dhcreit.com. Our website address is included several times in this Annual Report on Form 10-K as a textual reference only. The information on or accessible through our website is not incorporated by reference into this Annual Report on Form 10-K or other documents we file with, or furnish to, the SEC. We intend to use our website as a means of disclosing material non-public information and for complying with our disclosure obligations under Regulation FD. Those disclosures will be included on our website in the “Investors” section. Accordingly, investors should monitor our website, in addition to following our press releases, SEC filings and public conference calls and webcasts.

Segment Information

As of December 31, 2021, we had two reporting segments: Office Portfolio and SHOP. Non-aggregated assets are classified as “non-segment” and include corporate assets and liabilities, certain triple net leased senior living communities and wellness centers. For further information, see “Management's Discussion and Analysis of Financial Condition and Results of Operations” in Part II, Item 7 of this Annual Report on Form 10-K and our Consolidated Financial Statements included in Part IV, Item 15 of this Annual Report on Form 10-K.

MATERIAL UNITED STATES FEDERAL INCOME TAX CONSIDERATIONS

The following summary of material United States federal income tax considerations is based on existing law and is limited to investors who own our shares as investment assets rather than as inventory or as property used in a trade or business. The summary does not discuss all of the particular tax considerations that might be relevant to you if you are subject to special rules under federal income tax law, for example if you are:

•a bank, insurance company or other financial institution;

•a regulated investment company or REIT;

•a subchapter S corporation;

•a broker, dealer or trader in securities or foreign currencies;

•a person who marks-to-market our shares for U.S. federal income tax purposes;

•a U.S. shareholder (as defined below) that has a functional currency other than the U.S. dollar;

•a person who acquires or owns our shares in connection with employment or other performance of services;

•a person subject to alternative minimum tax;

•a person who acquires or owns our shares as part of a straddle, hedging transaction, constructive sale transaction, constructive ownership transaction or conversion transaction, or as part of a “synthetic security” or other integrated financial transaction;

•a person who owns 10% or more (by vote or value, directly or constructively under the United States Internal Revenue Code of 1986, as amended, or the IRC) of any class of our shares;

•a U.S. expatriate;

•a non-U.S. shareholder (as defined below) whose investment in our shares is effectively connected with the conduct of a trade or business in the United States;

16

•a nonresident alien individual present in the United States for 183 days or more during an applicable taxable year;

•a “qualified shareholder” (as defined in Section 897(k)(3)(A) of the IRC);

•a “qualified foreign pension fund” (as defined in Section 897(l)(2) of the IRC) or any entity wholly owned by one or more qualified foreign pension funds;

•a person subject to special tax accounting rules as a result of their use of applicable financial statements (within the meaning of Section 451(b)(3) of the IRC); or

•except as specifically described in the following summary, a trust, estate, tax-exempt entity or foreign person.

The sections of the IRC that govern the federal income tax qualification and treatment of a REIT and its shareholders are complex. This presentation is a summary of applicable IRC provisions, related rules and regulations, and administrative and judicial interpretations, all of which are subject to change, possibly with retroactive effect. Future legislative, judicial or administrative actions or decisions could also affect the accuracy of statements made in this summary. We have not received a ruling from the U.S. Internal Revenue Service, or the IRS, with respect to any matter described in this summary, and we cannot be sure that the IRS or a court will agree with all of the statements made in this summary. The IRS could, for example, take a different position from that described in this summary with respect to our acquisitions, operations, valuations, restructurings or other matters, which, if a court agreed, could result in significant tax liabilities for applicable parties. In addition, this summary is not exhaustive of all possible tax considerations and does not discuss any estate, gift, state, local or foreign tax considerations. For all these reasons, we urge you and any holder of or prospective acquiror of our shares to consult with a tax advisor about the federal income tax and other tax consequences of the acquisition, ownership and disposition of our shares. Our intentions and beliefs described in this summary are based upon our understanding of applicable laws and regulations that are in effect as of the date of this Annual Report on Form 10-K. If new laws or regulations are enacted which impact us directly or indirectly, we may change our intentions or beliefs.

Your federal income tax consequences generally will differ depending on whether or not you are a “U.S. shareholder.” For purposes of this summary, a “U.S. shareholder” is a beneficial owner of our shares that is:

•an individual who is a citizen or resident of the United States, including an alien individual who is a lawful permanent resident of the United States or meets the substantial presence residency test under the federal income tax laws;

•an entity treated as a corporation for federal income tax purposes that is created or organized in or under the laws of the United States, any state thereof or the District of Columbia;

•an estate the income of which is subject to federal income taxation regardless of its source; or

•a trust if a court within the United States is able to exercise primary supervision over the administration of the trust and one or more U.S. persons have the authority to control all substantial decisions of the trust, or, to the extent provided in Treasury regulations, a trust in existence on August 20, 1996 that has elected to be treated as a domestic trust;

whose status as a U.S. shareholder is not overridden by an applicable tax treaty. Conversely, a “non-U.S. shareholder” is a beneficial owner of our shares that is not an entity (or other arrangement) treated as a partnership for federal income tax purposes and is not a U.S. shareholder.

If any entity (or other arrangement) treated as a partnership for federal income tax purposes holds our shares, the tax treatment of a partner in the partnership generally will depend upon the tax status of the partner and the activities of the partnership. Any entity (or other arrangement) treated as a partnership for federal income tax purposes that is a holder of our shares and the partners in such a partnership (as determined for federal income tax purposes) are urged to consult their own tax advisors about the federal income tax consequences and other tax consequences of the acquisition, ownership and disposition of our shares.

Taxation as a REIT

We have elected to be taxed as a REIT under Sections 856 through 860 of the IRC, commencing with our 1999 taxable year. Our REIT election, assuming continuing compliance with the then applicable qualification tests, has continued and will continue in effect for subsequent taxable years. Although we cannot be sure, we believe that from and after our 1999 taxable

17

year we have been organized and have operated, and will continue to be organized and to operate, in a manner that qualified us and will continue to qualify us to be taxed as a REIT under the IRC.

As a REIT, we generally are not subject to federal income tax on our net income distributed as dividends to our shareholders. Distributions to our shareholders generally are included in our shareholders' income as dividends to the extent of our available current or accumulated earnings and profits. Our dividends are not generally entitled to the preferential tax rates on qualified dividend income, but a portion of our dividends may be treated as capital gain dividends or as qualified dividend income, all as explained below. In addition, for taxable years beginning before 2026 and pursuant to the deduction-without-outlay mechanism of Section 199A of the IRC, our noncorporate U.S. shareholders that meet specified holding period requirements are generally eligible for lower effective tax rates on our dividends that are not treated as capital gain dividends or as qualified dividend income. No portion of any of our dividends is eligible for the dividends received deduction for corporate shareholders. Distributions in excess of our current or accumulated earnings and profits generally are treated for federal income tax purposes as returns of capital to the extent of a recipient shareholder's basis in our shares, and will reduce this basis. Our current or accumulated earnings and profits are generally allocated first to distributions made on our preferred shares, of which there are none outstanding at this time, and thereafter to distributions made on our common shares. For all these purposes, our distributions include cash distributions, any in kind distributions of property that we might make, and deemed or constructive distributions resulting from capital market activities (such as some redemptions), as described below.

Our counsel, Sullivan & Worcester LLP, is of the opinion that we have been organized and have qualified for taxation as a REIT under the IRC for our 1999 through 2021 taxable years, and that our current and anticipated investments and plan of operation will enable us to continue to meet the requirements for qualification and taxation as a REIT under the IRC. Our counsel's opinions are conditioned upon the assumption that our leases, our declaration of trust, and all other legal documents to which we have been or are a party have been and will be complied with by all parties to those documents, upon the accuracy and completeness of the factual matters described in this Annual Report on Form 10-K and upon representations made by us to our counsel as to certain factual matters relating to our organization and operations and our expected manner of operation. If this assumption or a description or representation is inaccurate or incomplete, our counsel's opinions may be adversely affected and may not be relied upon. The opinions of our counsel are based upon the law as it exists today, but the law may change in the future, possibly with retroactive effect. Given the highly complex nature of the rules governing REITs, the ongoing importance of factual determinations, and the possibility of future changes in our circumstances, neither Sullivan & Worcester LLP nor we can be sure that we will qualify as or be taxed as a REIT for any particular year. Any opinion of Sullivan & Worcester LLP as to our qualification or taxation as a REIT will be expressed as of the date issued. Our counsel will have no obligation to advise us or our shareholders of any subsequent change in the matters stated, represented or assumed, or of any subsequent change in the applicable law. Also, the opinions of our counsel are not binding on either the IRS or a court, and either could take a position different from that expressed by our counsel.

Our continued qualification and taxation as a REIT will depend upon our compliance with various qualification tests imposed under the IRC and summarized below. While we believe that we have satisfied and will satisfy these tests, our counsel does not review compliance with these tests on a continuing basis. If we fail to qualify for taxation as a REIT in any year, then we will be subject to federal income taxation as if we were a corporation taxed under subchapter C of the IRC, or a C corporation, and our shareholders will be taxed like shareholders of regular C corporations, meaning that federal income tax generally will be applied at both the corporate and shareholder levels. In this event, we could be subject to significant tax liabilities, and the amount of cash available for distribution to our shareholders could be reduced or eliminated.

If we continue to qualify for taxation as a REIT and meet the tests described below, then we generally will not pay federal income tax on amounts that we distribute to our shareholders. However, even if we continue to qualify for taxation as a REIT, we may still be subject to federal tax in the following circumstances, as described below:

•We will be taxed at regular corporate income tax rates on any undistributed “real estate investment trust taxable income,” determined by including our undistributed ordinary income and net capital gains, if any.

•If we have net income from the disposition of “foreclosure property,” as described in Section 856(e) of the IRC, that is held primarily for sale to customers in the ordinary course of a trade or business or other nonqualifying income from foreclosure property, we will be subject to tax on this income at the highest regular corporate income tax rate.

•If we have net income from “prohibited transactions”—that is, dispositions at a gain of inventory or property held primarily for sale to customers in the ordinary course of a trade or business other than dispositions of foreclosure property and other than dispositions excepted by statutory safe harbors—we will be subject to tax on this income at a 100% rate.

18

•If we fail to satisfy the 75% gross income test or the 95% gross income test discussed below, due to reasonable cause and not due to willful neglect, but nonetheless maintain our qualification for taxation as a REIT because of specified cure provisions, we will be subject to tax at a 100% rate on the greater of the amount by which we fail the 75% gross income test or the 95% gross income test, with adjustments, multiplied by a fraction intended to reflect our profitability for the taxable year.

•If we fail to satisfy any of the REIT asset tests described below (other than a de minimis failure of the 5% or 10% asset tests) due to reasonable cause and not due to willful neglect, but nonetheless maintain our qualification for taxation as a REIT because of specified cure provisions, we will be subject to a tax equal to the greater of $50,000 or the highest regular corporate income tax rate multiplied by the net income generated by the nonqualifying assets that caused us to fail the test.

•If we fail to satisfy any provision of the IRC that would result in our failure to qualify for taxation as a REIT (other than violations of the REIT gross income tests or violations of the REIT asset tests described below) due to reasonable cause and not due to willful neglect, we may retain our qualification for taxation as a REIT but will be subject to a penalty of $50,000 for each failure.

•If we fail to distribute for any calendar year at least the sum of 85% of our REIT ordinary income for that year, 95% of our REIT capital gain net income for that year and any undistributed taxable income from prior periods, we will be subject to a 4% nondeductible excise tax on the excess of the required distribution over the amounts actually distributed.

•If we acquire a REIT asset where our adjusted tax basis in the asset is determined by reference to the adjusted tax basis of the asset in the hands of a C corporation, under specified circumstances we may be subject to federal income taxation on all or part of the built-in gain (calculated as of the date the property ceased being owned by the C corporation) on such asset. We generally do not expect to sell assets if doing so would result in the imposition of a material built-in gains tax liability; but if and when we do sell assets that may have associated built-in gains tax exposure, then we expect to make appropriate provision for the associated tax liabilities on our financial statements.

•If we acquire a corporation in a transaction where we succeed to its tax attributes, to preserve our qualification for taxation as a REIT we must generally distribute all of the C corporation earnings and profits inherited in that acquisition, if any, no later than the end of our taxable year in which the acquisition occurs. However, if we fail to do so, relief provisions would allow us to maintain our qualification for taxation as a REIT provided we distribute any subsequently discovered C corporation earnings and profits and pay an interest charge in respect of the period of delayed distribution.

•Our subsidiaries that are C corporations, including our TRSs, generally will be required to pay federal corporate income tax on their earnings, and a 100% tax may be imposed on any transaction between us and one of our TRSs that does not reflect arm's length terms.

•As discussed below, we are invested in real estate through subsidiaries that we believe qualify for taxation as REITs. If it is determined that one of these entities failed to qualify for taxation as a REIT, we may fail one or more of the REIT asset tests. In such case, we expect that we would be able to avail ourselves of the relief provisions described below, but would be subject to a tax equal to the greater of $50,000 or the highest regular corporate income tax rate multiplied by the net income we earned from this subsidiary.

If we fail to qualify for taxation as a REIT in any year, then we will be subject to federal income tax in the same manner as a regular C corporation. Further, as a regular C corporation, distributions to our shareholders will not be deductible by us, nor will distributions be required under the IRC. Also, to the extent of our current and accumulated earnings and profits, all distributions to our shareholders will generally be taxable as ordinary dividends potentially eligible for the preferential tax rates discussed below under the heading “—Taxation of Taxable U.S. Shareholders” and, subject to limitations in the IRC, will be potentially eligible for the dividends received deduction for corporate shareholders. Finally, we will generally be disqualified from taxation as a REIT for the four taxable years following the taxable year in which the termination of our REIT status is effective. Our failure to qualify for taxation as a REIT for even one year could result in us reducing or eliminating distributions to our shareholders, or in us incurring substantial indebtedness or liquidating substantial investments in order to pay the resulting corporate-level income taxes. Relief provisions under the IRC may allow us to continue to qualify for taxation as a REIT even if we fail to comply with various REIT requirements, all as discussed in more detail below. However, it is impossible to state whether in any particular circumstance we would be entitled to the benefit of these relief provisions.

19

REIT Qualification Requirements

General Requirements. Section 856(a) of the IRC defines a REIT as a corporation, trust or association:

(1)that is managed by one or more trustees or directors;

(2)the beneficial ownership of which is evidenced by transferable shares or by transferable certificates of beneficial interest;

(3)that would be taxable, but for Sections 856 through 859 of the IRC, as a domestic C corporation;

(4)that is not a financial institution or an insurance company subject to special provisions of the IRC;

(5)the beneficial ownership of which is held by 100 or more persons;

(6)that is not “closely held,” meaning that during the last half of each taxable year, not more than 50% in value of the outstanding shares are owned, directly or indirectly, by five or fewer “individuals” (as defined in the IRC to include specified tax-exempt entities); and

(7)that meets other tests regarding the nature of its income and assets and the amount of its distributions, all as described below.

Section 856(b) of the IRC provides that conditions (1) through (4) must be met during the entire taxable year and that condition (5) must be met during at least 335 days of a taxable year of 12 months, or during a proportionate part of a taxable year of less than 12 months. Although we cannot be sure, we believe that we have met conditions (1) through (7) during each of the requisite periods ending on or before the close of our most recently completed taxable year, and that we will continue to meet these conditions in our current and future taxable years. To help comply with condition (6), our declaration of trust restricts transfers of our shares that would otherwise result in concentrated ownership positions. These restrictions, however, do not ensure that we have previously satisfied, and may not ensure that we will in all cases be able to continue to satisfy, the share ownership requirements described in condition (6). If we comply with applicable Treasury regulations to ascertain the ownership of our outstanding shares and do not know, or by exercising reasonable diligence would not have known, that we failed condition (6), then we will be treated as having met condition (6). Accordingly, we have complied and will continue to comply with these regulations, including by requesting annually from holders of significant percentages of our shares information regarding the ownership of our shares. Under our declaration of trust, our shareholders are required to respond to these requests for information. A shareholder that fails or refuses to comply with the request is required by Treasury regulations to submit a statement with its federal income tax return disclosing its actual ownership of our shares and other information.

For purposes of condition (6), an “individual” generally includes a natural person, a supplemental unemployment compensation benefit plan, a private foundation, or a portion of a trust permanently set aside or used exclusively for charitable purposes, but does not include a qualified pension plan or profit-sharing trust. As a result, REIT shares owned by an entity that is not an “individual” are considered to be owned by the direct and indirect owners of the entity that are individuals (as so defined), rather than to be owned by the entity itself. Similarly, REIT shares held by a qualified pension plan or profit-sharing trust are treated as held directly by the individual beneficiaries in proportion to their actuarial interests in such plan or trust. Consequently, five or fewer such trusts could own more than 50% of the interests in an entity without jeopardizing that entity's qualification for taxation as a REIT.

The IRC provides that we will not automatically fail to qualify for taxation as a REIT if we do not meet conditions (1) through (6), provided we can establish that such failure was due to reasonable cause and not due to willful neglect. Each such excused failure will result in the imposition of a $50,000 penalty instead of REIT disqualification. This relief provision may apply to a failure of the applicable conditions even if the failure first occurred in a year prior to the taxable year in which the failure was discovered.

Our Wholly Owned Subsidiaries and Our Investments Through Partnerships. Except in respect of a TRS as discussed below, Section 856(i) of the IRC provides that any corporation, 100% of whose stock is held by a REIT and its disregarded subsidiaries, is a qualified REIT subsidiary and shall not be treated as a separate corporation for U.S. federal income tax purposes. The assets, liabilities and items of income, deduction and credit of a qualified REIT subsidiary are treated as the REIT's. We believe that each of our direct and indirect wholly owned subsidiaries, other than the TRSs discussed below (and entities whose equity is owned in whole or in part by such TRSs), will be either a qualified REIT subsidiary within the meaning of Section 856(i)(2) of the IRC or a noncorporate entity that for federal income tax purposes is not treated as separate from its

20

owner under Treasury regulations issued under Section 7701 of the IRC, each such entity referred to as a QRS. Thus, in applying all of the REIT qualification requirements described in this summary, all assets, liabilities and items of income, deduction and credit of our QRSs are treated as ours, and our investment in the stock and other securities of such QRSs will be disregarded.

We have invested and may in the future invest in real estate through one or more entities that are treated as partnerships for federal income tax purposes. In the case of a REIT that is a partner in a partnership, Treasury regulations under the IRC provide that, for purposes of the REIT qualification requirements regarding income and assets described below, the REIT is generally deemed to own its proportionate share, based on respective capital interests, of the income and assets of the partnership (except that for purposes of the 10% value test, described below, the REIT's proportionate share of the partnership's assets is based on its proportionate interest in the equity and specified debt securities issued by the partnership). In addition, for these purposes, the character of the assets and items of gross income of the partnership generally remains the same in the hands of the REIT. In contrast, for purposes of the distribution requirements discussed below, we must take into account as a partner our share of the partnership's income as determined under the general federal income tax rules governing partners and partnerships under Subchapter K of the IRC.

Subsidiary REITs. We indirectly own real estate through subsidiaries that we believe have qualified and will remain qualified for taxation as REITs under the IRC, and we may in the future invest in real estate through one or more other subsidiary entities that are intended to qualify for taxation as REITs. When a subsidiary qualifies for taxation as a REIT separate and apart from its REIT parent, the subsidiary's shares are qualifying real estate assets for purposes of the REIT parent's 75% asset test described below. However, failure of the subsidiary to separately satisfy the various REIT qualification requirements described in this summary or that are otherwise applicable (and failure to qualify for the applicable relief provisions) would generally result in (a) the subsidiary being subject to regular U.S. corporate income tax, as described above, and (b) the REIT parent's ownership in the subsidiary (i) ceasing to be qualifying real estate assets for purposes of the 75% asset test and (ii) becoming subject to the 5% asset test, the 10% vote test and the 10% value test generally applicable to a REIT's ownership in corporations other than REITs and TRSs. In such a situation, the REIT parent's own REIT qualification and taxation could be jeopardized on account of the subsidiary's failure cascading up to the REIT parent, all as described below under the heading “—Asset Tests”.

We have joined with our subsidiary REITs in filing protective TRS elections, and we may continue to annually make such elections unless and until our ownership of these subsidiaries falls below 10%. Pursuant to these protective TRS elections, we believe that if one of these subsidiaries is not a REIT for some reason, then that subsidiary would instead be considered one of our TRSs, and as such its value would fit within our REIT gross asset tests described below. We expect to make similar protective TRS elections with respect to any other subsidiary REIT that we form or acquire. We do not expect protective TRS elections to impact our compliance with the 75% and 95% gross income tests described below, because we do not expect our gains and dividends from a subsidiary REIT's shares to jeopardize compliance with these tests even if for some reason the subsidiary is not a REIT.

Taxable REIT Subsidiaries. As a REIT, we are permitted to own any or all of the securities of a TRS, provided that no more than 20% of the total value of our assets, at the close of each quarter, is comprised of our investments in the stock or other securities of our TRSs. Very generally, a TRS is a subsidiary corporation other than a REIT in which a REIT directly or indirectly holds stock and that has made a joint election with such REIT to be treated as a TRS. A TRS is taxed as a regular C corporation, separate and apart from any affiliated REIT. Our ownership of stock and other securities in our TRSs is exempt from the 5% asset test, the 10% vote test and the 10% value test discussed below. Among other requirements, a TRS of ours must:

(1)not directly or indirectly operate or manage a lodging facility or a health care facility; and

(2)not directly or indirectly provide to any person, under a franchise, license or otherwise, rights to any brand name under which any lodging facility or health care facility is operated, except that in limited circumstances a subfranchise, sublicense or similar right can be granted to an independent contractor to operate or manage a lodging facility or a health care facility.

In addition, any corporation (other than a REIT and other than a QRS) in which a TRS directly or indirectly owns more than 35% of the voting power or value of the outstanding securities is automatically a TRS (excluding, for this purpose, certain "straight debt" securities). Subject to the discussion below, we believe that we and each of our TRSs have complied with, and will continue to comply with, the requirements for TRS status at all times during which the subsidiary's TRS election is intended to be in effect, and we believe that the same will be true for any TRS that we later form or acquire.

21

As discussed below, TRSs can perform services for our tenants without disqualifying the rents we receive from those tenants under the 75% gross income test or the 95% gross income test discussed below. Moreover, because our TRSs are taxed as C corporations that are separate from us, their assets, liabilities and items of income, deduction and credit generally are not imputed to us for purposes of the REIT qualification requirements described in this summary. Therefore, our TRSs may generally conduct activities that would be treated as prohibited transactions or would give rise to nonqualified income if conducted by us directly. Additionally, while a REIT is generally limited in its ability to earn qualifying rental income from a TRS, a REIT can earn qualifying rental income from the lease of a qualified health care property to a TRS if an eligible independent contractor operates the facility, as discussed more fully below.

Restrictions and sanctions are imposed on TRSs and their affiliated REITs to ensure that the TRSs will be subject to an appropriate level of federal income taxation. For example, if a TRS pays interest, rent or other amounts to its affiliated REIT in an amount that exceeds what an unrelated third party would have paid in an arm's length transaction, then the REIT generally will be subject to an excise tax equal to 100% of the excessive portion of the payment. Further, if in comparison to an arm's length transaction, a third-party tenant has overpaid rent to the REIT in exchange for underpaying the TRS for services rendered, and if the REIT has not adequately compensated the TRS for services provided to or on behalf of the third-party tenant, then the REIT may be subject to an excise tax equal to 100% of the undercompensation to the TRS. A safe harbor exception to this excise tax applies if the TRS has been compensated at a rate at least equal to 150% of its direct cost in furnishing or rendering the service. Finally, the 100% excise tax also applies to the underpricing of services provided by a TRS to its affiliated REIT in contexts where the services are unrelated to services for REIT tenants. We cannot be sure that arrangements involving our TRSs will not result in the imposition of one or more of these restrictions or sanctions, but we do not believe that we or our TRSs are or will be subject to these impositions.

Income Tests. We must satisfy two gross income tests annually to maintain our qualification for taxation as a REIT. First, at least 75% of our gross income for each taxable year must be derived from investments relating to real property, including “rents from real property” within the meaning of Section 856(d) of the IRC, interest and gain from mortgages on real property or on interests in real property, income and gain from foreclosure property, gain from the sale or other disposition of real property (including specified ancillary personal property treated as real property under the IRC), or dividends on and gain from the sale or disposition of shares in other REITs (but excluding in all cases any gains subject to the 100% tax on prohibited transactions). When we receive new capital in exchange for our shares or in a public offering of our five-year or longer debt instruments, income attributable to the temporary investment of this new capital in stock or a debt instrument, if received or accrued within one year of our receipt of the new capital, is generally also qualifying income under the 75% gross income test. Second, at least 95% of our gross income for each taxable year must consist of income that is qualifying income for purposes of the 75% gross income test, other types of interest and dividends, gain from the sale or disposition of stock or securities, or any combination of these. Gross income from our sale of property that we hold primarily for sale to customers in the ordinary course of business, income and gain from specified “hedging transactions” that are clearly and timely identified as such, and income from the repurchase or discharge of indebtedness is excluded from both the numerator and the denominator in both gross income tests. In addition, specified foreign currency gains will be excluded from gross income for purposes of one or both of the gross income tests.

In order to qualify as “rents from real property” within the meaning of Section 856(d) of the IRC, several requirements must be met:

•The amount of rent received generally must not be based on the income or profits of any person, but may be based on a fixed percentage or percentages of receipts or sales.

•Rents generally do not qualify if the REIT owns 10% or more by vote or value of stock of the tenant (or 10% or more of the interests in the assets or net profits of the tenant, if the tenant is not a corporation), whether directly or after application of attribution rules. We generally do not intend to lease property to any party if rents from that property would not qualify as “rents from real property,” but application of the 10% ownership rule is dependent upon complex attribution rules and circumstances that may be beyond our control. In this regard, prior to the termination of our leases with Five Star, we owned close to, but less than, 10% of the outstanding common shares of AlerisLife. Our declaration of trust generally disallows transfers or purported acquisitions, directly or by attribution, of our shares to the extent necessary to maintain our qualification for taxation as a REIT under the IRC. Nevertheless, we cannot be sure that these restrictions will be effective to prevent our qualification for taxation as a REIT from being jeopardized under the 10% affiliated tenant rule. Furthermore, we cannot be sure that we will be able to monitor and enforce these restrictions, nor will our shareholders necessarily be aware of ownership of our shares attributed to them under the IRC's attribution rules.

22

•There is a limited exception to the above prohibition on earning “rents from real property” from a 10% affiliated tenant where the tenant is a TRS. If at least 90% of the leased space of a property is leased to tenants other than TRSs and 10% affiliated tenants, and if the TRS's rent to the REIT for space at that property is substantially comparable to the rents paid by nonaffiliated tenants for comparable space at the property, then otherwise qualifying rents paid by the TRS to the REIT will not be disqualified on account of the rule prohibiting 10% affiliated tenants.

•There is an additional exception to the above prohibition on earning “rents from real property” from a 10% affiliated tenant. For this additional exception to apply, a real property interest in a “qualified health care property” must be leased by the REIT to its TRS, and the facility must be operated on behalf of the TRS by a person who is an “eligible independent contractor,” all as described in Sections 856(d)(8)-(9) and 856(e)(6)(D) of the IRC. As described below, we believe our leases with our TRSs have satisfied and will continue to satisfy these requirements.

•In order for rents to qualify, a REIT generally must not manage the property or furnish or render services to the tenants of the property, except through an independent contractor from whom it derives no income or through one of its TRSs. There is an exception to this rule permitting a REIT to perform customary management and tenant services of the sort that a tax-exempt organization could perform without being considered in receipt of “unrelated business taxable income” as defined in Section 512(b)(3) of the IRC, or UBTI. In addition, a de minimis amount of noncustomary services provided to tenants will not disqualify income as “rents from real property” as long as the value of the impermissible tenant services does not exceed 1% of the gross income from the property.

•If rent attributable to personal property leased in connection with a lease of real property is 15% or less of the total rent received under the lease, then the rent attributable to personal property will qualify as “rents from real property;” if this 15% threshold is exceeded, then the rent attributable to personal property will not so qualify. The portion of rental income treated as attributable to personal property is determined according to the ratio of the fair market value of the personal property to the total fair market value of the real and personal property that is rented.

•In addition, “rents from real property” includes both charges we receive for services customarily rendered in connection with the rental of comparable real property in the same geographic area, even if the charges are separately stated, as well as charges we receive for services provided by our TRSs when the charges are not separately stated. Whether separately stated charges received by a REIT for services that are not geographically customary and provided by a TRS are included in “rents from real property” has not been addressed clearly by the IRS in published authorities; however, our counsel, Sullivan & Worcester LLP, is of the opinion that, although the matter is not free from doubt, “rents from real property” also includes charges we receive for services provided by our TRSs when the charges are separately stated, even if the services are not geographically customary. Accordingly, we believe that our revenues from TRS-provided services, whether the charges are separately stated or not, qualify as “rents from real property” because the services satisfy the geographically customary standard, because the services have been provided by a TRS, or for both reasons.

We believe that all or substantially all of our rents and related service charges have qualified and will continue to qualify as “rents from real property” for purposes of Section 856 of the IRC.

Absent the “foreclosure property” rules of Section 856(e) of the IRC, a REIT's receipt of active, nonrental gross income from a property would not qualify under the 75% and 95% gross income tests. But as foreclosure property, the active, nonrental gross income from the property would so qualify. Foreclosure property is generally any real property, including interests in real property, and any personal property incident to such real property:

•that is acquired by a REIT as a result of the REIT having bid on such property at foreclosure, or having otherwise reduced such property to ownership or possession by agreement or process of law, after there was a default or when default was imminent on a lease of such property or on indebtedness that such property secured;

•for which any related loan acquired by the REIT was acquired at a time when the default was not imminent or anticipated; and

•for which the REIT makes a proper election to treat the property as foreclosure property.

Any gain that a REIT recognizes on the sale of foreclosure property held as inventory or primarily for sale to customers, plus any income it receives from foreclosure property that would not otherwise qualify under the 75% gross income test in the absence of foreclosure property treatment, reduced by expenses directly connected with the production of those items of income, would be subject to income tax at the highest regular corporate income tax rate under the foreclosure property

23

income tax rules of Section 857(b)(4) of the IRC. Thus, if a REIT should lease foreclosure property in exchange for rent that qualifies as “rents from real property” as described above, then that rental income is not subject to the foreclosure property income tax.

Property generally ceases to be foreclosure property at the end of the third taxable year following the taxable year in which the REIT acquired the property, or longer if an extension is obtained from the IRS. However, this grace period terminates and foreclosure property ceases to be foreclosure property on the first day:

•on which a lease is entered into for the property that, by its terms, will give rise to income that does not qualify for purposes of the 75% gross income test (disregarding income from foreclosure property), or any nonqualified income under the 75% gross income test is received or accrued by the REIT, directly or indirectly, pursuant to a lease entered into on or after such day;

•on which any construction takes place on the property, other than completion of a building or any other improvement where more than 10% of the construction was completed before default became imminent and other than specifically exempted forms of maintenance or deferred maintenance; or

•which is more than 90 days after the day on which the REIT acquired the property and the property is used in a trade or business which is conducted by the REIT, other than through an independent contractor from whom the REIT itself does not derive or receive any income or a TRS.

Other than sales of foreclosure property, any gain that we realize on the sale of property held as inventory or other property held primarily for sale to customers in the ordinary course of a trade or business, together known as dealer gains, may be treated as income from a prohibited transaction that is subject to a penalty tax at a 100% rate. The 100% tax does not apply to gains from the sale of property that is held through a TRS, although such income will be subject to tax in the hands of the TRS at regular corporate income tax rates; we may therefore utilize our TRSs in transactions in which we might otherwise recognize dealer gains. Whether property is held as inventory or primarily for sale to customers in the ordinary course of a trade or business is a question of fact that depends on all the facts and circumstances surrounding each particular transaction. Sections 857(b)(6)(C) and (E) of the IRC provide safe harbors pursuant to which limited sales of real property held for at least two years and meeting specified additional requirements will not be treated as prohibited transactions. However, compliance with the safe harbors is not always achievable in practice. We attempt to structure our activities to avoid transactions that are prohibited transactions, or otherwise conduct such activities through TRSs; but, we cannot be sure whether or not the IRS might successfully assert that we are subject to the 100% penalty tax with respect to any particular transaction. Gains subject to the 100% penalty tax are excluded from the 75% and 95% gross income tests, whereas real property gains that are not dealer gains or that are exempted from the 100% penalty tax on account of the safe harbors are considered qualifying gross income for purposes of the 75% and 95% gross income tests.

We believe that any gain that we have recognized, or will recognize, in connection with our disposition of assets and other transactions, including through any partnerships, will generally qualify as income that satisfies the 75% and 95% gross income tests, and will not be dealer gains or subject to the 100% penalty tax. This is because our general intent has been and is to: (a) own our assets for investment (including through joint ventures) with a view to long-term income production and capital appreciation; (b) engage in the business of developing, owning, leasing and managing our existing properties and acquiring, developing, owning, leasing and managing new properties; and (c) make occasional dispositions of our assets consistent with our long-term investment objectives.

If we fail to satisfy one or both of the 75% gross income test or the 95% gross income test in any taxable year, we may nevertheless qualify for taxation as a REIT for that year if we satisfy the following requirements: (a) our failure to meet the test is due to reasonable cause and not due to willful neglect; and (b) after we identify the failure, we file a schedule describing each item of our gross income included in the 75% gross income test or the 95% gross income test for that taxable year. Even if this relief provision does apply, a 100% tax is imposed upon the greater of the amount by which we failed the 75% gross income test or the amount by which we failed the 95% gross income test, with adjustments, multiplied by a fraction intended to reflect our profitability for the taxable year. This relief provision may apply to a failure of the applicable income tests even if the failure first occurred in a year prior to the taxable year in which the failure was discovered.

Based on the discussion above, we believe that we have satisfied, and will continue to satisfy, the 75% and 95% gross income tests outlined above on a continuing basis beginning with our first taxable year as a REIT.

Asset Tests. At the close of each calendar quarter of each taxable year, we must also satisfy the following asset percentage tests in order to qualify for taxation as a REIT for federal income tax purposes:

24

•At least 75% of the value of our total assets must consist of “real estate assets,” defined as real property (including interests in real property and interests in mortgages on real property or on interests in real property), ancillary personal property to the extent that rents attributable to such personal property are treated as rents from real property in accordance with the rules described above, cash and cash items, shares in other REITs, debt instruments issued by “publicly offered REITs” as defined in Section 562(c)(2) of the IRC, government securities and temporary investments of new capital (that is, any stock or debt instrument that we hold that is attributable to any amount received by us (a) in exchange for our stock or (b) in a public offering of our five-year or longer debt instruments, but in each case only for the one-year period commencing with our receipt of the new capital).

•Not more than 25% of the value of our total assets may be represented by securities other than those securities that count favorably toward the preceding 75% asset test.

•Of the investments included in the preceding 25% asset class, the value of any one non-REIT issuer's securities that we own may not exceed 5% of the value of our total assets. In addition, we may not own more than 10% of the vote or value of any one non-REIT issuer's outstanding securities, unless the securities are “straight debt” securities or otherwise excepted as discussed below. Our stock and other securities in a TRS are exempted from these 5% and 10% asset tests.

•Not more than 20% of the value of our total assets may be represented by stock or other securities of our TRSs.

•Not more than 25% of the value of our total assets may be represented by “nonqualified publicly offered REIT debt instruments” as defined in Section 856(c)(5)(L)(ii) of the IRC.

Our counsel, Sullivan & Worcester LLP, is of the opinion that, although the matter is not free from doubt, our investments in the equity or debt of a TRS of ours, to the extent that and during the period in which they qualify as temporary investments of new capital, will be treated as real estate assets, and not as securities, for purposes of the above REIT asset tests.

The above REIT asset tests must be satisfied at the close of each calendar quarter of each taxable year as a REIT. After a REIT meets the asset tests at the close of any quarter, it will not lose its qualification for taxation as a REIT in any subsequent quarter solely because of fluctuations in the values of its assets. This grandfathering rule may be of limited benefit to a REIT such as us that makes periodic acquisitions of both qualifying and nonqualifying REIT assets. When a failure to satisfy the above asset tests results from an acquisition of securities or other property during a quarter, the failure can be cured by disposition of sufficient nonqualifying assets within thirty days after the close of that quarter.

In addition, if we fail the 5% asset test, the 10% vote test or the 10% value test at the close of any quarter and we do not cure such failure within thirty days after the close of that quarter, that failure will nevertheless be excused if (a) the failure is de minimis and (b) within six months after the last day of the quarter in which we identify the failure, we either dispose of the assets causing the failure or otherwise satisfy the 5% asset test, the 10% vote test and the 10% value test. For purposes of this relief provision, the failure will be de minimis if the value of the assets causing the failure does not exceed $10,000,000. If our failure is not de minimis, or if any of the other REIT asset tests have been violated, we may nevertheless qualify for taxation as a REIT if (a) we provide the IRS with a description of each asset causing the failure, (b) the failure was due to reasonable cause and not willful neglect, (c) we pay a tax equal to the greater of (1) $50,000 or (2) the highest regular corporate income tax rate imposed on the net income generated by the assets causing the failure during the period of the failure, and (d) within six months after the last day of the quarter in which we identify the failure, we either dispose of the assets causing the failure or otherwise satisfy all of the REIT asset tests. These relief provisions may apply to a failure of the applicable asset tests even if the failure first occurred in a year prior to the taxable year in which the failure was discovered.

The IRC also provides an excepted securities safe harbor to the 10% value test that includes among other items (a) “straight debt” securities, (b) specified rental agreements in which payment is to be made in subsequent years, (c) any obligation to pay “rents from real property,” (d) securities issued by governmental entities that are not dependent in whole or in part on the profits of or payments from a nongovernmental entity, and (e) any security issued by another REIT. In addition, any debt instrument issued by an entity classified as a partnership for federal income tax purposes, and not otherwise excepted from the definition of a security for purposes of the above safe harbor, will not be treated as a security for purposes of the 10% value test if at least 75% of the partnership's gross income, excluding income from prohibited transactions, is qualifying income for purposes of the 75% gross income test.

We have maintained and will continue to maintain records of the value of our assets to document our compliance with the above asset tests and intend to take actions as may be required to cure any failure to satisfy the tests within thirty days after the close of any quarter or within the six month periods described above.

25

Based on the discussion above, we believe that we have satisfied, and will continue to satisfy, the REIT asset tests outlined above on a continuing basis beginning with our first taxable year as a REIT.

Our Relationships with AlerisLife. Prior to January 1, 2020, we owned a significant percentage (but less than 10%) of the outstanding common shares of AlerisLife. Commencing with our 2002 taxable year and through and including our 2019 taxable year, we expect that the rental income we received from AlerisLife and its subsidiaries constituted “rents from real property” under Section 856(d) of the IRC, and therefore qualifying income under the 75% and 95% gross income tests described above. From and after January 1, 2020, we have come to own (directly and indirectly through one of our TRSs) additional common shares of AlerisLife. We have not elected to treat AlerisLife as a TRS, and it is not otherwise an automatic TRS because no TRS of ours owns more than 35% of AlerisLife. This structure for our AlerisLife ownership permits our continued engagement of a corporate subsidiary of AlerisLife to manage health care facilities leased to our TRSs, as described below in greater detail.

Our Relationship with Our Taxable REIT Subsidiaries. We currently own properties that we purchased to be leased to our TRSs or which are being leased to our TRSs as a result of modifications to, or expirations of, a prior lease, all as agreed to by applicable parties. For example, in connection with past lease defaults and expirations, we have terminated occupancy of some of our health care properties by the defaulting or expiring tenants and immediately leased these properties to our TRSs and entered into new third-party management agreements for these properties. We may from time to time lease additional health care properties to our TRSs.

In lease transactions involving our TRSs, our general intent is for the rents paid to us by the TRS to qualify as “rents from real property” under the REIT gross income tests summarized above. In order for this to be the case, the manager operating the leased property on behalf of the applicable TRS must be an “eligible independent contractor” within the meaning of Section 856(d)(9)(A) of the IRC, and the properties leased to the TRS must be “qualified health care properties” within the meaning of Section 856(e)(6)(D) of the IRC. Qualified health care properties are defined as health care facilities and other properties necessary or incidental to the use of a health care facility.

For these purposes, a contractor qualifies as an “eligible independent contractor” if it is less than 35% affiliated with the REIT and, at the time the contractor enters into the agreement with the TRS to operate the qualified health care property, that contractor or any person related to that contractor is actively engaged in the trade or business of operating qualified health care properties for persons unrelated to the TRS or its affiliated REIT. For these purposes, an otherwise eligible independent contractor is not disqualified from that status on account of (a) the TRS bearing the expenses of the operation of the qualified health care property, (b) the TRS receiving the revenues from the operation of the qualified health care property, net of expenses for that operation and fees payable to the eligible independent contractor, or (c) the REIT receiving income from the eligible independent contractor pursuant to a preexisting or otherwise grandfathered lease of another property.

We have engaged as an intended eligible independent contractor a particular corporate subsidiary of AlerisLife. This contractor and its affiliates are actively engaged in the trade or business of operating qualified health care properties for their own accounts, including pursuant to management contracts among themselves; however, this contractor and its affiliates have few if any management contracts for qualified health care properties with third parties other than us and our TRSs. Based on a plain reading of the statute as well as applicable legislative history, our counsel, Sullivan & Worcester LLP, has opined that this intended eligible independent contractor should in fact so qualify. If the IRS or a court determines that this opinion is incorrect, then the rental income we receive from our TRSs in respect of properties managed by this particular contractor would be nonqualifying income for purposes of the 75% and 95% gross income tests, possibly jeopardizing our compliance with one or both of these gross income tests. Under those circumstances, however, we expect we would qualify for the gross income tests' relief provision described above, and thereby would preserve our qualification for taxation as a REIT. If the relief provision were to apply to us, we would be subject to tax at a 100% rate upon the greater of the amount by which we failed the 75% gross income test or the amount by which we failed the 95% gross income test, with adjustments, multiplied by a fraction intended to reflect our profitability for the taxable year; even though we have little or no nonqualifying income from other sources in a typical taxable year, imposition of this 100% tax in this circumstance would be material because most of the properties leased to our TRSs are managed for the TRSs by this contractor.

As explained above, we will be subject to a 100% tax on the rents paid to us by any of our TRSs if the IRS successfully asserts that those rents exceed an arm's length rental rate. Although there is no clear precedent to distinguish for federal income tax purposes among leases, management contracts, partnerships, financings, and other contractual arrangements, we believe that our leases and our TRSs' management agreements will be respected for purposes of the requirements of the IRC discussed above. Accordingly, we expect that the rental income from our current and future TRSs will qualify as “rents from real property,” and that the 100% tax on excessive rents from a TRS will not apply.

26

Annual Distribution Requirements. In order to qualify for taxation as a REIT under the IRC, we are required to make annual distributions other than capital gain dividends to our shareholders in an amount at least equal to the excess of:    

(1)the sum of 90% of our “real estate investment trust taxable income” and 90% of our net income after tax, if any, from property received in foreclosure, over

(2)the amount by which our noncash income (e.g., imputed rental income or income from transactions inadvertently failing to qualify as like-kind exchanges) exceeds 5% of our “real estate investment trust taxable income.”

For these purposes, our “real estate investment trust taxable income” is as defined under Section 857 of the IRC and is computed without regard to the dividends paid deduction and our net capital gain and will generally be reduced by specified corporate-level income taxes that we pay (e.g., taxes on built-in gains or foreclosure property income).

The IRC generally limits the deductibility of net interest expense paid or accrued on debt properly allocable to a trade or business to 30% of “adjusted taxable income,” subject to specified exceptions. Any deduction in excess of the limitation is carried forward and may be used in a subsequent year, subject to that year's 30% limitation. Provided a taxpayer makes an election (which is irrevocable), the limitation on the deductibility of net interest expense does not apply to a trade or business involving real property development, redevelopment, construction, reconstruction, acquisition, conversion, rental, operation, management, leasing, or brokerage, within the meaning of Section 469(c)(7)(C) of the IRC. Treasury regulations provide that a real property trade or business includes a trade or business conducted by a REIT. We have made an election to be treated as a real property trade or business and accordingly do not expect the foregoing interest deduction limitations to apply to us or to the calculation of our "real estate investment trust taxable income."

Distributions must be paid in the taxable year to which they relate, or in the following taxable year if declared before we timely file our federal income tax return for the earlier taxable year and if paid on or before the first regular distribution payment after that declaration. If a dividend is declared in October, November or December to shareholders of record during one of those months and is paid during the following January, then for federal income tax purposes such dividend will be treated as having been both paid and received on December 31 of the prior taxable year to the extent of any undistributed earnings and profits.

The 90% distribution requirements may be waived by the IRS if a REIT establishes that it failed to meet them by reason of distributions previously made to meet the requirements of the 4% excise tax discussed below. To the extent that we do not distribute all of our net capital gain and all of our “real estate investment trust taxable income,” as adjusted, we will be subject to federal income tax at regular corporate income tax rates on undistributed amounts. In addition, we will be subject to a 4% nondeductible excise tax to the extent we fail within a calendar year to make required distributions to our shareholders of 85% of our ordinary income and 95% of our capital gain net income plus the excess, if any, of the “grossed up required distribution” for the preceding calendar year over the amount treated as distributed for that preceding calendar year. For this purpose, the term “grossed up required distribution” for any calendar year is the sum of our taxable income for the calendar year without regard to the deduction for dividends paid and all amounts from earlier years that are not treated as having been distributed under the provision. We will be treated as having sufficient earnings and profits to treat as a dividend any distribution by us up to the amount required to be distributed in order to avoid imposition of the 4% excise tax.

If we do not have enough cash or other liquid assets to meet our distribution requirements, or if we so choose, we may find it necessary or desirable to arrange for new debt or equity financing to provide funds for required distributions in order to maintain our qualification for taxation as a REIT. We cannot be sure that financing would be available for these purposes on favorable terms, or at all.

We may be able to rectify a failure to pay sufficient dividends for any year by paying “deficiency dividends” to shareholders in a later year. These deficiency dividends may be included in our deduction for dividends paid for the earlier year, but an interest charge would be imposed upon us for the delay in distribution. While the payment of a deficiency dividend will apply to a prior year for purposes of our REIT distribution requirements and our dividends paid deduction, it will be treated as an additional distribution to the shareholders receiving it in the year such dividend is paid.

In addition to the other distribution requirements above, to preserve our qualification for taxation as a REIT we are required to timely distribute all C corporation earnings and profits that we inherit from acquired corporations, as described below.

27

Acquisitions of C Corporations

We have engaged in and may in the future engage in transactions where we acquire all of the outstanding stock of a C corporation. Upon these acquisitions, except to the extent we have made or do make an applicable TRS election, each of our acquired entities and their various wholly-owned corporate and noncorporate subsidiaries generally became or will become our QRSs. Thus, after such acquisitions, all assets, liabilities and items of income, deduction and credit of the acquired and then disregarded entities have been and will be treated as ours for purposes of the various REIT qualification tests described above. In addition, we generally have been and will be treated as the successor to the acquired (and then disregarded) entities' federal income tax attributes, such as those entities' (a) adjusted tax bases in their assets and their depreciation schedules; and (b) earnings and profits for federal income tax purposes, if any. The carryover of these attributes creates REIT implications such as built-in gains tax exposure and additional distribution requirements, as described below. However, when we make an election under Section 338(g) of the IRC with respect to corporations that we acquire, as we have done from time to time in the past, we generally will not be subject to such attribute carryovers in respect of attributes existing prior to such election.

Built-in Gains from C Corporations. Notwithstanding our qualification and taxation as a REIT, under specified circumstances we may be subject to corporate income taxation if we acquire a REIT asset where our adjusted tax basis in the asset is determined by reference to the adjusted tax basis of the asset as owned by a C corporation. For instance, we may be subject to federal income taxation on all or part of the built-in gain that was present on the last date an asset was owned by a C corporation, if we succeed to a carryover tax basis in that asset directly or indirectly from such C corporation and if we sell the asset during the five year period beginning on the day the asset ceased being owned by such C corporation. To the extent of our income and gains in a taxable year that are subject to the built-in gains tax, net of any taxes paid on such income and gains with respect to that taxable year, our taxable dividends paid in the following year will be potentially eligible for taxation to noncorporate U.S. shareholders at the preferential tax rates for “qualified dividends” as described below under the heading “—Taxation of Taxable U.S. Shareholders”. We generally do not expect to sell assets if doing so would result in the imposition of a material built-in gains tax liability; but if and when we do sell assets that may have associated built-in gains tax exposure, then we expect to make appropriate provision for the associated tax liabilities on our financial statements.

Earnings and Profits. Following a corporate acquisition, we must generally distribute all of the C corporation earnings and profits inherited in that transaction, if any, no later than the end of our taxable year in which the transaction occurs, in order to preserve our qualification for taxation as a REIT. However, if we fail to do so, relief provisions would allow us to maintain our qualification for taxation as a REIT provided we distribute any subsequently discovered C corporation earnings and profits and pay an interest charge in respect of the period of delayed distribution. C corporation earnings and profits that we inherit are, in general, specially allocated under a priority rule to the earliest possible distributions following the event causing the inheritance, and only then is the balance of our earnings and profits for the taxable year allocated among our distributions to the extent not already treated as a distribution of C corporation earnings and profits under the priority rule. The distribution of these C corporation earnings and profits is potentially eligible for taxation to noncorporate U.S. shareholders at the preferential tax rates for “qualified dividends” as described below under the heading “—Taxation of Taxable U.S. Shareholders”.

Depreciation and Federal Income Tax Treatment of Leases

Our initial tax bases in our assets will generally be our acquisition cost. We will generally depreciate our depreciable real property on a straight-line basis over forty years and our personal property over the applicable shorter periods. These depreciation schedules, and our initial tax bases, may vary for properties that we acquire through tax-free or carryover basis acquisitions, or that are the subject of cost segregation analyses.

We are entitled to depreciation deductions from our properties only if we are treated for federal income tax purposes as the owner of the properties. This means that the leases of our properties must be classified for U.S. federal income tax purposes as true leases, rather than as sales or financing arrangements, and we believe this to be the case.

Distributions to our Shareholders

As described above, we expect to make distributions to our shareholders from time to time. These distributions may include cash distributions, in kind distributions of property, and deemed or constructive distributions resulting from capital market activities. The U.S. federal income tax treatment of our distributions will vary based on the status of the recipient shareholder as more fully described below under the headings “—Taxation of Taxable U.S. Shareholders,” “—Taxation of Tax-Exempt U.S. Shareholders,” and “—Taxation of Non-U.S. Shareholders.”

Section 302 of the IRC treats a redemption of our shares for cash only as a distribution under Section 301 of the IRC, and hence taxable as a dividend to the extent of our available current or accumulated earnings and profits, unless the redemption

28

satisfies one of the tests set forth in Section 302(b) of the IRC enabling the redemption to be treated as a sale or exchange of the shares. The redemption for cash only will be treated as a sale or exchange if it (a) is “substantially disproportionate” with respect to the surrendering shareholder's ownership in us, (b) results in a “complete termination” of the surrendering shareholder's entire share interest in us, or (c) is “not essentially equivalent to a dividend” with respect to the surrendering shareholder, all within the meaning of Section 302(b) of the IRC. In determining whether any of these tests have been met, a shareholder must generally take into account shares considered to be owned by such shareholder by reason of constructive ownership rules set forth in the IRC, as well as shares actually owned by such shareholder. In addition, if a redemption is treated as a distribution under the preceding tests, then a shareholder's tax basis in the redeemed shares generally will be transferred to the shareholder's remaining shares in us, if any, and if such shareholder owns no other shares in us, such basis generally may be transferred to a related person or may be lost entirely. Because the determination as to whether a shareholder will satisfy any of the tests of Section 302(b) of the IRC depends upon the facts and circumstances at the time that our shares are redeemed, we urge you to consult your own tax advisor to determine the particular tax treatment of any redemption.

Taxation of Taxable U.S. Shareholders

For noncorporate U.S. shareholders, to the extent that their total adjusted income does not exceed applicable thresholds, the maximum federal income tax rate for long-term capital gains and most corporate dividends is generally 15%. For those noncorporate U.S. shareholders whose total adjusted income exceeds the applicable thresholds, the maximum federal income tax rate for long-term capital gains and most corporate dividends is generally 20%. However, because we are not generally subject to federal income tax on the portion of our “real estate investment trust taxable income” distributed to our shareholders, dividends on our shares generally are not eligible for these preferential tax rates, except that any distribution of C corporation earnings and profits and taxed built-in gain items will potentially be eligible for these preferential tax rates. As a result, our ordinary dividends generally are taxed at the higher federal income tax rates applicable to ordinary income (subject to the lower effective tax rates applicable to qualified REIT dividends via the deduction-without-outlay mechanism of Section 199A of the IRC, which is generally available to our noncorporate U.S. shareholders that meet specified holding period requirements for taxable years before 2026). To summarize, the preferential federal income tax rates for long-term capital gains and for qualified dividends generally apply to:

(1)long-term capital gains, if any, recognized on the disposition of our shares;

(2)our distributions designated as long-term capital gain dividends (except to the extent attributable to real estate depreciation recapture, in which case the distributions are subject to a maximum 25% federal income tax rate);

(3)our dividends attributable to dividend income, if any, received by us from C corporations such as TRSs;

(4)our dividends attributable to earnings and profits that we inherit from C corporations; and

(5)our dividends to the extent attributable to income upon which we have paid federal corporate income tax (such as taxes on foreclosure property income or on built-in gains), net of the corporate income taxes thereon.

As long as we qualify for taxation as a REIT, a distribution to our U.S. shareholders that we do not designate as a capital gain dividend generally will be treated as an ordinary income dividend to the extent of our available current or accumulated earnings and profits (subject to the lower effective tax rates applicable to qualified REIT dividends via the deduction-without-outlay mechanism of Section 199A of the IRC, which is generally available to our noncorporate U.S. shareholders that meet specified holding period requirements for taxable years before 2026). Distributions made out of our current or accumulated earnings and profits that we properly designate as capital gain dividends generally will be taxed as long-term capital gains, as discussed below, to the extent they do not exceed our actual net capital gain for the taxable year. However, corporate shareholders may be required to treat up to 20% of any capital gain dividend as ordinary income under Section 291 of the IRC.

In addition, we may elect to retain net capital gain income and treat it as constructively distributed. In that case:

(1)we will be taxed at regular corporate capital gains tax rates on retained amounts;

(2)each of our U.S. shareholders will be taxed on its designated proportionate share of our retained net capital gains as though that amount were distributed and designated as a capital gain dividend;

29

(3)each of our U.S. shareholders will receive a credit or refund for its designated proportionate share of the tax that we pay;

(4)each of our U.S. shareholders will increase its adjusted basis in our shares by the excess of the amount of its proportionate share of these retained net capital gains over the U.S. shareholder's proportionate share of the tax that we pay; and

(5)both we and our corporate shareholders will make commensurate adjustments in our respective earnings and profits for federal income tax purposes.

If we elect to retain our net capital gains in this fashion, we will notify our U.S. shareholders of the relevant tax information within sixty days after the close of the affected taxable year.

If for any taxable year we designate capital gain dividends for our shareholders, then a portion of the capital gain dividends we designate will be allocated to the holders of a particular class of shares on a percentage basis equal to the ratio of the amount of the total dividends paid or made available for the year to the holders of that class of shares to the total dividends paid or made available for the year to holders of all outstanding classes of our shares. We will similarly designate the portion of any dividend that is to be taxed to noncorporate U.S. shareholders at preferential maximum rates (including any qualified dividend income and any capital gains attributable to real estate depreciation recapture that are subject to a maximum 25% federal income tax rate) so that the designations will be proportionate among all outstanding classes of our shares.

Distributions in excess of our current or accumulated earnings and profits will not be taxable to a U.S. shareholder to the extent that they do not exceed the shareholder's adjusted tax basis in our shares, but will reduce the shareholder's basis in such shares. To the extent that these excess distributions exceed a U.S. shareholder's adjusted basis in such shares, they will be included in income as capital gain, with long-term gain generally taxed to noncorporate U.S. shareholders at preferential maximum rates. No U.S. shareholder may include on its federal income tax return any of our net operating losses or any of our capital losses. In addition, no portion of any of our dividends is eligible for the dividends received deduction for corporate shareholders.

If a dividend is declared in October, November or December to shareholders of record during one of those months and is paid during the following January, then for federal income tax purposes the dividend will be treated as having been both paid and received on December 31 of the prior taxable year.

A U.S. shareholder will generally recognize gain or loss equal to the difference between the amount realized and the shareholder's adjusted basis in our shares that are sold or exchanged. This gain or loss will be capital gain or loss, and will be long-term capital gain or loss if the shareholder's holding period in our shares exceeds one year. In addition, any loss upon a sale or exchange of our shares held for six months or less will generally be treated as a long-term capital loss to the extent of any long-term capital gain dividends we paid on such shares during the holding period.

U.S. shareholders who are individuals, estates or trusts are generally required to pay a 3.8% Medicare tax on their net investment income (including dividends on our shares (without regard to any deduction allowed by Section 199A of the IRC) and gains from the sale or other disposition of our shares), or in the case of estates and trusts on their net investment income that is not distributed, in each case to the extent that their total adjusted income exceeds applicable thresholds. U.S. shareholders are urged to consult their tax advisors regarding the application of the 3.8% Medicare tax.

If a U.S. shareholder recognizes a loss upon a disposition of our shares in an amount that exceeds a prescribed threshold, it is possible that the provisions of Treasury regulations involving “reportable transactions” could apply, with a resulting requirement to separately disclose the loss-generating transaction to the IRS. These Treasury regulations are written quite broadly, and apply to many routine and simple transactions. A reportable transaction currently includes, among other things, a sale or exchange of our shares resulting in a tax loss in excess of (a) $10 million in any single year or $20 million in a prescribed combination of taxable years in the case of our shares held by a C corporation or by a partnership with only C corporation partners or (b) $2 million in any single year or $4 million in a prescribed combination of taxable years in the case of our shares held by any other partnership or an S corporation, trust or individual, including losses that flow through pass through entities to individuals. A taxpayer discloses a reportable transaction by filing IRS Form 8886 with its federal income tax return and, in the first year of filing, a copy of Form 8886 must be sent to the IRS's Office of Tax Shelter Analysis. The annual maximum penalty for failing to disclose a reportable transaction is generally $10,000 in the case of a natural person and $50,000 in any other case.

30

Noncorporate U.S. shareholders who borrow funds to finance their acquisition of our shares could be limited in the amount of deductions allowed for the interest paid on the indebtedness incurred. Under Section 163(d) of the IRC, interest paid or accrued on indebtedness incurred or continued to purchase or carry property held for investment is generally deductible only to the extent of the investor's net investment income. A U.S. shareholder's net investment income will include ordinary income dividend distributions received from us and, only if an appropriate election is made by the shareholder, capital gain dividend distributions and qualified dividends received from us; however, distributions treated as a nontaxable return of the shareholder's basis will not enter into the computation of net investment income.

Taxation of Tax-Exempt U.S. Shareholders

The rules governing the federal income taxation of tax-exempt entities are complex, and the following discussion is intended only as a summary of material considerations of an investment in our shares relevant to such investors. If you are a tax-exempt shareholder, we urge you to consult your own tax advisor to determine the impact of federal, state, local and foreign tax laws, including any tax return filing and other reporting requirements, with respect to your acquisition of or investment in our shares.

We expect that shareholders that are tax-exempt pension plans, individual retirement accounts or other qualifying tax-exempt entities, and that receive (a) distributions from us, or (b) proceeds from the sale of our shares, should not have such amounts treated as UBTI, provided in each case (x) that the shareholder has not financed its acquisition of our shares with “acquisition indebtedness” within the meaning of the IRC, (y) that the shares are not otherwise used in an unrelated trade or business of the tax-exempt entity, and (z) that, consistent with our present intent, we do not hold a residual interest in a real estate mortgage investment conduit or otherwise hold mortgage assets or conduct mortgage securitization activities that generate “excess inclusion” income.

Taxation of Non-U.S. Shareholders

The rules governing the U.S. federal income taxation of non-U.S. shareholders are complex, and the following discussion is intended only as a summary of material considerations of an investment in our shares relevant to such investors. If you are a non-U.S. shareholder, we urge you to consult your own tax advisor to determine the impact of U.S. federal, state, local and foreign tax laws, including any tax return filing and other reporting requirements, with respect to your acquisition of or investment in our shares.

We expect that a non-U.S. shareholder's receipt of (a) distributions from us, and (b) proceeds from the sale of our shares, will not be treated as income effectively connected with a U.S. trade or business and a non-U.S. shareholder will therefore not be subject to the often higher federal tax and withholding rates, branch profits taxes and increased reporting and filing requirements that apply to income effectively connected with a U.S. trade or business. This expectation and a number of the determinations below are predicated on our shares being listed on a U.S. national securities exchange, such as The Nasdaq Stock Market LLC, or Nasdaq. Each class of our shares has been listed on a U.S. national securities exchange; however, we cannot be sure that our shares will continue to be so listed in future taxable years or that any class of our shares that we may issue in the future will be so listed.

Distributions. A distribution by us to a non-U.S. shareholder that is not designated as a capital gain dividend will be treated as an ordinary income dividend to the extent that it is made out of our current or accumulated earnings and profits. A distribution of this type will generally be subject to U.S. federal income tax and withholding at the rate of 30%, or at a lower rate if the non-U.S. shareholder has in the manner prescribed by the IRS demonstrated to the applicable withholding agent its entitlement to benefits under a tax treaty. Because we cannot determine our current and accumulated earnings and profits until the end of the taxable year, withholding at the statutory rate of 30% or applicable lower treaty rate will generally be imposed on the gross amount of any distribution to a non-U.S. shareholder that we make and do not designate as a capital gain dividend. Notwithstanding this potential withholding on distributions in excess of our current and accumulated earnings and profits, these excess portions of distributions are a nontaxable return of capital to the extent that they do not exceed the non-U.S. shareholder's adjusted basis in our shares, and the nontaxable return of capital will reduce the adjusted basis in these shares. To the extent that distributions in excess of our current and accumulated earnings and profits exceed the non-U.S. shareholder's adjusted basis in our shares, the distributions will give rise to U.S. federal income tax liability only in the unlikely event that the non-U.S. shareholder would otherwise be subject to tax on any gain from the sale or exchange of these shares, as discussed below under the heading “—Dispositions of Our Shares.” A non-U.S. shareholder may seek a refund from the IRS of amounts withheld on distributions to it in excess of such shareholder's allocable share of our current and accumulated earnings and profits.

31

For so long as a class of our shares is listed on a U.S. national securities exchange, capital gain dividends that we declare and pay to a non-U.S. shareholder on those shares, as well as dividends to a non-U.S. shareholder on those shares attributable to our sale or exchange of “United States real property interests” within the meaning of Section 897 of the IRC, or USRPIs, will not be subject to withholding as though those amounts were effectively connected with a U.S. trade or business, and non-U.S. shareholders will not be required to file U.S. federal income tax returns or pay branch profits tax in respect of these dividends. Instead, these dividends will generally be treated as ordinary dividends and subject to withholding in the manner described above.

Tax treaties may reduce the withholding obligations on our distributions. Under some treaties, however, rates below 30% that are applicable to ordinary income dividends from U.S. corporations may not apply to ordinary income dividends from a REIT or may apply only if the REIT meets specified additional conditions. A non-U.S. shareholder must generally use an applicable IRS Form W-8, or substantially similar form, to claim tax treaty benefits. If the amount of tax withheld with respect to a distribution to a non-U.S. shareholder exceeds the shareholder's U.S. federal income tax liability with respect to the distribution, the non-U.S. shareholder may file for a refund of the excess from the IRS. Treasury regulations also provide special rules to determine whether, for purposes of determining the applicability of a tax treaty, our distributions to a non-U.S. shareholder that is an entity should be treated as paid to the entity or to those owning an interest in that entity, and whether the entity or its owners are entitled to benefits under the tax treaty.

If, contrary to our expectation, a class of our shares was not listed on a U.S. national securities exchange and we made a distribution on those shares that was attributable to gain from the sale or exchange of a USRPI, then a non-U.S. shareholder holding those shares would be taxed as if the distribution was gain effectively connected with a trade or business in the United States conducted by the non-U.S. shareholder. In addition, the applicable withholding agent would be required to withhold from a distribution to such a non-U.S. shareholder, and remit to the IRS, up to 21% of the maximum amount of any distribution that was or could have been designated as a capital gain dividend. The non-U.S. shareholder also would generally be subject to the same treatment as a U.S. shareholder with respect to the distribution (subject to any applicable alternative minimum tax and a special alternative minimum tax in the case of a nonresident alien individual), would be subject to fulsome U.S. federal income tax return reporting requirements, and, in the case of a corporate non-U.S. shareholder, may owe the up to 30% branch profits tax under Section 884 of the IRC (or lower applicable tax treaty rate) in respect of these amounts.

Dispositions of Our Shares. If as expected our shares are not USRPIs, then a non-U.S. shareholder's gain on the sale of these shares generally will not be subject to U.S. federal income taxation or withholding. We expect that our shares will not be USRPIs because one or both of the following exemptions will be available at all times.

First, for so long as a class of our shares is listed on a U.S. national securities exchange, a non-U.S. shareholder's gain on the sale of those shares will not be subject to U.S. federal income taxation as a sale of a USRPI. Second, our shares will not constitute USRPIs if we are a “domestically controlled” REIT. We will be a “domestically controlled” REIT if less than 50% of the value of our shares (including any future class of shares that we may issue) is held, directly or indirectly, by non-U.S. shareholders at all times during the preceding five years, after applying specified presumptions regarding the ownership of our shares as described in Section 897(h)(4)(E) of the IRC. For these purposes, we believe that the statutory ownership presumptions apply to validate our status as a “domestically controlled” REIT. Accordingly, we believe that we are and will remain a “domestically controlled” REIT.

If, contrary to our expectation, a gain on the sale of our shares is subject to U.S. federal income taxation (for example, because neither of the above exemptions were then available, i.e., that class of our shares were not then listed on a U.S. national securities exchange and we were not a “domestically controlled” REIT), then (a) a non-U.S. shareholder would generally be subject to the same treatment as a U.S. shareholder with respect to its gain (subject to any applicable alternative minimum tax and a special alternative minimum tax in the case of nonresident alien individuals), (b) the non-U.S. shareholder would also be subject to fulsome U.S. federal income tax return reporting requirements, and (c) a purchaser of that class of our shares from the non-U.S. shareholder may be required to withhold 15% of the purchase price paid to the non-U.S. shareholder and to remit the withheld amount to the IRS.

Information Reporting, Backup Withholding, and Foreign Account Withholding

Information reporting, backup withholding, and foreign account withholding may apply to distributions or proceeds paid to our shareholders under the circumstances discussed below. If a shareholder is subject to backup or other U.S. federal income tax withholding, then the applicable withholding agent will be required to withhold the appropriate amount with respect to a deemed or constructive distribution or a distribution in kind even though there is insufficient cash from which to satisfy the withholding obligation. To satisfy this withholding obligation, the applicable withholding agent may collect the amount of U.S. federal income tax required to be withheld by reducing to cash for remittance to the IRS a sufficient portion of the property that

32

the shareholder would otherwise receive or own, and the shareholder may bear brokerage or other costs for this withholding procedure.

Amounts withheld under backup withholding are generally not an additional tax and may be refunded by the IRS or credited against the shareholder's federal income tax liability, provided that such shareholder timely files for a refund or credit with the IRS. A U.S. shareholder may be subject to backup withholding when it receives distributions on our shares or proceeds upon the sale, exchange, redemption, retirement or other disposition of our shares, unless the U.S. shareholder properly executes, or has previously properly executed, under penalties of perjury an IRS Form W-9 or substantially similar form that:

•provides the U.S. shareholder's correct taxpayer identification number;

•certifies that the U.S. shareholder is exempt from backup withholding because (a) it comes within an enumerated exempt category, (b) it has not been notified by the IRS that it is subject to backup withholding, or (c) it has been notified by the IRS that it is no longer subject to backup withholding; and

•certifies that it is a U.S. citizen or other U.S. person.

If the U.S. shareholder has not provided and does not provide its correct taxpayer identification number and appropriate certifications on an IRS Form W-9 or substantially similar form, it may be subject to penalties imposed by the IRS, and the applicable withholding agent may have to withhold a portion of any distributions or proceeds paid to such U.S. shareholder. Unless the U.S. shareholder has established on a properly executed IRS Form W-9 or substantially similar form that it comes within an enumerated exempt category, distributions or proceeds on our shares paid to it during the calendar year, and the amount of tax withheld, if any, will be reported to it and to the IRS.

Distributions on our shares to a non-U.S. shareholder during each calendar year and the amount of tax withheld, if any, will generally be reported to the non-U.S. shareholder and to the IRS. This information reporting requirement applies regardless of whether the non-U.S. shareholder is subject to withholding on distributions on our shares or whether the withholding was reduced or eliminated by an applicable tax treaty. Also, distributions paid to a non-U.S. shareholder on our shares will generally be subject to backup withholding, unless the non-U.S. shareholder properly certifies to the applicable withholding agent its non-U.S. shareholder status on an applicable IRS Form W-8 or substantially similar form. Information reporting and backup withholding will not apply to proceeds a non-U.S. shareholder receives upon the sale, exchange, redemption, retirement or other disposition of our shares, if the non-U.S. shareholder properly certifies to the applicable withholding agent its non-U.S. shareholder status on an applicable IRS Form W-8 or substantially similar form. Even without having executed an applicable IRS Form W-8 or substantially similar form, however, in some cases information reporting and backup withholding will not apply to proceeds that a non-U.S. shareholder receives upon the sale, exchange, redemption, retirement or other disposition of our shares if the non-U.S. shareholder receives those proceeds through a broker's foreign office.

Non-U.S. financial institutions and other non-U.S. entities are subject to diligence and reporting requirements for purposes of identifying accounts and investments held directly or indirectly by U.S. persons. The failure to comply with these additional information reporting, certification and other requirements could result in a 30% U.S. withholding tax on applicable payments to non-U.S. persons, notwithstanding any otherwise applicable provisions of an income tax treaty. In particular, a payee that is a foreign financial institution that is subject to the diligence and reporting requirements described above must enter into an agreement with the U.S. Department of the Treasury requiring, among other things, that it undertake to identify accounts held by “specified United States persons” or “United States owned foreign entities” (each as defined in the IRC and administrative guidance thereunder), annually report information about such accounts, and withhold 30% on applicable payments to noncompliant foreign financial institutions and account holders. Foreign financial institutions located in jurisdictions that have an intergovernmental agreement with the United States with respect to these requirements may be subject to different rules. The foregoing withholding regime generally applies to payments of dividends on our shares. In general, to avoid withholding, any non-U.S. intermediary through which a shareholder owns our shares must establish its compliance with the foregoing regime, and a non-U.S. shareholder must provide specified documentation (usually an applicable IRS Form W-8) containing information about its identity, its status, and if required, its direct and indirect U.S. owners. Non-U.S. shareholders and shareholders who hold our shares through a non-U.S. intermediary are encouraged to consult their own tax advisors regarding foreign account tax compliance.

Other Tax Considerations

Our tax treatment and that of our shareholders may be modified by legislative, judicial or administrative actions at any time, which actions may have retroactive effect. The rules dealing with federal income taxation are constantly under review by the U.S. Congress, the IRS and the U.S. Department of the Treasury, and statutory changes, new regulations, revisions to

33

existing regulations and revised interpretations of established concepts are issued frequently. Likewise, the rules regarding taxes other than U.S. federal income taxes may also be modified. No prediction can be made as to the likelihood of passage of new tax legislation or other provisions, or the direct or indirect effect on us and our shareholders. Revisions to tax laws and interpretations of these laws could adversely affect our ability to qualify and be taxed as a REIT, as well as the tax or other consequences of an investment in our shares. We and our shareholders may also be subject to taxation by state, local or other jurisdictions, including those in which we or our shareholders transact business or reside. These tax consequences may not be comparable to the U.S. federal income tax consequences discussed above.

34

ERISA PLANS, KEOGH PLANS AND INDIVIDUAL RETIREMENT ACCOUNTS

General Fiduciary Obligations

The Employee Retirement Income Security Act of 1974, as amended, or ERISA, the IRC and similar provisions to those described below under applicable foreign or state law, individually and collectively, impose certain duties on persons who are fiduciaries of any employee benefit plan subject to Title I of ERISA, or an ERISA Plan, or an individual retirement account or annuity, or an IRA, a Roth IRA, a tax-favored account (such as an Archer MSA, Coverdell education savings account or health savings account), a Keogh plan or other qualified retirement plan not subject to Title I of ERISA, each a Non-ERISA Plan. Under ERISA and the IRC, any person who exercises any discretionary authority or control over the administration of, or the management or disposition of the assets of, an ERISA Plan or Non-ERISA Plan, or who renders investment advice for a fee or other compensation to an ERISA Plan or Non-ERISA Plan, is generally considered to be a fiduciary of the ERISA Plan or Non-ERISA Plan.

Fiduciaries of an ERISA Plan must consider whether:

•their investment in our shares or other securities satisfies the diversification requirements of ERISA;

•the investment is prudent in light of possible limitations on the marketability of our shares;

•they have authority to acquire our shares or other securities under the applicable governing instrument and Title I of ERISA; and

•the investment is otherwise consistent with their fiduciary responsibilities.

Fiduciaries of an ERISA Plan may incur personal liability for any loss suffered by the ERISA Plan on account of a violation of their fiduciary responsibilities. In addition, these fiduciaries may be subject to a civil penalty of up to 20% of any amount recovered by the ERISA Plan on account of a violation. Fiduciaries of any Non-ERISA Plan should consider that the Non-ERISA Plan may only make investments that are authorized by the appropriate governing instrument and applicable law.

Fiduciaries considering an investment in our securities should consult their own legal advisors if they have any concern as to whether the investment is consistent with the foregoing criteria or is otherwise appropriate. The sale of our securities to an ERISA Plan or Non-ERISA Plan is in no respect a representation by us or any underwriter of the securities that the investment meets all relevant legal requirements with respect to investments by the arrangements generally or any particular arrangement, or that the investment is appropriate for arrangements generally or any particular arrangement.

Prohibited Transactions

Fiduciaries of ERISA Plans and persons making the investment decision for Non-ERISA Plans should consider the application of the prohibited transaction provisions of ERISA and the IRC in making their investment decision. Sales and other transactions between an ERISA Plan or a Non-ERISA Plan and disqualified persons or parties in interest, as applicable, are prohibited transactions and result in adverse consequences absent an exemption. The particular facts concerning the sponsorship, operations and other investments of an ERISA Plan or Non-ERISA Plan may cause a wide range of persons to be treated as disqualified persons or parties in interest with respect to it. A non-exempt prohibited transaction, in addition to imposing potential personal liability upon ERISA Plan fiduciaries, may also result in the imposition of an excise tax under the IRC or a penalty under ERISA upon the disqualified person or party in interest. If the disqualified person who engages in the transaction is the individual on behalf of whom an IRA, Roth IRA or other tax-favored account is maintained (or his beneficiary), the IRA, Roth IRA or other tax-favored account may lose its tax-exempt status and its assets may be deemed to have been distributed to the individual in a taxable distribution on account of the non-exempt prohibited transaction, but no excise tax will be imposed. Fiduciaries considering an investment in our securities should consult their own legal advisors as to whether the ownership of our securities involves a non-exempt prohibited transaction.

“Plan Assets” Considerations

The U.S. Department of Labor has issued a regulation defining “plan assets.” The regulation, as subsequently modified by ERISA, generally provides that when an ERISA Plan or a Non-ERISA Plan otherwise subject to Title I of ERISA and/or Section 4975 of the IRC acquires an interest in an entity that is neither a “publicly offered security” nor a security issued by an investment company registered under the Investment Company Act of 1940, as amended, the assets of the ERISA Plan or Non-ERISA Plan include both the equity interest and an undivided interest in each of the underlying assets of the entity, unless it is

35

established either that the entity is an operating company or that equity participation in the entity by benefit plan investors is not significant. We are not an investment company registered under the Investment Company Act of 1940, as amended.

Each class of our equity (that is, our common shares and any other class of equity that we may issue) must be analyzed separately to ascertain whether it is a publicly offered security. The regulation defines a publicly offered security as a security that is “widely held,” “freely transferable” and either part of a class of securities registered under the Exchange Act, or sold under an effective registration statement under the Securities Act of 1933, as amended, or the Securities Act, provided the securities are registered under the Exchange Act within 120 days after the end of the fiscal year of the issuer during which the offering occurred. Each class of our outstanding shares has been registered under the Exchange Act within the necessary time frame to satisfy the foregoing condition.

The regulation provides that a security is “widely held” only if it is part of a class of securities that is owned by 100 or more investors independent of the issuer and of one another. However, a security will not fail to be “widely held” because the number of independent investors falls below 100 subsequent to the initial public offering as a result of events beyond the issuer's control. Although we cannot be sure, we believe our common shares have been and will remain widely held, and we expect the same to be true of any future class of equity that we may issue.

The regulation provides that whether a security is “freely transferable” is a factual question to be determined on the basis of all relevant facts and circumstances. The regulation further provides that, where a security is part of an offering in which the minimum investment is $10,000 or less, some restrictions on transfer ordinarily will not, alone or in combination, affect a finding that these securities are freely transferable. The restrictions on transfer enumerated in the regulation as not affecting that finding include:

•any restriction on or prohibition against any transfer or assignment that would result in a termination or reclassification for federal or state tax purposes, or would otherwise violate any state or federal law or court order;

•any requirement that advance notice of a transfer or assignment be given to the issuer and any requirement that either the transferor or transferee, or both, execute documentation setting forth representations as to compliance with any restrictions on transfer that are among those enumerated in the regulation as not affecting free transferability, including those described in the preceding clause of this sentence;

•any administrative procedure that establishes an effective date, or an event prior to which a transfer or assignment will not be effective; and

•any limitation or restriction on transfer or assignment that is not imposed by the issuer or a person acting on behalf of the issuer.

We believe that the restrictions imposed under our declaration of trust on the transfer of shares do not result in the failure of our shares to be “freely transferable.” Furthermore, we believe that no other facts or circumstances limiting the transferability of our shares exist, other than those that are enumerated under the regulation as not affecting the free transferability of shares. In addition, we do not expect or intend to impose in the future, or to permit any person to impose on our behalf, any limitations or restrictions on transfer that would not be among the enumerated permissible limitations or restrictions.

Assuming that each class of our shares will be “widely held” and that no other facts and circumstances exist that restrict transferability of these shares, our counsel, Sullivan & Worcester LLP, is of the opinion that our shares will not fail to be “freely transferable” for purposes of the regulation due to the restrictions on transfer of our shares in our declaration of trust and that under the regulation each class of our currently outstanding shares is publicly offered and our assets will not be deemed to be “plan assets” of any ERISA Plan or Non-ERISA Plan that acquires our shares in a public offering. This opinion is conditioned upon certain assumptions and representations, as discussed above under the heading “Material United States Federal Income Tax Considerations—Taxation as a REIT.”

Item 1A.  Risk Factors.

Summary of Risk Factors

Our business is subject to a number of risks and uncertainties. The summary below provides an overview of many of the risks we face that are described in this section. Additional risks, beyond those summarized below, discussed under the caption “Risk Factors” or described elsewhere in this Annual Report on Form 10-K, may also materially and adversely impact

36

our business, operations or financial results. Consistent with the foregoing, the risks we face include, but are not limited to, the following:

•the COVID-19 pandemic and its resulting economic impact have materially adversely affected the senior living industry, including us and our SHOP operators, and may continue to do so and may adversely affect our other businesses;

•we are dependent on our managers or other operators for the operation of our senior living communities, and we are exposed to operational risks, liabilities and claims with respect to our SHOP segment properties;

•changes and trends in the healthcare industry, including the continuing trend for seniors to delay or forgo moving to senior living communities and increased labor costs and decreased labor availability, have negatively impacted our managers and our SHOP business and operating results;

•we have substantial debt and may incur additional debt, and we are subject to the covenants and conditions contained in the agreements governing our debt, which may restrict our operations and ability to make investments and distributions, and if we fail to satisfy those covenants and conditions, we would be unable to incur additional indebtedness and we may need to repay outstanding debts from other sources of capital;

•we may need additional waivers from our lenders or waivers from our noteholders in order to avoid defaulting under our credit agreement or public debt agreements and the terms of our current waivers under our credit agreement impose restrictions on our ability to pay distributions and to make capital investments;

•if we default under our credit agreement, we may lose some or all of the equity interests in certain of our subsidiaries that we have pledged or face foreclosure on properties on which we have provided first mortgage liens to secure our obligations under the credit agreement;

•we may not be able to reduce our debt leverage and our debt leverage may remain at or above current levels for an indefinite period;

•we may be unable to renew our leases with current tenants when our leases expire or lease our properties to new tenants without decreasing rents or incurring significant costs, providing certain concessions or otherwise;

•risks associated with the development, redevelopment or repositioning of our properties may cause delays in leasing those properties and generating cash flows from those properties;

•we and our managers and other operators and tenants face significant competition;

•changes in market interest rates, including changes resulting from the phase out of LIBOR, may adversely affect us;

•REIT distribution requirements and any limitations on our ability to access reasonably priced capital may adversely impact our ability to carry out our business plan, and we are subject to risks associated with our qualification for taxation as a REIT;

•ownership of real estate is subject to environmental risks and liabilities, as well as risks from adverse weather, natural disasters and climate change and climate related events, and we may incur significant costs and invest significant amounts with respect to these matters;

•insurance may not adequately cover our losses, and insurance costs may continue to increase;

•we may not succeed in selling any assets we identify for sale, and the proceeds we receive from any sales we may complete may be less than expected, and we may incur losses with respect to any such sales;

•our existing and any future joint ventures may limit our flexibility with jointly owned investments and we may not realize the benefits we expect from these arrangements;

•we depend upon RMR LLC to manage our business and implement our growth strategy, and RMR LLC has broad discretion in operating our day to day business;

37

•any material failure, inadequacy, interruption or security breach of RMR LLC's or our senior living community managers' or other operators' information technology or systems could materially harm us;

•our management structure and agreements with RMR LLC and our relationships with our related parties, including our Managing Trustees, RMR LLC, AlerisLife (including Five Star) and others affiliated with them, may create conflicts of interest;

•ownership limitations and certain provisions in our declaration of trust, bylaws and agreements, as well as certain provisions of Maryland law, may deter, delay or prevent a change in our control or unsolicited acquisition proposals;

•our rights and the rights of our shareholders to take action against our Trustees and officers are limited, and our bylaws contain provisions that could limit our shareholders' ability to obtain a judicial forum they deem favorable for certain disputes;

•we may change our operational, financing and investment policies without shareholder approval; and

•our distributions to our shareholders may remain at $0.01 per share for an indefinite period or be eliminated and the form of payment could change.

The risks described below may not be the only risks we face but are risks we believe may be material at this time. Other risks of which we are not yet aware, or that we currently believe are not material, may also materially and adversely impact our business operations or financial results. If any of the events or circumstances described below occurs, our business, financial condition, liquidity, results of operations or ability to make distributions to our shareholders could be adversely impacted and the value of an investment in our securities could decline. Investors and prospective investors should consider the risks described below and the information contained under the caption “Warning Concerning Forward-Looking Statements” and elsewhere in this Annual Report on Form 10-K before deciding whether to invest in our securities.

Risks Related to Our Business

The COVID-19 pandemic and its resulting economic impact have materially adversely affected the senior living industry, including us and our SHOP operators, and may continue to do so and may adversely affect our other businesses.

The COVID-19 pandemic has had a substantial adverse impact on the global economy, including the U.S. economy, during various stages of the pandemic. Government requirements to stay in place and temporarily close businesses had a substantial negative impact on the economy. Government spending during the pandemic, and subsequent easing of the government restrictions, have since helped avert extended negative impacts to the economy and are believed to have helped foster a return to economic growth. However, the progression of the pandemic has been unpredictable, with infection rates rising and falling and new variants of the virus continuing to emerge. Those variants may have negative impacts on public health, including possibly being more transmissible, including to people who have been otherwise immunized due to natural immunity as a result of being previously infected with COVID-19 or vaccination. Variants of COVID-19 could have similar or worse impacts on the economy and public health as previous versions of COVID-19.

Our business is focused on healthcare related properties, including medical office and life science properties, senior living communities, wellness centers and other medical and healthcare related properties. We believe that the healthcare sector and many of our tenants, managers and other operators provide essential services across the United States. Due to restrictions intended to prevent the spread of the virus that causes COVID-19, certain of our medical office and wellness center tenants, which include physician practices that had discontinued non-essential surgeries and procedures and fitness centers, that had been ordered closed by state executive orders experienced disruptions to their businesses. Our managers and other operators also experienced disruptions, including limitations on in-person tours and new admissions, and experienced challenges in attracting new residents to their communities in addition to experiencing increased expenses due to increased labor costs, including higher health benefits costs, and increased costs and consumption of supplies, including personal protective equipment. Although operating conditions have improved in the senior living industry since low points experienced during the COVID-19 pandemic, they have not returned to pre-pandemic levels and could decline again as a result of increased COVID-19 infections and related negative impacts on public health conditions. In addition, if COVID-19 infections increase and public health conditions deteriorate, our other businesses may be negatively impacted if our tenants are not able to pay their rent obligations to us or if we are not able to lease our properties for sufficient effective rent amounts.

We are closely monitoring the impacts of the COVID-19 pandemic on all aspects of our business, including labor availability and costs and other cost pressures from supply chain disruptions and commodity price inflation. With respect to our

38

SHOP segment, we expect that our senior living community managers will be operating our communities at lower average occupancy with higher operating expenses per resident as a result of the COVID-19 pandemic, which will likely lead to decreased returns to us. Our managers continue to follow federal, state and local health department guidelines and their own infection prevention protocols but we expect to see additional cases of COVID-19 in our senior living communities.

The ultimate adverse impact of the COVID-19 pandemic or a similar health epidemic is highly uncertain and subject to change. We do not yet know the full extent of potential impacts on our business and operations, our tenants', managers' and other operators' businesses and operations or the global economy as a whole. While the spread of COVID-19 may eventually be contained or mitigated, there is no guarantee that a future outbreak or any other widespread epidemics will not occur, or that the global economy will fully recover, either of which could materially harm our business. The COVID-19 pandemic presents material uncertainty and risk with respect to our business, operating results, financial condition and cash flows. Moreover, many risk factors set forth in this section should be interpreted as heightened risks as a result of the impact of the COVID-19 pandemic.

Our acquisition activities have been significantly curtailed and we expect that to continue for an indefinite period.

We are not actively pursuing acquisitions at this time. In addition, our credit agreement limits our ability to make acquisitions. As a result, we are limited in pursuing investments, which may limit our ability to grow and to act upon opportunities we believe would benefit us.

We are limited in our ability to operate our senior living communities and are thus dependent on our managers or other operators.

Because federal income tax laws restrict REITs and their subsidiaries from operating or managing healthcare facilities, we do not operate or manage our senior living communities. Instead, we lease nearly all our senior living communities to subsidiaries of ours that qualify as TRSs under the IRC and retain third parties to manage those senior living communities. Our SHOP business is dependent on a limited number of managers and Five Star manages most of our senior living communities. The other communities in our SHOP segment not managed by Five Star are managed by other managers that are new to us, having only begun managing for us in 2021; as a result, our arrangements with the new managers are subject to transition and other risks and it may take an extended period to stabilize operations at these communities. Our income from our properties may be adversely affected if our managers or other operators fail to provide quality services and amenities to residents. While we monitor the performance of our managers and other operators and apply asset management strategies and discipline, we have limited recourse under our management agreements and leases if we believe that our managers or other operators are not performing adequately. Any failure by our managers or other operators to fully perform the duties agreed to in our management agreements and leases could adversely affect our results of operations. In addition, our managers and other operators operate, and in some cases own or have invested in, properties that compete with our properties, which may result in conflicts of interest. As a result, our managers and other operators have made, and may in the future make, decisions regarding competing properties or our properties' operations that may not be in our best interests and which may result in a reduction of our returns.

We are exposed to operational risks, liabilities and claims with respect to our SHOP segment properties that could adversely affect our revenues and operations.

We are exposed to various operational risks with respect to our SHOP segment properties that may increase our costs or adversely affect our ability to generate revenues. In addition to operational challenges related to the COVID-19 pandemic, these risks include fluctuations in occupancy experienced during the normal course of business, Medicare and Medicaid reimbursement, if applicable, and private pay rates; economic conditions; competition; federal, state, local, and industry-regulated licensure, certification and inspection laws, regulations, and standards; the availability and increases in cost of general and professional liability insurance coverage; increases in property taxes; state regulation and rights of residents related to entrance fees; federal and state housing laws and regulations, including rent and eviction restrictions related to the COVID-19 pandemic; the availability and increases in the cost of labor (as a result of unionization or otherwise); and increases in commodity prices, such as the prices of food and construction materials, as a result of, among other things, supply chain challenges currently being experienced in the global economy, including the U.S. economy. Any one or a combination of these factors may adversely affect our revenue and operations.

Further, we generally hold the applicable healthcare license and enroll in applicable government healthcare programs on behalf of the properties in our senior living operations segment. This subjects us to potential liability under various healthcare laws and regulations. Healthcare laws and regulations are wide-ranging, and noncompliance may result in the imposition of civil, criminal, and administrative penalties, including: the loss or suspension of accreditation, licenses or CONs;

39

suspension of or non-payment for new admissions; denial of reimbursement; fines; suspension, decertification, or exclusion from federal and state healthcare programs; or facility closure.

The trend for seniors to delay moving to senior living communities until they require greater care or to forgo moving to senior living communities altogether has been exacerbated by the COVID-19 pandemic and could have a material adverse effect on our business, financial condition and results of operations.

Seniors have been increasingly delaying their moves to senior living communities until they require greater care or forgoing moving to senior living communities altogether. The COVID-19 pandemic has exacerbated and may continue to exacerbate these trends. Further, rehabilitation therapy and other services are increasingly being provided to seniors on an outpatient basis or in seniors' personal residences in response to market demand and government regulation, which may increase the trend for seniors to delay moving to senior living communities. Such delays may cause decreases in occupancy rates and increases in resident turnover rates at our senior living communities. Moreover, older aged persons may have greater care needs and require higher acuity services, which may increase costs at our senior living communities, expose our managers or other operators to additional liability or result in lost business and shorter stays at our senior living communities if our managers or other operators are not able to provide the requisite care services or fail to adequately provide those services. Further, if we or our managers or other operators fail to successfully act upon and address these and other trends and changes in seniors' needs and preferences or in the healthcare industry generally, we or they may be unable to offset associated lost revenues by growing other revenue sources, such as by offering new or increased service offerings to seniors, and our senior living communities may become unprofitable and the value of our senior living communities may decline.

Increased labor costs, decreased labor availability and staffing turnover have negatively impacted our managers and our SHOP business and operating results, and these conditions may continue for an extended period.

Wages and employee benefits associated with the operations of our managed senior living communities represent a significant part of our managed senior living communities' operating expenses. Low unemployment and the ongoing COVID-19 pandemic have resulted in increased labor costs, including higher health benefits costs, in the senior living industry. Further, legislation has been enacted and proposed to increase the minimum wage in various jurisdictions in recent years, which has put upward pressure on wages. Moreover, the U.S. labor market has been experiencing labor shortages, which has negatively impacted our senior living communities' operations and increased our, our managers' and other senior living community operators' labor costs. If these conditions continue, our managers and other operators may increasingly be challenged in fully operating our senior living communities, which may require us to reduce our operations; as a result of these conditions, our revenues and growth may decline and our costs may continue to increase.

The market for qualified nurses and other healthcare professionals is highly competitive, and periodic or geographic area shortages of such healthcare professionals may require our managers or other operators to increase the wages and benefits they offer to their employees in order to attract and retain them or to utilize temporary personnel at an increased cost. In addition, employee benefit costs, including health insurance and workers' compensation insurance costs, have materially increased in recent years.

Staffing turnover at our senior living communities is common, and it increases in a competitive labor market, which has been the case during the COVID-19 pandemic. Heightened levels of staffing turnover at our senior living communities, particularly with respect to key and skilled positions, such as management, regional and executive directors and other skilled and qualified personnel, may disrupt operations, limit or slow the execution of business strategies, and decrease revenues and increase costs at our managed senior living communities, which may have a material adverse effect on our business, financial condition, results of operations and prospects.

Termination of assisted living resident agreements and resident attrition could adversely affect revenues and earnings at our senior living communities.

Unlike apartment leases that typically have a one-year term, state regulations governing assisted living communities typically require that senior living community residents have the right to terminate their assisted living resident agreements for any reason on reasonable (for example, 30 days') notice. Should a large number of our residents elect to terminate their resident agreements at or around the same time, revenues and earnings at our senior living communities could be materially and adversely affected. In addition, the advanced ages of our senior living residents may result in high resident turnover rates.

40

Our investments in our properties may not yield the returns we expect and may cost more than expected and take longer to complete.

We invest significant amounts in our properties. However, we may not realize the returns we expect from these investments, and these investments may cost more than we expect. For example, the global economy, including the U.S. economy, has been experiencing supply chain challenges, which, at times, has reduced the availability of goods and materials, caused price inflation and increased the time from order to receipt of goods and materials. These conditions could result in our planned capital expenditures costing more than expected and taking longer to complete.

Depressed U.S. housing market conditions and other factors may reduce the willingness or ability of seniors to relocate to our senior living communities.

Downturns or stagnation in the U.S. housing market could adversely affect the ability, or perceived ability, of seniors to afford our senior living community entrance and resident fees, as prospective residents frequently use the proceeds from the sale of their homes to cover the cost of such fees. If seniors have difficulty selling their homes, their ability to relocate to our senior living communities or finance their stays at our senior living communities with private resources could be adversely affected. Recent high unemployment as a result of the COVID-19 pandemic may also reduce the ability of family members to relocate seniors to senior living communities, and family members' willingness and ability to offer free care may also affect seniors' relocation to senior living communities. If these and other factors reduce seniors' willingness or ability to relocate to our senior living communities, occupancy rates, revenues and cash flows at our senior living communities and our results of operations could be negatively impacted.

REIT distribution requirements and limitations on our ability to access reasonably priced capital may adversely impact our ability to carry out our business plan.

To maintain our qualification for taxation as a REIT under the IRC, we are required to satisfy distribution requirements imposed by the IRC. See “Material United States Federal Income Tax Considerations—REIT Qualification Requirements—Annual Distribution Requirements” included in Part I, Item 1 of this Annual Report on Form 10-K. Accordingly, we may not be able to retain sufficient cash to fund our operations, repay our debts, invest in our properties or fund our acquisitions or development, redevelopment or repositioning efforts. Our business strategies therefore depend, in part, upon our ability to raise additional capital at reasonable costs. The volatility in the availability of capital to businesses on a global basis in most debt and equity markets generally may limit our ability to raise reasonably priced capital. We may also be unable to raise reasonably priced capital because of reasons related to our business, market perceptions of our prospects, the terms of our indebtedness, the extent of our leverage or for reasons beyond our control, such as market conditions. Because the earnings we are permitted to retain are limited by the rules governing REIT qualification and taxation, if we are unable to raise reasonably priced capital, we may not be able to carry out our business plan.

We have a substantial amount of debt and we may incur additional debt.

As of December 31, 2021, our consolidated indebtedness was $3.7 billion, our consolidated net debt to total gross assets ratio was 32.3% and we were fully drawn on our revolving credit facility.

We are subject to numerous risks associated with our debt, including the risk that our cash flows could be insufficient for us to make required payments on our debt. There are no limits in our organizational documents on the amount of debt we may incur, and we may incur substantial debt; however, our credit agreement and our senior unsecured notes indentures and their supplements contain certain restrictions on our ability to incur additional debt for so long as certain debt service ratios are not met and we are generally restricted during the Amendment Period from incurring additional debt. Our debt obligations could have important consequences to our security holders. Our incurrence of debt may increase our vulnerability to adverse economic, market and industry conditions, limit our flexibility in planning for, or reacting to, changes in our business, and place us at a disadvantage in relation to competitors that have lower debt levels. Our incurrence of debt could also increase the costs to us of incurring additional debt, increase our exposure to floating interest rates or expose us to potential events of default (if not cured or waived) under covenants contained in debt instruments that could have a material adverse effect on our business, financial condition and operating results. Excessive debt could reduce the available cash flow to fund, or limit our ability to obtain financing for, working capital, capital expenditures, acquisitions, construction projects, refinancing, lease obligations or other purposes and hinder our ability to make or sustain distributions to our shareholders.

If we default under any of our debt obligations, we may be in default under the agreements governing other debt obligations of ours which have cross default provisions, including our credit agreement and our senior unsecured notes indentures and their supplements. In such case, our lenders or noteholders may demand immediate payment of any outstanding

41

indebtedness and could seek payment from the subsidiary guarantors under our credit agreement, seek to sell any pledged equity interests of certain subsidiaries or the mortgaged properties owned by certain pledging subsidiaries, or we could be forced to liquidate our assets for less than the values we would receive in a more orderly process.

We may need additional waivers from our lenders or waivers from our noteholders in order to avoid defaulting under our credit agreement or our public debt agreements, and the terms of our current waivers under our credit agreement impose restrictions on our ability to pay distributions and make capital investments, and any future waiver or amendment may impose similar or additional restrictions.

During 2021, we and our lenders amended our credit agreement to, among other things, obtain waivers from compliance with then existing financial covenants through June 2022. To obtain these waivers, we agreed to restrictions on our ability to pay distributions, other than as currently contemplated or to maintain our qualification for taxation as a REIT and to avoid the payment of certain income and excise taxes and make capital investments. In February 2022, we amended our credit agreement to, among other things, extend the waiver of the fixed charge coverage ratio covenant through December 31, 2022, and we also exercised our option to extend the maturity date of our revolving credit facility to January 2024. We may need to further extend these waivers or obtain additional waivers from our lenders or waivers from our noteholders in order to avoid failing to satisfy certain financial covenants under our debt agreements, but our lenders or noteholders are not required to grant any such extensions or waivers and may determine not to do so. If we fail to receive any required extensions or waivers, we may be in default under our credit agreement and the lenders could terminate our revolving credit facility and require us to pay our then outstanding borrowings under our revolving credit facility. Any future extension or waiver we may obtain may impose similar or additional restrictions, which may limit our ability to pay or increase distributions to our shareholders or make investments that we believe we should make and could reduce our ability to pursue business opportunities, grow our business and improve our operating results. In addition, continued availability of borrowings under our revolving credit facility is subject to our satisfying certain financial covenants and other credit facility conditions.

We may fail to comply with the terms of our credit agreement and our senior unsecured notes indentures and their supplements, which could adversely affect our business, would limit our ability to incur indebtedness and may prevent our making distributions to our shareholders.

Our credit agreement and our senior unsecured notes indentures and their supplements include various conditions, covenants and events of default, including certain restrictions on our ability to incur debts or make distributions under certain circumstances. We may not be able to satisfy all of these conditions or may default on some of these covenants for various reasons, including for reasons beyond our control. For example, our credit agreement and our senior unsecured notes indentures and their supplements require us to maintain certain debt service ratios (to the extent not waived). Our ability to comply with those covenants will depend upon the net rental income and returns we receive from our properties. If the occupancy at our properties declines or if our rents or returns decline, we may be unable to borrow under our revolving credit facility. Complying with these covenants may limit our ability to take actions that may be beneficial to us and our security holders. In addition, continued availability of borrowings under our revolving credit facility is subject to our satisfying certain financial covenants and other credit facility conditions. If our operating results and financial condition are significantly negatively impacted by the current economic conditions or otherwise, we may fail to satisfy covenants and conditions under our credit agreement or fail to satisfy our public debt covenants. For example, our ratio of consolidated income available for debt service to debt service was below the 1.5x incurrence requirement under our credit agreement and our public debt covenants as of December 31, 2021, and we cannot be certain when or if this ratio will exceed 1.5x. We are currently unable to incur additional debt because this ratio is below 1.5x on a pro forma basis, but are not required to repay outstanding debt as a result of failure to comply with this financial requirement. We are currently fully drawn under our revolving credit facility and could also be required to repay our outstanding debt in the event of non-compliance with certain other requirements of our credit agreement or the agreements governing our public debt. We may therefore experience future liquidity constraints, as we are currently unable to incur additional debt under our credit agreement or otherwise for failure to comply with the requirements of our credit agreement and the agreements governing our public debt. An inability to incur additional indebtedness would require us to meet our capital needs from other sources, such as cash on hand, operating cash flow, equity financing or asset sales, which may not be available to us on attractive terms or at all and we may be unable to meet our obligations or grow our business by acquiring additional properties or otherwise.

Further, if we default under our credit agreement, our lenders may demand immediate payment and may elect not to fund future borrowings. During the continuance of any event of default under our credit agreement, we may be limited or in some cases prohibited from making distributions to our shareholders. Any default under our credit agreement that results in acceleration of our obligations to repay outstanding indebtedness or in our no longer being permitted to borrow under our revolving credit facility would likely have serious adverse consequences to us and would likely cause the value of our securities to decline.

42

In the future, we may obtain additional debt financing, and the covenants and conditions which apply to any such additional debt may be more restrictive than the covenants and conditions that are contained in our credit agreement or our senior unsecured notes indentures and their supplements.

Secured indebtedness exposes us to the possibility of foreclosure, which could result in the loss of our investment in certain of our subsidiaries or in a property or group of properties or other assets that secure that indebtedness.

At December 31, 2021, we had $62.5 million aggregate principal amount of mortgage notes (excluding premiums, discounts and net debt issuance costs) secured by six properties, which excludes $620.0 million related to a joint venture arrangement in which we own a 20% equity interest. We also had two properties subject to finance leases with lease obligations totaling $6.6 million at December 31, 2021. In addition, we have pledged certain equity interests of subsidiaries owning properties to secure our obligations under our credit agreement, and have provided first mortgage liens on 61 properties owned by certain pledged subsidiaries with an undepreciated book value of $1.0 billion as of December 31, 2021, to secure our obligations, which pledges and/or mortgage liens may be removed or new ones may be added during the Amendment Period based on outstanding debt amounts, among other things.

Incurring secured indebtedness, including mortgage indebtedness, increases our risk of asset and property losses because defaults on indebtedness secured by our assets may result in foreclosure actions initiated by lenders and ultimately our loss of the property or other assets securing our obligations under our credit agreement if we default on such obligations. Any foreclosure on a property or group of properties could have a material adverse effect on the overall value of our portfolio of properties and more generally on us. For tax purposes, a foreclosure of any of our properties would be treated as a sale of the property for a purchase price equal to the outstanding balance of the indebtedness secured by the mortgage. If the outstanding balance of the indebtedness secured by the mortgage exceeds our tax basis in the property, we would recognize taxable income on foreclosure, but would not receive any cash proceeds, which could materially and adversely affect us.

Changes in market interest rates, including changes resulting from the phase out of LIBOR, may adversely affect us.

Changes in market interest rates may be sudden and may significantly impede our growth. Interest rates have remained at relatively low levels on a historical basis, but the U.S. Federal Reserve recently indicated that, in light of the economic recovery and higher than anticipated inflation, it expects to raise interest rates as early as March 2022. However the timing, number and amount of any such future interest rate increases are uncertain.

In addition, as noted in Part II, Item 7A of this Annual Report on Form 10-K, LIBOR has been phased out for new contracts and is expected to be phased out for pre-existing contracts by June 30, 2023. We are required to pay interest on borrowings under our revolving credit facility at floating rates based on LIBOR, and interest we may pay on any future borrowings under our revolving credit facility may also require that we pay interest based upon LIBOR. In September 2021, we amended our credit agreement to set forth the mechanics for establishing a replacement benchmark rate under our revolving credit facility at such time as LIBOR is no longer available to calculate interest payable on amounts outstanding thereunder. We cannot be sure that any changes to the determination of interest under our credit agreement would approximate the current calculation in accordance with LIBOR. We also cannot be certain of what standard, if any, will replace LIBOR if it is phased out or transitioned, and any alternative interest rate index that may replace LIBOR may result in our paying increased interest.

Interest rate increases may materially and negatively affect us in several ways, including:

•investors may consider whether to buy or sell our common shares based upon the distribution rate on our common shares relative to the then prevailing market interest rates. If market interest rates go up, investors may expect a higher distribution rate than we are able to pay, which may increase our cost of capital, or they may sell our common shares and seek alternative investments that offer higher distribution rates. Sales of our common shares may cause a decline in the value of our common shares;

•amounts outstanding under our revolving credit facility require interest to be paid at floating interest rates. When interest rates increase, our interest costs will increase, which could adversely affect our cash flows, our ability to pay principal and interest on our debt, our cost of refinancing our fixed rate debts when they become due and our ability to make or sustain distributions to our shareholders. Additionally, if we choose to hedge our interest rate risk, we cannot be sure that the hedge will be effective or that our hedging counterparty will meet its obligations to us; and

•property values are often determined, in part, based upon a capitalization of rental income formula. When market interest rates increase, property investors often demand higher capitalization rates and that causes property values to

43

decline. Increases in interest rates could lower the value of our properties and cause the value of our securities to decline.

Our managers or other operators may fail to comply with laws relating to the operation of our senior living communities.

We and our managers or other operators are subject to, or impacted by, extensive and frequently changing federal, state and local laws and regulations, including: licensure laws; laws protecting consumers against deceptive practices; laws relating to the operation of our properties and how our managers and other operators conduct their operations, such as with respect to health and safety, fire and privacy matters; laws affecting communities that participate in Medicaid; clinics and other healthcare facilities that participate in both Medicare and Medicaid which mandate allowable costs, pricing, reimbursement procedures and limitations, quality of services and care, food service and physical plants; resident rights laws (including abuse and neglect laws) and fraud laws; anti-kickback and physician referral laws; the Americans with Disabilities Act and similar laws; and safety and health standards established by OSHA. We and our managers and other operators are also required to comply with federal and state laws governing the privacy, security, use and disclosure of individually identifiable information, including financial information and protected health information under HIPAA.

We and our managers and other operators expend significant resources to maintain compliance with these laws and regulations. However, if we or our managers or other operators are alleged to fail, or do fail, to comply with applicable legal requirements, we or they may have to expend significant resources to respond to such allegations, and if we or they are unable to cure deficiencies, certain sanctions may be imposed and we or they may be obligated to return payments and pay fines and interest, which may adversely affect the profitability of our senior living communities and ability to obtain, renew or maintain licenses at those communities.

We and our managers and other operators and tenants face significant competition.

We face significant competition for acquisition opportunities from other investors, including publicly traded and private REITs, numerous financial institutions, individuals, foreign investors and other public and private companies. Because of competition, we may be unable to acquire, or may pay a significantly increased purchase price for, a desired property, which would reduce our expected returns from that property. Some of our competitors may have greater financial and other resources than us. Low historical market interest rates and increased leverage utilized by financial and other buyers have caused purchase prices for healthcare real estate investments to increase, therefore decreasing rates of returns. Such conditions have resulted in increased competition for investments, fewer available investment opportunities and lower spreads over the cost of capital. If such conditions continue for a protracted period, our ability to grow our business and improve our financial results may be materially and adversely affected.

We also face competition for tenants at our properties, particularly at our medical office and life science properties. Some competing properties may be newer, better located or more attractive to tenants. Competing properties may have lower rates of occupancy than our properties, which may result in competing owners offering available space at lower rents than we offer at our properties. Development activities may increase the supply of properties of the type we own in the leasing markets in which we own properties and increase the competition we face. Competition may make it difficult for us to attract and retain tenants and may reduce the rents we are able to charge and the values of our properties.

In recent years, a significant number of new senior living communities have been developed and continue to be developed. Although the rate of new development of senior living communities has slowed, which decline has accelerated during the COVID-19 pandemic, the increased supply of senior living communities from recent development activity has increased competitive pressures on our managers and other operators, particularly in certain geographic markets where we own senior living communities, and we expect these competitive challenges to continue for at least the next few years. Further, our senior living communities compete with numerous other senior living service providers, such as home healthcare companies and other real estate based service providers. Some of these senior living competitors are larger and have greater financial resources than our managers or other operators do, and some of these competitors are not for-profit entities which have endowment income and may not face the same financial pressures that they do. We cannot be sure that our managers or other operators will be able to attract a sufficient number of residents to our senior living communities at rates that will generate acceptable returns or that our managers or other operators will be able to attract employees and keep wages and other employee benefits, insurance costs and other operating expenses at levels which will allow them to compete successfully and operate our senior living communities profitably.

These competitive challenges may prevent our managers and other operators from maintaining or improving occupancy and rates at our senior living communities, which may reduce our returns from our senior living communities and adversely affect the profitability of our senior living communities, and may cause the values of our properties to decline.

44

We may be unable to lease our properties when our leases expire.

Although we typically will seek to renew our leases with current tenants when they expire, we cannot be sure that we will be successful in doing so. If our tenants do not renew their leases, we may be unable to obtain new tenants to maintain or increase the historical occupancy rates of, or rents from, our properties.

We are exposed to risks associated with property development, redevelopment and repositioning that could adversely affect us, including our financial condition and results of operations.

We currently have several properties under development and we intend to continue to engage in development, redevelopment and repositioning activities with respect to our properties, and, as a result, we are subject to certain risks, which could adversely affect us, including our financial condition and results of operations. These risks include:

•the availability and pricing of financing on favorable terms or at all;

•development costs that may be higher than anticipated;

•cost overruns and untimely completion of construction (including risks beyond our control, such as weather or labor conditions, inflation or material shortages);

•the potential that we may expend funds on, and devote management time to, projects that we do not complete; and

•the inability to complete construction and leasing of a property on schedule resulting in increased debt service expense and development and renovation costs and possible loss of tenancies.

These risks could result in substantial unanticipated delays or expenses and could prevent the initiation or the completion of development, redevelopment and repositioning activities and cause delays in leasing these properties and generating cash flows from these properties, any of which could have a material adverse effect on our business, financial condition and results of operations.

Ownership of real estate is subject to environmental risks and liabilities.

Ownership of real estate is subject to risks associated with environmental hazards. Under various laws, owners as well as operators of real estate may be required to investigate and clean up or remove hazardous substances present at or migrating from properties they own or operate and may be held liable for property damage or personal injuries that result from hazardous substances. These laws also expose us to the possibility that we may become liable to government agencies or third parties for costs and damages they incur in connection with hazardous substances. The costs and damages that may arise from environmental hazards may be substantial and are difficult to assess and estimate for numerous reasons, including uncertainty about the extent of contamination, alternative treatment methods that may be applied, the location of the property which subjects it to differing local laws and regulations and their interpretations, as well as the time it may take to remediate contamination. In addition, these laws also impose various requirements regarding the operation and maintenance of properties and recordkeeping and reporting requirements relating to environmental matters that require us or the operators of our properties to incur costs to comply with. We may incur substantial liabilities and costs for environmental matters.

We are subject to risks from adverse weather, natural disasters and climate change and climate related events, and we incur significant costs and invest significant amounts with respect to these matters.

We are subject to risks and could be exposed to additional costs from adverse weather, natural disasters and climate change and climate related events. For example, our properties could be severely damaged or destroyed from either singular extreme weather events (for example floods, storms and wildfires) or through long-term impacts of climatic conditions (such as precipitation frequency, weather instability and rise of sea levels). Such events could also adversely impact us or the tenants of our properties if we or they are unable to operate our or their businesses due to damage resulting from such events. If we fail to adequately prepare for such events, our revenues, results of operations and financial condition may be impacted. In addition, we may incur significant costs in preparing for possible future climate change or climate related events or in response to our tenants' requests for such investments and we may not realize desirable returns on those investments.

45

Vacancies in a property could result in significant capital expenditures and illiquidity and reduce the value of the property.

The loss of a tenant may reduce the value of a property and require us to spend significant amounts of capital to renovate the property before it is suitable for a new tenant. Many of the leases we enter into or acquire are for properties that are especially suited to the particular business of our tenants, such as our medical office and life science properties. Because these properties have been designed or physically modified for a particular tenant, if the current lease is terminated or not renewed, we may be required to renovate the property at substantial costs, decrease the rent we charge or provide other concessions in order to lease the property to another tenant. We may also have difficulty selling the property due to the special purpose for which the property may have been designed or modified. This potential illiquidity may limit our ability to quickly modify our portfolio in response to changes in economic or other conditions, including tenant demand.

RMR LLC and our senior living community managers rely on information technology and systems in providing services to us, and any material failure, inadequacy, interruption or security breach of that technology or those systems could materially harm us.

RMR LLC and our senior living community managers rely on information technology and systems, including the Internet and cloud-based infrastructures, commercially available software and their respective internally developed applications, to process, transmit, store and safeguard information and to manage or support a variety of their business processes (including managing our building systems), including financial transactions and maintenance of records, which may include personal identifying information of employees, residents, tenants and guarantors and lease data. If these systems experience material failures, inadequacies or interruptions, we could incur material costs and losses and our operations could be disrupted as a result. RMR LLC and our senior living community managers take various actions, and incurs significant costs, to maintain and protect the operation and security of information technology and systems, including the data maintained in those systems. However, these measures may not prevent the systems' improper functioning or a compromise in security.

Security breaches, computer viruses, attacks by hackers, online fraud schemes and similar breaches can create significant system disruptions, shutdowns, fraudulent transfer of assets or unauthorized disclosure of confidential information. The risk of a security breach or disruption, particularly through cyberattack or cyber intrusion, including by computer hackers, foreign governments and cyber terrorists, has generally increased as the number, intensity and sophistication of attempted attacks and intrusions from around the world have increased. Our cybersecurity risks are heightened by, among other things, the evolving nature of the threats faced, advances in computer capabilities, new discoveries in the field of cryptography and new and increasingly sophisticated methods used to perpetrate illegal or fraudulent activities, including cyberattacks, email or wire fraud and other attacks exploiting security vulnerabilities in RMR LLC's, our senior living community managers' or other third parties' information technology networks and systems or operations. The COVID-19 pandemic may adversely impact RMR LLC's ability to maintain the security, proper function and availability of information technology and systems since a continued period of remote working by its employees or individuals with whom RMR LLC works outside of its organization could strain its technology resources and introduce operational risk, including heightened cybersecurity risk. Remote working environments may be less secure and more susceptible to hacking attacks, including phishing and social engineering attempts that seek to exploit the COVID-19 pandemic. Although most of RMR LLC's office-based employees have returned to the office, the ongoing transition to in person work arrangements, or any return to remote work in light of the resurgence of the COVID-19 pandemic may result in the continuation of many of the risks of offsite work arrangements. In addition, RMR LLC's data security, data privacy, investor reporting and business continuity processes could be impacted by a third party's inability to perform due to the COVID-19 pandemic or by the failure of, or attack on, their information systems and technology. Any failure by RMR LLC, our senior living community managers or other third party vendors to maintain the security, proper function and availability of their respective information technology and systems could result in financial losses, interrupt our operations, damage our reputation, cause us to be in default of material contracts and subject us to liability claims or regulatory penalties, any of which could materially and adversely affect our business and the value of our securities.

Third party expectations relating to ESG factors may impose additional costs and expose us to new risks.

There is an increasing focus from certain investors and certain of our tenants and other stakeholders concerning corporate responsibility, specifically related to ESG factors. Some investors may use these factors to guide their investment strategies and, in some cases, may choose not to invest in us, or otherwise do business with us, if they believe our or RMR LLC's policies relating to corporate responsibility are inadequate. Third party providers of corporate responsibility ratings and reports on companies have increased in number, resulting in varied and in some cases inconsistent standards. In addition, the criteria by which companies' corporate responsibility practices are assessed are evolving, which could result in greater expectations of us and RMR LLC and cause us and RMR LLC to undertake costly initiatives to satisfy such new criteria. Alternatively, if we or RMR LLC elect not to or are unable to satisfy such new criteria or do not meet the criteria of a specific third party provider, some investors may conclude that our or RMR LLC's policies with respect to corporate responsibility are

46

inadequate. We and RMR LLC may face reputational damage in the event that our or their corporate responsibility procedures or standards do not meet the standards set by various constituencies. If we and RMR LLC fail to satisfy the expectations of investors and our tenants and other stakeholders or our or RMR LLC's initiatives are not executed as planned, our and RMR LLC's reputation and financial results could be adversely affected, and our revenues, results of operations and ability to grow our business may be negatively impacted.

The nature of our managers' and other operators' businesses exposes us and them to litigation and regulatory and government proceedings.

Our managers and other operators have been, are currently, and expect in the future to be involved in claims, lawsuits and regulatory and government audits, investigations and proceedings arising in the ordinary course of their and our businesses, some of which may involve material amounts, and we may also be involved in such claims, lawsuits and regulatory and government audits, investigations and proceedings at our managed communities. The defense and resolution of such claims, lawsuits and other proceedings may require our managers or other operators or us to incur significant expenses. In several well publicized instances, private litigation by residents of senior living communities for alleged abuses has resulted in large damage awards against senior living companies. Also, our managers and other operators may face increased exposures to lawsuits or other legal proceedings related to COVID-19 outbreaks. As a result of these conditions, the cost of liability insurance continues to increase.

Insurance may not adequately cover our losses, and insurance costs may continue to increase.

We or our tenants are generally responsible for the costs of insurance coverage for our properties and the operations conducted on them, including for casualty, liability, malpractice, fire, extended coverage and rental or business interruption loss insurance. In the future, we may acquire properties for which we are responsible for the costs of insurance. In the past few years, the costs of insurance have increased significantly, and these increased costs have had an adverse effect on us and our managers or other operators and tenants. Increased insurance costs may adversely affect our managers' abilities to operate our properties profitably and provide us with desirable returns and our tenants' abilities to pay us rent or result in downward pressure on rents we can charge under new or renewed leases. Losses of a catastrophic nature, such as those caused by hurricanes, flooding, volcanic eruptions and earthquakes, among other things, losses as a result of outbreaks of pandemics, including the COVID-19 pandemic, or losses from terrorism, may be covered by insurance policies with limitations such as large deductibles or co-payments that we or a tenant may not be able to pay. Insurance proceeds may not be adequate to restore an affected property to its condition prior to a loss or to compensate us for our losses, including lost revenues or other costs. Certain losses, such as losses we may incur as a result of known or unknown environmental conditions, are not covered by our insurance. Market conditions or our loss history may limit the scope of insurance or coverage available to us on economic terms. If we determine that an uninsured loss or a loss in excess of insured limits occurs and if we are not able to recover amounts from our managers and tenants for certain losses, we may have to incur uninsured costs to mitigate such losses or lose all or a portion of the capital invested in a property, as well as the anticipated future revenue from the property.

We may not succeed in selling properties we may identify for sale and any proceeds we may receive from sales we do complete may be less than expected, and we may incur losses with respect to any such sales.

To reduce our leverage, we have sold properties and other assets. Our ability to sell properties or any other assets and the prices we receive upon any sale, may be affected by various factors, including those related to the impacts of the COVID-19 pandemic, and we may be unable to execute our strategy to reduce our leverage. In particular, these factors could arise from weaknesses in or a lack of established markets for the properties we may identify for sale, changes in the financial condition or prospects of prospective purchasers for and the tenants of the properties, the terms of leases with tenants at certain of the properties, the characteristics, quality and prospects of the properties, the availability of financing to potential purchasers on reasonable terms, the number of prospective purchasers, the number of competing properties in the market, unfavorable local, national or international economic conditions, industry trends and changes in laws, regulations or fiscal policies of jurisdictions in which the properties are located. We may not succeed in selling properties or other assets and any sales may be delayed or may not occur or, if sales do occur, the terms may not meet our expectations, and we may incur losses in connection with any sales. In addition, we may elect to change or abandon our strategy to reduce leverage and forego or abandon property or other asset sales. If we are unable to realize proceeds from the sale of assets sufficient to allow us to reduce our leverage to a level we believe appropriate or which ratings agencies and possible financing sources believe appropriate, our credit ratings may be lowered, and we may further reduce our acquisition activity or investments in our existing properties.

47

Our existing and any future joint ventures may limit our flexibility with jointly owned investments and we may not realize the benefits we expect from these arrangements.

We are party to joint ventures with institutional investors for certain properties that we previously owned within our Office Portfolio segment, and we may in the future sell or contribute additional properties to, or acquire, develop or recapitalize properties in joint ventures. Our participation in joint ventures is subject to risks, including the following:

•we share approval rights over major decisions affecting the ownership or operation of the joint ventures and any property owned by the joint ventures;

•we may need to contribute additional capital in order to preserve, maintain or grow the joint ventures and their investments;

•our joint venture investors may have economic or other business interests or goals that are inconsistent with our business interests or goals and that could affect our ability to lease, relet or operate the property owned by the joint ventures or maintain our or the joint ventures' qualification for taxation as a REIT;

•our joint venture investors may be subject to different laws or regulations than us, or may be structured differently than us for tax purposes, which could create conflicts of interest and/or affect our ability to maintain our qualification for taxation as a REIT;

•our ability to sell our interest in the joint ventures or the joint ventures' ability to sell additional interests of, or properties owned by, the joint ventures when we so desire are subject to the approval rights of other joint venture investors under the terms of the agreements governing the joint ventures; and

•disagreements with joint venture investors could result in litigation or arbitration that could be expensive and distracting to management and could delay important decisions.

Any of the foregoing risks could have a material adverse effect on our business, financial condition and results of operations. Further, these, similar, enhanced or additional risks, including possible mandatory capital contribution requirements, may apply to any future additional or amended joint ventures that we may enter into.

Bankruptcy law may adversely impact us.

The occurrence of a tenant bankruptcy could reduce the rent we receive from that tenant, and the continued existence of the COVID-19 pandemic may increase the risk of our tenants and the managers and other operators of our senior living communities filing for bankruptcy. If a tenant files for bankruptcy, federal law may prohibit us from evicting that tenant based solely upon its bankruptcy, and a bankrupt tenant may be authorized to reject and terminate its lease with us. Any claims against a bankrupt tenant for unpaid future rent would be subject to statutory limitations that may be substantially less than the contractually specified rent we are owed under the lease, and any claim we have for unpaid past rent may not be paid in full. If any of our senior living community managers or other operators files for bankruptcy, we may experience delays in enforcing our rights, and may be limited in our ability to replace the manager or other operator. In the case of any tenant or manager or other operator bankruptcy, we may incur substantial costs in protecting our investment and re-leasing or finding a replacement manager or other operator.

A severe cold or flu season, epidemics or any other widespread illnesses could adversely affect the operations of our senior living communities.

Our revenues and our managers' and other operators' and tenants' revenues with respect to our senior living communities are dependent on occupancy and could significantly decrease in the event of a severe cold and flu season, an epidemic or pandemic such as the COVID-19 pandemic or any other widespread illness. Such a decrease could significantly impact our and our managers' and tenants' revenues from our senior living communities. As experienced during the COVID-19 pandemic, a future flu or other epidemic or pandemic could significantly increase the cost burdens faced by our managers or tenants, including if they are required to implement quarantines for residents, and adversely affect their ability to meet their obligations to us and our returns, which would have a material adverse effect on our financial results.

48

Risks Related to Our Relationships with RMR LLC and AlerisLife (including Five Star)

We are dependent upon RMR LLC to manage our business and implement our growth strategy.

We have no employees. Personnel and services that we require are provided to us by RMR LLC pursuant to our management agreements with RMR LLC. Our ability to achieve our business objectives depends on RMR LLC and its ability to effectively manage our properties, to appropriately identify and complete our acquisitions and dispositions and to execute our growth strategy. Accordingly, our business is dependent upon RMR LLC's business contacts, its ability to successfully hire, train, supervise and manage its personnel and its ability to maintain its operating systems. If we lose the services provided by RMR LLC or its key personnel, our business and growth prospects may decline. We may be unable to duplicate the quality and depth of management available to us by becoming internally managed or by hiring another manager. In the event RMR LLC is unwilling or unable to continue to provide management services to us, our cost of obtaining substitute services may be greater than the fees we pay RMR LLC under our management agreements, and as a result our expenses may increase.

RMR LLC has broad discretion in operating our day to day business.

Our manager, RMR LLC, is authorized to follow broad operating and investment guidelines and, therefore, has discretion in identifying the properties that will be appropriate investments for us, as well as our individual operating and investment decisions. Our Board of Trustees periodically reviews our operating and investment guidelines and our operating activities and investments but it does not review or approve each decision made by RMR LLC on our behalf. In addition, in conducting periodic reviews, our Board of Trustees relies primarily on information provided to it by RMR LLC. RMR LLC may exercise its discretion in a manner that results in investment returns that are substantially below expectations or that results in losses.

Our management structure and agreements and relationships with RMR LLC and RMR LLC's and its controlling shareholder's relationships with others may create conflicts of interest, or the perception of such conflicts, and may restrict our investment activities.

RMR LLC is a majority-owned subsidiary of RMR Inc. The Chair of our Board of Trustees who is also one of our Managing Trustees, Adam Portnoy, as the sole trustee of ABP Trust, is the controlling shareholder of RMR Inc. and is a managing director and the president and chief executive officer of RMR Inc. and an officer and employee of RMR LLC. RMR LLC or its subsidiary also acts as the manager to certain other Nasdaq listed companies and private companies, as noted elsewhere in this Annual Report on Form 10-K, and Mr. Portnoy serves as a managing director, managing trustee, director or trustee, as applicable, of those companies, and as chair of the board of trustees or board of directors, as applicable, of certain of those companies.

Jennifer Francis, our other Managing Trustee and our President and Chief Executive Officer, and Richard Siedel, Jr., our Chief Financial Officer and Treasurer, are also officers and employees of RMR LLC. Mr. Siedel is also the chief financial officer and treasurer of ILPT. Messrs. Portnoy and Siedel and Ms. Francis have duties to RMR LLC, and Mr. Siedel has duties to ILPT, as well as to us, and we do not have their undivided attention. They and other RMR LLC personnel may have conflicts in allocating their time and resources between us and RMR LLC and other companies to which RMR LLC or its subsidiaries provide services. Some of our Independent Trustees also serve as independent directors or independent trustees of other public companies to which RMR LLC or its subsidiaries provide management services.

In addition, we may in the future enter into additional transactions with RMR LLC, its affiliates or entities managed by it or its subsidiaries. In addition to his investments in RMR Inc. and RMR LLC, Mr. Portnoy holds equity investments in other companies to which RMR LLC or its subsidiaries provide management services and some of these companies have significant cross ownership interests, including, for example: as of December 31, 2021, Mr. Portnoy beneficially owned 1.1% of our common shares and approximately 6.2% of AlerisLife's outstanding common shares (including through ABP Trust), and we owned approximately 32.7% of AlerisLife's outstanding common shares. Our executive officers may also own equity investments in other companies to which RMR LLC or its subsidiaries provide management services. These multiple responsibilities, relationships and cross ownerships may give rise to conflicts of interest or the perception of such conflicts of interest with respect to matters involving us, RMR Inc., RMR LLC, our Managing Trustees, the other companies to which RMR LLC or its subsidiaries provide management services and their related parties. Conflicts of interest or the perception of conflicts of interest could have a material adverse impact on our reputation, business and the market price of our common shares and other securities and we may be subject to increased risk of litigation as a result.

49

In our management agreements with RMR LLC, we acknowledge that RMR LLC may engage in other activities or businesses and act as the manager to any other person or entity (including other REITs) even though such person or entity has investment policies and objectives similar to our policies and objectives and we are not entitled to preferential treatment in receiving information, recommendations and other services from RMR LLC. Accordingly, we may lose investment opportunities to, and may compete for tenants with, other businesses managed by RMR LLC or its subsidiaries. We cannot be sure that our Code of Conduct or our Governance Guidelines, or other procedural protections we adopt will be sufficient to enable us to identify, adequately address or mitigate actual or alleged conflicts of interest or ensure that our transactions with related persons are made on terms that are at least as favorable to us as those that would have been obtained with an unrelated person.

Our management agreements with RMR LLC were not negotiated on an arm's length basis and their fee and expense structure may not create proper incentives for RMR LLC, which may increase the risk of an investment in our common shares.

As a result of our relationships with RMR LLC and its current and former controlling shareholder(s), our management agreements with RMR LLC were not negotiated on an arm's length basis between unrelated parties, and therefore, while such agreements were negotiated with the use of a special committee and disinterested Trustees, the terms, including the fees payable to RMR LLC, may be different from those negotiated on an arm's length basis between unrelated parties. Our property management fees are calculated based on rents we receive and construction supervision fees for construction at our properties overseen and managed by RMR LLC, and our base business management fee is calculated based upon the lower of the historical costs of our real estate investments and our market capitalization. We pay RMR LLC substantial base management fees regardless of our financial results. These fee arrangements could incentivize RMR LLC to pursue acquisitions, capital transactions, tenancies and construction projects or to avoid disposing of our assets in order to increase or maintain its management fees and might reduce RMR LLC's incentive to devote its time and effort to seeking investments that provide attractive returns for us. If we do not effectively manage our investment, disposition and capital transactions and leasing, construction and other property management activities, we may pay increased management fees without proportional benefits to us. In addition, we are obligated under our management agreements to reimburse RMR LLC for employment and related expenses of RMR LLC's employees assigned to work exclusively or partly at our properties, our share of the wages, benefits and other related costs of RMR LLC's centralized accounting personnel and our share of RMR LLC's costs for providing our internal audit function. We are also required to pay for third party costs incurred with respect to us. Our obligation to reimburse RMR LLC for certain of its costs and to pay third party costs may reduce RMR LLC's incentive to efficiently manage those costs, which may increase our costs.

The termination of our management agreements with RMR LLC may require us to pay a substantial termination fee, including in the case of a termination for unsatisfactory performance, which may limit our ability to end our relationship with RMR LLC.

The terms of our management agreements with RMR LLC automatically extend on December 31 of each year so that such terms thereafter end on the 20th anniversary of the date of the extension. We have the right to terminate these agreements: (1) at any time on 60 days' written notice for convenience, (2) immediately upon written notice for cause, as defined in the agreements, (3) on written notice given within 60 days after the end of any applicable calendar year for a performance reason, as defined in the agreements, and (4) by written notice during the 12 months following a manager change of control, as defined in the agreements. However, if we terminate a management agreement for convenience, or if RMR LLC terminates a management agreement with us for good reason, as defined in such agreement, we are obligated to pay RMR LLC a termination fee in an amount equal to the sum of the present values of the monthly future fees, as defined in the applicable agreement, payable to RMR LLC for the term that was remaining before such termination, which, depending on the time of termination, would be between 19 and 20 years. Additionally, if we terminate a management agreement for a performance reason, as defined in the agreement, we are obligated to pay RMR LLC the termination fee calculated as described above, but assuming a remaining term of 10 years. These provisions substantially increase the cost to us of terminating the management agreements without cause, which may limit our ability to end our relationship with RMR LLC as our manager. The payment of the termination fee could have a material adverse effect on our financial condition, including our ability to pay distributions to our shareholders.

Our management arrangements with RMR LLC may discourage a change of control of us.

Our management agreements with RMR LLC have continuing 20 year terms that renew annually. As noted in the preceding risk factor, if we terminate either of these management agreements other than for cause or upon a change of control of our manager, we are obligated to pay RMR LLC a substantial termination fee. For these reasons, our management

50

agreements with RMR LLC may discourage a change of control of us, including a change of control which might result in payment of a premium for our common shares.

Our business dealings with AlerisLife (including Five Star) comprise a significant part of our business and operations and they may create conflicts of interest or the perception of such conflicts of interest.

AlerisLife was originally organized as our subsidiary. We distributed substantially all of our AlerisLife common shares to our shareholders on December 31, 2001. RMR LLC provides management services to both us and AlerisLife. Adam Portnoy, the Chair of our Board who is also one of our Managing Trustees, as the sole trustee of ABP Trust, is a significant shareholder of AlerisLife, beneficially owning, including through ABP Trust, approximately 6.2% of AlerisLife's outstanding common shares as of December 31, 2021. Five Star, an operating division of AlerisLife, manages a significant number of our senior living communities. In addition, Mr. Portnoy is the chair of AlerisLife's board of directors and is also one of its managing directors.

The historical and continuing relationships which we, RMR LLC and Mr. Portnoy have with AlerisLife could create, or appear to create, conflicts of interest with respect to matters involving us, the other companies to which RMR LLC or its subsidiaries provide management services and their related parties. As a result of these relationships, our agreements with AlerisLife (including Five Star) were not negotiated on an arm's length basis between unrelated parties, and therefore the terms thereof may be different from those negotiated on an arm's length basis between unrelated parties. Conflicts of interest or the perception of conflicts of interest could have a material adverse impact on our reputation, business and the market price of our common shares and other securities and we may be subject to increased risk of litigation as a result.

We may not realize the benefits we expect from our investment in AlerisLife common shares.

As of December 31, 2021, we owned 10,691,658 AlerisLife common shares, or approximately 32.7% of AlerisLife's outstanding common shares. Our investment in AlerisLife is subject to various risks, including, among others, the COVID-19 pandemic and its aftermath; the highly competitive nature of the senior living industry; medical advances and healthcare services that allow some potential residents to defer the time when they require the services available at senior living communities that Five Star manages; a competitive labor market and labor shortages within the senior living industry that are increasing our and Five Star's employment costs, including labor costs that Five Star incurs and which we are not obligated to fund or reimburse; significant regulatory requirements imposed on Five Star's business; and other factors. Many of these factors are beyond our and Five Star's control. As a result, we may not realize the benefits we expect from our investment in AlerisLife common shares, and we could incur losses from our investment.

We may be required to pay a substantial termination fee to Five Star if Five Star terminates our management agreements due to our default.

If Five Star terminates our management agreements due to certain defaults by us, we are required to pay Five Star a termination fee equal to the present value of the base management fees that we would have paid to Five Star and the allocated incentive fee for the applicable communities, if any, between the date of termination and the scheduled initial expiration date of such management agreements (but not for a period exceeding 10 years), with such amounts determined based on the average base management and incentive fees for the applicable communities for each of the three calendar years ended prior to the date of termination. Further, the payment of the termination fee could have a material adverse effect on our financial condition, including our ability to pay distributions to our shareholders.

We are party to transactions with related parties that may increase the risk of allegations of conflicts of interest.

We are party to transactions with related parties, including with entities controlled by Adam Portnoy or to which RMR LLC or its subsidiaries provide management services. Our agreements with related parties or in respect of transactions among related parties may not be on terms as favorable to us as they would have been if they had been negotiated among unrelated parties. We are subject to the risk that our shareholders or the shareholders of RMR Inc. or other related parties may challenge any such related party transactions. If challenges to related party transactions were to be successful, we might not realize the benefits expected from the transactions being challenged. Moreover, any such challenge could result in substantial costs and a diversion of our management's attention, could have a material adverse effect on our reputation, business and growth and could adversely affect our ability to realize the benefits expected from the transactions, whether or not the allegations have merit or are substantiated.

51

We may be at an increased risk for dissident shareholder activities due to perceived conflicts of interest arising from our management structure and relationships.

Companies with business dealings with related persons and entities may more often be the target of dissident shareholder trustee nominations, dissident shareholder proposals and shareholder litigation alleging conflicts of interest in their business dealings. Our relationships with RMR LLC, AlerisLife (including Five Star), the other companies to which RMR LLC or its subsidiaries provide management services, Adam Portnoy and other related persons of RMR LLC may precipitate such activities. Certain proxy advisory firms which have significant influence over the voting by shareholders of public companies have, in the past, recommended, and in the future may recommend, that shareholders withhold votes for the election of our incumbent Trustees, vote against our say on pay vote or other management proposals or vote for shareholder proposals that we oppose. These recommendations by proxy advisory firms have affected the outcomes of past Board of Trustees elections and votes on our say on pay, and similar recommendations in the future would likely affect the outcome of future Board of Trustees elections and votes on our say on pay, which may increase shareholder activism and litigation. These activities, if instituted against us, could result in substantial costs and diversion of our management's attention and could have a material adverse impact on our reputation and business.

Risks Related to Our Organization and Structure

We may change our operational, financing and investment policies without shareholder approval and we may become more highly leveraged, which may increase our risk of default under our debt obligations.

Our Board of Trustees determines our operational, financing and investment policies and may amend or revise our policies, including our policies with respect to our intention to remain qualified for taxation as a REIT, acquisitions, dispositions, growth, operations, indebtedness, capitalization and distributions, or approve transactions that deviate from these policies, without a vote of, or notice to, our shareholders. Policy changes could adversely affect the market price of our common shares and our ability to make or sustain distributions to our shareholders. Further, our organizational documents do not limit the amount or percentage of indebtedness, funded or otherwise, that we may incur. Our Board of Trustees may alter or eliminate our current policy on borrowing at any time without shareholder approval. If this policy changes, we could become more highly leveraged, which could result in an increase in our debt service costs. Higher leverage also increases the risk of default on our obligations. In addition, a change in our investment policies, including the manner in which we allocate our resources across our portfolio or the types of assets in which we seek to invest, may increase our exposure to interest rate risk, real estate market fluctuations and liquidity risk.

Ownership limitations and certain provisions in our declaration of trust, bylaws and agreements, as well as certain provisions of Maryland law, may deter, delay or prevent a change in our control or unsolicited acquisition proposals.

Our declaration of trust prohibits any shareholder, other than RMR LLC and its affiliates (as defined under Maryland law) and certain persons who have been exempted by our Board of Trustees, from owning, directly and by attribution, more than 9.8% of the number or value of shares (whichever is more restrictive) of any class or series of our outstanding shares of beneficial interest, including our common shares. This provision of our declaration of trust is intended to, among other purposes, assist with our REIT compliance under the IRC and otherwise promote our orderly governance. However, this provision may also inhibit acquisitions of a significant stake in us and may deter, delay or prevent a change in control of us or unsolicited acquisition proposals that a shareholder may consider favorable. Additionally, provisions contained in our declaration of trust and bylaws or under Maryland law may have a similar impact, including, for example, provisions relating to:

•the current different terms of our Trustees, with a majority of our existing Trustees having terms expiring in 2022 and the remainder having terms expiring in 2023, which could delay a change of control of us (although beginning at our 2023 annual meeting of shareholders and thereafter, all of our Trustees will stand for election for one year terms);

•limitations on shareholder voting rights with respect to certain actions that are not approved by our Board of Trustees;

•the authority of our Board of Trustees, and not our shareholders, to adopt, amend or repeal our bylaws and to fill vacancies on our Board of Trustees;

•shareholder voting standards which require a supermajority of shares for approval of certain actions;

•the fact that only our Board of Trustees, or, if there are no Trustees, our officers, may call shareholder meetings and that shareholders are not entitled to act without a meeting;

52

•required qualifications for an individual to serve as a Trustee and a requirement that certain of our Trustees be “Managing Trustees” and other Trustees be “Independent Trustees,” as defined in our governing documents;

•limitations on the ability of our shareholders to propose nominees for election as Trustees and propose other business to be considered at a meeting of our shareholders;

•limitations on the ability of our shareholders to remove our Trustees;

•the authority of our Board of Trustees to create and issue new classes or series of shares (including shares with voting rights and other rights and privileges that may deter a change in control) and issue additional common shares;

•restrictions on business combinations between us and an interested shareholder that have not first been approved by our Board of Trustees (including a majority of Trustees not related to the interested shareholder); and

•the authority of our Board of Trustees, without shareholder approval, to implement certain takeover defenses.

As changes occur in the marketplace for corporate governance policies, the above provisions may change, be removed, or new ones may be added.

Our rights and the rights of our shareholders to take action against our Trustees and officers are limited.

Our declaration of trust limits the liability of our Trustees and officers to us and our shareholders for money damages to the maximum extent permitted under Maryland law. Under current Maryland law, our Trustees and officers will not have any liability to us and our shareholders for money damages other than liability resulting from:

•actual receipt of an improper benefit or profit in money, property or services; or

•active and deliberate dishonesty by the Trustee or officer that was established by a final judgment as being material to the cause of action adjudicated.

Our declaration of trust and indemnification agreements require us to indemnify, to the maximum extent permitted by Maryland law, any present or former Trustee or officer who is made or threatened to be made a party to a proceeding by reason of his or her service in these and certain other capacities. In addition, we may be obligated to pay or reimburse the expenses incurred by our present and former Trustees and officers without requiring a preliminary determination of their ultimate entitlement to indemnification. As a result, we and our shareholders may have more limited rights against our present and former Trustees and officers than might otherwise exist absent the provisions in our declaration of trust and indemnification agreements or that might exist with other companies, which could limit our shareholders' recourse in the event of actions not in their best interest.

Shareholder litigation against us or our Trustees, officers, managers or other agents may be referred to mandatory arbitration proceedings, which follow different procedures than in-court litigation and may be more restrictive to shareholders asserting claims than in-court litigation.

Our shareholders agree, by virtue of becoming shareholders, that they are bound by our governing documents, including the arbitration provisions of our bylaws, as they may be amended from time to time. Our bylaws provide that certain actions by one or more of our shareholders against us or any of our Trustees, officers, managers or other agents, other than disputes, or any portion thereof, regarding the meaning, interpretation or validity of any provision of our declaration of trust or bylaws, will be referred to mandatory, binding and final arbitration proceedings if we, or any other party to such dispute, including any of our Trustees, officers, managers or other agents, unilaterally so demands. As a result, we and our shareholders would not be able to pursue litigation in state or federal court against us or our Trustees, officers, managers or other agents, including, for example, claims alleging violations of federal securities laws or breach of fiduciary duties or similar director or officer duties under Maryland law, if we or any of our Trustees, officers, managers or other agents against whom the claim is made unilaterally demands the matter be resolved by arbitration. Instead, our shareholders would be required to pursue such claims through binding and final arbitration.

Our bylaws provide that such arbitration proceedings would be conducted in accordance with the procedures of the Commercial Arbitration Rules of the American Arbitration Association, as modified in our bylaws. These procedures may provide materially more limited rights to our shareholders than litigation in a federal or state court. For example, arbitration in accordance with these procedures does not include the opportunity for a jury trial, document discovery is limited, arbitration

53

hearings generally are not open to the public, there are no witness depositions in advance of arbitration hearings and arbitrators may have different qualifications or experiences than judges. In addition, although our bylaws' arbitration provisions contemplate that arbitration may be brought in a representative capacity or on behalf of a class of our shareholders, the rules governing such representation or class arbitration may be different from, and less favorable to shareholders than, the rules governing representative or class action litigation in courts. Our bylaws also generally provide that each party to such an arbitration is required to bear its own costs in the arbitration, including attorneys' fees, and that the arbitrators may not render an award that includes shifting of such costs or, in a derivative or class proceeding, award any portion of our award to any shareholder or such shareholder's attorneys. The arbitration provisions of our bylaws may discourage our shareholders from bringing, and attorneys from agreeing to represent our shareholders wishing to bring, litigation against us or our Trustees, officers, managers or other agents. Our agreements with AlerisLife (including Five Star) and RMR LLC have similar arbitration provisions to those in our bylaws.

We believe that the arbitration provisions in our bylaws are enforceable under both state and federal law, including with respect to federal securities laws claims. We are a Maryland real estate investment trust and Maryland courts have upheld the enforceability of arbitration bylaws. In addition, the U.S. Supreme Court has repeatedly upheld agreements to arbitrate other federal statutory claims, including those that implicate important federal policies. However, some academics, legal practitioners and others are of the view that charter or bylaw provisions mandating arbitration are not enforceable with respect to federal securities laws claims. It is possible that the arbitration provisions of our bylaws may ultimately be determined to be unenforceable.

By agreeing to the arbitration provisions of our bylaws, shareholders will not be deemed to have waived compliance by us with federal securities laws and the rules and regulations thereunder.

Our bylaws designate the Circuit Court for Baltimore City, Maryland as the sole and exclusive forum for certain actions and proceedings that may be initiated by our shareholders, which could limit our shareholders' ability to obtain a judicial forum they deem favorable for disputes with us or our Trustees, officers, managers or other agents.

Our bylaws currently provide that, unless the dispute has been referred to binding arbitration, the Circuit Court for Baltimore City, Maryland will be the sole and exclusive forum for: (1) any derivative action or proceeding brought on our behalf; (2) any action asserting a claim for breach of a duty owed by any Trustee, officer, manager, agent or employee of ours to us or our shareholders; (3) any action asserting a claim against us or any Trustee, officer, manager, agent or employee of ours arising pursuant to Maryland law, our declaration of trust or bylaws brought by or on behalf of a shareholder, either on his, her or its own behalf, on our behalf or on behalf of any series or class of shares of beneficial interest of ours or by our shareholders against us or any Trustee, officer, manager, agent or employee of ours, including any disputes, claims or controversies relating to the meaning, interpretation, effect, validity, performance or enforcement of our declaration of trust or bylaws; or (4) any action asserting a claim against us or any Trustee, officer, manager, agent or employee of ours that is governed by the internal affairs doctrine. Our bylaws currently also provide that the Circuit Court for Baltimore City, Maryland will be the sole and exclusive forum for any dispute, or portion thereof, regarding the meaning, interpretation or validity of any provision of our declaration of trust or bylaws. The exclusive forum provision of our bylaws does not apply to any action for which the Circuit Court for Baltimore City, Maryland does not have jurisdiction or to a dispute that has been referred to binding arbitration in accordance with our bylaws. The exclusive forum provision of our bylaws does not establish exclusive jurisdiction in the Circuit Court for Baltimore City, Maryland for claims that arise under the Securities Act, the Exchange Act or other federal securities laws if there is exclusive or concurrent jurisdiction in the federal courts. Any person or entity purchasing or otherwise acquiring or holding any interest in our shares of beneficial interest shall be deemed to have notice of and to have consented to these provisions of our bylaws, as they may be amended from time to time. The arbitration and exclusive forum provisions of our bylaws may limit a shareholder's ability to bring a claim in a judicial forum that the shareholder believes is favorable for disputes with us or our Trustees, officers, managers or other agents, which may discourage lawsuits against us and our Trustees, officers, managers or other agents.

Risks Related to Our Taxation

Our failure to remain qualified for taxation as a REIT under the IRC could have significant adverse consequences.

As a REIT, we generally do not pay federal or most state income taxes as long as we distribute all of our REIT taxable income and meet other qualifications set forth in the IRC. However, actual qualification for taxation as a REIT under the IRC depends on our satisfying complex statutory requirements, for which there are only limited judicial and administrative interpretations. We believe that we have been organized and have operated, and will continue to be organized and to operate, in a manner that qualified and will continue to qualify us to be taxed as a REIT under the IRC. However, we cannot be sure that

54

the IRS, upon review or audit, will agree with this conclusion. Furthermore, we cannot be sure that the federal government, or any state or other taxation authority, will continue to afford favorable income tax treatment to REITs and their shareholders.

Maintaining our qualification for taxation as a REIT under the IRC will require us to continue to satisfy tests concerning, among other things, the nature of our assets, the sources of our income and the amounts we distribute to our shareholders. In order to meet these requirements, it may be necessary for us to sell or forgo attractive investments.

If we cease to qualify for taxation as a REIT under the IRC, then our ability to raise capital might be adversely affected, we will be in breach under our credit agreement, we may be subject to material amounts of federal and state income taxes, our cash available for distribution to our shareholders could be reduced, and the market price of our common shares could decline. In addition, if we lose or revoke our qualification for taxation as a REIT under the IRC for a taxable year, we will generally be prevented from requalifying for taxation as a REIT for the next four taxable years.

Distributions to shareholders generally will not qualify for reduced tax rates applicable to “qualified dividends.”

Dividends payable by U.S. corporations to noncorporate shareholders, such as individuals, trusts and estates, are generally eligible for reduced federal income tax rates applicable to “qualified dividends.” Distributions paid by REITs generally are not treated as “qualified dividends” under the IRC and the reduced rates applicable to such dividends do not generally apply. However, for tax years beginning before 2026, REIT dividends paid to noncorporate shareholders are generally taxed at an effective tax rate lower than applicable ordinary income tax rates due to the availability of a deduction under the IRC for specified forms of income from passthrough entities. More favorable rates will nevertheless continue to apply to regular corporate “qualified” dividends, which may cause some investors to perceive that an investment in a REIT is less attractive than an investment in a non-REIT entity that pays dividends, thereby reducing the demand and market price of our common shares.

REIT distribution requirements could adversely affect us and our shareholders.

We generally must distribute annually at least 90% of our REIT taxable income, subject to specified adjustments and excluding any net capital gain, in order to maintain our qualification for taxation as a REIT under the IRC. To the extent that we satisfy this distribution requirement, federal corporate income tax will not apply to the earnings that we distribute, but if we distribute less than 100% of our REIT taxable income, then we will be subject to federal corporate income tax on our undistributed taxable income. We intend to make distributions to our shareholders to comply with the REIT requirements of the IRC. In addition, we will be subject to a 4% nondeductible excise tax if the actual amount that we pay out to our shareholders in a calendar year is less than a minimum amount specified under federal tax laws.

From time to time, we may generate taxable income greater than our income for financial reporting purposes prepared in accordance with U.S. generally accepted accounting principles, or GAAP, or differences in timing between the recognition of taxable income and the actual receipt of cash may occur. If we do not have other funds available in these situations, among other things, we may borrow funds on unfavorable terms, sell investments at disadvantageous prices or distribute amounts that would otherwise be invested in future acquisitions in order to make distributions sufficient to enable us to pay out enough of our taxable income to satisfy the REIT distribution requirement and to avoid corporate income tax and the 4% excise tax in a particular year. These alternatives could increase our costs or reduce our shareholders' equity. Thus, compliance with the REIT distribution requirements may hinder our ability to grow, which could cause the market price of our common shares to decline.

Even if we remain qualified for taxation as a REIT under the IRC, we may face other tax liabilities that reduce our cash flow.

Even if we remain qualified for taxation as a REIT under the IRC, we may be subject to federal, state and local taxes on our income and assets, including taxes on any undistributed income, excise taxes, state or local income, property and transfer taxes, and other taxes. Also, some jurisdictions may in the future limit or eliminate favorable income tax deductions, including the dividends paid deduction, which could increase our income tax expense. In addition, in order to meet the requirements for qualification and taxation as a REIT under the IRC, prevent the recognition of particular types of non-cash income, or avert the imposition of a 100% tax that applies to specified gains derived by a REIT from dealer property or inventory, we may hold or dispose of some of our assets and conduct some of our operations through our TRSs or other subsidiary corporations that will be subject to corporate level income tax at regular rates. In addition, while we intend that our transactions with our TRSs will be conducted on arm's length bases, we may be subject to a 100% excise tax on a transaction that the IRS or a court determines was not conducted at arm's length. Any of these taxes would decrease cash available for distribution to our shareholders.

55

If arrangements involving our TRSs fail to comply as intended with the REIT qualification and taxation rules, we may fail to qualify for taxation as a REIT under the IRC or be subject to significant penalty taxes.

We lease most of our properties to our TRSs pursuant to arrangements that, under the IRC, are intended to qualify the rents we receive from our TRSs as income that satisfies the REIT gross income tests. We also intend that our transactions with our TRSs be conducted on arm's length bases so that we and our TRSs will not be subject to penalty taxes under the IRC applicable to mispriced transactions. While relief provisions can sometimes excuse REIT gross income test failures, significant penalty taxes may still be imposed.

For those TRS arrangements intended to comply with the REIT qualification and taxation rules under the IRC, a number of requirements must be satisfied, including:

•our TRSs may not directly or indirectly operate or manage a healthcare facility, as defined by the IRC;

•the leases to our TRSs must be respected as true leases for federal income tax purposes and not as service contracts, partnerships, joint ventures, financings or other types of arrangements;

•the leased properties must constitute qualified healthcare properties (including necessary or incidental property) under the IRC;

•our leased properties must be managed and operated on behalf of the TRSs by independent contractors who are less than 35% affiliated with us and who are actively engaged (or have affiliates so engaged) in the trade or business of managing and operating qualified healthcare properties for any person unrelated to us; and

•the rental and other terms of the leases must be arm's length.

We cannot be sure that the IRS or a court will agree with our assessment that our TRS arrangements comply as intended with REIT qualification and taxation rules. If arrangements involving our TRSs fail to comply as we intended, we may fail to qualify for taxation as a REIT under the IRC or be subject to significant penalty taxes.

Legislative or other actions affecting REITs could materially and adversely affect us and our shareholders.

The rules dealing with U.S. federal, state, and local taxation are constantly under review by persons involved in the legislative process and by the IRS, the U.S. Department of the Treasury, and other taxation authorities. Changes to the tax laws, with or without retroactive application, could materially and adversely affect us and our shareholders. We cannot predict how changes in the tax laws might affect us or our shareholders. New legislation, Treasury regulations, administrative interpretations or court decisions could significantly and negatively affect our ability to remain qualified for taxation as a REIT or the tax consequences of such qualification to us and our shareholders.

Risks Related to Our Securities

Our quarterly cash distribution rate on our common shares is currently $0.01 per share and future distributions may remain at this level for an indefinite period or be eliminated and the form of payment could change.

During 2020, we reduced our quarterly cash distribution rate on our common shares to $0.01 per share. We currently intend to continue to make quarterly distributions to our shareholders at this rate at least through the Amendment Period, and possibly thereafter, subject to applicable REIT tax requirements. However:

•our ability to make or sustain the rate of distributions may continue to be adversely affected if any of the risks described in this Annual Report on Form 10-K occur, including any negative impact caused by the COVID-19 pandemic and its aftermath on our business, results of operations and liquidity;

•our making of distributions is subject to compliance with restrictions contained in our credit agreement, including being limited to amounts required to maintain our qualification for taxation as a REIT and $0.01 per common share per quarter during the Amendment Period, and during the continuance of any event of default under the agreements governing our debt, we may be limited or in some cases prohibited from making distributions to our shareholders; and

56

•the timing and amount of any distributions will be determined at the discretion of our Board of Trustees and will depend on various factors that our Board of Trustees deems relevant, including, but not limited to, our funds from operations attributable to common shareholders, or FFO attributable to common shareholders, our normalized funds from operations attributable to common shareholders, or Normalized FFO attributable to common shareholders, requirements to maintain our qualification for taxation as a REIT, limitations in the agreements governing our debt, the availability to us of debt and equity capital, our expectation of our future capital requirements and operating performance and our expected needs for and availability of cash to pay our obligations.

For these reasons, among others, our distribution rate may not increase for an indefinite period or we may cease making distributions to our shareholders.

Further, in order to preserve liquidity, we may elect to pay distributions to our shareholders in part in a form other than cash, such as issuing additional common shares of ours to our shareholders, as permitted by the applicable tax rules.

The Notes and the Guarantees are structurally subordinated to the payment of all indebtedness and other liabilities of our subsidiaries that do not guarantee the 2025 Notes and the 2031 Notes.

We are the sole obligor on our outstanding senior unsecured notes and any notes or other debt securities we may issue in the future, or, together with our outstanding senior unsecured notes, the Notes. Our subsidiaries that guarantee our 9.75% senior notes due 2025, or the 2025 Notes, and our 4.375% senior notes due 2031, or the 2031 Notes, are the sole obligor on the guarantees of such notes, or the Guarantees. The subsidiaries that guarantee the 2025 Notes and the 2031 Notes do not currently guarantee any of our other Notes. Our non-guarantor subsidiaries are separate and distinct legal entities and have no obligation, contingent or otherwise, to pay any amounts due on the Notes or the Guarantees, or to make any funds available therefor, whether by dividend, distribution, loan or other payments. The rights of holders of the Notes to benefit from any of the assets of our non-guarantor subsidiaries are subject to the prior satisfaction of claims of those subsidiaries' creditors. As a result, the Notes and the Guarantees are, and, except to the extent that future Notes are guaranteed by our non-guarantor subsidiaries, will be, structurally subordinated to all indebtedness and other liabilities of our subsidiaries that do not guarantee the 2025 Notes and the 2031 Notes, including guarantees of or pledges under other indebtedness of ours, payment obligations under lease agreements, trade payables and preferred equity. As of December 31, 2021, our non-guarantor subsidiaries had total indebtedness and other liabilities of approximately $88.0 million (including guarantees of other indebtedness and trade payables, but excluding liabilities to us or a subsidiary guarantor), which are structurally senior to the 2025 Notes and the 2031 Notes.

The Notes and the Guarantees are unsecured and effectively subordinated to all of our and the subsidiary guarantors’ existing and future secured indebtedness to the extent of the value of the assets securing such indebtedness.

The outstanding Notes and Guarantees are not secured and any Notes we may issue in the future may not be secured. Upon any distribution to our creditors in a bankruptcy, liquidation, reorganization or similar proceeding relating to us or our property, the holders of our secured debt, including debt under our credit agreement (to the extent such debt remains outstanding and is still then secured), will be entitled to exercise the remedies available to a secured lender under applicable law and pursuant to the instruments governing such debt and to be paid in full, from the assets securing that secured debt before any payment may be made with respect to the Notes that are not secured by those assets. In that event, because such Notes and the Guarantees will not be secured by any of our assets, it is possible that there will be no assets from which claims of holders of such Notes can be satisfied or, if any assets remain, that the remaining assets will be insufficient to satisfy those claims in full. If the value of such remaining assets is less than the aggregate outstanding principal amount of such Notes and accrued interest and all future debt ranking equally with such Notes and the Guarantees, we will be unable to fully satisfy our obligations under such Notes. In addition, if we fail to meet our payment or other obligations under our secured debt, the holders of that secured debt would be entitled to foreclose on our assets securing that secured debt and liquidate those assets. Accordingly, we may not have sufficient funds to pay amounts due on such Notes. As a result, noteholders may lose a portion or the entire value of their investment in such Notes. Further, the terms of the outstanding Notes and the Guarantees permit, and the terms of any Notes we may issue in the future may permit, us to incur additional secured indebtedness subject to compliance with certain debt ratios. The Notes and the Guarantees will be effectively subordinated to any such additional secured indebtedness. As of February 21, 2022, our secured debt included outstanding borrowings under our revolving credit facility, which is secured by pledges of equity in certain subsidiaries that own properties.

57

Federal and state statutes allow courts, under specific circumstances, to void guarantees and require holders of notes to return payments received from guarantors.

Under the federal bankruptcy law and comparable provisions of state fraudulent transfer laws, a guarantee of the 2025 Notes and the 2031 Notes (or any future Notes that are guaranteed by our subsidiaries) could be voided, or claims in respect of a guarantee could be subordinated to all other debts of that guarantor if, among other things, the guarantor, at the time it incurred the debt evidenced by its guarantee:

•received less than reasonably equivalent value or fair consideration for the incurrence of such guarantee; and

•was insolvent or rendered insolvent by reason of such incurrence;

•was engaged in a business or transaction for which the guarantor's remaining assets constituted unreasonably small capital; or

•intended to incur, or believed that it would incur, debts beyond its ability to pay such debts as they mature.

In addition, any payment by that guarantor pursuant to its guarantee could be voided and required to be returned to the guarantor, or to a fund for the benefit of our creditors or the creditors of the guarantor.

The measures of insolvency for purposes of these fraudulent transfer laws will vary depending upon the law applied in any proceeding to determine whether a fraudulent transfer has occurred. Generally, however, a guarantor would be considered insolvent if:

•the sum of its debts, including contingent liabilities, was greater than the fair saleable value of all of its assets;

•the present fair saleable value of its assets was less than the amount that would be required to pay its probable liability on its existing debts, including contingent liabilities, as they become absolute and mature; or

•it could not pay its debts as they become due.

We cannot be sure as to what standard a court would apply in making these determinations. In addition, each Guarantee contains, and any future guarantees may contain, a provision intended to limit the guarantor's liability to the maximum amount that it could incur without causing the incurrence of obligations under its guarantee to be a fraudulent transfer. This provision may not be effective to protect the Guarantees or any future guarantees from being voided under fraudulent transfer laws, or may eliminate the guarantor's obligations or reduce the guarantor's obligations to an amount that effectively makes the guarantee worthless.

There may be no public market for certain of the Notes, and one may not develop, be maintained or be liquid.

We have not applied for listing of certain of the Notes on any securities exchange or for quotation on any automatic dealer quotation system, and we may not do so for Notes issued in the future. We cannot be sure of the liquidity of any market that may develop for such Notes, the ability of any holder to sell such Notes or the price at which holders would be able to sell such Notes. If a market for such Notes does not develop, holders may be unable to resell such Notes for an extended period of time, if at all. If a market for such Notes does develop, it may not continue or it may not be sufficiently liquid to allow holders to resell such Notes. Consequently, holders of the Notes may not be able to liquidate their investment readily, and lenders may not readily accept such Notes as collateral for loans.

The Notes may trade at a discount from their initial issue price or principal amount, depending upon many factors, including prevailing interest rates, the ratings assigned by rating agencies, the market for similar securities and other factors, including general economic conditions and our financial condition, performance and prospects. Any decline in market prices, regardless of cause, may adversely affect the liquidity and trading markets for the Notes.

A downgrade in credit ratings could materially adversely affect the market price of the Notes and may increase our cost of capital.

The outstanding Notes are rated by two rating agencies and any Notes we may issue in the future may be rated by one or more rating agencies. These credit ratings are continually reviewed by rating agencies and may change at any time based upon, among other things, our results of operations and financial condition. In February 2022, Moody's Investors Service, or

58

Moody's, downgraded our senior unsecured debt rating from B1 to B3, our 9.75% senior notes due 2025 rating from Ba3 to B2 and our 4.375% senior notes due 2031 rating from Ba3 to B2. In February 2021, Standard & Poor's Ratings Services, or Standard & Poor's, downgraded our senior unsecured debt rating from BB to BB- and our 9.75% senior notes due 2025 rating from BB+ to BB and assigned a BB rating to our 4.375% senior notes due 2031. Negative changes in the ratings assigned to our debt securities could have an adverse effect on the market price of the Notes and our cost and availability of capital, which could in turn have a material adverse effect on our results of operations and our ability to satisfy our debt service obligations.

We may not have the ability to raise the funds necessary to finance the repurchase of the 2025 Notes upon a change of control event as will be required by the indenture for the notes.

Upon the occurrence of a change of control, we will be required to offer to repurchase the outstanding 2025 Notes and 2031 Notes at 101% of the principal amount thereof, plus accrued and unpaid interest on such Notes, if any, to, but not including, the date of repurchase. However, it is possible that we will not have sufficient funds, or the ability to raise sufficient funds, at the time of the change of control to make the required repurchase of such Notes. In addition, the occurrence of certain events that constitute a change of control would constitute an event of default under our credit agreement, and restrictions under future debt we may incur may not allow us to repurchase such Notes upon a change of control, which could result in such debt becoming immediately due and payable and the commitments thereunder terminated. If we could not refinance such debt or otherwise obtain a waiver from the holders of such debt, we would be prohibited from repurchasing the 2025 Notes and the 2031 Notes, which would constitute an event of default under the indenture and related supplements governing such Notes, which in turn would constitute a default under such debt arrangements. In addition, certain important corporate events, such as leveraged recapitalizations that would increase the level of our indebtedness, would not constitute a “Change of Control” under the indenture and related supplements governing the 2025 Notes and the 2031 Notes although these types of transactions could affect our capital structure or credit ratings and the holders of such Notes. Further, courts interpreting change of control provisions under New York law (which is the governing law of the indenture governing the 2025 Notes) have not provided clear and consistent meanings of such change of control provisions which leads to subjective judicial interpretation of what may constitute a “Change of Control.”

Some or all of the Guarantees may be released automatically.

A subsidiary guarantor may be released from its Guarantee under certain circumstances. Such release may occur at any time upon a sale, disposition or transfer, in compliance with the provisions of the indenture and related supplements governing the 2025 Notes and the 2031 Notes, of the capital stock of such subsidiary guarantor or of substantially all of the assets of such subsidiary guarantor, or if such subsidiary guarantor becomes an Excluded Subsidiary or a Foreign Subsidiary, as such terms are defined in the applicable supplemental indenture. In addition, if the 2025 Notes and the 2031 Notes have a rating equal to or higher than Baa2 (or the equivalent) by Moody's or BBB (or the equivalent) by Standard & Poor's and at such time no default or event of default under the indenture and related supplements governing the 2025 Notes and the 2031 Notes has occurred and is continuing, the Guarantees and all other obligations of the subsidiary guarantors under the indenture will automatically terminate and be released. Accordingly, the 2025 Notes and the 2031 Notes may not at all times be guaranteed by some or all of the subsidiaries which guaranteed the 2025 Notes or the 2031 Notes on the date they were initially issued.

Item 1B.  Unresolved Staff Comments.

None.

Item 2.  Properties.

At December 31, 2021, our portfolio was comprised of 390 wholly owned properties. The gross book value of real estate assets at cost plus certain acquisition costs, before depreciation and purchase price allocations and less impairment write downs, of these properties totaled $7.2 billion at December 31, 2021. As of December 31, 2021, eight properties with gross book value of real estate assets at cost plus certain acquisition costs, before depreciation and purchase price allocations and less impairment write downs, of $177.4 million and a net book value of $118.3 million were subject to secured financing and finance lease obligations with an aggregate principal balance of $69.1 million.

59

The following table summarizes certain information about our wholly owned properties as of December 31, 2021. All dollar amounts are in thousands:

	Office Portfolio					Senior Housing Operating Portfolio					All Other					Consolidated
State	Number  of Properties	Gross Book Value of Real Estate Assets(1)		Net Book Value		Number of Properties	Gross Book Value of Real Estate Assets(1)		Net Book Value		Number of Properties	Gross Book Value of Real Estate Assets(1)		Net Book Value		Number of Properties	Gross Book Value of Real Estate Assets(1)		Net Book Value
AL	—	$	—	$	—	8	$	97,152	$	70,717	—	$	—	$	—	8	$	97,152	$	70,717
AR	—	—		—		3	43,497		27,268		—	—		—		3	43,497		27,268
AZ	4	71,120		53,774		6	146,541		91,745		1	3,510		2,041		11	221,171		147,560
CA	13	654,494		500,771		9	190,162		126,709		1	7,281		4,521		23	851,937		632,001
CO	2	20,758		13,305		8	93,659		62,529		2	18,833		12,931		12	133,250		88,765
CT	1	7,644		5,490		—	—		—		—	—		—		1	7,644		5,490
DC	2	106,496		84,369		—	—		—		—	—		—		2	106,496		84,369
DE	—	—		—		6	99,651		63,491		—	—		—		6	99,651		63,491
FL	7	40,337		28,778		19	633,200		421,890		2	12,326		10,794		28	685,863		461,462
GA	5	77,426		51,740		22	269,251		187,618		5	96,969		72,693		32	443,646		312,051
HI	1	78,297		58,638		—	—		—		—	—		—		1	78,297		58,638
ID	—	—		—		—	—		—		2	22,703		16,250		2	22,703		16,250
IL	4	67,919		45,023		11	179,068		109,731		1	20,641		14,094		16	267,628		168,848
IN	1	22,434		13,282		11	171,812		122,885		2	69,167		51,931		14	263,413		188,098
KS	2	62,011		40,269		3	62,526		41,168		—	—		—		5	124,537		81,437
KY	—	—		—		9	107,418		63,219		—	—		—		9	107,418		63,219
MA	8	190,127		146,449		1	32,775		20,049		—	—		—		9	222,902		166,498
MD	3	45,528		30,778		11	253,450		179,096		1	20,964		15,429		15	319,942		225,303
MI	—	—		—		—	—		—		5	15,942		9,318		5	15,942		9,318
MN	9	121,914		86,431		1	15,313		13,651		2	6,319		3,715		12	143,546		103,797
MO	3	139,175		93,564		5	71,058		47,899		—	—		—		8	210,233		141,463
NC	2	60,748		44,325		16	228,353		175,732		1	6,839		3,990		19	295,940		224,047
NE	—	—		—		1	8,305		5,574		1	26,702		19,339		2	35,007		24,913
NJ	—	—		—		4	108,468		74,708		—	—		—		4	108,468		74,708
NM	2	38,111		27,932		1	33,485		20,516		3	33,303		22,077		6	104,899		70,525
NV	—	—		—		2	83,497		59,930		—	—		—		2	83,497		59,930
NY	5	116,108		84,846		1	114,262		84,065		—	—		—		6	230,370		168,911
OH	1	18,601		12,217		1	45,149		27,662		1	4,428		1,867		3	68,178		41,746
OR	—	—		—		1	47,216		43,649		—	—		—		1	47,216		43,649
PA	5	62,618		44,400		9	85,282		54,694		2	3,535		2,103		16	151,435		101,197
SC	2	15,978		10,103		18	136,680		103,526		2	3,935		2,362		22	156,593		115,991
TN	1	9,570		6,320		14	176,029		140,372		2	15,667		10,874		17	201,266		157,566
TX	13	268,920		182,831		13	360,285		248,113		1	20,502		14,514		27	649,707		445,458
VA	8	125,642		85,248		12	144,007		99,509		—	—		—		20	269,649		184,757
WA	2	38,349		25,372		—	—		—		2	18,940		11,827		4	57,289		37,199
WI	10	169,236		120,750		7	114,642		83,176		—	—		—		17	283,878		203,926
WY	—	—		—		2	10,147		5,183		—	—		—		2	10,147		5,183
Total	116	$	2,629,561	$	1,897,005	235	$	4,162,340	$	2,876,074	39	$	428,506	$	302,670	390	$	7,220,407	$	5,075,749

(1)     Represents gross book value of real estate assets at cost plus certain acquisition costs, before depreciation and purchase price allocations and less impairment write downs, if any.

60

Item 3.  Legal Proceedings.

From time to time, we may become involved in litigation matters incidental to the ordinary course of our business. Although we are unable to predict with certainty the eventual outcome of any litigation, we are currently not a party to any litigation which we expect to have a material adverse effect on our business.

Item 4.  Mine Safety Disclosures.

Not applicable.

PART II

Item 5.  Market for Registrant's Common Equity, Related Stockholder Matters and Issuer Purchases of Equity Securities.

Our common shares are traded on Nasdaq (symbol: DHC).

As of February 21, 2022, there were 1,350 shareholders of record of our common shares, although there is a larger number of beneficial owners.

Issuer purchases of equity securities. The following table provides information about our purchases of our equity securities during the quarter ended December 31, 2021:

Calendar Month	Number of Shares Purchased(1)	Average Price Paid per Share		Total Number of Shares Purchased as Part of Publicly Announced Plans or Programs	Maximum Approximate Dollar Value of Shares that May Yet Be Purchased Under the Plans or Programs
October 2021	541	$	3.50	—	$	—
Total	541	$	3.50	—	$	—

(1) These common share withholdings and purchases were made to satisfy tax withholding and payment obligations of a former employee of RMR LLC in connection with the vesting of prior awards of our common shares. We withheld and purchased these shares at their fair market value based upon the trading price of our common shares at the close of trading on Nasdaq on the purchase date.

Our current cash distribution rate to common shareholders is $0.01 per share per quarter, or $0.04 per share per year. However, the timing, amount and form of future distributions will be determined at the discretion of our Board of Trustees and will depend upon various factors that our Board of Trustees deems relevant, including our historical and projected net income, Normalized FFO, our then current and expected needs and availability of cash to pay our obligations, distributions which we may be required to pay to satisfy our REIT distribution requirements, limitations in the agreements governing our debt and other factors deemed relevant by our Board of Trustees in its discretion. Therefore, we cannot be sure that we will continue to pay distributions in the future or that the amount of any distributions we do pay will not decrease.

Item 6.  [Reserved]

61

Item 7.  Management's Discussion and Analysis of Financial Condition and Results of Operations.

The following discussion should be read in conjunction with our Consolidated Financial Statements included in Part IV, Item 15 of this Annual Report on Form 10-K.

OVERVIEW

We are a REIT that was organized under Maryland law and which owns medical office and life science properties, senior living communities and other healthcare related properties throughout the United States. As of December 31, 2021, we wholly owned 390 properties, including eight closed senior living communities, located in 36 states and Washington, D.C. At December 31, 2021, the gross book value of our real estate assets at cost plus certain acquisition costs, before depreciation and purchase price allocations and less impairment write downs, was $7.2 billion.

As of December 31, 2021, we owned a 20% equity interest in an unconsolidated joint venture that owns a life science property located in Boston, Massachusetts with approximately 1.1 million rentable square feet that was 100% leased with an average (by annualized rental revenues) remaining lease term of 7.0 years. In January 2022, we entered into a joint venture for 10 medical office and life science properties we owned with two unrelated third party global institutional investors. We continue to own a 20% equity interest in this joint venture.

Our business is focused on healthcare related properties, including medical office and life science properties, senior living communities, wellness centers and other medical and healthcare related properties. We believe that the healthcare sector and many of our tenants, managers and operators provide essential services across the United States. Due to restrictions intended to prevent the spread of the virus that causes COVID-19, certain of our medical office and wellness center tenants, which include physician practices that had discontinued non-essential surgeries and procedures and fitness centers, that had been ordered closed by state executive orders experienced disruptions to their businesses. Our senior living community operators also experienced disruptions, including limitations on in-person tours and new admissions, and experienced challenges in attracting new residents to their communities in addition to experiencing increased expenses due to increased labor costs, including higher health benefits costs, and increased costs and consumption of supplies, including personal protective equipment. There will be lasting impacts of the COVID-19 pandemic, even as states and municipalities have eased and may further ease restrictions. Our tenants and their businesses may become increasingly negatively impacted, which may result in our tenants seeking assistance from us regarding their rent obligations owed to us, their being unable or unwilling to pay us rent, their ceasing to pay us rent and their ceasing to continue as going concerns.

We are closely monitoring the impacts of the COVID-19 pandemic on all aspects of our business, including, but not limited to, labor availability and cost pressures from supply chain disruptions and commodity price inflation in our SHOP segment.

With respect to our SHOP segment, we expect that our senior living community managers will be operating our communities at lower average occupancy with higher operating expenses per resident as a result of the COVID-19 pandemic, which will likely lead to decreased returns to us. Our managers continue to follow federal, state and local health department guidelines and their own infection prevention protocols but we expect to see additional cases of COVID-19 in our senior living communities.

Throughout the first quarter of 2021, Five Star coordinated multiple COVID-19 vaccination clinics at all senior living communities in our SHOP segment for residents and staff. As previously disclosed, all of the communities in our SHOP segment completed vaccination clinics and are accepting new residents. On September 13, 2021, Five Star reported full compliance with its previously announced requirement that all of its team members at our communities managed by Five Star be fully vaccinated.

We also believe that we and our managers, operators and impacted tenants have and may continue to benefit from provisions of the CARES Act, signed into law in March 2020 and further supplemented by the Consolidated Appropriations Act, 2021, or other federal or state relief programs allowing them to continue or resume business activity. During the year ended December 31, 2021, we recognized $19.6 million in interest and other income in our consolidated statement of comprehensive income (loss) related to funds received under the CARES Act.

We believe that we are well positioned to weather the present disruptions facing the real estate industry and, in particular, the real estate healthcare industry, including senior living.

62

In the first quarters of 2021 and 2022, following the holiday season, the reopening of economies and the easing of restrictions, the United States experienced peak numbers of COVID-19 infections. In some cases, certain states and municipalities again required the closure of certain business activities and imposed certain other restrictions. It is unclear whether the number of COVID-19 infections will further increase or amplify in the United States or elsewhere and, if so, what the impact of that would be on human health and safety, the economy, or our managers', operators' and tenants' businesses. As a result of these uncertainties, we are unable to determine what the ultimate impacts will be on our, our tenants', our managers', our operators' and other stakeholders' businesses, operations, financial results and financial position. For further information and risks relating to the COVID-19 pandemic and its aftermath on us and our business, see elsewhere in this Annual Report on Form 10-K, including "Warning Concerning Forward-Looking Statements," Part I, Item 1 "Business" and Part I, Item 1A "Risk Factors".

PORTFOLIO OVERVIEW

The following tables present an overview of our portfolio (dollars in thousands, except investment per square foot or unit data):

(As of December 31, 2021)	Number  of Properties	Square  Feet or Number of Units		Gross Book Value of Real Estate Assets(1)		% of Total Gross Book Value of Real Estate Assets		Investment per Square Foot or Unit(2)		2021 Revenues (3)		% of 2021 Revenues		2021 NOI(3)(4)		% of 2021  NOI
Office Portfolio(5)	116	9,793,022	sq. ft.	$	2,629,561	36.4	%	$	269	$	367,597	26.6	%	$	240,284	82.5	%
SHOP	235	25,345	units	4,162,340		57.6	%	$	164,227	974,623		70.5	%	10,124		3.5	%
Other triple net leased senior living communities	29	2,327	units	250,396		3.5	%	$	107,605	26,874		1.9	%	26,874		9.2	%
Wellness centers	10	812,000	sq. ft.	178,110		2.5	%	$	219	14,118		1.0	%	14,118		4.8	%
Total	390			$	7,220,407	100.0	%			$	1,383,212	100.0	%	$	291,400	100.0	%

	Occupancy
	As of and for the Year Ended December 31,
	2021		2020
Office Portfolio (6)	91.3	%	91.4	%
SHOP	71.1	%	77.2	%
Other triple net leased senior living communities (7)(8)	76.5	%	83.4	%
Wellness centers	100.0	%	100.0	%

(1)Represents gross book value of real estate assets at cost plus certain acquisition costs, before depreciation and purchase price allocations and less impairment write downs, if any.

(2)Represents gross book value of real estate assets divided by number of rentable square feet or living units, as applicable, at December 31, 2021.

(3)Includes $3,592 of revenues and $2,963 of NOI from properties that we sold during the year ended December 31, 2021.

(4)We calculate our NOI on a consolidated basis and by reportable segment. Our definition of NOI and our reconciliation of net income (loss) to NOI are included below under the heading “Non-GAAP Financial Measures”.

(5)Our medical office and life science property leases include some triple net leases where, in addition to paying fixed rents, the tenants assume the obligation to operate and maintain the properties at their expense, and some net and modified gross leases where we are responsible for the operation and maintenance of the properties and we charge tenants for some or all of the property operating costs. A small percentage of our medical office and life science property leases are full-service leases where we receive fixed rent from our tenants and no reimbursement for our property operating costs.

63

(6)Medical office and life science property occupancy data is as of December 31, 2021 and 2020 and includes (i) out of service assets undergoing redevelopment, (ii) space which is leased but is not occupied or is being offered for sublease by tenants and (iii) space being fitted out for occupancy.

(7)Excludes data for periods prior to our ownership of certain properties, data for properties sold or classified as held for sale, if any, and data for which there was a transfer of operations during the periods presented.

(8)Operating data for other triple net leased senior living communities leased to third party operators and wellness centers are presented based upon the operating results provided by our tenants for the 12 months ended September 30, 2021 and 2020, or the most recent prior period for which tenant operating results are made available to us. We have not independently verified tenant operating data.

We operate in, and report financial information for, the following two segments: Office Portfolio and SHOP. Our Office Portfolio segment consists of medical office properties leased to medical providers and other medical related businesses, as well as life science properties leased to biotech laboratories and other similar tenants. Our SHOP segment consists of managed senior living communities that provide short term and long term residential living and in some instances care and other services for residents where we pay fees to managers to operate the communities. In addition, prior to January 1, 2020, our SHOP segment included triple net leased senior living communities that provided short term and long term residential living and in some instances care and other services for residents and from which we received rents from Five Star. Pursuant to the 2020 Restructuring Transaction, effective January 1, 2020, our previously existing master leases and management and pooling agreements with Five Star were terminated and replaced with new management agreements and a related omnibus agreement, which agreements were subsequently replaced in June 2021.

We also report “non-segment” operations, which consists of triple net leased senior living communities that are leased to third party operators from which we receive rents and wellness centers.

Office Portfolio

As of December 31, 2021, we wholly owned 116 medical office and life science properties located in 25 states and Washington, D.C. These properties have a total of 9.8 million square feet.

During the year ended December 31, 2021, we entered into new and renewal leases at our medical office and life science properties in our Office Portfolio segment as summarized in the following table (dollars and square feet in thousands, except per square foot amounts):

	Year Ended December 31, 2021
	New Leases			Renewals			Total
Square feet leased during the period	489			2,079			2,568
Weighted average rental rate change (by rentable square feet)	24.0		%	6.1		%	11.2		%
Weighted average lease term (years) (1)	10.1			8.8			9.2
Total leasing costs and concession commitments (2)	$	72,275		$	46,868		$	119,143
Total leasing costs and concession commitments per square foot (2)	$	147.98		$	22.53		$	46.38
Total leasing costs and concession commitments per square foot per year (2)	$	14.66		$	2.55		$	5.03

(1)Weighted based on annualized rental income pursuant to existing leases as of December 31, 2021, including straight line rent adjustments and estimated recurring expense reimbursements, and excluding lease value amortization.

(2)Includes commitments made for leasing expenditures and concessions, such as tenant improvements, leasing commissions, tenant reimbursements and free rent.

64

As of December 31, 2021, lease expirations at our medical office and life science properties in our Office Portfolio segment are as follows (dollars in thousands):

Year	Number of Tenants	Square Feet Leased	Percent of Total		Cumulative Percent of Total	Annualized  Rental Income(1)		Percent of Total	Cumulative Percent of Total
2022	120	1,133,067	12.7	%	12.7%	$	30,907	11.2%	11.2%
2023	53	664,858	7.4	%	20.1%	18,760		6.8%	18.0%
2024	81	1,146,074	12.8	%	32.9%	32,700		11.8%	29.8%
2025	77	905,105	10.1	%	43.0%	23,881		8.6%	38.4%
2026	72	826,918	9.2	%	52.2%	26,792		9.7%	48.1%
2027	48	663,099	7.4	%	59.6%	16,700		6.0%	54.1%
2028	33	861,884	9.6	%	69.2%	22,186		8.0%	62.1%
2029	36	377,343	4.2	%	73.4%	13,874		5.0%	67.1%
2030	23	568,069	6.4	%	79.8%	13,687		4.9%	72.0%
2031 and thereafter	53	1,798,940	20.2	%	100.0%	77,623		28.0%	100.0%
Total	596	8,945,357	100.0	%		$	277,110	100.0%
Weighted average remaining lease term (in years)		5.4				5.9

(1)Annualized rental income is based on rents pursuant to existing leases as of December 31, 2021, including straight line rent adjustments and estimated recurring expense reimbursements for certain net and modified gross leases and excluding lease value amortization at certain of our medical office and life science properties.

65

The following table presents information concerning our medical office and life science property tenants that represent 1% or more of total medical office and life science property annualized rental income as of December 31, 2021 (dollars in thousands):

Tenant	Square Feet Leased	Percent of Total Square Feet Leased	Annualized Rental Income(1)		Percent of Total Annualized Rental Income(1)	Lease Expiration
Advocate Aurora Health	643,499	7.2%	$	17,534	6.3%	2022 - 2031
Cedars-Sinai Medical Center	149,063	1.7%	17,046		6.2%	2022 - 2031
HCA Holdings Inc.	217,179	2.4%	7,071		2.6%	2022 - 2029
Surgalign Holdings, Inc.(2)	94,457	1.1%	6,694		2.4%	2034
Medtronic, Inc.	376,828	4.2%	5,766		2.1%	2022 - 2023
IQVIA Holdings Inc.	176,839	2.0%	5,365		1.9%	2023
Prometheus Biosciences, Inc.	55,102	0.6%	5,211		1.9%	2033
KSQ Therapeutics, Inc.(3)	54,633	0.6%	4,779		1.7%	2032
Boston Children's Hospital	99,063	1.1%	4,571		1.6%	2028
Sonova Holding AG	146,385	1.6%	4,570		1.6%	2024
Magellan Health Inc.	232,521	2.6%	4,498		1.6%	2025
Seattle Genetics, Inc.	144,900	1.6%	4,204		1.5%	2024
Abbvie Inc.	197,976	2.2%	3,983		1.4%	2027
United Healthcare Services, Inc.	149,719	1.7%	3,918		1.4%	2026
Cigna Holding Co.	219,644	2.5%	3,914		1.4%	2024
Tokio Marine Holdings Inc.	81,072	0.9%	3,840		1.4%	2022 - 2033
Duke University	126,225	1.4%	3,744		1.4%	2024
Caremark, L.L.C.	182,540	2.0%	3,718		1.3%	2022 - 2025
PerkinElmer Health Sciences, Inc.	105,462	1.2%	3,681		1.3%	2028
New York University	109,983	1.2%	3,239		1.2%	2022 - 2027
Stryker Corporation	122,092	1.4%	3,160		1.1%	2030
Hawai'i Pacific Health	85,956	1.0%	3,087		1.1%	2024 - 2029
Ultragenyx Pharmaceutical Inc.	63,048	0.7%	3,083		1.1%	2026
McKesson Corporation	470,991	5.3%	3,027		1.1%	2024 - 2028
Complete Genomics, Inc.	78,979	0.9%	2,990		1.1%	2025
Virginia Premier Health Plan, Inc.	135,375	1.5%	2,932		1.1%	2032
Emory University	126,461	1.4%	2,863		1.0%	2022 - 2023
All other	4,299,365	48.0%	138,622		50.2%	2022 - 2043
Totals	8,945,357	100.0%	$	277,110	100.0%

(1)    Annualized rental income is based on rents pursuant to existing leases as of December 31, 2021, including straight line rent adjustments and estimated recurring expense reimbursements for certain net and modified gross leases and excluding lease value amortization at certain of our medical office and life science properties.

(2)    In March 2021, we entered into a 12-year lease with Surgalign Holdings, Inc. The lease relates to a recently redeveloped property we own located in San Diego, CA. The term of the lease commences in the first quarter of 2022.

(3)    In July 2021, we entered into a 10-year lease with KSQ Therapeutics, Inc. The lease relates to an ongoing redevelopment of a property we own located in Lexington, MA. The term of the lease commences upon our delivery of the completed space, which is estimated to occur in the second quarter of 2022.

Senior Housing Operating Portfolio

As of December 31, 2019, Five Star operated 244 of our senior living communities in our SHOP segment, of which 166 communities were leased to Five Star and 78 communities were managed by Five Star for our account. Pursuant to the

66

2020 Restructuring Transaction, effective January 1, 2020, our previously existing master leases and management and pooling agreements with Five Star were terminated and replaced with new management agreements and a related omnibus agreement, which agreements were subsequently replaced in June 2021, as described below. The conversion of our leasing arrangements with Five Star to management arrangements was a significant change in our historical arrangements with Five Star and has resulted, and likely will continue to result in future periods, in our realizing significantly different operating results from our senior living communities, including increased variability. As of December 31, 2021, Five Star managed 120 senior living communities for our account.

Also pursuant to the 2020 Restructuring Transaction, for the period beginning February 1, 2019 through December 31, 2019, the aggregate amount of monthly minimum rent payable to us by Five Star was reduced to $11.0 million as of February 1, 2019, which amount was then reduced during such period to approximately $10.8 million as a result of dispositions, and no additional rent was payable to us by Five Star for the period beginning February 1, 2019 through December 31, 2019.

In June 2021, we amended our then existing management arrangements with Five Star. The principal changes to the management arrangements included:

•that Five Star agreed to cooperate with us in transitioning 108 of our senior living communities with approximately 7,500 living units to other third party managers without our payment of any termination fee to Five Star;

•that we no longer had the right to sell up to an additional $682 million of senior living communities then managed by Five Star and terminate Five Star's management of those communities without our payment of a fee to Five Star;

•that Five Star is continuing to manage 120 of our senior living communities, and that the skilled nursing units in all of our continuing care retirement communities that Five Star is continuing to manage, which then included approximately 1,500 living units, have been closed and are being evaluated and repositioned;

•that beginning in 2025, we will have the right to terminate up to 10% of the senior living communities that Five Star is continuing to manage, based on total revenues per year, for failure to meet 80% of a target EBITDA for the applicable period;

•that the incentive fee that Five Star may earn in any calendar year for the senior living communities that Five Star is continuing to manage is no longer subject to a cap and that any senior living communities that are undergoing a major renovation or repositioning are excluded from the calculation of the incentive fee;

•that RMR LLC will oversee any major renovation or repositioning activities at the senior living communities that Five Star is continuing to manage; and

•that the term of our management agreements with Five Star for our senior living communities that Five Star is continuing to manage was extended by two years to December 31, 2036.

Pursuant to these changes, we and Five Star entered into the Master Management Agreement for the senior living communities that Five Star is continuing to manage. In addition, Five Star delivered to us a related amended and restated guaranty agreement pursuant to which Five Star is continuing to guarantee the payment and performance of each of its applicable subsidiary's obligations under the applicable management agreements.

We have completed the transition of 107 senior living communities from Five Star to new third party managers and we have closed the remaining senior living community. The remaining senior living community was closed and we are assessing opportunities to redevelop that property. We lease nearly all of our senior living communities, including those managed by Five Star and by the new third party managers, to our TRSs. We incurred and expect to continue to incur costs related to retention and other transition costs for these communities. For the year ended December 31, 2021, we recorded $17.4 million of these costs to acquisition and certain other transaction related costs in our consolidated statements of comprehensive income (loss).

The terms of the management agreements with the new third party managers are generally as follows: the new third party managers will receive a management fee equal to 5% to 6% of the gross revenues realized at the applicable senior living communities plus reimbursement for direct costs and expenses related to such communities. These agreements generally also provide for the new third party managers to earn a minimum base fee for a portion of the term of the agreement. Additionally, the new third party managers have the ability to earn incentive fees equal to 15% to 25% of the amount by which EBITDA of the applicable communities exceeds the target EBITDA for the applicable communities. The new third party managers can also earn a construction supervision fee ranging between 3% and 5% of construction costs.

67

The initial terms of the management agreements with the new third party managers are generally five years, subject to automatic extensions of successive terms of two years each unless earlier terminated or timely notice of nonrenewal is delivered. The management agreements with the new third party managers also generally provide us with the right to terminate the management agreements for communities that do not earn 70% to 80% of the target EBITDA for such communities, after an agreed upon stabilized period.

The following table presents a summary of the new third party managers:

Manager	Location	Number of Communities	Number of Units
Cedarhurst Senior Living	IL/WI	13	785
Charter Senior Living	FL/MD/TN/VA	17	1,028
IntegraCare Senior Living	PA	2	155
Life Care Services	DE	3	519
Navion Senior Solutions	SC	5	239
Northstar Senior Living	AZ/CA	7	396
Oaks-Caravita Senior Care	GA/SC	26	1,483
Omega Senior Living	NE	1	69
Phoenix Senior Living	AL/AR/KY/MO/NC/SC	23	1,498
Stellar Senior Living	CO/TX/WY	10	1,168
Total		107	7,340

For further information regarding the 2020 Restructuring Transaction, the terms of the Master Management Agreement and of the management agreements with the new third party managers and our other business arrangements with Five Star, see Note 6 to our Consolidated Financial Statements included in Part IV, Item 15 of this Annual Report on Form 10-K, and for more information about our dealings and relationships with Five Star generally, and the risks which may arise as a result of these related person transactions, see “Risk Factors—Risks Related to Our Relationships with RMR LLC and AlerisLife (including Five Star)” in Part I, Item 1A of this Annual Report on Form 10-K, “—Related Person Transactions” below and Note 8 to our Consolidated Financial Statements included in Part IV, Item 15 of this Annual Report on Form 10-K.

All Other

As of December 31, 2021, lease expirations at our other triple net leased senior living communities leased to third party operators and wellness centers are as follows (dollars in thousands):

Year	Number of Properties	Number of Units or Square Feet	Annualized  Rental Income(1)		Percent of Total		Cumulative Percent of Total
2022	—	—	$	—	—	%	—	%
2023	—	—	—		—	%	—	%
2024	2	180 units	2,885		6.9	%	6.9	%
2025	—	—	—		—	%	6.9	%
2026	—	—	—		—	%	6.9	%
2027	4	534 units	4,319		10.3	%	17.2	%
2028 (2)	6	354,000 sq. ft.	6,000		14.3	%	31.5	%
2029	1	155 units	547		1.3	%	32.8	%
2030	3	367 units	5,134		12.2	%	45.0	%
2031 and thereafter	23	1,091 units and 458,000 sq. ft.	23,206		55.0	%	100.0	%
Total	39		$	42,091	100.0	%

(1)    Annualized rental income is based on rents pursuant to existing leases as of December 31, 2021. Annualized rental income includes estimated percentage rents and straight line rent adjustments and excludes lease value amortization.

68

(2)    As a result of the COVID-19 pandemic's impact on operations at our wellness centers, we are negotiating with the tenant of six of our wellness centers with total annualized rental income of approximately $6.0 million. In February 2022, we signed an amendment with this tenant to defer a portion of the rent owed to us for 12 months.

GENERAL INDUSTRY TRENDS

Our medical office and life science properties have been impacted by at least two major industry trends for the past 10 years which are continuing at this time and that have impacted our investment activities.

First, medical practices are being consolidated into hospital systems. This has caused the number of free standing medical practices to decline. At the same time, the number of multi-practice medical office buildings that are anchor leased by hospital systems who employ doctors has increased. We believe hospital systems will continue the trend of providing an increasing amount of services in off campus medical offices away from main hospital campuses in order to reduce costs and serve as many patients as possible, which is reinforced by consumers' preference for healthcare services to be provided away from hospital campuses and closer to their residence or work locations.

Second, various advances in medical science have caused a large investment in new bio-medical research companies that require office, lab and medical products manufacturing space. We believe that about 30% of our total investments in our Office Portfolio segment may be considered biotech and life science properties as of December 31, 2021.

We believe that the primary market for senior living services is individuals age 80 and older, and, according to U.S. Census data, that group is projected to be among the fastest growing age cohort in the United States over the next 20 years. Also, as a result of medical advances, seniors are living longer. Due to these demographic trends, we expect the demand for senior living services and housing to increase for the foreseeable future. Despite this trend, future economic downturns, softness in the U.S. housing market, higher levels of unemployment among our potential residents' family members, lower levels of consumer confidence, stock market volatility and/or changes in demographics could adversely affect the ability of seniors to afford the resident fees at our senior living communities.

The medical advances which are increasing average life spans are also causing some seniors to delay moving to senior living communities until they require greater care or to forgo moving to senior living communities altogether, but we do not believe this factor is sufficient to offset the long term positive demographic trends causing increased demand for senior living communities for the foreseeable future.

In recent years, a significant number of new senior living communities have been developed and continue to be developed. Although the rate of newly started developments declined due to the COVID-19 pandemic, the increased supply of senior living communities that has resulted from recent development activity has increased competitive pressures on our managers and tenants, particularly in certain geographic markets where we own senior living communities, and we expect these competitive challenges to continue for at least the next few years. These competitive challenges may prevent our managers and tenants from maintaining or improving occupancy and rates at our senior living communities, which may increase the risk of default under our leases, reduce the rents and returns we may receive and earn from our leased and managed senior living communities and adversely affect the profitability of our senior living communities, and may cause the value of our properties to decline. In response to these competitive pressures, we have invested capital in our existing senior living communities and expect to continue to do so in order that our communities may remain competitive with newer communities. For a discussion of and the risks relating to the COVID-19 pandemic on us and our business, see elsewhere in this Annual Report on Form 10-K, including "Warning Concerning Forward-Looking Statements," Part I, Item 1 "Business" and Part I, Item 1A "Risk Factors".

Recently, the costs of insurance have increased significantly, and these increased costs have had an adverse effect on us and our managers and tenants. Increased insurance costs may adversely affect our managers' ability to operate our properties profitably and provide us with desirable returns and our tenants' ability to pay us rent or result in downward pressure on rents we can charge under new or renewed leases.

The senior living industry is subject to extensive and frequently changing federal, state and local laws and regulations. For further information regarding these laws and regulations, and possible legislative and regulatory changes, see "Business—Government Regulation and Reimbursement" in Part I, Item 1 of this Annual Report on Form 10-K.

69

RESULTS OF OPERATIONS (dollars and square feet in thousands, unless otherwise noted)

The following table summarizes the results of operations of each of our segments for the years ended December 31, 2021 and 2020:

	For the Year Ended December 31,
	2021		2020
Revenues:
Office Portfolio	$	367,597	$	383,365
SHOP	974,623		1,204,811
Non-Segment	40,992		43,850
Total revenues	$	1,383,212	$	1,632,026
Net income (loss) attributable to common shareholders:
Office Portfolio	$	575,836	$	88,592
SHOP	(104,081)		(114,693)
Non-Segment	(297,240)		(113,352)
Net income (loss) attributable to common shareholders	$	174,515	$	(139,453)

The following sections analyze and discuss the results of operations of each of our segments for the periods presented.

Year Ended December 31, 2021 Compared to Year Ended December 31, 2020 (dollars and square feet in thousands, except average monthly rate):

Unless otherwise indicated, references in this section to changes or comparisons of results, income or expenses refer to comparisons of the results for the year ended December 31, 2021 to the year ended December 31, 2020. Our definition of NOI and our reconciliation of net income (loss) to NOI and a description of why we believe NOI is an appropriate supplemental measure are included below under the heading “Non-GAAP Financial Measures.” For a comparison of consolidated results for the year ended December 31, 2020 compared to the year ended December 31, 2019, see Part II, Item 7 “Management's Discussion and Analysis of Financial Condition and Results of Operations” in our Annual Report on Form 10-K for the fiscal year ended December 31, 2020.

	For the Year Ended December 31,
	2021		2020		$ Change		% Change
NOI by segment:
Office Portfolio	$	240,284	$	253,609	$	(13,325)	(5.3)	%
SHOP	10,124		98,210		(88,086)		(89.7)	%
Non-Segment	40,992		43,850		(2,858)		(6.5)	%
Total NOI	291,400		395,669		(104,269)		(26.4)	%
Depreciation and amortization	271,131		270,147		984		0.4	%
General and administrative	34,087		30,593		3,494		11.4	%
Acquisition and certain other transaction related costs	17,506		814		16,692		nm
Impairment of assets	(174)		106,972		(107,146)		(100.2)	%
Gain on sale of properties	492,272		6,487		485,785		nm
Gains and losses on equity securities, net	(42,232)		34,106		(76,338)		(223.8)	%
Interest and other income	20,635		18,221		2,414		13.2	%
Interest expense	(255,759)		(201,483)		(54,276)		26.9	%
Gain on lease termination	—		22,896		(22,896)		(100.0)	%
Loss on early extinguishment of debt	(2,410)		(427)		(1,983)		nm
Income (loss) from continuing operations before income tax expense	181,356		(133,057)		314,413		nm
Income tax expense	(1,430)		(1,250)		(180)		14.4	%
Net income (loss)	179,926		(134,307)		314,233		nm
Net income attributable to noncontrolling interest	(5,411)		(5,146)		(265)		5.1	%
Net income (loss) attributable to common shareholders	$	174,515	$	(139,453)	$	313,968	nm

nm – not meaningful

70

Office Portfolio:

	Comparable Properties(1)				All Properties
	As of December 31,				As of December 31,
	2021		2020		2021		2020
Total buildings	110		110		116		123
Total square feet (2)	9,378		9,378		9,793		11,282
Occupancy (3)	92.7	%	93.2	%	91.3	%	91.4	%

(1)Consists of medical office and life science properties that we have owned and which have been in service continuously since January 1, 2020; excludes properties classified as held for sale or out of service undergoing redevelopment, if any, and a life science property owned by an unconsolidated joint venture in which we own a 20% equity interest.

(2)Prior periods exclude space remeasurements made subsequent to those periods.

(3)Medical office and life science all properties occupancy includes (i) out of service assets undergoing redevelopment, (ii) space which is leased but is not occupied or is being offered for sublease by tenants, and (iii) space being fitted out for occupancy. Comparable property occupancy excludes out of service assets undergoing redevelopment and a life science property owned by an unconsolidated joint venture in which we own a 20% equity interest.

	Year Ended December 31,
	Comparable (1)								Non-Comparable
	Properties Results								Properties Results				Consolidated Properties Results
	2021		2020		$ Change		% Change		2021		2020		2021		2020		$ Change		% Change
Rental income	$	251,107	$	250,732	$	375	0.1	%	$	116,490	$	132,633	$	367,597	$	383,365	$	(15,768)	(4.1)	%
Property operating expenses	(95,345)		(95,319)		26		0.0	%	(31,968)		(34,437)		(127,313)		(129,756)		(2,443)		(1.9)	%
NOI	$	155,762	$	155,413	$	349	0.2	%	$	84,522	$	98,196	$	240,284	$	253,609	$	(13,325)	(5.3)	%

(1)Consists of medical office and life science properties that we have owned and which have been in service continuously since January 1, 2020; excludes properties classified as held for sale or out of service undergoing redevelopment, if any, and a life science property owned by an unconsolidated joint venture in which we own a 20% equity interest.

Rental income. Rental income decreased primarily due to our disposition of 20 properties since January 1, 2020 and assets being taken out of service and/or undergoing redevelopment, partially offset by an increase in rental income at our comparable properties. Rental income increased at our comparable properties primarily due to increased parking revenue at certain of our comparable properties as certain states and municipalities have eased restrictions related to the COVID-19 pandemic and tenants' employees have increasingly returned to the office and commercial activity has increased and higher average rents achieved from our new and renewal leasing activity, partially offset by decreases in occupancy and tax escalation income and other property operating expense reimbursements at certain of our comparable properties.

Property operating expenses. Property operating expenses consist of real estate taxes, utility expenses, insurance, management fees, salaries and benefit costs of property level personnel, repairs and maintenance expense, cleaning expense and other direct costs of operating these properties. The decrease in property operating expenses is primarily due to our disposition of 20 properties since January 1, 2020, partially offset by an increase in property operating expenses at our comparable properties. Property operating expenses at our comparable properties increased primarily due to increases in utility expenses and landscaping expenses, partially offset by decreases in real estate taxes, repairs and maintenance and other direct costs at certain of our comparable properties.

Net operating income. The change in NOI reflects the net changes in rental income and property operating expenses described above.

SHOP:

	Comparable Properties (1)						All Properties
	As of and For the Year Ended December 31,						As of and For the Year Ended December 31,
	2021			2020			2021			2020
Total properties	120			120			235			235
Number of units	17,899			17,899			25,345			26,969
Occupancy	73.3		%	80.7		%	71.1		%	77.2		%
Average monthly rate (2)	$	3,958		$	3,982		$	4,339		$	4,530

71

(1)Consists of senior living communities that we have owned and which have been operated by the same operator continuously since January 1, 2020; excludes communities classified as held for sale or closed, if any.

(2)Average monthly rate is calculated by taking the average daily rate, which is defined as total residents fees and services divided by occupied units during the period, and multiplying it by 30 days.

	Year Ended December 31,
	Comparable (1)								Non-Comparable
	Properties Results								Properties Results				Consolidated Properties Results
	2021		2020		$ Change		% Change		2021		2020		2021		2020		$ Change		% Change
Residents fees and services	$	668,278	$	815,437	$	(147,159)	(18.0)	%	$	306,345	$	389,374	$	974,623	$	1,204,811	$	(230,188)	(19.1)	%
Property operating expenses	(635,003)		(713,047)		(78,044)		(10.9)	%	(329,496)		(393,554)		(964,499)		(1,106,601)		(142,102)		(12.8)	%
NOI	$	33,275	$	102,390	$	(69,115)	(67.5)	%	$	(23,151)	$	(4,180)	$	10,124	$	98,210	$	(88,086)	(89.7)	%

(1)Consists of senior living communities that we have owned and which have been operated by the same operator continuously since January 1, 2020; excludes communities classified as held for sale or closed, if any.

Residents fees and services. Residents fees and services are the revenues earned at our managed senior living communities. We recognize these revenues as services are provided and related fees are accrued. Residents fees and services decreased primarily due to our disposition of nine properties and closure of eight properties since January 1, 2020 and decreases in occupancy primarily due to the continued impact of the COVID-19 pandemic at both comparable and non-comparable properties for the year ended December 31, 2021 compared to the year ended December 31, 2020. Additionally, residents fees and services at our comparable properties decreased due to the closure of skilled nursing units during the year ended December 31, 2021.

Property operating expenses. Property operating expenses consist of real estate taxes, utility expenses, insurance, salaries and benefit costs of property level personnel, repairs and maintenance expense, management fees, cleaning expense and other direct costs of operating these communities. Property operating expenses decreased primarily due to our disposition of nine properties and closure of eight properties since January 1, 2020 and a decrease in property operating expenses at our comparable properties. Property operating expenses at our comparable properties decreased primarily due to decreases in costs associated with staffing and dietary expenses primarily due to reduced occupancy at our comparable properties as a result of the continued impact of the COVID-19 pandemic and the closure of skilled nursing units during the year ended December 31, 2021. We continue to have elevated labor costs on a per resident basis.

Net operating income. The change in NOI reflects the net changes in residents fees and services and property operating expenses described above.

Non-Segment(1):

	Comparable Properties (2)				All Properties
	As of and For the Year Ended December 31,				As of and For the Year Ended December 31,
	2021		2020		2021		2020
Total properties:
Other triple net leased senior living communities	29		29		29		29
Wellness centers	10		10		10		10
Rent coverage:
Other triple net leased senior living communities (3)	1.21	x	1.61	x	1.21	x	1.61	x
Wellness centers (3)	1.23	x	1.05	x	1.23	x	1.05	x

(1)Non-segment operations consists of all of our other operations, including certain senior living communities leased to third party operators and wellness centers, which segment we do not consider to be sufficiently material to constitute a separate reporting segment, and any other income or expenses that are not attributable to a specific reporting segment.

(2)Comparable properties consists of properties that we have owned and which have been leased to the same operator continuously since January 1, 2020; excludes properties classified as held for sale, if any.

(3)All tenant operating data presented is based upon the operating results provided by our tenants for the 12 months ended September 30, 2021 and 2020 or the most recent prior period for which tenant operating results are available to us. Rent coverage is calculated using the operating cash flows from our triple net lease tenants' operations of our properties, before subordinated charges, if any, divided by triple net lease minimum rents payable to us. We have not independently verified tenant operating data. Excludes data for historical periods prior to our ownership of certain properties, as well as data for properties sold or classified as held for sale, if any, during the periods presented.

72

	Year Ended December 31,
	Comparable (1)								Non-Comparable
	Properties Results								Properties Results				Consolidated Properties Results
	2021		2020		$ Change		% Change		2021		2020		2021		2020		$ Change		% Change
Rental income	$	40,992	$	40,753	$	239	0.6	%	$	—	$	3,097	$	40,992	$	43,850	$	(2,858)	(6.5)	%
NOI	$	40,992	$	40,753	$	239	0.6	%	$	—	$	3,097	$	40,992	$	43,850	$	(2,858)	(6.5)	%

(1)Consists of properties that we have owned and which have been leased to the same operator continuously since January 1, 2020; excludes properties classified as held for sale, if any.

Rental income. Rental income decreased primarily due to the sale of three senior living communities leased to private operators since January 1, 2020, partially offset by an increase in rental income at our comparable properties and increased rents resulting from our purchase of improvements at our comparable properties since January 1, 2020. Rental income increased at our comparable properties primarily due to a tenant default under leases for six of our wellness centers during the 2020 period, partially offset by decreased rent due to lease renewals with tenants of certain of our wellness centers at lower average rental rates. As a result of the COVID-19 pandemic, in 2020 many of our wellness centers had been ordered closed by state or local executive orders. We have elected to recognize rental income from the previously defaulted tenant of six of our wellness centers as rent payments are received. In February 2022, the leases for these six wellness centers were amended and a portion of the rent due to us was deferred.

Net operating income. The change in NOI reflects the net changes in rental income described above.

Consolidated:

References to changes in the income and expense categories below relate to the comparison of consolidated results for the year ended December 31, 2021, compared to the year ended December 31, 2020.

Depreciation and amortization expense. Depreciation and amortization expense increased primarily due to the purchase of capital improvements at certain of our properties since January 1, 2020, partially offset by our disposition of 32 properties, certain depreciable leasing related assets becoming fully depreciated and certain of our acquired resident agreements becoming fully amortized since January 1, 2020.

General and administrative expense. General and administrative expense consists of fees paid to RMR LLC under our business management agreement, legal and accounting fees, fees and expenses of our Trustees, equity compensation expense and other costs relating to our status as a publicly traded company. General and administrative expense increased primarily due to an increase in our base business management fees expense as a result of higher consolidated indebtedness during 2021 compared to 2020.

Acquisition and certain other transaction related costs. For the year ended December 31, 2021, acquisition and certain other transaction related costs primarily represent costs related to the transition of certain senior living communities to new third party managers and costs incurred in connection with the Master Management Agreement. For the year ended December 31, 2020, acquisition and certain other transaction related costs primarily represent costs incurred in connection with the 2020 Restructuring Transaction. For information regarding the Master Management Agreement or the 2020 Restructuring Transaction, see Note 6 to our Consolidated Financial Statements included in Part IV, Item 15 of this Annual Report on Form 10-K.

Impairment of assets. For information about our asset impairment charges, see Note 3 to our Consolidated Financial Statements included in Part IV, Item 15 of this Annual Report on Form 10-K.

Gain on sale of properties. Gain on sale of properties is the net result of our sale of certain of our properties during 2021 and 2020. The gain on sale of properties during the year ended December 31, 2021 primarily reflects our sale of a 35% equity interest from our 55% equity interest in a joint venture that owns a life science property located in Boston, Massachusetts. For further information regarding gain on sale of properties, see Note 3 to our Consolidated Financial Statements included in Part IV, Item 15 of this Annual Report on Form 10-K.

Gains and losses on equity securities, net. Gains and losses on equity securities, net, represent the net unrealized gains and losses to adjust our investment in AlerisLife to its fair value. For further information regarding our investment in

73

AlerisLife, see Note 10 to our Consolidated Financial Statements included in Part IV, Item 15 of this Annual Report on Form 10-K.

Interest and other income. The increase in interest and other income is primarily due to $19,554 of funds we received from the U.S. government pursuant to the CARES Act during the year ended December 31, 2021 compared to $17,485 received during the year ended December 31, 2020.

Interest expense. Interest expense increased primarily due to our issuance in June 2020 of $1,000,000 aggregate principal amount of our 9.75% senior notes due 2025, our issuance in February 2021 of $500,000 aggregate principal amount of our 4.375% senior notes due 2031 and an increase in average borrowings under our revolving credit facility. This increase was partially offset by our redemption in April 2020 of all $200,000 of our 6.75% senior notes due 2020, our prepayment in June 2020 of our $250,000 term loan, our prepayment in February 2021 of our $200,000 term loan and our redemption in June 2021 of all $300,000 of our 6.75% senior notes due 2021.

Gain on lease termination. Gain on lease termination represents the gain recognized in connection with the 2020 Restructuring Transaction. For information regarding the 2020 Restructuring Transaction, see Note 6 to our Consolidated Financial Statements included in Part IV, Item 15 of this Annual Report on Form 10-K.

Loss on early extinguishment of debt. We recorded a loss on early extinguishment of debt in connection with the amendments to our credit agreement and the agreement governing our previously existing $200,000 term loan, our prepayment of our $200,000 term loan and our redemption of all $300,000 of our 6.75% senior notes due 2021 during the year ended December 31, 2021. We recorded a loss on early extinguishment of debt in connection with our prepayment of our $250,000 term loan and mortgage notes during the year ended December 31, 2020.

Income tax expense. Income tax expense is the result of operating income we earned in certain jurisdictions where we are subject to state income taxes.

Non-GAAP Financial Measures (dollars in thousands, except per share amounts)

We present certain "non-GAAP financial measures" within the meaning of applicable SEC rules, including FFO attributable to common shareholders, Normalized FFO attributable to common shareholders and NOI for the years ended December 31, 2021 and 2020. These measures do not represent cash generated by operating activities in accordance with GAAP and should not be considered alternatives to net income (loss) or net income (loss) attributable to common shareholders as indicators of our operating performance or as measures of our liquidity. These measures should be considered in conjunction with net income (loss) and net income (loss) attributable to common shareholders as presented in our consolidated statements of comprehensive income (loss). We consider these non-GAAP measures to be appropriate supplemental measures of operating performance for a REIT, along with net income (loss) and net income (loss) attributable to common shareholders. We believe these measures provide useful information to investors because by excluding the effects of certain historical amounts, such as depreciation and amortization, they may facilitate a comparison of our operating performance between periods and with other REITs and, in the case of NOI, reflecting only those income and expense items that are generated and incurred at the property level may help both investors and management to understand the operations of our properties.

Funds From Operations and Normalized Funds From Operations Attributable to Common Shareholders

We calculate FFO attributable to common shareholders and Normalized FFO attributable to common shareholders as shown below. FFO attributable to common shareholders is calculated on the basis defined by the National Association of Real Estate Investment Trusts, which is net income (loss) attributable to common shareholders, calculated in accordance with GAAP, excluding any gain or loss on sale of properties, equity in earnings of an unconsolidated joint venture, loss on impairment of real estate assets, gains or losses on equity securities, net, if any, including adjustments to reflect our proportionate share of FFO of our equity method investment in AlerisLife and our proportionate share of FFO from an unconsolidated joint venture property plus real estate depreciation and amortization of consolidated properties and minus FFO adjustments attributable to noncontrolling interest, as well as certain other adjustments currently not applicable to us. In calculating Normalized FFO attributable to common shareholders, we adjust for the items shown below including similar adjustments for our unconsolidated joint venture, if any. FFO attributable to common shareholders and Normalized FFO attributable to common shareholders are among the factors considered by our Board of Trustees when determining the amount of distributions to our shareholders. Other factors include, but are not limited to, requirements to maintain our qualification for taxation as a REIT, limitations in the agreements governing our debt, the availability to us of debt and equity capital, our expectation of our future capital requirements and operating performance, and our expected needs for and availability of cash to pay our obligations. Other real

74

estate companies and REITs may calculate FFO attributable to common shareholders and Normalized FFO attributable to common shareholders differently than we do.

Our calculations of FFO attributable to common shareholders and Normalized FFO attributable to common shareholders for the years ended December 31, 2021 and 2020 and reconciliations of net income (loss) attributable to common shareholders, the most directly comparable financial measure under GAAP reported in our consolidated financial statements, to FFO attributable to common shareholders and Normalized FFO attributable to common shareholders appear in the following table. This table also provides a comparison of distributions to shareholders, FFO attributable to common shareholders and Normalized FFO attributable to common shareholders and net income (loss) attributable to common shareholders per share for these periods.

	For the Year Ended December 31,
	2021		2020
Net income (loss) attributable to common shareholders	$	174,515	$	(139,453)
Depreciation and amortization	271,131		270,147
Gain on sale of properties	(492,272)		(6,487)
Impairment of assets	(174)		106,972
Gains and losses on equity securities, net	42,232		(34,106)
FFO adjustments attributable to noncontrolling interest	(20,584)		(21,100)
Share of FFO from unconsolidated joint venture	273		—
Adjustments to reflect our share of FFO attributable to an equity method investment	(6,017)		839
FFO attributable to common shareholders	(30,896)		176,812
Acquisition and certain other transaction related costs	17,506		814
Costs and payment obligations related to compliance assessment at one of our senior living communities	—		5,770
Gain on lease termination (1)	—		(22,896)
Loss on early extinguishment of debt	2,410		427
Adjustments to reflect our share of Normalized FFO attributable to an equity method investment	3,074		9,187
Normalized FFO attributable to common shareholders	$	(7,906)	$	170,114
Weighted average common shares outstanding (basic)	237,967		237,739
Weighted average common shares outstanding (diluted)	237,967		237,739
Per common share data (basic and diluted):
Net income (loss) attributable to common shareholders	$	0.73	$	(0.59)
FFO attributable to common shareholders	$	(0.13)	$	0.74
Normalized FFO attributable to common shareholders	$	(0.03)	$	0.72
Distributions declared	$	0.04	$	0.18

(1)    Gain on lease termination represents the gain recognized in connection with the 2020 Restructuring Transaction. For information regarding the 2020 Restructuring Transaction, see Note 6 to our Consolidated Financial Statements included in Part IV, Item 15 of this Annual Report on Form 10-K.

Property Net Operating Income (NOI)

We calculate NOI as shown below. The calculation of NOI excludes certain components of net income (loss) in order to provide results that are more closely related to our property level results of operations. We define NOI as income from our real estate less our property operating expenses. NOI excludes amortization of capitalized tenant improvement costs and leasing commissions that we record as depreciation and amortization. We use NOI to evaluate individual and company-wide property level performance. Other real estate companies and REITs may calculate NOI differently than we do.

The calculation of NOI by reportable segment is included above in this Item 7. The following table includes the reconciliation of net income (loss) to NOI for the years ended December 31, 2021 and 2020.

75

	For the Year Ended December 31,
	2021		2020
Reconciliation of Net Income (Loss) to NOI:
Net income (loss)	$	179,926	$	(134,307)
Income tax expense	1,430		1,250
Income (loss) from continuing operations before income tax expense	181,356		(133,057)
Loss on early extinguishment of debt	2,410		427
Gain on lease termination (1)	—		(22,896)
Interest expense	255,759		201,483
Interest and other income	(20,635)		(18,221)
Gains and losses on equity securities, net	42,232		(34,106)
Gain on sale of properties	(492,272)		(6,487)
Impairment of assets	(174)		106,972
Acquisition and certain other transaction related costs	17,506		814
General and administrative	34,087		30,593
Depreciation and amortization	271,131		270,147
Total NOI	$	291,400	$	395,669
Office Portfolio NOI	$	240,284	$	253,609
SHOP NOI	10,124		98,210
Non-Segment NOI	40,992		43,850
Total NOI	$	291,400	$	395,669

(1)    Gain on lease termination represents the gain recognized in connection with the 2020 Restructuring Transaction. For information regarding the 2020 Restructuring Transaction, see Note 6 to our Consolidated Financial Statements included in Part IV, Item 15 of this Annual Report on Form 10-K.

LIQUIDITY AND CAPITAL RESOURCES

Our principal sources of cash to meet operating and capital expenses, pay debt service obligations and make distributions to our shareholders are the operating cash flows we generate as rental income from our leased properties, residents fees and services revenues from our managed communities, borrowings under our revolving credit facility and proceeds from the disposition of certain properties. We believe that these sources will be sufficient to meet our operating and capital expenses, pay debt service obligations and make distributions to our shareholders for the next 12 months and for the foreseeable future thereafter. Our future cash flows from operating activities will depend primarily upon:

•our ability to receive rents from our tenants, including in light of the COVID-19 pandemic and its impact on our tenants' businesses;

•our ability to maintain or increase the occupancy of, and the rental rates at, our properties or reduce the extent of the declines in occupancy and rental rates in response to the COVID-19 pandemic, particularly at our senior living communities;

•our ability to control operating expenses and capital expenses at our properties, including increased operating expenses that we may incur in response to the COVID-19 pandemic, inflation or supply chain challenges; and

•our managers' abilities to manage our managed senior living communities, including throughout the COVID-19 pandemic, to maintain or increase our returns and to reduce the extent of the declines in our returns.

We continue to carefully monitor the developments of the COVID-19 pandemic and the resulting economic conditions and their impact on our tenants, managers, operators and other stakeholders, including at our senior living communities.

In February 2021, we issued $500.0 million aggregate principal amount of 4.375% senior notes due 2031. We used net proceeds from this offering to prepay in full our $200.0 million term loan and used the remaining net proceeds and cash on hand to redeem all of our outstanding 6.75% senior notes due 2021 for a redemption price equal to the principal amount of $300.0 million plus accrued and unpaid interest of $10.1 million in June 2021, when these notes became redeemable with no

76

prepayment premium. In addition, on March 31, 2021, we borrowed $800.0 million under our revolving credit facility as a precautionary measure to increase our cash position and preserve financial flexibility in light of continued uncertainties related to the COVID-19 pandemic. In February 2022, we repaid $100.0 million of this borrowing to reduce the borrowing capacity under our revolving credit facility to $700.0 million pursuant to the February 2022 amendment to our credit agreement. In addition, in February 2022, we exercised our option to extend the maturity date of our revolving credit facility by one year to January 2024. Pursuant to our credit agreement, the borrowing capacity under our revolving credit facility will be reduced to $586.4 million as of January 2023 and as such, further repayment of our revolving credit facility may be required. Although we have taken steps to enhance our ability to maintain sufficient liquidity, a protracted negative impact on the economy or the industries in which our properties and businesses operate resulting from the COVID-19 pandemic may cause further increased pressure on our ability to satisfy financial and other covenants. We may fail to satisfy covenants and conditions under our credit agreement or fail to satisfy our public debt covenants. As of December 31, 2021, our ratio of consolidated income available for debt service to debt service was below the 1.5x incurrence requirement under our revolving credit facility and our public debt covenants as the effects of the COVID-19 pandemic continued to adversely impact our operations. We are currently unable to incur additional debt because this ratio is below 1.5x on a pro forma basis.

In December 2021, we sold a 35% equity interest from our 55% equity interest in a joint venture that owns a life science property located in Boston, Massachusetts to another third party global institutional investor for $378.0 million, excluding closing costs. Following the sale, we continue to own a 20% equity interest in the joint venture and our pre-existing joint venture partner continues to own its 45% equity interest in the joint venture. The net proceeds of $373.8 million, which include working capital prorations and formation costs, are included in restricted cash in our consolidated balance sheet as of December 31, 2021 pursuant to the terms of our credit agreement. Effective as of the date of the sale, we deconsolidated this joint venture and we now account for this joint venture using the equity method of accounting under the fair value option.

In January 2022, we entered into a joint venture for 10 medical office and life science properties we owned with two unrelated third party global institutional investors for aggregate proceeds, before closing costs and other adjustments, of $653.3 million. The investors acquired 41% and 39% equity interests in the joint venture for investments of approximately $100.8 million and $95.9 million, respectively, and we retained a 20% equity interest in the joint venture. The investment amounts are based upon a property valuation of approximately $702.5 million, less approximately $456.6 million of secured debt on the properties incurred by this joint venture.

During the year ended December 31, 2021, we sold five properties for an aggregate sales price of $104.5 million, excluding closing costs. The measures we have taken to enhance our ability to maintain sufficient liquidity may not sufficiently offset the decrease in cash flows from operations and capital investments we make, particularly during the COVID-19 pandemic, in which case our liquidity would be negatively impacted.

The following is a summary of our sources and uses of cash flows for the periods presented, as reflected in our consolidated statements of cash flows (dollars in thousands):

	Year Ended December 31,
	2021		2020
Cash and cash equivalents and restricted cash at beginning of period	$	90,849	$	52,224
Net cash provided by (used in):
Operating activities	(63,323)		158,544
Investing activities	242,696		(40,436)
Financing activities	746,723		(79,483)
Cash and cash equivalents and restricted cash at end of period	$	1,016,945	$	90,849

Our Operating Liquidity and Resources

We generally receive minimum rents from our tenants monthly or quarterly, we receive residents fees and services revenues, net of expenses, from our managed senior living communities monthly and we receive percentage rents from certain of our senior living community tenants monthly, quarterly or annually.

The change in cash (used in) provided by operating activities for the year ended December 31, 2021 compared to the prior year was primarily due to the continued impact of the COVID-19 pandemic on the senior living communities in our SHOP segment, along with reduced NOI as a result of dispositions of properties during 2020 and 2021. Additionally, we had increased working capital needs in 2021 as compared to 2020, specifically related our senior living communities. As it relates to our SHOP segment, in September 2021, we paid approximately $22.2 million of payroll taxes reimbursed to Five Star pursuant to

77

our management agreements with Five Star that were deferred as allowed under the CARES Act as previously disclosed. As noted elsewhere in this Annual Report on Form 10-K, the transition of the management of the 107 senior living communities from Five Star to other third party managers was completed as of December 31, 2021 and we have closed the remaining senior living community that we and Five Star agreed to transition and are assessing opportunities to redevelop that property. We have incurred and expect to continue to incur costs related to retention and other transition costs for these communities. For the year ended December 31, 2021, we recorded $17.4 million of these costs to acquisition and certain other transaction related costs in our consolidated statements of comprehensive income (loss).

As noted elsewhere in this Annual Report on Form 10-K, the COVID-19 pandemic has had a substantial negative economic impact on our and our tenants', managers' and other operators' businesses, and in particular our senior living community and wellness center operators. Depending on the duration and severity of this pandemic and the resulting economic conditions, our tenants', managers' and operators' businesses may become significantly adversely affected, which may result in some tenants failing to pay rent to us or not renewing their leases upon expiration and in our senior living community managers realizing decreased returns from our senior living communities. Specifically as it relates to our SHOP segment, we face and may continue to face issues with labor availability and cost pressures from supply chain disruptions and commodity price inflation.

Our Investing Liquidity and Resources

The change in cash provided by (used in) investing activities for the year ended December 31, 2021 compared to the prior year was primarily due to proceeds from our sale of a 35% equity interest from our 55% equity interest in a joint venture that owns a life science property located in Boston, Massachusetts to another third party global institutional investor, partially offset by less proceeds from the sale of real estate properties and an increase in real estate improvements during 2021 compared to 2020.

As described above, in January 2022 we entered into a joint venture for 10 medical office and life science properties we owned with two unrelated third party global institutional investors for aggregate proceeds, before closing costs and other adjustments, of $653.3 million.

The following is a summary of capital expenditures, development, redevelopment and other activities for the periods presented (dollars in thousands):

	For the Year Ended December 31,
	2021		2020
Office Portfolio segment capital expenditures:
Lease related costs (1)	$	40,253	$	19,364
Building improvements (2)	15,407		18,119
SHOP segment fixed assets and capital improvements	141,122		64,446
Recurring capital expenditures	$	196,782	$	101,929
Development, redevelopment and other activities - Office Portfolio segment (3)	$	40,253	$	55,642
Development, redevelopment and other activities - SHOP segment(3)	17,274		27,098
Total development, redevelopment and other activities	$	57,527	$	82,740

(1)Office Portfolio segment lease related costs generally include capital expenditures to improve tenants' space or amounts paid directly to tenants to improve their space and other leasing related costs, such as brokerage commissions and tenant inducements.

(2)Office Portfolio segment building improvements generally include expenditures to replace obsolete building components that extend the useful life of existing assets or other improvements to increase the marketability of the property.

(3)Development, redevelopment and other activities generally include capital expenditures that reposition a property or result in new sources of revenue.

We plan to continue investing capital in our properties, including redevelopment projects, to better position these properties in their respective markets in order to increase our returns in future years. In 2022, we expect to incur capital expenditures in excess of 2021 levels, up to the $400.0 million limit allowed pursuant to our credit agreement.

78

As of December 31, 2021, we had estimated unspent leasing related obligations at our triple net leased senior living communities and our medical office and life science properties of approximately $76.6 million, of which we expect to spend approximately $54.7 million during calendar year 2022. We expect to fund these obligations using operating cash flows we generate as rental income from our leased properties, residents fees and services revenues from our managed communities, cash on hand, proceeds from the contributions of certain of our properties to investors in our joint ventures and proceeds from the disposition of certain properties.

Our redevelopment in San Diego, CA has been completed and we expect to incur additional lease related costs in 2022. During the year ended December 31, 2021, we entered into five leases with a weighted (by annualized rental income) average lease term of approximately 11 years at a weighted average rental rate that is approximately 23% higher than the prior rental rate for the same space at this San Diego, CA property. We have executed new leases for 100% of the leasable square footage at this property. We are currently in the process of redeveloping two properties in our Office Portfolio located in Lexington, MA and Tempe, AZ. Our redevelopments in Lexington, MA and Tempe, AZ are currently expected to be completed in the second quarter of 2022 and fourth quarter of 2022, respectively. We have entered into a new ten year lease for the entire building at the Lexington, MA property at a rental rate that is 46% higher than the prior rental rate for the same space. Additionally, in January 2022, we entered into a new 11 year lease for the entire building at the Tempe, AZ property at a rental rate that is 20% higher than the prior rental rate for the same space. We are also currently reviewing strategic alternatives at properties in our Office Portfolio located in Silver Springs, MD and in Decatur, GA, including opportunities to redevelop these properties. We continue to assess opportunities to redevelop other properties in our portfolio. These redevelopment projects may require significant capital expenditures and time to complete. We continue to assess opportunities to redevelop other properties in our portfolio.

As noted above, our ability to make capital investments is currently limited pursuant to our credit agreement. Additionally, due to supply chain disruptions and inflation, the capital investments we plan to make may be delayed or cost more than we expect. For further information regarding our acquisitions and dispositions, see Note 3 to our Consolidated Financial Statements included in Part IV, Item 15 of this Annual Report on Form 10-K.

Our Financing Liquidity and Resources

The change in cash provided by (used in) financing activities for the year ended December 31, 2021 compared to the prior year was primarily due to increased net borrowings under our revolving credit facility, net proceeds from our issuance in February 2021 of $500.0 million aggregate principal amount of our 4.375% senior notes, decreased term loan repayment amounts in 2021 compared to 2020, and a reduction in distributions paid to our shareholders in 2021, partially offset by increased senior unsecured notes repayment amounts in 2021 compared to 2020 and net proceeds from our issuance in June 2020 of $1.0 billion aggregate principal amount of our 9.75% senior notes.

As of December 31, 2021, we had $634.8 million of cash and cash equivalents and were fully drawn under our revolving credit facility. We typically use cash balances, borrowings under our revolving credit facility, net proceeds from offerings of debt or equity securities, net proceeds from the disposition of assets and the cash flows from our operations to fund our operations, debt repayments, distributions, property acquisitions, investments, capital expenditures and other general business purposes.

In order to fund investments and to meet cash needs that may result from timing differences between our receipt of rents and our desire or need to make distributions or pay operating or capital expenses, we maintain a revolving credit facility. As of December 31, 2021, the maturity date of our revolving credit facility was January 2023. In February 2022, we exercised our option to extend the maturity date of our revolving credit facility by one year to January 2024. Our revolving credit facility generally provides that we can borrow, repay and re-borrow funds available under our revolving credit facility until maturity, and no principal repayment is due until maturity. At December 31, 2021, our revolving credit facility required interest to be paid on borrowings at the annual rate of 2.9%, plus a facility fee of 30 basis points per annum on the total amount of lending commitments under the facility. The interest rate premium and facility fee are each subject to adjustment based upon changes to our credit ratings. On March 31, 2021, we borrowed $800.0 million under our revolving credit facility as a precautionary measure to increase our cash position and preserve financial flexibility in light of continued uncertainties related to the COVID-19 pandemic. In February 2022, we repaid $100.0 million of this borrowing to reduce the borrowing capacity under our revolving credit facility to $700.0 million pursuant to the February 2022 amendment to our credit agreement. Pursuant to our credit agreement, the borrowing capacity under our revolving credit facility will be reduced to $586.4 million as of January 2023 and as such, further repayment of our revolving credit facility may be required. As of December 31, 2021 and February 21, 2022, we were fully drawn under our revolving credit facility.

79

In January 2021, we and our lenders amended our credit agreement and the agreement governing our previously existing $200.0 million term loan in order to provide us with certain flexibility in light of continued uncertainties related to the COVID-19 pandemic. Pursuant to the amendments:

•certain of the financial covenants under our credit agreement and the agreement governing our previously existing $200.0 million term loan, including covenants that require us to maintain certain financial ratios, have been waived through the Amendment Period;

•the revolving credit facility commitments have been reduced from $1.0 billion to $800.0 million;

•we pledged certain equity interests of subsidiaries owning properties to secure our obligations under our credit agreement and the agreement governing our previously existing $200.0 million term loan and agreed to provide, and as of September 2021 had provided, first mortgage liens on 61 medical office and life science properties with an aggregate gross book value of real estate assets of $1.0 billion as of December 31, 2021 to secure our obligations, which pledges and/or mortgage liens may be removed or new ones may be added during the Amendment Period based on outstanding debt amounts, among other things;

•we have the ability to fund $350.0 million of capital expenditures per year and we are restricted in our ability to acquire real property as defined in our credit agreement;

•the interest rate premium over LIBOR under our revolving credit facility and our previously existing $200.0 million term loan increased by 30 basis points;

•certain covenants and restrictions on distributions to common shareholders, share repurchases, capital expenditures, acquiring additional properties and incurring additional indebtedness (in each case subject to various exceptions), and the minimum liquidity requirement of $200.0 million will remain in place during the Amendment Period; and

•we are generally required to apply the net cash proceeds from the disposition of assets, capital markets transactions, and debt financings to the repayment of any amounts outstanding under our revolving credit facility.

In September 2021, we and our lenders further amended our credit agreement. Among other things, the amendment sets forth the mechanics for establishing a replacement benchmark rate under our revolving credit facility at such time as LIBOR is no longer available to calculate interest payable on amounts outstanding thereunder.

In February 2022, we and our lenders further amended our credit agreement. Pursuant to the amendment:

•the waiver of the fixed charge coverage ratio covenant included in our credit agreement has been extended through December 31, 2022;

•the revolving credit facility commitments have been reduced from $800.0 million to $700.0 million;

•we have the ability to fund $400.0 million of capital expenditures per year and we are restricted in our ability to acquire real property as defined in our credit agreement;

•the interest rate premium under our revolving credit facility increased by 15 basis points; and

•certain covenants and restrictions on distributions to common shareholders, share repurchases, capital expenditures, acquiring additional properties and incurring additional indebtedness (in each case subject to various exceptions), and the minimum liquidity requirement of $200.0 million will remain in place during the Amendment Period.

Also in February 2022, we exercised our option to extend the maturity date of our revolving credit facility by one year to January 2024. Pursuant to our credit agreement, the borrowing capacity under our revolving credit facility will be reduced to $586.4 million as of January 2023 and as such, further repayment of our revolving credit facility may be required.

Generally, when significant amounts are outstanding under our revolving credit facility, or as the maturities of our indebtedness approach, we intend to explore refinancing alternatives. Such alternatives may include incurring additional debt, selling certain properties and issuing new equity securities. In addition, we may also seek to expand our existing joint venture arrangements or to participate in additional joint ventures or other arrangements that may provide us additional sources of financing. We currently have an effective shelf registration statement that allows us to issue public securities on an expedited

80

basis, but it does not assure that there will be buyers for such securities. We may also assume debt in connection with our acquisitions of properties or place new debt on properties we own.

During the year ended December 31, 2021, we paid quarterly cash distributions to our shareholders totaling approximately $9.5 million using existing cash balances. For further information regarding the distributions we paid during 2021, see Note 5 to our Consolidated Financial Statements included in Part IV, Item 15 of this Annual Report on Form 10-K.

On January 13, 2022, we declared a quarterly distribution payable to common shareholders of record on January 24, 2022 in the amount of $0.01 per share, or approximately $2.4 million. We paid this distribution on February 17, 2022 using cash on hand.

We believe we will have access to various types of financings, including debt or equity offerings, to fund our future acquisitions and to pay our debts and other obligations as they become due, subject to limitations on debt offerings in agreements governing our debt. Our ability to complete, and the costs associated with, future debt transactions depends primarily upon credit market conditions and our then creditworthiness. We have no control over market conditions. Our credit and debt ratings, which were downgraded in 2020, depend upon evaluations by credit rating agencies of our business practices and plans, including our ability to maintain our earnings, to stagger our debt maturities and to balance our use of debt and equity capital so that our financial performance and leverage ratios afford us flexibility to withstand any reasonably anticipated adverse changes. Similarly, our ability to raise equity capital in the future will depend primarily upon equity capital market conditions and our ability to conduct our business to maintain and grow our operating cash flows. We intend to conduct our business activities in a manner which will afford us reasonable access to capital for investment and financing activities, but we cannot be sure that we will be able to successfully carry out that intention. It is uncertain what the duration and severity of the COVID-19 pandemic and its economic impact will be. A protracted negative impact on the economy or the industries in which our properties and businesses operate resulting from the COVID-19 pandemic may have various negative consequences including a decline in financing availability and increased costs for financing. Further, those conditions could also disrupt capital markets and limit our access to financing from public sources, particularly if the global financial markets experience significant disruptions.

In February 2021, we issued $500.0 million aggregate principal amount of our 4.375% senior notes due 2031 in an underwritten public offering. These notes are guaranteed by all of our subsidiaries, except for certain excluded subsidiaries, including pledged subsidiaries under our credit agreement. We used the net proceeds from this offering to prepay in full our $200.0 million term loan which was scheduled to mature in September 2022. In June 2021, we used the remaining net proceeds from this offering and cash on hand to redeem all of our outstanding 6.75% senior notes due 2021 for a redemption price equal to the principal amount of $300.0 million plus accrued and unpaid interest of $10.1 million, when these notes became redeemable with no prepayment premium. Our next significant debt maturity does not occur until $250.0 million of our senior notes mature in May 2024.

In February 2021, Moody's downgraded our senior unsecured debt rating from Ba2 to B1 and our 9.75% senior notes due 2025 rating from Ba1 to Ba3 and assigned a Ba3 rating to our 4.375% senior notes due 2031, and Standard & Poor's downgraded our senior unsecured debt rating from BB to BB- and our 9.75% senior notes due 2025 rating from BB+ to BB and assigned a BB rating to our 4.375% senior notes due 2031.

In February 2022, Moody's downgraded our senior unsecured debt rating from B1 to B3, our 9.75% senior notes due 2025 rating from Ba3 to B2 and our 4.375% senior notes due 2031 rating from Ba3 to B2.

For further information regarding our outstanding debt, see Note 9 to our Consolidated Financial Statements included in Part IV, Item 15 of this Annual Report on Form 10-K.

Debt Covenants

Our principal debt obligations at December 31, 2021 were: (1) outstanding borrowings under our then $800.0 million revolving credit facility; (2) $2.9 billion outstanding principal amount of senior unsecured notes; and (3) $62.5 million aggregate principal amount of mortgage notes (excluding premiums, discounts and net debt issuance costs) secured by six properties. For further information regarding our indebtedness, see Note 9 to our Consolidated Financial Statements included in Part IV, Item 15 of this Annual Report on Form 10-K.

Our senior unsecured notes are governed by our senior unsecured notes indentures and their supplements. Our credit agreement and our senior unsecured notes indentures and their supplements provide for acceleration of payment of all amounts outstanding upon the occurrence and continuation of certain events of default, such as, in the case of our credit agreement, a

81

change of control of us, as defined, which includes RMR LLC ceasing to act as our business and property manager. Our senior unsecured notes indentures and their supplements and our credit agreement also contain covenants that restrict our ability to incur debts, including debts secured by mortgages on our properties, in excess of calculated amounts and require us to maintain various financial ratios, and our credit agreement contains covenants that restrict our ability to make distributions to our shareholders in certain circumstances. As of December 31, 2021, our ratio of consolidated income available for debt service to debt service was below the 1.5x incurrence requirement under our revolving credit facility and our public debt covenants as the effects of the COVID-19 pandemic continued to adversely impact our operations. We are currently unable to incur additional debt because this ratio is below 1.5x on a pro forma basis, and as such, prior to falling below the 1.5x incurrence requirement, we borrowed $800.0 million under our revolving credit facility as a precautionary measure to increase our cash position and preserve financial flexibility. The proceeds from this borrowing may be used for general business purposes. In February 2022, we repaid $100.0 million of this borrowing to reduce the borrowing capacity under our revolving credit facility to $700.0 million pursuant to the February 2022 amendment to our credit agreement. As of December 31, 2021, we believe we were in compliance with all of the other covenants under our senior unsecured notes indentures and their supplements, our credit agreement and our other debt obligations. Although we have taken steps to enhance our ability to maintain sufficient liquidity, as noted elsewhere in this Annual Report on Form 10-K, a protracted negative impact on the economy or the industries in which our properties and businesses operate resulting from the COVID-19 pandemic may cause increased pressure on our ability to satisfy financial and other covenants. Continued availability of borrowings under our revolving credit facility is subject to our satisfying certain financial covenants and other credit facility conditions. If our operating results and financial condition are significantly negatively impacted by the economic conditions or otherwise, we may fail to satisfy covenants and conditions under our credit agreement or fail to satisfy our public debt covenants. Further, if we believe we will not be able to satisfy our financial or other covenants, we will seek waivers, amendments, or in the case of our public debt covenants, borrow any undrawn amounts which may become available under our revolving credit facility prior to any covenant violation, consistent with our approach in March 2021, which may lead to increased costs and interest rates, additional restrictive covenants or other lender protections. We cannot assure that we would be able to obtain these waivers or amendments or repay the related debt facilities when due, or that there will be any amounts available to borrow under our revolving credit facility, which may result in an event of default under the agreements governing our debt or the potential acceleration of our outstanding debt.

Neither our senior unsecured notes indentures and their supplements, nor our credit agreement, contain provisions for acceleration which could be triggered by our debt ratings. However, under our credit agreement, our senior unsecured debt ratings are used to determine the fees and interest rates we pay. Accordingly, following our debt ratings downgrades, our interest expense and related costs under our credit agreement has increased. See "—Our Financing Liquidity and Resources" above for information regarding recent downgrades of our issuer credit rating and senior unsecured debt rating that resulted in a change in the interest rate premiums under our revolving credit facility.

Our senior unsecured notes indentures and their supplements contain cross default provisions to any other debts of more than $20.0 million ($50.0 million or more in the case of our senior unsecured notes indentures and supplements entered in February 2016, February 2018, June 2020 and February 2021). Similarly, our credit agreement has cross default provisions to other indebtedness that is recourse of $25.0 million or more and indebtedness that is non-recourse of $75.0 million or more.

The loan agreements governing the aggregate $620.0 million secured debt financing related to the joint venture for a life science property in Boston, Massachusetts contain customary covenants and provide for acceleration of payment of all amounts due thereunder upon the occurrence and continuation of certain events of default. We no longer include this $620.0 million of secured debt financing in our consolidated balance sheet following the deconsolidation of the net assets of this joint venture, as discussed above; however, DHC continues to provide certain guaranties on this debt.

Supplemental Guarantor Information

On May 28, 2020, we issued $1.0 billion of our 9.75% senior notes due 2025. On February 3, 2021, we issued $500.0 million of our 4.375% senior notes due 2031. As of December 31, 2021, all $1.0 billion of our 9.75% senior notes due 2025 and all $500.0 million of our 4.375% senior notes due 2031 were fully and unconditionally guaranteed, on a joint and several basis and on a senior unsecured basis, by all of our subsidiaries, except for certain excluded subsidiaries, including pledged subsidiaries under our credit agreement. The notes and the guarantees are effectively subordinated to all of our and the subsidiary guarantors' secured indebtedness, respectively, to the extent of the value of the collateral securing such secured indebtedness, and are structurally subordinated to all indebtedness and other liabilities and any preferred equity of any of our subsidiaries that do not guarantee the notes. Our remaining $1.35 billion of senior unsecured notes do not have the benefit of any guarantees as of December 31, 2021.

A subsidiary guarantor's guarantee of our 9.75% senior notes due 2025 and our 4.375% senior notes due 2031, as applicable, and all other obligations of such subsidiary guarantor under the indenture governing the notes will automatically

82

terminate and such subsidiary guarantor will automatically be released from all of its obligations under such subsidiary guarantee and the indenture under certain circumstances, including on or after the date (a) the notes have an investment grade rating from two rating agencies and one of such investment grade ratings is a mid-BBB investment grade rating and (b) no default or event of default has occurred and is continuing under the indenture. Our non-guarantor subsidiaries are separate and distinct legal entities and have no obligation, contingent or otherwise, to pay any amounts due on our 9.75% senior notes due 2025 or our 4.375% senior notes due 2031 or the respective guarantees, or to make any funds available therefor, whether by dividend, distribution, loan or other payments. The rights of holders of our 9.75% senior notes due 2025 and our 4.375% senior notes due 2031, as applicable, to benefit from any of the assets of our non-guarantor subsidiaries are subject to the prior satisfaction of claims of those subsidiaries' creditors and any preferred equity holders. As a result, our 9.75% senior notes due 2025 and our 4.375% senior notes due 2031 and the respective guarantees are structurally subordinated to all indebtedness, guarantees and other liabilities of our subsidiaries that do not guarantee our 9.75% senior notes due 2025 and our 4.375% senior notes due 2031, including guarantees of other indebtedness of ours, payment obligations under lease agreements, trade payables and preferred equity.

The following tables present summarized financial information for guarantor entities and issuer, on a combined basis after eliminating (i) intercompany transactions and balances among the guarantor entities and (ii) equity in earnings from, and any investments in, any subsidiary that is a non-guarantor (dollars in thousands):

	December 31, 2021
Real estate properties, net	$	3,822,547
Other assets, net	1,424,994
Total assets	$	5,247,541
Indebtedness, net	$	3,613,447
Other liabilities	259,670
Total liabilities	$	3,873,117

	Year Ended December 31, 2021
Revenues	$	1,074,108
Expenses	1,212,487
Loss from continuing operations	(393,418)
Net loss	(394,848)
Net loss attributable to DHC	(394,848)

Related Person Transactions

We have relationships and historical and continuing transactions with RMR LLC, RMR Inc., AlerisLife (including Five Star) and others related to them. For further information about these and other such relationships and related person transactions, see Notes 3, 6, 7 and 8 to our Consolidated Financial Statements included in Part IV, Item 15 of this Annual Report on Form 10-K, which are incorporated herein by reference and our other filings with the SEC including our definitive Proxy Statement for our 2022 Annual Meeting of Shareholders, or our definitive Proxy Statement, to be filed with the SEC within 120 days after the fiscal year ended December 31, 2021. For further information about the risks that may arise as a result of these and other related person transactions and relationships, see elsewhere in this Annual Report on Form 10-K, including “Warning Concerning Forward-Looking Statements,” Part I, Item 1, “Business” and Part I, Item 1A, “Risk Factors.” We may engage in additional transactions with related persons, including businesses to which RMR LLC or its subsidiaries provide management services.

83

Critical Accounting Estimates

Our critical accounting policies are those that will have the most impact on the reporting of our financial condition and results of operations and those requiring significant judgments and estimates. We believe that our judgments and estimates have been and will be consistently applied and produce financial information that fairly presents our results of operations. Our most critical accounting policies involve our investments in real property. These policies affect our:

•allocation of purchase prices among various asset categories, including allocations to above and below market leases, and the related impact on the recognition of rental income and depreciation and amortization expenses; and

•assessment of the carrying values and impairments of long lived assets.

We allocate the purchase prices of our properties to land, building and improvements based on determinations of the fair values of these assets assuming the properties are vacant. We determine the fair value of each property using methods similar to those used by independent appraisers, which may involve estimated cash flows that are based on a number of factors, including capitalization rates and discount rates, among others. In some circumstances, we engage independent real estate appraisal firms to provide market information and evaluations which are relevant to our purchase price allocations and determinations of depreciable useful lives; however, we are ultimately responsible for the purchase price allocations and determinations of useful lives. We allocate a portion of the purchase price to above market and below market leases based on the present value (using an interest rate which reflects the risks associated with acquired in place leases at the time each property was acquired by us) of the difference, if any, between (i) the contractual amounts to be paid pursuant to the acquired in place leases and (ii) our estimates of fair market lease rates for the corresponding leases, measured over a period equal to the terms of the respective leases. The terms of below market leases that include bargain renewal options, if any, are further adjusted if we determine that renewal is probable. We allocate a portion of the purchase price to acquired in place leases and tenant relationships based upon market estimates to lease up the property based on the leases in place at the time of purchase. In making these allocations, we consider factors such as estimated carrying costs during the expected lease up periods, including real estate taxes, insurance and other operating income and expenses and costs, such as leasing commissions, legal and other related expenses, to execute similar leases in current market conditions at the time a property was acquired by us. We allocate this aggregate value between acquired in place lease values and tenant relationships based on our evaluation of the specific characteristics of each tenant's lease. However, we have not separated the value of tenant relationships from the value of acquired in place leases because such value and related amortization expense is immaterial to our consolidated financial statements. If the value of tenant relationships becomes material in the future, we may separately allocate those amounts and amortize the allocated amount over the estimated life of the relationships.

We regularly evaluate our properties for indicators of impairment. Impairment indicators may include declining tenant or resident occupancy, weak or declining profitability from the property, decreasing tenant cash flows or liquidity, our decision to dispose of an asset before the end of its estimated useful life, and legislative, market or industry changes that could permanently reduce the value of a property. If indicators of impairment are present, we evaluate the carrying value of the related property by comparing it to the expected future cash flows to be generated from that property. If the sum of these expected future cash flows is less than the carrying value, we reduce the net carrying value of the property to its estimated fair value. This analysis requires us to judge whether indicators of impairment exist and to estimate likely future cash flows. The future cash flows are subjective and are based in part on assumptions regarding hold periods, market rents and terminal capitalization rates. If we misjudge or estimate incorrectly or if future tenant operations, market or industry factors differ from our expectations we may record an impairment charge that is inappropriate or fail to record a charge when we should have done so, or the amount of any such charges may be inaccurate.

These accounting policies involve significant judgments made based upon our experience and the experience of our management and our Board of Trustees, including judgments about current valuations, ultimate realizable value, estimated useful lives, salvage or residual value, the ability and willingness of our tenants to perform their obligations to us, and the current and likely future operating and competitive environments in which our properties are operated. In the future, we may need to revise our carrying value assessments to incorporate information which is not now known, and such revisions could increase or decrease our depreciation expense or impairment charges related to properties we own, result in the classification of our leases as other than operating leases or decrease the carrying values of our assets.

Impact of Government Reimbursement

For the year ended December 31, 2021, substantially all of our NOI was generated from properties where a majority of the revenues are derived from our tenants' and residents' private resources, and a small amount of our NOI was generated from properties where a majority of the revenues are derived from Medicare and Medicaid payments. Nonetheless, we own, and our

84

tenants, managers and operators operate, facilities in many states that participate in federal and state healthcare payment programs, including the federal Medicare and state Medicaid programs and other federal and state healthcare payment programs. Also, some of our medical office and life science property tenants participate in federal Medicare and state Medicaid programs and other government healthcare payment programs. Because of shifting policy priorities, the current and projected federal budget deficit, other federal spending priorities and challenging fiscal conditions in some states, there have been numerous recent legislative and regulatory actions or proposed actions with respect to federal Medicare rates, state Medicaid rates and federal payments to states for Medicaid programs, as well as existing regulations that impact these matters. Further, there are other existing and recently enacted legislation, and related litigation, related to government payments, insurance and healthcare delivery. Examples of these, and other information regarding such matters and developments, are provided under the caption “Business-Government Regulation and Reimbursement” above in this Annual Report on Form 10-K. We cannot currently predict the type and magnitude of the potential Medicare and Medicaid policy changes, rate changes or other changes that may be implemented, but we believe that some of these changes will cause these government funded healthcare programs to fail to provide rates that match our and our tenants' increasing expenses and that such changes may be material and adverse to our future financial results.

During the year ended December 31, 2021, we recognized $19.6 million in interest and other income in our consolidated statement of comprehensive income (loss) related to funds received under the CARES Act.

Seasonality

Senior housing operations have historically reflected modest seasonality. During fourth quarter holiday periods, residents at such facilities are sometimes discharged to spend time with family and admission decisions are often deferred. The first quarter of each calendar year usually coincides with increased illness among residents which can result in increased costs or discharges to hospitals. As a result of these and other factors, these operations sometimes produce greater earnings in the second and third quarters of a calendar year and lesser earnings in the fourth and first calendar quarters. We do not expect these seasonal differences to have a material impact upon the ability of our tenants to pay our rent or our ability to fund our managed senior living operations or our other businesses. Our medical office and life science properties and wellness centers do not typically experience seasonality.

Impact of Climate Change

Concerns about climate change have resulted in various treaties, laws and regulations that are intended to limit carbon emissions and address other environmental concerns. These and other laws may cause energy or other costs at our properties to increase. We do not expect the direct impact of these increases to be material to our results of operations, because the increased costs either would be the responsibility of our tenants directly or in the longer term, passed through and paid by tenants of our properties. Although we do not believe it is likely in the foreseeable future, laws enacted to mitigate climate change may make some of our buildings obsolete or cause us to make material investments in our properties, which could materially and adversely affect our financial condition or the financial condition of our tenants or managers and their ability to pay rent or returns to us.

In an effort to reduce the effects of any increased energy costs in the future, we continuously study ways to improve the energy efficiency at all of our properties. Our property manager, RMR LLC, is a member of the ENERGY STAR program, a joint program of the U.S. Environmental Protection Agency and the U.S. Department of Energy that is focused on promoting energy efficiency at commercial properties through its “ENERGY STAR” partner program, and a member of the U.S. Green Building Council, a nonprofit organization focused on promoting energy efficiency at commercial properties through its leadership in energy and environmental design, or LEED®, green building program.

Some observers believe severe weather in different parts of the world over the last few years is evidence of global climate change. Severe weather may have an adverse effect on certain properties we own. Rising sea levels could cause flooding at some of our properties, which may have an adverse effect on individual properties we own. We mitigate these risks by procuring, or requiring our tenants to procure, insurance coverage we believe adequate to protect us from material damages and losses resulting from the consequences of losses caused by climate change. However, we cannot be sure that our mitigation efforts will be sufficient or that future storms, rising sea levels or other changes that may occur due to future climate change could not have a material adverse effect on our financial results.

85

Item 7A.  Quantitative and Qualitative Disclosures About Market Risk.

We are exposed to risks associated with market changes in interest rates. We manage our exposure to this market risk by monitoring available financing alternatives. Other than as described below, we do not currently foresee any significant changes in our exposure to fluctuations in interest rates or in how we manage this exposure in the near future.

Although we have no present plans to do so, we may in the future enter into hedge arrangements or derivative contracts from time to time to mitigate our exposure to changes in interest rates.

Fixed Rate Debt

At December 31, 2021, our outstanding fixed rate debt included the following (dollars in thousands):

			Annual		Annual
	Principal		Interest		Interest			Interest
Debt	Balance (1)		Rate (1)		Expense		Maturity	Payments Due
Senior unsecured notes	$	250,000	4.750	%	$	11,875	2024	Semi-Annually
Senior unsecured notes	1,000,000		9.750	%	97,500		2025	Semi-Annually
Senior unsecured notes	500,000		4.750	%	23,750		2028	Semi-Annually
Senior unsecured notes	500,000		4.375	%	21,875		2031	Semi-Annually
Senior unsecured notes	350,000		5.625	%	19,688		2042	Quarterly
Senior unsecured notes	250,000		6.250	%	15,625		2046	Quarterly
Mortgage note	11,120		6.280	%	698		2022	Monthly
Mortgage note	10,479		4.850	%	508		2022	Monthly
Mortgage note	15,456		5.750	%	889		2022	Monthly
Mortgage note	15,204		6.640	%	1,010		2023	Monthly
Mortgage note	10,240		4.444	%	455		2043	Monthly
	$	2,912,499			$	193,873

(1)The principal balances and interest rates are the amounts stated in the applicable contracts. In accordance with GAAP, our carrying values and recorded interest expense may differ from these amounts because of market conditions at the time we assumed certain of these debts. This table does not include obligations under finance leases.

No principal repayments are due under our unsecured notes until maturity. Our mortgage notes generally require principal and interest payments through maturity pursuant to amortization schedules. Because these debts require interest to be paid at a fixed rate, changes in market interest rates during the term of these debts will not affect our interest obligations. If these debts were refinanced at interest rates which are one percentage point higher or lower than shown above, our annual interest cost would increase or decrease by approximately $29.1 million.

Changes in market interest rates also would affect the fair value of our fixed rate debt obligations; increases in market interest rates decrease the fair value of our fixed rate debt, while decreases in market interest rates increase the fair value of our fixed rate debt. Based on the balances outstanding at December 31, 2021, and discounted cash flows analyses through the respective maturity dates, and assuming no other changes in factors that may affect the fair value of our fixed rate debt obligations, a hypothetical immediate one percentage point increase in interest rates would change the fair value of those obligations by approximately $1.6 million.

Our senior unsecured notes and certain of our mortgages contain provisions that allow us to make repayments earlier than the stated maturity date. In some cases, we are not allowed to make early repayment prior to a cutoff date and we are generally allowed to make prepayments only at a premium equal to a make whole amount, as defined, which is generally designed to preserve a stated yield to the noteholder. In the past, we have repurchased and retired some of our outstanding debt and we may do so again in the future. These prepayment rights and our ability to repurchase and retire outstanding debt may afford us opportunities to mitigate the risk of refinancing our debts at maturity at higher rates by refinancing prior to maturity.

86

Floating Rate Debt

At December 31, 2021, our floating rate debt obligations consisted of $800.0 million outstanding under our revolving credit facility. As of December 31, 2021, the maturity date of our revolving credit facility was January 2023. In February 2022, we exercised our option to extend the maturity date of our revolving credit facility by one year to January 2024. Generally, no principal repayments are required under our revolving credit facility prior to maturity, and we can borrow, repay and re-borrow funds available, subject to conditions, at any time without penalty.

Borrowings under our revolving credit facility are in U.S. dollars and interest is required to be paid at the rate of LIBOR plus a premium that is subject to adjustment based upon changes to our credit ratings. Accordingly, we are exposed to interest rate risk for changes in U.S. dollar based short term rates, specifically LIBOR, and to changes in our credit ratings. In addition, upon renewal or refinancing of our revolving credit facility, we are vulnerable to increases in interest rate premiums due to market conditions or our perceived credit characteristics. Generally, a change in interest rates would not affect the value of our floating rate debt but would affect our operating results.

The following table presents the impact a one percentage point increase in interest rates would have on our annual floating rate interest expense as of December 31, 2021 (dollars in thousands except per share amounts):

	Impact of Changes in Interest Rates
	Interest Rate (1)		Outstanding Floating Rate Debt		Total Interest Expense Per Year		Annual Earnings per Share Impact(2)
At December 31, 2021	2.85	%	$	800,000	$	22,800	$	0.10
One percentage point increase	3.85	%	$	800,000	$	30,800	$	0.13

(1)Interest rate under our revolving credit facility as of December 31, 2021.

(2)Based on weighted average number of shares outstanding (basic and diluted) for the year ended December 31, 2021.

The foregoing table shows the impact of an immediate increase in floating interest rates. If interest rates were to increase gradually over time, the impact would be spread over time. Our exposure to fluctuations in floating interest rates will increase or decrease in the future with increases or decreases in the amount of our borrowings outstanding under our revolving credit facility or other floating rate debt.

LIBOR Phase Out

As of December 31, 2021, LIBOR has been phased out for new contracts and is currently expected to be phased out for pre-existing contracts by June 30, 2023. We are required to pay interest on borrowings under our revolving credit facility at floating rates based on LIBOR and interest we may pay on any future debt that we may incur may also require that we pay interest based upon LIBOR. In September 2021, we amended our credit agreement to set forth the mechanics for establishing a replacement benchmark rate under our revolving credit facility at such time as LIBOR is no longer available to calculate interest payable on amounts outstanding thereunder. Despite this amendment, we cannot be sure that any changes to the determination of interest under our agreement will approximate the current calculation in accordance with LIBOR. We cannot be sure what standard, if any, will replace LIBOR, and any alternative interest rate index that may replace LIBOR may result in our paying increased interest.

Item 8.  Financial Statements and Supplementary Data.

The information required by this item is included in Part IV, Item 15 of this Annual Report on Form 10-K.

Item 9.  Changes in and Disagreements With Accountants on Accounting and Financial Disclosure.

None.

Item 9A.  Controls and Procedures.

As of the end of the period covered by this Annual Report on Form 10-K, our management carried out an evaluation, under the supervision and with the participation of our President and Chief Executive Officer and our Chief Financial Officer and Treasurer, of the effectiveness of our disclosure controls and procedures pursuant to Rules 13a-15 and 15d-15 under the

87

Exchange Act. Based upon that evaluation, our President and Chief Executive Officer and our Chief Financial Officer and Treasurer concluded that our disclosure controls and procedures are effective.

There have been no changes in our internal control over financial reporting during the quarter ended December 31, 2021 that have materially affected, or are reasonably likely to materially affect, our internal control over financial reporting.

Management Report on Assessment of Internal Control Over Financial Reporting.

We are responsible for establishing and maintaining adequate internal control over financial reporting. Our internal control system is designed to provide reasonable assurance to our management and Board of Trustees regarding the preparation and fair presentation of published financial statements. All internal control systems, no matter how well designed, have inherent limitations. Therefore, even those systems determined to be effective can provide only reasonable assurance with respect to financial statement preparation and presentation.

Our management assessed the effectiveness of our internal control over financial reporting as of December 31, 2021. In making this assessment, it used the criteria set forth by the Committee of Sponsoring Organizations of the Treadway Commission in Internal Control—Integrated Framework (2013 framework). Based on this assessment, we believe that, as of December 31, 2021, our internal control over financial reporting is effective.

Deloitte & Touche LLP, the independent registered public accounting firm that audited our 2021 Consolidated Financial Statements included in Part IV, Item 15 of this Annual Report on Form 10-K, has issued an attestation report on our internal control over financial reporting. The report appears elsewhere herein.

Item 9B.  Other Information.

None.

Item 9C.  Disclosure Regarding Foreign Jurisdictions that Prevent Inspections.

Not applicable.

PART III

Item 10.  Directors, Executive Officers and Corporate Governance.

We have a Code of Conduct that applies to our officers and Trustees, RMR Inc. and RMR LLC, senior level officers of RMR LLC, senior level officers and directors of RMR Inc. and certain other officers and employees of RMR LLC. Our Code of Conduct is posted on our website, www.dhcreit.com. A printed copy of our Code of Conduct is also available free of charge to any person who requests a copy by writing to our Secretary, Diversified Healthcare Trust, Two Newton Place, 255 Washington Street, Suite 300, Newton, MA 02458-1634. We intend to satisfy the requirements under Item 5.05 of Form 8-K regarding disclosure of amendments to, or waivers from, provisions of our Code of Conduct to apply to our principal executive officer, principal financial officer, principal accounting officer or controller, or any persons performing similar functions, on our website.

The remainder of the information required by Item 10 is incorporated by reference to our definitive Proxy Statement.

Item 11.  Executive Compensation.

The information required by Item 11 is incorporated by reference to our definitive Proxy Statement. 

Item 12.  Security Ownership of Certain Beneficial Owners and Management and Related Stockholder Matters.

Equity Compensation Plan Information.  We may award common shares to our officers and other employees of RMR LLC under our 2012 Equity Compensation Plan, as amended, or the 2012 Plan. In addition, each of our Trustees receives common shares as part of his or her annual compensation for serving as a Trustee and such shares are awarded under the 2012 Plan. The terms of awards made under the 2012 Plan are determined by the Compensation Committee of our Board of Trustees at the time of the awards. The following table is as of December 31, 2021:

88

	Number of securities to be issued upon exercise of outstanding options, warrants and rights	Weighted-average exercise price of outstanding options, warrants and rights	Number of securities remaining available for future issuance under our equity compensation plan excluding securities reflected in column (a)
Plan Category	(a)	(b)	(c)
Equity compensation plans approved by securityholders—2012 Plan	None.	None.	1,117,201	(1)
Equity compensation plan not approved by securityholders	None.	None.	None.
Total	None.	None.	1,117,201	(1)

(1)Consists of common shares available for issuance pursuant to the terms of the 2012 Plan. Share awards that are repurchased or forfeited will be added to the common shares available for issuance under the 2012 Plan.

Payments by us to RMR LLC employees are described in Notes 5 and 8 to our Consolidated Financial Statements included in Part IV, Item 15 of this Annual Report on Form 10-K. The remainder of the information required by Item 12 is incorporated by reference to our definitive Proxy Statement.

Item 13.  Certain Relationships and Related Transactions, and Director Independence.

The information required by Item 13 is incorporated by reference to our definitive Proxy Statement.

Item 14.  Principal Accountant Fees and Services.

The information required by Item 14 is incorporated by reference to our definitive Proxy Statement. 

89

PART IV

Item 15.  Exhibits and Financial Statement Schedules.

(a)    Index to Financial Statements and Financial Statement Schedules

The following consolidated financial statements and financial statement schedules of Diversified Healthcare Trust are included on the pages indicated:

	Page
Reports of Independent Registered Public Accounting Firm (PCAOB ID No. 34)	F-1
Report of Independent Registered Public Accounting Firm (PCAOB ID No. 42)	F-4
Consolidated Balance Sheets as of December 31, 2021 and 2020	F-5
Consolidated Statements of Comprehensive Income (Loss) for each of the three years in the period ended December 31, 2021	F-6
Consolidated Statements of Shareholders' Equity for each of the three years in the period ended December 31, 2021	F-7
Consolidated Statements of Cash Flows for each of the three years in the period ended December 31, 2021	F-8
Notes to Consolidated Financial Statements	F-10
Schedule III – Real Estate and Accumulated Depreciation as of December 31, 2021	S-1

All other schedules for which provision is made in the applicable accounting regulations of the SEC are not required under the related instructions, or are inapplicable, and therefore have been omitted.

Financial information about AlerisLife may be found on the SEC's website by entering AlerisLife's name at http://www.sec.gov/edgar/searchedgar/companysearch.html. Reference to AlerisLife's financial information on this external website is presented to comply with applicable accounting regulations of the SEC. Except for such financial information contained therein as is required to be included herein under such regulations, AlerisLife's public filings and other information located in external websites are not incorporated by reference into these financial statements.

90

(b)    Exhibits

Exhibit Number	Description
3.1	Composite Copy of Articles of Amendment and Restatement, dated September 20, 1999, as amended to date. (Incorporated by reference to the Company's Quarterly Report on Form 10-Q for the quarter ended June 30, 2020.)
3.2	Articles Supplementary, dated May 11, 2000. (Incorporated by reference to the Company’s Quarterly Report on Form 10-Q for the quarter ended March 31, 2000.)
3.3	Articles Supplementary, dated June 30, 2017. (Incorporated by reference to the Company’s Current Report on Form 8-K filed on June 30, 2017.)
3.4	Articles Supplementary, dated May 19, 2020. (Incorporated by reference to the Company’s Current Report on Form 8-K filed on May 20, 2020.)
3.5	Amended and Restated Bylaws of the Company, adopted January 1, 2020. (Incorporated by reference to the Company’s Current Report on Form 8-K filed on January 2, 2020.)
4.1	Form of Common Share Certificate. (Incorporated by reference to the Company’s Current Report on Form 8-K filed on January 2, 2020.)
4.2	Indenture, dated as of December 20, 2001, between the Company and State Street Bank and Trust Company. (Incorporated by reference to the Company’s Registration Statement on Form S-3, File No. 333-76588.)
4.3	Supplemental Indenture No. 7, dated as of July 20, 2012, between the Company and U.S. Bank National Association, related to 5.625% Senior Notes due 2042, including form thereof. (Incorporated by reference to the Company’s Registration Statement on Form 8-A filed on July 20, 2012.)
4.4	Supplemental Indenture No. 9, dated as of April 28, 2014, between the Company and U.S. Bank National Association, related to 4.75% Senior Notes due 2024, including form thereof. (Incorporated by reference to the Company’s Quarterly Report on Form 10-Q for the quarter ended March 31, 2014.)
4.5	Indenture, dated as of February 18, 2016, between the Company and U.S. Bank National Association. (Incorporated by reference to the Company’s Current Report on Form 8-K filed on February 18, 2016.)
4.6	First Supplemental Indenture, dated as of February 18, 2016, between the Company and U.S. Bank National Association, related to 6.25% Senior Notes due 2046, including form thereof. (Incorporated by reference to the Company’s Current Report on Form 8-K filed on February 18, 2016.)
4.7	Second Supplemental Indenture, dated as of February 12, 2018, between the Company and U.S. Bank National Association, related to 4.75% Senior Notes due 2028, including form thereof. (Incorporated by reference to the Company’s Annual Report on Form 10-K for the year ended December 31, 2017.)
4.8	Third Supplemental Indenture, dated as of June 2, 2020, among the Company, certain subsidiaries of the Company named therein as guarantors and U.S. Bank, National Association, related to 9.750% Senior Notes due 2025, including form thereof. (Incorporated by reference to the Company’s Current Report on Form 8-K filed on June 5, 2020.)
4.9	Supplemental Indenture, dated as of March 5, 2021, among the Company, certain subsidiaries of the Company named therein as guarantors and U.S. Bank, National Association, related to 9.750% Senior Notes due 2025. (Incorporated by reference to the Company’s Quarterly Report on Form 10-Q for the quarter ended March 31, 2021.)
4.10	Fourth Supplemental Indenture, dated as of February 8, 2021, among the Company, certain subsidiaries of the Company named therein as guarantors and U.S. Bank, National Association, related to 4.375% Senior Notes due 2031, including form thereof. (Incorporated by reference to the Company's Annual Report on Form 10-K for the year ended December 31, 2020.)
4.11	Supplemental Indenture, dated as of March 5, 2021, among the Company, certain subsidiaries of the Company named therein as guarantors and U.S. Bank, National Association, related to 4.375% Senior Notes due 2025. (Incorporated by reference to the Company’s Quarterly Report on Form 10-Q for the quarter ended March 31, 2021.)
4.12	Registration Rights and Lock-Up Agreement, dated as of June 5, 2015, among the Company, ABP Trust (f/k/a Reit Management & Research Trust) and Adam D. Portnoy. (Incorporated by reference to the Company’s Current Report on Form 8-K filed on June 8, 2015.)
4.13	Description of Securities. (Incorporated by reference to the Company's Annual Report on Form 10-K for the year ended December 31, 2020.)
8.1	Opinion of Sullivan & Worcester LLP as to certain tax matters. (Filed herewith.)
10.1	Second Amended and Restated Business Management Agreement, dated as of June 5, 2015, between the Company and The RMR Group LLC.(+) (Incorporated by reference to the Company’s Current Report on Form 8-K filed on June 8, 2015.)

91

10.2	First Amendment to Second Amended and Restated Business Management Agreement, effective as of August 1, 2021, between the Company and The RMR Group LLC.(+) (Incorporated by reference to the Company’s Quarterly Report on Form 10-Q for the quarter ended September 30, 2021.)
10.3	Third Amended and Restated Property Management Agreement, dated as of June 9, 2021, between the Company and The RMR Group LLC.(+) (Incorporated by reference to the Company’s Current Report on Form 8-K filed on June 9, 2021.)
10.4	2012 Equity Compensation Plan.(+) (Incorporated by reference to the Company’s Current Report on Form 8-K filed on May 23, 2012.)
10.5	First Amendment to 2012 Equity Compensation Plan.(+) (Incorporated by reference to the Company’s Quarterly Report on Form 10-Q for the quarter ended September 30, 2015.)
10.6	Form of Share Award Agreement.(+) (Incorporated by reference to the Company’s Quarterly Report on Form 10-Q for the quarter ended September 30, 2020.)
10.7	Form of Indemnification Agreement.(+) (Incorporated by reference to the Company’s Quarterly Report on Form 10-Q for the quarter ended June 30, 2020.)
10.8	Summary of Trustee Compensation.(+) (Incorporated by reference to the Company’s Current Report on Form 8-K filed on June 4, 2021.)
10.9	Amended and Restated Credit Agreement, dated as of August 1, 2017, among the Company, Wells Fargo Bank, National Association, as Administrative Agent, and each of the other financial institutions party thereto. (Incorporated by reference to the Company’s Quarterly Report on Form 10-Q for the quarter ended June 30, 2017.)
10.10	First Amendment to Amended and Restated Credit Agreement, dated as of June 30, 2020, among the Company, Wells Fargo Bank, National Association, as Administrative Agent, and each of the other institutions party thereto. (Incorporated by reference to the Company’s Current Report on Form 8-K filed on July 2, 2020.)
10.11	Second Amendment to Amended and Restated Credit Agreement, dated as of January 29, 2021, among the Company, Wells Fargo Bank, National Association, as Administrative Agent, and each of the other institutions party thereto. (Incorporated by reference to the Company's Current Report on Form 8-K filed on February 1, 2021.)
10.12	Third Amendment to Amended and Restated Credit Agreement, dated as of September 3, 2021, among the Company, Wells Fargo Bank, National Association, as Administrative Agent, and each of the other institutions party thereto. (Incorporated by reference to the Company’s Quarterly Report on Form 10-Q for the quarter ended September 30, 2021.)
10.13	Fourth Amendment to Amended and Restated Credit Agreement, dated as of February 22, 2022, among the Company, Wells Fargo Bank, National Association, as Administrative Agent, and each of the other institutions party thereto. (Incorporated by reference to the Company's Current Report on Form 8-K dated February 23, 2022.)
10.14	Pledge Agreement, dated as of January 29, 2021, among the Company, certain subsidiaries of the Company party thereto and Wells Fargo Bank, National Association, as Collateral Agent. (Incorporated by reference to the Company's Current Report on Form 8-K filed on February 1, 2021.)
10.15	Pledge Amendment, dated as of February 12, 2021, by the Company and certain subsidiaries of the Company party thereto. (Incorporated by reference to the Company's Annual Report on Form 10-K for the year ended December 31, 2020.)
10.16	Pledged Interest Release Request Letter, dated as of March 4, 2021, between the Company and Wells Fargo Bank, National Association. (Incorporated by reference to the Company’s Quarterly Report on Form 10-Q for the quarter ended March 31, 2021.)
10.17	Release of Certain Guarantors, dated as of March 5, 2021, related to 9.750% Senior Notes due 2025, among the Company, certain subsidiaries of the Company named therein and U.S. Bank, National Association. (Incorporated by reference to the Company’s Quarterly Report on Form 10-Q for the quarter ended March 31, 2021.)
10.18	Release of Certain Guarantors, dated as of January 28, 2022, related to 9.750% Senior Notes due 2025, among the Company, certain subsidiaries of the Company named therein and U.S. Bank, National Association. (Filed herewith.)
10.19	Release of Certain Guarantors, dated as of January 28, 2022, related to 4.375% Senior Notes due 2031, among the Company, certain subsidiaries of the Company named therein and U.S. Bank, National Association. (Filed herewith.)
10.20	Transaction Agreement, dated December 7, 2001, among the Company, certain subsidiaries of the Company party thereto, AlerisLife Inc. (f/k/a Five Star Senior Living Inc.), certain subsidiaries of AlerisLife Inc. party thereto, FSQ, Inc., Service Properties Trust (f/k/a Hospitality Properties Trust) and The RMR Group LLC. (Incorporated by reference to the Company’s Current Report on Form 8-K filed on December 17, 2001.)
10.21	Transaction Agreement, dated as of April 1, 2019, between the Company and AlerisLife Inc. (Incorporated by reference to the Company’s Current Report on Form 8-K filed on April 5, 2019.)

92

10.22	Amended and Restated Master Management Agreement, dated as of June 9, 2021, among the Company and certain of its subsidiaries, and AlerisLife Inc. and certain of its subsidiaries. (Incorporated by reference to the Company’s Current Report on Form 8-K filed on June 9, 2021.)
10.23	Amended and Restated Guaranty Agreement, dated as of June 9, 2021, by AlerisLife Inc. for the benefit of certain subsidiaries of the Company. (Incorporated by reference to the Company’s Current Report on Form 8-K filed on June 9, 2021.)
21.1	Subsidiaries of the Company. (Filed herewith.)
22.1	List of Subsidiary Guarantors. (Filed herewith.)
23.1	Consent of Deloitte & Touche LLP. (Filed herewith.)
23.2	Consent of Ernst & Young LLP. (Filed herewith.)
23.3	Consent of Sullivan & Worcester LLP. (Contained in Exhibit 8.1.)
31.1	Rule 13a-14(a) Certification. (Filed herewith.)
31.2	Rule 13a-14(a) Certification. (Filed herewith.)
32.1	Section 1350 Certification. (Furnished herewith.)
99.1	Registration Rights Agreement, dated as of August 4, 2009, between AlerisLife Inc. and the Company. (Incorporated by reference to the Company’s Quarterly Report on Form 10-Q for the quarter ended June 30, 2009.)
101.INS	XBRL Instance Document - the instance document does not appear in the Interactive Data File because its XBRL tags are embedded within the Inline XBRL document.
101.SCH	XBRL Taxonomy Extension Schema Document. (Filed herewith.)
101.CAL	XBRL Taxonomy Extension Calculation Linkbase Document. (Filed herewith.)
101.DEF	XBRL Taxonomy Extension Definition Linkbase Document. (Filed herewith.)
101.LAB	XBRL Taxonomy Extension Label Linkbase Document. (Filed herewith.)
101.PRE	XBRL Taxonomy Extension Presentation Linkbase Document. (Filed herewith.)
104	Cover Page Interactive Data File. (Formatted as Inline XBRL and contained in Exhibit 101.)

(+) Management contract or compensatory plan or arrangement.

93

Item 16.  Form 10-K Summary.

None.

94

REPORT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM

To the Trustees and Shareholders of Diversified Healthcare Trust

Opinion on the Financial Statements

We have audited the accompanying consolidated balance sheets of Diversified Healthcare Trust (the "Company") as of December 31, 2021 and December 31, 2020, the related consolidated statements of comprehensive income (loss), shareholders' equity, and cash flows, for the years ended December 31, 2021 and 2020, and the related notes and financial statement schedule listed in the Index at Item 15(a) (collectively referred to as the "financial statements"). In our opinion, the financial statements present fairly, in all material respects, the financial position of the Company as of December 31, 2021 and December 31, 2020, and the results of its operations and its cash flows for the years ended December 31, 2021 and 2020, in conformity with accounting principles generally accepted in the United States of America.

We have also audited, in accordance with the standards of the Public Company Accounting Oversight Board (United States) (PCAOB), the Company's internal control over financial reporting as of December 31, 2021, based on criteria established in Internal Control — Integrated Framework (2013) issued by the Committee of Sponsoring Organizations of the Treadway Commission and our report dated February 23, 2022, expressed an unqualified opinion on the Company's internal control over financial reporting.

Basis for Opinion

These financial statements are the responsibility of the Company's management. Our responsibility is to express an opinion on the Company's financial statements based on our audit. We are a public accounting firm registered with the PCAOB and are required to be independent with respect to the Company in accordance with the U.S. federal securities laws and the applicable rules and regulations of the Securities and Exchange Commission and the PCAOB.

We conducted our audit in accordance with the standards of the PCAOB. Those standards require that we plan and perform the audit to obtain reasonable assurance about whether the financial statements are free of material misstatement, whether due to error or fraud. Our audit included performing procedures to assess the risks of material misstatement of the financial statements, whether due to error or fraud, and performing procedures that respond to those risks. Such procedures included examining, on a test basis, evidence regarding the amounts and disclosures in the financial statements. Our audit also included evaluating the accounting principles used and significant estimates made by management, as well as evaluating the overall presentation of the financial statements. We believe that our audit provides a reasonable basis for our opinion.

Critical Audit Matter

The critical audit matter communicated below is a matter arising from the current-period audit of the financial statements that was communicated or required to be communicated to the audit committee and that (1) relates to accounts or disclosures that are material to the financial statements and (2) involved our especially challenging, subjective, or complex judgments. The communication of critical audit matters does not alter in any way our opinion on the financial statements, taken as a whole, and we are not, by communicating the critical audit matter below, providing a separate opinion on the critical audit matter or on the accounts or disclosures to which it relates.

Impairment of Real Estate Properties - Refer to Note 3 to the financial statements

Critical Audit Matter Description

The Company's investments in real estate assets are evaluated for impairment periodically or when events or changes in circumstances indicate that the carrying amount of a real estate asset may not be recoverable. Impairment indicators may include declining tenant or resident occupancy, weak or declining profitability from the property, decreasing tenant cash flows or liquidity, the Company's decision to dispose of an asset before the end of its estimated useful life, and legislative, market or industry changes that could permanently reduce the value of an asset. If indicators of impairment are identified for any real estate asset, the Company evaluates the recoverability of that real estate asset by comparing undiscounted future cash flows expected to be generated by the real estate asset over the Company's expected remaining hold period to the respective carrying amount. The Company's undiscounted future cash flows analysis requires management to make significant estimates and assumptions related to expected remaining hold periods, market rents, and terminal capitalization rates.

F-1

We identified the impairment of real estate assets as a critical audit matter because of the significant estimates and assumptions management makes to evaluate the recoverability of real estate assets. This required a high degree of auditor judgment and an increased extent of effort when performing audit procedures to evaluate the reasonableness of the significant estimates and assumptions related to expected remaining hold periods, market rents, and terminal capitalization rates within management's undiscounted future cash flows analysis which are sensitive to future market or industry considerations.

How the Critical Audit Matter Was Addressed in the Audit

Our audit procedures related to the undiscounted cash flows analysis for each real estate asset or group of assets with possible impairment indicators included the following among others:

•We tested the effectiveness of controls over management's evaluation of the recoverability of real estate property assets, including the key assumptions utilized in estimating the undiscounted future cash flows.

•We evaluated the undiscounted cash flow analysis including estimates of expected remaining hold period, market rents, and terminal capitalization rates for each real estate asset or group of assets with possible impairment indicators by (1) evaluating the source information and assumptions used by management and (2) comparing management's projections to external market sources and evidence obtained in other areas of our audit.

•We evaluated the reasonableness of management's undiscounted future cash flows analysis by developing an independent expectation of future undiscounted cash flows based on third party market data and compared that independent estimate to the carrying amount of the real estate asset or group of assets with possible indicators of impairment. We compared our analysis of the recoverability of the real estate asset or group of assets to the Company's analysis.

•We made inquiries of management about the current status of potential transactions and about management's judgments to understand the probability of future events that could affect the expected remaining hold period and other cash flow assumptions for the properties.

/s/ Deloitte & Touche LLP

Boston, Massachusetts

February 23, 2022

We have served as the Company's auditor since 2020.

F-2

REPORT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM

To the Trustees and Shareholders of Diversified Healthcare Trust

Opinion on Internal Control over Financial Reporting

We have audited the internal control over financial reporting of Diversified Healthcare Trust (the “Company”) as of December 31, 2021, based on criteria established in Internal Control — Integrated Framework (2013) issued by the Committee of Sponsoring Organizations of the Treadway Commission (COSO). In our opinion, the Company maintained, in all material respects, effective internal control over financial reporting as of December 31, 2021, based on criteria established in Internal Control — Integrated Framework (2013) issued by COSO.

We have also audited, in accordance with the standards of the Public Company Accounting Oversight Board (United States) (PCAOB), the consolidated financial statements as of and for the year ended December 31, 2021, of the Company and our report dated February 23, 2022, expressed an unqualified opinion on those financial statements.

Basis for Opinion

The Company's management is responsible for maintaining effective internal control over financial reporting and for its assessment of the effectiveness of internal control over financial reporting, included in the accompanying Management Report on Assessment of Internal Control over Financial Reporting. Our responsibility is to express an opinion on the Company's internal control over financial reporting based on our audit. We are a public accounting firm registered with the PCAOB and are required to be independent with respect to the Company in accordance with the U.S. federal securities laws and the applicable rules and regulations of the Securities and Exchange Commission and the PCAOB.

We conducted our audit in accordance with the standards of the PCAOB. Those standards require that we plan and perform the audit to obtain reasonable assurance about whether effective internal control over financial reporting was maintained in all material respects. Our audit included obtaining an understanding of internal control over financial reporting, assessing the risk that a material weakness exists, testing and evaluating the design and operating effectiveness of internal control based on the assessed risk, and performing such other procedures as we considered necessary in the circumstances. We believe that our audit provides a reasonable basis for our opinion.

Definition and Limitations of Internal Control over Financial Reporting

A company's internal control over financial reporting is a process designed to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles. A company's internal control over financial reporting includes those policies and procedures that (1) pertain to the maintenance of records that, in reasonable detail, accurately and fairly reflect the transactions and dispositions of the assets of the company; (2) provide reasonable assurance that transactions are recorded as necessary to permit preparation of financial statements in accordance with generally accepted accounting principles, and that receipts and expenditures of the company are being made only in accordance with authorizations of management and directors of the company; and (3) provide reasonable assurance regarding prevention or timely detection of unauthorized acquisition, use, or disposition of the company's assets that could have a material effect on the financial statements.

Because of its inherent limitations, internal control over financial reporting may not prevent or detect misstatements. Also, projections of any evaluation of effectiveness to future periods are subject to the risk that controls may become inadequate because of changes in conditions, or that the degree of compliance with the policies or procedures may deteriorate.

/s/ Deloitte & Touche LLP

Boston, Massachusetts

February 23, 2022

F-3

REPORT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM

To the Trustees and Shareholders of Diversified Healthcare Trust

Opinion on the Financial Statements

We have audited the accompanying consolidated statements of comprehensive income (loss), shareholders' equity and cash flows of Diversified Healthcare Trust (the Company) for the year ended December 31, 2019, and the related notes and financial statement schedule listed in the Index at Item 15(a) (collectively referred to as the “consolidated financial statements”). In our opinion, the consolidated financial statements present fairly, in all material respects, the Company's results of its operations and its cash flows for the year ended December 31, 2019, in conformity with U.S. generally accepted accounting principles.

We also have audited, in accordance with the standards of the Public Company Accounting Oversight Board (United States) (PCAOB), the Company's internal control over financial reporting as of December 31, 2019, based on criteria established in Internal Control-Integrated Framework issued by the Committee of Sponsoring Organizations of the Treadway Commission (2013 framework), and our report dated March 2, 2020 expressed an unqualified opinion thereon.

Basis for Opinion

These financial statements are the responsibility of the Company's management. Our responsibility is to express an opinion on the Company's financial statements based on our audit. We are a public accounting firm registered with the PCAOB and are required to be independent with respect to the Company in accordance with the U.S. federal securities laws and the applicable rules and regulations of the Securities and Exchange Commission and the PCAOB.

We conducted our audit in accordance with the standards of the PCAOB. Those standards require that we plan and perform the audit to obtain reasonable assurance about whether the financial statements are free of material misstatement, whether due to error or fraud. Our audit included performing procedures to assess the risks of material misstatement of the financial statements, whether due to error or fraud, and performing procedures that respond to those risks. Such procedures included examining, on a test basis, evidence regarding the amounts and disclosures in the financial statements. Our audit also included evaluating the accounting principles used and significant estimates made by management, as well as evaluating the overall presentation of the financial statements. We believe that our audit provides a reasonable basis for our opinion.

/s/ Ernst & Young LLP

We served as the Company's auditor from 1998 to 2020.

Boston, Massachusetts

March 2, 2020

F-4

DIVERSIFIED HEALTHCARE TRUST

CONSOLIDATED BALANCE SHEETS

(dollars in thousands, except share data)

	December 31,
	2021		2020
ASSETS
Real estate properties:
Land	$	741,501	$	789,125
Buildings and improvements	6,072,055		6,621,605
Total real estate properties, gross	6,813,556		7,410,730
Accumulated depreciation	(1,737,807)		(1,694,901)
Total real estate properties, net	5,075,749		5,715,829
Investment in unconsolidated joint venture	215,127		—
Assets of properties held for sale	—		112,437
Cash and cash equivalents	634,848		74,417
Restricted cash	382,097		16,432
Investments in equity securities	31,540		73,772
Acquired real estate leases and other intangible assets, net	48,746		286,513
Other assets, net	235,407		197,024
Total assets	$	6,623,514	$	6,476,424
LIABILITIES AND SHAREHOLDERS' EQUITY
Revolving credit facility	$	800,000	$	—
Term loan, net	—		199,049
Senior unsecured notes, net	2,806,811		2,608,189
Secured debt and finance leases, net	69,713		691,573
Liabilities of properties held for sale	—		3,525
Accrued interest	29,845		23,772
Due to affiliates	8,270		24,547
Assumed real estate lease obligations, net	2,556		67,830
Other liabilities	243,929		238,717
Total liabilities	3,961,124		3,857,202
Commitments and contingencies
Equity:
Equity attributable to common shareholders:
Common shares of beneficial interest, $.01 par value: 300,000,000 shares authorized, 238,994,894 and 238,268,478 shares issued and outstanding, respectively	2,390		2,383
Additional paid in capital	4,615,475		4,613,904
Cumulative net income	2,087,624		1,913,109
Cumulative distributions	(4,043,099)		(4,033,559)
Total equity attributable to common shareholders	2,662,390		2,495,837
Noncontrolling interest:
Total equity attributable to noncontrolling interest	—		123,385
Total equity	2,662,390		2,619,222
Total liabilities and equity	$	6,623,514	$	6,476,424

The accompanying notes are an integral part of these consolidated financial statements.

F-5

DIVERSIFIED HEALTHCARE TRUST

CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME (LOSS)

(amounts in thousands, except per share data)

	Year Ended December 31,
	2021		2020		2019
Revenues:
Rental income	$	408,589	$	427,215	$	606,558
Residents fees and services	974,623		1,204,811		433,597
Total revenues	1,383,212		1,632,026		1,040,155
Expenses:
Property operating expenses	1,091,812		1,236,357		489,070
Depreciation and amortization	271,131		270,147		289,025
General and administrative	34,087		30,593		37,028
Acquisition and certain other transaction related costs	17,506		814		13,102
Impairment of assets	(174)		106,972		115,201
Total expenses	1,414,362		1,644,883		943,426
Gain on sale of properties	492,272		6,487		39,696
Dividend income	—		—		1,846
Gains and losses on equity securities, net	(42,232)		34,106		(41,898)
Interest and other income	20,635		18,221		941
Interest expense (including net amortization of debt premiums, discounts and issuance costs of $13,408, $8,022 and $6,032, respectively)	(255,759)		(201,483)		(180,112)
Gain on lease termination	—		22,896		—
Loss on early extinguishment of debt	(2,410)		(427)		(44)
Income (loss) from continuing operations before income tax expense and equity in earnings of an investee	181,356		(133,057)		(82,842)
Income tax expense	(1,430)		(1,250)		(436)
Equity in earnings of an investee	—		—		400
Net income (loss)	179,926		(134,307)		(82,878)
Net income attributable to noncontrolling interest	(5,411)		(5,146)		(5,356)
Net income (loss) attributable to common shareholders	$	174,515	$	(139,453)	$	(88,234)
Other comprehensive income:
Amounts reclassified from cumulative other comprehensive income to net income	$	—	$	—	$	175
Equity in unrealized gain of an investee	—		—		91
Other comprehensive income	—		—		266
Comprehensive income (loss)	179,926		(134,307)		(82,612)
Comprehensive income attributable to noncontrolling interest	(5,411)		(5,146)		(5,356)
Comprehensive income (loss) attributable to common shareholders	$	174,515	$	(139,453)	$	(87,968)
Weighted average common shares outstanding (basic)	237,967		237,739		237,604
Weighted average common shares outstanding (diluted)	237,967		237,739		237,604
Per common share amounts (basic and diluted)
Net income (loss) attributable to common shareholders	$	0.73	$	(0.59)	$	(0.37)

The accompanying notes are an integral part of these consolidated financial statements.

F-6

DIVERSIFIED HEALTHCARE TRUST

CONSOLIDATED STATEMENTS OF SHAREHOLDERS' EQUITY

(dollars in thousands)

	Number of Shares	Common Shares		Additional Paid In Capital		Cumulative Net Income		Cumulative Other Comprehensive Income (Loss)		Cumulative Distributions		Total Equity Attributable to Common Shareholders		Total Equity Attributable to Noncontrolling Interest		Total Equity
Balance at December 31, 2018:	237,729,900	$	2,377	$	4,611,419	$	2,140,796	$	(266)	$	(3,731,214)	$	3,023,112	$	156,758	$	3,179,870
Net (loss) income	—	—		—		(88,234)		—		—		(88,234)		5,356		(82,878)
Amounts reclassified from cumulative other comprehensive income to net income	—	—		—		—		175		—		175		—		175
Other comprehensive income	—	—		—		—		91		—		91		—		91
Distributions	—	—		—		—		—		(199,719)		(199,719)		—		(199,719)
Share grants	202,500	2		1,391		—		—		—		1,393		—		1,393
Share repurchases	(31,747)	—		(293)		—		—		—		(293)		—		(293)
Share forfeitures	(3,490)	—		(6)		—		—		—		(6)		—		(6)
Distributions to noncontrolling interest	—	—		—		—		—		—		—		(21,583)		(21,583)
Balance at December 31, 2019:	237,897,163	2,379		4,612,511		2,052,562		—		(3,930,933)		2,736,519		140,531		2,877,050
Net (loss) income	—	—		—		(139,453)		—		—		(139,453)		5,146		(134,307)
Distributions	—	—		—		—		—		(42,825)		(42,825)		—		(42,825)
Distribution to common shareholders of the right to receive AlerisLife Inc. common stock	—	—		—		—		—		(59,801)		(59,801)		—		(59,801)
Share grants	420,000	4		1,570		—		—		—		1,574		—		1,574
Share repurchases	(47,375)	—		(171)		—		—		—		(171)		—		(171)
Share forfeitures	(1,310)	—		(6)		—		—		—		(6)		—		(6)
Distributions to noncontrolling interest	—	—		—		—		—		—		—		(22,292)		(22,292)
Balance at December 31, 2020:	238,268,478	2,383		4,613,904		1,913,109		—		(4,033,559)		2,495,837		123,385		2,619,222
Net income	—	—		—		174,515		—		—		174,515		5,411		179,926
Distributions	—	—		—		—		—		(9,540)		(9,540)		—		(9,540)
Share grants	838,000	8		1,956		—		—		—		1,964		—		1,964
Share repurchases	(109,384)	(1)		(382)		—		—		—		(383)		—		(383)
Share forfeitures	(2,200)	—		(3)		—		—		—		(3)		—		(3)
Distributions to noncontrolling interest	—	—		—		—		—		—		—		(22,348)		(22,348)
Sale of interest in joint venture	—	—		—		—		—		—		—		(106,448)		(106,448)
Balance at December 31, 2021:	238,994,894	$	2,390	$	4,615,475	$	2,087,624	$	—	$	(4,043,099)	$	2,662,390	$	—	$	2,662,390

The accompanying notes are an integral part of these consolidated financial statements.

F-7

DIVERSIFIED HEALTHCARE TRUST

 CONSOLIDATED STATEMENTS OF CASH FLOWS

(dollars in thousands)

	Year Ended December 31,
	2021		2020		2019
CASH FLOWS FROM OPERATING ACTIVITIES:
Net income (loss)	$	179,926	$	(134,307)	$	(82,878)
Adjustments to reconcile net income (loss) to cash (used in) provided by operating activities:
Depreciation and amortization	271,131		270,147		289,025
Net amortization of debt premiums, discounts and issuance costs	13,408		8,022		6,032
Straight line rental income	(5,846)		(6,069)		(4,508)
Amortization of acquired real estate leases	(7,211)		(7,405)		(6,791)
Loss on early extinguishment of debt	2,410		51		44
Gain on lease termination	—		(22,896)		—
Impairment of assets	(174)		106,972		115,201
Gain on sale of properties	(492,272)		(6,487)		(39,696)
Gains and losses on equity securities, net	42,232		(34,106)		41,898
Other non-cash adjustments, net	(1,811)		(2,203)		(3,771)
Equity in earnings of an investee	—		—		(400)
Distribution of earnings from Affiliates Insurance Company	—		—		2,574
Change in assets and liabilities:
Deferred leasing costs, net	(20,701)		(7,672)		(8,625)
Other assets	(51,201)		(27,858)		12,267
Accrued interest	7,654		(305)		(2,105)
Other liabilities	(868)		22,660		(52,422)
Net cash (used in) provided by operating activities	(63,323)		158,544		265,845
CASH FLOWS FROM INVESTING ACTIVITIES:
Real estate acquisitions and deposits	—		(2,526)		(50,636)
Real estate improvements	(227,605)		(185,585)		(222,417)
Proceeds from sale of properties, net	103,257		147,388		254,241
Proceeds from sale of interest in joint venture, net	367,033		—		—
Proceeds from sale of RMR Inc. common shares, net	—		—		98,557
Distributions in excess of earnings from Affiliates Insurance Company	11		287		6,426
Net cash provided by (used in) investing activities	242,696		(40,436)		86,171
CASH FLOWS FROM FINANCING ACTIVITIES:
Proceeds from issuance of senior unsecured notes, net	492,500		985,000		—
Proceeds from borrowings on revolving credit facility	800,000		430,500		994,500
Repayments of borrowings on revolving credit facility	—		(968,000)		(596,000)
Repayment of senior unsecured notes	(300,000)		(200,000)		(400,000)
Repayment of term loan	(200,000)		(250,000)		(100,000)
Repayment of other debt	(3,159)		(5,941)		(46,345)
Loss on early extinguishment of debt settled in cash	—		(376)		—
Payment of debt issuance costs	(10,347)		(5,378)		(417)
Repurchase of common shares	(383)		(171)		(299)
Distributions to noncontrolling interest	(22,348)		(22,292)		(21,583)
Distributions to shareholders	(9,540)		(42,825)		(199,719)
Net cash provided by (used in) financing activities	746,723		(79,483)		(369,863)
Increase (decrease) in cash and cash equivalents and restricted cash	926,096		38,625		(17,847)
Cash and cash equivalents and restricted cash at beginning of period	90,849		52,224		70,071
Cash and cash equivalents and restricted cash at end of period	$	1,016,945	$	90,849	$	52,224

The accompanying notes are an integral part of these consolidated financial statements.

F-8

DIVERSIFIED HEALTHCARE TRUST

 CONSOLIDATED STATEMENTS OF CASH FLOWS (CONTINUED)

 (dollars in thousands)

	Year Ended December 31,
	2021		2020		2019
SUPPLEMENTAL CASH FLOW INFORMATION:
Interest paid	$	235,994	$	195,599	$	177,308
Income taxes paid	$	2,798	$	399	$	452
NON-CASH INVESTING ACTIVITIES:
Decrease in assets and liabilities resulting from the deconsolidation of an investment that was previously consolidated:
Real estate, net	$	(686,320)	$	—	$	—
Mortgage notes, net	$	618,452	$	—	$	—
AlerisLife Inc. common stock	$	—	$	97,896	$	—
Restructuring transaction additional consideration	$	—	$	(75,000)	$	—
Real estate improvements accrued, not paid	$	20,031	$	18,097	$	14,111
Capitalized interest	$	1,297	$	1,833	$	1,124
NON-CASH FINANCING ACTIVITIES:
Distribution to common shareholders of the right to receive AlerisLife Inc. common stock	$	—	$	(59,801)	$	—

Supplemental disclosure of cash and cash equivalents and restricted cash:

The following table provides a reconciliation of cash and cash equivalents and restricted cash reported within our consolidated balance sheets to the amount shown in our consolidated statements of cash flows:

	As of December 31,
	2021		2020		2019
Cash and cash equivalents	$	634,848	$	74,417	$	37,357
Restricted cash (1)	382,097		16,432		14,867
Total cash and cash equivalents and restricted cash shown in our consolidated statements of cash flows	$	1,016,945	$	90,849	$	52,224

(1) As of December 31, 2021, restricted cash consists of proceeds from the sale of an interest in the joint venture that owns a life science property located in Boston, Massachusetts held as collateral pursuant to the agreement governing our revolving credit facility, or our credit agreement. We may use these funds to pay for approved expenditures in accordance with our credit agreement. Effective as of the date of the sale, we deconsolidated this joint venture. Prior to the deconsolidation, restricted cash consisted primarily of cash held for the operations of this joint venture. Restricted cash also consists of amounts escrowed for real estate taxes, insurance and capital expenditures at certain of our mortgaged properties.

The accompanying notes are an integral part of these consolidated financial statements.

F-9

DIVERSIFIED HEALTHCARE TRUST

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

(dollar amounts in thousands, except per share data or as otherwise stated)

Note 1. Organization

Diversified Healthcare Trust is a real estate investment trust, or REIT, organized under Maryland law, which owns medical office and life science properties, senior living communities and other healthcare related properties throughout the United States. As of December 31, 2021, we wholly owned 390 properties located in 36 states and Washington, D.C. On that date, the gross book value of our real estate assets was $6,813,556.

As of December 31, 2021, we also owned a 20% equity interest in an unconsolidated joint venture that owns a life science property located in Boston, Massachusetts with approximately 1.1 million rentable square feet that was 100% leased with an average (by annualized rental revenues) remaining lease term of 7.0 years.

Note 2. Summary of Significant Accounting Policies

BASIS OF PRESENTATION.  Our consolidated financial statements include the accounts of Diversified Healthcare Trust, we, us or our, and our subsidiaries, all of which are 100% owned directly or indirectly by us. All intercompany transactions and balances with or among our consolidated subsidiaries have been eliminated. Accounting principles generally accepted in the United States, or GAAP, require us to make estimates and assumptions that may affect the amounts reported in these financial statements and related notes. The actual results could differ from these estimates. 

REAL ESTATE PROPERTIES.  We record properties at our cost and calculate depreciation on real estate investments on a straight line basis over estimated useful lives generally up to 40 years.

We allocate the purchase prices of our properties to land, building and improvements based on determinations of the fair values of these assets assuming the properties are vacant. We determine the fair value of each property using methods similar to those used by independent appraisers, which may involve estimated cash flows that are based on a number of factors, including capitalization rates and discount rates, among others. In some circumstances, we engage independent real estate appraisal firms to provide market information and evaluations which are relevant to our purchase price allocations and determinations of depreciable useful lives; however, we are ultimately responsible for the purchase price allocations and determinations of useful lives. We allocate a portion of the purchase price to above market and below market leases based on the present value (using an interest rate which reflects the risks associated with acquired in place leases at the time each property was acquired by us) of the difference, if any, between (i) the contractual amounts to be paid pursuant to the acquired in place leases and (ii) our estimates of fair market lease rates for the corresponding leases, measured over a period equal to the terms of the respective leases. The terms of below market leases that include bargain renewal options, if any, are further adjusted if we determine that renewal is probable. We allocate a portion of the purchase price to acquired in place leases and tenant relationships based upon market estimates to lease up the property based on the leases in place at the time of purchase. In making these allocations, we consider factors such as estimated carrying costs during the expected lease up periods, including real estate taxes, insurance and other operating income and expenses and costs, such as leasing commissions, legal and other related expenses, to execute similar leases in current market conditions at the time a property was acquired by us. We allocate this aggregate value between acquired in place lease values and tenant relationships based on our evaluation of the specific characteristics of each tenant's lease. However, we have not separated the value of tenant relationships from the value of acquired in place leases because such value and related amortization expense is immaterial to our consolidated financial statements. If the value of tenant relationships becomes material in the future, we may separately allocate those amounts and amortize the allocated amount over the estimated life of the relationships.

We amortize capitalized above market lease values (included in acquired real estate leases and other intangible assets, net in our consolidated balance sheets) as a reduction to rental income over the remaining non-cancelable terms of the respective leases. We amortize capitalized below market lease values (presented as assumed real estate lease obligations in our consolidated balance sheets) as an increase to rental income over the non-cancelable periods of the respective leases. For the years ended December 31, 2021, 2020 and 2019, such amortization resulted in a net increase in rental income of $7,211, $7,405 and $6,791, respectively. We amortize the value of in place leases exclusive of the value of above market and below market in place leases to expense over the remaining non-cancelable periods of the respective leases. During the years ended December 31, 2021, 2020 and 2019, such amortization included in depreciation totaled $42,783, $48,669 and $64,203, respectively. If a lease is terminated prior to its stated expiration, the unamortized amount relating to that lease is written off.

F-10

As of December 31, 2021 and 2020, our acquired real estate leases and assumed real estate lease obligations, excluding properties held for sale, were as follows:

	December 31,
	2021		2020
Acquired real estate leases:
Capitalized above market lease values (1)	$	8,092	$	12,304
Less: accumulated amortization	(6,268)		(9,236)
Capitalized above market lease values, net	1,824		3,068
Lease origination value	123,682		551,141
Less: accumulated amortization	(76,760)		(267,696)
Lease origination value, net	46,922		283,445
Acquired real estate leases and other intangible assets, net	$	48,746	$	286,513
Assumed real estate lease obligations:
Capitalized below market lease values	$	6,141	$	128,991
Less: accumulated amortization	(3,585)		(61,161)
Assumed real estate lease obligations, net	$	2,556	$	67,830

(1)Acquired real estate leases and other related intangible assets decreased due to our sale of a 35% equity interest from our then remaining 55% equity interest in the joint venture which owns a life science property located in Boston, Massachusetts to another third party global institutional investor. As a result of this sale, we deconsolidated the net assets of this joint venture.

As of December 31, 2021, the weighted average amortization periods for capitalized above market lease values, lease origination value and capitalized below market lease values were 3.7 years, 5.3 years and 6.9 years, respectively. Future amortization of net intangible acquired real estate lease assets and liabilities to be recognized over the current terms of the associated leases as of December 31, 2021 are estimated to be $12,095 in 2022, $11,326 in 2023, $8,030 in 2024, $4,869 in 2025, $3,267 in 2026 and $6,603 thereafter.

CASH AND CASH EQUIVALENTS.  We consider highly liquid investments with original maturities of three months or less at the date of purchase to be cash equivalents.

RESTRICTED CASH.  Restricted cash consists of amounts escrowed for real estate taxes, insurance and capital expenditures at certain of our mortgaged properties and amounts held as collateral pursuant to our credit agreement.

INVESTMENTS IN EQUITY SECURITIES. We previously owned 2,637,408 shares of class A common stock of The RMR Group Inc., or RMR Inc., that we sold on July 1, 2019. Prior to July 1, 2019, our equity securities were recorded at fair value based on their quoted market price at the end of each reporting period. We classify the common shares we own of AlerisLife Inc. (f/k/a Five Star Senior Living Inc.), or AlerisLife, as an equity method investment. This equity method investment is included in investments of equity securities in our consolidated balance sheets.

On April 1, 2019, we and Five Star Senior Living, or Five Star, which is an operating division of AlerisLife, entered into a transaction agreement, or the Transaction Agreement, to restructure our business arrangements with Five Star effective January 1, 2020, or the 2020 Restructuring Transaction. At December 31, 2019, we owned 423,500 AlerisLife common shares after giving effect to the one-for-ten reverse stock split effected by AlerisLife with respect to its common shares on September 30, 2019. Pursuant to the 2020 Restructuring Transaction, on January 1, 2020, AlerisLife issued 10,268,158 common shares to us. The fair value and initial cost basis of the AlerisLife common shares issued to us on January 1, 2020 was $38,095. At December 31, 2021, we owned 10,691,658 AlerisLife common shares. At December 31, 2021 and 2020, our investment in AlerisLife had a fair value of $31,540 and $73,772, respectively, including an unrealized loss of $42,232 and unrealized gain of $34,106, respectively. Based on the terms of the Transaction Agreement, including the issuance of additional AlerisLife shares to us, we concluded that we have significant influence over AlerisLife and therefor account for our investment in AlerisLife as an equity method investment starting January 1, 2020. We have elected the fair value option for our investment in AlerisLife. We continue to present our investment in AlerisLife in Investments in equity securities in our consolidated balance sheets due to the comparable accounting treatment of the shares we owned in AlerisLife as of December 31, 2021 and 2020.

See Notes 6 and 8 for further information regarding our investment in AlerisLife and former investment in RMR Inc.

F-11

EQUITY METHOD INVESTMENTS.  As of December 31, 2021, we owned a 20% equity interest in an unconsolidated joint venture which owns a life science property located in Boston, Massachusetts. The property owned by this joint venture is encumbered by an aggregate $620,000 of mortgage debts. We do not control the activities that are most significant to this joint venture and, as a result, we account for our investment in this joint venture under the equity method of accounting under the fair value option. See Notes 3, 10 and 11 for more information regarding this joint venture.

We account for our investment in Affiliates Insurance Company, or AIC, until AIC was dissolved as described in Note 8, using the equity method of accounting. Significant influence was present through common representation on our Board of Trustees and the board of directors of AIC until February 13, 2020. The Chair of our Board of Trustees and one of our Managing Trustees, Adam D. Portnoy, as the sole trustee of ABP Trust, is the controlling shareholder of RMR Inc. He is also a managing director and an executive officer of RMR Inc. Substantially all of the business of RMR Inc. is conducted by its majority owned subsidiary, The RMR Group LLC, or RMR LLC, which is our manager and provided management and administrative services to AIC. Most of our Trustees were directors of AIC. See Note 8 for more information about our investment in AIC. As previously discussed, we also account for our investment in AlerisLife as an equity method investment under the fair value option.

DEBT ISSUANCE COSTS.  Debt issuance costs include issuance or assumption costs related to borrowings and we amortize those costs as interest expense over the terms of the respective loans. Debt issuance costs for our revolving credit facility totaled $27,383 and $19,332 at December 31, 2021 and 2020, respectively, and accumulated amortization of debt issuance costs totaled $22,899 and $16,201 at December 31, 2021 and 2020, respectively, and are included in other assets in our consolidated balance sheets. Debt issuance costs for our previously existing term loans, senior notes, and mortgage notes payable totaled $53,649 and $53,496 at December 31, 2021 and 2020, respectively, and accumulated amortization of debt issuance costs totaled $15,800 and $15,589, respectively, and are presented in our consolidated balance sheet as a direct deduction from the associated debt liability. Future amortization of debt issuance costs to be recognized with respect to our loans as of December 31, 2021 are estimated to be $9,974 in 2022, $5,832 in 2023, $5,521 in 2024, $3,556 in 2025, $1,956 in 2026 and $15,494 thereafter.

DEFERRED LEASING COSTS.  Deferred leasing costs include capitalized brokerage and other fees associated with the successful negotiation of leases, which are amortized to depreciation and amortization expense on a straight line basis over the terms of the respective leases. Deferred leasing costs are included in other assets in our consolidated balance sheets. Deferred leasing costs totaled $64,255 and $44,506 at December 31, 2021 and 2020, respectively, and accumulated amortization of deferred leasing costs totaled $17,074 and $15,605 at December 31, 2021 and 2020, respectively. At December 31, 2021, the remaining weighted average amortization period is approximately 8.7 years. Future amortization of deferred leasing costs to be recognized during the current terms of our existing leases as of December 31, 2021, are estimated to be $7,168 in 2022, $6,502 in 2023, $5,903 in 2024, $5,397 in 2025, $4,732 in 2026 and $17,479 thereafter.

REVENUE RECOGNITION.  We are a lessor of medical office and life science properties, senior living communities and other healthcare related properties. Our leases provide our tenants with the contractual right to use and economically benefit from all of the premises demised under the leases; therefore, we have determined to evaluate our leases as lease arrangements.

For leases where we are the lessee, we recognize a right of use asset and a lease liability equal to the present value of the minimum lease payments with rental payments being applied to the lease liability and the right of use asset being amortized over the term of the lease. The right of use asset and related lease liability are included within other assets, net and other liabilities, respectively, within our consolidated balance sheets. In addition, we lease equipment at certain of our managed senior living communities. These leases are short term in nature, are cancelable with no fee or do not result in an annual expense in excess of our capitalization policy and, as a result, will not be recorded on our consolidated balance sheets.

Certain of our leases provide for base rent payments and in addition may include variable payments. Rental income from operating leases, including any payments derived by index or market based indices, is recognized on a straight line basis over the lease term when we have determined that the collectability of substantially all of the lease payments is probable. Some of our leases have options to extend or terminate the lease exercisable at the option of our tenants, which are considered when determining the lease term. We do not include in our measurement of our lease receivables certain variable payments, including changes in the index or market based indices after the inception of the lease, certain tenant reimbursements and other income until the specific events that trigger the variable payments have occurred.

Certain of our leases contain non-lease components, such as property level operating expenses and capital expenditures reimbursed by our tenants as well as other required lease payments. We have determined that all of our leases qualify for the practical expedient to not separate the lease and non-lease components because (i) the lease components are operating leases and (ii) the timing and pattern of recognition of the non-lease components are the same as those of the lease components. We

F-12

apply Codification Topic 842, Leases, to the combined component. Income derived by our leases is recorded in rental income in our consolidated statements of comprehensive income (loss).

Certain tenants are obligated to pay directly their obligations under their leases for insurance, real estate taxes and certain other expenses. These obligations, which have been assumed by the tenants under the terms of their respective leases, are not reflected in our consolidated financial statements. To the extent any tenant responsible for any such obligations under the applicable lease defaults on such lease or if it is deemed probable that the tenant will fail to pay for such obligations, we would record a liability for such obligations.

For the years ended December 31, 2021, 2020 and 2019, we recognized the rental income from our operating leases on a straight line basis over the term of each lease agreement. We recognized percentage rents when realizable and earned, which was generally during the fourth quarter of the year. For the years ended December 31, 2021, 2020 and 2019, percentage rents earned aggregated $1,993, $2,144 and $2,958, respectively.

As of December 31, 2021, we owned 235 senior living communities that are managed by third party managers for our account. We derive our revenues at these managed senior living communities primarily from services our managers provide to residents on our behalf and we record revenues when the services are provided. We use the TRS structure authorized by the REIT Investment Diversification and Empowerment Act for all of our managed senior living communities.

Under the Coronavirus Aid, Relief, and Economic Security Act, or the CARES Act, the U.S. Department of Health and Human Services, or HHS, established a Provider Relief Fund. Retention and use of the funds received under the CARES Act are subject to certain terms and conditions. The terms and conditions require that the funds be utilized to compensate for lost revenues that are attributable to the COVID-19 pandemic and for eligible costs to prevent, prepare for and respond to the COVID-19 pandemic that are not covered by other sources. Further, fund recipients are required to be participating in Medicare at the time of distribution and are subject to certain other terms and conditions, including quarterly reporting requirements. In addition, fund recipients are required to have billed Medicare during 2019 and to continue to provide care after January 31, 2020 for diagnosis, testing or care for individuals with possible or actual COVID-19 cases. Any funds not used in accordance with the terms and conditions must be returned to HHS. We recognize income from government grants on a systematic and rational basis over the period in which we recognize the related expenses or loss of revenues for which the grants are intended to compensate when there is reasonable assurance that we will comply with the applicable terms and conditions of the grant and there is reasonable assurance that the grant will be received. During the years ended December 31, 2021 and 2020, we received $20,800 and $19,961, respectively, in funds from the Provider Relief Fund to be used to support the operations of our managed senior living communities; we have currently determined that $19,554 and $17,485 of such funds meet the required terms and conditions. We have recognized $19,554 and $17,485 as other income in our consolidated statements of comprehensive income (loss) with respect to our senior housing operating portfolio, or SHOP, segment for the years ended December 31, 2021 and 2020, respectively. As of December 31, 2021 and 2020, we had not recognized $3,722 and $2,476, respectively, of funds from the Provider Relief Fund and included these amounts in other liabilities in our consolidated balance sheets. We currently expect to return the remaining $3,722 of such funds to HHS in 2022 unless and to the extent we determine that such funds meet the required terms and conditions. We have applied for additional funds that may be available under the CARES Act Provider Relief Fund; however, we may not receive any additional funding.

PER COMMON SHARE AMOUNTS.  We calculate basic earnings per common share by dividing net income (loss) by the weighted average number of our common shares of beneficial interest, $.01 par value, or our common shares, outstanding during the period. We calculate diluted earnings per common share using the more dilutive of the two class method or the treasury stock method. Unvested share awards and other potentially dilutive common shares and the related impact on earnings, are considered when calculating diluted earnings per share.

INCOME TAXES.  We have elected to be taxed as a REIT under the United States Internal Revenue Code of 1986, as amended, and as such are generally not subject to federal and most state income taxation on our operating income provided we distribute our taxable income to our shareholders and meet certain organization and operating requirements. We do, however, lease our managed senior living communities to our wholly owned TRSs that, unlike most of our subsidiaries, file a separate consolidated federal corporate income tax return and are subject to federal and state income taxes. Our consolidated income tax provision includes the income tax provision related to the operations of our TRSs and certain state income taxes we incur despite our taxation as a REIT.

The Income Taxes Topic of the Codification prescribes how we should recognize, measure and present in our financial statements uncertain tax positions that have been taken or are expected to be taken in a tax return. Tax benefits are recognized to the extent that it is “more likely than not” that a particular tax position will be sustained upon examination or audit. To the extent the “more likely than not” standard has been satisfied, the benefit associated with a tax position is measured as the largest

F-13

amount that has a greater than 50% likelihood of being realized upon settlement. We classify interest and penalties related to uncertain tax positions, if any, in our financial statements as a component of general and administrative expense.

SEGMENT REPORTING.  As of December 31, 2021, we operate in, and report financial information for, the following two segments: our portfolio of medical office and life science properties, or our Office Portfolio, and SHOP. We aggregate each of these two reporting segments based on their similar operating and economic characteristics. See Note 12 for further information regarding our reportable operating segments.

NEW ACCOUNTING PRONOUNCEMENTS. In June 2016, the Financial Accounting Standards Board, or FASB, issued Accounting Standards Update, or ASU, No. 2016-13, Financial Instruments - Credit Losses (Topic 326): Measurement of Credit Losses on Financial Instruments, which requires that entities use a new forward-looking “expected loss” model that generally will result in the earlier recognition of allowance for credit losses. The measurement of expected credit losses is based upon historical experience, current conditions, and reasonable and supportable forecasts that affect the collectability of the reported amount. We adopted this standard on January 1, 2020 using the modified retrospective approach. The implementation of this standard did not have a material impact on our consolidated financial statements.

In October 2021, the FASB issued ASU No. 2021-08, Business Combinations (Topic 805): Accounting for Contract Assets and Contract Liabilities from Contracts with Customers, or ASU No. 2021-08, which requires that an acquirer account for the related revenue contracts in accordance with Topic 606 as if it had originated the contracts. The acquiring entity shall recognize and measure the acquired contract assets and contract liabilities consistent with how they were recognized and measured in the acquiree’s financial statements, rather than at fair value at the acquisition date. ASU No. 2021-08 is effective for fiscal years beginning after December 15, 2022, with early adoption permitted. On October 1, 2021, we early adopted ASU No. 2021-08. The adoption of ASU No. 2021-08 did not have an impact on our consolidated financial statements.

In November 2021, the FASB issued ASU No. 2021-10, Government Assistance (Topic 832): Disclosures by Business Entities about Government Assistance, or ASU No. 2021-10, which requires business entities to disclose government assistance accounted for by applying a grant or contribution model by analogy. ASU No. 2021-10 states that an entity shall disclose the nature of the transactions, the related accounting policies used, the effect of the transactions on an entity's financial statements and significant terms and conditions of the transactions. ASU No. 2021-10 is effective for annual periods beginning after December 15, 2021, with early adoption permitted. On November 17, 2021, we early adopted ASU No. 2021-10. The adoption of ASU No. 2021-10 did not have a material impact on our consolidated financial statements.

Note 3. Real Estate Investments

Our real estate properties, excluding those classified as held for sale, if any, consisted of land of $741,501 and buildings and improvements of $6,072,055 as of December 31, 2021, and land of $789,125 and buildings and improvements of $6,621,605 as of December 31, 2020. Accumulated depreciation was $1,587,573 and $150,234 for buildings and improvements, respectively, as of December 31, 2021; and $1,561,751 and $133,150 for buildings and improvements, respectively, as of December 31, 2020.

Our portfolio as of December 31, 2021 includes: 116 medical office and life science properties with approximately 9.8 million rentable square feet; 264 senior living communities, including independent living (including active adult), assisted living, memory care and skilled nursing facilities, or SNFs, with 27,672 living units; and 10 wellness centers with approximately 812,000 square feet of interior space plus outdoor developed facilities.

We have accounted for our 2019 acquisitions as acquisitions of assets. We funded these acquisitions using cash on hand and borrowings under our revolving credit facility, unless otherwise noted.

Joint Venture Activities:

As of December 31, 2021, we had an equity investment in a joint venture as follows:

Joint Venture	DHC Ownership	DHC Carrying Value of Investment at December 31, 2021		Number of Properties	Location	Square Feet
Seaport Innovation LLC	20%	$	215,127	1	Massachusetts	1,134,479

F-14

The following table provides a summary of the mortgage debts of this joint venture:

Joint Venture	Coupon Rate	Maturity Date	Principal Balance at December 31, 2021 (1)
Mortgage Notes Payable (secured by one property in Massachusetts)	3.53%	8/6/2026	$	620,000

(1)Amounts are not adjusted for our minority interest. We no longer include this $620,000 of secured debt financing in our consolidated balance sheet following the deconsolidation in December 2021 of the net assets of our joint venture which owns a life science property located in Boston, Massachusetts; however, DHC continues to provide certain guaranties on this debt.

In March 2017, we entered into a joint venture arrangement with an institutional investor for one of our life science properties located in Boston, Massachusetts. The investor owned a 45% equity interest in the joint venture, and we owned the remaining 55% equity interest in the joint venture. We determined that, while we owned a 55% equity interest in this joint venture, this joint venture was a variable interest entity, or VIE, as defined under the Consolidation Topic of the FASB Codification. We concluded that we must consolidate this VIE, and we did so, until we sold an additional 35% equity interest in the joint venture in December 2021. We reached this determination because we were the entity with the power to direct the activities that most significantly impacted the VIE's economic performance and we had the obligation to absorb losses of, and the right to receive benefits from, the VIE that could be significant to the VIE, and therefore were the primary beneficiary of the VIE. The assets of this VIE were $970,142 as of December 31, 2020 and consisted primarily of the net real estate owned by the joint venture. The liabilities of this VIE were $697,129 as of December 31, 2020 and consisted primarily of mortgage debts secured by the property. The joint venture investor's interest in this consolidated entity was reflected as noncontrolling interest in our consolidated financial statements.

In December 2021, we sold an additional 35% equity interest from our then remaining 55% equity interest in the joint venture which owns a life science property located in Boston, Massachusetts to another third party global institutional investor for $373,847, which includes certain costs associated with the formation of this joint venture. We deconsolidated the net assets of this joint venture and recognized a net gain on sale of $461,434 on this transaction, which is included in gain on sale of properties in our consolidated statements of comprehensive income (loss). After giving effect to the sale, we continue to own a 20% equity interest in this joint venture, but have determined that we are no longer the primary beneficiary. Effective as of the date of the sale, we deconsolidated this joint venture and we now account for this joint venture using the equity method of accounting under the fair value option. Our investment amount was based on a property valuation of $1,700,000, less $620,000 of existing mortgage debts on the property that this joint venture assumed. Pursuant to our credit agreement, the net cash proceeds to us from this transaction will be held as restricted cash. See Note 10 for more information regarding the use of the equity method for this joint venture.

In January 2022, we entered into a joint venture for 10 medical office and life science properties we owned with two unrelated third party global institutional investors for aggregate proceeds, before closing costs and other adjustments, of approximately $653,300. The investors acquired a 41% and 39% equity interest in the joint venture for an investment of approximately $100,800 and $95,900, respectively, and we retained a 20% equity interest in the joint venture. The investment amounts are based upon a property valuation of approximately $702,500, less approximately $456,600 of secured debt on the properties incurred by this joint venture.

Acquisitions:

The table below represents the purchase price allocations (including net closing adjustments) of acquisitions for the years ended December 31, 2021, 2020 and 2019:

Date	Location	Type of Property	Number of Properties	Number of Units	Cash Paid plus Assumed Debt (1)		Land		Buildings and Improvements		FF&E		Acquired Real Estate Leases / Resident Agreements		Acquired Real Estate Lease Obligations		Assumed Debt		Premium on  Assumed Debt
Acquisitions during the year ended December 31, 2021:
We did not acquire any properties during the year ended December 31, 2021.
Acquisitions during the year ended December 31, 2020:
We did not acquire any properties during the year ended December 31, 2020.
Acquisitions during the year ended December 31, 2019:
December 2019	Texas	IL	1	169	$	50,506	$	3,463	$	44,189	$	652	$	2,202	$	—	$	—	$	—

(1)Cash paid plus assumed debt, if any, includes closing costs.

F-15

In January 2020, we acquired a vacant land parcel adjacent to a life science property we own located in Tempe, Arizona for $2,600, excluding acquisition costs.

Impairment:

We regularly evaluate our assets for indicators of impairment. Impairment indicators may include declining tenant or resident occupancy, weak or declining profitability from the property, decreasing tenant cash flows or liquidity, our decision to dispose of an asset before the end of its estimated useful life, and legislative, market or industry changes that could permanently reduce the value of an asset. If indicators of impairment are present, we evaluate the carrying value of the affected assets by comparing it to the expected future cash flows to be generated from those assets. The future cash flows are subjective and are based in part on assumptions regarding hold periods, market rents and terminal capitalization rates. If the sum of these expected future cash flows is less than the carrying value, we reduce the net carrying value of the asset to its estimated fair value.

During 2021, we recorded a reversal of impairment charges of $174 related to the estimated costs to sell 10 senior living communities that were classified as held for sale in our consolidated balance sheet as of December 31, 2020 and changed the status of those communities from held for sale to held and used as of March 31, 2021. These impairment charges, in aggregate, are included in impairment of assets in our consolidated statements of comprehensive income (loss).

During 2020, we recorded impairment charges of $98,414 to adjust the carrying values of 28 senior living communities to their aggregate estimated fair value. These 28 senior living communities included nine senior living communities which we sold in 2020, seven senior living communities which we closed in 2020 and 10 senior living communities which were classified as held for sale in our consolidated balance sheet as of December 31, 2020. During 2020, we also recorded impairment charges of $8,558 to adjust the carrying value of seven medical office properties to their estimated fair value. We sold four of these medical office properties in 2020. One of these medical office properties was classified as held for sale in our consolidated balance sheet as of December 31, 2020 and sold in February 2021. These impairment charges, in aggregate, are included in impairment of assets in our consolidated statements of comprehensive income (loss).

During 2019, we recorded impairment charges of $72,166 to adjust the carrying values of 25 senior living communities to their aggregate estimated fair value. These 25 senior living communities included 15 SNFs which we sold in September 2019 and eight senior living communities which we sold in 2020. Two of these 25 senior living communities were classified as held for sale in our consolidated balance sheet as of December 31, 2019. During 2019, we also recorded impairment charges of $43,035 to adjust the carrying value of 20 medical office properties and one life science property to their estimated fair value. We sold five of these medical office properties, along with the life science property, in 2019. The remaining 15 medical office properties were classified as held for sale in our consolidated balance sheet as of December 31, 2019. In 2020, we sold 10 of these 15 medical office properties classified as held for sale. These impairment charges, in aggregate, are included in impairment of assets in our consolidated statements of comprehensive income (loss).

Dispositions:

During the years ended December 31, 2021, 2020 and 2019, we sold five, 27, and 46 properties, respectively, for aggregate sales prices of $104,500, $152,893, and $260,783, respectively, excluding closing costs, as presented in the table below. The sales of these properties do not represent significant dispositions, individually or in the aggregate, and we do not believe these sales represent a strategic shift in our business. As a result, the results of operations for these properties are included in continuing operations through the date of sale of such properties in our consolidated statements of comprehensive income (loss).

F-16

Date of Sale	Location	Type of Property	Number of Properties	Square Feet or Number of Units		Sales Price (1)		Gain (loss) on Sale
Dispositions during the year ended December 31, 2021:
February 2021	Pennsylvania	Medical Office	1	92,000	sq. ft.	$	9,000	$	(122)
April 2021	Florida	Life Science / Medical Office	4	263,656	sq. ft.	95,500		30,760
			5			$	104,500	$	30,638
Dispositions during the year ended December 31, 2020:
January 2020	Louisiana	Medical Office	6	40,575	sq. ft.	$	5,925	$	(81)
February 2020	Pennsylvania	Medical Office	1	50,000	sq. ft.	2,900		—
March 2020	Texas	Medical Office	1	70,229	sq. ft.	8,779		2,863
April 2020 (2)	California	IL / AL	3	599	units	47,000		(256)
June 2020	South Carolina	Medical Office	1	49,242	sq. ft.	3,550		—
July 2020	Texas	Medical Office	1	6,849	sq. ft.	2,072		(30)
July 2020	Connecticut	Medical Office	1	32,162	sq. ft.	625		(25)
August 2020 (2)	Mississippi	AL	2	116	units	2,500		(42)
September 2020	Mississippi	Medical Office	1	78,747	sq. ft.	7,250		(114)
October 2020	Various	AL	3	239	units	46,000		4,292
November 2020 (2)	Nebraska	AL	1	131	units	3,000		(26)
December 2020	New York	Medical Office	1	64,060	sq. ft.	3,875		(273)
December 2020	Ohio	Life Science	2	232,016	sq. ft.	7,917		257
December 2020 (2)	Wisconsin	SNF / AL	3	537	units	11,500		(303)
			27			$	152,893	$	6,262
Dispositions during the year ended December 31, 2019:
February 2019	Florida	Life Science	1	60,396	sq. ft.	$	2,900	$	(69)
March 2019	Massachusetts	Medical Office	1	4,400	sq. ft.	75		(58)
May 2019 (2)	California	SNF	3	278	units	21,500		15,207
May 2019	Colorado	Medical Office	1	15,647	sq. ft.	2,590		1,029
June 2019	Massachusetts	Medical Office	7	164,121	sq. ft.	8,042		1,590
July 2019	Massachusetts	Medical Office	3	103,484	sq. ft.	4,955		2,332
August 2019	Massachusetts	Medical Office	1	49,357	sq. ft.	2,221		812
September 2019 (2)	Various	SNF	15	964	units	8,000		—
September 2019	Massachusetts	Medical Office	1	41,065	sq. ft.	2,750		1,044
October 2019	South Dakota	SNF / IL	3	245	units	10,500		6,661
October 2019	New Jersey	Life Science	1	205,439	sq. ft.	47,500		—
December 2019	Georgia	Medical Office	1	95,010	sq. ft.	14,000		(63)
December 2019	Washington	IL	1	150	units	32,500		7,618
December 2019	Various	AL	7	566	units	103,250		3,593
			46			$	260,783	$	39,696

(1)Sales price excludes closing costs.

(2)These senior living communities were previously operated by Five Star.

During the year ended December 31, 2021, we recognized a gain of $200 related to the sales of skilled nursing bed licenses at certain of our senior living communities. During the year ended December 31, 2020, we recognized a gain of $225 related to the sale of bed licenses at one of our senior living communities.

We classify all properties as held for sale in our consolidated balance sheets that meet the applicable criteria for that treatment as set forth in the Property, Plant and Equipment Topic of the Codification. As of December 31, 2021, we had no properties classified as held for sale. As of December 31, 2020, we had 10 senior living communities with 820 units and five medical office and life science properties with 355,656 square feet classified as held for sale. As of December 31, 2019, we had 21 medical office and life science properties with 875,617 square feet and 12 senior living communities with 1,670 units classified as held for sale.

F-17

Investments and Capital Expenditures:

Under our previously existing leases with Five Star, Five Star could request that we purchase certain improvements to the leased communities. Pursuant to the Transaction Agreement, the $111,603 of improvements to communities leased to Five Star, including $49,155 of fixed assets and improvements that were purchased pursuant to the Transaction Agreement, that we funded during the year ended December 31, 2019 did not result in increased rent payable by Five Star. See Note 6 for further information regarding the 2020 Restructuring Transaction and the Transaction Agreement.

During 2021, we committed $97,520 for capital expenditures related to 2.6 million square feet of leases executed at our medical office and life science properties. During 2020, we committed $17,901 for capital expenditures related to 1.0 million square feet of leases executed at our medical office and life science properties.

Committed and unspent tenant related obligations based on executed leases as of December 31, 2021 and 2020 were $76,573 and $19,159, respectively.

Note 4. Leases

We are a lessor of medical office and life science properties, senior living communities and other healthcare related properties. Our leases provide our tenants with the contractual right to use and economically benefit from all of the premises demised under the leases; therefore, we have determined to evaluate our leases as lease arrangements.

We increased rental income to record revenue on a straight line basis by $5,846, $6,069 and $4,508 for the years ended December 31, 2021, 2020 and 2019, respectively. Rents receivable, excluding receivables related to our properties classified as held for sale, if any, include $82,131 and $104,803 of straight line rent receivables at December 31, 2021 and 2020, respectively, and are included in other assets, net in our consolidated balance sheets.

We do not include in our measurement of our lease receivables certain variable payments, including changes in the index or market based indices after the inception of the lease, certain tenant reimbursements and other income until the specific events that trigger the variable payments have occurred. Such payments totaled $74,860, $77,599 and $78,668 for the years ended December 31, 2021, 2020 and 2019, respectively, of which tenant reimbursements totaled $72,690, $75,378 and $75,432, respectively.

The following table presents our operating lease maturity analysis, excluding lease payments from properties classified as held for sale, if any, as of December 31, 2021:

Year	Amount
2022	$	236,309
2023	234,633
2024	219,532
2025	197,712
2026	181,819
Thereafter	812,989
Total	$	1,882,994

Right of Use Asset and Lease Liability. For leases where we are the lessee, we recognized a right of use asset and a lease liability equal to the present value of the minimum lease payments with rental payments being applied to the lease liability and the right of use asset being amortized over the term of the lease. The values of the right of use asset and related liability representing our future obligation under the lease arrangement for which we are the lessee were $4,153 and $4,352, respectively, as of December 31, 2021, and $4,237 and $4,410, respectively, as of December 31, 2020. The right of use asset and related lease liability are included within other assets, net and other liabilities, respectively, within our consolidated balance sheets. In addition, we lease equipment at certain of our managed senior living communities. These leases are short term in nature, are cancelable with no fee or do not result in an annual expense in excess of our capitalization policy and, as a result, are not recorded on our consolidated balance sheets.

Note 5. Shareholders' Equity

F-18

We have common shares available for issuance under the terms of our equity compensation plan adopted in 2012, as amended, or the 2012 Plan. During the years ended December 31, 2021, 2020 and 2019, we awarded to our officers and other employees of RMR LLC annual share awards of 718,000, 360,000 and 187,500 of our common shares, respectively, valued at $2,448, $1,357 and $1,633, in aggregate, respectively. In accordance with our Trustee compensation arrangements, we also awarded each of our then Trustees 20,000 common shares with an aggregate value of $444 ($74 per Trustee), 10,000 common shares with an aggregate value of $176 ($29 per Trustee) and 3,000 common shares with an aggregate value of $119 ($24 per Trustee) in 2021, 2020 and 2019, respectively. The values of the share awards were based upon the closing price of our common shares trading on The Nasdaq Stock Market LLC, or Nasdaq, on the dates of awards. The common shares awarded to our Trustees vested immediately. The common shares awarded to our officers and certain other employees of RMR LLC vest in five equal annual installments beginning on the date of award. We include the value of awarded shares in general and administrative expenses in our consolidated statements of comprehensive income (loss) ratably over the vesting period. At December 31, 2021, 1,117,201 of our common shares remain available for issuance under the 2012 Plan.

A summary of shares awarded, forfeited, vested and unvested under the terms of the 2012 Plan from January 1, 2019 to December 31, 2021 is as follows:

	Number of Shares	Weighted Average Award Date Fair Value
Unvested shares at December 31, 2018	161,990	$	19.41
Shares awarded in 2019	202,500	$	8.65
Shares vested / forfeited in 2019	(137,150)	$	8.94
Unvested shares at December 31, 2019	227,340	$	12.52
Shares awarded in 2020	420,000	$	3.65
Shares vested / forfeited in 2020	(212,790)	$	7.04
Unvested shares at December 31, 2020	434,550	$	6.15
Shares awarded in 2021	838,000	$	3.45
Shares vested / forfeited in 2021	(426,930)	$	4.98
Unvested shares at December 31, 2021	845,620	$	4.07

The 845,620 unvested shares as of December 31, 2021 are scheduled to vest as follows: 253,520 shares in 2022, 239,700 shares in 2023, 208,800 shares in 2024 and 143,600 shares in 2025. As of December 31, 2021, the estimated future compensation for the unvested shares was $3,116 based on the adjusted award date fair value of these shares. At December 31, 2021, the weighted average period over which the compensation expense will be recorded is approximately 2.0 years. We recorded share based compensation expense of $1,960 in 2021, $1,568 in 2020 and $1,388 in 2019. We recognize forfeitures as they occur.

During 2021, 2020 and 2019, we purchased an aggregate of 109,384, 47,375 and 31,747, respectively, of our common shares from our officers and certain current and former officers and employees of RMR LLC in satisfaction of tax withholding and payment obligations in connection with the vesting of awards of our common shares. See Note 8 for further information regarding these purchases.

A summary of cash distributions paid to common shareholders, for federal income tax purposes, as are follows for the periods presented:

	Annual Per				Characterization of Distribution
	Share		Total		Ordinary		Capital		Return of
Year	Distribution		Distribution		Income		Gain		Capital
2021	$	0.04	$	9,540	—	%	100.0	%	—	%
2020	$	0.18	$	42,825	—	%	—	%	100.0	%
2019	$	0.84	$	199,719	—	%	25.7	%	74.3	%

On January 13, 2022, we declared a quarterly distribution to common shareholders of record on January 24, 2022 of $0.01 per share, or approximately $2,390 in aggregate. We paid this distribution on February 17, 2022, using cash on hand.

F-19

As described in Note 6, pursuant to the 2020 Restructuring Transaction, on January 1, 2020, AlerisLife issued an aggregate of 16,118,849 common shares, with an aggregate value of $59,801, to our shareholders of record as of December 13, 2019. We recorded this issuance as a non-cash distribution in our consolidated financial statements.

Note 6. Senior Living Community Leases and Management Agreements

As of December 31, 2019, we leased 166 senior living communities to Five Star. As of that date, we also leased to our TRSs 78 communities that we owned and that were managed by Five Star for our account.

Restructuring our Business Arrangements with Five Star

The Transaction Agreement with Five Star. Pursuant to the Transaction Agreement, effective January 1, 2020, or the Conversion Time:

•our previously existing master leases with Five Star for all of our senior living communities that Five Star leased, as well as our previously existing management agreements and pooling agreements with Five Star for our senior living communities that Five Star managed, were terminated and replaced with new management agreements and a related omnibus agreement, which agreements were subsequently replaced in June 2021, as described below;

•AlerisLife issued to us 10,268,158 of its common shares and an aggregate of approximately 16,118,849 to our shareholders of record as of December 13, 2019;

•as consideration for these share issuances, we provided Five Star with $75,000 of additional consideration by assuming certain of Five Star's working capital liabilities and making cash payments to Five Star, resulting in a gain on lease termination of $22,896 for the year ended December 31, 2020 in our consolidated statements of comprehensive income (loss); and

•pursuant to a guaranty agreement dated as of January 1, 2020 and amended and restated on June 9, 2021, made by AlerisLife in favor of our applicable subsidiaries, AlerisLife has guaranteed the payment and performance of each of its applicable subsidiary's obligations under our applicable management agreements with Five Star.

Also pursuant to the Transaction Agreement: (1) commencing February 1, 2019, the aggregate amount of monthly minimum rent payable to us by Five Star under our previously existing master leases with Five Star was set at $11,000 as of February 1, 2019, subject to adjustment, and subsequently reduced in accordance with the Transaction Agreement as a result of our subsequent sales of certain of the leased senior living communities, and no additional rent was payable to us by Five Star from such date until the Conversion Time; and (2) as of April 1, 2019, we purchased from Five Star $49,155 of unencumbered Qualifying PP&E (as defined in the Transaction Agreement) related to our senior living communities leased and operated by Five Star.

2021 Amendments to our Management Arrangements with Five Star. On June 9, 2021, we amended our management arrangements with Five Star. The principal changes to the management arrangements included:

•that Five Star agreed to cooperate with us in transitioning 108 of our senior living communities with approximately 7,500 living units to other third party managers without our payment of any termination fee to Five Star;

•that we no longer have the right to sell up to an additional $682,000 of senior living communities currently managed by Five Star and terminate Five Star's management of those communities without our payment of a fee to Five Star upon sale;

•that Five Star is continuing to manage 120 of our senior living communities, and that the skilled nursing units in all of our continuing care retirement communities that Five Star is continuing to manage, which then included approximately 1,500 living units, were closed and are being evaluated and repositioned;

•that beginning in 2025, we will have the right to terminate up to 10% of the senior living communities that Five Star is continuing to manage, based on total revenues per year for failure to meet 80% of a target EBITDA for the applicable period;

F-20

•that the incentive fee that Five Star may earn in any calendar year for the senior living communities that Five Star is continuing to manage is no longer subject to a cap and that any senior living communities that are undergoing a major renovation or repositioning are excluded from the calculation of the incentive fee;

•that RMR LLC will oversee any major renovation or repositioning activities at the senior living communities that Five Star is continuing to manage; and

•that the term of our management agreements with Five Star for our senior living communities that Five Star is continuing to manage was extended by two years to December 31, 2036.

Pursuant to these changes, we and Five Star entered into an amended and restated master management agreement, or the Master Management Agreement, for the senior living communities that Five Star is continuing to manage. In addition, AlerisLife delivered to us a related amended and restated guaranty agreement pursuant to which AlerisLife is continuing to guarantee the payment and performance of each of its applicable subsidiary's obligations under the applicable management agreements.

Pursuant to the Master Management Agreement, Five Star receives a management fee equal to 5% of the gross revenues realized at the applicable senior living communities plus reimbursement for its direct costs and expenses related to such communities. Commencing with the calendar year 2021, Five Star may receive an annual incentive fee equal to 15% of the amount by which the annual earnings before interest, taxes, depreciation and amortization, or EBITDA, of all communities on a combined basis exceeds the target EBITDA for all communities on a combined basis for such calendar year. The target EBITDA for those communities on a combined basis is increased annually based on the greater of the annual increase of the consumer price index, or CPI, or 2%, plus 6% of any capital investments funded at the managed communities on a combined basis in excess of the target capital investment. Unless otherwise agreed, the target capital investment increases annually based on the greater of the annual increase of CPI or 2%. Any senior living communities that are undergoing a major renovation or repositioning are excluded from the calculation of the incentive fee.

The Master Management Agreement expires in 2036, subject to Five Star's right to extend for two consecutive five year terms if Five Star achieves certain performance targets for the combined managed communities portfolio, unless earlier terminated. Pursuant to the Master Management Agreement, beginning in 2025, we have the right to terminate up to 10% of the senior living communities that Five Star is continuing to manage, based on total revenues per year for failure to meet 80% of a target EBITDA for the applicable period. Pursuant to a guaranty agreement dated as of January 1, 2020, and subsequently amended and restated on June 9, 2021, made by AlerisLife in favor of our applicable subsidiaries, AlerisLife has guaranteed the payment and performance of each of its applicable subsidiary's obligations under the Master Management Agreement.

On April 1, 2019, we concluded that the 2020 Restructuring Transaction constituted a reconsideration event requiring us to assess whether we held a controlling financial interest in AlerisLife. As a result of this assessment, we determined that AlerisLife was a VIE effective as of the date of the Transaction Agreement. We determined not to consolidate AlerisLife in our consolidated financial statements, as we do not have the power to direct the activities of AlerisLife that most significantly impact AlerisLife's economic performance and therefore are not the primary beneficiary of AlerisLife. Effective January 1, 2020, we determined that AlerisLife is not a VIE and we will account for our equity investment in AlerisLife using the equity method of accounting because we are deemed to exert significant influence, but not control, over AlerisLife's most significant activities. We have elected to use the fair value option to account for our investment in AlerisLife.

As of December 31, 2021, we had transitioned 107 of the 108 senior living communities, containing 7,340 living units, from Five Star to new third party managers. The remaining senior living community was closed and we are assessing opportunities to redevelop that property. We lease nearly all of our senior living communities, including those managed by Five Star and by the new third party managers, to our TRSs. We incurred and expect to continue to incur costs related to retention and other transition costs for the 107 transitioned communities. For the year ended December 31, 2021, we recorded $17,363 of these costs, of which $13,311 represent expenses reimbursed to Five Star, to acquisition and certain other transaction related costs in our consolidated statements of comprehensive income (loss).

The terms of the management agreements with the new third party managers are generally as follows: the new third party managers will receive a management fee equal to 5% to 6% of the gross revenues realized at the applicable senior living communities plus reimbursement for direct costs and expenses related to such communities. These agreements generally also provide for the new third party managers to earn a minimum base fee for a portion of the term of the agreement. Additionally, the new third party managers have the ability to earn incentive fees equal to 15% to 25% of the amount by which EBITDA of the applicable communities exceeds the target EBITDA for the applicable communities. The new third party managers can also earn a construction supervision fee ranging between 3% and 5% of construction costs.

F-21

The initial terms of the management agreements with the new third party managers are generally five years, subject to automatic extensions of successive terms of two years each unless earlier terminated or timely notice of nonrenewal is delivered. The management agreements with the new third party managers also generally provide us with the right to terminate the management agreements for communities that do not earn 70% to 80% of the target EBITDA for such communities, after an agreed upon stabilized period.

Our Senior Living Communities Formerly Leased by Five Star. Prior to the Conversion Time, we leased senior living communities to Five Star pursuant to five master leases with Five Star, each of which was terminated as of January 1, 2020 pursuant to the Transaction Agreement.

Under our previously existing leases with Five Star, Five Star paid us annual rent plus percentage rent equal to 4.0% of the increase in gross revenues at certain of our senior living communities over base year gross revenues as specified in the applicable leases. Pursuant to the Transaction Agreement, commencing February 1, 2019, no percentage rent was payable to us by Five Star and annual rent payable to us by Five Star was adjusted as noted above. We previously determined percentage rent due under these leases annually and recognized it when all contingencies were met, which was typically at year end. We recognized total rental income from Five Star of $137,898 (including percentage rent of $538) for the year ended December 31, 2019.

Our previously existing leases with Five Star were “triple net” leases, which generally required Five Star to pay rent and all property operating expenses, to indemnify us from liability which may arise by reason of our ownership of the properties, to maintain the properties at Five Star's expense, to remove and dispose of hazardous substances on the properties in compliance with applicable law and to maintain insurance on the properties for Five Star's and our benefit.

Under our previously existing leases with Five Star, Five Star could request that we purchase certain improvements to the leased communities and, until we entered into the Transaction Agreement, the annual rent payable to us by Five Star would increase in accordance with a formula specified in the applicable lease in return for such purchases. Pursuant to the Transaction Agreement, the $111,603 of improvements to communities leased to Five Star, including $49,155 of fixed assets and improvements that were purchased pursuant to the Transaction Agreement as discussed above, that we funded during the year ended December 31, 2019 did not result in increased rent payable by Five Star.

As of December 31, 2019, Five Star was our most significant tenant. The following is a summary of the assets leased to and revenues earned from Five Star as a tenant as of and for the year ended December 31, 2019 compared to all our other assets and revenues from all sources:

	As of December 31, 2019
	Gross Book Value of Real Estate Assets (1)		% of Total
Five Star (2)	$	2,286,951	27.2	%
All others (3)	6,133,672		72.8	%
	$	8,420,623	100.0	%

(1)    Represents the gross book value of real estate assets at cost plus certain acquisition costs, before depreciation and purchase price allocations, less impairment write downs, if any. Five Star also managed some of our managed senior living communities as of December 31, 2019. The gross book value of real estate assets of $1,920,070 as of December 31, 2019 for those managed senior living communities is included in the "All others" category.

(2)    Includes gross book value of real estate assets of $50,951 classified as held for sale in our consolidated balance sheet as of December 31, 2019.

(3)    Includes gross book value of real estate assets of $213,416 classified as held for sale in our consolidated balance sheet as of December 31, 2019.

F-22

	Year Ended
	December 31, 2019
	Total Revenues(1)		% of Total
Five Star	$	137,898	13.3	%
All others	902,257		86.7	%
	$	1,040,155	100.0	%

(1)    Five Star also managed some of our managed senior living communities as of December 31, 2019. Our revenues of $433,597 for the year ended December 31, 2019, from those communities are included in the “All others” category.

Our Senior Living Communities Managed by Five Star. Five Star managed 120, 235 and 78 senior living communities for our account as of December 31, 2021, 2020 and 2019, respectively. We lease our senior living communities that are managed by Five Star to our TRSs, and Five Star manages these communities pursuant to long term management agreements. As described above, pursuant to the Transaction Agreement, effective January 1, 2020, we replaced our long term management and pooling agreements with Five Star with new management agreements and a related omnibus agreement, which agreements were subsequently replaced in June 2021 with the Master Management Agreement, the terms of which are described above.

We incurred management fees payable to Five Star of $47,479, $62,880 and $15,327 for the years ended December 31, 2021, 2020 and 2019, respectively. For the years ended December 31, 2021 and 2020, $43,864 and $60,413, respectively, of the total management fees were expensed to property operating expenses in our consolidated statements of comprehensive income (loss) and $3,615 and $2,467, respectively, were capitalized in our consolidated balance sheets and are being depreciated over the estimated useful lives of the related capital assets.

In addition to providing management services to us, Five Star also provides certain other services to residents at some of the senior living communities it manages for us, such as rehabilitation services. At senior living communities Five Star manages for us where Five Star provides rehabilitation services on an outpatient basis, the residents, third party payers or government programs pay Five Star for those rehabilitation services. At senior living communities Five Star manages for us where Five Star provides both inpatient and outpatient rehabilitation services, we generally pay Five Star for those rehabilitation services and charges for these services are included in amounts charged to residents, third party payers or government programs. We incurred fees of $11,233, $25,687 and $5,920 for the years ended December 31, 2021, 2020 and 2019, respectively, with respect to rehabilitation services Five Star provided at senior living communities that are payable by us. These amounts are included in property operating expenses in our consolidated statements of comprehensive income (loss).

As a result of routine monitoring protocols that are a part of Five Star's compliance program activities related to Medicare billing, Five Star discovered potentially inadequate documentation at one of our senior living communities that Five Star manages. This monitoring was not initiated in response to any specific complaint or allegation but rather was of the type that Five Star periodically undertakes to test its compliance with applicable Medicare billing rules. We and Five Star voluntarily disclosed this matter to the United States Department of Health and Human Services, Office of the Inspector General, or the OIG, pursuant to the OIG's Provider Self-Disclosure Protocol. In January 2021, we and Five Star settled this matter with the OIG and we agreed to pay approximately $5,763 in exchange for a customary release, but we and Five Star did not admit any liability. We paid that amount to the OIG in January 2021. Five Star refunded to us $115 of management fees it previously received relating to the Medicare payments we refunded to the OIG. With respect to this settlement amount, we accrued a revenue reserve of $3,842 at December 31, 2020 for historical Medicare payments we received and agreed to repay to the OIG and we recorded expenses of $1,921 for the year ended December 31, 2020 for OIG-imposed penalties.

Since January 1, 2020, we sold certain senior living communities that were then managed by Five Star. We and Five Star terminated our management agreements for these senior living communities in connection with these sales. See Note 3 for further information regarding these sales. During 2021, we transitioned 107 senior living communities from Five Star to new third party managers and we closed one senior living community that was previously managed by Five Star.

We lease to Five Star space at certain of our senior living communities, which it uses to provide certain outpatient rehabilitation and wellness services. We recorded $1,591 and $1,561 for the years ended December 31, 2021 and 2020, respectively, with respect to these leases.

F-23

The following table presents residents fees and services revenue from our managed senior living communities disaggregated by the type of contract and payer:

	Year Ended December 31,
Revenue from contracts with customers:	2021		2020		2019
Basic housing and support services	$	750,644	$	856,687	$	353,699
Medicare and Medicaid programs	98,273		173,878		31,324
Private pay and other third party payer SNF services	125,706		174,246		48,574
Total residents fees and services	$	974,623	$	1,204,811	$	433,597

Note 7. Business and Property Management Agreements with RMR LLC

We have no employees. The personnel and various services we require to operate our business are provided to us by RMR LLC. We have two agreements with RMR LLC to provide management services to us: (1) a business management agreement, which relates to our business generally, and (2) a property management agreement, which relates to the property level operations of our medical office and life science properties and major renovation or repositioning activities at our senior living communities that we may request RMR LLC to manage from time to time. We also have a subsidiary level management agreement with RMR LLC related to the life science property located in Boston, Massachusetts, which we entered in connection with the joint venture arrangement for that life science property. Under that agreement, our subsidiary pays RMR LLC certain management fees directly, which fees are credited against the business management fees payable by us to RMR LLC. On December 23, 2021, we sold a 35% equity interest in that joint venture to another third party global institutional investor. As a result of that sale, our equity interest in the joint venture was reduced to 20% and the joint venture then ceased to be a subsidiary of ours. Accordingly, we will no longer consolidate this joint venture and fees payable by the joint venture to RMR LLC will no longer be credited against the fees we pay to RMR LLC. See Note 3 for further information regarding this sale and Note 8 for further information regarding our relationship, agreements and transactions with RMR LLC.

Management Agreements with RMR LLC. Our management agreements with RMR LLC provide for an annual base management fee, an annual incentive management fee and property management and construction supervision fees, payable in cash, among other terms:

•Base Management Fee. The annual base management fee payable to RMR LLC by us for each applicable period is equal to the lesser of:

◦the sum of (a) 0.5% of the daily weighted average of the aggregate book value of our real estate assets owned by us or our subsidiaries as of October 12, 1999, or the Transferred Assets, plus (b) 0.7% of the average aggregate historical cost of our real estate investments excluding the Transferred Assets up to $250,000, plus (c) 0.5% of the average aggregate historical cost of our real estate investments excluding the Transferred Assets exceeding $250,000; and

◦the sum of (a) 0.7% of the average closing price per share of our common shares on the stock exchange on which such shares are principally traded during such period, multiplied by the average number of our common shares outstanding during such period, plus the daily weighted average of the aggregate liquidation preference of each class of our preferred shares outstanding during such period, plus the daily weighted average of the aggregate principal amount of our consolidated indebtedness during such period, or, together, our Average Market Capitalization, up to $250,000, plus (b) 0.5% of our Average Market Capitalization exceeding $250,000.

The average aggregate historical cost of our real estate investments includes our consolidated assets invested, directly or indirectly, in equity interests in or loans secured by real estate and personal property owned in connection with such real estate (including acquisition related costs and costs which may be allocated to intangibles or are unallocated), all before reserves for depreciation, amortization, impairment charges or bad debts or other similar non-cash reserves.

•Incentive Management Fee. The incentive management fee which may be earned by RMR LLC for an annual period is calculated as follows:

•An amount, subject to a cap, based on the value of our common shares outstanding, equal to 12.0% of the product of:

F-24

◦our equity market capitalization on the last trading day of the year immediately prior to the relevant three year measurement period, and

◦the amount (expressed as a percentage) by which the total return per share, as defined in the business management agreement and further described below, of our common shareholders (i.e., share price appreciation plus dividends) exceeds the total shareholder return of the applicable market index, or the benchmark return per share, for the relevant measurement period. Effective August 1, 2021, we and RMR LLC amended our business management agreement to replace the benchmark index used in the calculation of incentive management fees. Pursuant to the amendment, for periods beginning on and after August 1, 2021, the MSCI U.S. REIT/Health Care REIT Index replaced the discontinued SNL U.S. REIT Healthcare Index and will be used to calculate benchmark returns per share for purposes of determining any incentive management fee payable by us to RMR LLC. For periods prior to August 1, 2021, the SNL U.S. REIT Healthcare Index continued to be used. Accordingly, the calculation of incentive management fees for the next two measurement periods will continue to use the SNL U.S. REIT Healthcare Index in calculating the benchmark returns for periods through July 31, 2021. This change of index was due to S&P Global ceasing to publish the SNL U.S. REIT Healthcare Index.

For purposes of the total return per share of our common shareholders, share price appreciation for a measurement period is determined by subtracting (1) the closing price of our common shares on Nasdaq on the last trading day of the year immediately before the first year of the applicable measurement period, or the initial share price, from (2) the average closing price of our common shares on the 10 consecutive trading days having the highest average closing prices during the final 30 trading days in the last year of the measurement period.

◦The calculation of the incentive management fee (including the determinations of our equity market capitalization, initial share price and the total return per share of our common shareholders) is subject to adjustments if we issue or repurchase our common shares, or if our common shares are forfeited, during the measurement period.

◦No incentive management fee is payable by us unless our total return per share during the measurement period is positive.

◦The measurement periods are three year periods ending with the year for which the incentive management fee is being calculated.

◦If our total return per share exceeds 12.0% per year in any measurement period, the benchmark return per share is adjusted to be the lesser of the total shareholder return of the applicable market index for such measurement period and 12.0% per year, or the adjusted benchmark return per share. In instances where the adjusted benchmark return per share applies, the incentive management fee will be reduced if our total return per share is between 200 basis points and 500 basis points below the applicable market index in any year, by a low return factor, as defined in the business management agreement, and there will be no incentive management fee paid if, in these instances, our total return per share is more than 500 basis points below the applicable market index in any year, determined on a cumulative basis (i.e., between 200 basis points and 500 basis point per year multiplied by the number of years in the measurement period and below the applicable market index).

◦The incentive management fee is subject to a cap. The cap is equal to the value of the number of our common shares which would, after issuance, represent 1.5% of the number of our common shares then outstanding multiplied by the average closing price of our common shares during the 10 consecutive trading days having the highest average closing prices during the final 30 trading days of the relevant measurement period.

◦Incentive management fees we paid to RMR LLC for any period may be subject to “clawback” if our financial statements for that period are restated due to material non-compliance with any financial reporting requirements under the securities laws as a result of the bad faith, fraud, willful misconduct or gross negligence of RMR LLC and the amount of the incentive management fee we paid was greater than the amount we would have paid based on the restated financial statements.

Pursuant to our business management agreement with RMR LLC, we recognized net business management fees of $23,378, $20,629 and $27,399 for the years ended December 31, 2021, 2020 and 2019, respectively. The net business management fees we recognized are included in general and administrative expenses in our consolidated statements of

F-25

comprehensive income (loss) for these periods. The net business management fees we recognized for the years ended December 31, 2021, 2020 and 2019 reflect a reduction of $2,974, for each of those years for the amortization of the liability we recorded in connection with, our former investment in RMR Inc., as further described in Note 8.

Pursuant to our business management agreement with RMR LLC, in January 2019, we paid RMR LLC an incentive management fee of $40,642 for the year ended December 31, 2018. We did not recognize an incentive management fee payable to RMR LLC for the years ended December 31, 2021, 2020 or 2019.

•Property Management and Construction Supervision Fees. The property management fees payable to RMR LLC by us for each applicable period are equal to 3.0% of gross collected rents and the construction supervision fees payable to RMR LLC by us for each applicable period are equal to 5.0% of construction costs. In connection with our entry into the Master Management Agreement, on June 9, 2021, we and RMR LLC amended our property management agreement to, among other things, provide for RMR LLC's oversight of any major capital projects and repositionings at our senior living communities, including our senior living communities which Five Star is continuing to manage, and that RMR LLC will receive the same fee previously paid to Five Star for such services, which is equal to 3.0% of the cost of any such major capital project or repositioning.

We recognized aggregate net property management and construction supervision fees of $12,504, $13,802 and $13,141 for the years ended December 31, 2021, 2020 and 2019, respectively. The net property management and construction supervision fees we recognized for the years ended December 31, 2021, 2020 and 2019 reflect a reduction of $797 for each of those years for the amortization of the liability we recorded in connection with our former investment in RMR Inc., as further described in Note 8. For the years ended December 31, 2021, 2020 and 2019, $9,684, $10,084 and $10,705, respectively, of property management fees were expensed to property operating expenses in our consolidated statements of comprehensive income (loss) and $2,820, $3,718 and $2,436, respectively, were capitalized as building improvements in our consolidated balance sheets and are being depreciated over the estimated useful lives of the related capital assets.

Expense Reimbursement. We are generally responsible for all our operating expenses, including certain expenses incurred or arranged by RMR LLC on our behalf. We are generally not responsible for payment of RMR LLC's employment, office or administrative expenses incurred to provide management services to us, except for the employment and related expenses of RMR LLC's employees assigned to work exclusively or partly at our properties, our share of the wages, benefits and other related costs of RMR LLC's centralized accounting personnel, our share of RMR LLC's costs for providing our internal audit function, or as otherwise agreed. Our Audit Committee appoints our Director of Internal Audit and our Compensation Committee approves the costs of our internal audit function. Our property level operating expenses are generally incorporated into the rents charged to our tenants, including certain payroll and related costs incurred by RMR LLC. We reimbursed RMR LLC $13,161, $13,805 and $13,373 for these costs and expenses for the years ended December 31, 2021, 2020 and 2019, respectively. These amounts are included in property operating expenses or general and administrative expenses, as applicable, in our consolidated statements of comprehensive income (loss) for these periods.

Term. Our management agreements with RMR LLC have terms that end on December 31, 2041, and automatically extend on December 31st of each year for an additional year, so that the terms of our management agreements thereafter end on the 20th anniversary of the date of the extension.

Termination Rights. We have the right to terminate one or both of our management agreements with RMR LLC: (i) at any time on 60 days' written notice for convenience, (ii) immediately on written notice for cause, as defined therein, (iii) on written notice given within 60 days after the end of an applicable calendar year for a performance reason, as defined therein, and (iv) by written notice during the 12 months following a change of control of RMR LLC, as defined therein. RMR LLC has the right to terminate the management agreements for good reason, as defined therein.

Termination Fee. If we terminate one or both of our management agreements with RMR LLC for convenience, or if RMR LLC terminates one or both of our management agreements for good reason, we have agreed to pay RMR LLC a termination fee in an amount equal to the sum of the present values of the monthly future fees, as defined therein, for the terminated management agreement(s) for the term that was remaining prior to such termination, which, depending on the time of termination would be between 19 and 20 years. If we terminate one or both of our management agreements with RMR LLC for a performance reason, we have agreed to pay RMR LLC the termination fee calculated as described above, but assuming a 10 year term was remaining prior to the termination. We are not required to pay any termination fee if we terminate our management agreements with RMR LLC for cause or as a result of a change of control of RMR LLC.

Transition Services. RMR LLC has agreed to provide certain transition services to us for 120 days following an applicable termination by us or notice of termination by RMR LLC, including cooperating with us and using commercially

F-26

reasonable efforts to facilitate the orderly transfer of the management and real estate investment services provided under our business management agreement and to facilitate the orderly transfer of the management of the managed properties under our property management agreement, as applicable.

Vendors. Pursuant to our management agreements with RMR LLC, RMR LLC may from time to time negotiate on our behalf with certain third party vendors and suppliers for the procurement of goods and services to us. As part of this arrangement, we may enter agreements with RMR LLC and other companies to which RMR LLC or its subsidiaries provide management services for the purpose of obtaining more favorable terms from such vendors and suppliers.

Investment Opportunities. Under our business management agreement with RMR LLC, we acknowledge that RMR LLC may engage in other activities or businesses and act as the manager to any other person or entity (including other REITs) even though such person or entity has investment policies and objectives similar to ours and we are not entitled to preferential treatment in receiving information, recommendations and other services from RMR LLC.

Note 8. Related Person Transactions

We have relationships and historical and continuing transactions with AlerisLife (including Five Star), RMR LLC, RMR Inc. and others related to them, including other companies to which RMR LLC or its subsidiaries provide management services and some of which have trustees, directors or officers who are also our Trustees or officers. RMR Inc. is the managing member of RMR LLC. The Chair of our Board and one of our Managing Trustees, Adam D. Portnoy, as the sole trustee of ABP Trust, is the controlling shareholder of RMR Inc., is a managing director and the president and chief executive officer of RMR Inc., an officer and employee of RMR LLC and the chair of the board and a managing director of AlerisLife. Jennifer F. Francis, our other Managing Trustee and our President and Chief Executive Officer, and our Chief Financial Officer and Treasurer are also employees and officers of RMR LLC. Jennifer B. Clark, our Secretary and former Managing Trustee, also serves as a managing director and the executive vice president, general counsel and secretary of RMR Inc., an officer and employee of RMR LLC, an officer of ABP Trust and a managing director and secretary of AlerisLife. Certain of AlerisLife's officers are officers and employees of RMR LLC. Some of our Independent Trustees also serve as independent trustees or independent directors of other public companies to which RMR LLC or its subsidiaries provide management services. Adam Portnoy serves as the chair of the board and as a managing director or managing trustee of these companies. Other officers of RMR LLC, including Ms. Clark and certain of our officers, serve as managing trustees, managing directors or officers of certain of these companies. In addition, officers of RMR LLC and RMR Inc. serve as our officers and officers of other companies to which RMR LLC or its subsidiaries provide management services.

AlerisLife. We are currently AlerisLife's largest stockholder. As of December 31, 2021, we owned 10,691,658 of AlerisLife's common shares, or approximately 32.7% of AlerisLife's outstanding common shares. As of December 31, 2019, Five Star was our largest tenant and the manager of our managed senior living communities. Five Star manages certain of the senior living communities we own pursuant to the Master Management Agreement. RMR LLC provides management services to both us and Five Star. Five Star participates in our property insurance program for the senior living communities Five Star owns and leases. The premiums Five Star pays for this coverage are allocated pursuant to a formula based on the profiles of the properties included in the program. See Note 6 for further information regarding our relationships, agreements and transactions with AlerisLife (including Five Star), and Note 10 for further information regarding our investment in AlerisLife.

As of December 31, 2021, ABP Acquisition LLC, a subsidiary of ABP Trust, the controlling shareholder of RMR Inc., together with ABP Trust, owned approximately 6.2% of AlerisLife's outstanding common shares.

In order to effect our distribution of AlerisLife common shares to our shareholders in 2001 and to govern our relations with AlerisLife (including Five Star), thereafter, AlerisLife (including Five Star) entered agreements with us and others, including RMR LLC. Since then, we have entered various leases, management agreements and other agreements with AlerisLife (including Five Star) that include provisions that confirm and modify these undertakings. Among other things, these agreements provide that:

•so long as we remain a REIT, AlerisLife may not waive the share ownership restrictions in its charter that prohibit any person or group from acquiring more than 9.8% (in value or number of shares, whichever is more restrictive) of the outstanding shares of any class of AlerisLife stock without our consent;

•so long as Five Star is our tenant or manager, AlerisLife will not permit nor take any action that, in our reasonable judgment, might jeopardize our qualification for taxation as a REIT;

F-27

•we have the right to terminate our management agreements with Five Star upon the acquisition by a person or group of more than 9.8% of AlerisLife's voting stock or other change in control events, as defined therein affecting AlerisLife, including the adoption of any shareholder proposal (other than a precatory proposal) or the election to AlerisLife's board of directors of any individual, if such proposal or individual was not approved, nominated or appointed, as the case may be, by a majority of AlerisLife's directors in office immediately prior to the making of such proposal or the nomination or appointment of such individual; and

•so long as Five Star is our tenant or manager or has a business management agreement with RMR LLC, AlerisLife will not acquire or finance any real estate of a type then owned or financed by us or any other company managed by RMR LLC without first giving us or such company managed by RMR LLC, as applicable, the opportunity to acquire or finance that real estate.

See Note 6 for further information regarding our relationships, agreements and transactions with AlerisLife (including Five Star).

Our Manager, RMR LLC. We have two agreements with RMR LLC to provide management services to us: (1) a business management agreement, which relates to our business generally, and (2) a property management agreement, which relates to the property level operations of our medical office and life science properties and major renovation or repositioning activities at our senior living communities that we may request RMR LLC to manage from time to time. See Note 7 for further information regarding our management agreements with RMR LLC.

Leases with RMR LLC. We lease office space to RMR LLC in certain of our properties for RMR LLC's property management offices. We recognized rental income from RMR LLC for leased office space of $190, $163 and $256 for the years ended December 31, 2021, 2020 and 2019, respectively. Our office space leases with RMR LLC are terminable by RMR LLC if our management agreements with RMR LLC are terminated.

Share Awards to RMR LLC Employees. As described in Note 5, we award shares to our officers and other employees of RMR LLC annually. Generally, one fifth of these awards vest on the grant date and one fifth vests on each of the next four anniversaries of the grant dates. In certain instances, we may accelerate the vesting of an award, such as in connection with the award holder's retirement as an officer of us or an officer or employee of RMR LLC. These awards to RMR LLC employees are in addition to the share awards to our Managing Trustees, as Trustee compensation, and the fees we paid to RMR LLC. See Note 5 for information regarding our share awards and activity as well as certain share purchases we made in connection with share award recipients satisfying tax withholding obligation on vesting share awards.

RMR Inc. On July 1, 2019, we sold all of the 2,637,408 shares of class A common stock of RMR Inc. that we owned in an underwritten public offering at a price to the public of $40.00 per share pursuant to the underwriting agreement among us, RMR Inc., certain other REITs managed by RMR LLC that also sold their class A common stock of RMR Inc. in the offering, and the underwriters named therein. We received net proceeds of $98,557 from this sale, after deducting the underwriting discounts and commissions and other offering expenses.

AIC. Until its dissolution on February 13, 2020, we, ABP Trust, AlerisLife and four other companies to which RMR LLC provides management services owned AIC in equal portions. We and the other AIC shareholders historically participated in a combined property insurance program arranged and insured or reinsured in part by AIC until June 30, 2019. We also had a one year standalone insurance policy that provided coverage for one of our life science properties located in Boston, Massachusetts that is owned in a joint venture, which we obtained as a part of this insurance program. We (including our then consolidated joint venture) paid aggregate annual premiums, including taxes and fees, of $4,413 in connection with this insurance program for the policy year ended June 30, 2019.

In connection with AIC's dissolution, we and each other AIC shareholder received an initial liquidating distribution of $9,000 from AIC in December 2019, an additional liquidating distribution of approximately $287 in June 2020 and a final liquidating distribution of $11 in December 2021. As of December 31, 2020 and 2019, our investment in AIC had a carrying value of $11 and $298, respectively. These amounts are included in other assets in our consolidated balance sheets. We recognized income of $400 related to our investment in AIC for the year ended December 31, 2019. These amounts are presented as equity in earnings of an investee in our consolidated statements of comprehensive income (loss). Our other comprehensive income includes our proportionate part of unrealized gains on securities which were owned and held for sale by AIC of $91 related to our investment in AIC for the year ended December 31, 2019.

F-28

Note 9. Indebtedness

At December 31, 2021 and 2020, our outstanding indebtedness consisted of the following:

		Principal Balance as of December 31,
Floating Rate Debt (1)	Maturity	2021		2020
Revolving credit facility (2)	January 2023	$	800,000	$	—
Term loan	September 2022	—		200,000
Total floating rate debt		$	800,000	$	200,000

(1)As of December 31, 2021 and 2020, the unamortized net debt issuance costs on certain of these debts were $0 and $951, respectively.

(2)Outstanding borrowings under our revolving credit facility. In February 2022, we exercised our option to extend the maturity date of our revolving credit facility by one year to January 2024.

				December 31, 2021				December 31, 2020
Senior Unsecured Notes (1)	Coupon		Maturity	Face Amount		Unamortized Discount		Face Amount		Unamortized Discount
Senior unsecured notes	6.750	%	December 2021	$	—	$	—	$	300,000	$	490
Senior unsecured notes	4.750	%	May 2024	250,000		184		250,000		263
Senior unsecured notes	9.750	%	June 2025	1,000,000		—		1,000,000		—
Senior unsecured notes	4.750	%	February 2028	500,000		5,169		500,000		6,013
Senior unsecured notes	4.375	%	March 2031	500,000		—		—		—
Senior unsecured notes	5.625	%	August 2042	350,000		—		350,000		—
Senior unsecured notes	6.250	%	February 2046	250,000		—		250,000		—
Total senior unsecured notes				$	2,850,000	$	5,353	$	2,650,000	$	6,766

(1)As of December 31, 2021 and 2020, the unamortized net debt issuance costs on certain of these notes were $37,836 and $35,045, respectively.

	Principal Balance as of December 31,							Number of Properties as Collateral	Net Book Value of Collateral as of December 31,
Secured and Other Debt	2021 (1)		2020 (1)		Interest Rate		Maturity	At December 31, 2021	2021		2020
Mortgage note	$	11,120	$	11,838	6.28	%	July 2022	1	$	23,525	$	23,500
Mortgage note	10,479		10,724		4.85	%	October 2022	1	19,211		19,675
Mortgage note	15,456		15,805		5.75	%	October 2022	2	19,099		19,180
Mortgage note	15,204		15,646		6.64	%	June 2023	1	24,593		23,023
Mortgage notes (2)	—		620,000		3.53	%	August 2026	—	—		705,096
Mortgage note	10,240		10,470		4.44	%	July 2043	1	13,387		13,582
Finance Leases	6,636		7,811		7.70	%	April 2026	2	18,527		18,097
Total secured	$	69,135	$	692,294				8	$	118,342	$	822,153

(1)The principal balances are the amounts stated in the contracts. In accordance with GAAP, our carrying values and recorded interest expense may be different because of market conditions at the time we assumed certain of these debts. As of December 31, 2021 and 2020, the unamortized net premiums and debt issuance costs on certain of these mortgages were $(578) and $721, respectively.

(2)The property encumbered by these mortgages is located in Boston, Massachusetts and was contributed in the first quarter of 2017 to a joint venture, which we deconsolidated in December 2021 and in which we currently own a 20% equity interest. As of December 31, 2020, this property was consolidated into our financial statements. See Note 3 for further information regarding this joint venture.

As of December 31, 2021, we had a $800,000 revolving credit facility that was available for general business purposes. As of December 31, 2021, the maturity date of our revolving credit facility was January 2023. In February 2022, we exercised our option to extend the maturity date of our revolving credit facility by one year to January 2024. Our revolving

F-29

credit facility generally provides that we can borrow, repay and re-borrow funds available under our revolving credit facility until maturity, and no principal repayment is due until maturity. As of December 31, 2021, our revolving credit facility required interest to be paid on borrowings at the annual rate of 2.9%, plus a facility fee of 30 basis points per annum on the total amount of lending commitments under the facility.

The weighted average annual interest rates for borrowings under our revolving credit facility were 2.9%, 2.2% and 3.4% for the years ended December 31, 2021, 2020 and 2019, respectively. The interest rate premium and facility fee are each subject to adjustment based upon changes to our credit ratings. On March 31, 2021, we borrowed $800,000 under our revolving credit facility as a precautionary measure to increase our cash position and preserve financial flexibility in light of continued uncertainties related to the COVID-19 pandemic. As of December 31, 2021 and February 21, 2022, we were fully drawn under our revolving credit facility.

In January 2021, we and our lenders amended our credit agreement and the agreement governing our previously existing $200,000 term loan in order to provide us with certain flexibility in light of continued uncertainties related to the COVID-19 pandemic. Pursuant to the amendments:

•certain of the financial covenants under our credit agreement and the agreement governing our previously existing $200,000 term loan, including covenants that require us to maintain certain financial ratios, have been waived through June 2022, or the Amendment Period;

•the revolving credit facility commitments have been reduced from $1,000,000 to $800,000, and as a result of the reduction in commitments, we recorded a loss on early extinguishment of debt of $563 for the year ended December 31, 2021;

•we pledged certain equity interests of subsidiaries owning properties to secure our obligations under our credit agreement and the agreement governing our previously existing $200,000 term loan and agreed to provide, and as of December 2021 had provided, first mortgage liens on 61 medical office and life science properties with an aggregate gross book value of real estate assets of $992,493 as of December 31, 2021 to secure our obligations, which pledges and/or mortgage liens may be removed or new ones may be added during the Amendment Period based on outstanding debt amounts, among other things;

•we had the ability to fund $250,000 of capital expenditures per year, which increased to $350,000 per year following the repayment of our $200,000 term loan in February 2021, and are restricted in our ability to acquire real property as defined in our credit agreement;

•the interest rate premium over LIBOR under our revolving credit facility and our previously existing $200,000 term loan increased by 30 basis points;

•certain covenants and restrictions on distributions to common shareholders, share repurchases, capital expenditures, acquiring additional properties and incurring additional indebtedness (in each case subject to various exceptions), and the minimum liquidity requirement of $200,000 will remain in place during the Amendment Period; and

•we are generally required to apply the net cash proceeds from the disposition of assets, capital markets transactions, and debt financings to the repayment of any amounts outstanding under our revolving credit facility.

In September 2021, we and our lenders further amended our credit agreement. Among other things, the amendment sets forth the mechanics for establishing a replacement benchmark rate under our credit agreement at such time as LIBOR is no longer available to calculate interest payable on amounts outstanding thereunder.

In February 2022, we and our lenders further amended our credit agreement. Pursuant to the amendment:

•the waiver of the fixed charge coverage ratio covenant included in our credit agreement has been extended through December 31, 2022;

•the revolving credit facility commitments have been reduced from $800,000 to $700,000 following our repayment of $100,000;

•we have the ability to fund $400,000 of capital expenditures per year and we are restricted in our ability to acquire real property as defined in our credit agreement;

F-30

•the interest rate premium under our revolving credit facility increased by 15 basis points; and

•certain covenants and restrictions on distributions to common shareholders, share repurchases, capital expenditures, acquiring additional properties and incurring additional indebtedness (in each case subject to various exceptions), and the minimum liquidity requirement of $200,000 will remain in place during the Amendment Period.

Also in February 2022, we exercised our option to extend the maturity date of our revolving credit facility by one year to January 2024. Pursuant to our credit agreement, the borrowing capacity under our revolving credit facility will be reduced to $586,373 as of January 2023 and as such, further repayment of our revolving credit facility may be required.

In May 2019, we redeemed at par all of our outstanding 3.25% senior notes due 2019 for a redemption price equal to the principal amount of $400,000, plus accrued and unpaid interest of $6,500. We funded this redemption with cash on hand and borrowings under our revolving credit facility.

Also in May 2019, we prepaid, at par plus accrued interest, a mortgage note secured by four of our senior living communities with an outstanding principal balance of approximately $42,211, a maturity date in July 2019 and an annual interest rate of 3.79%. As a result of this prepayment, we recorded a loss on early extinguishment of debt of $17 for the year ended December 31, 2019. We prepaid this mortgage using cash on hand and borrowings under our revolving credit facility.

In December 2019, we obtained a $250,000 term loan with a maturity date in June 2020, which we have prepaid in full as discussed further below. The weighted average annual interest rate for amounts outstanding under this term loan was 2.9% for the year ended December 31, 2019. We used the net proceeds from our $250,000 term loan, together with proceeds from our dispositions, borrowings under our revolving credit facility and cash on hand, to prepay in full our $350,000 term loan that was scheduled to mature on January 15, 2020. As a result of this prepayment, we recorded a loss on early extinguishment of debt of $27 for the year ended December 31, 2019.

In February 2020, we prepaid a mortgage note secured by one of our life science properties with an outstanding principal balance of approximately $1,554, a maturity date in March 2026 and an annual interest rate of 6.25%. As a result of this prepayment, we recorded a loss on early extinguishment of debt of $246 for the year ended December 31, 2020. We prepaid this mortgage using cash on hand and borrowings under our revolving credit facility.

In April 2020, we redeemed all of our outstanding 6.75% senior notes due 2020 for a redemption price equal to the principal amount of $200,000 plus accrued and unpaid interest of $6,750. We funded this redemption with cash on hand and borrowings under our revolving credit facility.

In May 2020, we prepaid a mortgage note secured by one of our medical office properties with an outstanding principal balance of approximately $1,213, a maturity date in January 2022 and an annual interest rate of 7.49%. As a result of the prepayment of this mortgage note, we recorded a loss on early extinguishment of debt of $155 for the year ended December 31, 2020. We prepaid this mortgage using cash on hand and borrowings under our revolving credit facility.

In June 2020, we issued $1,000,000 aggregate principal amount of our 9.75% senior notes due 2025 in an underwritten public offering raising net proceeds of $982,300, after deducting estimated offering expenses and underwriters' discounts. These notes are guaranteed by all of our subsidiaries, except for certain excluded subsidiaries, including pledged subsidiaries under our credit agreement. Prior to June 15, 2022, we may, at our option, redeem all or a portion of these notes at a redemption price equal to the outstanding principal amount of these notes, plus accrued and unpaid interest, plus the make-whole amount set forth in the indenture which governs these notes, as supplemented, or our 2025 Notes Indenture. Prior to June 15, 2022, we may also, at our option, redeem up to 40% of the aggregate principal amount of these notes with the net proceeds of certain equity offerings at the redemption price set forth in the 2025 Notes Indenture, so long as at least 50% of the original aggregate principal amount of these notes remains outstanding after each such redemption. In addition, we have the option to redeem all or a portion of these notes at any time on or after June 15, 2022 at the redemption prices set forth in the 2025 Notes Indenture. We used the net proceeds from this offering to prepay in full our $250,000 term loan which was scheduled to mature in June 2020 and to reduce amounts outstanding under our revolving credit facility. The weighted average interest rate under our $250,000 term loan was 2.4% for the period from January 1, 2020 to June 2, 2020. As a result of the repayment of our $250,000 term loan, we recorded a loss on early extinguishment of debt of $26 for the year ended December 31, 2020.

In February 2021, we issued $500,000 aggregate principal amount of our 4.375% senior notes due 2031 in an underwritten public offering raising net proceeds of $491,357, after deducting estimated offering expenses and underwriters' discounts. These notes are guaranteed by all of our subsidiaries, except for certain excluded subsidiaries, including pledged subsidiaries under our credit agreement and require semi-annual interest payments through maturity. We used the net proceeds

F-31

from this offering to prepay in full in February 2021 our $200,000 term loan which was scheduled to mature in September 2022. The weighted average interest rate under our $200,000 term loan was 2.9% for the period from January 1, 2021 to February 7, 2021 and 2.7% and 3.7% for the years ended December 31, 2020 and 2019, respectively. As a result of the prepayment of our $200,000 term loan, we recorded a loss on early extinguishment of debt of $1,477 for the year ended December 31, 2021. In June 2021, we used the remaining net proceeds from this offering and cash on hand to redeem all of our outstanding 6.75% senior notes due 2021 for a redemption price equal to the principal amount of $300,000 plus accrued and unpaid interest of $10,125, when these notes became redeemable with no prepayment premium. In connection with this redemption, we recorded a loss on early extinguishment of debt of $370 for the year ended December 31, 2021.

Interest on our senior unsecured notes are payable either semi-annually or quarterly in arrears; however, no principal repayments are due until maturity. Required monthly payments on our mortgages include principal and interest. Payments under our finance leases are due monthly. We include amortization of finance lease assets in depreciation and amortization expense.

Our credit agreement and our senior unsecured notes indentures and their supplements provide for acceleration of payment of all amounts due thereunder upon the occurrence and continuation of certain events of default, such as, in the case of our credit agreement, a change of control of us, as defined, which includes RMR LLC ceasing to act as our business and property manager. Our credit agreement and our senior unsecured notes indentures and their supplements also contain covenants, including covenants that restrict our ability to incur debts, and generally require us to maintain certain financial ratios, and our credit agreement restricts our ability to make distributions under certain circumstances. As of December 31, 2021, our ratio of consolidated income available for debt service to debt service was below the 1.5x incurrence requirement under our revolving credit facility and our public debt covenants as the effects of the COVID-19 pandemic continued to adversely impact our operations. We are currently unable to incur additional debt because this ratio is below 1.5x on a pro forma basis. We believe we were in compliance with the remaining terms and conditions of the respective covenants under our credit agreement and our senior unsecured notes indentures and their supplements at December 31, 2021. Although we have taken steps to enhance our ability to maintain sufficient liquidity, a protracted negative impact on the economy or the industries in which our properties and businesses operate resulting from the COVID-19 pandemic may cause increased pressure on our ability to satisfy financial and other covenants. Continued availability of borrowings under our revolving credit facility is subject to our satisfying certain financial covenants and other credit facility conditions. If our operating results and financial condition are significantly negatively impacted by economic conditions or otherwise, we may fail to satisfy covenants and conditions under our credit agreement or fail to satisfy our public debt covenants.

Required principal payments on our outstanding debt as of December 31, 2021, are as follows:

Year	Principal Payment
2022	$	39,067
2023	816,413
2024	251,834
2025	1,002,001
2026	904
Thereafter	1,608,916		(1)

(1) The carrying value of our total debt outstanding as of December 31, 2021, including unamortized debt issuance costs, premiums and discounts was $3,676,524.

Note 10. Fair Value of Assets and Liabilities

The following table presents certain of our assets that are measured at fair value at December 31, 2021 and 2020, categorized by the level of inputs as defined in the fair value hierarchy under GAAP, used in the valuation of each asset.

F-32

	As of December 31, 2021				As of December 31, 2020
Description	Carrying Amount		Fair Value		Carrying Amount		Fair Value
Recurring Fair Value Measurement Assets:
Investment in AlerisLife (Level 1) (1)	$	31,540	$	31,540	$	73,772	$	73,772
Investment in unconsolidated joint venture (Level 3) (2)	$	215,127	$	215,127	$	—	$	—

(1)Our 10,691,658 shares of common stock of AlerisLife are included in investments in equity securities in our consolidated balance sheets, and are reported at fair value, which is based upon quoted market prices on Nasdaq (Level 1 inputs). During the years ended December 31, 2021 and 2020, we recorded an unrealized loss of $42,232 and an unrealized gain of $34,106, respectively, which are included in gains and losses on equity securities, net in our consolidated statements of comprehensive income (loss), to adjust the carrying value of our investment in AlerisLife common shares to their fair value. See Notes 2 and 8 for further information about our investment in AlerisLife.

(2)We own a 20% equity interest in a joint venture that owns a life science property located in Boston, Massachusetts and is included in investment in unconsolidated joint venture in our consolidated balance sheet, and is reported at fair value, which is based on significant unobservable inputs (Level 3 inputs). The significant unobservable inputs used in the fair value are a discount rate of 5.58%, an exit capitalization rate of 5.25% and a holding period of approximately 10 years and market rents. The assumptions are based on the location, type and nature of the property, and current and anticipated market conditions, which are derived from appraisers, industry publications and our experience. See Note 3 for further information regarding this joint venture.

In addition to the assets described in the table above, our financial instruments at December 31, 2021 and December 31, 2020 included cash and cash equivalents, restricted cash, other assets, our revolving credit facility, our previously existing $200,000 term loan, senior unsecured notes, secured debt and finance leases and other unsecured obligations and liabilities. The fair values of these financial instruments approximated their carrying values in our consolidated financial statements as of such dates, except as follows:

	As of December 31, 2021				As of December 31, 2020
Description	Carrying Amount (1)		Estimated Fair Value		Carrying Amount (1)		Estimated Fair Value
Senior unsecured notes, 6.750% coupon rate, due 2021	$	—	$	—	$	299,273	$	303,891
Senior unsecured notes, 4.750% coupon rate, due 2024	249,348		257,695		249,068		256,258
Senior unsecured notes, 9.750% coupon rate, due 2025	987,903		1,081,990		984,359		1,135,800
Senior unsecured notes, 4.750% coupon rate, due 2028	492,199		491,480		490,925		502,648
Senior unsecured notes, 4.375% coupon rate, due 2031	492,127		480,763		—		—
Senior unsecured notes, 5.625% coupon rate, due 2042	342,183		309,260		341,802		330,120
Senior unsecured notes, 6.250% coupon rate, due 2046	243,051		226,500		242,762		245,000
Secured debts (2)	69,713		71,963		691,573		716,185
	$	2,876,524	$	2,919,651	$	3,299,762	$	3,489,902

(1)Includes unamortized net debt issuance costs, premiums and discounts.

(2)We assumed certain of these secured debts in connection with our acquisition of certain properties. We recorded the assumed mortgage notes at estimated fair value on the date of acquisition and we are amortizing the fair value adjustments, if any, to interest expense over the respective terms of the mortgage notes to adjust interest expense to the estimated market interest rates as of the date of acquisition.

We estimated the fair value of our two issuances of senior unsecured notes due 2042 and 2046 based on the closing price on Nasdaq (Level 1 input) as of December 31, 2021. We estimated the fair values of our four issuances of senior unsecured notes due 2024, 2025, 2028 and 2031 using an average of the bid and ask price on Nasdaq on or about December 31, 2021 (Level 2 inputs as defined in the fair value hierarchy under GAAP). We estimated the fair values of our secured debts by using discounted cash flows analyses and currently prevailing market terms as of the measurement date (Level 3 inputs as defined in the fair value hierarchy under GAAP). Because Level 3 inputs are unobservable, our estimated fair values may differ materially from the actual fair values.

F-33

Note 11. Noncontrolling Interest

In March 2017, we entered into a joint venture arrangement with an institutional investor for one of our life science properties located in Boston, Massachusetts. The investor owned a 45% equity interest in the joint venture, and we owned the remaining 55% equity interest in the joint venture. We determined that, while we owned a 55% equity interest in this joint venture, this joint venture was a VIE and that we controlled the activities that most significantly impacted the economic performance of this entity; we therefore consolidated this property in our financial statements until we sold an additional 35% equity interest in the joint venture in December 2021 to another third party global institutional investor. After giving effect to the sale, we continue to own a 20% equity interest in this joint venture, but have determined that we are no longer the primary beneficiary. Effective as of the date of the sale, we deconsolidated this joint venture and we now account for this joint venture using the equity method of accounting under the fair value option. The portion of the joint venture's net income and comprehensive income not attributable to us, or $5,411, $5,146 and $5,356 for the years ended December 31, 2021, 2020 and 2019, respectively, is reported as a noncontrolling interest in our consolidated statements of comprehensive income (loss). The joint venture made aggregate cash distributions to the other joint venture investor of $22,348, $22,292 and $21,583 for the years ended December 31, 2021, 2020 and 2019, respectively, which are reflected as a decrease in total equity attributable to noncontrolling interest in our consolidated balance sheets.

Note 12. Segment Reporting

In connection with the 2020 Restructuring Transaction, we determined to redefine our reportable segments to better reflect our current operating environment. As of December 31, 2021, we operate in, and report financial information for, the following two segments: Office Portfolio and SHOP. We aggregate each of these two reporting segments based on their similar operating and economic characteristics. Our Office Portfolio segment consists of medical office properties leased to medical providers and other medical related businesses, as well as life science properties leased to biotech laboratories and other similar tenants. Our SHOP segment consists of managed senior living communities that provide short term and long term residential living and in some instances care and other services for residents where we pay fees to managers to operate the communities. In addition, prior to January 1, 2020, our SHOP segment included triple net leased senior living communities that provided short term and long term residential living and in some instances care and other services for residents and from which we received rents from Five Star. Pursuant to the 2020 Restructuring Transaction, effective January 1, 2020, our previously existing master leases and management and pooling agreements with Five Star were terminated and replaced with new management agreements and a related omnibus agreement, which agreements were later replaced in June 2021. Prior periods have been recast to reflect these reportable segments for all periods presented.

We also report “non-segment” operations, which consists of triple net leased senior living communities, that are leased to third party operators from which we receive rents, and wellness centers, which we do not consider to be sufficiently material to constitute a separate reporting segment, and any other income or expenses that are not attributable to a specific reporting segment.

F-34

	For the Year Ended December 31, 2021
	Office Portfolio		SHOP		Non-Segment		Consolidated
Revenues:
Rental income	$	367,597	$	—	$	40,992	$	408,589
Residents fees and services	—		974,623		—		974,623
Total revenues	367,597		974,623		40,992		1,383,212
Expenses:
Property operating expenses	127,313		964,499		—		1,091,812
Depreciation and amortization	127,632		132,044		11,455		271,131
General and administrative	—		—		34,087		34,087
Acquisition and certain other transaction related costs	—		—		17,506		17,506
Impairment of assets	—		(174)		—		(174)
Total expenses	254,945		1,096,369		63,048		1,414,362
Gain on sale of properties	492,072		200		—		492,272
Losses on equity securities, net	—		—		(42,232)		(42,232)
Interest and other income	—		19,554		1,081		20,635
Interest expense	(23,477)		(2,089)		(230,193)		(255,759)
Loss on early extinguishment of debt	—		—		(2,410)		(2,410)
Income (loss) from continuing operations before income tax expense	581,247		(104,081)		(295,810)		181,356
Income tax expense	—		—		(1,430)		(1,430)
Net income (loss)	581,247		(104,081)		(297,240)		179,926
Net income attributable to noncontrolling interest	(5,411)		—		—		(5,411)
Net income (loss) attributable to common shareholders	$	575,836	$	(104,081)	$	(297,240)	$	174,515
	As of December 31, 2021
	Office Portfolio		SHOP		Non-Segment		Consolidated
Total assets	$	2,282,652	$	2,995,819	$	1,345,043	$	6,623,514

F-35

	For the Year Ended December 31, 2020
	Office Portfolio		SHOP		Non-Segment		Consolidated
Revenues:
Rental income	$	383,365	$	—	$	43,850	$	427,215
Residents fees and services	—		1,204,811		—		1,204,811
Total revenues	383,365		1,204,811		43,850		1,632,026
Expenses:
Property operating expenses	129,756		1,106,601		—		1,236,357
Depreciation and amortization	129,321		129,124		11,702		270,147
General and administrative	—		—		30,593		30,593
Acquisition and certain other transaction related costs	—		—		814		814
Impairment of assets	8,558		98,414		—		106,972
Total expenses	267,635		1,334,139		43,109		1,644,883
Gain (loss) on sale of properties	2,597		(627)		4,517		6,487
Gains on equity securities, net	—		—		34,106		34,106
Interest and other income	—		17,485		736		18,221
Interest expense	(24,188)		(2,223)		(175,072)		(201,483)
Gain on lease termination	—		—		22,896		22,896
Loss on early extinguishment of debt	(401)		—		(26)		(427)
Income (loss) from continuing operations before income tax expense	93,738		(114,693)		(112,102)		(133,057)
Income tax expense	—		—		(1,250)		(1,250)
Net income (loss)	93,738		(114,693)		(113,352)		(134,307)
Net income attributable to noncontrolling interest	(5,146)		—		—		(5,146)
Net income (loss) attributable to common shareholders	$	88,592	$	(114,693)	$	(113,352)	$	(139,453)
	As of December 31, 2020
	Office Portfolio		SHOP		Non-Segment		Consolidated
Total assets	$	3,092,289	$	2,912,570	$	471,565	$	6,476,424

F-36

	For the Year Ended December 31, 2019
	Office Portfolio		SHOP		Non-Segment		Consolidated
Revenues:
Rental income	$	405,016	$	137,898	$	63,644	$	606,558
Residents fees and services	—		433,597		—		433,597
Total revenues	405,016		571,495		63,644		1,040,155
Expenses:
Property operating expenses	132,348		356,722		—		489,070
Depreciation and amortization	137,611		132,637		18,777		289,025
General and administrative	—		—		37,028		37,028
Acquisition and certain other transaction related costs	—		—		13,102		13,102
Impairment of assets	43,035		65,822		6,344		115,201
Total expenses	312,994		555,181		75,251		943,426
Gain on sale of properties	6,617		15,207		17,872		39,696
Dividend income	—		—		1,846		1,846
Losses on equity securities, net	—		—		(41,898)		(41,898)
Interest and other income	—		—		941		941
Interest expense	(24,399)		(3,058)		(152,655)		(180,112)
Loss on early extinguishment of debt	—		(17)		(27)		(44)
Income (loss) from continuing operations before income tax expense and equity in earnings of an investee	74,240		28,446		(185,528)		(82,842)
Income tax expense	—		—		(436)		(436)
Equity in earnings of an investee	—		—		400		400
Net income (loss)	74,240		28,446		(185,564)		(82,878)
Net income attributable to noncontrolling interest	(5,356)		—		—		(5,356)
Net income (loss) attributable to common shareholders	$	68,884	$	28,446	$	(185,564)	$	(88,234)
	As of December 31, 2019
	Office Portfolio		SHOP		Non-Segment		Consolidated
Total assets	$	3,165,577	$	3,044,989	$	443,260	$	6,653,826

Note 13. Income Taxes

Our provision for income taxes consists of the following:

	For the Year Ended December 31,
	2021		2020		2019
Current:
Federal	$	200	$	—	$	—
State	1,230		1,250		436
	1,430		1,250		436
Deferred:
Federal	—		—		—
State	—		—		—
	—		—		—
Income tax provision	$	1,430	$	1,250	$	436

F-37

A reconciliation of our effective tax rate and the U.S. federal statutory income tax rate is as follows:

	For the Year Ended December 31,
	2021		2020		2019
Taxes at statutory U.S. federal income tax rate	21.0	%	21.0	%	21.0	%
Nontaxable income	(21.0)	%	(21.0)	%	(21.0)	%
Federal excise tax	0.1	%	—	%	—	%
State and local income taxes, net of federal tax benefit	0.8	%	(1.3)	%	0.5	%
Effective tax rate	0.9	%	(1.3)	%	0.5	%

Deferred income tax balances reflect the net tax effects of temporary differences between the carrying amounts of assets and liabilities in our consolidated balance sheets and the amounts used for income tax purposes and are stated at enacted tax rates expected to be in effect when taxes are actually paid or recovered. Significant components of our deferred tax assets and liabilities are as follows:

	For the Year Ended December 31,
	2021		2020
Deferred tax assets:
Deferred income	$	2,132	$	3,252
Fair market value adjustment	1,577		10,856
Other	784		758
Tax loss carryforwards	25,829		28,358
	30,322		43,224
Valuation allowance	(30,322)		(43,224)
	—		—
Net deferred income taxes	$	—	$	—

Because of our TRSs' history of losses, we are not able to conclude that it is more likely than not we will realize the future benefit of our deferred tax assets; thus we have provided a 100% valuation allowance as of December 31, 2021 and 2020. If and when we believe it is more likely than not that we will recover our deferred tax assets, we will reverse the valuation allowance as an income tax benefit in our consolidated statements of comprehensive income (loss). As of December 31, 2021, our consolidated TRSs had net operating loss carry forwards for federal income tax purposes of approximately $103,682, which do not expire. As of December 31, 2021, we, excluding our subsidiaries, had net operating loss carry forwards for federal income tax purposes of approximately $141,160, which do not expire. In the normal course of business, income tax authorities in various income tax jurisdictions conduct routine audits of our income tax returns filed in prior years. Income tax years subsequent to 2016 may be open to examination in some of the income tax jurisdictions in which we operate.

Note 14. Weighted Average Common Shares

The following table provides a reconciliation of the weighted average number of common shares used in the calculation of basic and diluted earnings per share (in thousands):

	Year Ended December 31,
	2021	2020	2019
Weighted average common shares for basic earnings per share	237,967	237,739	237,604
Effect of dilutive securities: restricted share awards	—	—	—
Weighted average common shares for diluted earnings per share (1)	237,967	237,739	237,604

(1) For the years ended December 31, 2021, 2020 and 2019, 60, 223 and 36, respectively, of our unvested common shares were not included in the calculation of diluted earnings per share because to do so would have been antidilutive.

F-38

DIVERSIFIED HEALTHCARE TRUST

SCHEDULE III

REAL ESTATE AND ACCUMULATED DEPRECIATION

DECEMBER 31, 2021

(dollars in thousands)

				Initial Cost to Company					Cost at December 31, 2021
Address	City	State	Encumbrances (1)	Land	Buildings, Improvements & Equipment	Cost Capitalized Subsequent to Acquisition	Impairment	Cost Basis Adjustment (2)	Land	Buildings, Improvements & Equipment	Total (3)	Accumulated Depreciation (4)	Date Acquired	Original Construction Date
2184 Parkway Lake Drive	Birmingham	AL	$—	$580	$5,980	$2,576	$—	$—	$580	$8,556	$9,136	$2,597	8/1/2008	2001
2634 Valleydale Road	Birmingham	AL	—	600	7,574	2,333	—	(83)	1,559	8,865	10,424	2,905	8/1/2008	2000
2021 Dahlke Drive NE	Cullman	AL	—	287	3,415	853	—	(301)	287	3,967	4,254	1,516	11/19/2004	1998
101 Tulip Lane	Dothan	AL	—	3,543	14,619	608	—	—	3,543	15,227	18,770	2,111	12/27/2017	2000
49 Hughes Road	Madison	AL	—	334	3,981	1,225	—	(243)	334	4,963	5,297	1,900	11/19/2004	1998
200 Terrace Lane	Priceville	AL	—	1,300	9,447	843	—	(110)	1,365	10,115	11,480	2,791	2/1/2012	2006
413 Cox Boulevard	Sheffield	AL	—	394	4,684	942	—	(294)	394	5,332	5,726	2,109	11/19/2004	1998
2435 Columbiana Road	Vestavia Hills	AL	—	843	23,472	2,722	—	—	902	26,135	27,037	5,477	7/12/2016	1991
4461 N Crossover Road	Fayetteville	AR	—	733	10,432	293	—	—	733	10,725	11,458	2,037	5/1/2015	2011
4210 S Caraway Road	Jonesboro	AR	—	653	9,515	370	—	—	653	9,885	10,538	1,871	5/1/2015	2008
672 Jones Road	Springdale	AR	—	572	9,364	1,193	—	—	572	10,557	11,129	1,948	5/1/2015	2007
13840 North Desert Harbor Drive	Peoria	AZ	—	2,687	15,843	8,569	—	(2,252)	2,693	22,154	24,847	9,634	1/11/2002	1990
11209 N. Tatum Boulevard	Phoenix	AZ	—	1,380	6,349	4,757	—	(303)	1,573	10,610	12,183	2,945	9/30/2011	1987
2444 West Las Palmaritas Drive	Phoenix	AZ	—	3,820	6,669	2,979	—	—	3,831	9,637	13,468	2,018	12/22/2010	1982
4121 East Cotton Center	Phoenix	AZ	—	5,166	12,724	541	—	—	5,205	13,226	18,431	2,292	1/29/2015	2000
3850 North US Hwy 89 (5)	Prescott	AZ	15,204	2,017	17,513	7,786	—	—	2,017	25,299	27,316	2,723	2/1/2018	1986
6001 East Thomas Road	Scottsdale	AZ	—	941	8,807	5,373	—	(367)	946	13,808	14,754	7,738	9/1/2012	1990
7090 East Mescal Street	Scottsdale	AZ	—	2,315	13,650	12,755	—	(2,094)	2,349	24,277	26,626	9,498	1/11/2002	1984
17225 North Boswell Boulevard	Sun City	AZ	—	1,189	10,569	3,218	—	(517)	1,189	13,270	14,459	7,971	9/1/2012	1990
14001 W. Meeker Boulevard	Sun City West	AZ	—	395	3,307	—	—	(192)	395	3,115	3,510	1,469	2/28/2003	1998
1415 West 3rd Street	Tempe	AZ	—	2,186	13,446	3,721	—	—	4,896	14,457	19,353	2,405	1/29/2015	1981
2500 North Rosemont Boulevard	Tucson	AZ	—	4,429	26,119	8,041	—	(3,141)	4,576	30,872	35,448	14,140	1/11/2002	1989
710 North Euclid	Anaheim	CA	—	2,850	6,964	2,215	(1,350)	(2,405)	2,518	5,756	8,274	449	7/9/2008	1992
5000 Marina Boulevard	Brisbane	CA	—	7,957	13,430	745	—	—	7,957	14,175	22,132	1,547	11/14/2017	2000
5770 Armada Drive (5)	Carlsbad	CA	10,479	3,875	18,543	—	—	—	3,875	18,543	22,418	3,207	1/29/2015	1997
1350 South El Camino Real	Encinitas	CA	—	1,510	18,042	2,372	—	(53)	1,517	20,354	21,871	6,455	3/31/2008	1999
47201 Lakeview Boulevard	Fremont	CA	—	3,200	10,177	36	—	—	3,200	10,213	13,413	2,626	9/30/2011	1990
47211/47215 Lakeview Boulevard	Fremont	CA	—	3,750	12,656	3,732	—	—	3,750	16,388	20,138	3,265	9/30/2011	1985
47900 Bayside Parkway	Fremont	CA	—	4,580	10,370	2,203	—	—	4,580	12,573	17,153	2,901	9/30/2011	1991
577 South Peach Street	Fresno	CA	—	738	2,577	4,175	—	(211)	738	6,541	7,279	2,758	12/28/1990	1963
6075 North Marks Avenue	Fresno	CA	—	880	12,751	938	—	—	889	13,680	14,569	4,546	3/31/2008	1996
8631 West 3rd Street	Los Angeles	CA	—	24,640	88,277	18,122	—	(908)	25,391	104,740	130,131	28,026	11/22/2010	1979
8635 West 3rd Street	Los Angeles	CA	—	24,640	90,352	15,367	—	(764)	25,331	104,264	129,595	28,178	11/22/2010	1979

S-1

DIVERSIFIED HEALTHCARE TRUST

SCHEDULE III

REAL ESTATE AND ACCUMULATED DEPRECIATION

DECEMBER 31, 2021

(dollars in thousands)

				Initial Cost to Company					Cost at December 31, 2021
Address	City	State	Encumbrances (1)	Land	Buildings, Improvements & Equipment	Cost Capitalized Subsequent to Acquisition	Impairment	Cost Basis Adjustment (2)	Land	Buildings, Improvements & Equipment	Total (3)	Accumulated Depreciation (4)	Date Acquired	Original Construction Date
1319 Brookside Avenue	Redlands	CA	—	1,770	9,982	1,361	—	—	1,770	11,343	13,113	3,640	3/31/2008	1999
110 Sterling Court	Roseville	CA	—	1,620	10,262	2,245	—	—	1,620	12,507	14,127	3,905	3/31/2008	1998
16925 & 16916 Hierba Drive	San Diego	CA	—	9,142	53,904	20,060	—	(6,938)	9,180	66,988	76,168	29,785	1/11/2002	1987
3030 Science Park	San Diego	CA	—	2,466	46,473	29,559	—	—	2,466	76,032	78,498	15,054	8/6/2009	1986
3040 Science Park	San Diego	CA	—	1,225	23,077	22,654	—	—	1,225	45,731	46,956	7,593	8/6/2009	1986
3050 Science Park	San Diego	CA	—	1,508	28,753	24,549	—	—	1,508	53,302	54,810	9,303	8/6/2009	1986
2904 Orchard Parkway	San Jose	CA	—	10,788	8,890	2,621	—	—	10,804	11,495	22,299	1,860	1/25/2018	1979
3530 Deer Park Drive	Stockton	CA	—	670	14,419	2,079	—	—	682	16,486	17,168	5,299	3/31/2008	1999
877 East March Lane	Stockton	CA	—	1,176	11,171	6,892	—	(1,885)	1,411	15,943	17,354	6,648	9/30/2003	1988
28515 Westinghouse Place	Valencia	CA	—	$4,669	41,440	20	—	—	4,689	41,440	46,129	7,169	1/29/2015	2008
1866 San Miguel Drive	Walnut Creek	CA	—	$2,010	9,290	5,415	—	(930)	3,417	12,368	15,785	3,178	12/1/2011	1996
1950 South Dayton Street	Aurora	CO	—	$3,062	46,195	3,601	—	—	3,120	49,738	52,858	9,725	5/1/2015	1987
515 Fairview Avenue	Canon City	CO	—	$292	6,228	2,000	(3,512)	(517)	299	4,192	4,491	1,969	9/26/1997	1970
110 West Van Buren Street	Colorado Springs	CO	—	$245	5,236	3,170	(3,031)	(701)	245	4,674	4,919	1,771	9/26/1997	1972
3920 East San Miguel Street	Colorado Springs	CO	—	$1,380	8,894	4,218	—	(34)	1,612	12,846	14,458	3,673	7/31/2012	1977
2050 South Main Street	Delta	CO	—	$167	3,570	1,461	—	(415)	167	4,616	4,783	2,411	9/26/1997	1963
2501 Little Bookcliff Drive	Grand Junction	CO	—	$204	3,875	2,210	—	(908)	207	5,174	5,381	3,029	12/30/1993	1968
2825 Patterson Road	Grand Junction	CO	—	$173	2,583	3,293	—	(786)	173	5,090	5,263	2,732	12/30/1993	1978
1599 Ingalls Street	Lakewood	CO	—	$232	3,766	4,094	—	(860)	232	7,000	7,232	4,294	12/28/1990	1972
5555 South Elati Street	Littleton	CO	—	$185	5,043	4,277	—	(1,068)	191	8,246	8,437	4,899	12/28/1990	1965
8271 South Continental Divide Road	Littleton	CO	—	$400	3,507	—	—	(202)	400	3,305	3,705	1,559	2/28/2003	1998
9005 Grant Street	Thornton	CO	—	$961	10,867	1,179	—	—	1,269	11,738	13,007	2,640	12/28/2012	2001
7809 W. 38th Avenue	Wheat Ridge	CO	—	$470	3,373	88	—	—	475	3,456	3,931	993	4/1/2010	2004
40 Sebethe Drive	Cromwell	CT	—	$570	5,304	1,787	—	(424)	596	6,641	7,237	1,747	12/22/2010	1998
1145 19th Street NW	Washington	DC	—	$13,600	24,880	36,435	—	(597)	13,600	60,718	74,318	12,553	5/20/2009	1976
2141 K Street, NW	Washington	DC	—	$13,700	8,400	5,442	—	(518)	13,700	13,324	27,024	4,420	12/22/2008	1966
255 Possum Park Road	Newark	DE	—	$2,010	11,852	8,039	—	(1,759)	2,761	17,381	20,142	7,010	1/11/2002	1982
4175 Ogletown Stanton Rd	Newark	DE	—	$1,500	19,447	1,639	—	—	1,563	21,023	22,586	7,180	3/31/2008	1998
1212 Foulk Road	Wilmington	DE	—	$1,179	6,950	2,603	—	(1,310)	1,202	8,220	9,422	3,869	1/11/2002	1974
1912 Marsh Road	Wilmington	DE	—	4,365	25,739	7,498	—	(2,293)	4,431	30,878	35,309	13,640	1/11/2002	1988
2723 Shipley Road	Wilmington	DE	—	869	5,126	5,327	—	(1,726)	978	8,618	9,596	3,729	1/11/2002	1989
407 Foulk Road	Wilmington	DE	—	38	227	2,763	—	(433)	84	2,511	2,595	731	1/11/2002	1965
22601 Camino Del Mar	Boca Raton	FL	—	3,200	46,800	7,802	—	(1,816)	3,204	52,782	55,986	13,932	12/15/2011	1990

S-2

DIVERSIFIED HEALTHCARE TRUST

SCHEDULE III

REAL ESTATE AND ACCUMULATED DEPRECIATION

DECEMBER 31, 2021

(dollars in thousands)

				Initial Cost to Company					Cost at December 31, 2021
Address	City	State	Encumbrances (1)	Land	Buildings, Improvements & Equipment	Cost Capitalized Subsequent to Acquisition	Impairment	Cost Basis Adjustment (2)	Land	Buildings, Improvements & Equipment	Total (3)	Accumulated Depreciation (4)	Date Acquired	Original Construction Date
1325 S Congress Avenue	Boynton Beach	FL	—	1,620	5,341	1,717	—	(121)	1,628	6,929	8,557	1,660	7/27/2012	1985
1425 Congress Avenue	Boynton Beach	FL	—	2,390	14,768	3,827	—	(721)	2,390	17,874	20,264	5,041	8/9/2011	1994
1416 Country Club Blvd.	Cape Coral	FL	—	400	2,907	—	—	(173)	400	2,734	3,134	1,290	2/28/2003	1998
8500 Royal Palm Boulevard	Coral Springs	FL	—	3,410	20,104	32,030	—	(3,859)	3,421	48,264	51,685	17,262	1/11/2002	1984
1208 South Military Trail	Deerfield Beach	FL	—	1,690	14,972	32,207	—	(2,251)	1,777	44,841	46,618	17,974	10/1/2012	1986
3001 DC Country Club Boulevard	Deerfield Beach	FL	—	3,196	18,848	22,290	—	(2,813)	3,222	38,299	41,521	14,935	1/11/2002	1990
12780 Kenwood Lane	Fort Myers	FL	—	369	2,174	3,709	—	(444)	859	4,949	5,808	2,054	1/11/2002	1990
2525 First Street	Fort Myers	FL	—	2,385	21,137	23,381	—	(1,322)	2,577	43,004	45,581	20,860	10/1/2012	1984
1825 Ridgewood Avenue	Holly Hill	FL	—	700	16,700	3,261	(2,636)	(4,649)	684	12,692	13,376	1,640	7/22/2011	1926/2006
2480 North Park Road	Hollywood	FL	—	4,500	40,500	19,755	—	(1,637)	4,556	58,562	63,118	15,903	12/15/2011	1986
8901 Tamiami Trail East	Naples	FL	—	3,200	2,898	15,068	—	(837)	3,200	17,129	20,329	5,631	8/31/2006	1984
12780 Waterford Lakes Parkway	Orlando	FL	—	977	3,946	579	—	—	1,052	4,450	5,502	854	12/18/2013	2002
1603 S. Hiawassee Road	Orlando	FL	—	488	2,621	352	—	(81)	488	2,892	3,380	569	12/18/2013	2003
1825 N. Mills Avenue	Orlando	FL	—	519	1,799	415	—	—	580	2,153	2,733	763	12/22/2008	1997
1911 N. Mills Avenue	Orlando	FL	—	1,946	7,197	866	—	(538)	2,042	7,429	9,471	2,386	12/22/2008	1997
1925 N. Mills Avenue	Orlando	FL	—	135	532	252	—	—	199	720	919	292	12/22/2008	1997
250 N. Alafaya Trail	Orlando	FL	—	967	4,362	389	—	—	967	4,751	5,718	979	12/18/2013	1999
45 Katherine Boulevard	Palm Harbor	FL	—	3,379	29,945	9,045	—	(816)	3,392	38,161	41,553	24,079	10/1/2012	1992
900 West Lake Road	Palm Harbor	FL	—	3,449	20,336	11,916	—	(3,160)	3,493	29,048	32,541	12,465	1/11/2002	1989
8500 West Sunrise Boulevard	Plantation	FL	—	4,700	24,300	10,999	—	(2,475)	4,717	32,807	37,524	9,850	12/15/2011	1989
1371 South Ocean Boulevard	Pompano Beach	FL	—	2,500	15,500	15,927	—	(1,564)	2,560	29,803	32,363	8,891	12/15/2011	1991
2701 North Course Drive	Pompano Beach	FL	—	7,700	2,127	41,511	—	(2,332)	7,700	41,306	49,006	14,027	8/31/2006	1985
20480 Veterans Boulevard	Port Charlotte	FL	—	400	11,934	2,107	—	(550)	440	13,451	13,891	4,090	7/22/2011	1996
1699 S.E. Lyngate Drive	Port St. Lucie	FL	—	1,242	11,009	4,799	—	(269)	1,249	15,532	16,781	9,152	10/1/2012	1993
501 N.W. Cashmere Boulevard	Port St. Lucie	FL	—	890	9,345	2,911	—	(135)	1,673	11,338	13,011	3,142	7/22/2011	2007
900 South Harbour Island Blvd.	Tampa	FL	—	4,850	6,349	7	—	—	4,850	6,356	11,206	2,257	10/30/2007	1986
111 Executive Center Drive	West Palm Beach	FL	—	2,061	12,153	20,856	—	(2,982)	2,075	30,013	32,088	10,227	1/11/2002	1988
2351 Cedarcrest Road	Acworth	GA	—	2,000	6,674	618	—	—	2,000	7,292	9,292	1,363	5/1/2016	2014
1200 Bluegrass Lakes Parkway	Alpharetta	GA	—	1,689	15,936	142	—	—	1,761	16,006	17,767	2,762	1/29/2015	2001
855 North Point Pkwy	Alpharetta	GA	—	5,390	26,712	—	—	—	5,390	26,712	32,102	8,931	8/21/2008	2006
253 N. Main Street	Alpharetta	GA	—	1,325	12,377	1,170	—	(64)	1,221	13,587	14,808	2,591	5/1/2015	1997
1291 Cedar Shoals Drive	Athens	GA	—	337	4,006	1,615	—	(290)	368	5,300	5,668	1,918	11/19/2004	1998
1515 Sheridan Road	Atlanta	GA	—	5,800	9,305	3	—	—	5,800	9,308	15,108	3,286	11/30/2007	1978

S-3

DIVERSIFIED HEALTHCARE TRUST

SCHEDULE III

REAL ESTATE AND ACCUMULATED DEPRECIATION

DECEMBER 31, 2021

(dollars in thousands)

				Initial Cost to Company					Cost at December 31, 2021
Address	City	State	Encumbrances (1)	Land	Buildings, Improvements & Equipment	Cost Capitalized Subsequent to Acquisition	Impairment	Cost Basis Adjustment (2)	Land	Buildings, Improvements & Equipment	Total (3)	Accumulated Depreciation (4)	Date Acquired	Original Construction Date
240 Marietta Highway	Canton	GA	—	806	8,555	2,397	—	(55)	806	10,897	11,703	2,510	10/1/2013	1997
4500 South Stadium Drive	Columbus	GA	—	294	3,505	946	—	(225)	298	4,222	4,520	1,550	11/19/2004	1999
1352 Wellbrook Circle	Conyers	GA	—	342	4,068	1,769	(1,366)	(2,032)	206	2,575	2,781	70	11/19/2004	1997
1501 Milstead Road	Conyers	GA	—	750	7,796	712	—	—	777	8,481	9,258	2,498	9/30/2010	2008
3875 Post Road	Cumming	GA	—	954	12,796	248	—	—	960	13,038	13,998	2,638	5/1/2015	2007
4960 Jot Em Down Road	Cumming	GA	—	1,548	18,666	13,033	—	(257)	3,416	29,574	32,990	6,913	8/1/2013	2011
5610 Hampton Park Drive	Cumming	GA	—	3,479	14,771	233	—	—	3,481	15,002	18,483	3,071	9/3/2015	2014
7955 Majors Road	Cumming	GA	—	1,325	7,770	904	—	—	1,325	8,674	9,999	1,645	5/1/2015	2009
2470 Dug Gap Road	Dalton	GA	—	262	3,119	1,285	—	(133)	262	4,271	4,533	1,515	11/19/2004	1997
101 West Ponce De Leon Avenue	Decatur	GA	—	3,500	13,179	2,145	—	—	3,500	15,324	18,824	3,185	5/30/2012	1992
2801 North Decatur Road	Decatur	GA	—	3,100	4,436	2,533	—	—	3,260	6,809	10,069	2,148	7/9/2008	1986
114 Penland Street	Ellijay	GA	—	496	7,107	1,455	—	(157)	496	8,405	8,901	1,765	10/1/2013	2008
353 North Belair Road	Evans	GA	—	230	2,663	1,326	—	(244)	230	3,745	3,975	1,333	11/19/2004	1998
1294 Highway 54 West	Fayetteville	GA	—	853	9,903	1,324	—	—	943	11,137	12,080	2,170	5/1/2015	1999
2435 Limestone Parkway	Gainesville	GA	—	268	3,186	1,621	—	(224)	268	4,583	4,851	1,585	11/19/2004	1998
3315 Thompson Bridge Road	Gainesville	GA	—	934	30,962	1,937	—	—	956	32,877	33,833	6,319	5/1/2015	1999
5373 Thompson Mill Road	Hoschton	GA	—	944	12,171	216	—	—	959	12,372	13,331	2,404	5/1/2015	2011
8080 Summit Business Parkway	Jonesboro	GA	—	1,800	20,664	4,460	—	(456)	1,800	24,668	26,468	7,010	6/20/2011	2007
6191 Peake Road	Macon	GA	—	183	2,179	1,329	(848)	(1,142)	110	1,591	1,701	47	11/19/2004	1998
1360 Upper Hembree Road	Roswell	GA	—	1,080	6,138	752	—	—	1,067	6,903	7,970	1,555	5/7/2012	2007
1 Savannah Square Drive	Savannah	GA	—	1,200	19,090	7,990	(6,993)	(8,926)	835	11,526	12,361	510	10/1/2006	1987
5200 Habersham Street	Savannah	GA	—	800	7,800	2,096	(3,082)	(2,627)	476	4,511	4,987	100	6/23/2011	2005
7410 Skidaway Road	Savannah	GA	—	400	5,670	1,957	(1,870)	(2,626)	252	3,279	3,531	106	11/1/2006	1989
2078 Scenic Highway	Snellville	GA	—	870	4,030	1,517	—	(256)	870	5,291	6,161	1,318	12/10/2009	1997
475 Country Club Drive	Stockbridge	GA	—	512	9,560	1,047	—	—	551	10,568	11,119	2,097	5/1/2015	1998
1300 Montreal Road	Tucker	GA	—	690	6,210	2,142	—	(469)	694	7,879	8,573	2,776	6/3/2005	1997
1100 Ward Avenue	Honolulu	HI	—	$11,200	55,618	7,232	—	(71)	11,247	62,732	73,979	15,341	6/18/2012	1961
2340 West Seltice Way	Coeur d'Alene	ID	—	$910	7,170	3,360	—	—	1,052	10,388	11,440	2,826	7/31/2012	1993
850 Lincoln Drive	Idaho Falls	ID	—	$510	6,640	2,970	—	—	760	9,360	10,120	2,484	7/31/2012	1978
1250 West Central Road	Arlington Heights	IL	—	$3,665	32,587	10,441	—	(385)	3,781	42,527	46,308	26,487	11/1/2012	1986
1450 Busch Parkway	Buffalo Grove	IL	—	$3,800	11,456	929	—	—	3,815	12,370	16,185	3,548	9/16/2010	2009
2601 Patriot Boulevard	Glenview	IL	—	$2,285	9,593	—	—	—	2,285	9,593	11,878	1,659	1/29/2015	2005
1373 D'Adrian Professional Park	Godfrey	IL	—	$281	15,088	731	—	(135)	281	15,684	15,965	3,020	5/1/2015	2010

S-4

DIVERSIFIED HEALTHCARE TRUST

SCHEDULE III

REAL ESTATE AND ACCUMULATED DEPRECIATION

DECEMBER 31, 2021

(dollars in thousands)

				Initial Cost to Company					Cost at December 31, 2021
Address	City	State	Encumbrances (1)	Land	Buildings, Improvements & Equipment	Cost Capitalized Subsequent to Acquisition	Impairment	Cost Basis Adjustment (2)	Land	Buildings, Improvements & Equipment	Total (3)	Accumulated Depreciation (4)	Date Acquired	Original Construction Date
900 43rd Avenue	Moline	IL	—	$482	7,651	573	—	(76)	482	8,148	8,630	1,515	5/1/2015	2003 / 2012
221 11th Avenue	Moline	IL	—	$161	7,244	1,513	—	—	161	8,757	8,918	1,713	5/1/2015	2008
2700 14th Street	Pekin	IL	—	$171	11,475	554	—	(159)	172	11,869	12,041	2,277	5/1/2015	2009
7130 Crimson Ridge Drive	Rockford	IL	—	$200	7,300	2,336	—	—	1,596	8,240	9,836	2,352	5/1/2011	1999
1220 Lakeview Drive	Romeoville	IL	—	$1,120	19,582	(61)	—	—	1,058	19,583	20,641	6,547	8/21/2008	2005
1201 Hartman Lane	Shiloh	IL	—	$743	7,232	2,113	—	—	1,237	8,851	10,088	1,461	12/8/2016	2003
900 Southwind Road	Springfield	IL	—	$300	6,744	2,304	—	(403)	300	8,645	8,945	3,052	8/31/2006	1990
2705 Avenue E	Sterling	IL	—	$341	14,331	638	—	—	343	14,967	15,310	2,951	5/1/2015	2008
39 Dorothy Drive	Troy	IL	—	$1,002	7,010	1,577	—	—	1,002	8,587	9,589	1,416	12/8/2016	2003
100 Grand Victorian Place	Washington	IL	—	$241	12,046	416	—	—	241	12,462	12,703	2,360	5/1/2015	2009
1615 Lakeside Drive	Waukegan	IL	—	$2,700	9,590	3,139	—	(944)	3,478	11,007	14,485	2,967	9/30/2011	1990
1675 Lakeside Drive	Waukegan	IL	—	$2,420	9,382	2,589	—	(957)	2,873	10,561	13,434	2,785	9/30/2011	1998
406 Smith Drive	Auburn	IN	—	$380	8,246	631	—	(253)	524	8,480	9,004	2,766	9/1/2008	1999
6990 East County Road 100 North	Avon	IN	—	$850	11,888	1,082	—	(333)	850	12,637	13,487	4,082	9/1/2008	1999
2455 Tamarack Trail	Bloomington	IN	—	$5,400	25,129	30,110	—	(529)	6,339	53,771	60,110	13,131	11/1/2008	1983
2460 Glebe Street	Carmel	IN	—	$2,108	57,741	1,106	—	—	2,125	58,830	60,955	10,932	5/1/2015	2008
701 East County Line Road	Greenwood	IN	—	$1,830	14,303	1,304	—	(61)	1,875	15,501	17,376	4,094	12/1/2011	2007
8505 Woodfield Crossing Boulevard	Indianapolis	IN	—	2,785	16,396	7,084	—	(2,127)	2,838	21,300	24,138	9,651	1/11/2002	1986
2501 Friendship Boulevard	Kokomo	IN	—	512	13,009	1,081	—	—	512	14,090	14,602	1,725	12/27/2017	1997
603 Saint Joseph Drive	Kokomo	IN	—	220	5,899	1,223	—	(256)	220	6,866	7,086	2,139	9/1/2008	1998
1211 Longwood Drive	La Porte	IN	—	770	5,550	1,478	—	(288)	923	6,587	7,510	2,026	9/1/2008	1998
1590 West Timberview Drive	Marion	IN	—	410	5,409	1,476	—	(267)	410	6,618	7,028	1,915	9/1/2008	2000
1473 East McKay Road	Shelbyville	IN	—	190	5,328	635	—	(236)	190	5,727	5,917	1,801	9/1/2008	1999
17441 State Road 23	South Bend	IN	—	400	3,107	(38)	—	(182)	363	2,924	3,287	1,380	2/28/2003	1998
222 South 25th Street	Terra Haute	IN	—	300	13,115	1,157	—	(492)	300	13,780	14,080	4,445	9/1/2008	2005
150 Fox Ridge Drive	Vincennes	IN	—	110	3,603	1,820	—	(208)	110	5,215	5,325	1,722	9/1/2008	1985
1501 Inverness Drive	Lawrence	KS	—	1,600	18,565	3,457	—	(1,232)	1,758	20,632	22,390	5,995	10/1/2009	1988
5799 Broadmoor Street	Mission	KS	—	1,522	7,246	1,882	—	—	1,530	9,120	10,650	1,470	1/17/2017	1986
3501 West 95th Street	Overland Park	KS	—	2,568	15,140	7,587	—	(2,141)	2,580	20,574	23,154	8,677	1/11/2002	1989
6555 West 75th Street	Overland Park	KS	—	1,274	1,126	15,505	—	(1,102)	1,487	15,316	16,803	6,507	10/25/2002	1985
6700 W. 115th Street	Overland Park	KS	—	4,503	29,387	177	—	—	4,503	29,564	34,067	2,977	1/3/2018	2006
981 Campbell Lane	Bowling Green	KY	—	365	4,345	1,844	—	(203)	365	5,986	6,351	2,119	11/19/2004	1999
102 Leonardwood Drive	Frankfort	KY	—	560	8,282	2,529	—	(605)	579	10,187	10,766	3,702	8/31/2006	1989

S-5

DIVERSIFIED HEALTHCARE TRUST

SCHEDULE III

REAL ESTATE AND ACCUMULATED DEPRECIATION

DECEMBER 31, 2021

(dollars in thousands)

				Initial Cost to Company					Cost at December 31, 2021
Address	City	State	Encumbrances (1)	Land	Buildings, Improvements & Equipment	Cost Capitalized Subsequent to Acquisition	Impairment	Cost Basis Adjustment (2)	Land	Buildings, Improvements & Equipment	Total (3)	Accumulated Depreciation (4)	Date Acquired	Original Construction Date
4190 Lafayette Road	Hopkinsville	KY	—	316	3,761	748	—	(193)	316	4,316	4,632	1,718	11/19/2004	1999
690 Mason Headley Road (6)	Lexington	KY	5,355	—	10,848	13,419	—	(1,389)	42	22,836	22,878	11,738	1/11/2002	1985
700 Mason Headley Road (6)	Lexington	KY	1,281	—	6,394	8,409	—	(951)	52	13,800	13,852	6,465	1/11/2002	1980
200 Brookside Drive	Louisville	KY	—	3,524	20,779	10,672	—	(3,217)	3,549	28,209	31,758	12,173	1/11/2002	1984
1517 West Broadway	Mayfield	KY	—	268	2,730	1,617	—	(221)	268	4,126	4,394	1,567	11/19/2004	1999
1700 Elmdale Road	Paducah	KY	—	450	5,358	1,477	—	(319)	451	6,515	6,966	2,646	11/19/2004	2000
100 Neighborly Way	Somerset	KY	—	200	4,919	701	—	—	200	5,620	5,820	2,068	11/6/2006	2000
1295 Boylston Street	Boston	MA	—	7,600	18,140	3,187	—	—	7,625	21,302	28,927	6,065	1/26/2011	1930
549 Albany Street	Boston	MA	—	4,576	45,029	—	—	—	4,569	45,036	49,605	9,385	8/22/2013	1895
330 Baker Avenue	Concord	MA	—	3,775	19,906	—	—	—	3,775	19,906	23,681	3,442	1/29/2015	2013
4 Maguire Road	Lexington	MA	—	3,600	15,555	19,813	(7,255)	(1,003)	3,884	26,826	30,710	3,016	12/22/2008	1994
100 Hampshire Street	Mansfield	MA	—	2,090	8,215	1,664	—	—	2,486	9,483	11,969	2,665	12/22/2010	1975
15 Hampshire Street	Mansfield	MA	—	1,360	7,326	507	—	—	1,748	7,445	9,193	2,202	12/22/2010	1988
5 Hampshire Street	Mansfield	MA	—	1,190	5,737	1,831	—	(143)	1,465	7,150	8,615	2,019	12/22/2010	1988
30 New Crossing Road	Reading	MA	—	1,443	14,153	285	—	—	1,455	14,426	15,881	3,338	9/27/2012	1986
299 Cambridge Street	Winchester	MA	—	3,218	18,988	12,424	—	(1,855)	3,218	29,557	32,775	12,726	1/11/2002	1991
2717 Riva Road	Annapolis	MD	—	1,290	12,373	1,370	—	—	1,290	13,743	15,033	4,594	3/31/2008	2001
658 Boulton Street	Bel Air	MD	—	4,750	16,504	2	—	—	4,750	16,506	21,256	5,827	11/30/2007	1980
7600 Laurel Bowie Road	Bowie	MD	—	408	3,421	1,488	—	(393)	408	4,516	4,924	1,841	10/25/2002	2000
8100 Connecticut Avenue	Chevy Chase	MD	—	15,170	92,830	12,492	—	(1,924)	15,177	103,391	118,568	26,915	12/15/2011	1990
8220 Snowden River Parkway	Columbia	MD	—	1,390	10,303	934	—	—	1,390	11,237	12,627	3,811	3/31/2008	2001
700 Port Street	Easton	MD	—	383	4,555	4,042	—	(473)	394	8,113	8,507	3,169	10/25/2002	2000
3004 North Ridge Road	Ellicott City	MD	—	1,409	22,691	11,847	—	(2,505)	1,613	31,829	33,442	12,430	3/1/2004	1997
1820 Latham Drive	Frederick	MD	—	385	3,444	1,319	—	(444)	385	4,319	4,704	1,818	10/25/2002	1998
2100 Whittier Drive	Frederick	MD	—	1,260	9,464	2,444	—	—	1,260	11,908	13,168	3,871	3/31/2008	1999
10116 Sharpsburg Pike	Hagerstown	MD	—	1,040	7,471	5,273	—	—	1,044	12,740	13,784	4,317	3/31/2008	1999
4000 Old Court Road	Pikesville	MD	—	2,000	4,974	914	—	(82)	2,000	5,806	7,806	1,947	12/22/2008	1987
12725 Twinbrook Parkway	Rockville	MD	—	6,138	6,526	683	—	(148)	6,218	6,981	13,199	1,108	7/12/2017	1968
715 Benfield Road	Severna Park	MD	—	229	9,798	2,502	—	(1,103)	246	11,180	11,426	5,112	10/25/2002	1998
14400 Homecrest Road	Silver Spring	MD	—	1,200	9,288	8,287	—	(1,509)	1,207	16,059	17,266	6,477	10/25/2002	1996
801 Roeder Road	Silver Spring	MD	—	1,900	12,858	1,956	—	(326)	1,900	14,488	16,388	3,560	6/27/2012	1976
720 & 734 N. Pine Road	Hampton	MI	—	300	2,406	—	—	(142)	300	2,264	2,564	1,068	2/28/2003	1998
4004 & 4012 Waldo Road	Midland	MI	—	400	2,606	—	—	(162)	400	2,444	2,844	1,153	2/28/2003	1998

S-6

DIVERSIFIED HEALTHCARE TRUST

SCHEDULE III

REAL ESTATE AND ACCUMULATED DEPRECIATION

DECEMBER 31, 2021

(dollars in thousands)

				Initial Cost to Company					Cost at December 31, 2021
Address	City	State	Encumbrances (1)	Land	Buildings, Improvements & Equipment	Cost Capitalized Subsequent to Acquisition	Impairment	Cost Basis Adjustment (2)	Land	Buildings, Improvements & Equipment	Total (3)	Accumulated Depreciation (4)	Date Acquired	Original Construction Date
1605 & 1615 Fredericks Drive	Monroe	MI	—	300	2,506	—	—	(152)	300	2,354	2,654	1,110	2/28/2003	1998
3150 & 3100 Old Centre Road	Portage	MI	—	300	2,206	—	—	(133)	300	2,073	2,373	978	2/28/2003	1998
2445 & 2485 Mc Carty Road	Saginaw	MI	—	600	5,212	—	—	(305)	600	4,907	5,507	2,315	2/28/2003	1998
11855 Ulysses Street NE	Blaine	MN	—	2,774	9,276	389	—	—	2,781	9,658	12,439	2,300	12/21/2012	2007
1305 Corporate Center Drive	Eagan	MN	—	2,300	13,105	10,691	—	—	2,735	23,361	26,096	5,042	12/22/2010	1986
8301 Golden Valley Road	Golden Valley	MN	—	1,256	4,680	579	—	—	1,256	5,259	6,515	803	2/10/2016	1998
8401 Golden Valley Road	Golden Valley	MN	—	1,510	5,742	2,297	—	—	1,510	8,039	9,549	1,362	2/10/2016	1998
8501 Golden Valley Road	Golden Valley	MN	—	1,263	4,288	1,013	—	—	1,263	5,301	6,564	840	2/10/2016	1998
1201 Northland Drive	Mendota Heights	MN	—	1,220	10,208	1,257	—	—	1,468	11,217	12,685	3,516	1/25/2011	1989
12700 Whitewater Drive	Minnetonka	MN	—	5,453	8,108	8,415	—	—	5,453	16,523	21,976	2,808	10/2/2017	1998
20600 South Diamond Lake Road	Rogers	MN	—	2,760	45,789	2,809	(20,359)	(15,686)	1,195	14,118	15,313	1,663	3/1/2008	1999
2200 County Road C West	Roseville	MN	—	590	702	640	—	(82)	792	1,058	1,850	306	9/30/2011	1991
4166 Lexington Avenue N	Shoreview	MN	—	1,300	4,547	1,285	—	—	1,507	5,625	7,132	1,398	5/20/2011	1988
1365 Crestridge Lane	West St. Paul	MN	—	400	2,506	—	—	(292)	400	2,214	2,614	1,044	2/28/2003	1998
305 & 315 Thompson Avenue	West St. Paul	MN	—	400	3,608	99	—	(402)	400	3,305	3,705	1,559	2/28/2003	1998
5351 Gretna Road	Branson	MO	—	743	10,973	1,015	—	(227)	754	11,750	12,504	2,212	5/1/2015	2002
845 N New Ballas Court	Creve Coeur	MO	—	1,582	16,328	1,230	—	—	1,582	17,558	19,140	1,780	1/22/2018	2006
3828 College View Drive	Joplin	MO	—	260	11,382	820	—	(14)	260	12,188	12,448	3,271	8/31/2012	2003
14100 Magellan Plaza	Maryland Heights	MO	—	3,719	37,304	4,836	—	—	3,179	42,680	45,859	9,271	1/29/2015	2003
640 E Highland Avenue	Nevada	MO	—	311	5,703	509	—	—	311	6,212	6,523	1,172	5/1/2015	1997
2410 W Chesterfield Blvd	Springfield	MO	—	924	12,772	608	—	—	924	13,380	14,304	2,452	5/1/2015	1999
3540 East Cherokee Street	Springfield	MO	—	1,084	11,339	1,160	—	—	1,129	12,454	13,583	2,353	5/1/2015	1996
4700 North Hanley Road	St. Louis	MO	—	5,166	41,587	131	—	—	5,166	41,718	46,884	7,268	1/29/2015	2014
118 Alamance Road	Burlington	NC	—	575	9,697	1,359	—	(190)	575	10,866	11,441	3,048	6/20/2011	1998
1050 Crescent Green Drive	Cary	NC	—	713	4,628	3,066	—	(922)	713	6,772	7,485	2,991	10/25/2002	1999
2220 & 2230 Farmington Drive	Chapel Hill	NC	—	800	6,414	—	—	(375)	800	6,039	6,839	2,849	2/28/2003	1996
2101 Runnymede Lane	Charlotte	NC	—	2,475	11,451	1,318	—	(301)	2,458	12,485	14,943	3,823	6/20/2011	1999
5920 McChesney Drive & 6101 Clarke Creek Parkway	Charlotte	NC	—	1,320	21,750	2,350	—	(1,175)	1,320	22,925	24,245	6,847	11/17/2009	1999 / 2001
500 Penny Lane NE	Concord	NC	—	1,687	17,603	783	—	—	1,687	18,386	20,073	3,226	6/29/2016	1997
1002 Highway 54	Durham	NC	—	595	5,200	554	—	(114)	595	5,640	6,235	1,504	6/20/2011	1988
4505 Emperor Boulevard	Durham	NC	—	1,285	16,932	687	—	—	1,285	17,619	18,904	1,990	10/11/2017	2001
5213 South Alston Avenue	Durham	NC	—	1,093	31,377	393	—	—	1,093	31,770	32,863	5,452	1/29/2015	2010
2755 Union Road	Gastonia	NC	—	1,104	17,834	1,058	—	(1,133)	1,104	17,759	18,863	2,551	6/29/2016	1998

S-7

DIVERSIFIED HEALTHCARE TRUST

SCHEDULE III

REAL ESTATE AND ACCUMULATED DEPRECIATION

DECEMBER 31, 2021

(dollars in thousands)

				Initial Cost to Company					Cost at December 31, 2021
Address	City	State	Encumbrances (1)	Land	Buildings, Improvements & Equipment	Cost Capitalized Subsequent to Acquisition	Impairment	Cost Basis Adjustment (2)	Land	Buildings, Improvements & Equipment	Total (3)	Accumulated Depreciation (4)	Date Acquired	Original Construction Date
1001 Phifer Road	Kings Mountain	NC	—	655	8,283	1,179	—	(308)	657	9,152	9,809	2,496	6/23/2011	1998
128 Brawley School Road	Mooresville	NC	—	595	7,305	1,379	—	(369)	601	8,309	8,910	2,219	6/23/2011	1999
1309 , 1321, & 1325 McCarthy Boulevard	New Bern	NC	—	1,245	20,898	2,886	—	(159)	1,245	23,625	24,870	6,091	6/20/2011	2001/2005/2008
13150 & 13180 Dorman Road	Pineville	NC	—	1,180	22,800	3,030	—	(1,234)	1,180	24,596	25,776	7,187	11/17/2009	1998
801 Dixie Trail	Raleigh	NC	—	3,233	17,788	1,166	—	(1,114)	3,236	17,837	21,073	2,492	6/29/2016	1992
2744 South 17th Street	Wilmington	NC	—	1,134	14,771	1,881	—	—	1,139	16,647	17,786	3,554	4/18/2016	1998
1730 Parkwood Boulevard West	Wilson	NC	—	610	14,787	1,296	—	(163)	610	15,920	16,530	4,278	6/20/2011	2004/2006
17007 Elm Plaza	Omaha	NE	—	4,680	22,022	—	—	—	4,680	22,022	26,702	7,363	8/21/2008	2007
3030 South 80th Street	Omaha	NE	—	650	5,850	2,224	—	(419)	650	7,655	8,305	2,729	6/3/2005	1992
490 Cooper Landing Road	Cherry Hill	NJ	—	1,001	8,175	3,307	(6,080)	(4,163)	2,240	—	2,240	—	12/29/2003	1999
1400 Route 70	Lakewood	NJ	—	4,885	28,803	8,222	—	(2,881)	4,905	34,124	39,029	14,951	1/11/2002	1987
2 Hillside Drive	Mt. Arlington	NJ	—	1,375	11,232	1,529	—	(399)	1,393	12,344	13,737	5,366	12/29/2003	2001
655 Pomander Walk	Teaneck	NJ	—	4,950	44,550	5,842	—	(1,884)	4,984	48,474	53,458	13,437	12/15/2011	1989
10500 Academy Road NE	Albuquerque	NM	—	3,828	22,572	9,313	—	(2,228)	3,828	29,657	33,485	12,968	1/11/2002	1986
4100 Prospect Avenue NE	Albuquerque	NM	—	540	10,105	8	—	—	540	10,113	10,653	3,591	10/30/2007	1977
4300 Landau Street NE	Albuquerque	NM	—	1,060	9,875	8	—	—	1,060	9,883	10,943	3,510	10/30/2007	1973
4411 The 25 Way	Albuquerque	NM	—	3,480	25,245	4,677	—	(1,061)	3,978	28,363	32,341	8,449	12/22/2010	1970
4420 The 25 Way	Albuquerque	NM	—	1,430	2,609	1,018	—	(152)	1,614	3,291	4,905	863	12/22/2010	1970
9190 Coors Boulevard NW	Albuquerque	NM	—	1,660	9,173	8	—	—	1,660	9,181	10,841	3,260	10/30/2007	1983
2200 East Long Street	Carson City	NV	—	622	17,900	752	—	—	622	18,652	19,274	3,645	5/1/2015	2009
3201 Plumas Street	Reno	NV	—	2,420	49,580	7,657	—	(1,004)	2,420	56,233	58,653	14,353	12/15/2011	1989
6300 Eighth Avenue	Brooklyn	NY	—	3,870	8,545	460	—	—	3,870	9,005	12,875	2,877	8/8/2008	1971
4939 Brittonfield Parkway	East Syracuse	NY	—	720	17,084	1,721	(2,826)	(5,312)	900	10,487	11,387	725	9/30/2008	2001
5008 Brittonfield Parkway	East Syracuse	NY	—	420	18,407	1,670	(3,144)	(5,393)	586	11,374	11,960	700	7/9/2008	1999
200 Old County Road	Mineola	NY	—	4,920	24,056	15,557	—	(153)	4,920	39,460	44,380	10,007	9/30/2011	1971
15 North Broadway	White Plains	NY	—	4,900	13,594	5,056	—	—	4,900	18,650	23,550	5,000	1/26/2009	1952
537 Riverdale Avenue	Yonkers	NY	—	8,460	90,561	12,905	—	(392)	8,465	103,069	111,534	27,467	8/31/2012	2000
4590 Knightsbridge Boulevard	Columbus	OH	—	3,623	27,778	17,430	—	(3,682)	3,732	41,417	45,149	17,487	1/11/2002	1989
3929 Hoover Road	Grove City	OH	—	332	3,081	1,015	—	—	332	4,096	4,428	2,561	6/4/1993	1965
7555 Innovation Way	Mason	OH	—	1,025	12,883	—	—	—	1,025	12,883	13,908	1,691	10/6/2016	2015
8709 S.E. Causey Avenue	Portland	OR	—	3,303	77,428	1,738	(26,073)	(9,749)	2,201	44,446	46,647	2,998	5/1/2015	1985 / 1991
71 Darlington Road	Beaver Falls	PA	—	1,500	13,500	1,041	—	(879)	1,523	13,639	15,162	5,391	10/31/2005	1997
950 Morgan Highway	Clarks Summit	PA	—	1,001	8,233	1,192	—	(277)	1,017	9,132	10,149	3,850	12/29/2003	2001

S-8

DIVERSIFIED HEALTHCARE TRUST

SCHEDULE III

REAL ESTATE AND ACCUMULATED DEPRECIATION

DECEMBER 31, 2021

(dollars in thousands)

				Initial Cost to Company					Cost at December 31, 2021
Address	City	State	Encumbrances (1)	Land	Buildings, Improvements & Equipment	Cost Capitalized Subsequent to Acquisition	Impairment	Cost Basis Adjustment (2)	Land	Buildings, Improvements & Equipment	Total (3)	Accumulated Depreciation (4)	Date Acquired	Original Construction Date
145 Broadlawn Drive	Elizabeth	PA	—	696	6,304	672	(4,280)	(3,017)	375	—	375	—	10/31/2005	1986
600 N. Pottstown Pike	Exton	PA	—	1,001	8,233	2,368	—	(308)	1,001	10,293	11,294	4,199	12/29/2003	2000
242 Baltimore Pike	Glen Mills	PA	—	1,001	8,233	1,046	—	(382)	1,001	8,897	9,898	3,844	12/29/2003	2001
20 Capital Drive	Harrisburg	PA	—	397	9,333	10	—	—	397	9,343	9,740	1,614	1/29/2015	2013
210 Mall Boulevard	King of Prussia	PA	—	1,540	4,743	2,698	—	—	1,934	7,047	8,981	2,255	8/8/2008	1970
216 Mall Boulevard	King of Prussia	PA	—	880	2,871	2,378	—	—	978	5,151	6,129	1,241	1/26/2011	1970
5300 Old William Penn Highway	Murrysville	PA	—	300	2,506	—	—	(272)	300	2,234	2,534	1,054	2/28/2003	1998
800 Manor Drive	New Britain (Chalfont)	PA	—	979	8,052	1,713	—	(440)	981	9,323	10,304	3,902	12/29/2003	1998
7151 Saltsburg Road	Penn Hills	PA	—	200	904	—	—	(103)	200	801	1,001	378	2/28/2003	1997
5750 Centre Avenue	Pittsburgh	PA	—	3,000	11,828	4,477	—	(259)	3,788	15,258	19,046	5,189	6/11/2008	1991
730 Holiday Drive	Pittsburgh	PA	—	2,480	6,395	5,835	—	(936)	2,711	11,063	13,774	2,971	12/22/2010	1985
1400 Riggs Road	South Park	PA	—	898	8,102	1,361	(5,192)	(3,499)	1,670	—	1,670	—	10/31/2005	1995
700 Northampton Street	Tiffany Court (Kingston)	PA	—	—	5,682	2,246	—	(359)	—	7,569	7,569	3,036	12/29/2003	1997
5250 Meadowgreen Drive	Whitehall	PA	—	1,599	14,401	4,007	—	(1,106)	1,599	17,302	18,901	6,365	10/31/2005	1987
1304 McLees Road	Anderson	SC	—	295	3,509	1,224	—	(253)	295	4,480	4,775	1,572	11/19/2004	1999
109 Old Salem Road	Beaufort	SC	—	188	2,234	1,625	(807)	(1,514)	104	1,622	1,726	96	11/19/2004	1999
1119 Pick Pocket Plantation Drive	Beaufort	SC	—	1,200	10,810	1,531	(3,927)	(3,270)	733	5,611	6,344	30	6/20/2011	2005
719 Kershaw Highway	Camden	SC	—	322	3,697	1,777	—	(376)	322	5,098	5,420	1,972	11/19/2004	1999
2333 Ashley River Road	Charleston	SC	—	848	14,000	2,849	(7,118)	(4,415)	377	5,787	6,164	565	6/20/2011	1999
320 Seven Farms Drive	Charleston	SC	—	1,092	6,605	1,760	—	(274)	1,092	8,091	9,183	2,008	5/29/2012	1998
251 Springtree Drive	Columbia	SC	—	300	1,905	—	—	(112)	300	1,793	2,093	846	2/28/2003	1998
3 Summit Terrace	Columbia	SC	—	610	7,900	887	(6,314)	(2,698)	385	—	385	—	11/17/2009	2002
7909 Parklane Road	Columbia	SC	—	1,580	4,520	2,323	—	(314)	1,725	6,384	8,109	1,423	9/30/2011	1990
355 Berkmans Lane	Greenville	SC	—	700	7,240	1,725	(2,593)	(2,387)	417	4,268	4,685	131	11/17/2009	2002
116 Enterprise Court	Greenwood	SC	—	310	2,790	1,283	—	(213)	310	3,860	4,170	1,324	6/3/2005	1999
1901 West Carolina Avenue	Hartsville	SC	—	401	4,775	1,068	—	(302)	401	5,541	5,942	2,237	11/19/2004	1999
218 Old Chapin Road	Lexington	SC	—	363	4,322	979	—	(400)	363	4,901	5,264	2,004	11/19/2004	1999
491 Highway 17	Little River	SC	—	750	9,018	1,349	—	(314)	750	10,053	10,803	2,821	6/23/2011	2000
1010 Anna Knapp Boulevard	Mt. Pleasant	SC	—	1,797	6,132	624	—	(458)	1,797	6,298	8,095	842	6/29/2016	1997
601 Mathis Ferry Road	Mt. Pleasant	SC	—	1,687	12,612	706	(10,794)	(2,021)	2,190	—	2,190	—	6/29/2016	1999
937 Bowman Road	Mt. Pleasant	SC	—	3,898	31,613	7,988	—	(997)	3,830	38,672	42,502	10,603	7/1/2012	1997 / 1983
9547 Highway 17 North	Myrtle Beach	SC	—	543	3,202	9,360	(3,192)	(4,437)	333	5,143	5,476	218	1/11/2002	1980
2306 Riverbank Drive	Orangeburg	SC	—	303	3,607	1,043	—	(358)	303	4,292	4,595	1,748	11/19/2004	1999

S-9

DIVERSIFIED HEALTHCARE TRUST

SCHEDULE III

REAL ESTATE AND ACCUMULATED DEPRECIATION

DECEMBER 31, 2021

(dollars in thousands)

				Initial Cost to Company					Cost at December 31, 2021
Address	City	State	Encumbrances (1)	Land	Buildings, Improvements & Equipment	Cost Capitalized Subsequent to Acquisition	Impairment	Cost Basis Adjustment (2)	Land	Buildings, Improvements & Equipment	Total (3)	Accumulated Depreciation (4)	Date Acquired	Original Construction Date
1920 Ebenezer Road	Rock Hill	SC	—	300	1,705	—	—	(162)	300	1,543	1,843	728	2/28/2003	1998
15855 Wells Highway	Seneca	SC	—	396	4,714	1,416	—	(353)	396	5,777	6,173	2,198	11/19/2004	2000
One Southern Court	West Columbia	SC	—	520	3,831	612	—	—	557	4,406	4,963	1,545	12/22/2010	2000
6716 Nolensville Road	Brentwood	TN	—	1,528	6,037	223	—	—	1,528	6,260	7,788	1,468	11/30/2012	2010
207 Uffelman Drive	Clarksville	TN	—	320	2,994	2,133	—	(161)	320	4,966	5,286	1,425	12/31/2006	1997
51 Patel Way	Clarksville	TN	—	800	10,322	6,990	—	(318)	833	16,961	17,794	3,840	12/19/2012	2005
2900 Westside Drive NW	Cleveland	TN	—	305	3,627	1,544	—	(284)	305	4,887	5,192	1,830	11/19/2004	1998
1010 East Spring Street	Cookeville	TN	—	322	3,828	1,777	—	(230)	322	5,375	5,697	1,968	11/19/2004	1998
105 Sunrise Circle	Franklin	TN	—	322	3,833	1,312	—	(268)	329	4,870	5,199	1,877	11/19/2004	1997
1085 Hartsville Pike	Gallatin	TN	—	280	3,327	1,840	—	(212)	280	4,955	5,235	1,589	11/19/2004	1998
2025 Caldwell Drive	Goodlettsville	TN	—	400	3,507	8,547	—	(202)	400	11,852	12,252	3,324	2/28/2003	1998
1200 North Parkway	Jackson	TN	—	295	3,506	968	—	(300)	299	4,170	4,469	1,567	11/19/2004	1999
550 Deer View Way	Jefferson City	TN	—	940	8,057	2,297	—	(94)	948	10,252	11,200	2,166	10/15/2013	2001
10914 Kingston Pike (5)	Knoxville	TN	9,817	613	12,410	370	—	—	613	12,780	13,393	1,630	6/29/2018	2008
3020 Heatherton Way	Knoxville	TN	—	304	3,618	3,199	(2,697)	(2,357)	1,440	627	2,067	29	11/19/2004	1998
3030 Holbrook Drive (5)	Knoxville	TN	5,639	352	7,128	852	—	—	360	7,972	8,332	996	6/29/2018	1999
100 Chatuga Drive West	Loudon	TN	—	580	16,093	31,831	—	—	580	47,924	48,504	3,015	1/19/2018	2003
511 Pearson Springs Road	Maryville	TN	—	300	3,207	100	—	(192)	300	3,115	3,415	1,469	2/28/2003	1998
1710 Magnolia Boulevard	Nashville	TN	—	750	6,750	17,521	—	(1,023)	750	23,248	23,998	4,413	6/3/2005	1979
350 Volunteer Drive	Paris	TN	—	110	12,100	720	—	(905)	110	11,915	12,025	1,676	6/29/2016	1997
971 State Hwy 121	Allen	TX	—	2,590	17,912	—	—	—	2,590	17,912	20,502	5,989	8/21/2008	2006
1111 W. 34th Street	Austin	TX	—	400	21,021	2,108	—	—	694	22,835	23,529	7,664	6/25/2008	1975
6818 Austin Center Boulevard	Austin	TX	—	1,540	27,467	2,977	—	(558)	1,585	29,841	31,426	9,757	10/31/2008	1994
7600 N Capital Texas Highway	Austin	TX	—	300	4,557	1,608	—	—	300	6,165	6,465	1,460	12/22/2010	1996
4620 Bellaire Boulevard	Bellaire	TX	—	1,238	11,010	4,948	—	(243)	1,325	15,628	16,953	9,547	10/1/2012	1991
120 Crosspoint Drive	Boerne	TX	—	220	4,926	960	—	—	227	5,879	6,106	1,864	2/7/2008	1990
4015 Interstate 45	Conroe	TX	—	620	14,074	1,270	—	(373)	620	14,971	15,591	4,115	10/26/2010	2009
5455 La Sierra Drive	Dallas	TX	—	2,300	25,200	8,177	—	(902)	2,324	32,451	34,775	8,645	12/15/2011	1989
7831 Park Lane	Dallas	TX	—	4,709	27,768	23,525	—	(2,998)	5,432	47,572	53,004	18,453	1/11/2002	1990
1575 Belvidere Street	El Paso	TX	—	2,301	13,567	7,482	—	(1,537)	2,316	19,497	21,813	7,713	1/11/2002	1987
96 Frederick Road	Fredericksburg	TX	—	280	4,866	6,770	—	—	280	11,636	11,916	2,871	2/7/2008	1999
6435 S.F.M. 549	Heath	TX	—	1,135	7,892	998	(288)	(1,493)	1,192	7,052	8,244	426	12/31/2012	2004
13215 Dotson Road	Houston	TX	—	990	13,887	1,458	—	—	990	15,345	16,335	3,994	7/17/2012	2007

S-10

DIVERSIFIED HEALTHCARE TRUST

SCHEDULE III

REAL ESTATE AND ACCUMULATED DEPRECIATION

DECEMBER 31, 2021

(dollars in thousands)

				Initial Cost to Company					Cost at December 31, 2021
Address	City	State	Encumbrances (1)	Land	Buildings, Improvements & Equipment	Cost Capitalized Subsequent to Acquisition	Impairment	Cost Basis Adjustment (2)	Land	Buildings, Improvements & Equipment	Total (3)	Accumulated Depreciation (4)	Date Acquired	Original Construction Date
777 North Post Oak Road	Houston	TX	—	5,537	32,647	27,154	—	(4,460)	5,540	55,338	60,878	21,503	1/11/2002	1989
10030 North MacArthur Boulevard	Irving	TX	—	2,186	15,869	755	—	—	2,186	16,624	18,810	2,848	1/29/2015	1999
4770 Regent Boulevard	Irving	TX	—	2,830	15,082	4,467	—	—	2,830	19,549	22,379	6,835	6/25/2008	1995
9812 Slide Road	Lubbock	TX	—	1,110	9,798	665	—	—	1,110	10,463	11,573	2,882	6/4/2010	2009
605 Gateway Central	Marble Falls	TX	—	1,440	7,125	1,380	—	(34)	1,440	8,471	9,911	2,332	12/19/2012	1994 / 2002
7150 N. President George Bush Turnpike	North Garland	TX	—	1,981	8,548	1,147	(346)	(1,557)	1,941	7,832	9,773	485	12/31/2012	2006
500 Coit Road	Plano	TX	—	3,463	44,841	67	—	—	3,468	44,903	48,371	2,436	12/20/2019	2016
2265 North Lakeshore Drive	Rockwall	TX	—	497	3,582	—	—	—	497	3,582	4,079	619	1/29/2015	2013
18302 Talavera Ridge	San Antonio	TX	—	6,855	30,630	—	—	—	6,855	30,630	37,485	5,297	1/29/2015	2008
21 Spurs Lane (5)	San Antonio	TX	11,120	3,141	23,142	2,199	—	—	3,192	25,290	28,482	4,957	4/10/2014	2006
311 West Nottingham Place	San Antonio	TX	—	4,283	25,256	13,831	—	(3,063)	4,359	35,948	40,307	15,661	1/11/2002	1989
511 & 575 Knights Cross Drive	San Antonio	TX	—	2,300	20,400	2,307	—	(1,150)	2,306	21,551	23,857	6,484	11/17/2009	2003
5055 West Panther Creek Drive	Woodlands	TX	—	3,694	21,782	7,488	—	(3,490)	3,706	25,768	29,474	11,746	1/11/2002	1988
491 Crestwood Drive	Charlottesville	VA	—	641	7,633	2,711	—	(585)	646	9,754	10,400	3,844	11/19/2004	1998
1005 Elysian Place	Chesapeake	VA	—	2,370	23,705	2,291	—	(153)	2,381	25,832	28,213	7,035	6/20/2011	2006
2856 Forehand Drive	Chesapeake	VA	—	160	1,498	2,398	(1,427)	(1,159)	1,470	—	1,470	—	5/30/2003	1987
4027 Martinsburg Pike	Clear Brook	VA	—	3,775	21,768	—	—	—	3,775	21,768	25,543	3,764	1/29/2015	2013
4001 Fair Ridge Drive	Fairfax	VA	—	2,500	7,147	3,129	—	(222)	2,646	9,908	12,554	3,099	12/22/2008	1990
20 HeartFields Lane	Fredericksburg	VA	—	287	8,480	1,864	—	(781)	287	9,563	9,850	4,493	10/25/2002	1998
2800 Polo Parkway	Midlothian	VA	—	1,103	13,126	4,986	—	(920)	1,108	17,187	18,295	6,502	11/19/2004	1996
655 Denbigh Boulevard	Newport News	VA	—	581	6,921	2,170	—	(438)	584	8,650	9,234	3,373	11/19/2004	1998
6160 Kempsville Circle	Norfolk	VA	—	3,263	7,615	4,016	—	(115)	3,372	11,407	14,779	1,458	12/22/2017	1987
6161 Kempsville Road	Norfolk	VA	—	1,530	9,531	2,984	—	(323)	1,530	12,192	13,722	3,628	12/22/2008	1999
6311 Granby Street	Norfolk	VA	—	1,920	16,538	3,078	—	(188)	1,932	19,416	21,348	5,116	6/20/2011	2005
885 Kempsville Road	Norfolk	VA	—	1,780	8,354	2,823	—	(865)	1,798	10,294	12,092	3,070	5/20/2009	1981
531 Wythe Creek Road	Poquoson	VA	—	220	2,041	1,031	—	(275)	220	2,797	3,017	1,132	5/30/2003	1987
10800 Nuckols Road (5)	Glen Allen	VA	10,240	2,863	11,105	698	—	—	2,863	11,803	14,666	1,278	3/28/2018	2000
3000 Skipwith Road	Richmond	VA	—	732	8,717	1,434	—	(519)	732	9,632	10,364	3,951	11/19/2004	1999
9900 Independence Park Drive	Richmond	VA	—	326	3,166	272	—	(92)	326	3,346	3,672	882	11/22/2011	2005
9930 Independence Park Drive	Richmond	VA	—	604	4,975	1,160	—	—	700	6,039	6,739	1,340	11/22/2011	2005
5620 Wesleyan Drive	Virginia Beach	VA	—	893	7,926	2,685	—	(124)	893	10,487	11,380	6,309	9/1/2012	1990
4132 Longhill Road	Williamsburg	VA	—	270	2,468	1,392	(945)	(1,583)	162	1,440	1,602	53	5/30/2003	1987
440 McLaws Circle	Williamsburg	VA	—	1,466	17,340	713	—	(1,040)	1,466	17,013	18,479	2,339	6/29/2016	1998

S-11

DIVERSIFIED HEALTHCARE TRUST

SCHEDULE III

REAL ESTATE AND ACCUMULATED DEPRECIATION

DECEMBER 31, 2021

(dollars in thousands)

				Initial Cost to Company					Cost at December 31, 2021
Address	City	State	Encumbrances (1)	Land	Buildings, Improvements & Equipment	Cost Capitalized Subsequent to Acquisition	Impairment	Cost Basis Adjustment (2)	Land	Buildings, Improvements & Equipment	Total (3)	Accumulated Depreciation (4)	Date Acquired	Original Construction Date
21717 30th Drive SE	Bothell	WA	—	3,012	12,582	69	—	—	3,081	12,582	15,663	2,807	2/14/2013	1998
21823 30th Drive SE	Bothell	WA	—	2,627	12,657	55	—	—	2,682	12,657	15,339	2,823	2/14/2013	2000
516 Kenosia Avenue South	Kent	WA	—	1,300	8,458	3,728	—	—	1,368	12,118	13,486	3,228	7/31/2012	1971
555 16th Avenue	Seattle	WA	—	256	4,869	68	—	(513)	256	4,424	4,680	3,111	11/1/1993	1964
3003 West Good Hope Road	Glendale	WI	—	1,500	33,747	—	—	—	1,500	33,747	35,247	10,335	9/30/2009	1963
7007 North Range Line Road	Glendale	WI	—	250	3,797	—	—	—	250	3,797	4,047	1,163	9/30/2009	1964
215 Washington Street	Grafton	WI	—	500	10,058	—	—	—	500	10,058	10,558	3,080	9/30/2009	2009
N168W22022 Main Street	Jackson	WI	—	188	5,962	912	—	(101)	192	6,769	6,961	1,352	12/1/2014	2005
8351 Sheridan Road	Kenosha	WI	—	750	7,669	386	—	—	758	8,047	8,805	2,817	1/1/2008	2000
5601 Burke Road	Madison	WI	—	700	7,461	922	—	—	712	8,371	9,083	2,767	1/1/2008	2000
7707 N. Brookline Drive	Madison	WI	—	2,615	35,545	3,584	—	(51)	2,631	39,062	41,693	7,676	12/1/2014	1999 / 2004
10803 North Port Washington Road	Mequon	WI	—	800	8,388	900	—	(25)	805	9,258	10,063	3,232	1/1/2008	1999
701 East Puetz Road	Oak Creek	WI	—	650	18,396	2,522	—	(105)	1,376	20,087	21,463	6,874	1/1/2008	2001
W231 N1440 Corporate Court	Pewaukee	WI	—	3,900	41,140	—	—	—	3,900	41,140	45,040	12,599	9/30/2009	1994
8348 & 8400 Washington Avenue	Racine	WI	—	1,150	22,436	—	—	—	1,150	22,436	23,586	6,871	9/30/2009	1986
1221 North 26th Street	Sheboygan	WI	—	300	975	—	—	—	300	975	1,275	299	9/30/2009	1987
1222 North 23rd Street	Sheboygan	WI	—	120	4,014	—	—	—	120	4,014	4,134	1,229	9/30/2009	1987
2414 Kohler Memorial Drive	Sheboygan	WI	—	1,400	35,168	—	—	—	1,400	35,168	36,568	10,770	9/30/2009	1986
1125 N Edge Trail	Verona	WI	—	1,365	9,581	1,721	—	(340)	1,372	10,955	12,327	2,524	11/1/2013	2001
3289 North Mayfair Road	Wauwatosa	WI	—	2,300	6,245	—	—	—	2,300	6,245	8,545	1,913	9/30/2009	1964
503 South 18th Street	Laramie	WY	—	191	3,632	2,846	—	(884)	202	5,583	5,785	2,651	12/30/1993	1964
1901 Howell Avenue	Worland	WY	—	132	2,508	2,293	—	(571)	132	4,230	4,362	2,313	12/30/1993	1970
		Total	$69,135	$715,799	$5,050,945	$1,455,137	$(140,345)	$(267,980)	$741,501	$6,072,055	$6,813,556	$1,737,807

(1)    Represents mortgage debts and finance leases, excluding the unamortized balance of fair value adjustments and debt issuance costs totaling approximately $(578).

(2)    Represents reclassifications between accumulated depreciation and buildings, improvements and equipment made to record certain properties at fair value in accordance with GAAP.

(3)    Aggregate cost for federal income tax purposes is approximately $7,405,729.

(4)    We depreciate buildings and improvements over periods ranging up to 40 years and equipment over periods ranging up to 12 years.

(5)    These properties are collateral for our $62,499 of mortgage debts.

(6)    These properties are subject to our $6,636 of finance leases.

S-12

DIVERSIFIED HEALTHCARE TRUST

SCHEDULE III

REAL ESTATE AND ACCUMULATED DEPRECIATION

DECEMBER 31, 2021

(dollars in thousands)

Analysis of the carrying amount of real estate and equipment and accumulated depreciation during the period:

	Real Estate and Equipment		Accumulated Depreciation
Balance as of December 31, 2018	$	7,876,300	$	1,534,392
Additions	277,350		221,165
Disposals	(250,996)		(54,816)
Impairment	(114,786)		—
Cost basis adjustment (1)	(77,642)		(77,642)
Reclassification of assets held for sale, net	(248,640)		(52,298)
Balance as of December 31, 2019	7,461,586		1,570,801
Additions	192,124		216,418
Disposals	(145,430)		(10,228)
Impairment	(106,972)		—
Cost basis adjustment (1)	(126,127)		(126,127)
Reclassification of assets held for sale, net	135,549		44,037
Balance as of December 31, 2020	7,410,730		1,694,901
Additions	229,735		223,039
Disposals	(910,372)		(158,523)
Impairment	174		—
Cost basis adjustment (1)	(29,762)		(29,762)
Reclassification of assets held for sale, net	113,051		8,152
Balance as of December 31, 2021	$	6,813,556	$	1,737,807

(1)    Represents reclassifications between accumulated depreciation and buildings, improvements and equipment made to record certain properties at fair value in accordance with GAAP.

S-13

SIGNATURES

Pursuant to the requirements of Section 13 or 15(d) of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

DIVERSIFIED HEALTHCARE TRUST
By:	/s/ Jennifer F. Francis
	Jennifer F. Francis President and Chief Executive Officer
	Dated: February 23, 2022

Pursuant to the requirements of the Securities Exchange Act of 1934, this report has been signed below by the following persons on behalf of the registrant and in the capacities and on the dates indicated.

Signature	Title	Date
/s/ Jennifer F. Francis	Managing Trustee, President and Chief Executive Officer (principal executive officer)	February 23, 2022
Jennifer F. Francis
/s/ Richard W. Siedel, Jr.	Chief Financial Officer and Treasurer (principal financial and accounting officer)	February 23, 2022
Richard W. Siedel, Jr.
/s/ John L. Harrington	Independent Trustee	February 23, 2022
John L. Harrington
/s/ Lisa Harris Jones	Independent Trustee	February 23, 2022
Lisa Harris Jones
/s/ Daniel F. LePage	Independent Trustee	February 23, 2022
Daniel F. LePage
/s/ Adam D. Portnoy	Managing Trustee	February 23, 2022
Adam D. Portnoy
/s/ Jeffrey P. Somers	Independent Trustee	February 23, 2022
Jeffrey P. Somers

S-14

EX-8.1

Exhibit 8.1

February 23, 2022

Diversified Healthcare Trust

Two Newton Place

255 Washington Street, Suite 300

Newton, Massachusetts 02458

Ladies and Gentlemen:

The following opinion is furnished to Diversified Healthcare Trust, a Maryland real estate investment trust (the “Company”), to be filed with the Securities and Exchange Commission (the “SEC”) as Exhibit 8.1 to the Company’s Annual Report on Form 10-K for the year ended December 31, 2021 (the “Form 10-K”) under the Securities Exchange Act of 1934, as amended.

We have acted as counsel for the Company in connection with the preparation of the Form 10-K. We have reviewed originals or copies of such corporate records, such certificates and statements of officers of the Company and of public officials, and such other documents as we have considered relevant and necessary in order to furnish the opinion hereinafter set forth. In doing so, we have assumed the genuineness of all signatures, the legal capacity of natural persons, the authenticity of all documents submitted to us as originals, the conformity to original documents of all documents submitted to us as copies, and the authenticity of the originals of such documents. Specifically, and without limiting the generality of the foregoing, we have reviewed: (i) the Company’s amended and restated declaration of trust, as amended and supplemented, and its amended and restated bylaws; and (ii) the Form 10-K. For purposes of the opinion set forth below, we have assumed that any documents (other than documents which have been executed, delivered, adopted, or filed, as applicable, by the Company prior to the date hereof) that have been provided to us in draft form will be executed, delivered, adopted, and filed, as applicable, without material modification.

The opinion set forth below is based upon the Internal Revenue Code of 1986, as amended, the Treasury regulations issued thereunder, published administrative interpretations thereof, and judicial decisions with respect thereto, all as of the date hereof (collectively, “Tax Laws”), and upon the Employee Retirement Income Security Act of 1974, as amended, the Department of Labor regulations issued thereunder, published administrative interpretations thereof, and judicial decisions with respect thereto, all as of the date hereof (collectively, “ERISA Laws”). No assurance can be given that Tax Laws or ERISA Laws will not change. In the discussions with respect to Tax Laws matters and ERISA Laws matters in the sections of Item 1 of the Form 10-K captioned “Material United States Federal Income Tax Considerations” and “ERISA Plans, Keogh Plans and Individual Retirement Accounts”, certain assumptions have been made therein and certain conditions and qualifications have been expressed therein, all of which assumptions, conditions, and qualifications are incorporated herein by reference. With respect to all questions of fact on which our opinion is based, we have assumed the initial and continuing truth, accuracy, and completeness of: (i) the information set forth in the Form 10-K and in the exhibits thereto; and (ii) representations made to us by officers of the Company or contained in the Form 10-K and in the exhibits thereto, in each such instance without regard to

Diversified Healthcare Trust

February 23, 2022

Page 2

qualifications such as “to the best knowledge of” or “in the belief of”. We have not independently verified such information.

We have relied upon, but not independently verified, the foregoing assumptions. If any of the foregoing assumptions are inaccurate or incomplete for any reason, or if the transactions described in the Form 10-K or in the exhibits thereto have been or are consummated in a manner that is inconsistent with the manner contemplated therein, our opinion as expressed below may be adversely affected and may not be relied upon.

Based upon and subject to the foregoing: (i) we are of the opinion that the discussions with respect to Tax Laws matters and ERISA Laws matters in the sections of Item 1 of the Form 10-K captioned “Material United States Federal Income Tax Considerations” and “ERISA Plans, Keogh Plans and Individual Retirement Accounts” in all material respects are, subject to the limitations set forth therein, the material Tax Laws considerations and the material ERISA Laws considerations relevant to holders of the securities of the Company discussed therein (the “Securities”); and (ii) we hereby confirm that the opinions of counsel referred to in said sections represent our opinions on the subject matters thereof.

Our opinion above is limited to the matters specifically covered hereby, and we have not been asked to address, nor have we addressed, any other matters or any other transactions. Further, we disclaim any undertaking to advise you of any subsequent changes of the matters stated, represented, or assumed herein or any subsequent changes in Tax Laws or ERISA Laws.

This opinion is rendered to you in connection with the filing of the Form 10-K. Purchasers and holders of the Securities are urged to consult their own tax advisors or counsel, particularly with respect to their particular tax consequences of acquiring, holding, and disposing of the Securities, which may vary for investors in different tax situations. We hereby consent to the filing of a copy of this opinion as an exhibit to the Form 10-K, which is incorporated by reference in the Company’s Registration Statement on Form S-3, File No. 333-257277 (the “Registration Statement”), under the Securities Act of 1933, as amended (the “Securities Act”), and to the references to our firm in the Form 10-K and the Registration Statement. In giving such consent, we do not thereby admit that we come within the category of persons whose consent is required under Section 7 of the Securities Act or under the rules and regulations of the SEC promulgated thereunder.

Very truly yours,

/s/ Sullivan & Worcester LLP

SULLIVAN & WORCESTER LLP

EX-10.18

Exhibit 10.18

RELEASE OF CERTAIN GUARANTORS

Reference is made to that certain Third Supplemental Indenture, dated as of June 2, 2020 (the “Third Supplemental Indenture”), among Diversified Healthcare Trust (formerly known as Senior Housing Properties Trust), a Maryland real estate investment trust, U.S. Bank National Association, as Trustee (the “Trustee”), each of the Subsidiaries listed on Schedule 1 attached hereto (each, a “Released Guarantor”) and certain other Subsidiaries of the Company, as Guarantors, to the Indenture, dated as of February 18, 2016 (the “Indenture”), between the Company and the Trustee, relating to the Company’s 9.750% Senior Notes due 2025 (the “Notes”). The terms defined in the Third Supplemental Indenture are used herein as therein defined, unless otherwise defined herein.

Pursuant to Section 6 of the Third Supplemental Indenture, the undersigned, as Trustee, hereby confirms the release and discharge of each Released Guarantor from any and all obligations and liabilities under the Subsidiary Guarantee, and further hereby confirms the termination and release of each Released Guarantor of all other obligations under the Third Supplemental Indenture, the Indenture or the Notes, each as of January 28, 2022.

Dated as of January 28, 2022.

U.S. Bank National Association, as Trustee

By:    /s/ David W. Doucette        

Name: David W. Doucette

Title: Vice President

SCHEDULE 1

RELEASED GUARANTORS

1.The LSMD Fund 30 Newcrossing LLC (formerly known as SNH 30 Newcrossing Inc.)

2.The LSMD Fund Concord LLC (formerly known as SNH Concord LLC)

EX-10.19

Exhibit 10.19

RELEASE OF CERTAIN GUARANTORS

Reference is made to that certain Fourth Supplemental Indenture, dated as of February 8, 2021 (the “Fourth Supplemental Indenture”), among Diversified Healthcare Trust (formerly known as Senior Housing Properties Trust), a Maryland real estate investment trust, U.S. Bank National Association, as Trustee (the “Trustee”), each of the Subsidiaries listed on Schedule 1 attached hereto (each, a “Released Guarantor”) and certain other Subsidiaries of the Company, as Guarantors, to the Indenture, dated as of February 18, 2016 (the “Indenture”), between the Company and the Trustee, relating to the Company’s 4.375% Senior Notes due 2031 (the “Notes”). The terms defined in the Fourth Supplemental Indenture are used herein as therein defined, unless otherwise defined herein.

Pursuant to Section 6 of the Fourth Supplemental Indenture, the undersigned, as Trustee, hereby confirms the release and discharge of each Released Guarantor from any and all obligations and liabilities under the Subsidiary Guarantee, and further hereby confirms the termination and release of each Released Guarantor of all other obligations under the Fourth Supplemental Indenture, the Indenture or the Notes, each as of January 28, 2022.

Dated as of January 28, 2022.

U.S. Bank National Association, as Trustee

By:    /s/ David W. Doucette        

Name: David W. Doucette

Title: Vice President

SCHEDULE 1

RELEASED GUARANTORS

1.The LSMD Fund 30 Newcrossing LLC (formerly known as SNH 30 Newcrossing Inc.)

2.The LSMD Fund Concord LLC (formerly known as SNH Concord LLC)

EX-21.1

Exhibit 21.1

DIVERSIFIED HEALTHCARE TRUST

SUBSIDIARIES OF THE REGISTRANT

Name	State of Formation,Organization or Incorporation
JV LSMD Fund Member Trust	Maryland
SNH/LTA Properties Trust	Maryland
SNH Medical Office Properties Trust	Maryland
SNH Proj Lincoln TRS LLC	Maryland
SNH SE Properties Trust	Maryland
SNH SE Tenant TRS, Inc.	Maryland
SNH TRS Inc.	Maryland
SNH TRS Licensee Holdco LLC	Maryland

EX-22.1

Exhibit 22.1

List of Guarantor Subsidiaries

The following subsidiaries of Diversified Healthcare Trust, a Maryland real estate investment trust (the “Trust”), jointly and severally and fully and unconditionally, guaranteed the Trust’s 9.75% Senior Notes due 2025 and the Trust’s 4.375% Senior Notes due 2031:

Exact Name of Guarantor Subsidiary	Jurisdiction
CCC Alpha Investments Trust	Maryland
CCC Delaware Trust	Maryland
CCC Financing I Trust	Maryland
CCC Financing Limited, L.P.	Delaware
CCC Investments I, L.L.C.	Delaware
CCC Leisure Park Corporation	Delaware
CCC Pueblo Norte Trust	Maryland
CCC Retirement Communities II, L.P.	Delaware
CCC Retirement Partners Trust	Maryland
CCC Retirement Trust	Maryland
CCDE Senior Living LLC	Delaware
CCOP Senior Living LLC	Delaware
Crestline Ventures LLC	Delaware
CSL Group, Inc.	Indiana
DHC Holdings LLC	Maryland
Ellicott City Land I, LLC	Delaware
HRES1 Properties Trust	Maryland
HRES2 Properties Trust	Maryland
Leisure Park Venture Limited Partnership	Delaware
Lexington Office Realty Trust	Massachusetts
MSD Pool 1 LLC	Maryland
MSD Pool 2 LLC	Maryland
O.F.C. Corporation	Indiana
SNH AL AIMO II, Inc.	Maryland
SNH AL AIMO Tenant II, Inc.	Maryland
SNH AL AIMO Tenant, Inc.	Maryland
SNH AL AIMO, Inc.	Maryland
SNH AL Crimson Tenant Inc.	Maryland
SNH AL Cumming LLC	Maryland
SNH AL Cumming Tenant LLC	Maryland
SNH AL Georgia Holdings LLC	Maryland
SNH AL Georgia LLC	Maryland
SNH AL Georgia Tenant LLC	Maryland
SNH AL Properties LLC	Maryland
SNH AL Properties Trust	Maryland
SNH AL TRS, Inc.	Maryland
SNH AL Wilmington Tenant Inc.	Maryland

SNH ALT Leased Properties Trust	Maryland
SNH Alpharetta LLC	Delaware
SNH AZ Tenant LLC	Maryland
SNH Bakersfield LLC	Maryland
SNH BAMA Tenant LLC	Maryland
SNH Baton Rouge (North) LLC	Delaware
SNH Baton Rouge (Realtors) LLC	Delaware
SNH BRFL Properties LLC	Delaware
SNH BRFL Tenant LLC	Delaware
SNH Bridgewater LLC	Delaware
SNH CAL Tenant LLC	Maryland
SNH CALI Tenant LLC	Delaware
SNH CCMD Properties Borrower LLC	Delaware
SNH CCMD Properties LLC	Delaware
SNH CCMD Tenant LLC	Delaware
SNH CHS Properties Trust	Maryland
SNH CO Tenant LLC	Maryland
SNH DEL Tenant LLC	Maryland
SNH Denham Springs LLC	Delaware
SNH Derby Tenant LLC	Maryland
SNH FLA Tenant LLC	Maryland
SNH FM Financing LLC	Delaware
SNH FM Financing Trust	Maryland
SNH Georgia Tenant LLC	Maryland
SNH GP Valencia LLC	Delaware
SNH Granite Gate Lands Tenant LLC	Maryland
SNH Granite Gate Lands Trust	Maryland
SNH Grove Park Tenant LLC	Maryland
SNH Grove Park Trust	Maryland
SNH IL Joplin Inc.	Maryland
SNH IL Properties Trust	Maryland
SNH Independence Park LLC	Delaware
SNH INDY Tenant LLC	Maryland
SNH Jackson LLC	Delaware
SNH Kent Properties LLC	Maryland
SNH Lincoln Tenant LLC	Maryland
SNH Longhorn Tenant LLC	Maryland
SNH LTF Properties LLC	Maryland
SNH MASS Tenant LLC	Maryland
SNH MD Tenant LLC	Maryland
SNH Medical Office Realty Trust	Massachusetts
SNH MezzCo San Antonio LLC	Delaware
SNH MO Tenant LLC	Maryland
SNH Modesto LLC	Maryland
SNH NC Tenant LLC	Maryland

SNH Neb Tenant LLC	Maryland
SNH NJ Tenant GP LLC	Maryland
SNH NJ Tenant LLC	Maryland
SNH NJ Tenant LP	Delaware
SNH NM Tenant LLC	Maryland
SNH Northwoods LLC	Maryland
SNH Northwoods Tenant LLC	Maryland
SNH NS Properties Trust	Maryland
SNH Ohio Tenant LLC	Maryland
SNH OMISS Tenant LLC	Maryland
SNH Parkview Properties Trust	Maryland
SNH PENN Tenant LLC	Maryland
SNH Plaquemine LLC	Delaware
SNH PLFL Properties LLC	Delaware
SNH PLFL Tenant LLC	Delaware
SNH Prairieville LLC	Delaware
SNH Proj Lincoln TRS LLC	Maryland
SNH Redmond Properties LLC	Maryland
SNH REIT Irving LLC	Delaware
SNH REIT San Antonio LLC	Delaware
SNH REIT Victoria LLC	Delaware
SNH RMI Fox Ridge Manor Properties LLC	Maryland
SNH RMI Jefferson Manor Properties LLC	Maryland
SNH RMI McKay Manor Properties LLC	Maryland
SNH RMI Northwood Manor Properties LLC	Maryland
SNH RMI Oak Woods Manor Properties LLC	Maryland
SNH RMI Park Square Manor Properties LLC	Maryland
SNH RMI Properties Holding Company LLC	Maryland
SNH RMI Smith Farms Manor Properties LLC	Maryland
SNH RMI Sycamore Manor Properties LLC	Maryland
SNH SC Tenant LLC	Maryland
SNH SE Ashley River LLC	Delaware
SNH SE Ashley River Tenant LLC	Delaware
SNH SE Barrington Boynton LLC	Delaware
SNH SE Barrington Boynton Tenant LLC	Delaware
SNH SE Burlington LLC	Delaware
SNH SE Burlington Tenant LLC	Delaware
SNH SE Daniel Island LLC	Delaware
SNH SE Daniel Island Tenant LLC	Delaware
SNH SE Habersham Savannah LLC	Delaware
SNH SE Habersham Savannah Tenant LLC	Delaware
SNH SE Holly Hill LLC	Delaware
SNH SE Holly Hill Tenant LLC	Delaware
SNH SE Kings Mtn LLC	Delaware
SNH SE Kings Mtn Tenant LLC	Delaware

SNH SE Mooresville LLC	Delaware
SNH SE Mooresville Tenant LLC	Delaware
SNH SE N. Myrtle Beach LLC	Delaware
SNH SE N. Myrtle Beach Tenant LLC	Delaware
SNH SE Properties LLC	Delaware
SNH SE Properties Trust	Maryland
SNH SE SG LLC	Delaware
SNH SE SG Tenant LLC	Delaware
SNH SE Tenant 2 TRS, Inc.	Maryland
SNH SE Tenant TRS, Inc.	Maryland
SNH Somerford Properties Trust	Maryland
SNH St. Louis LLC	Delaware
SNH Teaneck Properties LLC	Delaware
SNH Teaneck Tenant LLC	Delaware
SNH Tellico Tenant LLC	Maryland
SNH Tellico Trust	Maryland
SNH Tempe LLC	Delaware
SNH TENN Tenant LLC	Maryland
SNH Toto Tenant LLC	Maryland
SNH TRS Inc.	Maryland
SNH TRS Licensee Holdco LLC	Maryland
SNH VA Tenant LLC	Maryland
SNH Viking Tenant LLC	Maryland
SNH Ward Ave. Properties I Inc.	Maryland
SNH Well Properties GA-MD LLC	Delaware
SNH Well Properties Trust	Maryland
SNH Wilmington LLC	Maryland
SNH WIS Tenant LLC	Maryland
SNH WY Tenant LLC	Maryland
SNH Yonkers Properties Trust	Maryland
SNH Yonkers Tenant Inc.	Maryland
SNH/CSL Properties Trust	Maryland
SNH/LTA Properties GA LLC	Maryland
SNH/LTA Properties Trust	Maryland
SNH/LTA SE Home Place New Bern LLC	Delaware
SNH/LTA SE McCarthy New Bern LLC	Delaware
SNH/LTA SE Wilson LLC	Delaware
SPTGEN Properties Trust	Maryland
SPTIHS Properties Trust	Maryland
SPTMISC Properties Trust	Maryland
SPTMNR Properties Trust	Maryland
SPTMRT Properties Trust	Maryland
SPTSUN II Properties Trust	Maryland

EX-23.1

Exhibit 23.1

Consent of Independent Registered Public Accounting Firm

We consent to the incorporation by reference in Registration Statement No. 333-257277 on Form S-3 and Registration Statement No. 333-191081 on Form S-8 of our reports dated February 23, 2022, relating to the financial statements of Diversified Healthcare Trust and the effectiveness of Diversified Healthcare Trust's internal control over financial reporting appearing in this Annual Report on Form 10-K for the year ended December 31, 2021.

/s/ Deloitte & Touche LLP

Boston, Massachusetts

February 23, 2022

EX-23.2

Exhibit 23.2

Consent of Independent Registered Public Accounting Firm

We consent to the incorporation by reference in the following Registration Statements:

(1)Registration Statement (Form S-3 No. 333-257277) of Diversified Healthcare Trust, and

(2)Registration Statement (Form S-8 No. 333-191081) pertaining to the 2012 Equity Compensation Plan of Diversified Healthcare Trust;

of our report dated March 2, 2020, with respect to the consolidated financial statements and schedule of Diversified Healthcare Trust included in this Annual Report (Form 10-K) of Diversified Healthcare Trust for the year ended December 31, 2021.

/s/ Ernst & Young LLP

Boston, Massachusetts

February 23, 2022

EX-31.1

Exhibit 31.1

CERTIFICATION PURSUANT TO EXCHANGE ACT RULES 13a-14(a) AND 15d-14(a)

I, Jennifer F. Francis, certify that:

1.I have reviewed this Annual Report on Form 10-K of Diversified Healthcare Trust;

2.Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

3.Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;

4.The registrant’s other certifying officer(s) and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:

a.Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;

b.Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;

c.Evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and

d.Disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter (the registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and

5.The registrant’s other certifying officer(s) and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of the registrant’s board of directors (or persons performing the equivalent functions):

a.All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and

b.Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.

Date: February 23, 2022	/s/ Jennifer F. Francis
	Jennifer F. Francis
	President and Chief Executive Officer

EX-31.2

Exhibit 31.2

CERTIFICATION PURSUANT TO EXCHANGE ACT RULES 13a-14(a) AND 15d-14(a)

I, Richard W. Siedel, Jr., certify that:

1.I have reviewed this Annual Report on Form 10-K of Diversified Healthcare Trust;

2.Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

3.Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;

4.The registrant’s other certifying officer(s) and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:

a.Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;

b.Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;

c.Evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and

d.Disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter (the registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and

5.The registrant’s other certifying officer(s) and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of the registrant’s board of directors (or persons performing the equivalent functions):

a.All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and

b.Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.

Date: February 23, 2022	/s/ Richard W. Siedel, Jr.
	Richard W. Siedel, Jr.
	Chief Financial Officer and Treasurer

EX-32.1

Exhibit 32.1

CERTIFICATION PURSUANT TO 18 U.S.C. SEC. 1350

    In connection with the filing by Diversified Healthcare Trust (the “Company”) of the Annual Report on Form 10-K for the period ended December 31, 2021 (the “Report”), each of the undersigned hereby certifies, to the best of his or her knowledge:

1.The Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and

2.The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.

/s/ Jennifer F. Francis

Jennifer F. Francis

President and Chief Executive Officer

/s/ Richard W. Siedel, Jr.

Richard W. Siedel, Jr.

Chief Financial Officer and Treasurer

Date: February 23, 2022

XML

Cover Page - USD ($) $ in Billions	12 Months Ended
	Dec. 31, 2021	Feb. 21, 2022	Jun. 30, 2021
Entity Information
Document Type	10-K
Document Annual Report	true
Document Period End Date	Dec. 31, 2021
Current Fiscal Year End Date	--12-31
Document Transition Report	false
Entity File Number	1-15319
Entity Registrant Name	DIVERSIFIED HEALTHCARE TRUST
Entity Incorporation, State or Country Code	MD
Entity Tax Identification Number	04-3445278
Entity Address, Street	Two Newton Place, 255 Washington Street, Suite 300
Entity Address, City	Newton
Entity Address, State	MA
Entity Address, Postal Zip Code	02458-1634
City Area Code	617
Local Phone Number	796-8350
Title of 12(b) Security	Common Shares of Beneficial Interest
Trading Symbol	DHC
Security Exchange Name	NASDAQ
Entity Well-known Seasoned Issuer	Yes
Entity Voluntary Filers	No
Entity Current Reporting Status	Yes
Entity Interactive Data Current	Yes
Entity Filer Category	Large Accelerated Filer
Entity Smaller Reporting Company	false
Entity Emerging Growth Company	false
ICFR Auditor Attestation Flag	true
Entity Shell Company	false
Entity Public Float			$ 1.0
Entity Common Stock, Shares Outstanding (in shares)		238,994,894
Documents Incorporated by Reference	Certain information required by Items 10, 11, 12, 13 and 14 of Part III of this Annual Report on Form 10-K is incorporated by reference to our definitive Proxy Statement for the 2022 Annual Meeting of Shareholders, to be filed with the Securities and Exchange Commission within 120 days after the fiscal year ended December 31, 2021.
Entity Central Index Key	0001075415
Amendment Flag	false
Document Fiscal Year Focus	2021
Document Fiscal Period Focus	FY
Senior Notes Due 2042
Entity Information
Title of 12(b) Security	5.625% Senior Notes due 2042
Trading Symbol	DHCNI
Security Exchange Name	NASDAQ
Senior Notes Due 2046
Entity Information
Title of 12(b) Security	6.25% Senior Notes due 2046
Trading Symbol	DHCNL
Security Exchange Name	NASDAQ

XML

Audit Information	12 Months Ended
	Dec. 31, 2021	Dec. 31, 2019
Audit Information [Abstract]
Auditor Name	Deloitte & Touche LLP	Ernst & Young LLP
Auditor Firm ID	34	42
Auditor Location	Boston, Massachusetts	Boston, Massachusetts

XML

CONSOLIDATED BALANCE SHEETS - USD ($) $ in Thousands		Dec. 31, 2021	Dec. 31, 2020
Real estate properties:
Land		$ 741,501	$ 789,125
Buildings and improvements		6,072,055	6,621,605
Total real estate properties, gross		6,813,556	7,410,730
Accumulated depreciation		(1,737,807)	(1,694,901)
Total real estate properties, net		5,075,749	5,715,829
Investment in unconsolidated joint venture		215,127	0
Assets of properties held for sale		0	112,437
Cash and cash equivalents		634,848	74,417
Restricted cash	[1]	382,097	16,432
Investments in equity securities		31,540	73,772
Acquired real estate leases and other intangible assets, net		48,746	286,513
Other assets, net		235,407	197,024
Total assets		6,623,514	6,476,424
LIABILITIES AND SHAREHOLDERS' EQUITY
Revolving credit facility		800,000	0
Term loan, net		0	199,049
Senior unsecured notes, net		2,806,811	2,608,189
Secured debt and finance leases, net		69,713	691,573
Liabilities of properties held for sale		0	3,525
Accrued interest		29,845	23,772
Due to affiliates		8,270	24,547
Assumed real estate lease obligations, net		2,556	67,830
Other liabilities		243,929	238,717
Total liabilities		3,961,124	3,857,202
Commitments and contingencies
Equity attributable to common shareholders:
Common shares of beneficial interest, $.01 par value: 300,000,000 shares authorized, 238,994,894 and 238,268,478 shares issued and outstanding, respectively		2,390	2,383
Additional paid in capital		4,615,475	4,613,904
Cumulative net income		2,087,624	1,913,109
Cumulative distributions		(4,043,099)	(4,033,559)
Total equity attributable to common shareholders		2,662,390	2,495,837
Noncontrolling interest:
Total equity attributable to noncontrolling interest		0	123,385
Total equity		2,662,390	2,619,222
Total liabilities and equity		$ 6,623,514	$ 6,476,424

[1] As of December 31, 2021, restricted cash consists of proceeds from the sale of an interest in the joint venture that owns a life science property located in Boston, Massachusetts held as collateral pursuant to the agreement governing our revolving credit facility, or our credit agreement. We may use these funds to pay for approved expenditures in accordance with our credit agreement. Effective as of the date of the sale, we deconsolidated this joint venture. Prior to the deconsolidation, restricted cash consisted primarily of cash held for the operations of this joint venture. Restricted cash also consists of amounts escrowed for real estate taxes, insurance and capital expenditures at certain of our mortgaged properties.

XML

CONSOLIDATED BALANCE SHEETS (Parenthetical) - $ / shares	Dec. 31, 2021	Dec. 31, 2020
Statement of Financial Position [Abstract]
Common shares, par value (in dollars per share)	$ 0.01	$ 0.01
Common shares, shares authorized (in shares)	300,000,000	300,000,000
Common shares, shares issued (in shares)	238,994,894	238,268,478
Common shares, shares outstanding (in shares)	238,994,894	238,268,478

XML

CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME (LOSS) - USD ($) shares in Thousands, $ in Thousands	12 Months Ended
	Dec. 31, 2021	Dec. 31, 2020	Dec. 31, 2019
Revenues:
Revenue	$ 1,383,212	$ 1,632,026	$ 1,040,155
Gains and losses on equity securities, net	(42,232)	34,106	(41,898)
Expenses:
Property operating expenses	1,091,812	1,236,357	489,070
Depreciation and amortization	271,131	270,147	289,025
General and administrative	34,087	30,593	37,028
Acquisition and certain other transaction related costs	17,506	814	13,102
Impairment of assets	(174)	106,972	115,201
Total expenses	1,414,362	1,644,883	943,426
Gain on sale of properties	492,272	6,487	39,696
Dividend income	0	0	1,846
Gains and losses on equity securities, net	(42,232)	34,106	(41,898)
Interest and other income	20,635	18,221	941
Interest expense (including net amortization of debt premiums, discounts and issuance costs of $13,408, $8,022 and $6,032, respectively)	(255,759)	(201,483)	(180,112)
Gain on lease termination	0	22,896	0
Loss on early extinguishment of debt	(2,410)	(427)	(44)
Income (loss) from continuing operations before income tax expense and equity in earnings of an investee	181,356	(133,057)	(82,842)
Income tax expense	(1,430)	(1,250)	(436)
Equity in earnings of an investee	0	0	400
Net income (loss)	179,926	(134,307)	(82,878)
Net income attributable to noncontrolling interest	(5,411)	(5,146)	(5,356)
Net income (loss) attributable to common shareholders	174,515	(139,453)	(88,234)
Other comprehensive income:
Amounts reclassified from cumulative other comprehensive income to net income	0	0	175
Equity in unrealized gain of an investee	0	0	91
Other comprehensive income	0	0	266
Comprehensive income (loss)	179,926	(134,307)	(82,612)
Comprehensive income attributable to noncontrolling interest	(5,411)	(5,146)	(5,356)
Comprehensive income (loss) attributable to common shareholders	$ 174,515	$ (139,453)	$ (87,968)
Weighted average shares used in computing earnings per common share:
Weighted average common shares outstanding (basic) (in shares)	237,967	237,739	237,604
Weighted average common shares outstanding (diluted) (in shares)	237,967	237,739	237,604
Per common share amounts (basic and diluted)
Net loss attributable to common shareholders - basic (in dollars per share)	$ 0.73	$ (0.59)	$ (0.37)
Net loss attributable to common shareholders - diluted (in dollars per share)	$ 0.73	$ (0.59)	$ (0.37)
Rental income
Revenues:
Revenue	$ 408,589	$ 427,215	$ 606,558
Residents fees and services
Revenues:
Revenue	$ 974,623	$ 1,204,811	$ 433,597

XML

CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME (LOSS) (Parenthetical) - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2021	Dec. 31, 2020	Dec. 31, 2019
Income Statement [Abstract]
Net amortization of debt premiums, discounts and issuance costs	$ 13,408	$ 8,022	$ 6,032

XML

CONSOLIDATED STATEMENTS OF SHAREHOLDERS' EQUITY - USD ($) $ in Thousands	Total	Shareholders ALR	Total Equity Attributable to Common Shareholders	Total Equity Attributable to Common Shareholders Shareholders ALR	Common Shares	Additional Paid In Capital	Cumulative Net Income	Cumulative Other Comprehensive Income (Loss)	Cumulative Distributions	Cumulative Distributions Shareholders ALR	Total Equity Attributable to Noncontrolling Interest
Balance at Dec. 31, 2018	$ 3,179,870		$ 3,023,112		$ 2,377	$ 4,611,419	$ 2,140,796	$ (266)	$ (3,731,214)		$ 156,758
Balance (in shares) at Dec. 31, 2018					237,729,900
Increase (Decrease) in Shareholders' Equity
Net income (loss)	(82,878)		(88,234)				(88,234)				5,356
Amounts reclassified from cumulative other comprehensive income to net income	175		175					175
Other comprehensive income (loss)	91		91					91
Distributions	(199,719)		(199,719)						(199,719)
Share grants	1,393		1,393		$ 2	1,391
Share grants (in shares)					202,500
Share repurchases	(293)		(293)			(293)
Share repurchases (in shares)					(31,747)
Share forfeitures	(6)		(6)			(6)
Share forfeitures (in shares)					(3,490)
Distributions to noncontrolling interest	(21,583)										(21,583)
Balance (in shares) at Dec. 31, 2019					237,897,163
Balance at Dec. 31, 2019	2,877,050		2,736,519		$ 2,379	4,612,511	2,052,562	0	(3,930,933)		140,531
Increase (Decrease) in Shareholders' Equity
Net income (loss)	(134,307)		(139,453)				(139,453)				5,146
Amounts reclassified from cumulative other comprehensive income to net income	0
Other comprehensive income (loss)	0
Distributions	(42,825)	$ (59,801)	(42,825)	$ (59,801)					(42,825)	$ (59,801)
Share grants	1,574		1,574		$ 4	1,570
Share grants (in shares)					420,000
Share repurchases	(171)		(171)			(171)
Share repurchases (in shares)					(47,375)
Share forfeitures	(6)		(6)			(6)
Share forfeitures (in shares)					(1,310)
Distributions to noncontrolling interest	$ (22,292)										(22,292)
Balance (in shares) at Dec. 31, 2020	238,268,478				238,268,478
Balance at Dec. 31, 2020	$ 2,619,222		2,495,837		$ 2,383	4,613,904	1,913,109	0	(4,033,559)		123,385
Increase (Decrease) in Shareholders' Equity
Net income (loss)	179,926		174,515				174,515				5,411
Amounts reclassified from cumulative other comprehensive income to net income	0
Other comprehensive income (loss)	0
Distributions	(9,540)		(9,540)						(9,540)
Share grants	1,964		1,964		$ 8	1,956
Share grants (in shares)					838,000
Share repurchases	(383)		(383)		$ (1)	(382)
Share repurchases (in shares)					(109,384)
Share forfeitures	(3)		(3)			(3)
Share forfeitures (in shares)					(2,200)
Distributions to noncontrolling interest	(22,348)										(22,348)
Sale of interest in joint venture	$ (106,448)										(106,448)
Balance (in shares) at Dec. 31, 2021	238,994,894				238,994,894
Balance at Dec. 31, 2021	$ 2,662,390		$ 2,662,390		$ 2,390	$ 4,615,475	$ 2,087,624	$ 0	$ (4,043,099)		$ 0

XML

CONSOLIDATED STATEMENTS OF CASH FLOWS - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2021	Dec. 31, 2020	Dec. 31, 2019
CASH FLOWS FROM OPERATING ACTIVITIES:
Net income (loss)	$ 179,926	$ (134,307)	$ (82,878)
Adjustments to reconcile net income (loss) to cash (used in) provided by operating activities:
Depreciation and amortization	271,131	270,147	289,025
Net amortization of debt premiums, discounts and issuance costs	13,408	8,022	6,032
Straight line rental income	(5,846)	(6,069)	(4,508)
Amortization of acquired real estate leases	(7,211)	(7,405)	(6,791)
Loss on early extinguishment of debt	2,410	51	44
Gain on lease termination	0	(22,896)	0
Impairment of assets	(174)	106,972	115,201
Gain on sale of properties	(492,272)	(6,487)	(39,696)
Gains and losses on equity securities, net	42,232	(34,106)	41,898
Other non-cash adjustments, net	(1,811)	(2,203)	(3,771)
Equity in earnings of an investee	0	0	(400)
Distribution of earnings from Affiliates Insurance Company	0	0	2,574
Change in assets and liabilities:
Deferred leasing costs, net	(20,701)	(7,672)	(8,625)
Other assets	(51,201)	(27,858)	12,267
Accrued interest	7,654	(305)	(2,105)
Other liabilities	(868)	22,660	(52,422)
Net cash (used in) provided by operating activities	(63,323)	158,544	265,845
CASH FLOWS FROM INVESTING ACTIVITIES:
Real estate acquisitions and deposits	0	(2,526)	(50,636)
Real estate improvements	(227,605)	(185,585)	(222,417)
Proceeds from sale of properties, net	103,257	147,388	254,241
Proceeds from sale of interest in joint venture, net	367,033	0	0
Proceeds from sale of RMR Inc. common shares, net	0	0	98,557
Distributions in excess of earnings from Affiliates Insurance Company	11	287	6,426
Net cash provided by (used in) investing activities	242,696	(40,436)	86,171
CASH FLOWS FROM FINANCING ACTIVITIES:
Proceeds from issuance of senior unsecured notes, net	492,500	985,000	0
Proceeds from borrowings on revolving credit facility	800,000	430,500	994,500
Repayments of borrowings on revolving credit facility	0	(968,000)	(596,000)
Repayment of senior unsecured notes	(300,000)	(200,000)	(400,000)
Repayment of term loan	(200,000)	(250,000)	(100,000)
Repayment of other debt	(3,159)	(5,941)	(46,345)
Loss on early extinguishment of debt settled in cash	0	(376)	0
Payment of debt issuance costs	(10,347)	(5,378)	(417)
Repurchase of common shares	(383)	(171)	(299)
Distributions to noncontrolling interest	(22,348)	(22,292)	(21,583)
Distributions to shareholders	(9,540)	(42,825)	(199,719)
Net cash provided by (used in) financing activities	746,723	(79,483)	(369,863)
Increase (decrease) in cash and cash equivalents and restricted cash	926,096	38,625	(17,847)
Cash and cash equivalents and restricted cash at end of period	1,016,945	90,849	52,224
Cash and cash equivalents and restricted cash at beginning of period	$ 90,849	$ 52,224	$ 70,071

XML

CONSOLIDATED STATEMENTS OF CASH FLOWS - Supplemental (Parenthetical) - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2021	Dec. 31, 2020	Dec. 31, 2019
SUPPLEMENTAL CASH FLOW INFORMATION:
Interest paid	$ 235,994	$ 195,599	$ 177,308
Income taxes paid	2,798	399	452
Decrease in assets and liabilities resulting from the deconsolidation of an investment that was previously consolidated:
Real estate, net	(686,320)	0	0
Mortgage notes, net	618,452	0	0
Real estate improvements accrued, not paid	20,031	18,097	14,111
Capitalized interest	1,297	1,833	1,124
Joint venture | ALR
Decrease in assets and liabilities resulting from the deconsolidation of an investment that was previously consolidated:
Restructuring transaction additional consideration	0	(75,000)	0
ALR
Decrease in assets and liabilities resulting from the deconsolidation of an investment that was previously consolidated:
AlerisLife Inc. common stock	0	97,896	0
NON-CASH FINANCING ACTIVITIES:
Distribution to common shareholders of the right to receive AlerisLife Inc. common stock	$ 0	$ (59,801)	$ 0

XML

CONSOLIDATED STATEMENTS OF CASH FLOWS - Cash and Restricted Cash (Parenthetical) - USD ($) $ in Thousands		Dec. 31, 2021	Dec. 31, 2020	Dec. 31, 2019	Dec. 31, 2018
Statement of Cash Flows [Abstract]
Cash and cash equivalents		$ 634,848	$ 74,417	$ 37,357
Restricted cash	[1]	382,097	16,432	14,867
Total cash and cash equivalents and restricted cash shown in our consolidated statements of cash flows		$ 1,016,945	$ 90,849	$ 52,224	$ 70,071

[1] As of December 31, 2021, restricted cash consists of proceeds from the sale of an interest in the joint venture that owns a life science property located in Boston, Massachusetts held as collateral pursuant to the agreement governing our revolving credit facility, or our credit agreement. We may use these funds to pay for approved expenditures in accordance with our credit agreement. Effective as of the date of the sale, we deconsolidated this joint venture. Prior to the deconsolidation, restricted cash consisted primarily of cash held for the operations of this joint venture. Restricted cash also consists of amounts escrowed for real estate taxes, insurance and capital expenditures at certain of our mortgaged properties.

XML

Organization

12 Months Ended

Dec. 31, 2021

Organization, Consolidation and Presentation of Financial Statements [Abstract]

Organization

Organization

Diversified Healthcare Trust is a real estate investment trust, or REIT, organized under Maryland law, which owns medical office and life science properties, senior living communities and other healthcare related properties throughout the United States. As of December 31, 2021, we wholly owned 390 properties located in 36 states and Washington, D.C. On that date, the gross book value of our real estate assets was $6,813,556.

As of December 31, 2021, we also owned a 20% equity interest in an unconsolidated joint venture that owns a life science property located in Boston, Massachusetts with approximately 1.1 million rentable square feet that was 100% leased with an average (by annualized rental revenues) remaining lease term of 7.0 years.

XML

Summary of Significant Accounting Policies

12 Months Ended

Dec. 31, 2021

Accounting Policies [Abstract]

Summary of Significant Accounting Policies

Summary of Significant Accounting Policies

BASIS OF PRESENTATION.  Our consolidated financial statements include the accounts of Diversified Healthcare Trust, we, us or our, and our subsidiaries, all of which are 100% owned directly or indirectly by us. All intercompany transactions and balances with or among our consolidated subsidiaries have been eliminated. Accounting principles generally accepted in the United States, or GAAP, require us to make estimates and assumptions that may affect the amounts reported in these financial statements and related notes. The actual results could differ from these estimates. 

REAL ESTATE PROPERTIES.  We record properties at our cost and calculate depreciation on real estate investments on a straight line basis over estimated useful lives generally up to 40 years.

We allocate the purchase prices of our properties to land, building and improvements based on determinations of the fair values of these assets assuming the properties are vacant. We determine the fair value of each property using methods similar to those used by independent appraisers, which may involve estimated cash flows that are based on a number of factors, including capitalization rates and discount rates, among others. In some circumstances, we engage independent real estate appraisal firms to provide market information and evaluations which are relevant to our purchase price allocations and determinations of depreciable useful lives; however, we are ultimately responsible for the purchase price allocations and determinations of useful lives. We allocate a portion of the purchase price to above market and below market leases based on the present value (using an interest rate which reflects the risks associated with acquired in place leases at the time each property was acquired by us) of the difference, if any, between (i) the contractual amounts to be paid pursuant to the acquired in place leases and (ii) our estimates of fair market lease rates for the corresponding leases, measured over a period equal to the terms of the respective leases. The terms of below market leases that include bargain renewal options, if any, are further adjusted if we determine that renewal is probable. We allocate a portion of the purchase price to acquired in place leases and tenant relationships based upon market estimates to lease up the property based on the leases in place at the time of purchase. In making these allocations, we consider factors such as estimated carrying costs during the expected lease up periods, including real estate taxes, insurance and other operating income and expenses and costs, such as leasing commissions, legal and other related expenses, to execute similar leases in current market conditions at the time a property was acquired by us. We allocate this aggregate value between acquired in place lease values and tenant relationships based on our evaluation of the specific characteristics of each tenant's lease. However, we have not separated the value of tenant relationships from the value of acquired in place leases because such value and related amortization expense is immaterial to our consolidated financial statements. If the value of tenant relationships becomes material in the future, we may separately allocate those amounts and amortize the allocated amount over the estimated life of the relationships.

We amortize capitalized above market lease values (included in acquired real estate leases and other intangible assets, net in our consolidated balance sheets) as a reduction to rental income over the remaining non-cancelable terms of the respective leases. We amortize capitalized below market lease values (presented as assumed real estate lease obligations in our consolidated balance sheets) as an increase to rental income over the non-cancelable periods of the respective leases. For the years ended December 31, 2021, 2020 and 2019, such amortization resulted in a net increase in rental income of $7,211, $7,405 and $6,791, respectively. We amortize the value of in place leases exclusive of the value of above market and below market in place leases to expense over the remaining non-cancelable periods of the respective leases. During the years ended December 31, 2021, 2020 and 2019, such amortization included in depreciation totaled $42,783, $48,669 and $64,203, respectively. If a lease is terminated prior to its stated expiration, the unamortized amount relating to that lease is written off.

As of December 31, 2021 and 2020, our acquired real estate leases and assumed real estate lease obligations, excluding properties held for sale, were as follows:

	December 31,
	2021		2020
Acquired real estate leases:
Capitalized above market lease values (1)	$	8,092	$	12,304
Less: accumulated amortization	(6,268)		(9,236)
Capitalized above market lease values, net	1,824		3,068
Lease origination value	123,682		551,141
Less: accumulated amortization	(76,760)		(267,696)
Lease origination value, net	46,922		283,445
Acquired real estate leases and other intangible assets, net	$	48,746	$	286,513
Assumed real estate lease obligations:
Capitalized below market lease values	$	6,141	$	128,991
Less: accumulated amortization	(3,585)		(61,161)
Assumed real estate lease obligations, net	$	2,556	$	67,830

(1)Acquired real estate leases and other related intangible assets decreased due to our sale of a 35% equity interest from our then remaining 55% equity interest in the joint venture which owns a life science property located in Boston, Massachusetts to another third party global institutional investor. As a result of this sale, we deconsolidated the net assets of this joint venture.

As of December 31, 2021, the weighted average amortization periods for capitalized above market lease values, lease origination value and capitalized below market lease values were 3.7 years, 5.3 years and 6.9 years, respectively. Future amortization of net intangible acquired real estate lease assets and liabilities to be recognized over the current terms of the associated leases as of December 31, 2021 are estimated to be $12,095 in 2022, $11,326 in 2023, $8,030 in 2024, $4,869 in 2025, $3,267 in 2026 and $6,603 thereafter.

CASH AND CASH EQUIVALENTS.  We consider highly liquid investments with original maturities of three months or less at the date of purchase to be cash equivalents.

RESTRICTED CASH.  Restricted cash consists of amounts escrowed for real estate taxes, insurance and capital expenditures at certain of our mortgaged properties and amounts held as collateral pursuant to our credit agreement.

INVESTMENTS IN EQUITY SECURITIES. We previously owned 2,637,408 shares of class A common stock of The RMR Group Inc., or RMR Inc., that we sold on July 1, 2019. Prior to July 1, 2019, our equity securities were recorded at fair value based on their quoted market price at the end of each reporting period. We classify the common shares we own of AlerisLife Inc. (f/k/a Five Star Senior Living Inc.), or AlerisLife, as an equity method investment. This equity method investment is included in investments of equity securities in our consolidated balance sheets.

On April 1, 2019, we and Five Star Senior Living, or Five Star, which is an operating division of AlerisLife, entered into a transaction agreement, or the Transaction Agreement, to restructure our business arrangements with Five Star effective January 1, 2020, or the 2020 Restructuring Transaction. At December 31, 2019, we owned 423,500 AlerisLife common shares after giving effect to the one-for-ten reverse stock split effected by AlerisLife with respect to its common shares on September 30, 2019. Pursuant to the 2020 Restructuring Transaction, on January 1, 2020, AlerisLife issued 10,268,158 common shares to us. The fair value and initial cost basis of the AlerisLife common shares issued to us on January 1, 2020 was $38,095. At December 31, 2021, we owned 10,691,658 AlerisLife common shares. At December 31, 2021 and 2020, our investment in AlerisLife had a fair value of $31,540 and $73,772, respectively, including an unrealized loss of $42,232 and unrealized gain of $34,106, respectively. Based on the terms of the Transaction Agreement, including the issuance of additional AlerisLife shares to us, we concluded that we have significant influence over AlerisLife and therefor account for our investment in AlerisLife as an equity method investment starting January 1, 2020. We have elected the fair value option for our investment in AlerisLife. We continue to present our investment in AlerisLife in Investments in equity securities in our consolidated balance sheets due to the comparable accounting treatment of the shares we owned in AlerisLife as of December 31, 2021 and 2020.

See Notes 6 and 8 for further information regarding our investment in AlerisLife and former investment in RMR Inc.

EQUITY METHOD INVESTMENTS.  As of December 31, 2021, we owned a 20% equity interest in an unconsolidated joint venture which owns a life science property located in Boston, Massachusetts. The property owned by this joint venture is encumbered by an aggregate $620,000 of mortgage debts. We do not control the activities that are most significant to this joint venture and, as a result, we account for our investment in this joint venture under the equity method of accounting under the fair value option. See Notes 3, 10 and 11 for more information regarding this joint venture.

We account for our investment in Affiliates Insurance Company, or AIC, until AIC was dissolved as described in Note 8, using the equity method of accounting. Significant influence was present through common representation on our Board of Trustees and the board of directors of AIC until February 13, 2020. The Chair of our Board of Trustees and one of our Managing Trustees, Adam D. Portnoy, as the sole trustee of ABP Trust, is the controlling shareholder of RMR Inc. He is also a managing director and an executive officer of RMR Inc. Substantially all of the business of RMR Inc. is conducted by its majority owned subsidiary, The RMR Group LLC, or RMR LLC, which is our manager and provided management and administrative services to AIC. Most of our Trustees were directors of AIC. See Note 8 for more information about our investment in AIC. As previously discussed, we also account for our investment in AlerisLife as an equity method investment under the fair value option.

DEBT ISSUANCE COSTS.  Debt issuance costs include issuance or assumption costs related to borrowings and we amortize those costs as interest expense over the terms of the respective loans. Debt issuance costs for our revolving credit facility totaled $27,383 and $19,332 at December 31, 2021 and 2020, respectively, and accumulated amortization of debt issuance costs totaled $22,899 and $16,201 at December 31, 2021 and 2020, respectively, and are included in other assets in our consolidated balance sheets. Debt issuance costs for our previously existing term loans, senior notes, and mortgage notes payable totaled $53,649 and $53,496 at December 31, 2021 and 2020, respectively, and accumulated amortization of debt issuance costs totaled $15,800 and $15,589, respectively, and are presented in our consolidated balance sheet as a direct deduction from the associated debt liability. Future amortization of debt issuance costs to be recognized with respect to our loans as of December 31, 2021 are estimated to be $9,974 in 2022, $5,832 in 2023, $5,521 in 2024, $3,556 in 2025, $1,956 in 2026 and $15,494 thereafter.

DEFERRED LEASING COSTS.  Deferred leasing costs include capitalized brokerage and other fees associated with the successful negotiation of leases, which are amortized to depreciation and amortization expense on a straight line basis over the terms of the respective leases. Deferred leasing costs are included in other assets in our consolidated balance sheets. Deferred leasing costs totaled $64,255 and $44,506 at December 31, 2021 and 2020, respectively, and accumulated amortization of deferred leasing costs totaled $17,074 and $15,605 at December 31, 2021 and 2020, respectively. At December 31, 2021, the remaining weighted average amortization period is approximately 8.7 years. Future amortization of deferred leasing costs to be recognized during the current terms of our existing leases as of December 31, 2021, are estimated to be $7,168 in 2022, $6,502 in 2023, $5,903 in 2024, $5,397 in 2025, $4,732 in 2026 and $17,479 thereafter.

REVENUE RECOGNITION.  We are a lessor of medical office and life science properties, senior living communities and other healthcare related properties. Our leases provide our tenants with the contractual right to use and economically benefit from all of the premises demised under the leases; therefore, we have determined to evaluate our leases as lease arrangements.

For leases where we are the lessee, we recognize a right of use asset and a lease liability equal to the present value of the minimum lease payments with rental payments being applied to the lease liability and the right of use asset being amortized over the term of the lease. The right of use asset and related lease liability are included within other assets, net and other liabilities, respectively, within our consolidated balance sheets. In addition, we lease equipment at certain of our managed senior living communities. These leases are short term in nature, are cancelable with no fee or do not result in an annual expense in excess of our capitalization policy and, as a result, will not be recorded on our consolidated balance sheets.

Certain of our leases provide for base rent payments and in addition may include variable payments. Rental income from operating leases, including any payments derived by index or market based indices, is recognized on a straight line basis over the lease term when we have determined that the collectability of substantially all of the lease payments is probable. Some of our leases have options to extend or terminate the lease exercisable at the option of our tenants, which are considered when determining the lease term. We do not include in our measurement of our lease receivables certain variable payments, including changes in the index or market based indices after the inception of the lease, certain tenant reimbursements and other income until the specific events that trigger the variable payments have occurred.

Certain of our leases contain non-lease components, such as property level operating expenses and capital expenditures reimbursed by our tenants as well as other required lease payments. We have determined that all of our leases qualify for the practical expedient to not separate the lease and non-lease components because (i) the lease components are operating leases and (ii) the timing and pattern of recognition of the non-lease components are the same as those of the lease components. We

apply Codification Topic 842, Leases, to the combined component. Income derived by our leases is recorded in rental income in our consolidated statements of comprehensive income (loss).

Certain tenants are obligated to pay directly their obligations under their leases for insurance, real estate taxes and certain other expenses. These obligations, which have been assumed by the tenants under the terms of their respective leases, are not reflected in our consolidated financial statements. To the extent any tenant responsible for any such obligations under the applicable lease defaults on such lease or if it is deemed probable that the tenant will fail to pay for such obligations, we would record a liability for such obligations.

For the years ended December 31, 2021, 2020 and 2019, we recognized the rental income from our operating leases on a straight line basis over the term of each lease agreement. We recognized percentage rents when realizable and earned, which was generally during the fourth quarter of the year. For the years ended December 31, 2021, 2020 and 2019, percentage rents earned aggregated $1,993, $2,144 and $2,958, respectively.

As of December 31, 2021, we owned 235 senior living communities that are managed by third party managers for our account. We derive our revenues at these managed senior living communities primarily from services our managers provide to residents on our behalf and we record revenues when the services are provided. We use the TRS structure authorized by the REIT Investment Diversification and Empowerment Act for all of our managed senior living communities.

Under the Coronavirus Aid, Relief, and Economic Security Act, or the CARES Act, the U.S. Department of Health and Human Services, or HHS, established a Provider Relief Fund. Retention and use of the funds received under the CARES Act are subject to certain terms and conditions. The terms and conditions require that the funds be utilized to compensate for lost revenues that are attributable to the COVID-19 pandemic and for eligible costs to prevent, prepare for and respond to the COVID-19 pandemic that are not covered by other sources. Further, fund recipients are required to be participating in Medicare at the time of distribution and are subject to certain other terms and conditions, including quarterly reporting requirements. In addition, fund recipients are required to have billed Medicare during 2019 and to continue to provide care after January 31, 2020 for diagnosis, testing or care for individuals with possible or actual COVID-19 cases. Any funds not used in accordance with the terms and conditions must be returned to HHS. We recognize income from government grants on a systematic and rational basis over the period in which we recognize the related expenses or loss of revenues for which the grants are intended to compensate when there is reasonable assurance that we will comply with the applicable terms and conditions of the grant and there is reasonable assurance that the grant will be received. During the years ended December 31, 2021 and 2020, we received $20,800 and $19,961, respectively, in funds from the Provider Relief Fund to be used to support the operations of our managed senior living communities; we have currently determined that $19,554 and $17,485 of such funds meet the required terms and conditions. We have recognized $19,554 and $17,485 as other income in our consolidated statements of comprehensive income (loss) with respect to our senior housing operating portfolio, or SHOP, segment for the years ended December 31, 2021 and 2020, respectively. As of December 31, 2021 and 2020, we had not recognized $3,722 and $2,476, respectively, of funds from the Provider Relief Fund and included these amounts in other liabilities in our consolidated balance sheets. We currently expect to return the remaining $3,722 of such funds to HHS in 2022 unless and to the extent we determine that such funds meet the required terms and conditions. We have applied for additional funds that may be available under the CARES Act Provider Relief Fund; however, we may not receive any additional funding.

PER COMMON SHARE AMOUNTS.  We calculate basic earnings per common share by dividing net income (loss) by the weighted average number of our common shares of beneficial interest, $.01 par value, or our common shares, outstanding during the period. We calculate diluted earnings per common share using the more dilutive of the two class method or the treasury stock method. Unvested share awards and other potentially dilutive common shares and the related impact on earnings, are considered when calculating diluted earnings per share.

INCOME TAXES.  We have elected to be taxed as a REIT under the United States Internal Revenue Code of 1986, as amended, and as such are generally not subject to federal and most state income taxation on our operating income provided we distribute our taxable income to our shareholders and meet certain organization and operating requirements. We do, however, lease our managed senior living communities to our wholly owned TRSs that, unlike most of our subsidiaries, file a separate consolidated federal corporate income tax return and are subject to federal and state income taxes. Our consolidated income tax provision includes the income tax provision related to the operations of our TRSs and certain state income taxes we incur despite our taxation as a REIT.

The Income Taxes Topic of the Codification prescribes how we should recognize, measure and present in our financial statements uncertain tax positions that have been taken or are expected to be taken in a tax return. Tax benefits are recognized to the extent that it is “more likely than not” that a particular tax position will be sustained upon examination or audit. To the extent the “more likely than not” standard has been satisfied, the benefit associated with a tax position is measured as the largest

amount that has a greater than 50% likelihood of being realized upon settlement. We classify interest and penalties related to uncertain tax positions, if any, in our financial statements as a component of general and administrative expense.

SEGMENT REPORTING.  As of December 31, 2021, we operate in, and report financial information for, the following two segments: our portfolio of medical office and life science properties, or our Office Portfolio, and SHOP. We aggregate each of these two reporting segments based on their similar operating and economic characteristics. See Note 12 for further information regarding our reportable operating segments.

NEW ACCOUNTING PRONOUNCEMENTS. In June 2016, the Financial Accounting Standards Board, or FASB, issued Accounting Standards Update, or ASU, No. 2016-13, Financial Instruments - Credit Losses (Topic 326): Measurement of Credit Losses on Financial Instruments, which requires that entities use a new forward-looking “expected loss” model that generally will result in the earlier recognition of allowance for credit losses. The measurement of expected credit losses is based upon historical experience, current conditions, and reasonable and supportable forecasts that affect the collectability of the reported amount. We adopted this standard on January 1, 2020 using the modified retrospective approach. The implementation of this standard did not have a material impact on our consolidated financial statements.

In October 2021, the FASB issued ASU No. 2021-08, Business Combinations (Topic 805): Accounting for Contract Assets and Contract Liabilities from Contracts with Customers, or ASU No. 2021-08, which requires that an acquirer account for the related revenue contracts in accordance with Topic 606 as if it had originated the contracts. The acquiring entity shall recognize and measure the acquired contract assets and contract liabilities consistent with how they were recognized and measured in the acquiree’s financial statements, rather than at fair value at the acquisition date. ASU No. 2021-08 is effective for fiscal years beginning after December 15, 2022, with early adoption permitted. On October 1, 2021, we early adopted ASU No. 2021-08. The adoption of ASU No. 2021-08 did not have an impact on our consolidated financial statements.

In November 2021, the FASB issued ASU No. 2021-10, Government Assistance (Topic 832): Disclosures by Business Entities about Government Assistance, or ASU No. 2021-10, which requires business entities to disclose government assistance accounted for by applying a grant or contribution model by analogy. ASU No. 2021-10 states that an entity shall disclose the nature of the transactions, the related accounting policies used, the effect of the transactions on an entity's financial statements and significant terms and conditions of the transactions. ASU No. 2021-10 is effective for annual periods beginning after December 15, 2021, with early adoption permitted. On November 17, 2021, we early adopted ASU No. 2021-10. The adoption of ASU No. 2021-10 did not have a material impact on our consolidated financial statements.

XML

Real Estate Investments

12 Months Ended

Dec. 31, 2021

Real Estate [Abstract]

Real Estate Investments

Real Estate Investments

Our real estate properties, excluding those classified as held for sale, if any, consisted of land of $741,501 and buildings and improvements of $6,072,055 as of December 31, 2021, and land of $789,125 and buildings and improvements of $6,621,605 as of December 31, 2020. Accumulated depreciation was $1,587,573 and $150,234 for buildings and improvements, respectively, as of December 31, 2021; and $1,561,751 and $133,150 for buildings and improvements, respectively, as of December 31, 2020.

Our portfolio as of December 31, 2021 includes: 116 medical office and life science properties with approximately 9.8 million rentable square feet; 264 senior living communities, including independent living (including active adult), assisted living, memory care and skilled nursing facilities, or SNFs, with 27,672 living units; and 10 wellness centers with approximately 812,000 square feet of interior space plus outdoor developed facilities.

We have accounted for our 2019 acquisitions as acquisitions of assets. We funded these acquisitions using cash on hand and borrowings under our revolving credit facility, unless otherwise noted.

Joint Venture Activities:

As of December 31, 2021, we had an equity investment in a joint venture as follows:

Joint Venture	DHC Ownership	DHC Carrying Value of Investment at December 31, 2021		Number of Properties	Location	Square Feet
Seaport Innovation LLC	20%	$	215,127	1	Massachusetts	1,134,479

The following table provides a summary of the mortgage debts of this joint venture:

Joint Venture	Coupon Rate	Maturity Date	Principal Balance at December 31, 2021 (1)
Mortgage Notes Payable (secured by one property in Massachusetts)	3.53%	8/6/2026	$	620,000

(1)Amounts are not adjusted for our minority interest. We no longer include this $620,000 of secured debt financing in our consolidated balance sheet following the deconsolidation in December 2021 of the net assets of our joint venture which owns a life science property located in Boston, Massachusetts; however, DHC continues to provide certain guaranties on this debt.

In March 2017, we entered into a joint venture arrangement with an institutional investor for one of our life science properties located in Boston, Massachusetts. The investor owned a 45% equity interest in the joint venture, and we owned the remaining 55% equity interest in the joint venture. We determined that, while we owned a 55% equity interest in this joint venture, this joint venture was a variable interest entity, or VIE, as defined under the Consolidation Topic of the FASB Codification. We concluded that we must consolidate this VIE, and we did so, until we sold an additional 35% equity interest in the joint venture in December 2021. We reached this determination because we were the entity with the power to direct the activities that most significantly impacted the VIE's economic performance and we had the obligation to absorb losses of, and the right to receive benefits from, the VIE that could be significant to the VIE, and therefore were the primary beneficiary of the VIE. The assets of this VIE were $970,142 as of December 31, 2020 and consisted primarily of the net real estate owned by the joint venture. The liabilities of this VIE were $697,129 as of December 31, 2020 and consisted primarily of mortgage debts secured by the property. The joint venture investor's interest in this consolidated entity was reflected as noncontrolling interest in our consolidated financial statements.

In December 2021, we sold an additional 35% equity interest from our then remaining 55% equity interest in the joint venture which owns a life science property located in Boston, Massachusetts to another third party global institutional investor for $373,847, which includes certain costs associated with the formation of this joint venture. We deconsolidated the net assets of this joint venture and recognized a net gain on sale of $461,434 on this transaction, which is included in gain on sale of properties in our consolidated statements of comprehensive income (loss). After giving effect to the sale, we continue to own a 20% equity interest in this joint venture, but have determined that we are no longer the primary beneficiary. Effective as of the date of the sale, we deconsolidated this joint venture and we now account for this joint venture using the equity method of accounting under the fair value option. Our investment amount was based on a property valuation of $1,700,000, less $620,000 of existing mortgage debts on the property that this joint venture assumed. Pursuant to our credit agreement, the net cash proceeds to us from this transaction will be held as restricted cash. See Note 10 for more information regarding the use of the equity method for this joint venture.

In January 2022, we entered into a joint venture for 10 medical office and life science properties we owned with two unrelated third party global institutional investors for aggregate proceeds, before closing costs and other adjustments, of approximately $653,300. The investors acquired a 41% and 39% equity interest in the joint venture for an investment of approximately $100,800 and $95,900, respectively, and we retained a 20% equity interest in the joint venture. The investment amounts are based upon a property valuation of approximately $702,500, less approximately $456,600 of secured debt on the properties incurred by this joint venture.

Acquisitions:

The table below represents the purchase price allocations (including net closing adjustments) of acquisitions for the years ended December 31, 2021, 2020 and 2019:

Date	Location	Type of Property	Number of Properties	Number of Units	Cash Paid plus Assumed Debt (1)		Land		Buildings and Improvements		FF&E		Acquired Real Estate Leases / Resident Agreements		Acquired Real Estate Lease Obligations		Assumed Debt		Premium on  Assumed Debt
Acquisitions during the year ended December 31, 2021:
We did not acquire any properties during the year ended December 31, 2021.
Acquisitions during the year ended December 31, 2020:
We did not acquire any properties during the year ended December 31, 2020.
Acquisitions during the year ended December 31, 2019:
December 2019	Texas	IL	1	169	$	50,506	$	3,463	$	44,189	$	652	$	2,202	$	—	$	—	$	—

(1)Cash paid plus assumed debt, if any, includes closing costs.

In January 2020, we acquired a vacant land parcel adjacent to a life science property we own located in Tempe, Arizona for $2,600, excluding acquisition costs.

Impairment:

We regularly evaluate our assets for indicators of impairment. Impairment indicators may include declining tenant or resident occupancy, weak or declining profitability from the property, decreasing tenant cash flows or liquidity, our decision to dispose of an asset before the end of its estimated useful life, and legislative, market or industry changes that could permanently reduce the value of an asset. If indicators of impairment are present, we evaluate the carrying value of the affected assets by comparing it to the expected future cash flows to be generated from those assets. The future cash flows are subjective and are based in part on assumptions regarding hold periods, market rents and terminal capitalization rates. If the sum of these expected future cash flows is less than the carrying value, we reduce the net carrying value of the asset to its estimated fair value.

During 2021, we recorded a reversal of impairment charges of $174 related to the estimated costs to sell 10 senior living communities that were classified as held for sale in our consolidated balance sheet as of December 31, 2020 and changed the status of those communities from held for sale to held and used as of March 31, 2021. These impairment charges, in aggregate, are included in impairment of assets in our consolidated statements of comprehensive income (loss).

During 2020, we recorded impairment charges of $98,414 to adjust the carrying values of 28 senior living communities to their aggregate estimated fair value. These 28 senior living communities included nine senior living communities which we sold in 2020, seven senior living communities which we closed in 2020 and 10 senior living communities which were classified as held for sale in our consolidated balance sheet as of December 31, 2020. During 2020, we also recorded impairment charges of $8,558 to adjust the carrying value of seven medical office properties to their estimated fair value. We sold four of these medical office properties in 2020. One of these medical office properties was classified as held for sale in our consolidated balance sheet as of December 31, 2020 and sold in February 2021. These impairment charges, in aggregate, are included in impairment of assets in our consolidated statements of comprehensive income (loss).

During 2019, we recorded impairment charges of $72,166 to adjust the carrying values of 25 senior living communities to their aggregate estimated fair value. These 25 senior living communities included 15 SNFs which we sold in September 2019 and eight senior living communities which we sold in 2020. Two of these 25 senior living communities were classified as held for sale in our consolidated balance sheet as of December 31, 2019. During 2019, we also recorded impairment charges of $43,035 to adjust the carrying value of 20 medical office properties and one life science property to their estimated fair value. We sold five of these medical office properties, along with the life science property, in 2019. The remaining 15 medical office properties were classified as held for sale in our consolidated balance sheet as of December 31, 2019. In 2020, we sold 10 of these 15 medical office properties classified as held for sale. These impairment charges, in aggregate, are included in impairment of assets in our consolidated statements of comprehensive income (loss).

Dispositions:

During the years ended December 31, 2021, 2020 and 2019, we sold five, 27, and 46 properties, respectively, for aggregate sales prices of $104,500, $152,893, and $260,783, respectively, excluding closing costs, as presented in the table below. The sales of these properties do not represent significant dispositions, individually or in the aggregate, and we do not believe these sales represent a strategic shift in our business. As a result, the results of operations for these properties are included in continuing operations through the date of sale of such properties in our consolidated statements of comprehensive income (loss).

Date of Sale	Location	Type of Property	Number of Properties	Square Feet or Number of Units		Sales Price (1)		Gain (loss) on Sale
Dispositions during the year ended December 31, 2021:
February 2021	Pennsylvania	Medical Office	1	92,000	sq. ft.	$	9,000	$	(122)
April 2021	Florida	Life Science / Medical Office	4	263,656	sq. ft.	95,500		30,760
			5			$	104,500	$	30,638
Dispositions during the year ended December 31, 2020:
January 2020	Louisiana	Medical Office	6	40,575	sq. ft.	$	5,925	$	(81)
February 2020	Pennsylvania	Medical Office	1	50,000	sq. ft.	2,900		—
March 2020	Texas	Medical Office	1	70,229	sq. ft.	8,779		2,863
April 2020 (2)	California	IL / AL	3	599	units	47,000		(256)
June 2020	South Carolina	Medical Office	1	49,242	sq. ft.	3,550		—
July 2020	Texas	Medical Office	1	6,849	sq. ft.	2,072		(30)
July 2020	Connecticut	Medical Office	1	32,162	sq. ft.	625		(25)
August 2020 (2)	Mississippi	AL	2	116	units	2,500		(42)
September 2020	Mississippi	Medical Office	1	78,747	sq. ft.	7,250		(114)
October 2020	Various	AL	3	239	units	46,000		4,292
November 2020 (2)	Nebraska	AL	1	131	units	3,000		(26)
December 2020	New York	Medical Office	1	64,060	sq. ft.	3,875		(273)
December 2020	Ohio	Life Science	2	232,016	sq. ft.	7,917		257
December 2020 (2)	Wisconsin	SNF / AL	3	537	units	11,500		(303)
			27			$	152,893	$	6,262
Dispositions during the year ended December 31, 2019:
February 2019	Florida	Life Science	1	60,396	sq. ft.	$	2,900	$	(69)
March 2019	Massachusetts	Medical Office	1	4,400	sq. ft.	75		(58)
May 2019 (2)	California	SNF	3	278	units	21,500		15,207
May 2019	Colorado	Medical Office	1	15,647	sq. ft.	2,590		1,029
June 2019	Massachusetts	Medical Office	7	164,121	sq. ft.	8,042		1,590
July 2019	Massachusetts	Medical Office	3	103,484	sq. ft.	4,955		2,332
August 2019	Massachusetts	Medical Office	1	49,357	sq. ft.	2,221		812
September 2019 (2)	Various	SNF	15	964	units	8,000		—
September 2019	Massachusetts	Medical Office	1	41,065	sq. ft.	2,750		1,044
October 2019	South Dakota	SNF / IL	3	245	units	10,500		6,661
October 2019	New Jersey	Life Science	1	205,439	sq. ft.	47,500		—
December 2019	Georgia	Medical Office	1	95,010	sq. ft.	14,000		(63)
December 2019	Washington	IL	1	150	units	32,500		7,618
December 2019	Various	AL	7	566	units	103,250		3,593
			46			$	260,783	$	39,696

(1)Sales price excludes closing costs.

(2)These senior living communities were previously operated by Five Star.

During the year ended December 31, 2021, we recognized a gain of $200 related to the sales of skilled nursing bed licenses at certain of our senior living communities. During the year ended December 31, 2020, we recognized a gain of $225 related to the sale of bed licenses at one of our senior living communities.

We classify all properties as held for sale in our consolidated balance sheets that meet the applicable criteria for that treatment as set forth in the Property, Plant and Equipment Topic of the Codification. As of December 31, 2021, we had no properties classified as held for sale. As of December 31, 2020, we had 10 senior living communities with 820 units and five medical office and life science properties with 355,656 square feet classified as held for sale. As of December 31, 2019, we had 21 medical office and life science properties with 875,617 square feet and 12 senior living communities with 1,670 units classified as held for sale.

Investments and Capital Expenditures:

Under our previously existing leases with Five Star, Five Star could request that we purchase certain improvements to the leased communities. Pursuant to the Transaction Agreement, the $111,603 of improvements to communities leased to Five Star, including $49,155 of fixed assets and improvements that were purchased pursuant to the Transaction Agreement, that we funded during the year ended December 31, 2019 did not result in increased rent payable by Five Star. See Note 6 for further information regarding the 2020 Restructuring Transaction and the Transaction Agreement.

During 2021, we committed $97,520 for capital expenditures related to 2.6 million square feet of leases executed at our medical office and life science properties. During 2020, we committed $17,901 for capital expenditures related to 1.0 million square feet of leases executed at our medical office and life science properties.

Committed and unspent tenant related obligations based on executed leases as of December 31, 2021 and 2020 were $76,573 and $19,159, respectively.

XML

Leases

12 Months Ended

Dec. 31, 2021

Leases [Abstract]

Leases

Leases

We are a lessor of medical office and life science properties, senior living communities and other healthcare related properties. Our leases provide our tenants with the contractual right to use and economically benefit from all of the premises demised under the leases; therefore, we have determined to evaluate our leases as lease arrangements.

We increased rental income to record revenue on a straight line basis by $5,846, $6,069 and $4,508 for the years ended December 31, 2021, 2020 and 2019, respectively. Rents receivable, excluding receivables related to our properties classified as held for sale, if any, include $82,131 and $104,803 of straight line rent receivables at December 31, 2021 and 2020, respectively, and are included in other assets, net in our consolidated balance sheets.

We do not include in our measurement of our lease receivables certain variable payments, including changes in the index or market based indices after the inception of the lease, certain tenant reimbursements and other income until the specific events that trigger the variable payments have occurred. Such payments totaled $74,860, $77,599 and $78,668 for the years ended December 31, 2021, 2020 and 2019, respectively, of which tenant reimbursements totaled $72,690, $75,378 and $75,432, respectively.

The following table presents our operating lease maturity analysis, excluding lease payments from properties classified as held for sale, if any, as of December 31, 2021:

Year	Amount
2022	$	236,309
2023	234,633
2024	219,532
2025	197,712
2026	181,819
Thereafter	812,989
Total	$	1,882,994

Right of Use Asset and Lease Liability. For leases where we are the lessee, we recognized a right of use asset and a lease liability equal to the present value of the minimum lease payments with rental payments being applied to the lease liability and the right of use asset being amortized over the term of the lease. The values of the right of use asset and related liability representing our future obligation under the lease arrangement for which we are the lessee were $4,153 and $4,352, respectively, as of December 31, 2021, and $4,237 and $4,410, respectively, as of December 31, 2020. The right of use asset and related lease liability are included within other assets, net and other liabilities, respectively, within our consolidated balance sheets. In addition, we lease equipment at certain of our managed senior living communities. These leases are short term in nature, are cancelable with no fee or do not result in an annual expense in excess of our capitalization policy and, as a result, are not recorded on our consolidated balance sheets.

XML

Shareholders' Equity

12 Months Ended

Dec. 31, 2021

Stockholders' Equity Note [Abstract]

Shareholders' Equity

Shareholders' Equity

We have common shares available for issuance under the terms of our equity compensation plan adopted in 2012, as amended, or the 2012 Plan. During the years ended December 31, 2021, 2020 and 2019, we awarded to our officers and other employees of RMR LLC annual share awards of 718,000, 360,000 and 187,500 of our common shares, respectively, valued at $2,448, $1,357 and $1,633, in aggregate, respectively. In accordance with our Trustee compensation arrangements, we also awarded each of our then Trustees 20,000 common shares with an aggregate value of $444 ($74 per Trustee), 10,000 common shares with an aggregate value of $176 ($29 per Trustee) and 3,000 common shares with an aggregate value of $119 ($24 per Trustee) in 2021, 2020 and 2019, respectively. The values of the share awards were based upon the closing price of our common shares trading on The Nasdaq Stock Market LLC, or Nasdaq, on the dates of awards. The common shares awarded to our Trustees vested immediately. The common shares awarded to our officers and certain other employees of RMR LLC vest in five equal annual installments beginning on the date of award. We include the value of awarded shares in general and administrative expenses in our consolidated statements of comprehensive income (loss) ratably over the vesting period. At December 31, 2021, 1,117,201 of our common shares remain available for issuance under the 2012 Plan.

A summary of shares awarded, forfeited, vested and unvested under the terms of the 2012 Plan from January 1, 2019 to December 31, 2021 is as follows:

	Number of Shares	Weighted Average Award Date Fair Value
Unvested shares at December 31, 2018	161,990	$	19.41
Shares awarded in 2019	202,500	$	8.65
Shares vested / forfeited in 2019	(137,150)	$	8.94
Unvested shares at December 31, 2019	227,340	$	12.52
Shares awarded in 2020	420,000	$	3.65
Shares vested / forfeited in 2020	(212,790)	$	7.04
Unvested shares at December 31, 2020	434,550	$	6.15
Shares awarded in 2021	838,000	$	3.45
Shares vested / forfeited in 2021	(426,930)	$	4.98
Unvested shares at December 31, 2021	845,620	$	4.07

The 845,620 unvested shares as of December 31, 2021 are scheduled to vest as follows: 253,520 shares in 2022, 239,700 shares in 2023, 208,800 shares in 2024 and 143,600 shares in 2025. As of December 31, 2021, the estimated future compensation for the unvested shares was $3,116 based on the adjusted award date fair value of these shares. At December 31, 2021, the weighted average period over which the compensation expense will be recorded is approximately 2.0 years. We recorded share based compensation expense of $1,960 in 2021, $1,568 in 2020 and $1,388 in 2019. We recognize forfeitures as they occur.

During 2021, 2020 and 2019, we purchased an aggregate of 109,384, 47,375 and 31,747, respectively, of our common shares from our officers and certain current and former officers and employees of RMR LLC in satisfaction of tax withholding and payment obligations in connection with the vesting of awards of our common shares. See Note 8 for further information regarding these purchases.

A summary of cash distributions paid to common shareholders, for federal income tax purposes, as are follows for the periods presented:

	Annual Per				Characterization of Distribution
	Share		Total		Ordinary		Capital		Return of
Year	Distribution		Distribution		Income		Gain		Capital
2021	$	0.04	$	9,540	—	%	100.0	%	—	%
2020	$	0.18	$	42,825	—	%	—	%	100.0	%
2019	$	0.84	$	199,719	—	%	25.7	%	74.3	%

On January 13, 2022, we declared a quarterly distribution to common shareholders of record on January 24, 2022 of $0.01 per share, or approximately $2,390 in aggregate. We paid this distribution on February 17, 2022, using cash on hand.

As described in Note 6, pursuant to the 2020 Restructuring Transaction, on January 1, 2020, AlerisLife issued an aggregate of 16,118,849 common shares, with an aggregate value of $59,801, to our shareholders of record as of December 13, 2019. We recorded this issuance as a non-cash distribution in our consolidated financial statements.

XML

Senior Living Community Leases and Management Agreements

12 Months Ended

Dec. 31, 2021

Risks and Uncertainties [Abstract]

Senior Living Community Leases and Management Agreements

Senior Living Community Leases and Management Agreements

As of December 31, 2019, we leased 166 senior living communities to Five Star. As of that date, we also leased to our TRSs 78 communities that we owned and that were managed by Five Star for our account.

Restructuring our Business Arrangements with Five Star

The Transaction Agreement with Five Star. Pursuant to the Transaction Agreement, effective January 1, 2020, or the Conversion Time:

•our previously existing master leases with Five Star for all of our senior living communities that Five Star leased, as well as our previously existing management agreements and pooling agreements with Five Star for our senior living communities that Five Star managed, were terminated and replaced with new management agreements and a related omnibus agreement, which agreements were subsequently replaced in June 2021, as described below;

•AlerisLife issued to us 10,268,158 of its common shares and an aggregate of approximately 16,118,849 to our shareholders of record as of December 13, 2019;

•as consideration for these share issuances, we provided Five Star with $75,000 of additional consideration by assuming certain of Five Star's working capital liabilities and making cash payments to Five Star, resulting in a gain on lease termination of $22,896 for the year ended December 31, 2020 in our consolidated statements of comprehensive income (loss); and

•pursuant to a guaranty agreement dated as of January 1, 2020 and amended and restated on June 9, 2021, made by AlerisLife in favor of our applicable subsidiaries, AlerisLife has guaranteed the payment and performance of each of its applicable subsidiary's obligations under our applicable management agreements with Five Star.

Also pursuant to the Transaction Agreement: (1) commencing February 1, 2019, the aggregate amount of monthly minimum rent payable to us by Five Star under our previously existing master leases with Five Star was set at $11,000 as of February 1, 2019, subject to adjustment, and subsequently reduced in accordance with the Transaction Agreement as a result of our subsequent sales of certain of the leased senior living communities, and no additional rent was payable to us by Five Star from such date until the Conversion Time; and (2) as of April 1, 2019, we purchased from Five Star $49,155 of unencumbered Qualifying PP&E (as defined in the Transaction Agreement) related to our senior living communities leased and operated by Five Star.

2021 Amendments to our Management Arrangements with Five Star. On June 9, 2021, we amended our management arrangements with Five Star. The principal changes to the management arrangements included:

•that Five Star agreed to cooperate with us in transitioning 108 of our senior living communities with approximately 7,500 living units to other third party managers without our payment of any termination fee to Five Star;

•that we no longer have the right to sell up to an additional $682,000 of senior living communities currently managed by Five Star and terminate Five Star's management of those communities without our payment of a fee to Five Star upon sale;

•that Five Star is continuing to manage 120 of our senior living communities, and that the skilled nursing units in all of our continuing care retirement communities that Five Star is continuing to manage, which then included approximately 1,500 living units, were closed and are being evaluated and repositioned;

•that beginning in 2025, we will have the right to terminate up to 10% of the senior living communities that Five Star is continuing to manage, based on total revenues per year for failure to meet 80% of a target EBITDA for the applicable period;

•that the incentive fee that Five Star may earn in any calendar year for the senior living communities that Five Star is continuing to manage is no longer subject to a cap and that any senior living communities that are undergoing a major renovation or repositioning are excluded from the calculation of the incentive fee;

•that RMR LLC will oversee any major renovation or repositioning activities at the senior living communities that Five Star is continuing to manage; and

•that the term of our management agreements with Five Star for our senior living communities that Five Star is continuing to manage was extended by two years to December 31, 2036.

Pursuant to these changes, we and Five Star entered into an amended and restated master management agreement, or the Master Management Agreement, for the senior living communities that Five Star is continuing to manage. In addition, AlerisLife delivered to us a related amended and restated guaranty agreement pursuant to which AlerisLife is continuing to guarantee the payment and performance of each of its applicable subsidiary's obligations under the applicable management agreements.

Pursuant to the Master Management Agreement, Five Star receives a management fee equal to 5% of the gross revenues realized at the applicable senior living communities plus reimbursement for its direct costs and expenses related to such communities. Commencing with the calendar year 2021, Five Star may receive an annual incentive fee equal to 15% of the amount by which the annual earnings before interest, taxes, depreciation and amortization, or EBITDA, of all communities on a combined basis exceeds the target EBITDA for all communities on a combined basis for such calendar year. The target EBITDA for those communities on a combined basis is increased annually based on the greater of the annual increase of the consumer price index, or CPI, or 2%, plus 6% of any capital investments funded at the managed communities on a combined basis in excess of the target capital investment. Unless otherwise agreed, the target capital investment increases annually based on the greater of the annual increase of CPI or 2%. Any senior living communities that are undergoing a major renovation or repositioning are excluded from the calculation of the incentive fee.

The Master Management Agreement expires in 2036, subject to Five Star's right to extend for two consecutive five year terms if Five Star achieves certain performance targets for the combined managed communities portfolio, unless earlier terminated. Pursuant to the Master Management Agreement, beginning in 2025, we have the right to terminate up to 10% of the senior living communities that Five Star is continuing to manage, based on total revenues per year for failure to meet 80% of a target EBITDA for the applicable period. Pursuant to a guaranty agreement dated as of January 1, 2020, and subsequently amended and restated on June 9, 2021, made by AlerisLife in favor of our applicable subsidiaries, AlerisLife has guaranteed the payment and performance of each of its applicable subsidiary's obligations under the Master Management Agreement.

On April 1, 2019, we concluded that the 2020 Restructuring Transaction constituted a reconsideration event requiring us to assess whether we held a controlling financial interest in AlerisLife. As a result of this assessment, we determined that AlerisLife was a VIE effective as of the date of the Transaction Agreement. We determined not to consolidate AlerisLife in our consolidated financial statements, as we do not have the power to direct the activities of AlerisLife that most significantly impact AlerisLife's economic performance and therefore are not the primary beneficiary of AlerisLife. Effective January 1, 2020, we determined that AlerisLife is not a VIE and we will account for our equity investment in AlerisLife using the equity method of accounting because we are deemed to exert significant influence, but not control, over AlerisLife's most significant activities. We have elected to use the fair value option to account for our investment in AlerisLife.

As of December 31, 2021, we had transitioned 107 of the 108 senior living communities, containing 7,340 living units, from Five Star to new third party managers. The remaining senior living community was closed and we are assessing opportunities to redevelop that property. We lease nearly all of our senior living communities, including those managed by Five Star and by the new third party managers, to our TRSs. We incurred and expect to continue to incur costs related to retention and other transition costs for the 107 transitioned communities. For the year ended December 31, 2021, we recorded $17,363 of these costs, of which $13,311 represent expenses reimbursed to Five Star, to acquisition and certain other transaction related costs in our consolidated statements of comprehensive income (loss).

The terms of the management agreements with the new third party managers are generally as follows: the new third party managers will receive a management fee equal to 5% to 6% of the gross revenues realized at the applicable senior living communities plus reimbursement for direct costs and expenses related to such communities. These agreements generally also provide for the new third party managers to earn a minimum base fee for a portion of the term of the agreement. Additionally, the new third party managers have the ability to earn incentive fees equal to 15% to 25% of the amount by which EBITDA of the applicable communities exceeds the target EBITDA for the applicable communities. The new third party managers can also earn a construction supervision fee ranging between 3% and 5% of construction costs.

The initial terms of the management agreements with the new third party managers are generally five years, subject to automatic extensions of successive terms of two years each unless earlier terminated or timely notice of nonrenewal is delivered. The management agreements with the new third party managers also generally provide us with the right to terminate the management agreements for communities that do not earn 70% to 80% of the target EBITDA for such communities, after an agreed upon stabilized period.

Our Senior Living Communities Formerly Leased by Five Star. Prior to the Conversion Time, we leased senior living communities to Five Star pursuant to five master leases with Five Star, each of which was terminated as of January 1, 2020 pursuant to the Transaction Agreement.

Under our previously existing leases with Five Star, Five Star paid us annual rent plus percentage rent equal to 4.0% of the increase in gross revenues at certain of our senior living communities over base year gross revenues as specified in the applicable leases. Pursuant to the Transaction Agreement, commencing February 1, 2019, no percentage rent was payable to us by Five Star and annual rent payable to us by Five Star was adjusted as noted above. We previously determined percentage rent due under these leases annually and recognized it when all contingencies were met, which was typically at year end. We recognized total rental income from Five Star of $137,898 (including percentage rent of $538) for the year ended December 31, 2019.

Our previously existing leases with Five Star were “triple net” leases, which generally required Five Star to pay rent and all property operating expenses, to indemnify us from liability which may arise by reason of our ownership of the properties, to maintain the properties at Five Star's expense, to remove and dispose of hazardous substances on the properties in compliance with applicable law and to maintain insurance on the properties for Five Star's and our benefit.

Under our previously existing leases with Five Star, Five Star could request that we purchase certain improvements to the leased communities and, until we entered into the Transaction Agreement, the annual rent payable to us by Five Star would increase in accordance with a formula specified in the applicable lease in return for such purchases. Pursuant to the Transaction Agreement, the $111,603 of improvements to communities leased to Five Star, including $49,155 of fixed assets and improvements that were purchased pursuant to the Transaction Agreement as discussed above, that we funded during the year ended December 31, 2019 did not result in increased rent payable by Five Star.

As of December 31, 2019, Five Star was our most significant tenant. The following is a summary of the assets leased to and revenues earned from Five Star as a tenant as of and for the year ended December 31, 2019 compared to all our other assets and revenues from all sources:

	As of December 31, 2019
	Gross Book Value of Real Estate Assets (1)		% of Total
Five Star (2)	$	2,286,951	27.2	%
All others (3)	6,133,672		72.8	%
	$	8,420,623	100.0	%

(1)    Represents the gross book value of real estate assets at cost plus certain acquisition costs, before depreciation and purchase price allocations, less impairment write downs, if any. Five Star also managed some of our managed senior living communities as of December 31, 2019. The gross book value of real estate assets of $1,920,070 as of December 31, 2019 for those managed senior living communities is included in the "All others" category.

(2)    Includes gross book value of real estate assets of $50,951 classified as held for sale in our consolidated balance sheet as of December 31, 2019.

(3)    Includes gross book value of real estate assets of $213,416 classified as held for sale in our consolidated balance sheet as of December 31, 2019.

	Year Ended
	December 31, 2019
	Total Revenues(1)		% of Total
Five Star	$	137,898	13.3	%
All others	902,257		86.7	%
	$	1,040,155	100.0	%

(1)    Five Star also managed some of our managed senior living communities as of December 31, 2019. Our revenues of $433,597 for the year ended December 31, 2019, from those communities are included in the “All others” category.

Our Senior Living Communities Managed by Five Star. Five Star managed 120, 235 and 78 senior living communities for our account as of December 31, 2021, 2020 and 2019, respectively. We lease our senior living communities that are managed by Five Star to our TRSs, and Five Star manages these communities pursuant to long term management agreements. As described above, pursuant to the Transaction Agreement, effective January 1, 2020, we replaced our long term management and pooling agreements with Five Star with new management agreements and a related omnibus agreement, which agreements were subsequently replaced in June 2021 with the Master Management Agreement, the terms of which are described above.

We incurred management fees payable to Five Star of $47,479, $62,880 and $15,327 for the years ended December 31, 2021, 2020 and 2019, respectively. For the years ended December 31, 2021 and 2020, $43,864 and $60,413, respectively, of the total management fees were expensed to property operating expenses in our consolidated statements of comprehensive income (loss) and $3,615 and $2,467, respectively, were capitalized in our consolidated balance sheets and are being depreciated over the estimated useful lives of the related capital assets.

In addition to providing management services to us, Five Star also provides certain other services to residents at some of the senior living communities it manages for us, such as rehabilitation services. At senior living communities Five Star manages for us where Five Star provides rehabilitation services on an outpatient basis, the residents, third party payers or government programs pay Five Star for those rehabilitation services. At senior living communities Five Star manages for us where Five Star provides both inpatient and outpatient rehabilitation services, we generally pay Five Star for those rehabilitation services and charges for these services are included in amounts charged to residents, third party payers or government programs. We incurred fees of $11,233, $25,687 and $5,920 for the years ended December 31, 2021, 2020 and 2019, respectively, with respect to rehabilitation services Five Star provided at senior living communities that are payable by us. These amounts are included in property operating expenses in our consolidated statements of comprehensive income (loss).

As a result of routine monitoring protocols that are a part of Five Star's compliance program activities related to Medicare billing, Five Star discovered potentially inadequate documentation at one of our senior living communities that Five Star manages. This monitoring was not initiated in response to any specific complaint or allegation but rather was of the type that Five Star periodically undertakes to test its compliance with applicable Medicare billing rules. We and Five Star voluntarily disclosed this matter to the United States Department of Health and Human Services, Office of the Inspector General, or the OIG, pursuant to the OIG's Provider Self-Disclosure Protocol. In January 2021, we and Five Star settled this matter with the OIG and we agreed to pay approximately $5,763 in exchange for a customary release, but we and Five Star did not admit any liability. We paid that amount to the OIG in January 2021. Five Star refunded to us $115 of management fees it previously received relating to the Medicare payments we refunded to the OIG. With respect to this settlement amount, we accrued a revenue reserve of $3,842 at December 31, 2020 for historical Medicare payments we received and agreed to repay to the OIG and we recorded expenses of $1,921 for the year ended December 31, 2020 for OIG-imposed penalties.

Since January 1, 2020, we sold certain senior living communities that were then managed by Five Star. We and Five Star terminated our management agreements for these senior living communities in connection with these sales. See Note 3 for further information regarding these sales. During 2021, we transitioned 107 senior living communities from Five Star to new third party managers and we closed one senior living community that was previously managed by Five Star.

We lease to Five Star space at certain of our senior living communities, which it uses to provide certain outpatient rehabilitation and wellness services. We recorded $1,591 and $1,561 for the years ended December 31, 2021 and 2020, respectively, with respect to these leases.

The following table presents residents fees and services revenue from our managed senior living communities disaggregated by the type of contract and payer:

	Year Ended December 31,
Revenue from contracts with customers:	2021		2020		2019
Basic housing and support services	$	750,644	$	856,687	$	353,699
Medicare and Medicaid programs	98,273		173,878		31,324
Private pay and other third party payer SNF services	125,706		174,246		48,574
Total residents fees and services	$	974,623	$	1,204,811	$	433,597

XML

Business and Property Management Agreements with RMR LLC

12 Months Ended

Dec. 31, 2021

Related Party Transactions [Abstract]

Business and Property Management Agreements with RMR LLC

Business and Property Management Agreements with RMR LLC

We have no employees. The personnel and various services we require to operate our business are provided to us by RMR LLC. We have two agreements with RMR LLC to provide management services to us: (1) a business management agreement, which relates to our business generally, and (2) a property management agreement, which relates to the property level operations of our medical office and life science properties and major renovation or repositioning activities at our senior living communities that we may request RMR LLC to manage from time to time. We also have a subsidiary level management agreement with RMR LLC related to the life science property located in Boston, Massachusetts, which we entered in connection with the joint venture arrangement for that life science property. Under that agreement, our subsidiary pays RMR LLC certain management fees directly, which fees are credited against the business management fees payable by us to RMR LLC. On December 23, 2021, we sold a 35% equity interest in that joint venture to another third party global institutional investor. As a result of that sale, our equity interest in the joint venture was reduced to 20% and the joint venture then ceased to be a subsidiary of ours. Accordingly, we will no longer consolidate this joint venture and fees payable by the joint venture to RMR LLC will no longer be credited against the fees we pay to RMR LLC. See Note 3 for further information regarding this sale and Note 8 for further information regarding our relationship, agreements and transactions with RMR LLC.

Management Agreements with RMR LLC. Our management agreements with RMR LLC provide for an annual base management fee, an annual incentive management fee and property management and construction supervision fees, payable in cash, among other terms:

•Base Management Fee. The annual base management fee payable to RMR LLC by us for each applicable period is equal to the lesser of:

◦the sum of (a) 0.5% of the daily weighted average of the aggregate book value of our real estate assets owned by us or our subsidiaries as of October 12, 1999, or the Transferred Assets, plus (b) 0.7% of the average aggregate historical cost of our real estate investments excluding the Transferred Assets up to $250,000, plus (c) 0.5% of the average aggregate historical cost of our real estate investments excluding the Transferred Assets exceeding $250,000; and

◦the sum of (a) 0.7% of the average closing price per share of our common shares on the stock exchange on which such shares are principally traded during such period, multiplied by the average number of our common shares outstanding during such period, plus the daily weighted average of the aggregate liquidation preference of each class of our preferred shares outstanding during such period, plus the daily weighted average of the aggregate principal amount of our consolidated indebtedness during such period, or, together, our Average Market Capitalization, up to $250,000, plus (b) 0.5% of our Average Market Capitalization exceeding $250,000.

The average aggregate historical cost of our real estate investments includes our consolidated assets invested, directly or indirectly, in equity interests in or loans secured by real estate and personal property owned in connection with such real estate (including acquisition related costs and costs which may be allocated to intangibles or are unallocated), all before reserves for depreciation, amortization, impairment charges or bad debts or other similar non-cash reserves.

•Incentive Management Fee. The incentive management fee which may be earned by RMR LLC for an annual period is calculated as follows:

•An amount, subject to a cap, based on the value of our common shares outstanding, equal to 12.0% of the product of:

◦our equity market capitalization on the last trading day of the year immediately prior to the relevant three year measurement period, and

◦the amount (expressed as a percentage) by which the total return per share, as defined in the business management agreement and further described below, of our common shareholders (i.e., share price appreciation plus dividends) exceeds the total shareholder return of the applicable market index, or the benchmark return per share, for the relevant measurement period. Effective August 1, 2021, we and RMR LLC amended our business management agreement to replace the benchmark index used in the calculation of incentive management fees. Pursuant to the amendment, for periods beginning on and after August 1, 2021, the MSCI U.S. REIT/Health Care REIT Index replaced the discontinued SNL U.S. REIT Healthcare Index and will be used to calculate benchmark returns per share for purposes of determining any incentive management fee payable by us to RMR LLC. For periods prior to August 1, 2021, the SNL U.S. REIT Healthcare Index continued to be used. Accordingly, the calculation of incentive management fees for the next two measurement periods will continue to use the SNL U.S. REIT Healthcare Index in calculating the benchmark returns for periods through July 31, 2021. This change of index was due to S&P Global ceasing to publish the SNL U.S. REIT Healthcare Index.

For purposes of the total return per share of our common shareholders, share price appreciation for a measurement period is determined by subtracting (1) the closing price of our common shares on Nasdaq on the last trading day of the year immediately before the first year of the applicable measurement period, or the initial share price, from (2) the average closing price of our common shares on the 10 consecutive trading days having the highest average closing prices during the final 30 trading days in the last year of the measurement period.

◦The calculation of the incentive management fee (including the determinations of our equity market capitalization, initial share price and the total return per share of our common shareholders) is subject to adjustments if we issue or repurchase our common shares, or if our common shares are forfeited, during the measurement period.

◦No incentive management fee is payable by us unless our total return per share during the measurement period is positive.

◦The measurement periods are three year periods ending with the year for which the incentive management fee is being calculated.

◦If our total return per share exceeds 12.0% per year in any measurement period, the benchmark return per share is adjusted to be the lesser of the total shareholder return of the applicable market index for such measurement period and 12.0% per year, or the adjusted benchmark return per share. In instances where the adjusted benchmark return per share applies, the incentive management fee will be reduced if our total return per share is between 200 basis points and 500 basis points below the applicable market index in any year, by a low return factor, as defined in the business management agreement, and there will be no incentive management fee paid if, in these instances, our total return per share is more than 500 basis points below the applicable market index in any year, determined on a cumulative basis (i.e., between 200 basis points and 500 basis point per year multiplied by the number of years in the measurement period and below the applicable market index).

◦The incentive management fee is subject to a cap. The cap is equal to the value of the number of our common shares which would, after issuance, represent 1.5% of the number of our common shares then outstanding multiplied by the average closing price of our common shares during the 10 consecutive trading days having the highest average closing prices during the final 30 trading days of the relevant measurement period.

◦Incentive management fees we paid to RMR LLC for any period may be subject to “clawback” if our financial statements for that period are restated due to material non-compliance with any financial reporting requirements under the securities laws as a result of the bad faith, fraud, willful misconduct or gross negligence of RMR LLC and the amount of the incentive management fee we paid was greater than the amount we would have paid based on the restated financial statements.

Pursuant to our business management agreement with RMR LLC, we recognized net business management fees of $23,378, $20,629 and $27,399 for the years ended December 31, 2021, 2020 and 2019, respectively. The net business management fees we recognized are included in general and administrative expenses in our consolidated statements of

comprehensive income (loss) for these periods. The net business management fees we recognized for the years ended December 31, 2021, 2020 and 2019 reflect a reduction of $2,974, for each of those years for the amortization of the liability we recorded in connection with, our former investment in RMR Inc., as further described in Note 8.

Pursuant to our business management agreement with RMR LLC, in January 2019, we paid RMR LLC an incentive management fee of $40,642 for the year ended December 31, 2018. We did not recognize an incentive management fee payable to RMR LLC for the years ended December 31, 2021, 2020 or 2019.

•Property Management and Construction Supervision Fees. The property management fees payable to RMR LLC by us for each applicable period are equal to 3.0% of gross collected rents and the construction supervision fees payable to RMR LLC by us for each applicable period are equal to 5.0% of construction costs. In connection with our entry into the Master Management Agreement, on June 9, 2021, we and RMR LLC amended our property management agreement to, among other things, provide for RMR LLC's oversight of any major capital projects and repositionings at our senior living communities, including our senior living communities which Five Star is continuing to manage, and that RMR LLC will receive the same fee previously paid to Five Star for such services, which is equal to 3.0% of the cost of any such major capital project or repositioning.

We recognized aggregate net property management and construction supervision fees of $12,504, $13,802 and $13,141 for the years ended December 31, 2021, 2020 and 2019, respectively. The net property management and construction supervision fees we recognized for the years ended December 31, 2021, 2020 and 2019 reflect a reduction of $797 for each of those years for the amortization of the liability we recorded in connection with our former investment in RMR Inc., as further described in Note 8. For the years ended December 31, 2021, 2020 and 2019, $9,684, $10,084 and $10,705, respectively, of property management fees were expensed to property operating expenses in our consolidated statements of comprehensive income (loss) and $2,820, $3,718 and $2,436, respectively, were capitalized as building improvements in our consolidated balance sheets and are being depreciated over the estimated useful lives of the related capital assets.

Expense Reimbursement. We are generally responsible for all our operating expenses, including certain expenses incurred or arranged by RMR LLC on our behalf. We are generally not responsible for payment of RMR LLC's employment, office or administrative expenses incurred to provide management services to us, except for the employment and related expenses of RMR LLC's employees assigned to work exclusively or partly at our properties, our share of the wages, benefits and other related costs of RMR LLC's centralized accounting personnel, our share of RMR LLC's costs for providing our internal audit function, or as otherwise agreed. Our Audit Committee appoints our Director of Internal Audit and our Compensation Committee approves the costs of our internal audit function. Our property level operating expenses are generally incorporated into the rents charged to our tenants, including certain payroll and related costs incurred by RMR LLC. We reimbursed RMR LLC $13,161, $13,805 and $13,373 for these costs and expenses for the years ended December 31, 2021, 2020 and 2019, respectively. These amounts are included in property operating expenses or general and administrative expenses, as applicable, in our consolidated statements of comprehensive income (loss) for these periods.

Term. Our management agreements with RMR LLC have terms that end on December 31, 2041, and automatically extend on December 31st of each year for an additional year, so that the terms of our management agreements thereafter end on the 20th anniversary of the date of the extension.

Termination Rights. We have the right to terminate one or both of our management agreements with RMR LLC: (i) at any time on 60 days' written notice for convenience, (ii) immediately on written notice for cause, as defined therein, (iii) on written notice given within 60 days after the end of an applicable calendar year for a performance reason, as defined therein, and (iv) by written notice during the 12 months following a change of control of RMR LLC, as defined therein. RMR LLC has the right to terminate the management agreements for good reason, as defined therein.

Termination Fee. If we terminate one or both of our management agreements with RMR LLC for convenience, or if RMR LLC terminates one or both of our management agreements for good reason, we have agreed to pay RMR LLC a termination fee in an amount equal to the sum of the present values of the monthly future fees, as defined therein, for the terminated management agreement(s) for the term that was remaining prior to such termination, which, depending on the time of termination would be between 19 and 20 years. If we terminate one or both of our management agreements with RMR LLC for a performance reason, we have agreed to pay RMR LLC the termination fee calculated as described above, but assuming a 10 year term was remaining prior to the termination. We are not required to pay any termination fee if we terminate our management agreements with RMR LLC for cause or as a result of a change of control of RMR LLC.

Transition Services. RMR LLC has agreed to provide certain transition services to us for 120 days following an applicable termination by us or notice of termination by RMR LLC, including cooperating with us and using commercially

reasonable efforts to facilitate the orderly transfer of the management and real estate investment services provided under our business management agreement and to facilitate the orderly transfer of the management of the managed properties under our property management agreement, as applicable.

Vendors. Pursuant to our management agreements with RMR LLC, RMR LLC may from time to time negotiate on our behalf with certain third party vendors and suppliers for the procurement of goods and services to us. As part of this arrangement, we may enter agreements with RMR LLC and other companies to which RMR LLC or its subsidiaries provide management services for the purpose of obtaining more favorable terms from such vendors and suppliers.

Investment Opportunities. Under our business management agreement with RMR LLC, we acknowledge that RMR LLC may engage in other activities or businesses and act as the manager to any other person or entity (including other REITs) even though such person or entity has investment policies and objectives similar to ours and we are not entitled to preferential treatment in receiving information, recommendations and other services from RMR LLC.

XML

Related Person Transactions

12 Months Ended

Dec. 31, 2021

Related Party Transactions [Abstract]

Related Person Transactions

Related Person Transactions

We have relationships and historical and continuing transactions with AlerisLife (including Five Star), RMR LLC, RMR Inc. and others related to them, including other companies to which RMR LLC or its subsidiaries provide management services and some of which have trustees, directors or officers who are also our Trustees or officers. RMR Inc. is the managing member of RMR LLC. The Chair of our Board and one of our Managing Trustees, Adam D. Portnoy, as the sole trustee of ABP Trust, is the controlling shareholder of RMR Inc., is a managing director and the president and chief executive officer of RMR Inc., an officer and employee of RMR LLC and the chair of the board and a managing director of AlerisLife. Jennifer F. Francis, our other Managing Trustee and our President and Chief Executive Officer, and our Chief Financial Officer and Treasurer are also employees and officers of RMR LLC. Jennifer B. Clark, our Secretary and former Managing Trustee, also serves as a managing director and the executive vice president, general counsel and secretary of RMR Inc., an officer and employee of RMR LLC, an officer of ABP Trust and a managing director and secretary of AlerisLife. Certain of AlerisLife's officers are officers and employees of RMR LLC. Some of our Independent Trustees also serve as independent trustees or independent directors of other public companies to which RMR LLC or its subsidiaries provide management services. Adam Portnoy serves as the chair of the board and as a managing director or managing trustee of these companies. Other officers of RMR LLC, including Ms. Clark and certain of our officers, serve as managing trustees, managing directors or officers of certain of these companies. In addition, officers of RMR LLC and RMR Inc. serve as our officers and officers of other companies to which RMR LLC or its subsidiaries provide management services.

AlerisLife. We are currently AlerisLife's largest stockholder. As of December 31, 2021, we owned 10,691,658 of AlerisLife's common shares, or approximately 32.7% of AlerisLife's outstanding common shares. As of December 31, 2019, Five Star was our largest tenant and the manager of our managed senior living communities. Five Star manages certain of the senior living communities we own pursuant to the Master Management Agreement. RMR LLC provides management services to both us and Five Star. Five Star participates in our property insurance program for the senior living communities Five Star owns and leases. The premiums Five Star pays for this coverage are allocated pursuant to a formula based on the profiles of the properties included in the program. See Note 6 for further information regarding our relationships, agreements and transactions with AlerisLife (including Five Star), and Note 10 for further information regarding our investment in AlerisLife.

As of December 31, 2021, ABP Acquisition LLC, a subsidiary of ABP Trust, the controlling shareholder of RMR Inc., together with ABP Trust, owned approximately 6.2% of AlerisLife's outstanding common shares.

In order to effect our distribution of AlerisLife common shares to our shareholders in 2001 and to govern our relations with AlerisLife (including Five Star), thereafter, AlerisLife (including Five Star) entered agreements with us and others, including RMR LLC. Since then, we have entered various leases, management agreements and other agreements with AlerisLife (including Five Star) that include provisions that confirm and modify these undertakings. Among other things, these agreements provide that:

•so long as we remain a REIT, AlerisLife may not waive the share ownership restrictions in its charter that prohibit any person or group from acquiring more than 9.8% (in value or number of shares, whichever is more restrictive) of the outstanding shares of any class of AlerisLife stock without our consent;

•so long as Five Star is our tenant or manager, AlerisLife will not permit nor take any action that, in our reasonable judgment, might jeopardize our qualification for taxation as a REIT;

•we have the right to terminate our management agreements with Five Star upon the acquisition by a person or group of more than 9.8% of AlerisLife's voting stock or other change in control events, as defined therein affecting AlerisLife, including the adoption of any shareholder proposal (other than a precatory proposal) or the election to AlerisLife's board of directors of any individual, if such proposal or individual was not approved, nominated or appointed, as the case may be, by a majority of AlerisLife's directors in office immediately prior to the making of such proposal or the nomination or appointment of such individual; and

•so long as Five Star is our tenant or manager or has a business management agreement with RMR LLC, AlerisLife will not acquire or finance any real estate of a type then owned or financed by us or any other company managed by RMR LLC without first giving us or such company managed by RMR LLC, as applicable, the opportunity to acquire or finance that real estate.

See Note 6 for further information regarding our relationships, agreements and transactions with AlerisLife (including Five Star).

Our Manager, RMR LLC. We have two agreements with RMR LLC to provide management services to us: (1) a business management agreement, which relates to our business generally, and (2) a property management agreement, which relates to the property level operations of our medical office and life science properties and major renovation or repositioning activities at our senior living communities that we may request RMR LLC to manage from time to time. See Note 7 for further information regarding our management agreements with RMR LLC.

Leases with RMR LLC. We lease office space to RMR LLC in certain of our properties for RMR LLC's property management offices. We recognized rental income from RMR LLC for leased office space of $190, $163 and $256 for the years ended December 31, 2021, 2020 and 2019, respectively. Our office space leases with RMR LLC are terminable by RMR LLC if our management agreements with RMR LLC are terminated.

Share Awards to RMR LLC Employees. As described in Note 5, we award shares to our officers and other employees of RMR LLC annually. Generally, one fifth of these awards vest on the grant date and one fifth vests on each of the next four anniversaries of the grant dates. In certain instances, we may accelerate the vesting of an award, such as in connection with the award holder's retirement as an officer of us or an officer or employee of RMR LLC. These awards to RMR LLC employees are in addition to the share awards to our Managing Trustees, as Trustee compensation, and the fees we paid to RMR LLC. See Note 5 for information regarding our share awards and activity as well as certain share purchases we made in connection with share award recipients satisfying tax withholding obligation on vesting share awards.

RMR Inc. On July 1, 2019, we sold all of the 2,637,408 shares of class A common stock of RMR Inc. that we owned in an underwritten public offering at a price to the public of $40.00 per share pursuant to the underwriting agreement among us, RMR Inc., certain other REITs managed by RMR LLC that also sold their class A common stock of RMR Inc. in the offering, and the underwriters named therein. We received net proceeds of $98,557 from this sale, after deducting the underwriting discounts and commissions and other offering expenses.

AIC. Until its dissolution on February 13, 2020, we, ABP Trust, AlerisLife and four other companies to which RMR LLC provides management services owned AIC in equal portions. We and the other AIC shareholders historically participated in a combined property insurance program arranged and insured or reinsured in part by AIC until June 30, 2019. We also had a one year standalone insurance policy that provided coverage for one of our life science properties located in Boston, Massachusetts that is owned in a joint venture, which we obtained as a part of this insurance program. We (including our then consolidated joint venture) paid aggregate annual premiums, including taxes and fees, of $4,413 in connection with this insurance program for the policy year ended June 30, 2019.

In connection with AIC's dissolution, we and each other AIC shareholder received an initial liquidating distribution of $9,000 from AIC in December 2019, an additional liquidating distribution of approximately $287 in June 2020 and a final liquidating distribution of $11 in December 2021. As of December 31, 2020 and 2019, our investment in AIC had a carrying value of $11 and $298, respectively. These amounts are included in other assets in our consolidated balance sheets. We recognized income of $400 related to our investment in AIC for the year ended December 31, 2019. These amounts are presented as equity in earnings of an investee in our consolidated statements of comprehensive income (loss). Our other comprehensive income includes our proportionate part of unrealized gains on securities which were owned and held for sale by AIC of $91 related to our investment in AIC for the year ended December 31, 2019.

XML

Indebtedness

12 Months Ended

Dec. 31, 2021

Debt Disclosure [Abstract]

Indebtedness

Indebtedness

At December 31, 2021 and 2020, our outstanding indebtedness consisted of the following:

		Principal Balance as of December 31,
Floating Rate Debt (1)	Maturity	2021		2020
Revolving credit facility (2)	January 2023	$	800,000	$	—
Term loan	September 2022	—		200,000
Total floating rate debt		$	800,000	$	200,000

(1)As of December 31, 2021 and 2020, the unamortized net debt issuance costs on certain of these debts were $0 and $951, respectively.

(2)Outstanding borrowings under our revolving credit facility. In February 2022, we exercised our option to extend the maturity date of our revolving credit facility by one year to January 2024.

				December 31, 2021				December 31, 2020
Senior Unsecured Notes (1)	Coupon		Maturity	Face Amount		Unamortized Discount		Face Amount		Unamortized Discount
Senior unsecured notes	6.750	%	December 2021	$	—	$	—	$	300,000	$	490
Senior unsecured notes	4.750	%	May 2024	250,000		184		250,000		263
Senior unsecured notes	9.750	%	June 2025	1,000,000		—		1,000,000		—
Senior unsecured notes	4.750	%	February 2028	500,000		5,169		500,000		6,013
Senior unsecured notes	4.375	%	March 2031	500,000		—		—		—
Senior unsecured notes	5.625	%	August 2042	350,000		—		350,000		—
Senior unsecured notes	6.250	%	February 2046	250,000		—		250,000		—
Total senior unsecured notes				$	2,850,000	$	5,353	$	2,650,000	$	6,766

(1)As of December 31, 2021 and 2020, the unamortized net debt issuance costs on certain of these notes were $37,836 and $35,045, respectively.

	Principal Balance as of December 31,							Number of Properties as Collateral	Net Book Value of Collateral as of December 31,
Secured and Other Debt	2021 (1)		2020 (1)		Interest Rate		Maturity	At December 31, 2021	2021		2020
Mortgage note	$	11,120	$	11,838	6.28	%	July 2022	1	$	23,525	$	23,500
Mortgage note	10,479		10,724		4.85	%	October 2022	1	19,211		19,675
Mortgage note	15,456		15,805		5.75	%	October 2022	2	19,099		19,180
Mortgage note	15,204		15,646		6.64	%	June 2023	1	24,593		23,023
Mortgage notes (2)	—		620,000		3.53	%	August 2026	—	—		705,096
Mortgage note	10,240		10,470		4.44	%	July 2043	1	13,387		13,582
Finance Leases	6,636		7,811		7.70	%	April 2026	2	18,527		18,097
Total secured	$	69,135	$	692,294				8	$	118,342	$	822,153

(1)The principal balances are the amounts stated in the contracts. In accordance with GAAP, our carrying values and recorded interest expense may be different because of market conditions at the time we assumed certain of these debts. As of December 31, 2021 and 2020, the unamortized net premiums and debt issuance costs on certain of these mortgages were $(578) and $721, respectively.

(2)The property encumbered by these mortgages is located in Boston, Massachusetts and was contributed in the first quarter of 2017 to a joint venture, which we deconsolidated in December 2021 and in which we currently own a 20% equity interest. As of December 31, 2020, this property was consolidated into our financial statements. See Note 3 for further information regarding this joint venture.

As of December 31, 2021, we had a $800,000 revolving credit facility that was available for general business purposes. As of December 31, 2021, the maturity date of our revolving credit facility was January 2023. In February 2022, we exercised our option to extend the maturity date of our revolving credit facility by one year to January 2024. Our revolving

credit facility generally provides that we can borrow, repay and re-borrow funds available under our revolving credit facility until maturity, and no principal repayment is due until maturity. As of December 31, 2021, our revolving credit facility required interest to be paid on borrowings at the annual rate of 2.9%, plus a facility fee of 30 basis points per annum on the total amount of lending commitments under the facility.

The weighted average annual interest rates for borrowings under our revolving credit facility were 2.9%, 2.2% and 3.4% for the years ended December 31, 2021, 2020 and 2019, respectively. The interest rate premium and facility fee are each subject to adjustment based upon changes to our credit ratings. On March 31, 2021, we borrowed $800,000 under our revolving credit facility as a precautionary measure to increase our cash position and preserve financial flexibility in light of continued uncertainties related to the COVID-19 pandemic. As of December 31, 2021 and February 21, 2022, we were fully drawn under our revolving credit facility.

In January 2021, we and our lenders amended our credit agreement and the agreement governing our previously existing $200,000 term loan in order to provide us with certain flexibility in light of continued uncertainties related to the COVID-19 pandemic. Pursuant to the amendments:

•certain of the financial covenants under our credit agreement and the agreement governing our previously existing $200,000 term loan, including covenants that require us to maintain certain financial ratios, have been waived through June 2022, or the Amendment Period;

•the revolving credit facility commitments have been reduced from $1,000,000 to $800,000, and as a result of the reduction in commitments, we recorded a loss on early extinguishment of debt of $563 for the year ended December 31, 2021;

•we pledged certain equity interests of subsidiaries owning properties to secure our obligations under our credit agreement and the agreement governing our previously existing $200,000 term loan and agreed to provide, and as of December 2021 had provided, first mortgage liens on 61 medical office and life science properties with an aggregate gross book value of real estate assets of $992,493 as of December 31, 2021 to secure our obligations, which pledges and/or mortgage liens may be removed or new ones may be added during the Amendment Period based on outstanding debt amounts, among other things;

•we had the ability to fund $250,000 of capital expenditures per year, which increased to $350,000 per year following the repayment of our $200,000 term loan in February 2021, and are restricted in our ability to acquire real property as defined in our credit agreement;

•the interest rate premium over LIBOR under our revolving credit facility and our previously existing $200,000 term loan increased by 30 basis points;

•certain covenants and restrictions on distributions to common shareholders, share repurchases, capital expenditures, acquiring additional properties and incurring additional indebtedness (in each case subject to various exceptions), and the minimum liquidity requirement of $200,000 will remain in place during the Amendment Period; and

•we are generally required to apply the net cash proceeds from the disposition of assets, capital markets transactions, and debt financings to the repayment of any amounts outstanding under our revolving credit facility.

In September 2021, we and our lenders further amended our credit agreement. Among other things, the amendment sets forth the mechanics for establishing a replacement benchmark rate under our credit agreement at such time as LIBOR is no longer available to calculate interest payable on amounts outstanding thereunder.

In February 2022, we and our lenders further amended our credit agreement. Pursuant to the amendment:

•the waiver of the fixed charge coverage ratio covenant included in our credit agreement has been extended through December 31, 2022;

•the revolving credit facility commitments have been reduced from $800,000 to $700,000 following our repayment of $100,000;

•we have the ability to fund $400,000 of capital expenditures per year and we are restricted in our ability to acquire real property as defined in our credit agreement;

•the interest rate premium under our revolving credit facility increased by 15 basis points; and

•certain covenants and restrictions on distributions to common shareholders, share repurchases, capital expenditures, acquiring additional properties and incurring additional indebtedness (in each case subject to various exceptions), and the minimum liquidity requirement of $200,000 will remain in place during the Amendment Period.

Also in February 2022, we exercised our option to extend the maturity date of our revolving credit facility by one year to January 2024. Pursuant to our credit agreement, the borrowing capacity under our revolving credit facility will be reduced to $586,373 as of January 2023 and as such, further repayment of our revolving credit facility may be required.

In May 2019, we redeemed at par all of our outstanding 3.25% senior notes due 2019 for a redemption price equal to the principal amount of $400,000, plus accrued and unpaid interest of $6,500. We funded this redemption with cash on hand and borrowings under our revolving credit facility.

Also in May 2019, we prepaid, at par plus accrued interest, a mortgage note secured by four of our senior living communities with an outstanding principal balance of approximately $42,211, a maturity date in July 2019 and an annual interest rate of 3.79%. As a result of this prepayment, we recorded a loss on early extinguishment of debt of $17 for the year ended December 31, 2019. We prepaid this mortgage using cash on hand and borrowings under our revolving credit facility.

In December 2019, we obtained a $250,000 term loan with a maturity date in June 2020, which we have prepaid in full as discussed further below. The weighted average annual interest rate for amounts outstanding under this term loan was 2.9% for the year ended December 31, 2019. We used the net proceeds from our $250,000 term loan, together with proceeds from our dispositions, borrowings under our revolving credit facility and cash on hand, to prepay in full our $350,000 term loan that was scheduled to mature on January 15, 2020. As a result of this prepayment, we recorded a loss on early extinguishment of debt of $27 for the year ended December 31, 2019.

In February 2020, we prepaid a mortgage note secured by one of our life science properties with an outstanding principal balance of approximately $1,554, a maturity date in March 2026 and an annual interest rate of 6.25%. As a result of this prepayment, we recorded a loss on early extinguishment of debt of $246 for the year ended December 31, 2020. We prepaid this mortgage using cash on hand and borrowings under our revolving credit facility.

In April 2020, we redeemed all of our outstanding 6.75% senior notes due 2020 for a redemption price equal to the principal amount of $200,000 plus accrued and unpaid interest of $6,750. We funded this redemption with cash on hand and borrowings under our revolving credit facility.

In May 2020, we prepaid a mortgage note secured by one of our medical office properties with an outstanding principal balance of approximately $1,213, a maturity date in January 2022 and an annual interest rate of 7.49%. As a result of the prepayment of this mortgage note, we recorded a loss on early extinguishment of debt of $155 for the year ended December 31, 2020. We prepaid this mortgage using cash on hand and borrowings under our revolving credit facility.

In June 2020, we issued $1,000,000 aggregate principal amount of our 9.75% senior notes due 2025 in an underwritten public offering raising net proceeds of $982,300, after deducting estimated offering expenses and underwriters' discounts. These notes are guaranteed by all of our subsidiaries, except for certain excluded subsidiaries, including pledged subsidiaries under our credit agreement. Prior to June 15, 2022, we may, at our option, redeem all or a portion of these notes at a redemption price equal to the outstanding principal amount of these notes, plus accrued and unpaid interest, plus the make-whole amount set forth in the indenture which governs these notes, as supplemented, or our 2025 Notes Indenture. Prior to June 15, 2022, we may also, at our option, redeem up to 40% of the aggregate principal amount of these notes with the net proceeds of certain equity offerings at the redemption price set forth in the 2025 Notes Indenture, so long as at least 50% of the original aggregate principal amount of these notes remains outstanding after each such redemption. In addition, we have the option to redeem all or a portion of these notes at any time on or after June 15, 2022 at the redemption prices set forth in the 2025 Notes Indenture. We used the net proceeds from this offering to prepay in full our $250,000 term loan which was scheduled to mature in June 2020 and to reduce amounts outstanding under our revolving credit facility. The weighted average interest rate under our $250,000 term loan was 2.4% for the period from January 1, 2020 to June 2, 2020. As a result of the repayment of our $250,000 term loan, we recorded a loss on early extinguishment of debt of $26 for the year ended December 31, 2020.

In February 2021, we issued $500,000 aggregate principal amount of our 4.375% senior notes due 2031 in an underwritten public offering raising net proceeds of $491,357, after deducting estimated offering expenses and underwriters' discounts. These notes are guaranteed by all of our subsidiaries, except for certain excluded subsidiaries, including pledged subsidiaries under our credit agreement and require semi-annual interest payments through maturity. We used the net proceeds

from this offering to prepay in full in February 2021 our $200,000 term loan which was scheduled to mature in September 2022. The weighted average interest rate under our $200,000 term loan was 2.9% for the period from January 1, 2021 to February 7, 2021 and 2.7% and 3.7% for the years ended December 31, 2020 and 2019, respectively. As a result of the prepayment of our $200,000 term loan, we recorded a loss on early extinguishment of debt of $1,477 for the year ended December 31, 2021. In June 2021, we used the remaining net proceeds from this offering and cash on hand to redeem all of our outstanding 6.75% senior notes due 2021 for a redemption price equal to the principal amount of $300,000 plus accrued and unpaid interest of $10,125, when these notes became redeemable with no prepayment premium. In connection with this redemption, we recorded a loss on early extinguishment of debt of $370 for the year ended December 31, 2021.

Interest on our senior unsecured notes are payable either semi-annually or quarterly in arrears; however, no principal repayments are due until maturity. Required monthly payments on our mortgages include principal and interest. Payments under our finance leases are due monthly. We include amortization of finance lease assets in depreciation and amortization expense.

Our credit agreement and our senior unsecured notes indentures and their supplements provide for acceleration of payment of all amounts due thereunder upon the occurrence and continuation of certain events of default, such as, in the case of our credit agreement, a change of control of us, as defined, which includes RMR LLC ceasing to act as our business and property manager. Our credit agreement and our senior unsecured notes indentures and their supplements also contain covenants, including covenants that restrict our ability to incur debts, and generally require us to maintain certain financial ratios, and our credit agreement restricts our ability to make distributions under certain circumstances. As of December 31, 2021, our ratio of consolidated income available for debt service to debt service was below the 1.5x incurrence requirement under our revolving credit facility and our public debt covenants as the effects of the COVID-19 pandemic continued to adversely impact our operations. We are currently unable to incur additional debt because this ratio is below 1.5x on a pro forma basis. We believe we were in compliance with the remaining terms and conditions of the respective covenants under our credit agreement and our senior unsecured notes indentures and their supplements at December 31, 2021. Although we have taken steps to enhance our ability to maintain sufficient liquidity, a protracted negative impact on the economy or the industries in which our properties and businesses operate resulting from the COVID-19 pandemic may cause increased pressure on our ability to satisfy financial and other covenants. Continued availability of borrowings under our revolving credit facility is subject to our satisfying certain financial covenants and other credit facility conditions. If our operating results and financial condition are significantly negatively impacted by economic conditions or otherwise, we may fail to satisfy covenants and conditions under our credit agreement or fail to satisfy our public debt covenants.

Required principal payments on our outstanding debt as of December 31, 2021, are as follows:

Year	Principal Payment
2022	$	39,067
2023	816,413
2024	251,834
2025	1,002,001
2026	904
Thereafter	1,608,916		(1)

(1) The carrying value of our total debt outstanding as of December 31, 2021, including unamortized debt issuance costs, premiums and discounts was $3,676,524.

XML

Fair Value of Assets and Liabilities

12 Months Ended

Dec. 31, 2021

Fair Value Disclosures [Abstract]

Fair Value of Assets and Liabilities

Fair Value of Assets and LiabilitiesThe following table presents certain of our assets that are measured at fair value at December 31, 2021 and 2020, categorized by the level of inputs as defined in the fair value hierarchy under GAAP, used in the valuation of each asset.

	As of December 31, 2021				As of December 31, 2020
Description	Carrying Amount		Fair Value		Carrying Amount		Fair Value
Recurring Fair Value Measurement Assets:
Investment in AlerisLife (Level 1) (1)	$	31,540	$	31,540	$	73,772	$	73,772
Investment in unconsolidated joint venture (Level 3) (2)	$	215,127	$	215,127	$	—	$	—

(1)Our 10,691,658 shares of common stock of AlerisLife are included in investments in equity securities in our consolidated balance sheets, and are reported at fair value, which is based upon quoted market prices on Nasdaq (Level 1 inputs). During the years ended December 31, 2021 and 2020, we recorded an unrealized loss of $42,232 and an unrealized gain of $34,106, respectively, which are included in gains and losses on equity securities, net in our consolidated statements of comprehensive income (loss), to adjust the carrying value of our investment in AlerisLife common shares to their fair value. See Notes 2 and 8 for further information about our investment in AlerisLife.

(2)We own a 20% equity interest in a joint venture that owns a life science property located in Boston, Massachusetts and is included in investment in unconsolidated joint venture in our consolidated balance sheet, and is reported at fair value, which is based on significant unobservable inputs (Level 3 inputs). The significant unobservable inputs used in the fair value are a discount rate of 5.58%, an exit capitalization rate of 5.25% and a holding period of approximately 10 years and market rents. The assumptions are based on the location, type and nature of the property, and current and anticipated market conditions, which are derived from appraisers, industry publications and our experience. See Note 3 for further information regarding this joint venture.

In addition to the assets described in the table above, our financial instruments at December 31, 2021 and December 31, 2020 included cash and cash equivalents, restricted cash, other assets, our revolving credit facility, our previously existing $200,000 term loan, senior unsecured notes, secured debt and finance leases and other unsecured obligations and liabilities. The fair values of these financial instruments approximated their carrying values in our consolidated financial statements as of such dates, except as follows:

	As of December 31, 2021				As of December 31, 2020
Description	Carrying Amount (1)		Estimated Fair Value		Carrying Amount (1)		Estimated Fair Value
Senior unsecured notes, 6.750% coupon rate, due 2021	$	—	$	—	$	299,273	$	303,891
Senior unsecured notes, 4.750% coupon rate, due 2024	249,348		257,695		249,068		256,258
Senior unsecured notes, 9.750% coupon rate, due 2025	987,903		1,081,990		984,359		1,135,800
Senior unsecured notes, 4.750% coupon rate, due 2028	492,199		491,480		490,925		502,648
Senior unsecured notes, 4.375% coupon rate, due 2031	492,127		480,763		—		—
Senior unsecured notes, 5.625% coupon rate, due 2042	342,183		309,260		341,802		330,120
Senior unsecured notes, 6.250% coupon rate, due 2046	243,051		226,500		242,762		245,000
Secured debts (2)	69,713		71,963		691,573		716,185
	$	2,876,524	$	2,919,651	$	3,299,762	$	3,489,902

(1)Includes unamortized net debt issuance costs, premiums and discounts.

(2)We assumed certain of these secured debts in connection with our acquisition of certain properties. We recorded the assumed mortgage notes at estimated fair value on the date of acquisition and we are amortizing the fair value adjustments, if any, to interest expense over the respective terms of the mortgage notes to adjust interest expense to the estimated market interest rates as of the date of acquisition.

We estimated the fair value of our two issuances of senior unsecured notes due 2042 and 2046 based on the closing price on Nasdaq (Level 1 input) as of December 31, 2021. We estimated the fair values of our four issuances of senior unsecured notes due 2024, 2025, 2028 and 2031 using an average of the bid and ask price on Nasdaq on or about December 31, 2021 (Level 2 inputs as defined in the fair value hierarchy under GAAP). We estimated the fair values of our secured debts by using discounted cash flows analyses and currently prevailing market terms as of the measurement date (Level 3 inputs as defined in the fair value hierarchy under GAAP). Because Level 3 inputs are unobservable, our estimated fair values may differ materially from the actual fair values.

XML

Noncontrolling Interest	12 Months Ended
	Dec. 31, 2021
Noncontrolling Interest [Abstract]
Noncontrolling Interest	Noncontrolling InterestIn March 2017, we entered into a joint venture arrangement with an institutional investor for one of our life science properties located in Boston, Massachusetts. The investor owned a 45% equity interest in the joint venture, and we owned the remaining 55% equity interest in the joint venture. We determined that, while we owned a 55% equity interest in this joint venture, this joint venture was a VIE and that we controlled the activities that most significantly impacted the economic performance of this entity; we therefore consolidated this property in our financial statements until we sold an additional 35% equity interest in the joint venture in December 2021 to another third party global institutional investor. After giving effect to the sale, we continue to own a 20% equity interest in this joint venture, but have determined that we are no longer the primary beneficiary. Effective as of the date of the sale, we deconsolidated this joint venture and we now account for this joint venture using the equity method of accounting under the fair value option. The portion of the joint venture's net income and comprehensive income not attributable to us, or $5,411, $5,146 and $5,356 for the years ended December 31, 2021, 2020 and 2019, respectively, is reported as a noncontrolling interest in our consolidated statements of comprehensive income (loss). The joint venture made aggregate cash distributions to the other joint venture investor of $22,348, $22,292 and $21,583 for the years ended December 31, 2021, 2020 and 2019, respectively, which are reflected as a decrease in total equity attributable to noncontrolling interest in our consolidated balance sheets.

XML

Segment Reporting

12 Months Ended

Dec. 31, 2021

Segment Reporting [Abstract]

Segment Reporting

Segment Reporting

In connection with the 2020 Restructuring Transaction, we determined to redefine our reportable segments to better reflect our current operating environment. As of December 31, 2021, we operate in, and report financial information for, the following two segments: Office Portfolio and SHOP. We aggregate each of these two reporting segments based on their similar operating and economic characteristics. Our Office Portfolio segment consists of medical office properties leased to medical providers and other medical related businesses, as well as life science properties leased to biotech laboratories and other similar tenants. Our SHOP segment consists of managed senior living communities that provide short term and long term residential living and in some instances care and other services for residents where we pay fees to managers to operate the communities. In addition, prior to January 1, 2020, our SHOP segment included triple net leased senior living communities that provided short term and long term residential living and in some instances care and other services for residents and from which we received rents from Five Star. Pursuant to the 2020 Restructuring Transaction, effective January 1, 2020, our previously existing master leases and management and pooling agreements with Five Star were terminated and replaced with new management agreements and a related omnibus agreement, which agreements were later replaced in June 2021. Prior periods have been recast to reflect these reportable segments for all periods presented.

We also report “non-segment” operations, which consists of triple net leased senior living communities, that are leased to third party operators from which we receive rents, and wellness centers, which we do not consider to be sufficiently material to constitute a separate reporting segment, and any other income or expenses that are not attributable to a specific reporting segment.

	For the Year Ended December 31, 2021
	Office Portfolio		SHOP		Non-Segment		Consolidated
Revenues:
Rental income	$	367,597	$	—	$	40,992	$	408,589
Residents fees and services	—		974,623		—		974,623
Total revenues	367,597		974,623		40,992		1,383,212
Expenses:
Property operating expenses	127,313		964,499		—		1,091,812
Depreciation and amortization	127,632		132,044		11,455		271,131
General and administrative	—		—		34,087		34,087
Acquisition and certain other transaction related costs	—		—		17,506		17,506
Impairment of assets	—		(174)		—		(174)
Total expenses	254,945		1,096,369		63,048		1,414,362
Gain on sale of properties	492,072		200		—		492,272
Losses on equity securities, net	—		—		(42,232)		(42,232)
Interest and other income	—		19,554		1,081		20,635
Interest expense	(23,477)		(2,089)		(230,193)		(255,759)
Loss on early extinguishment of debt	—		—		(2,410)		(2,410)
Income (loss) from continuing operations before income tax expense	581,247		(104,081)		(295,810)		181,356
Income tax expense	—		—		(1,430)		(1,430)
Net income (loss)	581,247		(104,081)		(297,240)		179,926
Net income attributable to noncontrolling interest	(5,411)		—		—		(5,411)
Net income (loss) attributable to common shareholders	$	575,836	$	(104,081)	$	(297,240)	$	174,515
	As of December 31, 2021
	Office Portfolio		SHOP		Non-Segment		Consolidated
Total assets	$	2,282,652	$	2,995,819	$	1,345,043	$	6,623,514

	For the Year Ended December 31, 2020
	Office Portfolio		SHOP		Non-Segment		Consolidated
Revenues:
Rental income	$	383,365	$	—	$	43,850	$	427,215
Residents fees and services	—		1,204,811		—		1,204,811
Total revenues	383,365		1,204,811		43,850		1,632,026
Expenses:
Property operating expenses	129,756		1,106,601		—		1,236,357
Depreciation and amortization	129,321		129,124		11,702		270,147
General and administrative	—		—		30,593		30,593
Acquisition and certain other transaction related costs	—		—		814		814
Impairment of assets	8,558		98,414		—		106,972
Total expenses	267,635		1,334,139		43,109		1,644,883
Gain (loss) on sale of properties	2,597		(627)		4,517		6,487
Gains on equity securities, net	—		—		34,106		34,106
Interest and other income	—		17,485		736		18,221
Interest expense	(24,188)		(2,223)		(175,072)		(201,483)
Gain on lease termination	—		—		22,896		22,896
Loss on early extinguishment of debt	(401)		—		(26)		(427)
Income (loss) from continuing operations before income tax expense	93,738		(114,693)		(112,102)		(133,057)
Income tax expense	—		—		(1,250)		(1,250)
Net income (loss)	93,738		(114,693)		(113,352)		(134,307)
Net income attributable to noncontrolling interest	(5,146)		—		—		(5,146)
Net income (loss) attributable to common shareholders	$	88,592	$	(114,693)	$	(113,352)	$	(139,453)
	As of December 31, 2020
	Office Portfolio		SHOP		Non-Segment		Consolidated
Total assets	$	3,092,289	$	2,912,570	$	471,565	$	6,476,424

	For the Year Ended December 31, 2019
	Office Portfolio		SHOP		Non-Segment		Consolidated
Revenues:
Rental income	$	405,016	$	137,898	$	63,644	$	606,558
Residents fees and services	—		433,597		—		433,597
Total revenues	405,016		571,495		63,644		1,040,155
Expenses:
Property operating expenses	132,348		356,722		—		489,070
Depreciation and amortization	137,611		132,637		18,777		289,025
General and administrative	—		—		37,028		37,028
Acquisition and certain other transaction related costs	—		—		13,102		13,102
Impairment of assets	43,035		65,822		6,344		115,201
Total expenses	312,994		555,181		75,251		943,426
Gain on sale of properties	6,617		15,207		17,872		39,696
Dividend income	—		—		1,846		1,846
Losses on equity securities, net	—		—		(41,898)		(41,898)
Interest and other income	—		—		941		941
Interest expense	(24,399)		(3,058)		(152,655)		(180,112)
Loss on early extinguishment of debt	—		(17)		(27)		(44)
Income (loss) from continuing operations before income tax expense and equity in earnings of an investee	74,240		28,446		(185,528)		(82,842)
Income tax expense	—		—		(436)		(436)
Equity in earnings of an investee	—		—		400		400
Net income (loss)	74,240		28,446		(185,564)		(82,878)
Net income attributable to noncontrolling interest	(5,356)		—		—		(5,356)
Net income (loss) attributable to common shareholders	$	68,884	$	28,446	$	(185,564)	$	(88,234)
	As of December 31, 2019
	Office Portfolio		SHOP		Non-Segment		Consolidated
Total assets	$	3,165,577	$	3,044,989	$	443,260	$	6,653,826

XML

Income Taxes

12 Months Ended

Dec. 31, 2021

Income Tax Disclosure [Abstract]

Income Taxes

Income Taxes

Our provision for income taxes consists of the following:

	For the Year Ended December 31,
	2021		2020		2019
Current:
Federal	$	200	$	—	$	—
State	1,230		1,250		436
	1,430		1,250		436
Deferred:
Federal	—		—		—
State	—		—		—
	—		—		—
Income tax provision	$	1,430	$	1,250	$	436

A reconciliation of our effective tax rate and the U.S. federal statutory income tax rate is as follows:

	For the Year Ended December 31,
	2021		2020		2019
Taxes at statutory U.S. federal income tax rate	21.0	%	21.0	%	21.0	%
Nontaxable income	(21.0)	%	(21.0)	%	(21.0)	%
Federal excise tax	0.1	%	—	%	—	%
State and local income taxes, net of federal tax benefit	0.8	%	(1.3)	%	0.5	%
Effective tax rate	0.9	%	(1.3)	%	0.5	%

Deferred income tax balances reflect the net tax effects of temporary differences between the carrying amounts of assets and liabilities in our consolidated balance sheets and the amounts used for income tax purposes and are stated at enacted tax rates expected to be in effect when taxes are actually paid or recovered. Significant components of our deferred tax assets and liabilities are as follows:

	For the Year Ended December 31,
	2021		2020
Deferred tax assets:
Deferred income	$	2,132	$	3,252
Fair market value adjustment	1,577		10,856
Other	784		758
Tax loss carryforwards	25,829		28,358
	30,322		43,224
Valuation allowance	(30,322)		(43,224)
	—		—
Net deferred income taxes	$	—	$	—

Because of our TRSs' history of losses, we are not able to conclude that it is more likely than not we will realize the future benefit of our deferred tax assets; thus we have provided a 100% valuation allowance as of December 31, 2021 and 2020. If and when we believe it is more likely than not that we will recover our deferred tax assets, we will reverse the valuation allowance as an income tax benefit in our consolidated statements of comprehensive income (loss). As of December 31, 2021, our consolidated TRSs had net operating loss carry forwards for federal income tax purposes of approximately $103,682, which do not expire. As of December 31, 2021, we, excluding our subsidiaries, had net operating loss carry forwards for federal income tax purposes of approximately $141,160, which do not expire. In the normal course of business, income tax authorities in various income tax jurisdictions conduct routine audits of our income tax returns filed in prior years. Income tax years subsequent to 2016 may be open to examination in some of the income tax jurisdictions in which we operate.

XML

Weighted Average Common Shares

12 Months Ended

Dec. 31, 2021

Earnings Per Share [Abstract]

Weighted Average Common Shares

Weighted Average Common Shares

The following table provides a reconciliation of the weighted average number of common shares used in the calculation of basic and diluted earnings per share (in thousands):

	Year Ended December 31,
	2021	2020	2019
Weighted average common shares for basic earnings per share	237,967	237,739	237,604
Effect of dilutive securities: restricted share awards	—	—	—
Weighted average common shares for diluted earnings per share (1)	237,967	237,739	237,604

(1) For the years ended December 31, 2021, 2020 and 2019, 60, 223 and 36, respectively, of our unvested common shares were not included in the calculation of diluted earnings per share because to do so would have been antidilutive.

XML

SCHEDULE III REAL ESTATE AND ACCUMULATED DEPRECIATION

12 Months Ended

Dec. 31, 2021

SEC Schedule, 12-28, Real Estate Companies, Investment in Real Estate and Accumulated Depreciation Disclosure [Abstract]

SCHEDULE III REAL ESTATE AND ACCUMULATED DEPRECIATION

				Initial Cost to Company					Cost at December 31, 2021
Address	City	State	Encumbrances (1)	Land	Buildings, Improvements & Equipment	Cost Capitalized Subsequent to Acquisition	Impairment	Cost Basis Adjustment (2)	Land	Buildings, Improvements & Equipment	Total (3)	Accumulated Depreciation (4)	Date Acquired	Original Construction Date
2184 Parkway Lake Drive	Birmingham	AL	$—	$580	$5,980	$2,576	$—	$—	$580	$8,556	$9,136	$2,597	8/1/2008	2001
2634 Valleydale Road	Birmingham	AL	—	600	7,574	2,333	—	(83)	1,559	8,865	10,424	2,905	8/1/2008	2000
2021 Dahlke Drive NE	Cullman	AL	—	287	3,415	853	—	(301)	287	3,967	4,254	1,516	11/19/2004	1998
101 Tulip Lane	Dothan	AL	—	3,543	14,619	608	—	—	3,543	15,227	18,770	2,111	12/27/2017	2000
49 Hughes Road	Madison	AL	—	334	3,981	1,225	—	(243)	334	4,963	5,297	1,900	11/19/2004	1998
200 Terrace Lane	Priceville	AL	—	1,300	9,447	843	—	(110)	1,365	10,115	11,480	2,791	2/1/2012	2006
413 Cox Boulevard	Sheffield	AL	—	394	4,684	942	—	(294)	394	5,332	5,726	2,109	11/19/2004	1998
2435 Columbiana Road	Vestavia Hills	AL	—	843	23,472	2,722	—	—	902	26,135	27,037	5,477	7/12/2016	1991
4461 N Crossover Road	Fayetteville	AR	—	733	10,432	293	—	—	733	10,725	11,458	2,037	5/1/2015	2011
4210 S Caraway Road	Jonesboro	AR	—	653	9,515	370	—	—	653	9,885	10,538	1,871	5/1/2015	2008
672 Jones Road	Springdale	AR	—	572	9,364	1,193	—	—	572	10,557	11,129	1,948	5/1/2015	2007
13840 North Desert Harbor Drive	Peoria	AZ	—	2,687	15,843	8,569	—	(2,252)	2,693	22,154	24,847	9,634	1/11/2002	1990
11209 N. Tatum Boulevard	Phoenix	AZ	—	1,380	6,349	4,757	—	(303)	1,573	10,610	12,183	2,945	9/30/2011	1987
2444 West Las Palmaritas Drive	Phoenix	AZ	—	3,820	6,669	2,979	—	—	3,831	9,637	13,468	2,018	12/22/2010	1982
4121 East Cotton Center	Phoenix	AZ	—	5,166	12,724	541	—	—	5,205	13,226	18,431	2,292	1/29/2015	2000
3850 North US Hwy 89 (5)	Prescott	AZ	15,204	2,017	17,513	7,786	—	—	2,017	25,299	27,316	2,723	2/1/2018	1986
6001 East Thomas Road	Scottsdale	AZ	—	941	8,807	5,373	—	(367)	946	13,808	14,754	7,738	9/1/2012	1990
7090 East Mescal Street	Scottsdale	AZ	—	2,315	13,650	12,755	—	(2,094)	2,349	24,277	26,626	9,498	1/11/2002	1984
17225 North Boswell Boulevard	Sun City	AZ	—	1,189	10,569	3,218	—	(517)	1,189	13,270	14,459	7,971	9/1/2012	1990
14001 W. Meeker Boulevard	Sun City West	AZ	—	395	3,307	—	—	(192)	395	3,115	3,510	1,469	2/28/2003	1998
1415 West 3rd Street	Tempe	AZ	—	2,186	13,446	3,721	—	—	4,896	14,457	19,353	2,405	1/29/2015	1981
2500 North Rosemont Boulevard	Tucson	AZ	—	4,429	26,119	8,041	—	(3,141)	4,576	30,872	35,448	14,140	1/11/2002	1989
710 North Euclid	Anaheim	CA	—	2,850	6,964	2,215	(1,350)	(2,405)	2,518	5,756	8,274	449	7/9/2008	1992
5000 Marina Boulevard	Brisbane	CA	—	7,957	13,430	745	—	—	7,957	14,175	22,132	1,547	11/14/2017	2000
5770 Armada Drive (5)	Carlsbad	CA	10,479	3,875	18,543	—	—	—	3,875	18,543	22,418	3,207	1/29/2015	1997
1350 South El Camino Real	Encinitas	CA	—	1,510	18,042	2,372	—	(53)	1,517	20,354	21,871	6,455	3/31/2008	1999
47201 Lakeview Boulevard	Fremont	CA	—	3,200	10,177	36	—	—	3,200	10,213	13,413	2,626	9/30/2011	1990
47211/47215 Lakeview Boulevard	Fremont	CA	—	3,750	12,656	3,732	—	—	3,750	16,388	20,138	3,265	9/30/2011	1985
47900 Bayside Parkway	Fremont	CA	—	4,580	10,370	2,203	—	—	4,580	12,573	17,153	2,901	9/30/2011	1991
577 South Peach Street	Fresno	CA	—	738	2,577	4,175	—	(211)	738	6,541	7,279	2,758	12/28/1990	1963
6075 North Marks Avenue	Fresno	CA	—	880	12,751	938	—	—	889	13,680	14,569	4,546	3/31/2008	1996
8631 West 3rd Street	Los Angeles	CA	—	24,640	88,277	18,122	—	(908)	25,391	104,740	130,131	28,026	11/22/2010	1979
8635 West 3rd Street	Los Angeles	CA	—	24,640	90,352	15,367	—	(764)	25,331	104,264	129,595	28,178	11/22/2010	1979

				Initial Cost to Company					Cost at December 31, 2021
Address	City	State	Encumbrances (1)	Land	Buildings, Improvements & Equipment	Cost Capitalized Subsequent to Acquisition	Impairment	Cost Basis Adjustment (2)	Land	Buildings, Improvements & Equipment	Total (3)	Accumulated Depreciation (4)	Date Acquired	Original Construction Date
1319 Brookside Avenue	Redlands	CA	—	1,770	9,982	1,361	—	—	1,770	11,343	13,113	3,640	3/31/2008	1999
110 Sterling Court	Roseville	CA	—	1,620	10,262	2,245	—	—	1,620	12,507	14,127	3,905	3/31/2008	1998
16925 & 16916 Hierba Drive	San Diego	CA	—	9,142	53,904	20,060	—	(6,938)	9,180	66,988	76,168	29,785	1/11/2002	1987
3030 Science Park	San Diego	CA	—	2,466	46,473	29,559	—	—	2,466	76,032	78,498	15,054	8/6/2009	1986
3040 Science Park	San Diego	CA	—	1,225	23,077	22,654	—	—	1,225	45,731	46,956	7,593	8/6/2009	1986
3050 Science Park	San Diego	CA	—	1,508	28,753	24,549	—	—	1,508	53,302	54,810	9,303	8/6/2009	1986
2904 Orchard Parkway	San Jose	CA	—	10,788	8,890	2,621	—	—	10,804	11,495	22,299	1,860	1/25/2018	1979
3530 Deer Park Drive	Stockton	CA	—	670	14,419	2,079	—	—	682	16,486	17,168	5,299	3/31/2008	1999
877 East March Lane	Stockton	CA	—	1,176	11,171	6,892	—	(1,885)	1,411	15,943	17,354	6,648	9/30/2003	1988
28515 Westinghouse Place	Valencia	CA	—	$4,669	41,440	20	—	—	4,689	41,440	46,129	7,169	1/29/2015	2008
1866 San Miguel Drive	Walnut Creek	CA	—	$2,010	9,290	5,415	—	(930)	3,417	12,368	15,785	3,178	12/1/2011	1996
1950 South Dayton Street	Aurora	CO	—	$3,062	46,195	3,601	—	—	3,120	49,738	52,858	9,725	5/1/2015	1987
515 Fairview Avenue	Canon City	CO	—	$292	6,228	2,000	(3,512)	(517)	299	4,192	4,491	1,969	9/26/1997	1970
110 West Van Buren Street	Colorado Springs	CO	—	$245	5,236	3,170	(3,031)	(701)	245	4,674	4,919	1,771	9/26/1997	1972
3920 East San Miguel Street	Colorado Springs	CO	—	$1,380	8,894	4,218	—	(34)	1,612	12,846	14,458	3,673	7/31/2012	1977
2050 South Main Street	Delta	CO	—	$167	3,570	1,461	—	(415)	167	4,616	4,783	2,411	9/26/1997	1963
2501 Little Bookcliff Drive	Grand Junction	CO	—	$204	3,875	2,210	—	(908)	207	5,174	5,381	3,029	12/30/1993	1968
2825 Patterson Road	Grand Junction	CO	—	$173	2,583	3,293	—	(786)	173	5,090	5,263	2,732	12/30/1993	1978
1599 Ingalls Street	Lakewood	CO	—	$232	3,766	4,094	—	(860)	232	7,000	7,232	4,294	12/28/1990	1972
5555 South Elati Street	Littleton	CO	—	$185	5,043	4,277	—	(1,068)	191	8,246	8,437	4,899	12/28/1990	1965
8271 South Continental Divide Road	Littleton	CO	—	$400	3,507	—	—	(202)	400	3,305	3,705	1,559	2/28/2003	1998
9005 Grant Street	Thornton	CO	—	$961	10,867	1,179	—	—	1,269	11,738	13,007	2,640	12/28/2012	2001
7809 W. 38th Avenue	Wheat Ridge	CO	—	$470	3,373	88	—	—	475	3,456	3,931	993	4/1/2010	2004
40 Sebethe Drive	Cromwell	CT	—	$570	5,304	1,787	—	(424)	596	6,641	7,237	1,747	12/22/2010	1998
1145 19th Street NW	Washington	DC	—	$13,600	24,880	36,435	—	(597)	13,600	60,718	74,318	12,553	5/20/2009	1976
2141 K Street, NW	Washington	DC	—	$13,700	8,400	5,442	—	(518)	13,700	13,324	27,024	4,420	12/22/2008	1966
255 Possum Park Road	Newark	DE	—	$2,010	11,852	8,039	—	(1,759)	2,761	17,381	20,142	7,010	1/11/2002	1982
4175 Ogletown Stanton Rd	Newark	DE	—	$1,500	19,447	1,639	—	—	1,563	21,023	22,586	7,180	3/31/2008	1998
1212 Foulk Road	Wilmington	DE	—	$1,179	6,950	2,603	—	(1,310)	1,202	8,220	9,422	3,869	1/11/2002	1974
1912 Marsh Road	Wilmington	DE	—	4,365	25,739	7,498	—	(2,293)	4,431	30,878	35,309	13,640	1/11/2002	1988
2723 Shipley Road	Wilmington	DE	—	869	5,126	5,327	—	(1,726)	978	8,618	9,596	3,729	1/11/2002	1989
407 Foulk Road	Wilmington	DE	—	38	227	2,763	—	(433)	84	2,511	2,595	731	1/11/2002	1965
22601 Camino Del Mar	Boca Raton	FL	—	3,200	46,800	7,802	—	(1,816)	3,204	52,782	55,986	13,932	12/15/2011	1990

				Initial Cost to Company					Cost at December 31, 2021
Address	City	State	Encumbrances (1)	Land	Buildings, Improvements & Equipment	Cost Capitalized Subsequent to Acquisition	Impairment	Cost Basis Adjustment (2)	Land	Buildings, Improvements & Equipment	Total (3)	Accumulated Depreciation (4)	Date Acquired	Original Construction Date
1325 S Congress Avenue	Boynton Beach	FL	—	1,620	5,341	1,717	—	(121)	1,628	6,929	8,557	1,660	7/27/2012	1985
1425 Congress Avenue	Boynton Beach	FL	—	2,390	14,768	3,827	—	(721)	2,390	17,874	20,264	5,041	8/9/2011	1994
1416 Country Club Blvd.	Cape Coral	FL	—	400	2,907	—	—	(173)	400	2,734	3,134	1,290	2/28/2003	1998
8500 Royal Palm Boulevard	Coral Springs	FL	—	3,410	20,104	32,030	—	(3,859)	3,421	48,264	51,685	17,262	1/11/2002	1984
1208 South Military Trail	Deerfield Beach	FL	—	1,690	14,972	32,207	—	(2,251)	1,777	44,841	46,618	17,974	10/1/2012	1986
3001 DC Country Club Boulevard	Deerfield Beach	FL	—	3,196	18,848	22,290	—	(2,813)	3,222	38,299	41,521	14,935	1/11/2002	1990
12780 Kenwood Lane	Fort Myers	FL	—	369	2,174	3,709	—	(444)	859	4,949	5,808	2,054	1/11/2002	1990
2525 First Street	Fort Myers	FL	—	2,385	21,137	23,381	—	(1,322)	2,577	43,004	45,581	20,860	10/1/2012	1984
1825 Ridgewood Avenue	Holly Hill	FL	—	700	16,700	3,261	(2,636)	(4,649)	684	12,692	13,376	1,640	7/22/2011	1926/2006
2480 North Park Road	Hollywood	FL	—	4,500	40,500	19,755	—	(1,637)	4,556	58,562	63,118	15,903	12/15/2011	1986
8901 Tamiami Trail East	Naples	FL	—	3,200	2,898	15,068	—	(837)	3,200	17,129	20,329	5,631	8/31/2006	1984
12780 Waterford Lakes Parkway	Orlando	FL	—	977	3,946	579	—	—	1,052	4,450	5,502	854	12/18/2013	2002
1603 S. Hiawassee Road	Orlando	FL	—	488	2,621	352	—	(81)	488	2,892	3,380	569	12/18/2013	2003
1825 N. Mills Avenue	Orlando	FL	—	519	1,799	415	—	—	580	2,153	2,733	763	12/22/2008	1997
1911 N. Mills Avenue	Orlando	FL	—	1,946	7,197	866	—	(538)	2,042	7,429	9,471	2,386	12/22/2008	1997
1925 N. Mills Avenue	Orlando	FL	—	135	532	252	—	—	199	720	919	292	12/22/2008	1997
250 N. Alafaya Trail	Orlando	FL	—	967	4,362	389	—	—	967	4,751	5,718	979	12/18/2013	1999
45 Katherine Boulevard	Palm Harbor	FL	—	3,379	29,945	9,045	—	(816)	3,392	38,161	41,553	24,079	10/1/2012	1992
900 West Lake Road	Palm Harbor	FL	—	3,449	20,336	11,916	—	(3,160)	3,493	29,048	32,541	12,465	1/11/2002	1989
8500 West Sunrise Boulevard	Plantation	FL	—	4,700	24,300	10,999	—	(2,475)	4,717	32,807	37,524	9,850	12/15/2011	1989
1371 South Ocean Boulevard	Pompano Beach	FL	—	2,500	15,500	15,927	—	(1,564)	2,560	29,803	32,363	8,891	12/15/2011	1991
2701 North Course Drive	Pompano Beach	FL	—	7,700	2,127	41,511	—	(2,332)	7,700	41,306	49,006	14,027	8/31/2006	1985
20480 Veterans Boulevard	Port Charlotte	FL	—	400	11,934	2,107	—	(550)	440	13,451	13,891	4,090	7/22/2011	1996
1699 S.E. Lyngate Drive	Port St. Lucie	FL	—	1,242	11,009	4,799	—	(269)	1,249	15,532	16,781	9,152	10/1/2012	1993
501 N.W. Cashmere Boulevard	Port St. Lucie	FL	—	890	9,345	2,911	—	(135)	1,673	11,338	13,011	3,142	7/22/2011	2007
900 South Harbour Island Blvd.	Tampa	FL	—	4,850	6,349	7	—	—	4,850	6,356	11,206	2,257	10/30/2007	1986
111 Executive Center Drive	West Palm Beach	FL	—	2,061	12,153	20,856	—	(2,982)	2,075	30,013	32,088	10,227	1/11/2002	1988
2351 Cedarcrest Road	Acworth	GA	—	2,000	6,674	618	—	—	2,000	7,292	9,292	1,363	5/1/2016	2014
1200 Bluegrass Lakes Parkway	Alpharetta	GA	—	1,689	15,936	142	—	—	1,761	16,006	17,767	2,762	1/29/2015	2001
855 North Point Pkwy	Alpharetta	GA	—	5,390	26,712	—	—	—	5,390	26,712	32,102	8,931	8/21/2008	2006
253 N. Main Street	Alpharetta	GA	—	1,325	12,377	1,170	—	(64)	1,221	13,587	14,808	2,591	5/1/2015	1997
1291 Cedar Shoals Drive	Athens	GA	—	337	4,006	1,615	—	(290)	368	5,300	5,668	1,918	11/19/2004	1998
1515 Sheridan Road	Atlanta	GA	—	5,800	9,305	3	—	—	5,800	9,308	15,108	3,286	11/30/2007	1978

				Initial Cost to Company					Cost at December 31, 2021
Address	City	State	Encumbrances (1)	Land	Buildings, Improvements & Equipment	Cost Capitalized Subsequent to Acquisition	Impairment	Cost Basis Adjustment (2)	Land	Buildings, Improvements & Equipment	Total (3)	Accumulated Depreciation (4)	Date Acquired	Original Construction Date
240 Marietta Highway	Canton	GA	—	806	8,555	2,397	—	(55)	806	10,897	11,703	2,510	10/1/2013	1997
4500 South Stadium Drive	Columbus	GA	—	294	3,505	946	—	(225)	298	4,222	4,520	1,550	11/19/2004	1999
1352 Wellbrook Circle	Conyers	GA	—	342	4,068	1,769	(1,366)	(2,032)	206	2,575	2,781	70	11/19/2004	1997
1501 Milstead Road	Conyers	GA	—	750	7,796	712	—	—	777	8,481	9,258	2,498	9/30/2010	2008
3875 Post Road	Cumming	GA	—	954	12,796	248	—	—	960	13,038	13,998	2,638	5/1/2015	2007
4960 Jot Em Down Road	Cumming	GA	—	1,548	18,666	13,033	—	(257)	3,416	29,574	32,990	6,913	8/1/2013	2011
5610 Hampton Park Drive	Cumming	GA	—	3,479	14,771	233	—	—	3,481	15,002	18,483	3,071	9/3/2015	2014
7955 Majors Road	Cumming	GA	—	1,325	7,770	904	—	—	1,325	8,674	9,999	1,645	5/1/2015	2009
2470 Dug Gap Road	Dalton	GA	—	262	3,119	1,285	—	(133)	262	4,271	4,533	1,515	11/19/2004	1997
101 West Ponce De Leon Avenue	Decatur	GA	—	3,500	13,179	2,145	—	—	3,500	15,324	18,824	3,185	5/30/2012	1992
2801 North Decatur Road	Decatur	GA	—	3,100	4,436	2,533	—	—	3,260	6,809	10,069	2,148	7/9/2008	1986
114 Penland Street	Ellijay	GA	—	496	7,107	1,455	—	(157)	496	8,405	8,901	1,765	10/1/2013	2008
353 North Belair Road	Evans	GA	—	230	2,663	1,326	—	(244)	230	3,745	3,975	1,333	11/19/2004	1998
1294 Highway 54 West	Fayetteville	GA	—	853	9,903	1,324	—	—	943	11,137	12,080	2,170	5/1/2015	1999
2435 Limestone Parkway	Gainesville	GA	—	268	3,186	1,621	—	(224)	268	4,583	4,851	1,585	11/19/2004	1998
3315 Thompson Bridge Road	Gainesville	GA	—	934	30,962	1,937	—	—	956	32,877	33,833	6,319	5/1/2015	1999
5373 Thompson Mill Road	Hoschton	GA	—	944	12,171	216	—	—	959	12,372	13,331	2,404	5/1/2015	2011
8080 Summit Business Parkway	Jonesboro	GA	—	1,800	20,664	4,460	—	(456)	1,800	24,668	26,468	7,010	6/20/2011	2007
6191 Peake Road	Macon	GA	—	183	2,179	1,329	(848)	(1,142)	110	1,591	1,701	47	11/19/2004	1998
1360 Upper Hembree Road	Roswell	GA	—	1,080	6,138	752	—	—	1,067	6,903	7,970	1,555	5/7/2012	2007
1 Savannah Square Drive	Savannah	GA	—	1,200	19,090	7,990	(6,993)	(8,926)	835	11,526	12,361	510	10/1/2006	1987
5200 Habersham Street	Savannah	GA	—	800	7,800	2,096	(3,082)	(2,627)	476	4,511	4,987	100	6/23/2011	2005
7410 Skidaway Road	Savannah	GA	—	400	5,670	1,957	(1,870)	(2,626)	252	3,279	3,531	106	11/1/2006	1989
2078 Scenic Highway	Snellville	GA	—	870	4,030	1,517	—	(256)	870	5,291	6,161	1,318	12/10/2009	1997
475 Country Club Drive	Stockbridge	GA	—	512	9,560	1,047	—	—	551	10,568	11,119	2,097	5/1/2015	1998
1300 Montreal Road	Tucker	GA	—	690	6,210	2,142	—	(469)	694	7,879	8,573	2,776	6/3/2005	1997
1100 Ward Avenue	Honolulu	HI	—	$11,200	55,618	7,232	—	(71)	11,247	62,732	73,979	15,341	6/18/2012	1961
2340 West Seltice Way	Coeur d'Alene	ID	—	$910	7,170	3,360	—	—	1,052	10,388	11,440	2,826	7/31/2012	1993
850 Lincoln Drive	Idaho Falls	ID	—	$510	6,640	2,970	—	—	760	9,360	10,120	2,484	7/31/2012	1978
1250 West Central Road	Arlington Heights	IL	—	$3,665	32,587	10,441	—	(385)	3,781	42,527	46,308	26,487	11/1/2012	1986
1450 Busch Parkway	Buffalo Grove	IL	—	$3,800	11,456	929	—	—	3,815	12,370	16,185	3,548	9/16/2010	2009
2601 Patriot Boulevard	Glenview	IL	—	$2,285	9,593	—	—	—	2,285	9,593	11,878	1,659	1/29/2015	2005
1373 D'Adrian Professional Park	Godfrey	IL	—	$281	15,088	731	—	(135)	281	15,684	15,965	3,020	5/1/2015	2010

				Initial Cost to Company					Cost at December 31, 2021
Address	City	State	Encumbrances (1)	Land	Buildings, Improvements & Equipment	Cost Capitalized Subsequent to Acquisition	Impairment	Cost Basis Adjustment (2)	Land	Buildings, Improvements & Equipment	Total (3)	Accumulated Depreciation (4)	Date Acquired	Original Construction Date
900 43rd Avenue	Moline	IL	—	$482	7,651	573	—	(76)	482	8,148	8,630	1,515	5/1/2015	2003 / 2012
221 11th Avenue	Moline	IL	—	$161	7,244	1,513	—	—	161	8,757	8,918	1,713	5/1/2015	2008
2700 14th Street	Pekin	IL	—	$171	11,475	554	—	(159)	172	11,869	12,041	2,277	5/1/2015	2009
7130 Crimson Ridge Drive	Rockford	IL	—	$200	7,300	2,336	—	—	1,596	8,240	9,836	2,352	5/1/2011	1999
1220 Lakeview Drive	Romeoville	IL	—	$1,120	19,582	(61)	—	—	1,058	19,583	20,641	6,547	8/21/2008	2005
1201 Hartman Lane	Shiloh	IL	—	$743	7,232	2,113	—	—	1,237	8,851	10,088	1,461	12/8/2016	2003
900 Southwind Road	Springfield	IL	—	$300	6,744	2,304	—	(403)	300	8,645	8,945	3,052	8/31/2006	1990
2705 Avenue E	Sterling	IL	—	$341	14,331	638	—	—	343	14,967	15,310	2,951	5/1/2015	2008
39 Dorothy Drive	Troy	IL	—	$1,002	7,010	1,577	—	—	1,002	8,587	9,589	1,416	12/8/2016	2003
100 Grand Victorian Place	Washington	IL	—	$241	12,046	416	—	—	241	12,462	12,703	2,360	5/1/2015	2009
1615 Lakeside Drive	Waukegan	IL	—	$2,700	9,590	3,139	—	(944)	3,478	11,007	14,485	2,967	9/30/2011	1990
1675 Lakeside Drive	Waukegan	IL	—	$2,420	9,382	2,589	—	(957)	2,873	10,561	13,434	2,785	9/30/2011	1998
406 Smith Drive	Auburn	IN	—	$380	8,246	631	—	(253)	524	8,480	9,004	2,766	9/1/2008	1999
6990 East County Road 100 North	Avon	IN	—	$850	11,888	1,082	—	(333)	850	12,637	13,487	4,082	9/1/2008	1999
2455 Tamarack Trail	Bloomington	IN	—	$5,400	25,129	30,110	—	(529)	6,339	53,771	60,110	13,131	11/1/2008	1983
2460 Glebe Street	Carmel	IN	—	$2,108	57,741	1,106	—	—	2,125	58,830	60,955	10,932	5/1/2015	2008
701 East County Line Road	Greenwood	IN	—	$1,830	14,303	1,304	—	(61)	1,875	15,501	17,376	4,094	12/1/2011	2007
8505 Woodfield Crossing Boulevard	Indianapolis	IN	—	2,785	16,396	7,084	—	(2,127)	2,838	21,300	24,138	9,651	1/11/2002	1986
2501 Friendship Boulevard	Kokomo	IN	—	512	13,009	1,081	—	—	512	14,090	14,602	1,725	12/27/2017	1997
603 Saint Joseph Drive	Kokomo	IN	—	220	5,899	1,223	—	(256)	220	6,866	7,086	2,139	9/1/2008	1998
1211 Longwood Drive	La Porte	IN	—	770	5,550	1,478	—	(288)	923	6,587	7,510	2,026	9/1/2008	1998
1590 West Timberview Drive	Marion	IN	—	410	5,409	1,476	—	(267)	410	6,618	7,028	1,915	9/1/2008	2000
1473 East McKay Road	Shelbyville	IN	—	190	5,328	635	—	(236)	190	5,727	5,917	1,801	9/1/2008	1999
17441 State Road 23	South Bend	IN	—	400	3,107	(38)	—	(182)	363	2,924	3,287	1,380	2/28/2003	1998
222 South 25th Street	Terra Haute	IN	—	300	13,115	1,157	—	(492)	300	13,780	14,080	4,445	9/1/2008	2005
150 Fox Ridge Drive	Vincennes	IN	—	110	3,603	1,820	—	(208)	110	5,215	5,325	1,722	9/1/2008	1985
1501 Inverness Drive	Lawrence	KS	—	1,600	18,565	3,457	—	(1,232)	1,758	20,632	22,390	5,995	10/1/2009	1988
5799 Broadmoor Street	Mission	KS	—	1,522	7,246	1,882	—	—	1,530	9,120	10,650	1,470	1/17/2017	1986
3501 West 95th Street	Overland Park	KS	—	2,568	15,140	7,587	—	(2,141)	2,580	20,574	23,154	8,677	1/11/2002	1989
6555 West 75th Street	Overland Park	KS	—	1,274	1,126	15,505	—	(1,102)	1,487	15,316	16,803	6,507	10/25/2002	1985
6700 W. 115th Street	Overland Park	KS	—	4,503	29,387	177	—	—	4,503	29,564	34,067	2,977	1/3/2018	2006
981 Campbell Lane	Bowling Green	KY	—	365	4,345	1,844	—	(203)	365	5,986	6,351	2,119	11/19/2004	1999
102 Leonardwood Drive	Frankfort	KY	—	560	8,282	2,529	—	(605)	579	10,187	10,766	3,702	8/31/2006	1989

				Initial Cost to Company					Cost at December 31, 2021
Address	City	State	Encumbrances (1)	Land	Buildings, Improvements & Equipment	Cost Capitalized Subsequent to Acquisition	Impairment	Cost Basis Adjustment (2)	Land	Buildings, Improvements & Equipment	Total (3)	Accumulated Depreciation (4)	Date Acquired	Original Construction Date
4190 Lafayette Road	Hopkinsville	KY	—	316	3,761	748	—	(193)	316	4,316	4,632	1,718	11/19/2004	1999
690 Mason Headley Road (6)	Lexington	KY	5,355	—	10,848	13,419	—	(1,389)	42	22,836	22,878	11,738	1/11/2002	1985
700 Mason Headley Road (6)	Lexington	KY	1,281	—	6,394	8,409	—	(951)	52	13,800	13,852	6,465	1/11/2002	1980
200 Brookside Drive	Louisville	KY	—	3,524	20,779	10,672	—	(3,217)	3,549	28,209	31,758	12,173	1/11/2002	1984
1517 West Broadway	Mayfield	KY	—	268	2,730	1,617	—	(221)	268	4,126	4,394	1,567	11/19/2004	1999
1700 Elmdale Road	Paducah	KY	—	450	5,358	1,477	—	(319)	451	6,515	6,966	2,646	11/19/2004	2000
100 Neighborly Way	Somerset	KY	—	200	4,919	701	—	—	200	5,620	5,820	2,068	11/6/2006	2000
1295 Boylston Street	Boston	MA	—	7,600	18,140	3,187	—	—	7,625	21,302	28,927	6,065	1/26/2011	1930
549 Albany Street	Boston	MA	—	4,576	45,029	—	—	—	4,569	45,036	49,605	9,385	8/22/2013	1895
330 Baker Avenue	Concord	MA	—	3,775	19,906	—	—	—	3,775	19,906	23,681	3,442	1/29/2015	2013
4 Maguire Road	Lexington	MA	—	3,600	15,555	19,813	(7,255)	(1,003)	3,884	26,826	30,710	3,016	12/22/2008	1994
100 Hampshire Street	Mansfield	MA	—	2,090	8,215	1,664	—	—	2,486	9,483	11,969	2,665	12/22/2010	1975
15 Hampshire Street	Mansfield	MA	—	1,360	7,326	507	—	—	1,748	7,445	9,193	2,202	12/22/2010	1988
5 Hampshire Street	Mansfield	MA	—	1,190	5,737	1,831	—	(143)	1,465	7,150	8,615	2,019	12/22/2010	1988
30 New Crossing Road	Reading	MA	—	1,443	14,153	285	—	—	1,455	14,426	15,881	3,338	9/27/2012	1986
299 Cambridge Street	Winchester	MA	—	3,218	18,988	12,424	—	(1,855)	3,218	29,557	32,775	12,726	1/11/2002	1991
2717 Riva Road	Annapolis	MD	—	1,290	12,373	1,370	—	—	1,290	13,743	15,033	4,594	3/31/2008	2001
658 Boulton Street	Bel Air	MD	—	4,750	16,504	2	—	—	4,750	16,506	21,256	5,827	11/30/2007	1980
7600 Laurel Bowie Road	Bowie	MD	—	408	3,421	1,488	—	(393)	408	4,516	4,924	1,841	10/25/2002	2000
8100 Connecticut Avenue	Chevy Chase	MD	—	15,170	92,830	12,492	—	(1,924)	15,177	103,391	118,568	26,915	12/15/2011	1990
8220 Snowden River Parkway	Columbia	MD	—	1,390	10,303	934	—	—	1,390	11,237	12,627	3,811	3/31/2008	2001
700 Port Street	Easton	MD	—	383	4,555	4,042	—	(473)	394	8,113	8,507	3,169	10/25/2002	2000
3004 North Ridge Road	Ellicott City	MD	—	1,409	22,691	11,847	—	(2,505)	1,613	31,829	33,442	12,430	3/1/2004	1997
1820 Latham Drive	Frederick	MD	—	385	3,444	1,319	—	(444)	385	4,319	4,704	1,818	10/25/2002	1998
2100 Whittier Drive	Frederick	MD	—	1,260	9,464	2,444	—	—	1,260	11,908	13,168	3,871	3/31/2008	1999
10116 Sharpsburg Pike	Hagerstown	MD	—	1,040	7,471	5,273	—	—	1,044	12,740	13,784	4,317	3/31/2008	1999
4000 Old Court Road	Pikesville	MD	—	2,000	4,974	914	—	(82)	2,000	5,806	7,806	1,947	12/22/2008	1987
12725 Twinbrook Parkway	Rockville	MD	—	6,138	6,526	683	—	(148)	6,218	6,981	13,199	1,108	7/12/2017	1968
715 Benfield Road	Severna Park	MD	—	229	9,798	2,502	—	(1,103)	246	11,180	11,426	5,112	10/25/2002	1998
14400 Homecrest Road	Silver Spring	MD	—	1,200	9,288	8,287	—	(1,509)	1,207	16,059	17,266	6,477	10/25/2002	1996
801 Roeder Road	Silver Spring	MD	—	1,900	12,858	1,956	—	(326)	1,900	14,488	16,388	3,560	6/27/2012	1976
720 & 734 N. Pine Road	Hampton	MI	—	300	2,406	—	—	(142)	300	2,264	2,564	1,068	2/28/2003	1998
4004 & 4012 Waldo Road	Midland	MI	—	400	2,606	—	—	(162)	400	2,444	2,844	1,153	2/28/2003	1998

				Initial Cost to Company					Cost at December 31, 2021
Address	City	State	Encumbrances (1)	Land	Buildings, Improvements & Equipment	Cost Capitalized Subsequent to Acquisition	Impairment	Cost Basis Adjustment (2)	Land	Buildings, Improvements & Equipment	Total (3)	Accumulated Depreciation (4)	Date Acquired	Original Construction Date
1605 & 1615 Fredericks Drive	Monroe	MI	—	300	2,506	—	—	(152)	300	2,354	2,654	1,110	2/28/2003	1998
3150 & 3100 Old Centre Road	Portage	MI	—	300	2,206	—	—	(133)	300	2,073	2,373	978	2/28/2003	1998
2445 & 2485 Mc Carty Road	Saginaw	MI	—	600	5,212	—	—	(305)	600	4,907	5,507	2,315	2/28/2003	1998
11855 Ulysses Street NE	Blaine	MN	—	2,774	9,276	389	—	—	2,781	9,658	12,439	2,300	12/21/2012	2007
1305 Corporate Center Drive	Eagan	MN	—	2,300	13,105	10,691	—	—	2,735	23,361	26,096	5,042	12/22/2010	1986
8301 Golden Valley Road	Golden Valley	MN	—	1,256	4,680	579	—	—	1,256	5,259	6,515	803	2/10/2016	1998
8401 Golden Valley Road	Golden Valley	MN	—	1,510	5,742	2,297	—	—	1,510	8,039	9,549	1,362	2/10/2016	1998
8501 Golden Valley Road	Golden Valley	MN	—	1,263	4,288	1,013	—	—	1,263	5,301	6,564	840	2/10/2016	1998
1201 Northland Drive	Mendota Heights	MN	—	1,220	10,208	1,257	—	—	1,468	11,217	12,685	3,516	1/25/2011	1989
12700 Whitewater Drive	Minnetonka	MN	—	5,453	8,108	8,415	—	—	5,453	16,523	21,976	2,808	10/2/2017	1998
20600 South Diamond Lake Road	Rogers	MN	—	2,760	45,789	2,809	(20,359)	(15,686)	1,195	14,118	15,313	1,663	3/1/2008	1999
2200 County Road C West	Roseville	MN	—	590	702	640	—	(82)	792	1,058	1,850	306	9/30/2011	1991
4166 Lexington Avenue N	Shoreview	MN	—	1,300	4,547	1,285	—	—	1,507	5,625	7,132	1,398	5/20/2011	1988
1365 Crestridge Lane	West St. Paul	MN	—	400	2,506	—	—	(292)	400	2,214	2,614	1,044	2/28/2003	1998
305 & 315 Thompson Avenue	West St. Paul	MN	—	400	3,608	99	—	(402)	400	3,305	3,705	1,559	2/28/2003	1998
5351 Gretna Road	Branson	MO	—	743	10,973	1,015	—	(227)	754	11,750	12,504	2,212	5/1/2015	2002
845 N New Ballas Court	Creve Coeur	MO	—	1,582	16,328	1,230	—	—	1,582	17,558	19,140	1,780	1/22/2018	2006
3828 College View Drive	Joplin	MO	—	260	11,382	820	—	(14)	260	12,188	12,448	3,271	8/31/2012	2003
14100 Magellan Plaza	Maryland Heights	MO	—	3,719	37,304	4,836	—	—	3,179	42,680	45,859	9,271	1/29/2015	2003
640 E Highland Avenue	Nevada	MO	—	311	5,703	509	—	—	311	6,212	6,523	1,172	5/1/2015	1997
2410 W Chesterfield Blvd	Springfield	MO	—	924	12,772	608	—	—	924	13,380	14,304	2,452	5/1/2015	1999
3540 East Cherokee Street	Springfield	MO	—	1,084	11,339	1,160	—	—	1,129	12,454	13,583	2,353	5/1/2015	1996
4700 North Hanley Road	St. Louis	MO	—	5,166	41,587	131	—	—	5,166	41,718	46,884	7,268	1/29/2015	2014
118 Alamance Road	Burlington	NC	—	575	9,697	1,359	—	(190)	575	10,866	11,441	3,048	6/20/2011	1998
1050 Crescent Green Drive	Cary	NC	—	713	4,628	3,066	—	(922)	713	6,772	7,485	2,991	10/25/2002	1999
2220 & 2230 Farmington Drive	Chapel Hill	NC	—	800	6,414	—	—	(375)	800	6,039	6,839	2,849	2/28/2003	1996
2101 Runnymede Lane	Charlotte	NC	—	2,475	11,451	1,318	—	(301)	2,458	12,485	14,943	3,823	6/20/2011	1999
5920 McChesney Drive & 6101 Clarke Creek Parkway	Charlotte	NC	—	1,320	21,750	2,350	—	(1,175)	1,320	22,925	24,245	6,847	11/17/2009	1999 / 2001
500 Penny Lane NE	Concord	NC	—	1,687	17,603	783	—	—	1,687	18,386	20,073	3,226	6/29/2016	1997
1002 Highway 54	Durham	NC	—	595	5,200	554	—	(114)	595	5,640	6,235	1,504	6/20/2011	1988
4505 Emperor Boulevard	Durham	NC	—	1,285	16,932	687	—	—	1,285	17,619	18,904	1,990	10/11/2017	2001
5213 South Alston Avenue	Durham	NC	—	1,093	31,377	393	—	—	1,093	31,770	32,863	5,452	1/29/2015	2010
2755 Union Road	Gastonia	NC	—	1,104	17,834	1,058	—	(1,133)	1,104	17,759	18,863	2,551	6/29/2016	1998

				Initial Cost to Company					Cost at December 31, 2021
Address	City	State	Encumbrances (1)	Land	Buildings, Improvements & Equipment	Cost Capitalized Subsequent to Acquisition	Impairment	Cost Basis Adjustment (2)	Land	Buildings, Improvements & Equipment	Total (3)	Accumulated Depreciation (4)	Date Acquired	Original Construction Date
1001 Phifer Road	Kings Mountain	NC	—	655	8,283	1,179	—	(308)	657	9,152	9,809	2,496	6/23/2011	1998
128 Brawley School Road	Mooresville	NC	—	595	7,305	1,379	—	(369)	601	8,309	8,910	2,219	6/23/2011	1999
1309 , 1321, & 1325 McCarthy Boulevard	New Bern	NC	—	1,245	20,898	2,886	—	(159)	1,245	23,625	24,870	6,091	6/20/2011	2001/2005/2008
13150 & 13180 Dorman Road	Pineville	NC	—	1,180	22,800	3,030	—	(1,234)	1,180	24,596	25,776	7,187	11/17/2009	1998
801 Dixie Trail	Raleigh	NC	—	3,233	17,788	1,166	—	(1,114)	3,236	17,837	21,073	2,492	6/29/2016	1992
2744 South 17th Street	Wilmington	NC	—	1,134	14,771	1,881	—	—	1,139	16,647	17,786	3,554	4/18/2016	1998
1730 Parkwood Boulevard West	Wilson	NC	—	610	14,787	1,296	—	(163)	610	15,920	16,530	4,278	6/20/2011	2004/2006
17007 Elm Plaza	Omaha	NE	—	4,680	22,022	—	—	—	4,680	22,022	26,702	7,363	8/21/2008	2007
3030 South 80th Street	Omaha	NE	—	650	5,850	2,224	—	(419)	650	7,655	8,305	2,729	6/3/2005	1992
490 Cooper Landing Road	Cherry Hill	NJ	—	1,001	8,175	3,307	(6,080)	(4,163)	2,240	—	2,240	—	12/29/2003	1999
1400 Route 70	Lakewood	NJ	—	4,885	28,803	8,222	—	(2,881)	4,905	34,124	39,029	14,951	1/11/2002	1987
2 Hillside Drive	Mt. Arlington	NJ	—	1,375	11,232	1,529	—	(399)	1,393	12,344	13,737	5,366	12/29/2003	2001
655 Pomander Walk	Teaneck	NJ	—	4,950	44,550	5,842	—	(1,884)	4,984	48,474	53,458	13,437	12/15/2011	1989
10500 Academy Road NE	Albuquerque	NM	—	3,828	22,572	9,313	—	(2,228)	3,828	29,657	33,485	12,968	1/11/2002	1986
4100 Prospect Avenue NE	Albuquerque	NM	—	540	10,105	8	—	—	540	10,113	10,653	3,591	10/30/2007	1977
4300 Landau Street NE	Albuquerque	NM	—	1,060	9,875	8	—	—	1,060	9,883	10,943	3,510	10/30/2007	1973
4411 The 25 Way	Albuquerque	NM	—	3,480	25,245	4,677	—	(1,061)	3,978	28,363	32,341	8,449	12/22/2010	1970
4420 The 25 Way	Albuquerque	NM	—	1,430	2,609	1,018	—	(152)	1,614	3,291	4,905	863	12/22/2010	1970
9190 Coors Boulevard NW	Albuquerque	NM	—	1,660	9,173	8	—	—	1,660	9,181	10,841	3,260	10/30/2007	1983
2200 East Long Street	Carson City	NV	—	622	17,900	752	—	—	622	18,652	19,274	3,645	5/1/2015	2009
3201 Plumas Street	Reno	NV	—	2,420	49,580	7,657	—	(1,004)	2,420	56,233	58,653	14,353	12/15/2011	1989
6300 Eighth Avenue	Brooklyn	NY	—	3,870	8,545	460	—	—	3,870	9,005	12,875	2,877	8/8/2008	1971
4939 Brittonfield Parkway	East Syracuse	NY	—	720	17,084	1,721	(2,826)	(5,312)	900	10,487	11,387	725	9/30/2008	2001
5008 Brittonfield Parkway	East Syracuse	NY	—	420	18,407	1,670	(3,144)	(5,393)	586	11,374	11,960	700	7/9/2008	1999
200 Old County Road	Mineola	NY	—	4,920	24,056	15,557	—	(153)	4,920	39,460	44,380	10,007	9/30/2011	1971
15 North Broadway	White Plains	NY	—	4,900	13,594	5,056	—	—	4,900	18,650	23,550	5,000	1/26/2009	1952
537 Riverdale Avenue	Yonkers	NY	—	8,460	90,561	12,905	—	(392)	8,465	103,069	111,534	27,467	8/31/2012	2000
4590 Knightsbridge Boulevard	Columbus	OH	—	3,623	27,778	17,430	—	(3,682)	3,732	41,417	45,149	17,487	1/11/2002	1989
3929 Hoover Road	Grove City	OH	—	332	3,081	1,015	—	—	332	4,096	4,428	2,561	6/4/1993	1965
7555 Innovation Way	Mason	OH	—	1,025	12,883	—	—	—	1,025	12,883	13,908	1,691	10/6/2016	2015
8709 S.E. Causey Avenue	Portland	OR	—	3,303	77,428	1,738	(26,073)	(9,749)	2,201	44,446	46,647	2,998	5/1/2015	1985 / 1991
71 Darlington Road	Beaver Falls	PA	—	1,500	13,500	1,041	—	(879)	1,523	13,639	15,162	5,391	10/31/2005	1997
950 Morgan Highway	Clarks Summit	PA	—	1,001	8,233	1,192	—	(277)	1,017	9,132	10,149	3,850	12/29/2003	2001

				Initial Cost to Company					Cost at December 31, 2021
Address	City	State	Encumbrances (1)	Land	Buildings, Improvements & Equipment	Cost Capitalized Subsequent to Acquisition	Impairment	Cost Basis Adjustment (2)	Land	Buildings, Improvements & Equipment	Total (3)	Accumulated Depreciation (4)	Date Acquired	Original Construction Date
145 Broadlawn Drive	Elizabeth	PA	—	696	6,304	672	(4,280)	(3,017)	375	—	375	—	10/31/2005	1986
600 N. Pottstown Pike	Exton	PA	—	1,001	8,233	2,368	—	(308)	1,001	10,293	11,294	4,199	12/29/2003	2000
242 Baltimore Pike	Glen Mills	PA	—	1,001	8,233	1,046	—	(382)	1,001	8,897	9,898	3,844	12/29/2003	2001
20 Capital Drive	Harrisburg	PA	—	397	9,333	10	—	—	397	9,343	9,740	1,614	1/29/2015	2013
210 Mall Boulevard	King of Prussia	PA	—	1,540	4,743	2,698	—	—	1,934	7,047	8,981	2,255	8/8/2008	1970
216 Mall Boulevard	King of Prussia	PA	—	880	2,871	2,378	—	—	978	5,151	6,129	1,241	1/26/2011	1970
5300 Old William Penn Highway	Murrysville	PA	—	300	2,506	—	—	(272)	300	2,234	2,534	1,054	2/28/2003	1998
800 Manor Drive	New Britain (Chalfont)	PA	—	979	8,052	1,713	—	(440)	981	9,323	10,304	3,902	12/29/2003	1998
7151 Saltsburg Road	Penn Hills	PA	—	200	904	—	—	(103)	200	801	1,001	378	2/28/2003	1997
5750 Centre Avenue	Pittsburgh	PA	—	3,000	11,828	4,477	—	(259)	3,788	15,258	19,046	5,189	6/11/2008	1991
730 Holiday Drive	Pittsburgh	PA	—	2,480	6,395	5,835	—	(936)	2,711	11,063	13,774	2,971	12/22/2010	1985
1400 Riggs Road	South Park	PA	—	898	8,102	1,361	(5,192)	(3,499)	1,670	—	1,670	—	10/31/2005	1995
700 Northampton Street	Tiffany Court (Kingston)	PA	—	—	5,682	2,246	—	(359)	—	7,569	7,569	3,036	12/29/2003	1997
5250 Meadowgreen Drive	Whitehall	PA	—	1,599	14,401	4,007	—	(1,106)	1,599	17,302	18,901	6,365	10/31/2005	1987
1304 McLees Road	Anderson	SC	—	295	3,509	1,224	—	(253)	295	4,480	4,775	1,572	11/19/2004	1999
109 Old Salem Road	Beaufort	SC	—	188	2,234	1,625	(807)	(1,514)	104	1,622	1,726	96	11/19/2004	1999
1119 Pick Pocket Plantation Drive	Beaufort	SC	—	1,200	10,810	1,531	(3,927)	(3,270)	733	5,611	6,344	30	6/20/2011	2005
719 Kershaw Highway	Camden	SC	—	322	3,697	1,777	—	(376)	322	5,098	5,420	1,972	11/19/2004	1999
2333 Ashley River Road	Charleston	SC	—	848	14,000	2,849	(7,118)	(4,415)	377	5,787	6,164	565	6/20/2011	1999
320 Seven Farms Drive	Charleston	SC	—	1,092	6,605	1,760	—	(274)	1,092	8,091	9,183	2,008	5/29/2012	1998
251 Springtree Drive	Columbia	SC	—	300	1,905	—	—	(112)	300	1,793	2,093	846	2/28/2003	1998
3 Summit Terrace	Columbia	SC	—	610	7,900	887	(6,314)	(2,698)	385	—	385	—	11/17/2009	2002
7909 Parklane Road	Columbia	SC	—	1,580	4,520	2,323	—	(314)	1,725	6,384	8,109	1,423	9/30/2011	1990
355 Berkmans Lane	Greenville	SC	—	700	7,240	1,725	(2,593)	(2,387)	417	4,268	4,685	131	11/17/2009	2002
116 Enterprise Court	Greenwood	SC	—	310	2,790	1,283	—	(213)	310	3,860	4,170	1,324	6/3/2005	1999
1901 West Carolina Avenue	Hartsville	SC	—	401	4,775	1,068	—	(302)	401	5,541	5,942	2,237	11/19/2004	1999
218 Old Chapin Road	Lexington	SC	—	363	4,322	979	—	(400)	363	4,901	5,264	2,004	11/19/2004	1999
491 Highway 17	Little River	SC	—	750	9,018	1,349	—	(314)	750	10,053	10,803	2,821	6/23/2011	2000
1010 Anna Knapp Boulevard	Mt. Pleasant	SC	—	1,797	6,132	624	—	(458)	1,797	6,298	8,095	842	6/29/2016	1997
601 Mathis Ferry Road	Mt. Pleasant	SC	—	1,687	12,612	706	(10,794)	(2,021)	2,190	—	2,190	—	6/29/2016	1999
937 Bowman Road	Mt. Pleasant	SC	—	3,898	31,613	7,988	—	(997)	3,830	38,672	42,502	10,603	7/1/2012	1997 / 1983
9547 Highway 17 North	Myrtle Beach	SC	—	543	3,202	9,360	(3,192)	(4,437)	333	5,143	5,476	218	1/11/2002	1980
2306 Riverbank Drive	Orangeburg	SC	—	303	3,607	1,043	—	(358)	303	4,292	4,595	1,748	11/19/2004	1999

				Initial Cost to Company					Cost at December 31, 2021
Address	City	State	Encumbrances (1)	Land	Buildings, Improvements & Equipment	Cost Capitalized Subsequent to Acquisition	Impairment	Cost Basis Adjustment (2)	Land	Buildings, Improvements & Equipment	Total (3)	Accumulated Depreciation (4)	Date Acquired	Original Construction Date
1920 Ebenezer Road	Rock Hill	SC	—	300	1,705	—	—	(162)	300	1,543	1,843	728	2/28/2003	1998
15855 Wells Highway	Seneca	SC	—	396	4,714	1,416	—	(353)	396	5,777	6,173	2,198	11/19/2004	2000
One Southern Court	West Columbia	SC	—	520	3,831	612	—	—	557	4,406	4,963	1,545	12/22/2010	2000
6716 Nolensville Road	Brentwood	TN	—	1,528	6,037	223	—	—	1,528	6,260	7,788	1,468	11/30/2012	2010
207 Uffelman Drive	Clarksville	TN	—	320	2,994	2,133	—	(161)	320	4,966	5,286	1,425	12/31/2006	1997
51 Patel Way	Clarksville	TN	—	800	10,322	6,990	—	(318)	833	16,961	17,794	3,840	12/19/2012	2005
2900 Westside Drive NW	Cleveland	TN	—	305	3,627	1,544	—	(284)	305	4,887	5,192	1,830	11/19/2004	1998
1010 East Spring Street	Cookeville	TN	—	322	3,828	1,777	—	(230)	322	5,375	5,697	1,968	11/19/2004	1998
105 Sunrise Circle	Franklin	TN	—	322	3,833	1,312	—	(268)	329	4,870	5,199	1,877	11/19/2004	1997
1085 Hartsville Pike	Gallatin	TN	—	280	3,327	1,840	—	(212)	280	4,955	5,235	1,589	11/19/2004	1998
2025 Caldwell Drive	Goodlettsville	TN	—	400	3,507	8,547	—	(202)	400	11,852	12,252	3,324	2/28/2003	1998
1200 North Parkway	Jackson	TN	—	295	3,506	968	—	(300)	299	4,170	4,469	1,567	11/19/2004	1999
550 Deer View Way	Jefferson City	TN	—	940	8,057	2,297	—	(94)	948	10,252	11,200	2,166	10/15/2013	2001
10914 Kingston Pike (5)	Knoxville	TN	9,817	613	12,410	370	—	—	613	12,780	13,393	1,630	6/29/2018	2008
3020 Heatherton Way	Knoxville	TN	—	304	3,618	3,199	(2,697)	(2,357)	1,440	627	2,067	29	11/19/2004	1998
3030 Holbrook Drive (5)	Knoxville	TN	5,639	352	7,128	852	—	—	360	7,972	8,332	996	6/29/2018	1999
100 Chatuga Drive West	Loudon	TN	—	580	16,093	31,831	—	—	580	47,924	48,504	3,015	1/19/2018	2003
511 Pearson Springs Road	Maryville	TN	—	300	3,207	100	—	(192)	300	3,115	3,415	1,469	2/28/2003	1998
1710 Magnolia Boulevard	Nashville	TN	—	750	6,750	17,521	—	(1,023)	750	23,248	23,998	4,413	6/3/2005	1979
350 Volunteer Drive	Paris	TN	—	110	12,100	720	—	(905)	110	11,915	12,025	1,676	6/29/2016	1997
971 State Hwy 121	Allen	TX	—	2,590	17,912	—	—	—	2,590	17,912	20,502	5,989	8/21/2008	2006
1111 W. 34th Street	Austin	TX	—	400	21,021	2,108	—	—	694	22,835	23,529	7,664	6/25/2008	1975
6818 Austin Center Boulevard	Austin	TX	—	1,540	27,467	2,977	—	(558)	1,585	29,841	31,426	9,757	10/31/2008	1994
7600 N Capital Texas Highway	Austin	TX	—	300	4,557	1,608	—	—	300	6,165	6,465	1,460	12/22/2010	1996
4620 Bellaire Boulevard	Bellaire	TX	—	1,238	11,010	4,948	—	(243)	1,325	15,628	16,953	9,547	10/1/2012	1991
120 Crosspoint Drive	Boerne	TX	—	220	4,926	960	—	—	227	5,879	6,106	1,864	2/7/2008	1990
4015 Interstate 45	Conroe	TX	—	620	14,074	1,270	—	(373)	620	14,971	15,591	4,115	10/26/2010	2009
5455 La Sierra Drive	Dallas	TX	—	2,300	25,200	8,177	—	(902)	2,324	32,451	34,775	8,645	12/15/2011	1989
7831 Park Lane	Dallas	TX	—	4,709	27,768	23,525	—	(2,998)	5,432	47,572	53,004	18,453	1/11/2002	1990
1575 Belvidere Street	El Paso	TX	—	2,301	13,567	7,482	—	(1,537)	2,316	19,497	21,813	7,713	1/11/2002	1987
96 Frederick Road	Fredericksburg	TX	—	280	4,866	6,770	—	—	280	11,636	11,916	2,871	2/7/2008	1999
6435 S.F.M. 549	Heath	TX	—	1,135	7,892	998	(288)	(1,493)	1,192	7,052	8,244	426	12/31/2012	2004
13215 Dotson Road	Houston	TX	—	990	13,887	1,458	—	—	990	15,345	16,335	3,994	7/17/2012	2007

				Initial Cost to Company					Cost at December 31, 2021
Address	City	State	Encumbrances (1)	Land	Buildings, Improvements & Equipment	Cost Capitalized Subsequent to Acquisition	Impairment	Cost Basis Adjustment (2)	Land	Buildings, Improvements & Equipment	Total (3)	Accumulated Depreciation (4)	Date Acquired	Original Construction Date
777 North Post Oak Road	Houston	TX	—	5,537	32,647	27,154	—	(4,460)	5,540	55,338	60,878	21,503	1/11/2002	1989
10030 North MacArthur Boulevard	Irving	TX	—	2,186	15,869	755	—	—	2,186	16,624	18,810	2,848	1/29/2015	1999
4770 Regent Boulevard	Irving	TX	—	2,830	15,082	4,467	—	—	2,830	19,549	22,379	6,835	6/25/2008	1995
9812 Slide Road	Lubbock	TX	—	1,110	9,798	665	—	—	1,110	10,463	11,573	2,882	6/4/2010	2009
605 Gateway Central	Marble Falls	TX	—	1,440	7,125	1,380	—	(34)	1,440	8,471	9,911	2,332	12/19/2012	1994 / 2002
7150 N. President George Bush Turnpike	North Garland	TX	—	1,981	8,548	1,147	(346)	(1,557)	1,941	7,832	9,773	485	12/31/2012	2006
500 Coit Road	Plano	TX	—	3,463	44,841	67	—	—	3,468	44,903	48,371	2,436	12/20/2019	2016
2265 North Lakeshore Drive	Rockwall	TX	—	497	3,582	—	—	—	497	3,582	4,079	619	1/29/2015	2013
18302 Talavera Ridge	San Antonio	TX	—	6,855	30,630	—	—	—	6,855	30,630	37,485	5,297	1/29/2015	2008
21 Spurs Lane (5)	San Antonio	TX	11,120	3,141	23,142	2,199	—	—	3,192	25,290	28,482	4,957	4/10/2014	2006
311 West Nottingham Place	San Antonio	TX	—	4,283	25,256	13,831	—	(3,063)	4,359	35,948	40,307	15,661	1/11/2002	1989
511 & 575 Knights Cross Drive	San Antonio	TX	—	2,300	20,400	2,307	—	(1,150)	2,306	21,551	23,857	6,484	11/17/2009	2003
5055 West Panther Creek Drive	Woodlands	TX	—	3,694	21,782	7,488	—	(3,490)	3,706	25,768	29,474	11,746	1/11/2002	1988
491 Crestwood Drive	Charlottesville	VA	—	641	7,633	2,711	—	(585)	646	9,754	10,400	3,844	11/19/2004	1998
1005 Elysian Place	Chesapeake	VA	—	2,370	23,705	2,291	—	(153)	2,381	25,832	28,213	7,035	6/20/2011	2006
2856 Forehand Drive	Chesapeake	VA	—	160	1,498	2,398	(1,427)	(1,159)	1,470	—	1,470	—	5/30/2003	1987
4027 Martinsburg Pike	Clear Brook	VA	—	3,775	21,768	—	—	—	3,775	21,768	25,543	3,764	1/29/2015	2013
4001 Fair Ridge Drive	Fairfax	VA	—	2,500	7,147	3,129	—	(222)	2,646	9,908	12,554	3,099	12/22/2008	1990
20 HeartFields Lane	Fredericksburg	VA	—	287	8,480	1,864	—	(781)	287	9,563	9,850	4,493	10/25/2002	1998
2800 Polo Parkway	Midlothian	VA	—	1,103	13,126	4,986	—	(920)	1,108	17,187	18,295	6,502	11/19/2004	1996
655 Denbigh Boulevard	Newport News	VA	—	581	6,921	2,170	—	(438)	584	8,650	9,234	3,373	11/19/2004	1998
6160 Kempsville Circle	Norfolk	VA	—	3,263	7,615	4,016	—	(115)	3,372	11,407	14,779	1,458	12/22/2017	1987
6161 Kempsville Road	Norfolk	VA	—	1,530	9,531	2,984	—	(323)	1,530	12,192	13,722	3,628	12/22/2008	1999
6311 Granby Street	Norfolk	VA	—	1,920	16,538	3,078	—	(188)	1,932	19,416	21,348	5,116	6/20/2011	2005
885 Kempsville Road	Norfolk	VA	—	1,780	8,354	2,823	—	(865)	1,798	10,294	12,092	3,070	5/20/2009	1981
531 Wythe Creek Road	Poquoson	VA	—	220	2,041	1,031	—	(275)	220	2,797	3,017	1,132	5/30/2003	1987
10800 Nuckols Road (5)	Glen Allen	VA	10,240	2,863	11,105	698	—	—	2,863	11,803	14,666	1,278	3/28/2018	2000
3000 Skipwith Road	Richmond	VA	—	732	8,717	1,434	—	(519)	732	9,632	10,364	3,951	11/19/2004	1999
9900 Independence Park Drive	Richmond	VA	—	326	3,166	272	—	(92)	326	3,346	3,672	882	11/22/2011	2005
9930 Independence Park Drive	Richmond	VA	—	604	4,975	1,160	—	—	700	6,039	6,739	1,340	11/22/2011	2005
5620 Wesleyan Drive	Virginia Beach	VA	—	893	7,926	2,685	—	(124)	893	10,487	11,380	6,309	9/1/2012	1990
4132 Longhill Road	Williamsburg	VA	—	270	2,468	1,392	(945)	(1,583)	162	1,440	1,602	53	5/30/2003	1987
440 McLaws Circle	Williamsburg	VA	—	1,466	17,340	713	—	(1,040)	1,466	17,013	18,479	2,339	6/29/2016	1998

				Initial Cost to Company					Cost at December 31, 2021
Address	City	State	Encumbrances (1)	Land	Buildings, Improvements & Equipment	Cost Capitalized Subsequent to Acquisition	Impairment	Cost Basis Adjustment (2)	Land	Buildings, Improvements & Equipment	Total (3)	Accumulated Depreciation (4)	Date Acquired	Original Construction Date
21717 30th Drive SE	Bothell	WA	—	3,012	12,582	69	—	—	3,081	12,582	15,663	2,807	2/14/2013	1998
21823 30th Drive SE	Bothell	WA	—	2,627	12,657	55	—	—	2,682	12,657	15,339	2,823	2/14/2013	2000
516 Kenosia Avenue South	Kent	WA	—	1,300	8,458	3,728	—	—	1,368	12,118	13,486	3,228	7/31/2012	1971
555 16th Avenue	Seattle	WA	—	256	4,869	68	—	(513)	256	4,424	4,680	3,111	11/1/1993	1964
3003 West Good Hope Road	Glendale	WI	—	1,500	33,747	—	—	—	1,500	33,747	35,247	10,335	9/30/2009	1963
7007 North Range Line Road	Glendale	WI	—	250	3,797	—	—	—	250	3,797	4,047	1,163	9/30/2009	1964
215 Washington Street	Grafton	WI	—	500	10,058	—	—	—	500	10,058	10,558	3,080	9/30/2009	2009
N168W22022 Main Street	Jackson	WI	—	188	5,962	912	—	(101)	192	6,769	6,961	1,352	12/1/2014	2005
8351 Sheridan Road	Kenosha	WI	—	750	7,669	386	—	—	758	8,047	8,805	2,817	1/1/2008	2000
5601 Burke Road	Madison	WI	—	700	7,461	922	—	—	712	8,371	9,083	2,767	1/1/2008	2000
7707 N. Brookline Drive	Madison	WI	—	2,615	35,545	3,584	—	(51)	2,631	39,062	41,693	7,676	12/1/2014	1999 / 2004
10803 North Port Washington Road	Mequon	WI	—	800	8,388	900	—	(25)	805	9,258	10,063	3,232	1/1/2008	1999
701 East Puetz Road	Oak Creek	WI	—	650	18,396	2,522	—	(105)	1,376	20,087	21,463	6,874	1/1/2008	2001
W231 N1440 Corporate Court	Pewaukee	WI	—	3,900	41,140	—	—	—	3,900	41,140	45,040	12,599	9/30/2009	1994
8348 & 8400 Washington Avenue	Racine	WI	—	1,150	22,436	—	—	—	1,150	22,436	23,586	6,871	9/30/2009	1986
1221 North 26th Street	Sheboygan	WI	—	300	975	—	—	—	300	975	1,275	299	9/30/2009	1987
1222 North 23rd Street	Sheboygan	WI	—	120	4,014	—	—	—	120	4,014	4,134	1,229	9/30/2009	1987
2414 Kohler Memorial Drive	Sheboygan	WI	—	1,400	35,168	—	—	—	1,400	35,168	36,568	10,770	9/30/2009	1986
1125 N Edge Trail	Verona	WI	—	1,365	9,581	1,721	—	(340)	1,372	10,955	12,327	2,524	11/1/2013	2001
3289 North Mayfair Road	Wauwatosa	WI	—	2,300	6,245	—	—	—	2,300	6,245	8,545	1,913	9/30/2009	1964
503 South 18th Street	Laramie	WY	—	191	3,632	2,846	—	(884)	202	5,583	5,785	2,651	12/30/1993	1964
1901 Howell Avenue	Worland	WY	—	132	2,508	2,293	—	(571)	132	4,230	4,362	2,313	12/30/1993	1970
		Total	$69,135	$715,799	$5,050,945	$1,455,137	$(140,345)	$(267,980)	$741,501	$6,072,055	$6,813,556	$1,737,807

(1)    Represents mortgage debts and finance leases, excluding the unamortized balance of fair value adjustments and debt issuance costs totaling approximately $(578).

(2)    Represents reclassifications between accumulated depreciation and buildings, improvements and equipment made to record certain properties at fair value in accordance with GAAP.

(3)    Aggregate cost for federal income tax purposes is approximately $7,405,729.

(4)    We depreciate buildings and improvements over periods ranging up to 40 years and equipment over periods ranging up to 12 years.

(5)    These properties are collateral for our $62,499 of mortgage debts.

(6)    These properties are subject to our $6,636 of finance leases.

Analysis of the carrying amount of real estate and equipment and accumulated depreciation during the period:

	Real Estate and Equipment		Accumulated Depreciation
Balance as of December 31, 2018	$	7,876,300	$	1,534,392
Additions	277,350		221,165
Disposals	(250,996)		(54,816)
Impairment	(114,786)		—
Cost basis adjustment (1)	(77,642)		(77,642)
Reclassification of assets held for sale, net	(248,640)		(52,298)
Balance as of December 31, 2019	7,461,586		1,570,801
Additions	192,124		216,418
Disposals	(145,430)		(10,228)
Impairment	(106,972)		—
Cost basis adjustment (1)	(126,127)		(126,127)
Reclassification of assets held for sale, net	135,549		44,037
Balance as of December 31, 2020	7,410,730		1,694,901
Additions	229,735		223,039
Disposals	(910,372)		(158,523)
Impairment	174		—
Cost basis adjustment (1)	(29,762)		(29,762)
Reclassification of assets held for sale, net	113,051		8,152
Balance as of December 31, 2021	$	6,813,556	$	1,737,807

(1)    Represents reclassifications between accumulated depreciation and buildings, improvements and equipment made to record certain properties at fair value in accordance with GAAP.

XML

Summary of Significant Accounting Policies (Policies)

12 Months Ended

Dec. 31, 2021

Accounting Policies [Abstract]

BASIS OF PRESENTATION

BASIS OF PRESENTATION.  Our consolidated financial statements include the accounts of Diversified Healthcare Trust, we, us or our, and our subsidiaries, all of which are 100% owned directly or indirectly by us. All intercompany transactions and balances with or among our consolidated subsidiaries have been eliminated. Accounting principles generally accepted in the United States, or GAAP, require us to make estimates and assumptions that may affect the amounts reported in these financial statements and related notes. The actual results could differ from these estimates.

REAL ESTATE PROPERTIES

REAL ESTATE PROPERTIES.  We record properties at our cost and calculate depreciation on real estate investments on a straight line basis over estimated useful lives generally up to 40 years.

We allocate the purchase prices of our properties to land, building and improvements based on determinations of the fair values of these assets assuming the properties are vacant. We determine the fair value of each property using methods similar to those used by independent appraisers, which may involve estimated cash flows that are based on a number of factors, including capitalization rates and discount rates, among others. In some circumstances, we engage independent real estate appraisal firms to provide market information and evaluations which are relevant to our purchase price allocations and determinations of depreciable useful lives; however, we are ultimately responsible for the purchase price allocations and determinations of useful lives. We allocate a portion of the purchase price to above market and below market leases based on the present value (using an interest rate which reflects the risks associated with acquired in place leases at the time each property was acquired by us) of the difference, if any, between (i) the contractual amounts to be paid pursuant to the acquired in place leases and (ii) our estimates of fair market lease rates for the corresponding leases, measured over a period equal to the terms of the respective leases. The terms of below market leases that include bargain renewal options, if any, are further adjusted if we determine that renewal is probable. We allocate a portion of the purchase price to acquired in place leases and tenant relationships based upon market estimates to lease up the property based on the leases in place at the time of purchase. In making these allocations, we consider factors such as estimated carrying costs during the expected lease up periods, including real estate taxes, insurance and other operating income and expenses and costs, such as leasing commissions, legal and other related expenses, to execute similar leases in current market conditions at the time a property was acquired by us. We allocate this aggregate value between acquired in place lease values and tenant relationships based on our evaluation of the specific characteristics of each tenant's lease. However, we have not separated the value of tenant relationships from the value of acquired in place leases because such value and related amortization expense is immaterial to our consolidated financial statements. If the value of tenant relationships becomes material in the future, we may separately allocate those amounts and amortize the allocated amount over the estimated life of the relationships.

We amortize capitalized above market lease values (included in acquired real estate leases and other intangible assets, net in our consolidated balance sheets) as a reduction to rental income over the remaining non-cancelable terms of the respective leases. We amortize capitalized below market lease values (presented as assumed real estate lease obligations in our consolidated balance sheets) as an increase to rental income over the non-cancelable periods of the respective leases. For the years ended December 31, 2021, 2020 and 2019, such amortization resulted in a net increase in rental income of $7,211, $7,405 and $6,791, respectively. We amortize the value of in place leases exclusive of the value of above market and below market in place leases to expense over the remaining non-cancelable periods of the respective leases. During the years ended December 31, 2021, 2020 and 2019, such amortization included in depreciation totaled $42,783, $48,669 and $64,203, respectively. If a lease is terminated prior to its stated expiration, the unamortized amount relating to that lease is written off.

CASH AND CASH EQUIVALENTS

CASH AND CASH EQUIVALENTS.  We consider highly liquid investments with original maturities of three months or less at the date of purchase to be cash equivalents.

RESTRICTED CASH

RESTRICTED CASH.  Restricted cash consists of amounts escrowed for real estate taxes, insurance and capital expenditures at certain of our mortgaged properties and amounts held as collateral pursuant to our credit agreement.

INVESTMENTS IN EQUITY SECURITIES

INVESTMENTS IN EQUITY SECURITIES. We previously owned 2,637,408 shares of class A common stock of The RMR Group Inc., or RMR Inc., that we sold on July 1, 2019. Prior to July 1, 2019, our equity securities were recorded at fair value based on their quoted market price at the end of each reporting period. We classify the common shares we own of AlerisLife Inc. (f/k/a Five Star Senior Living Inc.), or AlerisLife, as an equity method investment. This equity method investment is included in investments of equity securities in our consolidated balance sheets.

EQUITY METHOD INVESTMENTS

EQUITY METHOD INVESTMENTS.  As of December 31, 2021, we owned a 20% equity interest in an unconsolidated joint venture which owns a life science property located in Boston, Massachusetts. The property owned by this joint venture is encumbered by an aggregate $620,000 of mortgage debts. We do not control the activities that are most significant to this joint venture and, as a result, we account for our investment in this joint venture under the equity method of accounting under the fair value option. See Notes 3, 10 and 11 for more information regarding this joint venture.We account for our investment in Affiliates Insurance Company, or AIC, until AIC was dissolved as described in Note 8, using the equity method of accounting. Significant influence was present through common representation on our Board of Trustees and the board of directors of AIC until February 13, 2020. The Chair of our Board of Trustees and one of our Managing Trustees, Adam D. Portnoy, as the sole trustee of ABP Trust, is the controlling shareholder of RMR Inc. He is also a managing director and an executive officer of RMR Inc. Substantially all of the business of RMR Inc. is conducted by its majority owned subsidiary, The RMR Group LLC, or RMR LLC, which is our manager and provided management and administrative services to AIC. Most of our Trustees were directors of AIC. See Note 8 for more information about our investment in AIC. As previously discussed, we also account for our investment in AlerisLife as an equity method investment under the fair value option.

DEBT ISSUANCE COSTS

DEBT ISSUANCE COSTS.  Debt issuance costs include issuance or assumption costs related to borrowings and we amortize those costs as interest expense over the terms of the respective loans.

DEFERRED LEASING COSTS

DEFERRED LEASING COSTS.  Deferred leasing costs include capitalized brokerage and other fees associated with the successful negotiation of leases, which are amortized to depreciation and amortization expense on a straight line basis over the terms of the respective leases. Deferred leasing costs are included in other assets in our consolidated balance sheets.

REVENUE RECOGNITION

REVENUE RECOGNITION.  We are a lessor of medical office and life science properties, senior living communities and other healthcare related properties. Our leases provide our tenants with the contractual right to use and economically benefit from all of the premises demised under the leases; therefore, we have determined to evaluate our leases as lease arrangements.

PER COMMON SHARE AMOUNTS

PER COMMON SHARE AMOUNTS.  We calculate basic earnings per common share by dividing net income (loss) by the weighted average number of our common shares of beneficial interest, $.01 par value, or our common shares, outstanding during the period. We calculate diluted earnings per common share using the more dilutive of the two class method or the treasury stock method. Unvested share awards and other potentially dilutive common shares and the related impact on earnings, are considered when calculating diluted earnings per share.

INCOME TAXES

INCOME TAXES.  We have elected to be taxed as a REIT under the United States Internal Revenue Code of 1986, as amended, and as such are generally not subject to federal and most state income taxation on our operating income provided we distribute our taxable income to our shareholders and meet certain organization and operating requirements. We do, however, lease our managed senior living communities to our wholly owned TRSs that, unlike most of our subsidiaries, file a separate consolidated federal corporate income tax return and are subject to federal and state income taxes. Our consolidated income tax provision includes the income tax provision related to the operations of our TRSs and certain state income taxes we incur despite our taxation as a REIT.

The Income Taxes Topic of the Codification prescribes how we should recognize, measure and present in our financial statements uncertain tax positions that have been taken or are expected to be taken in a tax return. Tax benefits are recognized to the extent that it is “more likely than not” that a particular tax position will be sustained upon examination or audit. To the extent the “more likely than not” standard has been satisfied, the benefit associated with a tax position is measured as the largest

amount that has a greater than 50% likelihood of being realized upon settlement. We classify interest and penalties related to uncertain tax positions, if any, in our financial statements as a component of general and administrative expense.

SEGMENT REPORTING

SEGMENT REPORTING.  As of December 31, 2021, we operate in, and report financial information for, the following two segments: our portfolio of medical office and life science properties, or our Office Portfolio, and SHOP. We aggregate each of these two reporting segments based on their similar operating and economic characteristics.

NEW ACCOUNTING PRONOUNCEMENTS

NEW ACCOUNTING PRONOUNCEMENTS. In June 2016, the Financial Accounting Standards Board, or FASB, issued Accounting Standards Update, or ASU, No. 2016-13, Financial Instruments - Credit Losses (Topic 326): Measurement of Credit Losses on Financial Instruments, which requires that entities use a new forward-looking “expected loss” model that generally will result in the earlier recognition of allowance for credit losses. The measurement of expected credit losses is based upon historical experience, current conditions, and reasonable and supportable forecasts that affect the collectability of the reported amount. We adopted this standard on January 1, 2020 using the modified retrospective approach. The implementation of this standard did not have a material impact on our consolidated financial statements.

In October 2021, the FASB issued ASU No. 2021-08, Business Combinations (Topic 805): Accounting for Contract Assets and Contract Liabilities from Contracts with Customers, or ASU No. 2021-08, which requires that an acquirer account for the related revenue contracts in accordance with Topic 606 as if it had originated the contracts. The acquiring entity shall recognize and measure the acquired contract assets and contract liabilities consistent with how they were recognized and measured in the acquiree’s financial statements, rather than at fair value at the acquisition date. ASU No. 2021-08 is effective for fiscal years beginning after December 15, 2022, with early adoption permitted. On October 1, 2021, we early adopted ASU No. 2021-08. The adoption of ASU No. 2021-08 did not have an impact on our consolidated financial statements.

In November 2021, the FASB issued ASU No. 2021-10, Government Assistance (Topic 832): Disclosures by Business Entities about Government Assistance, or ASU No. 2021-10, which requires business entities to disclose government assistance accounted for by applying a grant or contribution model by analogy. ASU No. 2021-10 states that an entity shall disclose the nature of the transactions, the related accounting policies used, the effect of the transactions on an entity's financial statements and significant terms and conditions of the transactions. ASU No. 2021-10 is effective for annual periods beginning after December 15, 2021, with early adoption permitted. On November 17, 2021, we early adopted ASU No. 2021-10. The adoption of ASU No. 2021-10 did not have a material impact on our consolidated financial statements.

XML

Summary of Significant Accounting Policies (Tables)

12 Months Ended

Dec. 31, 2021

Accounting Policies [Abstract]

Schedule of Real Estate Lease Obligations

As of December 31, 2021 and 2020, our acquired real estate leases and assumed real estate lease obligations, excluding properties held for sale, were as follows:

	December 31,
	2021		2020
Acquired real estate leases:
Capitalized above market lease values (1)	$	8,092	$	12,304
Less: accumulated amortization	(6,268)		(9,236)
Capitalized above market lease values, net	1,824		3,068
Lease origination value	123,682		551,141
Less: accumulated amortization	(76,760)		(267,696)
Lease origination value, net	46,922		283,445
Acquired real estate leases and other intangible assets, net	$	48,746	$	286,513
Assumed real estate lease obligations:
Capitalized below market lease values	$	6,141	$	128,991
Less: accumulated amortization	(3,585)		(61,161)
Assumed real estate lease obligations, net	$	2,556	$	67,830

(1)Acquired real estate leases and other related intangible assets decreased due to our sale of a 35% equity interest from our then remaining 55% equity interest in the joint venture which owns a life science property located in Boston, Massachusetts to another third party global institutional investor. As a result of this sale, we deconsolidated the net assets of this joint venture.

XML

Real Estate Investments (Tables)

12 Months Ended

Dec. 31, 2021

Real Estate [Abstract]

Schedule of equity method investments

As of December 31, 2021, we had an equity investment in a joint venture as follows:

Joint Venture	DHC Ownership	DHC Carrying Value of Investment at December 31, 2021		Number of Properties	Location	Square Feet
Seaport Innovation LLC	20%	$	215,127	1	Massachusetts	1,134,479

The following table provides a summary of the mortgage debts of this joint venture:

Joint Venture	Coupon Rate	Maturity Date	Principal Balance at December 31, 2021 (1)
Mortgage Notes Payable (secured by one property in Massachusetts)	3.53%	8/6/2026	$	620,000

(1)Amounts are not adjusted for our minority interest. We no longer include this $620,000 of secured debt financing in our consolidated balance sheet following the deconsolidation in December 2021 of the net assets of our joint venture which owns a life science property located in Boston, Massachusetts; however, DHC continues to provide certain guaranties on this debt.

Schedule of real estate property acquisition

The table below represents the purchase price allocations (including net closing adjustments) of acquisitions for the years ended December 31, 2021, 2020 and 2019:

Date	Location	Type of Property	Number of Properties	Number of Units	Cash Paid plus Assumed Debt (1)		Land		Buildings and Improvements		FF&E		Acquired Real Estate Leases / Resident Agreements		Acquired Real Estate Lease Obligations		Assumed Debt		Premium on  Assumed Debt
Acquisitions during the year ended December 31, 2021:
We did not acquire any properties during the year ended December 31, 2021.
Acquisitions during the year ended December 31, 2020:
We did not acquire any properties during the year ended December 31, 2020.
Acquisitions during the year ended December 31, 2019:
December 2019	Texas	IL	1	169	$	50,506	$	3,463	$	44,189	$	652	$	2,202	$	—	$	—	$	—

(1)Cash paid plus assumed debt, if any, includes closing costs.

Schedule of disposal groups

Date of Sale	Location	Type of Property	Number of Properties	Square Feet or Number of Units		Sales Price (1)		Gain (loss) on Sale
Dispositions during the year ended December 31, 2021:
February 2021	Pennsylvania	Medical Office	1	92,000	sq. ft.	$	9,000	$	(122)
April 2021	Florida	Life Science / Medical Office	4	263,656	sq. ft.	95,500		30,760
			5			$	104,500	$	30,638
Dispositions during the year ended December 31, 2020:
January 2020	Louisiana	Medical Office	6	40,575	sq. ft.	$	5,925	$	(81)
February 2020	Pennsylvania	Medical Office	1	50,000	sq. ft.	2,900		—
March 2020	Texas	Medical Office	1	70,229	sq. ft.	8,779		2,863
April 2020 (2)	California	IL / AL	3	599	units	47,000		(256)
June 2020	South Carolina	Medical Office	1	49,242	sq. ft.	3,550		—
July 2020	Texas	Medical Office	1	6,849	sq. ft.	2,072		(30)
July 2020	Connecticut	Medical Office	1	32,162	sq. ft.	625		(25)
August 2020 (2)	Mississippi	AL	2	116	units	2,500		(42)
September 2020	Mississippi	Medical Office	1	78,747	sq. ft.	7,250		(114)
October 2020	Various	AL	3	239	units	46,000		4,292
November 2020 (2)	Nebraska	AL	1	131	units	3,000		(26)
December 2020	New York	Medical Office	1	64,060	sq. ft.	3,875		(273)
December 2020	Ohio	Life Science	2	232,016	sq. ft.	7,917		257
December 2020 (2)	Wisconsin	SNF / AL	3	537	units	11,500		(303)
			27			$	152,893	$	6,262
Dispositions during the year ended December 31, 2019:
February 2019	Florida	Life Science	1	60,396	sq. ft.	$	2,900	$	(69)
March 2019	Massachusetts	Medical Office	1	4,400	sq. ft.	75		(58)
May 2019 (2)	California	SNF	3	278	units	21,500		15,207
May 2019	Colorado	Medical Office	1	15,647	sq. ft.	2,590		1,029
June 2019	Massachusetts	Medical Office	7	164,121	sq. ft.	8,042		1,590
July 2019	Massachusetts	Medical Office	3	103,484	sq. ft.	4,955		2,332
August 2019	Massachusetts	Medical Office	1	49,357	sq. ft.	2,221		812
September 2019 (2)	Various	SNF	15	964	units	8,000		—
September 2019	Massachusetts	Medical Office	1	41,065	sq. ft.	2,750		1,044
October 2019	South Dakota	SNF / IL	3	245	units	10,500		6,661
October 2019	New Jersey	Life Science	1	205,439	sq. ft.	47,500		—
December 2019	Georgia	Medical Office	1	95,010	sq. ft.	14,000		(63)
December 2019	Washington	IL	1	150	units	32,500		7,618
December 2019	Various	AL	7	566	units	103,250		3,593
			46			$	260,783	$	39,696

(1)Sales price excludes closing costs.

(2)These senior living communities were previously operated by Five Star.

XML

Leases (Tables)

12 Months Ended

Dec. 31, 2021

Leases [Abstract]

Maturities of Operating Lease Liabilities

The following table presents our operating lease maturity analysis, excluding lease payments from properties classified as held for sale, if any, as of December 31, 2021:

Year	Amount
2022	$	236,309
2023	234,633
2024	219,532
2025	197,712
2026	181,819
Thereafter	812,989
Total	$	1,882,994

XML

Shareholders' Equity (Tables)

12 Months Ended

Dec. 31, 2021

Stockholders' Equity Note [Abstract]

Schedule of summary of shares granted and vested

A summary of shares awarded, forfeited, vested and unvested under the terms of the 2012 Plan from January 1, 2019 to December 31, 2021 is as follows:

	Number of Shares	Weighted Average Award Date Fair Value
Unvested shares at December 31, 2018	161,990	$	19.41
Shares awarded in 2019	202,500	$	8.65
Shares vested / forfeited in 2019	(137,150)	$	8.94
Unvested shares at December 31, 2019	227,340	$	12.52
Shares awarded in 2020	420,000	$	3.65
Shares vested / forfeited in 2020	(212,790)	$	7.04
Unvested shares at December 31, 2020	434,550	$	6.15
Shares awarded in 2021	838,000	$	3.45
Shares vested / forfeited in 2021	(426,930)	$	4.98
Unvested shares at December 31, 2021	845,620	$	4.07

Schedule of dividends declared and paid

A summary of cash distributions paid to common shareholders, for federal income tax purposes, as are follows for the periods presented:

	Annual Per				Characterization of Distribution
	Share		Total		Ordinary		Capital		Return of
Year	Distribution		Distribution		Income		Gain		Capital
2021	$	0.04	$	9,540	—	%	100.0	%	—	%
2020	$	0.18	$	42,825	—	%	—	%	100.0	%
2019	$	0.84	$	199,719	—	%	25.7	%	74.3	%

XML

Senior Living Community Leases and Management Agreements (Tables)

12 Months Ended

Dec. 31, 2021

Risks and Uncertainties [Abstract]

Schedule of Assets Leased and Revenues Earned

The following is a summary of the assets leased to and revenues earned from Five Star as a tenant as of and for the year ended December 31, 2019 compared to all our other assets and revenues from all sources:

	As of December 31, 2019
	Gross Book Value of Real Estate Assets (1)		% of Total
Five Star (2)	$	2,286,951	27.2	%
All others (3)	6,133,672		72.8	%
	$	8,420,623	100.0	%

(1)    Represents the gross book value of real estate assets at cost plus certain acquisition costs, before depreciation and purchase price allocations, less impairment write downs, if any. Five Star also managed some of our managed senior living communities as of December 31, 2019. The gross book value of real estate assets of $1,920,070 as of December 31, 2019 for those managed senior living communities is included in the "All others" category.

(2)    Includes gross book value of real estate assets of $50,951 classified as held for sale in our consolidated balance sheet as of December 31, 2019.

(3)    Includes gross book value of real estate assets of $213,416 classified as held for sale in our consolidated balance sheet as of December 31, 2019.

	Year Ended
	December 31, 2019
	Total Revenues(1)		% of Total
Five Star	$	137,898	13.3	%
All others	902,257		86.7	%
	$	1,040,155	100.0	%

(1)    Five Star also managed some of our managed senior living communities as of December 31, 2019. Our revenues of $433,597 for the year ended December 31, 2019, from those communities are included in the “All others” category.

Schedule of Disaggregation of Revenue

The following table presents residents fees and services revenue from our managed senior living communities disaggregated by the type of contract and payer:

	Year Ended December 31,
Revenue from contracts with customers:	2021		2020		2019
Basic housing and support services	$	750,644	$	856,687	$	353,699
Medicare and Medicaid programs	98,273		173,878		31,324
Private pay and other third party payer SNF services	125,706		174,246		48,574
Total residents fees and services	$	974,623	$	1,204,811	$	433,597

XML

Indebtedness (Tables)

12 Months Ended

Dec. 31, 2021

Debt Disclosure [Abstract]

Schedule of additional outstanding debt

At December 31, 2021 and 2020, our outstanding indebtedness consisted of the following:

		Principal Balance as of December 31,
Floating Rate Debt (1)	Maturity	2021		2020
Revolving credit facility (2)	January 2023	$	800,000	$	—
Term loan	September 2022	—		200,000
Total floating rate debt		$	800,000	$	200,000

(1)As of December 31, 2021 and 2020, the unamortized net debt issuance costs on certain of these debts were $0 and $951, respectively.

(2)Outstanding borrowings under our revolving credit facility. In February 2022, we exercised our option to extend the maturity date of our revolving credit facility by one year to January 2024.

				December 31, 2021				December 31, 2020
Senior Unsecured Notes (1)	Coupon		Maturity	Face Amount		Unamortized Discount		Face Amount		Unamortized Discount
Senior unsecured notes	6.750	%	December 2021	$	—	$	—	$	300,000	$	490
Senior unsecured notes	4.750	%	May 2024	250,000		184		250,000		263
Senior unsecured notes	9.750	%	June 2025	1,000,000		—		1,000,000		—
Senior unsecured notes	4.750	%	February 2028	500,000		5,169		500,000		6,013
Senior unsecured notes	4.375	%	March 2031	500,000		—		—		—
Senior unsecured notes	5.625	%	August 2042	350,000		—		350,000		—
Senior unsecured notes	6.250	%	February 2046	250,000		—		250,000		—
Total senior unsecured notes				$	2,850,000	$	5,353	$	2,650,000	$	6,766

(1)As of December 31, 2021 and 2020, the unamortized net debt issuance costs on certain of these notes were $37,836 and $35,045, respectively.

Schedule of secured and other debt

	Principal Balance as of December 31,							Number of Properties as Collateral	Net Book Value of Collateral as of December 31,
Secured and Other Debt	2021 (1)		2020 (1)		Interest Rate		Maturity	At December 31, 2021	2021		2020
Mortgage note	$	11,120	$	11,838	6.28	%	July 2022	1	$	23,525	$	23,500
Mortgage note	10,479		10,724		4.85	%	October 2022	1	19,211		19,675
Mortgage note	15,456		15,805		5.75	%	October 2022	2	19,099		19,180
Mortgage note	15,204		15,646		6.64	%	June 2023	1	24,593		23,023
Mortgage notes (2)	—		620,000		3.53	%	August 2026	—	—		705,096
Mortgage note	10,240		10,470		4.44	%	July 2043	1	13,387		13,582
Finance Leases	6,636		7,811		7.70	%	April 2026	2	18,527		18,097
Total secured	$	69,135	$	692,294				8	$	118,342	$	822,153

(1)The principal balances are the amounts stated in the contracts. In accordance with GAAP, our carrying values and recorded interest expense may be different because of market conditions at the time we assumed certain of these debts. As of December 31, 2021 and 2020, the unamortized net premiums and debt issuance costs on certain of these mortgages were $(578) and $721, respectively.

(2)The property encumbered by these mortgages is located in Boston, Massachusetts and was contributed in the first quarter of 2017 to a joint venture, which we deconsolidated in December 2021 and in which we currently own a 20% equity interest. As of December 31, 2020, this property was consolidated into our financial statements. See Note 3 for further information regarding this joint venture.

Schedule of required principal payments on outstanding debt

Required principal payments on our outstanding debt as of December 31, 2021, are as follows:

Year	Principal Payment
2022	$	39,067
2023	816,413
2024	251,834
2025	1,002,001
2026	904
Thereafter	1,608,916		(1)

(1) The carrying value of our total debt outstanding as of December 31, 2021, including unamortized debt issuance costs, premiums and discounts was $3,676,524.

XML

Fair Value of Assets and Liabilities (Tables)

12 Months Ended

Dec. 31, 2021

Fair Value Disclosures [Abstract]

Assets and Liabilities Recurring and Nonrecurring Measured at Fair Value

The following table presents certain of our assets that are measured at fair value at December 31, 2021 and 2020, categorized by the level of inputs as defined in the fair value hierarchy under GAAP, used in the valuation of each asset.

	As of December 31, 2021				As of December 31, 2020
Description	Carrying Amount		Fair Value		Carrying Amount		Fair Value
Recurring Fair Value Measurement Assets:
Investment in AlerisLife (Level 1) (1)	$	31,540	$	31,540	$	73,772	$	73,772
Investment in unconsolidated joint venture (Level 3) (2)	$	215,127	$	215,127	$	—	$	—

(1)Our 10,691,658 shares of common stock of AlerisLife are included in investments in equity securities in our consolidated balance sheets, and are reported at fair value, which is based upon quoted market prices on Nasdaq (Level 1 inputs). During the years ended December 31, 2021 and 2020, we recorded an unrealized loss of $42,232 and an unrealized gain of $34,106, respectively, which are included in gains and losses on equity securities, net in our consolidated statements of comprehensive income (loss), to adjust the carrying value of our investment in AlerisLife common shares to their fair value. See Notes 2 and 8 for further information about our investment in AlerisLife.

(2)We own a 20% equity interest in a joint venture that owns a life science property located in Boston, Massachusetts and is included in investment in unconsolidated joint venture in our consolidated balance sheet, and is reported at fair value, which is based on significant unobservable inputs (Level 3 inputs). The significant unobservable inputs used in the fair value are a discount rate of 5.58%, an exit capitalization rate of 5.25% and a holding period of approximately 10 years and market rents. The assumptions are based on the location, type and nature of the property, and current and anticipated market conditions, which are derived from appraisers, industry publications and our experience. See Note 3 for further information regarding this joint venture.

Schedule of Carrying Values and Estimated Fair Values of Debt Instruments

The fair values of these financial instruments approximated their carrying values in our consolidated financial statements as of such dates, except as follows:

	As of December 31, 2021				As of December 31, 2020
Description	Carrying Amount (1)		Estimated Fair Value		Carrying Amount (1)		Estimated Fair Value
Senior unsecured notes, 6.750% coupon rate, due 2021	$	—	$	—	$	299,273	$	303,891
Senior unsecured notes, 4.750% coupon rate, due 2024	249,348		257,695		249,068		256,258
Senior unsecured notes, 9.750% coupon rate, due 2025	987,903		1,081,990		984,359		1,135,800
Senior unsecured notes, 4.750% coupon rate, due 2028	492,199		491,480		490,925		502,648
Senior unsecured notes, 4.375% coupon rate, due 2031	492,127		480,763		—		—
Senior unsecured notes, 5.625% coupon rate, due 2042	342,183		309,260		341,802		330,120
Senior unsecured notes, 6.250% coupon rate, due 2046	243,051		226,500		242,762		245,000
Secured debts (2)	69,713		71,963		691,573		716,185
	$	2,876,524	$	2,919,651	$	3,299,762	$	3,489,902

(1)Includes unamortized net debt issuance costs, premiums and discounts.

(2)We assumed certain of these secured debts in connection with our acquisition of certain properties. We recorded the assumed mortgage notes at estimated fair value on the date of acquisition and we are amortizing the fair value adjustments, if any, to interest expense over the respective terms of the mortgage notes to adjust interest expense to the estimated market interest rates as of the date of acquisition.

XML

Segment Reporting (Tables)

12 Months Ended

Dec. 31, 2021

Segment Reporting [Abstract]

Schedule of segment reporting information

	For the Year Ended December 31, 2021
	Office Portfolio		SHOP		Non-Segment		Consolidated
Revenues:
Rental income	$	367,597	$	—	$	40,992	$	408,589
Residents fees and services	—		974,623		—		974,623
Total revenues	367,597		974,623		40,992		1,383,212
Expenses:
Property operating expenses	127,313		964,499		—		1,091,812
Depreciation and amortization	127,632		132,044		11,455		271,131
General and administrative	—		—		34,087		34,087
Acquisition and certain other transaction related costs	—		—		17,506		17,506
Impairment of assets	—		(174)		—		(174)
Total expenses	254,945		1,096,369		63,048		1,414,362
Gain on sale of properties	492,072		200		—		492,272
Losses on equity securities, net	—		—		(42,232)		(42,232)
Interest and other income	—		19,554		1,081		20,635
Interest expense	(23,477)		(2,089)		(230,193)		(255,759)
Loss on early extinguishment of debt	—		—		(2,410)		(2,410)
Income (loss) from continuing operations before income tax expense	581,247		(104,081)		(295,810)		181,356
Income tax expense	—		—		(1,430)		(1,430)
Net income (loss)	581,247		(104,081)		(297,240)		179,926
Net income attributable to noncontrolling interest	(5,411)		—		—		(5,411)
Net income (loss) attributable to common shareholders	$	575,836	$	(104,081)	$	(297,240)	$	174,515
	As of December 31, 2021
	Office Portfolio		SHOP		Non-Segment		Consolidated
Total assets	$	2,282,652	$	2,995,819	$	1,345,043	$	6,623,514

	For the Year Ended December 31, 2020
	Office Portfolio		SHOP		Non-Segment		Consolidated
Revenues:
Rental income	$	383,365	$	—	$	43,850	$	427,215
Residents fees and services	—		1,204,811		—		1,204,811
Total revenues	383,365		1,204,811		43,850		1,632,026
Expenses:
Property operating expenses	129,756		1,106,601		—		1,236,357
Depreciation and amortization	129,321		129,124		11,702		270,147
General and administrative	—		—		30,593		30,593
Acquisition and certain other transaction related costs	—		—		814		814
Impairment of assets	8,558		98,414		—		106,972
Total expenses	267,635		1,334,139		43,109		1,644,883
Gain (loss) on sale of properties	2,597		(627)		4,517		6,487
Gains on equity securities, net	—		—		34,106		34,106
Interest and other income	—		17,485		736		18,221
Interest expense	(24,188)		(2,223)		(175,072)		(201,483)
Gain on lease termination	—		—		22,896		22,896
Loss on early extinguishment of debt	(401)		—		(26)		(427)
Income (loss) from continuing operations before income tax expense	93,738		(114,693)		(112,102)		(133,057)
Income tax expense	—		—		(1,250)		(1,250)
Net income (loss)	93,738		(114,693)		(113,352)		(134,307)
Net income attributable to noncontrolling interest	(5,146)		—		—		(5,146)
Net income (loss) attributable to common shareholders	$	88,592	$	(114,693)	$	(113,352)	$	(139,453)
	As of December 31, 2020
	Office Portfolio		SHOP		Non-Segment		Consolidated
Total assets	$	3,092,289	$	2,912,570	$	471,565	$	6,476,424

	For the Year Ended December 31, 2019
	Office Portfolio		SHOP		Non-Segment		Consolidated
Revenues:
Rental income	$	405,016	$	137,898	$	63,644	$	606,558
Residents fees and services	—		433,597		—		433,597
Total revenues	405,016		571,495		63,644		1,040,155
Expenses:
Property operating expenses	132,348		356,722		—		489,070
Depreciation and amortization	137,611		132,637		18,777		289,025
General and administrative	—		—		37,028		37,028
Acquisition and certain other transaction related costs	—		—		13,102		13,102
Impairment of assets	43,035		65,822		6,344		115,201
Total expenses	312,994		555,181		75,251		943,426
Gain on sale of properties	6,617		15,207		17,872		39,696
Dividend income	—		—		1,846		1,846
Losses on equity securities, net	—		—		(41,898)		(41,898)
Interest and other income	—		—		941		941
Interest expense	(24,399)		(3,058)		(152,655)		(180,112)
Loss on early extinguishment of debt	—		(17)		(27)		(44)
Income (loss) from continuing operations before income tax expense and equity in earnings of an investee	74,240		28,446		(185,528)		(82,842)
Income tax expense	—		—		(436)		(436)
Equity in earnings of an investee	—		—		400		400
Net income (loss)	74,240		28,446		(185,564)		(82,878)
Net income attributable to noncontrolling interest	(5,356)		—		—		(5,356)
Net income (loss) attributable to common shareholders	$	68,884	$	28,446	$	(185,564)	$	(88,234)
	As of December 31, 2019
	Office Portfolio		SHOP		Non-Segment		Consolidated
Total assets	$	3,165,577	$	3,044,989	$	443,260	$	6,653,826

XML

Income Taxes (Tables)

12 Months Ended

Dec. 31, 2021

Income Tax Disclosure [Abstract]

Schedule of components of provision for income taxes

Our provision for income taxes consists of the following:

	For the Year Ended December 31,
	2021		2020		2019
Current:
Federal	$	200	$	—	$	—
State	1,230		1,250		436
	1,430		1,250		436
Deferred:
Federal	—		—		—
State	—		—		—
	—		—		—
Income tax provision	$	1,430	$	1,250	$	436

Schedule of reconciliation of effective tax rate and the U.S. federal statutory income tax rate

A reconciliation of our effective tax rate and the U.S. federal statutory income tax rate is as follows:

	For the Year Ended December 31,
	2021		2020		2019
Taxes at statutory U.S. federal income tax rate	21.0	%	21.0	%	21.0	%
Nontaxable income	(21.0)	%	(21.0)	%	(21.0)	%
Federal excise tax	0.1	%	—	%	—	%
State and local income taxes, net of federal tax benefit	0.8	%	(1.3)	%	0.5	%
Effective tax rate	0.9	%	(1.3)	%	0.5	%

Schedule of significant components of our deferred tax assets and liabilities

Significant components of our deferred tax assets and liabilities are as follows:

	For the Year Ended December 31,
	2021		2020
Deferred tax assets:
Deferred income	$	2,132	$	3,252
Fair market value adjustment	1,577		10,856
Other	784		758
Tax loss carryforwards	25,829		28,358
	30,322		43,224
Valuation allowance	(30,322)		(43,224)
	—		—
Net deferred income taxes	$	—	$	—

XML

Weighted Average Common Shares (Tables)

12 Months Ended

Dec. 31, 2021

Earnings Per Share [Abstract]

Schedule of Weighted Average Number of Shares

The following table provides a reconciliation of the weighted average number of common shares used in the calculation of basic and diluted earnings per share (in thousands):

	Year Ended December 31,
	2021	2020	2019
Weighted average common shares for basic earnings per share	237,967	237,739	237,604
Effect of dilutive securities: restricted share awards	—	—	—
Weighted average common shares for diluted earnings per share (1)	237,967	237,739	237,604

(1) For the years ended December 31, 2021, 2020 and 2019, 60, 223 and 36, respectively, of our unvested common shares were not included in the calculation of diluted earnings per share because to do so would have been antidilutive.

XML

Organization (Details) $ in Thousands	Dec. 31, 2021 USD ($) ft² property	Dec. 23, 2021	Dec. 31, 2020 USD ($)	Mar. 31, 2017
Real Estate Properties [Line Items]
Number of properties owned (property)	390
Number of states in which properties are located	36
Total real estate properties, gross | $	$ 6,813,556		$ 7,410,730
Seaport Innovation LLC | Joint Venture
Real Estate Properties [Line Items]
Number of properties owned (property)	1
Equity method investment ownership percentage	20.00%	20.00%		55.00%
Area of real estate properties (in square feet) | ft²	1,134,479
Occupancy rate	100.00%
Lessee, operating lease, remaining lease term	7 years

XML

Summary of Significant Accounting Policies - Basis of Presentation and Real Estate Properties (Details) - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2021	Dec. 31, 2020	Dec. 31, 2019
Basis of Presentation
Ownership interest in subsidiaries (as a percent)	100.00%
Increase in capitalized above and below market leases rental income	$ 7,211	$ 7,405	$ 6,791
Amortization of acquired real estate leases and other intangible assets	$ 42,783	$ 48,669	$ 64,203
Above market lease, weighted average amortization period, lease term	3 years 8 months 12 days
Lease, weighted average amortization period, lease term	5 years 3 months 18 days
Below market lease, weighted average amortization period, lease term	6 years 10 months 24 days
Finite lived intangible asset, future amortization
2021	$ 12,095
2022	11,326
2023	8,030
2024	4,869
2025	3,267
Thereafter	$ 6,603
Land and Building | Real Estate Investment | Maximum
Basis of Presentation
Estimated useful lives (up to)	40 years

XML

Summary of Significant Accounting Policies - Real Estate Lease Obligations (Details) - USD ($) $ in Thousands	Dec. 31, 2021	Dec. 31, 2020
Acquired real estate leases:
Capitalized above market lease values (1)	$ 8,092	$ 12,304
Less: accumulated amortization	(6,268)	(9,236)
Capitalized above market lease values, net	1,824	3,068
Lease, Net
Lease origination value	123,682	551,141
Less: accumulated amortization	(76,760)	(267,696)
Lease origination value, net	46,922	283,445
Acquired real estate leases and other intangible assets, net	48,746	286,513
Assumed real estate lease obligations:
Capitalized below market lease values	6,141	128,991
Less: accumulated amortization	(3,585)	(61,161)
Assumed real estate lease obligations, net	$ 2,556	$ 67,830

XML

Summary of Significant Accounting Policies - Investments (Details)			12 Months Ended
	Jan. 01, 2020 USD ($) shares	Dec. 31, 2019 shares	Dec. 31, 2021 USD ($) shares	Dec. 31, 2020 USD ($)	Dec. 31, 2019 USD ($) shares	Dec. 23, 2021	Jun. 30, 2019 shares	Mar. 31, 2017
Investment in available for sale securities
Gains and losses on equity securities, net | $			$ (42,232,000)	$ 34,106,000	$ (41,898,000)
ALR
Investment in available for sale securities
Shares issued, value | $			$ 0	$ 59,801,000	$ 0
ALR | Common Shares
Investment in available for sale securities
Issued (in shares) | shares	10,268,158
Shares issued, value | $	$ 38,095,000
ALR | Common Shares
Investment in available for sale securities
Investment in common shares (in shares) | shares		423,500			423,500
Reverse stock split ratio		0.100
Affiliated Entity | Common Shares | Recurring | ALR
Investment in available for sale securities
Investment in common shares (in shares) | shares			10,691,658
RMR Inc. | Class A common shares
Investment in available for sale securities
Equity investments shares held (in shares) | shares							2,637,408
Seaport Innovation LLC | Joint Venture
Investment in available for sale securities
Equity method investment ownership percentage			20.00%			20.00%		55.00%
Principal amount of debt | $			$ 620,000,000

XML

Summary of Significant Accounting Policies - Debt Issuance Costs (Details) - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2021	Dec. 31, 2020
Amortization of deferred financing fees
Amortization expense in 2022	$ 9,974
Amortization expense in 2023	5,832
Amortization expense in 2024	5,521
Amortization expense in 2025	3,556
Amortization expense in 2026	1,956
Amortization expense thereafter	15,494
Unsecured Term Loans, Senior Notes, and Mortgage Notes Payable
Debt Instrument
Deb issuance costs, gross	53,649	$ 53,496
Accumulated amortization, debt issuance costs gross	15,800	15,589
Revolving Credit Facility
Debt Instrument
Deb issuance costs, gross	27,383	19,332
Accumulated amortization, debt issuance costs gross	$ 22,899	$ 16,201

XML

Summary of Significant Accounting Policies - Leasing Costs and Revenue Recognition (Details) $ in Thousands	12 Months Ended
	Dec. 31, 2021 USD ($) community	Dec. 31, 2020 USD ($)	Dec. 31, 2019 USD ($)
DEFERRED LEASING COSTS
Unamortized gross balance of deferred leasing costs	$ 64,255	$ 44,506
Accumulated amortization	$ 17,074	15,605
Weighted average amortization period for deferred leasing cost	8 years 8 months 12 days
Expected amortization expense for the five years
Expected amortization expense, 2022	$ 7,168
Expected amortization expense, 2023	6,502
Expected amortization expense, 2024	5,903
Expected amortization expense, 2025	5,397
Expected amortization expense, 2026	4,732
Expected amortization expense, thereafter	17,479
Percentage rents earned	1,993	2,144	$ 2,958
Proceeds from the relief fund amount	20,800	19,961
Interest and other income	20,635	18,221	$ 941
Provider relief fund other liabilities	3,722	2,476
SHOP
Expected amortization expense for the five years
Interest and other income	$ 19,554	$ 17,485
Third Party Managers | Senior Living Communities
Expected amortization expense for the five years
Number of communities managed | community	235

XML

Summary of Significant Accounting Policies - Per Common Share and Segment (Details)	12 Months Ended
	Dec. 31, 2021 segment $ / shares	Dec. 31, 2020 $ / shares
Accounting Policies [Abstract]
Common shares, par value (in dollars per share) | $ / shares	$ 0.01	$ 0.01
Number of operating segments | segment	2

XML

Real Estate Investments - Narrative (Details) $ in Thousands		1 Months Ended				12 Months Ended
	Dec. 23, 2021	Jan. 31, 2022 USD ($) property	Dec. 31, 2021 USD ($) ft² building property community unit	Jan. 31, 2020 USD ($)	May 31, 2019 USD ($) unit building	Dec. 31, 2021 USD ($) ft² property building community unit	Dec. 31, 2020 USD ($) ft² property building	Dec. 31, 2019 USD ($) ft² unit building property	Jun. 09, 2021 unit community	Sep. 30, 2019 property	Mar. 31, 2017
Real Estate Properties
Real estate investment properties, net			$ 5,075,749			$ 5,075,749	$ 5,715,829
Real estate property - accumulated depreciation			$ 1,737,807			$ 1,737,807	1,694,901
Number of properties owned (property) | property			390			390
Total assets			$ 6,623,514			$ 6,623,514	6,476,424	$ 6,653,826
Secured debt and finance leases, net			69,713			69,713	691,573
Proceeds from sale of interest in joint venture, net						367,033	0	0
Gain on sale of properties						492,272	6,487	39,696
Equity method investments, carrying value			31,540			31,540	73,772
Impairment of assets						(174)	106,972	$ 115,201
Lease committed but unspent tenant related obligations						76,573	19,159
Variable Interest Entity, Primary Beneficiary
Real Estate Properties
Total assets							970,142
Secured debt and finance leases, net							697,129
Seaport Innovation LLC
Real Estate Properties
Aggregate property valuation amount			1,700,000			1,700,000
Aggregate principal amount of mortgage debt			620,000			620,000
Land
Real Estate Properties
Real estate investment properties, net			741,501			741,501	789,125
Buildings and Improvements
Real Estate Properties
Real estate investment properties, net			6,072,055			6,072,055	6,621,605
Building
Real Estate Properties
Real estate property - accumulated depreciation			1,587,573			1,587,573	1,561,751
Building Improvements
Real Estate Properties
Real estate property - accumulated depreciation			$ 150,234			$ 150,234	$ 133,150
Medical Office Building
Real Estate Properties
Number of properties owned (property) | property							7	20
Impairment of assets							$ 8,558	$ 43,035
Senior Living Communities
Real Estate Properties
Number of properties owned (property) | property							28	25
Number of units in real estate property | unit			27,672			27,672
Gain on sale of properties							$ 225
Impairment of assets							$ 98,414	$ 72,166
Welness Centers
Real Estate Properties
Number of properties owned (property) | property			10			10
Area of real estate properties (in square feet) | ft²			812,000			812,000
SNF
Real Estate Properties
Gain on sale of properties						$ 200
Life Science
Real Estate Properties
Number of properties owned (property) | property								1
Medical Office Building and Life Science Building
Real Estate Properties
Number of properties owned (property) | property			116			116
Area of real estate properties (in square feet) | ft²			9,800,000			9,800,000
Medical Office Building and Life Science Building | Capital Commitments
Real Estate Properties
Area of real estate properties (in square feet) | ft²			2,600,000			2,600,000	1,000,000
Leases committed expenditure						$ 97,520	$ 17,901
Medical Office Building and Life Science Building | Subsequent Event | Unrelated Investor One
Real Estate Properties
Equity method investments, carrying value		$ 100,800
Medical Office Building and Life Science Building | Subsequent Event | Unrelated Investor Two
Real Estate Properties
Equity method investments, carrying value		95,900
Senior Living Communities, Independent Living, Assisted Living, and Skilled Nursing Facility
Real Estate Properties
Number of properties owned (property) | property			264			264
Land Parcel | Arizona
Real Estate Properties
Real estate purchase price				$ 2,600
Joint Venture
Real Estate Properties
Gain on sale of properties			$ 461,434
Joint Venture | Seaport Innovation LLC
Real Estate Properties
Number of properties owned (property) | property			1			1
Area of real estate properties (in square feet) | ft²			1,134,479			1,134,479
Number of properties included in joint venture agreement | property						1
Equity method investment ownership percentage	20.00%		20.00%			20.00%					55.00%
Additional equity joint venture percentage	35.00%		35.00%
Proceeds from sale of interest in joint venture, net			$ 373,847
Joint Venture | Investor | Seaport Innovation LLC
Real Estate Properties
Equity method investment ownership percentage											45.00%
Joint Venture | Subsequent Event
Real Estate Properties
Aggregate property valuation amount		702,500
Aggregate principal amount of mortgage debt		$ 456,600
Joint Venture | Medical Office Building and Life Science Building | Subsequent Event
Real Estate Properties
Number of properties included in joint venture agreement | property		10
Equity method investment ownership percentage		20.00%
Proceeds from sale of interest in joint venture, net		$ 653,300
Joint Venture | Medical Office Building and Life Science Building | Subsequent Event | Unrelated Investor One
Real Estate Properties
Equity method investment ownership percentage		41.00%
Joint Venture | Medical Office Building and Life Science Building | Subsequent Event | Unrelated Investor Two
Real Estate Properties
Equity method investment ownership percentage		39.00%
Five Star | Senior Living Communities
Real Estate Properties
Number of properties owned (property) | community									120
Five Star | Five Star
Real Estate Properties
Amount of improvements to communities								$ 111,603
Payments to acquire property, plant, and equipment								$ 49,155
Scenario, Adjustment | Senior Living Communities
Real Estate Properties
Number of properties owned (property) | property			10			10
Impairment of assets						$ (174)
Disposal Group, Held-for-sale, Not Discontinued Operations | Medical Office Building
Real Estate Properties
Number of properties owned (property) | property							1	15
Disposal Group, Held-for-sale, Not Discontinued Operations | Senior Living Communities
Real Estate Properties
Number of properties owned (property) | property							10	2
Number of units in real estate property | property							820
Disposal Group, Held-for-sale, Not Discontinued Operations | Medical Office Building and Life Science Building
Real Estate Properties
Area of real estate properties (in square feet) | ft²							355,656
Number of units in real estate property | property							5
Disposal Group, Held-for-sale, Not Discontinued Operations | Five Star | Senior Living Communities
Real Estate Properties
Number of properties owned (property) | community			108			108			108
Number of units in real estate property | unit									1,500
Disposal Group, Held-for-sale, Not Discontinued Operations | Scenario, Adjustment | Five Star | Senior Living Communities
Real Estate Properties
Number of units in real estate property | unit									7,500
Disposal Group, Disposed of by Sale, Not Discontinued Operations
Real Estate Properties
Number of properties owned (property) | building			5			5	27	46
Sale price of property sold and agreed to be sold						$ 104,500	$ 152,893	$ 260,783
Disposal Group, Disposed of by Sale, Not Discontinued Operations | Medical Office Building
Real Estate Properties
Number of properties owned (property) | property							4
Disposal Group, Disposed of by Sale, Not Discontinued Operations | Senior Living Communities
Real Estate Properties
Number of properties owned (property) | property							9
Number of real estate properties closed | property							7
Disposal Group, Disposed of by Sale, Not Discontinued Operations | SNF
Real Estate Properties
Number of properties owned (property) | property			8			8
Number of units in real estate property | property										15
Disposal Group, Disposed of by Sale, Not Discontinued Operations | SNF | California
Real Estate Properties
Number of properties owned (property) | building					3
Number of units in real estate property | unit					278
Sale price of property sold and agreed to be sold					$ 21,500
Disposal Group, Disposed of by Sale, Not Discontinued Operations | Medical Office Building and Life Science Building
Real Estate Properties
Number of properties owned (property) | property								5
Discontinued Operations, Held-for-sale | Senior Living Communities
Real Estate Properties
Number of properties owned (property) | property								12
Number of units in real estate property | unit								1,670
Discontinued Operations, Held-for-sale | Medical Office Building and Life Science Building
Real Estate Properties
Number of properties owned (property) | property								21
Area of real estate properties (in square feet) | ft²								875,617
Disposal Group, Held-for-sale or Disposed of by Sale, Not Discontinued Operations | Medical Office Building
Real Estate Properties
Number of properties owned (property) | property							10

XML

Real Estate Investments - Equity Investment In Joint Venture (Details) $ in Thousands	Dec. 31, 2021 USD ($) ft² property	Dec. 23, 2021	Dec. 31, 2020 USD ($)	Mar. 31, 2017
Real Estate
DHC Carrying value | $	$ 215,127		$ 0
Number of properties owned (property) | property	390
Seaport Innovation LLC | Joint Venture
Real Estate
Equity method investment ownership percentage	20.00%	20.00%		55.00%
DHC Carrying value | $	$ 215,127
Number of properties owned (property) | property	1
Area of real estate properties (in square feet) | ft²	1,134,479

XML

Real Estate Investments - Mortgage Debt Joint Venture (Details) - Seaport Innovation LLC - Joint Venture	Dec. 31, 2021 USD ($)
Real Estate
Coupon	3.53%
Principal balance	$ 620,000,000

XML

Real Estate Investments - Schedule of Acquisitions (Details) $ in Thousands	1 Months Ended
	Dec. 31, 2019 USD ($) property unit	Dec. 31, 2021 USD ($) property	Dec. 31, 2020 USD ($)
Real Estate
Number of Properties | property		390
Net book value of collateral		$ 5,075,749	$ 5,715,829
IL | Texas | Acquisitions
Real Estate
Number of Properties | property	1
Number of Units | unit	169
Cash Paid plus Assumed Debt	$ 50,506
Acquired Real Estate Leases / Resident Agreements	2,202
Acquired Real Estate Lease Obligations	0
Assumed Debt	0
Premium on  Assumed Debt	0
Land
Real Estate
Net book value of collateral		741,501	789,125
Land | IL | Texas | Acquisitions
Real Estate
Net book value of collateral	3,463
Buildings and Improvements
Real Estate
Net book value of collateral		$ 6,072,055	$ 6,621,605
Buildings and Improvements | IL | Texas | Acquisitions
Real Estate
Net book value of collateral	44,189
FF&E | IL | Texas | Acquisitions
Real Estate
Net book value of collateral	$ 652

XML

Real Estate Investments - Schedule of Disposal Groups (Details) $ in Thousands	1 Months Ended																						12 Months Ended
	Apr. 30, 2021 USD ($) building	Feb. 28, 2021 USD ($) ft² building	Dec. 31, 2020 USD ($) ft² property unit building	Nov. 30, 2020 USD ($) building unit	Oct. 31, 2020 USD ($) building unit	Sep. 30, 2020 USD ($) ft² building	Aug. 31, 2020 USD ($) building unit	Jul. 31, 2020 USD ($) ft² building	Jun. 30, 2020 USD ($) ft² building	Apr. 30, 2020 USD ($) building unit	Mar. 31, 2020 USD ($) ft² building	Feb. 29, 2020 USD ($)	Jan. 31, 2020 USD ($) ft² building	Dec. 31, 2019 USD ($) ft² building property unit	Oct. 31, 2019 USD ($) ft² building unit	Sep. 30, 2019 USD ($) ft² building property unit	Aug. 31, 2019 USD ($) ft² building	Jul. 31, 2019 USD ($) ft² building	Jun. 30, 2019 USD ($) ft² building	May 31, 2019 USD ($) ft² building unit	Mar. 31, 2019 USD ($) ft² building	Feb. 28, 2019 USD ($) ft² building	Dec. 31, 2021 USD ($) ft² property building	Dec. 31, 2020 USD ($) ft² property unit building	Dec. 31, 2019 USD ($) ft² building property unit	Feb. 28, 2020 ft² building
Real Estate
Number of Properties | property																							390
Disposal Group, Disposed of by Sale, Not Discontinued Operations
Real Estate
Number of Properties | building			27											46									5	27	46
Sales Price																							$ 104,500	$ 152,893	$ 260,783
Gain (loss) on Sale																							$ 30,638	$ 6,262	$ 39,696
Medical Office
Real Estate
Number of Properties | property			7											20										7	20
Medical Office | Disposal Group, Disposed of by Sale, Not Discontinued Operations
Real Estate
Number of Properties | property			4																					4
Medical Office | Disposal Group, Disposed of by Sale, Not Discontinued Operations | Pennsylvania
Real Estate
Number of Properties | building		1																								1
Area of real estate properties (in square feet) | ft²		92,000																								50,000
Sales Price		$ 9,000										$ 2,900
Gain (loss) on Sale		$ (122)										$ 0
Medical Office | Disposal Group, Disposed of by Sale, Not Discontinued Operations | Louisiana
Real Estate
Number of Properties | building													6
Area of real estate properties (in square feet) | ft²													40,575
Sales Price													$ 5,925
Gain (loss) on Sale													$ (81)
Medical Office | Disposal Group, Disposed of by Sale, Not Discontinued Operations | Texas
Real Estate
Number of Properties | building								1			1
Area of real estate properties (in square feet) | ft²								6,849			70,229
Sales Price								$ 2,072			$ 8,779
Gain (loss) on Sale								$ (30)			$ 2,863
Medical Office | Disposal Group, Disposed of by Sale, Not Discontinued Operations | South Carolina
Real Estate
Number of Properties | building									1
Area of real estate properties (in square feet) | ft²									49,242
Sales Price									$ 3,550
Gain (loss) on Sale									$ 0
Medical Office | Disposal Group, Disposed of by Sale, Not Discontinued Operations | Connecticut
Real Estate
Number of Properties | building								1
Area of real estate properties (in square feet) | ft²								32,162
Sales Price								$ 625
Gain (loss) on Sale								$ (25)
Medical Office | Disposal Group, Disposed of by Sale, Not Discontinued Operations | Mississippi
Real Estate
Number of Properties | building						1
Area of real estate properties (in square feet) | ft²						78,747
Sales Price						$ 7,250
Gain (loss) on Sale						$ (114)
Medical Office | Disposal Group, Disposed of by Sale, Not Discontinued Operations | New York
Real Estate
Number of Properties | building			1																					1
Area of real estate properties (in square feet) | ft²			64,060																					64,060
Sales Price			$ 3,875
Gain (loss) on Sale			$ (273)
Medical Office | Disposal Group, Disposed of by Sale, Not Discontinued Operations | Massachusetts
Real Estate
Number of Properties | building																1	1	3	7		1
Area of real estate properties (in square feet) | ft²																41,065	49,357	103,484	164,121		4,400
Sales Price																$ 2,750	$ 2,221	$ 4,955	$ 8,042		$ 75
Gain (loss) on Sale																$ 1,044	$ 812	$ 2,332	$ 1,590		$ (58)
Medical Office | Disposal Group, Disposed of by Sale, Not Discontinued Operations | Colorado
Real Estate
Number of Properties | building																				1
Area of real estate properties (in square feet) | ft²																				15,647
Sales Price																				$ 2,590
Gain (loss) on Sale																				$ 1,029
Medical Office | Disposal Group, Disposed of by Sale, Not Discontinued Operations | Georgia
Real Estate
Number of Properties | building														1											1
Area of real estate properties (in square feet) | ft²														95,010											95,010
Sales Price														$ 14,000
Gain (loss) on Sale														$ (63)
Life Science / Medical Office | Disposal Group, Disposed of by Sale, Not Discontinued Operations | Florida
Real Estate
Number of Properties | building	4
Area of real estate properties (in square feet) | ft²																							263,656
Sales Price	$ 95,500
Gain (loss) on Sale	$ 30,760
IL / AL | Disposal Group, Disposed of by Sale, Not Discontinued Operations | California
Real Estate
Number of Properties | building										3
Number of units in real estate property | unit										599
Sales Price										$ 47,000
Gain (loss) on Sale										$ (256)
AL | Disposal Group, Disposed of by Sale, Not Discontinued Operations | Mississippi
Real Estate
Number of Properties | building							2
Number of units in real estate property | unit							116
Sales Price							$ 2,500
Gain (loss) on Sale							$ (42)
AL | Disposal Group, Disposed of by Sale, Not Discontinued Operations | Various
Real Estate
Number of Properties | building					3									7											7
Number of units in real estate property | unit					239									566											566
Sales Price					$ 46,000									$ 103,250
Gain (loss) on Sale					$ 4,292									$ 3,593
AL | Disposal Group, Disposed of by Sale, Not Discontinued Operations | Nebraska
Real Estate
Number of Properties | building				1
Number of units in real estate property | unit				131
Sales Price				$ 3,000
Gain (loss) on Sale				$ (26)
Life Science
Real Estate
Number of Properties | property														1											1
Life Science | Disposal Group, Disposed of by Sale, Not Discontinued Operations | Florida
Real Estate
Number of Properties | building																						1
Area of real estate properties (in square feet) | ft²																						60,396
Sales Price																						$ 2,900
Gain (loss) on Sale																						$ (69)
Life Science | Disposal Group, Disposed of by Sale, Not Discontinued Operations | Ohio
Real Estate
Number of Properties | building			2																					2
Area of real estate properties (in square feet) | ft²			232,016																					232,016
Sales Price			$ 7,917
Gain (loss) on Sale			$ 257
Life Science | Disposal Group, Disposed of by Sale, Not Discontinued Operations | New Jersey
Real Estate
Number of Properties | building															1
Area of real estate properties (in square feet) | ft²															205,439
Sales Price															$ 47,500
Gain (loss) on Sale															$ 0
SNF / AL | Disposal Group, Disposed of by Sale, Not Discontinued Operations | Wisconsin
Real Estate
Number of Properties | building			3																					3
Number of units in real estate property | unit			537																					537
Sales Price			$ 11,500
Gain (loss) on Sale			$ (303)
SNF / AL | Disposal Group, Disposed of by Sale, Not Discontinued Operations | South Dakota
Real Estate
Number of Properties | building															3
Number of units in real estate property | unit															245
Sales Price															$ 10,500
Gain (loss) on Sale															$ 6,661
SNF | Disposal Group, Disposed of by Sale, Not Discontinued Operations
Real Estate
Number of Properties | property																							8
Number of units in real estate property | property																15
SNF | Disposal Group, Disposed of by Sale, Not Discontinued Operations | California
Real Estate
Number of Properties | building																				3
Number of units in real estate property | unit																				278
Sales Price																				$ 21,500
Gain (loss) on Sale																				$ 15,207
SNF | Disposal Group, Disposed of by Sale, Not Discontinued Operations | Various
Real Estate
Number of Properties | building																15
Number of units in real estate property | unit																964
Sales Price																$ 8,000
Gain (loss) on Sale																$ 0
IL | Disposal Group, Disposed of by Sale, Not Discontinued Operations | Washington
Real Estate
Number of Properties | building														1											1
Number of units in real estate property | unit														150											150
Sales Price														$ 32,500
Gain (loss) on Sale														$ 7,618

XML

Leases - Narrative (Details) - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2021	Dec. 31, 2020	Dec. 31, 2019
Leases [Abstract]
Straight line rental income	$ 5,846	$ 6,069	$ 4,508
Straight line rental income, excluding properties held-for-sale	82,131	104,803
Variable lease, payment	74,860	77,599	78,668
Reimbursement revenue lease	72,690	75,378	$ 75,432
Operating lease, right-of-use asset	$ 4,153	$ 4,237
Operating Lease, Right-of-Use Asset, Statement of Financial Position	Other assets, net	Other assets, net
Operating lease, liability	$ 4,352	$ 4,410
Operating Lease, Liability, Statement of Financial Position	Other liabilities	Other liabilities

XML

Leases - Maturities of Operating Lease Liabilities (Details) $ in Thousands	Dec. 31, 2021 USD ($)
Year
2022	$ 236,309
2023	234,633
2024	219,532
2025	197,712
2026	181,819
Thereafter	812,989
Total	$ 1,882,994

XML

Shareholders' Equity - Narrative (Details) - USD ($) $ / shares in Units, $ in Thousands			12 Months Ended
	Jan. 13, 2022	Jan. 01, 2020	Dec. 31, 2021	Dec. 31, 2020	Dec. 31, 2019	Dec. 31, 2018
Scheduled to vest unvested shares
Share-based compensation expense			$ 1,960	$ 1,568	$ 1,388
Distributions to shareholders			$ 9,540	$ 42,825	$ 199,719
ALR
Scheduled to vest unvested shares
Aggregate shares issued (shares)		16,118,849
Subsequent Event
Scheduled to vest unvested shares
Common distributions declared (in dollars per share)	$ 0.01
Distributions to shareholders	$ 2,390
Certain our Officers and Employees of RMR LLC
Scheduled to vest unvested shares
Shares purchased from certain of our officers and other employees of RMR LLC (in shares)			109,384	47,375	31,747
ALR
Share-based Compensation Arrangement by Share-based Payment Award
Aggregate market value of shares awarded		$ 59,801
Share Award Plans
Share-based Compensation Arrangement by Share-based Payment Award
Remaining common shares available for issuance (in shares)			1,117,201
Number of unvested shares (in shares)			845,620	434,550	227,340	161,990
Scheduled to vest unvested shares
2022 (in shares)			253,520
2023 (in shares)			239,700
2024 (in shares)			208,800
2025 (in shares)			143,600
Estimated future compensation for the unvested shares			$ 3,116
Weighted average period over which the compensation expense will be recorded			2 years
Officers and Employees | Share Award Plans | RMR LLC
Share-based Compensation Arrangement by Share-based Payment Award
Common shares awarded (in shares)			718,000	360,000	187,500
Aggregate market value of shares awarded			$ 2,448	$ 1,357	$ 1,633
Award vesting period			5 years
Trustees | Share Award Plans | RMR LLC
Share-based Compensation Arrangement by Share-based Payment Award
Common shares awarded (in shares)			20,000	10,000	3,000
Aggregate market value of shares awarded			$ 444	$ 176	$ 119
Market value of shares awarded to each Trustee			$ 74	$ 29	$ 24

XML

Shareholders' Equity - Schedule of Shares Granted and Vested (Details) - Share Award Plans - $ / shares	12 Months Ended
	Dec. 31, 2021	Dec. 31, 2020	Dec. 31, 2019
Number of Shares
Unvested shares at the beginning of the year (in shares)	434,550	227,340	161,990
Shares awarded (in shares)	838,000	420,000	202,500
Shares vested/forfeited (in shares)	(426,930)	(212,790)	(137,150)
Unvested shares at the end of the year (in shares)	845,620	434,550	227,340
Weighted Average Award Date Fair Value
Unvested shares at the beginning of the year (in dollars per share)	$ 6.15	$ 12.52	$ 19.41
Shares awarded (in dollars per share)	3.45	3.65	8.65
Shares vested/forfeited (in dollars per share)	4.98	7.04	8.94
Unvested shares at the end of the year (in dollars per share)	$ 4.07	$ 6.15	$ 12.52

XML

Shareholders' Equity - Schedule of Dividends Declared and Paid (Details) - USD ($) $ / shares in Units, $ in Thousands	12 Months Ended
	Dec. 31, 2021	Dec. 31, 2020	Dec. 31, 2019
Stockholders' Equity Note [Abstract]
Annual Per Share Distribution (in dollars per share)	$ 0.04	$ 0.18	$ 0.84
Total Distribution	$ 9,540	$ 42,825	$ 199,719
Ordinary Income	0.00%	0.00%	0.00%
Capital Gain	100.00%	0.00%	25.70%
Return of Capital	0.00%	100.00%	74.30%

XML

Senior Living Community Leases and Management Agreements - Narrative (Details) $ in Thousands			1 Months Ended	12 Months Ended
	Jun. 09, 2021 USD ($) community unit	Apr. 01, 2019 USD ($)	Jan. 31, 2021 USD ($)	Dec. 31, 2021 USD ($) trustee option community property lease unit shares	Dec. 31, 2020 USD ($) property community shares	Dec. 31, 2019 USD ($) community property	Jan. 01, 2020 shares	Feb. 01, 2019 USD ($)
Concentration Risk
Common shares, shares issued (in shares) | shares				238,994,894	238,268,478
Gain on lease termination				$ 0	$ 22,896	$ 0
Number of properties owned (property) | property				390
Acquisition and certain other transaction related costs				$ 17,506	$ 814	$ 13,102
ALR
Concentration Risk
Common shares, shares issued (in shares) | shares							10,268,158
Aggregate shares issued (shares) | shares							16,118,849
Senior Living Communities
Concentration Risk
Number of properties owned (property) | property					28	25
Number of units in real estate property | unit				27,672
Five Star | Minimum
Concentration Risk
Management fees as a percentage of gross revenues				5.00%
Construction supervision fee				3.00%
Property management agreement, management fees				70.00%
Five Star | Maximum
Concentration Risk
Management fees as a percentage of gross revenues				6.00%
Construction supervision fee				5.00%
Property management agreement, management fees				80.00%
Five Star | Investor | Minimum
Concentration Risk
Percentage of annual incentive fee				15.00%
Five Star | Investor | Maximum
Concentration Risk
Percentage of annual incentive fee				25.00%
Affiliated Entity | ALR
Concentration Risk
Number of communities managed | community						78
Affiliated Entity | Five Star
Concentration Risk
Number of communities leased by the company | community						166
Amounts of transaction					$ 75,000	$ 137,898
Gain on lease termination					22,896
Monthly minimum rent payable								$ 11,000
Payments to acquire property, plant, and equipment						49,155
Management fees as a percentage of gross revenues				5.00%
Percentage of annual incentive fee				15.00%
Consumer price index annual estimated increase				2.00%
Trigger basis for capital investment ratio (percent)				6.00%
Business and property management agreement, number of agreements | option				2
Renewal term (years)				5 years
Number of leases with related party | lease				5
Amount of improvements to communities						111,603
Expenses from property management agreement transactions with related party				$ 47,479	62,880	$ 15,327
Related party transaction capitalized amount				3,615	2,467
Payments made in exchange for customary release			$ 5,763
Refunded management fees			$ 115
Lease income				1,591	1,561
Affiliated Entity | Five Star | Property Operating Expense
Concentration Risk
Expenses from property management agreement transactions with related party				$ 43,864	$ 60,413
Affiliated Entity | Five Star | Senior Living Communities
Concentration Risk
Number of communities managed | community				120	235	78
Expenses from transactions with related party				$ 11,233	$ 25,687	$ 5,920
Number of real estate properties inadequate documentation | trustee				1
Five Star | Senior Living Communities
Concentration Risk
Number of properties owned (property) | community	120
Related party transactions, termination percentage	10.00%
Percentage of EBITDA threshold for contract termination	80.00%
Five Star | Five Star
Concentration Risk
Payments to acquire property, plant, and equipment						49,155
Amount of improvements to communities						111,603
Five Star | Affiliated Entity | Five Star
Concentration Risk
Annual rent as a percentage of gross revenues, percent				4.00%
Annual rent as a percentage of gross revenues, amount						$ 538
Disposal Group, Held-for-sale, Not Discontinued Operations | Senior Living Communities
Concentration Risk
Number of properties owned (property) | property					10	2
Number of units in real estate property | property					820
Disposal Group, Held-for-sale, Not Discontinued Operations | Five Star | Senior Living Communities
Concentration Risk
Amounts of transaction	$ 682,000
Number of properties owned (property) | community	108			108
Number of units in real estate property | unit	1,500
Disposal Group, Disposed of by Means Other than Sale, Not Discontinued Operations | Five Star | Senior Living Communities
Concentration Risk
Amounts of transaction				$ 17,363
Number of units in real estate property | unit				7,340
Acquisition and certain other transaction related costs				$ 13,311
Number of properties transitioned | community				107
Five Star | Senior Living Communities
Concentration Risk
Payments to acquire property, plant, and equipment		$ 49,155
Scenario, Adjustment | Senior Living Communities
Concentration Risk
Number of properties owned (property) | property				10
Scenario, Adjustment | Disposal Group, Held-for-sale, Not Discontinued Operations | Five Star | Senior Living Communities
Concentration Risk
Number of units in real estate property | unit	7,500
Residents fees and services | SHOP | Affiliated Entity | Five Star
Concentration Risk
Revenue reserve for inadequate documentation					$ 3,842
Penalties for inadequate documentation					$ 1,921

XML

Senior Living Community Leases and Management Agreements - Schedule of Assets Leased and Revenues Earned (Details) - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2021	Dec. 31, 2020	Dec. 31, 2019
Concentration Risk
Gross Book Value of Real Estate Assets	$ 6,813,556	$ 7,410,730
Revenue	1,383,212	1,632,026	$ 1,040,155
Senior Living Communities
Concentration Risk
Revenue	$ 974,623	$ 1,204,811	433,597
Real Estate Investment Property At Cost | Rents from significant lessee
Concentration Risk
Gross Book Value of Real Estate Assets			$ 8,420,623
Concentration of credit risk (as a percent)			100.00%
Revenue | Senior Living Communities
Concentration Risk
Revenue			$ 433,597
Revenue | Rents from significant lessee
Concentration Risk
Concentration of credit risk (as a percent)			100.00%
Revenue			$ 1,040,155
All others | Real Estate Investment Property At Cost | Rents from significant lessee
Concentration Risk
Gross Book Value of Real Estate Assets			$ 6,133,672
Concentration of credit risk (as a percent)			72.80%
All others | Real Estate Investment Property At Cost | Rents from significant lessee | Discontinued Operations, Held-for-sale
Concentration Risk
Gross Book Value of Real Estate Assets			$ 213,416
All others | Revenue | Rents from significant lessee
Concentration Risk
Concentration of credit risk (as a percent)			86.70%
Revenue			$ 902,257
Five Star | Real Estate Investment Property At Cost | Rents from significant lessee
Concentration Risk
Gross Book Value of Real Estate Assets			$ 2,286,951
Concentration of credit risk (as a percent)			27.20%
Five Star | Real Estate Investment Property At Cost | Rents from significant lessee | Discontinued Operations, Held-for-sale
Concentration Risk
Gross Book Value of Real Estate Assets			$ 50,951
Five Star | Real Estate Investment Property At Cost | Rents from significant lessee | Senior Living Communities
Concentration Risk
Gross Book Value of Real Estate Assets			$ 1,920,070
Five Star | Revenue | Rents from significant lessee
Concentration Risk
Concentration of credit risk (as a percent)			13.30%
Revenue			$ 137,898

XML

Leases and Management Agreements with Five Star - Schedule of Disaggregation of Revenue (Details) - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2021	Dec. 31, 2020	Dec. 31, 2019
Disaggregation of Revenue
Revenue	$ 1,383,212	$ 1,632,026	$ 1,040,155
Senior Living Communities
Disaggregation of Revenue
Revenue	974,623	1,204,811	433,597
Residents fees and services
Disaggregation of Revenue
Revenue	974,623	1,204,811	433,597
Residents fees and services | Basic housing and support services | Senior Living Communities
Disaggregation of Revenue
Revenue	750,644	856,687	353,699
Residents fees and services | Medicare and Medicaid programs | Senior Living Communities
Disaggregation of Revenue
Revenue	98,273	173,878	31,324
Residents fees and services | Private pay and other third party payer SNF services | Senior Living Communities
Disaggregation of Revenue
Revenue	$ 125,706	$ 174,246	$ 48,574

XML

Business and Property Management Agreements with RMR LLC (Details)		1 Months Ended	12 Months Ended
	Dec. 23, 2021	Dec. 31, 2021 USD ($) employee	Dec. 31, 2021 USD ($) employee lease agreement	Dec. 31, 2020 USD ($)	Dec. 31, 2019 USD ($)	Mar. 31, 2017
Related Party Transaction
Number of employees | employee		0	0
Professional fees			$ 13,161,000	$ 13,805,000	$ 13,373,000
Seaport Innovation LLC | Joint Venture
Related Party Transaction
Additional equity joint venture percentage	35.00%	35.00%
Equity method investment ownership percentage	20.00%	20.00%	20.00%			55.00%
RMR LLC
Related Party Transaction
Business management fees incurred			$ 23,378,000	20,629,000	27,399,000
Recognized amortization of the liability			$ 2,974,000	2,974,000	2,974,000
Management agreement fee payments					40,642,000
Percentage of property management fees payable			3.00%
Construction supervision fees payable under property management agreement as a percentage of construction costs		5.00%	5.00%
Property management and construction supervision fees			$ 12,504,000	13,802,000	13,141,000
Amortization of liability related to property management and construction supervision fees			797,000	797,000	797,000
Party transaction property management and construction supervision fees capitalized		$ 2,820,000	$ 2,820,000	3,718,000	2,436,000
Period over which transition services will be provided by the related party after termination of the agreement			120 days
RMR LLC | Operating Expense
Related Party Transaction
Property management and construction supervision fees			$ 9,684,000	$ 10,084,000	$ 10,705,000
RMR LLC | Senior Living Communities
Related Party Transaction
Number of consecutive renewal terms of agreement | agreement			2
RMR LLC | Amended Agreement
Related Party Transaction
Base management fee payable as a percentage of average historical cost of real estate investments, excluding transferred assets for investments exceeding specified amount		0.50%	0.50%
Base management fee payable as a percentage of average historical cost of real estate investments, excluding transferred assets for investments up to specified amount		0.70%	0.70%
Threshold amount of other real estate investments for payment of base management fee		$ 250,000,000	$ 250,000,000
Base management fee payable as a percentage of average market capitalization exceeding specified amount		0.50%	0.50%
Threshold amount of average market capitalization for payment of base management fee		$ 250,000,000	$ 250,000,000
Base management fee payable as a percentage of average closing price per share of common shares on NYSE		0.70%	0.70%
Base management fee payable as a percentage of aggregate book value of real estate assets or transferred assets		0.50%	0.50%
Incentive management fee payable (as a percent)		12.00%	12.00%
Period of measurement			3 years
Top consecutive trading days			10 days
Consecutive trading days			30 days
Management agreement incentive fee payable		$ 0	$ 0
Incentive management fee cap on common shares		1.50%	1.50%
RMR LLC | Amended Agreement | Up C Transaction
Related Party Transaction
Number of business days notice for termination of property management agreement for convenience by the related party			60 days
Window for providing notice of termination of property management agreement for performance by the related party			60 days
Window for providing notice of termination of property management agreement for change of control by the related party			12 months
Number of terminated management agreements for convenience before termination fee is incurred | lease			1
Number of RMR LLC terminated management agreements for good cause before termination fee is incurred | lease			1
Number of terminated management agreements for a performance reason before termination fee is incurred | lease			1
Termination fee remaining term assumption			10 years
RMR LLC | Maximum
Related Party Transaction
Threshold amount of real estate investments for payment of base management fee		$ 250,000,000	$ 250,000,000
Base management fee payable, average market capitalization		$ 250,000,000	$ 250,000,000
RMR LLC | Maximum | Amended Agreement | Up C Transaction
Related Party Transaction
Termination fee term			20 years
RMR LLC | Minimum | Amended Agreement | Up C Transaction
Related Party Transaction
Termination fee term			19 years
RMR LLC | SNL US REIT Healthcare Index | Maximum | Amended Agreement
Related Party Transaction
Incentive management fee reduction, basis spread			5.00%
RMR LLC | SNL US REIT Healthcare Index | Minimum | Amended Agreement
Related Party Transaction
Incentive management fee reduction, basis spread			2.00%

XML

Related Person Transactions (Details) $ / shares in Units, $ in Thousands		1 Months Ended		12 Months Ended			13 Months Ended
	Jul. 01, 2019 USD ($) $ / shares shares	Jun. 30, 2020 USD ($)	Dec. 31, 2019 USD ($)	Dec. 31, 2021 USD ($) agreement shares	Dec. 31, 2020 USD ($)	Dec. 31, 2019 USD ($)	Jun. 30, 2019 USD ($)	Feb. 13, 2020 party
Related Party Transaction
Distributions in excess of earnings from Affiliates Insurance Company				$ 11	$ 287	$ 6,426
Equity method investments, carrying value				31,540	73,772
Equity in earnings of an investee				0	0	400
Equity in unrealized gain of an investee				0	0	91
Revenue				1,383,212	1,632,026	1,040,155
Rental income
Related Party Transaction
Revenue				$ 408,589	427,215	606,558
Medical Office
Related Party Transaction
Standalone insurance policy coverage period				1 year
ALR
Related Party Transaction
Investment in common shares (in shares) | shares				10,691,658
Ownership interest by parent				32.70%
Affiliated Entity
Related Party Transaction
Minimum percentage of ownership of lessee's voting stock above which the entity has the option to cancel all its rights				9.80%
Equity in earnings of an investee				$ 0	0	400
Affiliated Entity | The RMR Group Inc
Related Party Transaction
Number of unrelated parties | party								4
ALR
Related Party Transaction
Maximum percentage of any class of equity shares that can be acquired without approval				9.80%
RMR LLC
Related Party Transaction
Number of management agreements with related party | agreement				2
RMR LLC | Rental income
Related Party Transaction
Revenue				$ 190	163	256
AIC | Affiliated Entity
Related Party Transaction
Total premiums including taxes and fees							$ 4,413
Distributions in excess of earnings from Affiliates Insurance Company		$ 287	$ 9,000	$ 11
Equity method investments, carrying value			$ 298		$ 11	$ 298
ABP Acquisition LLC | ALR
Related Party Transaction
Ownership interest by noncontrolling owners				6.20%
RMR LLC | Year one
Related Party Transaction
Award vesting rights, percentage				20.00%
RMR LLC | Year two
Related Party Transaction
Award vesting rights, percentage				20.00%
RMR LLC | Year three
Related Party Transaction
Award vesting rights, percentage				20.00%
RMR LLC | Year four
Related Party Transaction
Award vesting rights, percentage				20.00%
RMR LLC | Year five
Related Party Transaction
Award vesting rights, percentage				20.00%
Class A common shares | Affiliated Entity | RMR Inc.
Related Party Transaction
Number of shares issued in transaction | shares	2,637,408
Sale of stock, price per share (in dollars per share) | $ / shares	$ 40.00
Proceeds from sale of RMR Inc. common shares, net	$ 98,557

XML

Indebtedness - Narrative (Details)	1 Months Ended									5 Months Ended	12 Months Ended
	Feb. 23, 2022 USD ($)	Feb. 28, 2021 USD ($)	Feb. 07, 2021	Jan. 31, 2021 USD ($)	Jun. 30, 2020 USD ($)	May 31, 2020 USD ($) property	Apr. 30, 2020 USD ($)	Feb. 29, 2020 USD ($) property	May 31, 2019 USD ($) community	Jun. 02, 2020	Dec. 31, 2021 USD ($) property	Dec. 31, 2020 USD ($) property	Dec. 31, 2019 USD ($) property	Jan. 31, 2023 USD ($)	Jun. 30, 2021 USD ($)	Mar. 31, 2021 USD ($)	Jan. 30, 2021 USD ($)
Debt Instrument
Revolving credit facility											$ 800,000,000	$ 0
Loss on early extinguishment of debt											$ 2,410,000	427,000	$ 44,000
Number of properties owned (property) | property											390
Total real estate properties, gross											$ 6,813,556,000	7,410,730,000
Repayments of borrowings on revolving credit facility											0	968,000,000	$ 596,000,000
Accrued interest											$ 29,845,000	23,772,000
Debt ratio											150.00%
Senior unsecured notes
Debt Instrument
Principal amount of debt											$ 2,850,000,000	$ 2,650,000,000
Medical Office
Debt Instrument
Number of properties owned (property) | property												7	20
Life Science
Debt Instrument
Number of properties owned (property) | property													1
Unsecured Revolving Credit Facility
Debt Instrument
Unsecured revolving credit facility, maximum borrowing capacity				$ 800,000,000							$ 800,000,000						$ 1,000,000,000
Revolving credit facility, interest rate payable (as a percent)											2.90%
Loan commitment fee percentage											0.30%
Weighted average interest rate on debt (as a percent)											2.90%	2.20%	3.40%
Revolving credit facility																$ 800,000,000
Loss on early extinguishment of debt											$ 563,000
Capital expenditure funding capacity		$ 350,000,000		250,000,000
Minimum liquidity requirement amount				$ 200,000,000
Weighted average annual interest rate (as a percent)													2.90%
Unsecured Revolving Credit Facility | Subsequent Event
Debt Instrument
Unsecured revolving credit facility, maximum borrowing capacity	$ 700,000,000
Option term (years)	1 year
Capital expenditure funding capacity	$ 400,000,000
Repayments of borrowings on revolving credit facility	100,000,000
Minimum liquidity requirement amount	$ 200,000,000
Unsecured Revolving Credit Facility | Subsequent Event | Forecast
Debt Instrument
Unsecured revolving credit facility, maximum borrowing capacity														$ 586,373,000
Unsecured Revolving Credit Facility | Life Science / Medical Office
Debt Instrument
Number of properties owned (property) | property											61
Total real estate properties, gross											$ 992,493,000
Term loan due 2022 | Senior unsecured notes
Debt Instrument
Revolving credit facility																	$ 200,000,000
Loss on early extinguishment of debt											1,477,000
Principal amount of debt		200,000,000
Debt Instrument, Interest Rate During Period			2.90%									2.70%	3.70%
Senior Unsecured Notes Due June 2021 | Senior unsecured notes
Debt Instrument
Loss on early extinguishment of debt											370,000
Principal amount of debt											$ 300,000,000
Interest rate (as a percent)											6.75%
Accrued interest											$ 10,125,000
Senior unsecured notes due 2019
Debt Instrument
Loss on early extinguishment of debt													$ 17,000
Interest rate (as a percent)									325.00%
Debt extinguishment, amount									$ 400,000
Debt extinguishment, accrued and interest payable									6,500,000
Senior Unsecured Note Due July 2019
Debt Instrument
Principal amount of debt									$ 42,211,000
Interest rate (as a percent)									3.79%
Number of communities | community									4
Term loan due 2020
Debt Instrument
Loss on early extinguishment of debt												$ 26,000	(27,000)
Principal amount of debt													250,000,000		$ 250,000
Weighted average annual interest rate (as a percent)										2.40%
Unsecured term loan due January 2020
Debt Instrument
Principal amount of debt													$ 350,000,000
Senior Unsecured Notes Due March 2026 | Life Science
Debt Instrument
Loss on early extinguishment of debt												$ 246,000
Number of properties owned (property) | property								1
Interest rate (as a percent)								6.25%
Repayments of debt								$ 1,554,000
Senior unsecured note due 2020
Debt Instrument
Interest rate (as a percent)							6.75%
Debt extinguishment, amount							$ 200,000
Accrued and unpaid interest							$ 6,750,000
Mortgage notes 7.49% maturing in January 2022 | Medical Office
Debt Instrument
Loss on early extinguishment of debt											$ 155,000
Number of properties owned (property) | property						1
Interest rate (as a percent)						7.49%
Repayments of debt						$ 1,213,000
Senior Unsecured Note Due March 2025
Debt Instrument
Principal amount of debt															$ 1,000,000
Interest rate (as a percent)															9.75%
Net proceeds from offering					$ 982,300,000
Debt instrument, redemption percentage, maximum															40.00%
Debt instrument, outstanding percentage, maximum															50.00%
Senior Note 4.375 Due 2031 | Senior unsecured notes
Debt Instrument
Principal amount of debt		$ 500,000,000
Interest rate (as a percent)		4.375%
Net proceeds from offering		$ 491,357,000
Revolving Credit Facility | Unsecured Revolving Credit Facility | Subsequent Event
Debt Instrument
Basis points per annum (as a percent)	0.15%
Revolving Credit Facility | Unsecured Revolving Credit Facility | LIBOR
Debt Instrument
Basis points per annum (as a percent)				0.30%

XML

Indebtedness - Schedule of Outstanding Debts (Details) - USD ($)	Dec. 31, 2021	Dec. 31, 2020
Unsecured debt
Debt Instrument
Total floating rate debt	$ 800,000,000	$ 200,000,000
Debt issuance costs, net	0	951,000
Senior unsecured notes
Debt Instrument
Debt issuance costs, net	37,836,000	35,045,000
Face Amount	2,850,000,000	2,650,000,000
Unamortized Discount	5,353,000	6,766,000
Unsecured Revolving Credit Facility | Unsecured debt
Debt Instrument
Unsecured revolving credit facility	800,000,000	0
Unsecured term loan due September 2022 | Unsecured debt
Debt Instrument
Unsecured term loans	$ 0	200,000,000
Senior unsecured notes due 2021 | Senior unsecured notes
Debt Instrument
Coupon	6.75%
Face Amount	$ 0	300,000,000
Unamortized Discount	$ 0	490,000
Senior unsecured notes due 2024 | Senior unsecured notes
Debt Instrument
Coupon	4.75%
Face Amount	$ 250,000,000	250,000,000
Unamortized Discount	$ 184,000	263,000
Senior unsecured notes due 2025 | Senior unsecured notes
Debt Instrument
Coupon	9.75%
Face Amount	$ 1,000,000,000	1,000,000,000
Unamortized Discount	$ 0	0
Senior unsecured notes due 2028 | Senior unsecured notes
Debt Instrument
Coupon	4.75%
Face Amount	$ 500,000,000	500,000,000
Unamortized Discount	$ 5,169,000	6,013,000
Senior unsecured notes due 2031 | Senior unsecured notes
Debt Instrument
Coupon	4.375%
Face Amount	$ 500,000,000	0
Unamortized Discount	$ 0	0
Senior unsecured notes due 2042 | Senior unsecured notes
Debt Instrument
Coupon	5.625%
Face Amount	$ 350,000,000	350,000,000
Unamortized Discount	$ 0	0
Senior unsecured notes due 2046 | Senior unsecured notes
Debt Instrument
Coupon	6.25%
Face Amount	$ 250,000,000	250,000,000
Unamortized Discount	$ 0	$ 0
Senior Unsecured Notes Due June 2021 | Senior unsecured notes
Debt Instrument
Coupon	6.75%
Face Amount	$ 300,000,000

XML

Indebtedness - Schedule of Secured and Other Debt (Details) $ in Thousands	Dec. 31, 2021 USD ($) property	Dec. 31, 2020 USD ($)
Debt Instrument
Principal Balance	$ 69,713	$ 691,573
Net book value of collateral	5,075,749	5,715,829
Unamortized discount (premium) and debt issuance costs, net	3,676,524
Secured Debt
Debt Instrument
Principal Balance	$ 69,135	692,294
Number of Properties as Collateral | property	8
Net book value of collateral	$ 118,342	822,153
Secured Debt | Mortgage notes 6.28% maturing July 2022
Debt Instrument
Principal Balance	$ 11,120	11,838
Interest rate (as a percent)	6.28%
Number of Properties as Collateral | property	1
Net book value of collateral	$ 23,525	23,500
Secured Debt | Mortgage notes 4.85% maturing October 2022
Debt Instrument
Principal Balance	$ 10,479	10,724
Interest rate (as a percent)	4.85%
Number of Properties as Collateral | property	1
Net book value of collateral	$ 19,211	19,675
Secured Debt | Mortgage notes 5.75% maturing October 2022
Debt Instrument
Principal Balance	$ 15,456	15,805
Interest rate (as a percent)	5.75%
Number of Properties as Collateral | property	2
Net book value of collateral	$ 19,099	19,180
Secured Debt | Mortgage notes 6.64% maturing June 2023
Debt Instrument
Principal Balance	$ 15,204	15,646
Interest rate (as a percent)	6.64%
Number of Properties as Collateral | property	1
Net book value of collateral	$ 24,593	23,023
Secured Debt | Mortgage notes 3.53% maturing in August 2026
Debt Instrument
Principal Balance	$ 0	620,000
Interest rate (as a percent)	3.53%
Number of Properties as Collateral | property	0
Net book value of collateral	$ 0	705,096
Secured Debt | Mortgage notes 4.44% maturing July 2043
Debt Instrument
Principal Balance	$ 10,240	10,470
Interest rate (as a percent)	4.44%
Number of Properties as Collateral | property	1
Net book value of collateral	$ 13,387	13,582
Secured Debt | Capital leases 7.70% maturing in April 2026
Debt Instrument
Principal Balance	$ 6,636	7,811
Interest rate (as a percent)	7.70%
Number of Properties as Collateral | property	2
Net book value of collateral	$ 18,527	18,097
Secured Debt | Mortgage notes 7.49% maturing in January 2022
Debt Instrument
Unamortized discount (premium) and debt issuance costs, net	$ (578)	$ 721
Joint Venture | Secured Debt | Mortgage notes 3.53% maturing in August 2026
Debt Instrument
Ownership interest by parent	20.00%

XML

Indebtedness - Schedule of Principal Payments of Debt (Details) $ in Thousands	Dec. 31, 2021 USD ($)
Debt Disclosure [Abstract]
2022	$ 39,067
2023	816,413
2024	251,834
2025	1,002,001
2026	904
Thereafter	1,608,916
Unamortized discount (premium) and debt issuance costs, net	$ 3,676,524

XML

Fair Value of Assets and Liabilities - Assets and Liabilities (Details) - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2021	Dec. 31, 2020	Dec. 31, 2019	Dec. 23, 2021	Mar. 31, 2017
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis
Gains and losses on equity securities, net	$ (42,232)	$ 34,106	$ (41,898)
ALR
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis
Investment in common shares (in shares)	10,691,658
Joint Venture | Seaport Innovation LLC
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis
Equity method investment ownership percentage	20.00%			20.00%	55.00%
Holding period	10 years
Joint Venture | Seaport Innovation LLC | Discount Rate
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis
Measurement input	0.0558
Joint Venture | Seaport Innovation LLC | Market Capitalization Rate
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis
Measurement input	0.0525
Recurring | Level 1 | Carrying Amount | ALR
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis
Investments	$ 31,540	73,772
Investment in common shares (in shares)	10,691,658
Gains and losses on equity securities, net		34,106
Recurring | Level 1 | Estimated Fair Value | ALR
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis
Investments	$ 31,540	73,772
Recurring | Level 3 | Carrying Amount | Joint Venture
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis
Investments	215,127	0
Recurring | Level 3 | Estimated Fair Value | Joint Venture
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis
Investments	$ 215,127	$ 0

XML

Fair Value of Assets and Liabilities - Liabilities (Details) - USD ($) $ in Thousands	Dec. 31, 2021	Dec. 31, 2020
Carrying Amount
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis
Secured and secured debt	$ 2,876,524	$ 3,299,762
Estimated Fair Value
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis
Secured and secured debt	$ 2,919,651	3,489,902
Senior unsecured notes | Senior unsecured notes, 6.750% coupon rate, due 2021
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis
Coupon	6.75%
Senior unsecured notes | Senior unsecured notes, 4.750% coupon rate, due 2024
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis
Coupon	4.75%
Senior unsecured notes | Senior unsecured notes, 9.750% coupon rate, due 2025
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis
Coupon	9.75%
Senior unsecured notes | Senior unsecured notes, 4.750% coupon rate, due 2028
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis
Coupon	4.75%
Senior unsecured notes | Senior unsecured notes, 4.375% coupon rate, due 2031
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis
Coupon	4.375%
Senior unsecured notes | Carrying Amount | Senior unsecured notes, 6.750% coupon rate, due 2021
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis
Coupon	6.75%
Secured and secured debt	$ 0	299,273
Senior unsecured notes | Carrying Amount | Senior unsecured notes, 4.750% coupon rate, due 2024
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis
Coupon	4.75%
Secured and secured debt	$ 249,348	249,068
Senior unsecured notes | Carrying Amount | Senior unsecured notes, 9.750% coupon rate, due 2025
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis
Coupon	9.75%
Secured and secured debt	$ 987,903	984,359
Senior unsecured notes | Carrying Amount | Senior unsecured notes, 4.750% coupon rate, due 2028
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis
Coupon	4.75%
Secured and secured debt	$ 492,199	490,925
Senior unsecured notes | Carrying Amount | Senior unsecured notes, 4.375% coupon rate, due 2031
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis
Coupon	4.375%
Secured and secured debt	$ 492,127	0
Senior unsecured notes | Carrying Amount | Senior unsecured notes, 5.625% coupon rate, due 2042
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis
Coupon	5.625%
Secured and secured debt	$ 342,183	341,802
Senior unsecured notes | Carrying Amount | Senior unsecured notes, 6.250% coupon rate, due 2046
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis
Coupon	6.25%
Secured and secured debt	$ 243,051	242,762
Senior unsecured notes | Estimated Fair Value | Senior unsecured notes, 6.750% coupon rate, due 2021
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis
Secured and secured debt	0	303,891
Senior unsecured notes | Estimated Fair Value | Senior unsecured notes, 4.750% coupon rate, due 2024
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis
Secured and secured debt	257,695	256,258
Senior unsecured notes | Estimated Fair Value | Senior unsecured notes, 9.750% coupon rate, due 2025
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis
Secured and secured debt	1,081,990	1,135,800
Senior unsecured notes | Estimated Fair Value | Senior unsecured notes, 4.750% coupon rate, due 2028
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis
Secured and secured debt	491,480	502,648
Senior unsecured notes | Estimated Fair Value | Senior unsecured notes, 4.375% coupon rate, due 2031
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis
Secured and secured debt	480,763	0
Senior unsecured notes | Estimated Fair Value | Senior unsecured notes, 5.625% coupon rate, due 2042
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis
Secured and secured debt	309,260	330,120
Senior unsecured notes | Estimated Fair Value | Senior unsecured notes, 6.250% coupon rate, due 2046
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis
Secured and secured debt	226,500	245,000
Secured debts | Carrying Amount
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis
Secured and secured debt	69,713	691,573
Secured debts | Estimated Fair Value
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis
Secured and secured debt	$ 71,963	$ 716,185

XML

Fair Value of Assets and Liabilities - Narrative (Details) $ in Thousands	12 Months Ended
	Dec. 31, 2021 USD ($) security	Dec. 23, 2021	Jan. 30, 2021 USD ($)	Dec. 31, 2020 USD ($)	Mar. 31, 2017
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis
Revolving credit facility | $	$ 800,000			$ 0
Term loan due 2022 | Senior unsecured notes
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis
Revolving credit facility | $			$ 200,000
Seaport Innovation LLC | Joint Venture
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis
Equity method investment ownership percentage	20.00%	20.00%			55.00%
Holding period	10 years
Seaport Innovation LLC | Joint Venture | Discount Rate
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis
Measurement input	0.0558
Seaport Innovation LLC | Joint Venture | Market Capitalization Rate
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis
Measurement input	0.0525
Quoted Prices in Active Markets for Identical Assets (Level 1)
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis
Number of debt securities | security	2
Significant Other Observable Inputs (Level 2)
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis
Number of debt securities | security	4

XML

Noncontrolling Interest (Details) $ in Thousands		1 Months Ended	12 Months Ended
	Dec. 23, 2021	Dec. 31, 2021	Dec. 31, 2021 USD ($) property	Dec. 31, 2020 USD ($)	Dec. 31, 2019 USD ($)	Mar. 31, 2017
Noncontrolling Interest
Net income attributable to noncontrolling interest			$ 5,411	$ 5,146	$ 5,356
Comprehensive income attributable to noncontrolling interest			5,411	5,146	5,356
Distributions to noncontrolling interest			$ 22,348	$ 22,292	$ 21,583
Seaport Innovation LLC | Joint Venture
Noncontrolling Interest
Number of properties included in joint venture agreement | property			1
Equity method investment ownership percentage	20.00%	20.00%	20.00%			55.00%
Additional equity joint venture percentage	35.00%	35.00%
Seaport Innovation LLC | Joint Venture | Investor
Noncontrolling Interest
Equity method investment ownership percentage						45.00%

XML

Segment Reporting (Details) $ in Thousands	12 Months Ended
	Dec. 31, 2021 USD ($) segment	Dec. 31, 2020 USD ($)	Dec. 31, 2019 USD ($)
Segment reporting
Number of reportable segments | segment	2
Total revenues	$ 1,383,212	$ 1,632,026	$ 1,040,155
Expenses:
Property operating expenses	1,091,812	1,236,357	489,070
Depreciation and amortization	271,131	270,147	289,025
General and administrative	34,087	30,593	37,028
Acquisition and certain other transaction related costs	17,506	814	13,102
Impairment of assets	(174)	106,972	115,201
Total expenses	1,414,362	1,644,883	943,426
Gain on sale of properties	492,272	6,487	39,696
Dividend income	0	0	1,846
Gains and losses on equity securities, net	(42,232)	34,106	(41,898)
Interest and other income	20,635	18,221	941
Interest expense	(255,759)	(201,483)	(180,112)
Gain on lease termination	0	22,896	0
Loss on early extinguishment of debt	(2,410)	(427)	(44)
Income (loss) from continuing operations before income tax expense and equity in earnings of an investee	181,356	(133,057)	(82,842)
Income tax expense	(1,430)	(1,250)	(436)
Equity in earnings of an investee	0	0	400
Net income (loss)	179,926	(134,307)	(82,878)
Net income attributable to noncontrolling interest	(5,411)	(5,146)	(5,356)
Net income (loss) attributable to common shareholders	174,515	(139,453)	(88,234)
Total assets	6,623,514	6,476,424	6,653,826
Non-Segment
Segment reporting
Total revenues	40,992	43,850	63,644
Expenses:
Property operating expenses	0	0	0
Depreciation and amortization	11,455	11,702	18,777
General and administrative	34,087	30,593	37,028
Acquisition and certain other transaction related costs	17,506	814	13,102
Impairment of assets	0	0	6,344
Total expenses	63,048	43,109	75,251
Gain on sale of properties	0	4,517	17,872
Dividend income			1,846
Gains and losses on equity securities, net	(42,232)	34,106	(41,898)
Interest and other income	1,081	736	941
Interest expense	(230,193)	(175,072)	(152,655)
Gain on lease termination		22,896
Loss on early extinguishment of debt	(2,410)	(26)	(27)
Income (loss) from continuing operations before income tax expense and equity in earnings of an investee	(295,810)	(112,102)	(185,528)
Income tax expense	(1,430)	(1,250)	(436)
Equity in earnings of an investee			400
Net income (loss)	(297,240)	(113,352)	(185,564)
Net income attributable to noncontrolling interest	0	0	0
Net income (loss) attributable to common shareholders	(297,240)	(113,352)	(185,564)
Total assets	1,345,043	471,565	443,260
Office Portfolio | Operating Segments
Segment reporting
Total revenues	367,597	383,365	405,016
Expenses:
Property operating expenses	127,313	129,756	132,348
Depreciation and amortization	127,632	129,321	137,611
General and administrative	0	0	0
Acquisition and certain other transaction related costs	0	0	0
Impairment of assets	0	8,558	43,035
Total expenses	254,945	267,635	312,994
Gain on sale of properties	492,072	2,597	6,617
Dividend income			0
Gains and losses on equity securities, net	0	0	0
Interest and other income	0	0	0
Interest expense	(23,477)	(24,188)	(24,399)
Gain on lease termination		0
Loss on early extinguishment of debt	0	(401)	0
Income (loss) from continuing operations before income tax expense and equity in earnings of an investee	581,247	93,738	74,240
Income tax expense	0	0	0
Equity in earnings of an investee			0
Net income (loss)	581,247	93,738	74,240
Net income attributable to noncontrolling interest	(5,411)	(5,146)	(5,356)
Net income (loss) attributable to common shareholders	575,836	88,592	68,884
Total assets	2,282,652	3,092,289	3,165,577
SHOP
Expenses:
Interest and other income	19,554	17,485
SHOP | Operating Segments
Segment reporting
Total revenues	974,623	1,204,811	571,495
Expenses:
Property operating expenses	964,499	1,106,601	356,722
Depreciation and amortization	132,044	129,124	132,637
General and administrative	0	0	0
Acquisition and certain other transaction related costs	0	0	0
Impairment of assets	(174)	98,414	65,822
Total expenses	1,096,369	1,334,139	555,181
Gain on sale of properties	200	(627)	15,207
Dividend income			0
Gains and losses on equity securities, net	0	0	0
Interest and other income			0
Interest expense	(2,089)	(2,223)	(3,058)
Gain on lease termination		0
Loss on early extinguishment of debt	0	0	(17)
Income (loss) from continuing operations before income tax expense and equity in earnings of an investee	(104,081)	(114,693)	28,446
Income tax expense	0	0	0
Equity in earnings of an investee			0
Net income (loss)	(104,081)	(114,693)	28,446
Net income attributable to noncontrolling interest	0	0	0
Net income (loss) attributable to common shareholders	(104,081)	(114,693)	28,446
Total assets	2,995,819	2,912,570	3,044,989
Rental income
Segment reporting
Total revenues	408,589	427,215	606,558
Rental income | Non-Segment
Segment reporting
Total revenues	40,992	43,850	63,644
Rental income | Office Portfolio | Operating Segments
Segment reporting
Total revenues	367,597	383,365	405,016
Rental income | SHOP | Operating Segments
Segment reporting
Total revenues	0	0	137,898
Residents fees and services
Segment reporting
Total revenues	974,623	1,204,811	433,597
Residents fees and services | Non-Segment
Segment reporting
Total revenues	0	0	0
Residents fees and services | Office Portfolio | Operating Segments
Segment reporting
Total revenues	0	0	0
Residents fees and services | SHOP | Operating Segments
Segment reporting
Total revenues	$ 974,623	$ 1,204,811	$ 433,597

XML

Income Taxes - Provision for Income Taxes (Details) - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2021	Dec. 31, 2020	Dec. 31, 2019
Current:
Federal	$ 200	$ 0	$ 0
State	1,230	1,250	436
Current income tax expense (benefit)	1,430	1,250	436
Deferred:
Federal	0	0	0
State	0	0	0
Deferred tax expense (benefit)	0	0	0
Income tax provision	$ 1,430	$ 1,250	$ 436

XML

Income Taxes - Reconciliation of Effective Tax Rate (Details)	12 Months Ended
	Dec. 31, 2021	Dec. 31, 2020	Dec. 31, 2019
Effective Income Tax Rate Reconciliation, Percent
Taxes at statutory U.S. federal income tax rate	21.00%	21.00%	21.00%
Nontaxable income	(21.00%)	(21.00%)	(21.00%)
Federal excise tax	0.10%	0.00%	0.00%
State and local income taxes, net of federal tax benefit	0.80%	(1.30%)	0.50%
Effective tax rate	0.90%	(1.30%)	0.50%

XML

Income Taxes - Deferred Income Taxes (Details) - USD ($) $ in Thousands	Dec. 31, 2021	Dec. 31, 2020
Deferred tax assets:
Deferred income	$ 2,132	$ 3,252
Fair market value adjustment	1,577	10,856
Other	784	758
Tax loss carryforwards	25,829	28,358
Deferred tax assets, gross	30,322	43,224
Valuation allowance	(30,322)	(43,224)
Deferred tax assets, net of valuation allowance	0	0
Net deferred income taxes	$ 0	$ 0

XML

Income Taxes - Narrative (Details) - USD ($) $ in Thousands	Dec. 31, 2021	Dec. 31, 2020
Income Tax Disclosure [Abstract]
Percentage of valuation allowance provided	100.00%	100.00%
TRSs operating loss carryforwards	$ 103,682
Operating loss carry forwards not subject to expiration	$ 141,160

XML

Weighted Average Common Shares (Details) - shares shares in Thousands	12 Months Ended
	Dec. 31, 2021	Dec. 31, 2020	Dec. 31, 2019
Weighted average shares used in computing earnings per common share:
Weighted average common shares for basic earnings per share (in shares)	237,967	237,739	237,604
Effect of dilutive securities: restricted share awards (in shares)	0	0	0
Weighted average common shares for diluted earnings per share (in shares)	237,967	237,739	237,604
Antidilutive securities excluded from computation of earnings per share (in shares)	60	223	36

XML

SCHEDULE III REAL ESTATE AND ACCUMULATED DEPRECIATION - Properties (Details) - Continuing Operations - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2021	Dec. 31, 2020	Dec. 31, 2019	Dec. 31, 2018
Real Estate And Accumulated Depreciation
Encumbrances	$ 69,135
Initial Cost to Company
Land	715,799
Buildings, Improvements & Equipment	5,050,945
Cost Capitalized Subsequent to Acquisition	1,455,137
Impairment	(140,345)
Cost Basis Adjustment	(267,980)
Cost at the end of the period
Land	741,501
Buildings, Improvements & Equipment	6,072,055
Total	6,813,556	$ 7,410,730	$ 7,461,586	$ 7,876,300
Accumulated Depreciation	1,737,807	$ 1,694,901	$ 1,570,801	$ 1,534,392
2184 Parkway Lake Drive, Birmingham, AL
Real Estate And Accumulated Depreciation
Encumbrances	0
Initial Cost to Company
Land	580
Buildings, Improvements & Equipment	5,980
Cost Capitalized Subsequent to Acquisition	2,576
Impairment	0
Cost Basis Adjustment	0
Cost at the end of the period
Land	580
Buildings, Improvements & Equipment	8,556
Total	9,136
Accumulated Depreciation	2,597
2634 Valleydale Road, Birmingham, AL
Real Estate And Accumulated Depreciation
Encumbrances	0
Initial Cost to Company
Land	600
Buildings, Improvements & Equipment	7,574
Cost Capitalized Subsequent to Acquisition	2,333
Impairment	0
Cost Basis Adjustment	(83)
Cost at the end of the period
Land	1,559
Buildings, Improvements & Equipment	8,865
Total	10,424
Accumulated Depreciation	2,905
2021 Dahlke Drive NE, Cullman, AL
Real Estate And Accumulated Depreciation
Encumbrances	0
Initial Cost to Company
Land	287
Buildings, Improvements & Equipment	3,415
Cost Capitalized Subsequent to Acquisition	853
Impairment	0
Cost Basis Adjustment	(301)
Cost at the end of the period
Land	287
Buildings, Improvements & Equipment	3,967
Total	4,254
Accumulated Depreciation	1,516
101 Tulip Lane, Dothan, AL
Real Estate And Accumulated Depreciation
Encumbrances	0
Initial Cost to Company
Land	3,543
Buildings, Improvements & Equipment	14,619
Cost Capitalized Subsequent to Acquisition	608
Impairment	0
Cost Basis Adjustment	0
Cost at the end of the period
Land	3,543
Buildings, Improvements & Equipment	15,227
Total	18,770
Accumulated Depreciation	2,111
49 Hughes Road, Madison, AL
Real Estate And Accumulated Depreciation
Encumbrances	0
Initial Cost to Company
Land	334
Buildings, Improvements & Equipment	3,981
Cost Capitalized Subsequent to Acquisition	1,225
Impairment	0
Cost Basis Adjustment	(243)
Cost at the end of the period
Land	334
Buildings, Improvements & Equipment	4,963
Total	5,297
Accumulated Depreciation	1,900
200 Terrace Lane, Priceville, AL
Real Estate And Accumulated Depreciation
Encumbrances	0
Initial Cost to Company
Land	1,300
Buildings, Improvements & Equipment	9,447
Cost Capitalized Subsequent to Acquisition	843
Impairment	0
Cost Basis Adjustment	(110)
Cost at the end of the period
Land	1,365
Buildings, Improvements & Equipment	10,115
Total	11,480
Accumulated Depreciation	2,791
413 Cox Boulevard, Sheffield, AL
Real Estate And Accumulated Depreciation
Encumbrances	0
Initial Cost to Company
Land	394
Buildings, Improvements & Equipment	4,684
Cost Capitalized Subsequent to Acquisition	942
Impairment	0
Cost Basis Adjustment	(294)
Cost at the end of the period
Land	394
Buildings, Improvements & Equipment	5,332
Total	5,726
Accumulated Depreciation	2,109
2435 Columbiana Road, Vestavia Hills, AL
Real Estate And Accumulated Depreciation
Encumbrances	0
Initial Cost to Company
Land	843
Buildings, Improvements & Equipment	23,472
Cost Capitalized Subsequent to Acquisition	2,722
Impairment	0
Cost Basis Adjustment	0
Cost at the end of the period
Land	902
Buildings, Improvements & Equipment	26,135
Total	27,037
Accumulated Depreciation	5,477
4461 N Crossover Road, Fayetteville, AR
Real Estate And Accumulated Depreciation
Encumbrances	0
Initial Cost to Company
Land	733
Buildings, Improvements & Equipment	10,432
Cost Capitalized Subsequent to Acquisition	293
Impairment	0
Cost Basis Adjustment	0
Cost at the end of the period
Land	733
Buildings, Improvements & Equipment	10,725
Total	11,458
Accumulated Depreciation	2,037
4210 S Caraway Road, Jonesboro, AR
Real Estate And Accumulated Depreciation
Encumbrances	0
Initial Cost to Company
Land	653
Buildings, Improvements & Equipment	9,515
Cost Capitalized Subsequent to Acquisition	370
Impairment	0
Cost Basis Adjustment	0
Cost at the end of the period
Land	653
Buildings, Improvements & Equipment	9,885
Total	10,538
Accumulated Depreciation	1,871
672 Jones Road, Springdale, AR
Real Estate And Accumulated Depreciation
Encumbrances	0
Initial Cost to Company
Land	572
Buildings, Improvements & Equipment	9,364
Cost Capitalized Subsequent to Acquisition	1,193
Impairment	0
Cost Basis Adjustment	0
Cost at the end of the period
Land	572
Buildings, Improvements & Equipment	10,557
Total	11,129
Accumulated Depreciation	1,948
13840 North Desert Harbor Drive, Peoria, AZ
Real Estate And Accumulated Depreciation
Encumbrances	0
Initial Cost to Company
Land	2,687
Buildings, Improvements & Equipment	15,843
Cost Capitalized Subsequent to Acquisition	8,569
Impairment	0
Cost Basis Adjustment	(2,252)
Cost at the end of the period
Land	2,693
Buildings, Improvements & Equipment	22,154
Total	24,847
Accumulated Depreciation	9,634
11209 N. Tatum Boulevard, Phoenix, AZ
Real Estate And Accumulated Depreciation
Encumbrances	0
Initial Cost to Company
Land	1,380
Buildings, Improvements & Equipment	6,349
Cost Capitalized Subsequent to Acquisition	4,757
Impairment	0
Cost Basis Adjustment	(303)
Cost at the end of the period
Land	1,573
Buildings, Improvements & Equipment	10,610
Total	12,183
Accumulated Depreciation	2,945
2444 West Las Palmaritas Drive, Phoenix, AZ
Real Estate And Accumulated Depreciation
Encumbrances	0
Initial Cost to Company
Land	3,820
Buildings, Improvements & Equipment	6,669
Cost Capitalized Subsequent to Acquisition	2,979
Impairment	0
Cost Basis Adjustment	0
Cost at the end of the period
Land	3,831
Buildings, Improvements & Equipment	9,637
Total	13,468
Accumulated Depreciation	2,018
4121 East Cotton Center, Phoenix, AZ
Real Estate And Accumulated Depreciation
Encumbrances	0
Initial Cost to Company
Land	5,166
Buildings, Improvements & Equipment	12,724
Cost Capitalized Subsequent to Acquisition	541
Impairment	0
Cost Basis Adjustment	0
Cost at the end of the period
Land	5,205
Buildings, Improvements & Equipment	13,226
Total	18,431
Accumulated Depreciation	2,292
3850 N US Hwy 89 Prescott, AZ
Real Estate And Accumulated Depreciation
Encumbrances	15,204
Initial Cost to Company
Land	2,017
Buildings, Improvements & Equipment	17,513
Cost Capitalized Subsequent to Acquisition	7,786
Impairment	0
Cost Basis Adjustment	0
Cost at the end of the period
Land	2,017
Buildings, Improvements & Equipment	25,299
Total	27,316
Accumulated Depreciation	2,723
6001 East Thomas Road, Scottsdale, AZ
Real Estate And Accumulated Depreciation
Encumbrances	0
Initial Cost to Company
Land	941
Buildings, Improvements & Equipment	8,807
Cost Capitalized Subsequent to Acquisition	5,373
Impairment	0
Cost Basis Adjustment	(367)
Cost at the end of the period
Land	946
Buildings, Improvements & Equipment	13,808
Total	14,754
Accumulated Depreciation	7,738
7090 East Mescal Street Scottsdale, A Z
Real Estate And Accumulated Depreciation
Encumbrances	0
Initial Cost to Company
Land	2,315
Buildings, Improvements & Equipment	13,650
Cost Capitalized Subsequent to Acquisition	12,755
Impairment	0
Cost Basis Adjustment	(2,094)
Cost at the end of the period
Land	2,349
Buildings, Improvements & Equipment	24,277
Total	26,626
Accumulated Depreciation	9,498
17225 North Boswell Boulevard Sun City, A Z
Real Estate And Accumulated Depreciation
Encumbrances	0
Initial Cost to Company
Land	1,189
Buildings, Improvements & Equipment	10,569
Cost Capitalized Subsequent to Acquisition	3,218
Impairment	0
Cost Basis Adjustment	(517)
Cost at the end of the period
Land	1,189
Buildings, Improvements & Equipment	13,270
Total	14,459
Accumulated Depreciation	7,971
14001 W. Meeker Boulevard Sun City West, A Z
Real Estate And Accumulated Depreciation
Encumbrances	0
Initial Cost to Company
Land	395
Buildings, Improvements & Equipment	3,307
Cost Capitalized Subsequent to Acquisition	0
Impairment	0
Cost Basis Adjustment	(192)
Cost at the end of the period
Land	395
Buildings, Improvements & Equipment	3,115
Total	3,510
Accumulated Depreciation	1,469
1415 West 3rd Street Tempe, AZ
Real Estate And Accumulated Depreciation
Encumbrances	0
Initial Cost to Company
Land	2,186
Buildings, Improvements & Equipment	13,446
Cost Capitalized Subsequent to Acquisition	3,721
Impairment	0
Cost Basis Adjustment	0
Cost at the end of the period
Land	4,896
Buildings, Improvements & Equipment	14,457
Total	19,353
Accumulated Depreciation	2,405
2500 North Rosemont Boulevard Tucson, A Z
Real Estate And Accumulated Depreciation
Encumbrances	0
Initial Cost to Company
Land	4,429
Buildings, Improvements & Equipment	26,119
Cost Capitalized Subsequent to Acquisition	8,041
Impairment	0
Cost Basis Adjustment	(3,141)
Cost at the end of the period
Land	4,576
Buildings, Improvements & Equipment	30,872
Total	35,448
Accumulated Depreciation	14,140
710 North Euclid, Anaheim, CA
Real Estate And Accumulated Depreciation
Encumbrances	0
Initial Cost to Company
Land	2,850
Buildings, Improvements & Equipment	6,964
Cost Capitalized Subsequent to Acquisition	2,215
Impairment	(1,350)
Cost Basis Adjustment	(2,405)
Cost at the end of the period
Land	2,518
Buildings, Improvements & Equipment	5,756
Total	8,274
Accumulated Depreciation	449
5000 Marina Boulevard, Brisbane, CA
Real Estate And Accumulated Depreciation
Encumbrances	0
Initial Cost to Company
Land	7,957
Buildings, Improvements & Equipment	13,430
Cost Capitalized Subsequent to Acquisition	745
Impairment	0
Cost Basis Adjustment	0
Cost at the end of the period
Land	7,957
Buildings, Improvements & Equipment	14,175
Total	22,132
Accumulated Depreciation	1,547
5770 Armada Drive, Carlsbad, CA
Real Estate And Accumulated Depreciation
Encumbrances	10,479
Initial Cost to Company
Land	3,875
Buildings, Improvements & Equipment	18,543
Cost Capitalized Subsequent to Acquisition	0
Impairment	0
Cost Basis Adjustment	0
Cost at the end of the period
Land	3,875
Buildings, Improvements & Equipment	18,543
Total	22,418
Accumulated Depreciation	3,207
1350 South El Camino Real, Encinitas, CA
Real Estate And Accumulated Depreciation
Encumbrances	0
Initial Cost to Company
Land	1,510
Buildings, Improvements & Equipment	18,042
Cost Capitalized Subsequent to Acquisition	2,372
Impairment	0
Cost Basis Adjustment	(53)
Cost at the end of the period
Land	1,517
Buildings, Improvements & Equipment	20,354
Total	21,871
Accumulated Depreciation	6,455
47201 Lakeview Boulevard, Fremont, CA
Real Estate And Accumulated Depreciation
Encumbrances	0
Initial Cost to Company
Land	3,200
Buildings, Improvements & Equipment	10,177
Cost Capitalized Subsequent to Acquisition	36
Impairment	0
Cost Basis Adjustment	0
Cost at the end of the period
Land	3,200
Buildings, Improvements & Equipment	10,213
Total	13,413
Accumulated Depreciation	2,626
47211/47215 Lakeview Boulevard, Fremont, CA
Real Estate And Accumulated Depreciation
Encumbrances	0
Initial Cost to Company
Land	3,750
Buildings, Improvements & Equipment	12,656
Cost Capitalized Subsequent to Acquisition	3,732
Impairment	0
Cost Basis Adjustment	0
Cost at the end of the period
Land	3,750
Buildings, Improvements & Equipment	16,388
Total	20,138
Accumulated Depreciation	3,265
47900 Bayside Parkway Fremont, C A
Real Estate And Accumulated Depreciation
Encumbrances	0
Initial Cost to Company
Land	4,580
Buildings, Improvements & Equipment	10,370
Cost Capitalized Subsequent to Acquisition	2,203
Impairment	0
Cost Basis Adjustment	0
Cost at the end of the period
Land	4,580
Buildings, Improvements & Equipment	12,573
Total	17,153
Accumulated Depreciation	2,901
577 South Peach Street Fresno, C A
Real Estate And Accumulated Depreciation
Encumbrances	0
Initial Cost to Company
Land	738
Buildings, Improvements & Equipment	2,577
Cost Capitalized Subsequent to Acquisition	4,175
Impairment	0
Cost Basis Adjustment	(211)
Cost at the end of the period
Land	738
Buildings, Improvements & Equipment	6,541
Total	7,279
Accumulated Depreciation	2,758
6075 North Marks Avenue Fresno, C A
Real Estate And Accumulated Depreciation
Encumbrances	0
Initial Cost to Company
Land	880
Buildings, Improvements & Equipment	12,751
Cost Capitalized Subsequent to Acquisition	938
Impairment	0
Cost Basis Adjustment	0
Cost at the end of the period
Land	889
Buildings, Improvements & Equipment	13,680
Total	14,569
Accumulated Depreciation	4,546
8631 West 3rd Street Los Angeles, C A
Real Estate And Accumulated Depreciation
Encumbrances	0
Initial Cost to Company
Land	24,640
Buildings, Improvements & Equipment	88,277
Cost Capitalized Subsequent to Acquisition	18,122
Impairment	0
Cost Basis Adjustment	(908)
Cost at the end of the period
Land	25,391
Buildings, Improvements & Equipment	104,740
Total	130,131
Accumulated Depreciation	28,026
8635 West 3rd Street Los Angeles, C A
Real Estate And Accumulated Depreciation
Encumbrances	0
Initial Cost to Company
Land	24,640
Buildings, Improvements & Equipment	90,352
Cost Capitalized Subsequent to Acquisition	15,367
Impairment	0
Cost Basis Adjustment	(764)
Cost at the end of the period
Land	25,331
Buildings, Improvements & Equipment	104,264
Total	129,595
Accumulated Depreciation	28,178
1319 Brookside Avenue, Redlands, CA
Real Estate And Accumulated Depreciation
Encumbrances	0
Initial Cost to Company
Land	1,770
Buildings, Improvements & Equipment	9,982
Cost Capitalized Subsequent to Acquisition	1,361
Impairment	0
Cost Basis Adjustment	0
Cost at the end of the period
Land	1,770
Buildings, Improvements & Equipment	11,343
Total	13,113
Accumulated Depreciation	3,640
110 Sterling Court Roseville, C A
Real Estate And Accumulated Depreciation
Encumbrances	0
Initial Cost to Company
Land	1,620
Buildings, Improvements & Equipment	10,262
Cost Capitalized Subsequent to Acquisition	2,245
Impairment	0
Cost Basis Adjustment	0
Cost at the end of the period
Land	1,620
Buildings, Improvements & Equipment	12,507
Total	14,127
Accumulated Depreciation	3,905
16925 & 16916 Hierba Drive San Diego, C A
Real Estate And Accumulated Depreciation
Encumbrances	0
Initial Cost to Company
Land	9,142
Buildings, Improvements & Equipment	53,904
Cost Capitalized Subsequent to Acquisition	20,060
Impairment	0
Cost Basis Adjustment	(6,938)
Cost at the end of the period
Land	9,180
Buildings, Improvements & Equipment	66,988
Total	76,168
Accumulated Depreciation	29,785
3030 Science Park San Diego, C A
Real Estate And Accumulated Depreciation
Encumbrances	0
Initial Cost to Company
Land	2,466
Buildings, Improvements & Equipment	46,473
Cost Capitalized Subsequent to Acquisition	29,559
Impairment	0
Cost Basis Adjustment	0
Cost at the end of the period
Land	2,466
Buildings, Improvements & Equipment	76,032
Total	78,498
Accumulated Depreciation	15,054
3040 Science Park San Diego, C A
Real Estate And Accumulated Depreciation
Encumbrances	0
Initial Cost to Company
Land	1,225
Buildings, Improvements & Equipment	23,077
Cost Capitalized Subsequent to Acquisition	22,654
Impairment	0
Cost Basis Adjustment	0
Cost at the end of the period
Land	1,225
Buildings, Improvements & Equipment	45,731
Total	46,956
Accumulated Depreciation	7,593
3050 Science Park San Diego, C A
Real Estate And Accumulated Depreciation
Encumbrances	0
Initial Cost to Company
Land	1,508
Buildings, Improvements & Equipment	28,753
Cost Capitalized Subsequent to Acquisition	24,549
Impairment	0
Cost Basis Adjustment	0
Cost at the end of the period
Land	1,508
Buildings, Improvements & Equipment	53,302
Total	54,810
Accumulated Depreciation	9,303
2904 Orchard Parkway, San Jose, CA
Real Estate And Accumulated Depreciation
Encumbrances	0
Initial Cost to Company
Land	10,788
Buildings, Improvements & Equipment	8,890
Cost Capitalized Subsequent to Acquisition	2,621
Impairment	0
Cost Basis Adjustment	0
Cost at the end of the period
Land	10,804
Buildings, Improvements & Equipment	11,495
Total	22,299
Accumulated Depreciation	1,860
3530 Deer Park Drive Stockton CA
Real Estate And Accumulated Depreciation
Encumbrances	0
Initial Cost to Company
Land	670
Buildings, Improvements & Equipment	14,419
Cost Capitalized Subsequent to Acquisition	2,079
Impairment	0
Cost Basis Adjustment	0
Cost at the end of the period
Land	682
Buildings, Improvements & Equipment	16,486
Total	17,168
Accumulated Depreciation	5,299
877 East March Lane Stockton, CA
Real Estate And Accumulated Depreciation
Encumbrances	0
Initial Cost to Company
Land	1,176
Buildings, Improvements & Equipment	11,171
Cost Capitalized Subsequent to Acquisition	6,892
Impairment	0
Cost Basis Adjustment	(1,885)
Cost at the end of the period
Land	1,411
Buildings, Improvements & Equipment	15,943
Total	17,354
Accumulated Depreciation	6,648
28515 Westinghouse Place Valencia, CA
Real Estate And Accumulated Depreciation
Encumbrances	0
Initial Cost to Company
Land	4,669
Buildings, Improvements & Equipment	41,440
Cost Capitalized Subsequent to Acquisition	20
Impairment	0
Cost Basis Adjustment	0
Cost at the end of the period
Land	4,689
Buildings, Improvements & Equipment	41,440
Total	46,129
Accumulated Depreciation	7,169
1866 San Miguel Drive Walnut Creek, C A
Real Estate And Accumulated Depreciation
Encumbrances	0
Initial Cost to Company
Land	2,010
Buildings, Improvements & Equipment	9,290
Cost Capitalized Subsequent to Acquisition	5,415
Impairment	0
Cost Basis Adjustment	(930)
Cost at the end of the period
Land	3,417
Buildings, Improvements & Equipment	12,368
Total	15,785
Accumulated Depreciation	3,178
1950 South Dayton Street, Aurora, CO
Real Estate And Accumulated Depreciation
Encumbrances	0
Initial Cost to Company
Land	3,062
Buildings, Improvements & Equipment	46,195
Cost Capitalized Subsequent to Acquisition	3,601
Impairment	0
Cost Basis Adjustment	0
Cost at the end of the period
Land	3,120
Buildings, Improvements & Equipment	49,738
Total	52,858
Accumulated Depreciation	9,725
515 Fairview Avenue, Canon City, CO
Real Estate And Accumulated Depreciation
Encumbrances	0
Initial Cost to Company
Land	292
Buildings, Improvements & Equipment	6,228
Cost Capitalized Subsequent to Acquisition	2,000
Impairment	(3,512)
Cost Basis Adjustment	(517)
Cost at the end of the period
Land	299
Buildings, Improvements & Equipment	4,192
Total	4,491
Accumulated Depreciation	1,969
110 West Van Buren Street, Colorado Springs, CO
Real Estate And Accumulated Depreciation
Encumbrances	0
Initial Cost to Company
Land	245
Buildings, Improvements & Equipment	5,236
Cost Capitalized Subsequent to Acquisition	3,170
Impairment	(3,031)
Cost Basis Adjustment	(701)
Cost at the end of the period
Land	245
Buildings, Improvements & Equipment	4,674
Total	4,919
Accumulated Depreciation	1,771
3920 East San Miguel Street, Colorado Springs, CO
Real Estate And Accumulated Depreciation
Encumbrances	0
Initial Cost to Company
Land	1,380
Buildings, Improvements & Equipment	8,894
Cost Capitalized Subsequent to Acquisition	4,218
Impairment	0
Cost Basis Adjustment	(34)
Cost at the end of the period
Land	1,612
Buildings, Improvements & Equipment	12,846
Total	14,458
Accumulated Depreciation	3,673
2050 South Main Street, Delta, CO
Real Estate And Accumulated Depreciation
Encumbrances	0
Initial Cost to Company
Land	167
Buildings, Improvements & Equipment	3,570
Cost Capitalized Subsequent to Acquisition	1,461
Impairment	0
Cost Basis Adjustment	(415)
Cost at the end of the period
Land	167
Buildings, Improvements & Equipment	4,616
Total	4,783
Accumulated Depreciation	2,411
2501 Little Bookcliff Drive, Grand Junction, CO
Real Estate And Accumulated Depreciation
Encumbrances	0
Initial Cost to Company
Land	204
Buildings, Improvements & Equipment	3,875
Cost Capitalized Subsequent to Acquisition	2,210
Impairment	0
Cost Basis Adjustment	(908)
Cost at the end of the period
Land	207
Buildings, Improvements & Equipment	5,174
Total	5,381
Accumulated Depreciation	3,029
2825 Patterson Road, Grand Junction, CO
Real Estate And Accumulated Depreciation
Encumbrances	0
Initial Cost to Company
Land	173
Buildings, Improvements & Equipment	2,583
Cost Capitalized Subsequent to Acquisition	3,293
Impairment	0
Cost Basis Adjustment	(786)
Cost at the end of the period
Land	173
Buildings, Improvements & Equipment	5,090
Total	5,263
Accumulated Depreciation	2,732
1599 Ingalls Street, Lakewood, CO
Real Estate And Accumulated Depreciation
Encumbrances	0
Initial Cost to Company
Land	232
Buildings, Improvements & Equipment	3,766
Cost Capitalized Subsequent to Acquisition	4,094
Impairment	0
Cost Basis Adjustment	(860)
Cost at the end of the period
Land	232
Buildings, Improvements & Equipment	7,000
Total	7,232
Accumulated Depreciation	4,294
5555 South Elati Street, Littleton, CO
Real Estate And Accumulated Depreciation
Encumbrances	0
Initial Cost to Company
Land	185
Buildings, Improvements & Equipment	5,043
Cost Capitalized Subsequent to Acquisition	4,277
Impairment	0
Cost Basis Adjustment	(1,068)
Cost at the end of the period
Land	191
Buildings, Improvements & Equipment	8,246
Total	8,437
Accumulated Depreciation	4,899
8271 South Continental Divide Road, Littleton, CO
Real Estate And Accumulated Depreciation
Encumbrances	0
Initial Cost to Company
Land	400
Buildings, Improvements & Equipment	3,507
Cost Capitalized Subsequent to Acquisition	0
Impairment	0
Cost Basis Adjustment	(202)
Cost at the end of the period
Land	400
Buildings, Improvements & Equipment	3,305
Total	3,705
Accumulated Depreciation	1,559
9005 Grant Street, Thornton, CO
Real Estate And Accumulated Depreciation
Encumbrances	0
Initial Cost to Company
Land	961
Buildings, Improvements & Equipment	10,867
Cost Capitalized Subsequent to Acquisition	1,179
Impairment	0
Cost Basis Adjustment	0
Cost at the end of the period
Land	1,269
Buildings, Improvements & Equipment	11,738
Total	13,007
Accumulated Depreciation	2,640
7809 W. 38th Avenue, Wheat Ridge, CO
Real Estate And Accumulated Depreciation
Encumbrances	0
Initial Cost to Company
Land	470
Buildings, Improvements & Equipment	3,373
Cost Capitalized Subsequent to Acquisition	88
Impairment	0
Cost Basis Adjustment	0
Cost at the end of the period
Land	475
Buildings, Improvements & Equipment	3,456
Total	3,931
Accumulated Depreciation	993
40 Sebethe Drive, Cromwell, CT
Real Estate And Accumulated Depreciation
Encumbrances	0
Initial Cost to Company
Land	570
Buildings, Improvements & Equipment	5,304
Cost Capitalized Subsequent to Acquisition	1,787
Impairment	0
Cost Basis Adjustment	(424)
Cost at the end of the period
Land	596
Buildings, Improvements & Equipment	6,641
Total	7,237
Accumulated Depreciation	1,747
1145 19th Street NW, Washington, DC
Real Estate And Accumulated Depreciation
Encumbrances	0
Initial Cost to Company
Land	13,600
Buildings, Improvements & Equipment	24,880
Cost Capitalized Subsequent to Acquisition	36,435
Impairment	0
Cost Basis Adjustment	(597)
Cost at the end of the period
Land	13,600
Buildings, Improvements & Equipment	60,718
Total	74,318
Accumulated Depreciation	12,553
2141 K Street, NW, Washington, DC
Real Estate And Accumulated Depreciation
Encumbrances	0
Initial Cost to Company
Land	13,700
Buildings, Improvements & Equipment	8,400
Cost Capitalized Subsequent to Acquisition	5,442
Impairment	0
Cost Basis Adjustment	(518)
Cost at the end of the period
Land	13,700
Buildings, Improvements & Equipment	13,324
Total	27,024
Accumulated Depreciation	4,420
255 Possum Park Road, Newark, DE
Real Estate And Accumulated Depreciation
Encumbrances	0
Initial Cost to Company
Land	2,010
Buildings, Improvements & Equipment	11,852
Cost Capitalized Subsequent to Acquisition	8,039
Impairment	0
Cost Basis Adjustment	(1,759)
Cost at the end of the period
Land	2,761
Buildings, Improvements & Equipment	17,381
Total	20,142
Accumulated Depreciation	7,010
4175 Ogletown Stanton Rd, Newark, DE
Real Estate And Accumulated Depreciation
Encumbrances	0
Initial Cost to Company
Land	1,500
Buildings, Improvements & Equipment	19,447
Cost Capitalized Subsequent to Acquisition	1,639
Impairment	0
Cost Basis Adjustment	0
Cost at the end of the period
Land	1,563
Buildings, Improvements & Equipment	21,023
Total	22,586
Accumulated Depreciation	7,180
1212 Foulk Road, Wilmington, DE
Real Estate And Accumulated Depreciation
Encumbrances	0
Initial Cost to Company
Land	1,179
Buildings, Improvements & Equipment	6,950
Cost Capitalized Subsequent to Acquisition	2,603
Impairment	0
Cost Basis Adjustment	(1,310)
Cost at the end of the period
Land	1,202
Buildings, Improvements & Equipment	8,220
Total	9,422
Accumulated Depreciation	3,869
1912 Marsh Road Wilmington, DE
Real Estate And Accumulated Depreciation
Encumbrances	0
Initial Cost to Company
Land	4,365
Buildings, Improvements & Equipment	25,739
Cost Capitalized Subsequent to Acquisition	7,498
Impairment	0
Cost Basis Adjustment	(2,293)
Cost at the end of the period
Land	4,431
Buildings, Improvements & Equipment	30,878
Total	35,309
Accumulated Depreciation	13,640
2723 Shipley Road Wilmington, DE
Real Estate And Accumulated Depreciation
Encumbrances	0
Initial Cost to Company
Land	869
Buildings, Improvements & Equipment	5,126
Cost Capitalized Subsequent to Acquisition	5,327
Impairment	0
Cost Basis Adjustment	(1,726)
Cost at the end of the period
Land	978
Buildings, Improvements & Equipment	8,618
Total	9,596
Accumulated Depreciation	3,729
407 Foulk Road Wilmington, DE
Real Estate And Accumulated Depreciation
Encumbrances	0
Initial Cost to Company
Land	38
Buildings, Improvements & Equipment	227
Cost Capitalized Subsequent to Acquisition	2,763
Impairment	0
Cost Basis Adjustment	(433)
Cost at the end of the period
Land	84
Buildings, Improvements & Equipment	2,511
Total	2,595
Accumulated Depreciation	731
22601 Camino Del Mar, Boca Raton, FL
Real Estate And Accumulated Depreciation
Encumbrances	0
Initial Cost to Company
Land	3,200
Buildings, Improvements & Equipment	46,800
Cost Capitalized Subsequent to Acquisition	7,802
Impairment	0
Cost Basis Adjustment	(1,816)
Cost at the end of the period
Land	3,204
Buildings, Improvements & Equipment	52,782
Total	55,986
Accumulated Depreciation	13,932
1325 S Congress Avenue, Boynton Beach, FL
Real Estate And Accumulated Depreciation
Encumbrances	0
Initial Cost to Company
Land	1,620
Buildings, Improvements & Equipment	5,341
Cost Capitalized Subsequent to Acquisition	1,717
Impairment	0
Cost Basis Adjustment	(121)
Cost at the end of the period
Land	1,628
Buildings, Improvements & Equipment	6,929
Total	8,557
Accumulated Depreciation	1,660
1425 Congress Avenue, Boynton Beach, FL
Real Estate And Accumulated Depreciation
Encumbrances	0
Initial Cost to Company
Land	2,390
Buildings, Improvements & Equipment	14,768
Cost Capitalized Subsequent to Acquisition	3,827
Impairment	0
Cost Basis Adjustment	(721)
Cost at the end of the period
Land	2,390
Buildings, Improvements & Equipment	17,874
Total	20,264
Accumulated Depreciation	5,041
1416 Country Club Blvd, Cape Coral, FL
Real Estate And Accumulated Depreciation
Encumbrances	0
Initial Cost to Company
Land	400
Buildings, Improvements & Equipment	2,907
Cost Capitalized Subsequent to Acquisition	0
Impairment	0
Cost Basis Adjustment	(173)
Cost at the end of the period
Land	400
Buildings, Improvements & Equipment	2,734
Total	3,134
Accumulated Depreciation	1,290
8500 Royal Palm Boulevard, Coral Springs, FL
Real Estate And Accumulated Depreciation
Encumbrances	0
Initial Cost to Company
Land	3,410
Buildings, Improvements & Equipment	20,104
Cost Capitalized Subsequent to Acquisition	32,030
Impairment	0
Cost Basis Adjustment	(3,859)
Cost at the end of the period
Land	3,421
Buildings, Improvements & Equipment	48,264
Total	51,685
Accumulated Depreciation	17,262
1208 South Military Trail, Deerfield Beach, FL
Real Estate And Accumulated Depreciation
Encumbrances	0
Initial Cost to Company
Land	1,690
Buildings, Improvements & Equipment	14,972
Cost Capitalized Subsequent to Acquisition	32,207
Impairment	0
Cost Basis Adjustment	(2,251)
Cost at the end of the period
Land	1,777
Buildings, Improvements & Equipment	44,841
Total	46,618
Accumulated Depreciation	17,974
3001 DC Country Club Boulevard, Deerfield Beach, FL
Real Estate And Accumulated Depreciation
Encumbrances	0
Initial Cost to Company
Land	3,196
Buildings, Improvements & Equipment	18,848
Cost Capitalized Subsequent to Acquisition	22,290
Impairment	0
Cost Basis Adjustment	(2,813)
Cost at the end of the period
Land	3,222
Buildings, Improvements & Equipment	38,299
Total	41,521
Accumulated Depreciation	14,935
12780 Kenwood Lane, Fort Myers, FL
Real Estate And Accumulated Depreciation
Encumbrances	0
Initial Cost to Company
Land	369
Buildings, Improvements & Equipment	2,174
Cost Capitalized Subsequent to Acquisition	3,709
Impairment	0
Cost Basis Adjustment	(444)
Cost at the end of the period
Land	859
Buildings, Improvements & Equipment	4,949
Total	5,808
Accumulated Depreciation	2,054
2525 First Street, Fort Myers, FL
Real Estate And Accumulated Depreciation
Encumbrances	0
Initial Cost to Company
Land	2,385
Buildings, Improvements & Equipment	21,137
Cost Capitalized Subsequent to Acquisition	23,381
Impairment	0
Cost Basis Adjustment	(1,322)
Cost at the end of the period
Land	2,577
Buildings, Improvements & Equipment	43,004
Total	45,581
Accumulated Depreciation	20,860
1825 Ridgewood Avenue, Holly Hill, FL
Real Estate And Accumulated Depreciation
Encumbrances	0
Initial Cost to Company
Land	700
Buildings, Improvements & Equipment	16,700
Cost Capitalized Subsequent to Acquisition	3,261
Impairment	(2,636)
Cost Basis Adjustment	(4,649)
Cost at the end of the period
Land	684
Buildings, Improvements & Equipment	12,692
Total	13,376
Accumulated Depreciation	1,640
2480 North Park Road, Hollywood, FL
Real Estate And Accumulated Depreciation
Encumbrances	0
Initial Cost to Company
Land	4,500
Buildings, Improvements & Equipment	40,500
Cost Capitalized Subsequent to Acquisition	19,755
Impairment	0
Cost Basis Adjustment	(1,637)
Cost at the end of the period
Land	4,556
Buildings, Improvements & Equipment	58,562
Total	63,118
Accumulated Depreciation	15,903
8901 Tamiami Trail East, Naples, FL
Real Estate And Accumulated Depreciation
Encumbrances	0
Initial Cost to Company
Land	3,200
Buildings, Improvements & Equipment	2,898
Cost Capitalized Subsequent to Acquisition	15,068
Impairment	0
Cost Basis Adjustment	(837)
Cost at the end of the period
Land	3,200
Buildings, Improvements & Equipment	17,129
Total	20,329
Accumulated Depreciation	5,631
12780 Waterford Lakes Parkway, Orlando, FL
Real Estate And Accumulated Depreciation
Encumbrances	0
Initial Cost to Company
Land	977
Buildings, Improvements & Equipment	3,946
Cost Capitalized Subsequent to Acquisition	579
Impairment	0
Cost Basis Adjustment	0
Cost at the end of the period
Land	1,052
Buildings, Improvements & Equipment	4,450
Total	5,502
Accumulated Depreciation	854
1603 S. Hiawassee Road, Orlando, FL
Real Estate And Accumulated Depreciation
Encumbrances	0
Initial Cost to Company
Land	488
Buildings, Improvements & Equipment	2,621
Cost Capitalized Subsequent to Acquisition	352
Impairment	0
Cost Basis Adjustment	(81)
Cost at the end of the period
Land	488
Buildings, Improvements & Equipment	2,892
Total	3,380
Accumulated Depreciation	569
1825 N. Mills Avenue, Orlando, FL
Real Estate And Accumulated Depreciation
Encumbrances	0
Initial Cost to Company
Land	519
Buildings, Improvements & Equipment	1,799
Cost Capitalized Subsequent to Acquisition	415
Impairment	0
Cost Basis Adjustment	0
Cost at the end of the period
Land	580
Buildings, Improvements & Equipment	2,153
Total	2,733
Accumulated Depreciation	763
1911 N. Mills Avenue, Orlando, FL
Real Estate And Accumulated Depreciation
Encumbrances	0
Initial Cost to Company
Land	1,946
Buildings, Improvements & Equipment	7,197
Cost Capitalized Subsequent to Acquisition	866
Impairment	0
Cost Basis Adjustment	(538)
Cost at the end of the period
Land	2,042
Buildings, Improvements & Equipment	7,429
Total	9,471
Accumulated Depreciation	2,386
1925 N. Mills Avenue, Orlando, FL
Real Estate And Accumulated Depreciation
Encumbrances	0
Initial Cost to Company
Land	135
Buildings, Improvements & Equipment	532
Cost Capitalized Subsequent to Acquisition	252
Impairment	0
Cost Basis Adjustment	0
Cost at the end of the period
Land	199
Buildings, Improvements & Equipment	720
Total	919
Accumulated Depreciation	292
250 N. Alafaya Trail, Orlando, FL
Real Estate And Accumulated Depreciation
Encumbrances	0
Initial Cost to Company
Land	967
Buildings, Improvements & Equipment	4,362
Cost Capitalized Subsequent to Acquisition	389
Impairment	0
Cost Basis Adjustment	0
Cost at the end of the period
Land	967
Buildings, Improvements & Equipment	4,751
Total	5,718
Accumulated Depreciation	979
45 Katherine Boulevard, Palm Harbor, FL
Real Estate And Accumulated Depreciation
Encumbrances	0
Initial Cost to Company
Land	3,379
Buildings, Improvements & Equipment	29,945
Cost Capitalized Subsequent to Acquisition	9,045
Impairment	0
Cost Basis Adjustment	(816)
Cost at the end of the period
Land	3,392
Buildings, Improvements & Equipment	38,161
Total	41,553
Accumulated Depreciation	24,079
900 West Lake Road, Palm Harbor, FL
Real Estate And Accumulated Depreciation
Encumbrances	0
Initial Cost to Company
Land	3,449
Buildings, Improvements & Equipment	20,336
Cost Capitalized Subsequent to Acquisition	11,916
Impairment	0
Cost Basis Adjustment	(3,160)
Cost at the end of the period
Land	3,493
Buildings, Improvements & Equipment	29,048
Total	32,541
Accumulated Depreciation	12,465
8500 West Sunrise Boulevard, Plantation, FL
Real Estate And Accumulated Depreciation
Encumbrances	0
Initial Cost to Company
Land	4,700
Buildings, Improvements & Equipment	24,300
Cost Capitalized Subsequent to Acquisition	10,999
Impairment	0
Cost Basis Adjustment	(2,475)
Cost at the end of the period
Land	4,717
Buildings, Improvements & Equipment	32,807
Total	37,524
Accumulated Depreciation	9,850
1371 South Ocean Boulevard, Pompano Beach, FL
Real Estate And Accumulated Depreciation
Encumbrances	0
Initial Cost to Company
Land	2,500
Buildings, Improvements & Equipment	15,500
Cost Capitalized Subsequent to Acquisition	15,927
Impairment	0
Cost Basis Adjustment	(1,564)
Cost at the end of the period
Land	2,560
Buildings, Improvements & Equipment	29,803
Total	32,363
Accumulated Depreciation	8,891
2701 North Course Drive, Pompano Beach, FL
Real Estate And Accumulated Depreciation
Encumbrances	0
Initial Cost to Company
Land	7,700
Buildings, Improvements & Equipment	2,127
Cost Capitalized Subsequent to Acquisition	41,511
Impairment	0
Cost Basis Adjustment	(2,332)
Cost at the end of the period
Land	7,700
Buildings, Improvements & Equipment	41,306
Total	49,006
Accumulated Depreciation	14,027
20480 Veterans Boulevard, Port Charlotte, FL
Real Estate And Accumulated Depreciation
Encumbrances	0
Initial Cost to Company
Land	400
Buildings, Improvements & Equipment	11,934
Cost Capitalized Subsequent to Acquisition	2,107
Impairment	0
Cost Basis Adjustment	(550)
Cost at the end of the period
Land	440
Buildings, Improvements & Equipment	13,451
Total	13,891
Accumulated Depreciation	4,090
1699 S.E. Lyngate Drive, Port St. Lucie, FL
Real Estate And Accumulated Depreciation
Encumbrances	0
Initial Cost to Company
Land	1,242
Buildings, Improvements & Equipment	11,009
Cost Capitalized Subsequent to Acquisition	4,799
Impairment	0
Cost Basis Adjustment	(269)
Cost at the end of the period
Land	1,249
Buildings, Improvements & Equipment	15,532
Total	16,781
Accumulated Depreciation	9,152
501 N.W. Cashmere Boulevard, Port St. Lucie, FL
Real Estate And Accumulated Depreciation
Encumbrances	0
Initial Cost to Company
Land	890
Buildings, Improvements & Equipment	9,345
Cost Capitalized Subsequent to Acquisition	2,911
Impairment	0
Cost Basis Adjustment	(135)
Cost at the end of the period
Land	1,673
Buildings, Improvements & Equipment	11,338
Total	13,011
Accumulated Depreciation	3,142
900 South Harbour Island Blvd, Tampa, FL
Real Estate And Accumulated Depreciation
Encumbrances	0
Initial Cost to Company
Land	4,850
Buildings, Improvements & Equipment	6,349
Cost Capitalized Subsequent to Acquisition	7
Impairment	0
Cost Basis Adjustment	0
Cost at the end of the period
Land	4,850
Buildings, Improvements & Equipment	6,356
Total	11,206
Accumulated Depreciation	2,257
111 Executive Center Drive, West Palm Beach, FL
Real Estate And Accumulated Depreciation
Encumbrances	0
Initial Cost to Company
Land	2,061
Buildings, Improvements & Equipment	12,153
Cost Capitalized Subsequent to Acquisition	20,856
Impairment	0
Cost Basis Adjustment	(2,982)
Cost at the end of the period
Land	2,075
Buildings, Improvements & Equipment	30,013
Total	32,088
Accumulated Depreciation	10,227
2351 Cedarcrest Road, Acworth, GA
Real Estate And Accumulated Depreciation
Encumbrances	0
Initial Cost to Company
Land	2,000
Buildings, Improvements & Equipment	6,674
Cost Capitalized Subsequent to Acquisition	618
Impairment	0
Cost Basis Adjustment	0
Cost at the end of the period
Land	2,000
Buildings, Improvements & Equipment	7,292
Total	9,292
Accumulated Depreciation	1,363
1200 Bluegrass Lakes Parkway, Alpharetta, GA
Real Estate And Accumulated Depreciation
Encumbrances	0
Initial Cost to Company
Land	1,689
Buildings, Improvements & Equipment	15,936
Cost Capitalized Subsequent to Acquisition	142
Impairment	0
Cost Basis Adjustment	0
Cost at the end of the period
Land	1,761
Buildings, Improvements & Equipment	16,006
Total	17,767
Accumulated Depreciation	2,762
855 North Point Pkwy, Alpharetta, GA
Real Estate And Accumulated Depreciation
Encumbrances	0
Initial Cost to Company
Land	5,390
Buildings, Improvements & Equipment	26,712
Cost Capitalized Subsequent to Acquisition	0
Impairment	0
Cost Basis Adjustment	0
Cost at the end of the period
Land	5,390
Buildings, Improvements & Equipment	26,712
Total	32,102
Accumulated Depreciation	8,931
253 N. Main Street, Alpharetta, GA
Real Estate And Accumulated Depreciation
Encumbrances	0
Initial Cost to Company
Land	1,325
Buildings, Improvements & Equipment	12,377
Cost Capitalized Subsequent to Acquisition	1,170
Impairment	0
Cost Basis Adjustment	(64)
Cost at the end of the period
Land	1,221
Buildings, Improvements & Equipment	13,587
Total	14,808
Accumulated Depreciation	2,591
1291 Cedar Shoals Drive, Athens, GA
Real Estate And Accumulated Depreciation
Encumbrances	0
Initial Cost to Company
Land	337
Buildings, Improvements & Equipment	4,006
Cost Capitalized Subsequent to Acquisition	1,615
Impairment	0
Cost Basis Adjustment	(290)
Cost at the end of the period
Land	368
Buildings, Improvements & Equipment	5,300
Total	5,668
Accumulated Depreciation	1,918
1515 Sheridan Road, Atlanta, GA
Real Estate And Accumulated Depreciation
Encumbrances	0
Initial Cost to Company
Land	5,800
Buildings, Improvements & Equipment	9,305
Cost Capitalized Subsequent to Acquisition	3
Impairment	0
Cost Basis Adjustment	0
Cost at the end of the period
Land	5,800
Buildings, Improvements & Equipment	9,308
Total	15,108
Accumulated Depreciation	3,286
240 Marietta Highway, Canton, GA
Real Estate And Accumulated Depreciation
Encumbrances	0
Initial Cost to Company
Land	806
Buildings, Improvements & Equipment	8,555
Cost Capitalized Subsequent to Acquisition	2,397
Impairment	0
Cost Basis Adjustment	(55)
Cost at the end of the period
Land	806
Buildings, Improvements & Equipment	10,897
Total	11,703
Accumulated Depreciation	2,510
4500 South Stadium Drive, Columbus, GA
Real Estate And Accumulated Depreciation
Encumbrances	0
Initial Cost to Company
Land	294
Buildings, Improvements & Equipment	3,505
Cost Capitalized Subsequent to Acquisition	946
Impairment	0
Cost Basis Adjustment	(225)
Cost at the end of the period
Land	298
Buildings, Improvements & Equipment	4,222
Total	4,520
Accumulated Depreciation	1,550
Wellbrook Circle 1352 Conyers GA 1 [Member]
Real Estate And Accumulated Depreciation
Encumbrances	0
Initial Cost to Company
Land	342
Buildings, Improvements & Equipment	4,068
Cost Capitalized Subsequent to Acquisition	1,769
Impairment	(1,366)
Cost Basis Adjustment	(2,032)
Cost at the end of the period
Land	206
Buildings, Improvements & Equipment	2,575
Total	2,781
Accumulated Depreciation	70
1501 Milstead Road, Conyers, GA
Real Estate And Accumulated Depreciation
Encumbrances	0
Initial Cost to Company
Land	750
Buildings, Improvements & Equipment	7,796
Cost Capitalized Subsequent to Acquisition	712
Impairment	0
Cost Basis Adjustment	0
Cost at the end of the period
Land	777
Buildings, Improvements & Equipment	8,481
Total	9,258
Accumulated Depreciation	2,498
3875 Post Road, Cumming, GA
Real Estate And Accumulated Depreciation
Encumbrances	0
Initial Cost to Company
Land	954
Buildings, Improvements & Equipment	12,796
Cost Capitalized Subsequent to Acquisition	248
Impairment	0
Cost Basis Adjustment	0
Cost at the end of the period
Land	960
Buildings, Improvements & Equipment	13,038
Total	13,998
Accumulated Depreciation	2,638
4960 Jot Em Down Road, Cumming, GA
Real Estate And Accumulated Depreciation
Encumbrances	0
Initial Cost to Company
Land	1,548
Buildings, Improvements & Equipment	18,666
Cost Capitalized Subsequent to Acquisition	13,033
Impairment	0
Cost Basis Adjustment	(257)
Cost at the end of the period
Land	3,416
Buildings, Improvements & Equipment	29,574
Total	32,990
Accumulated Depreciation	6,913
5610 Hampton Park Dr., Cumming, GA
Real Estate And Accumulated Depreciation
Encumbrances	0
Initial Cost to Company
Land	3,479
Buildings, Improvements & Equipment	14,771
Cost Capitalized Subsequent to Acquisition	233
Impairment	0
Cost Basis Adjustment	0
Cost at the end of the period
Land	3,481
Buildings, Improvements & Equipment	15,002
Total	18,483
Accumulated Depreciation	3,071
7955 Majors Road, Cumming, GA
Real Estate And Accumulated Depreciation
Encumbrances	0
Initial Cost to Company
Land	1,325
Buildings, Improvements & Equipment	7,770
Cost Capitalized Subsequent to Acquisition	904
Impairment	0
Cost Basis Adjustment	0
Cost at the end of the period
Land	1,325
Buildings, Improvements & Equipment	8,674
Total	9,999
Accumulated Depreciation	1,645
2470 Dug Gap Road, Dalton, GA
Real Estate And Accumulated Depreciation
Encumbrances	0
Initial Cost to Company
Land	262
Buildings, Improvements & Equipment	3,119
Cost Capitalized Subsequent to Acquisition	1,285
Impairment	0
Cost Basis Adjustment	(133)
Cost at the end of the period
Land	262
Buildings, Improvements & Equipment	4,271
Total	4,533
Accumulated Depreciation	1,515
101 West Ponce De Leon Avenue, Decatur, GA
Real Estate And Accumulated Depreciation
Encumbrances	0
Initial Cost to Company
Land	3,500
Buildings, Improvements & Equipment	13,179
Cost Capitalized Subsequent to Acquisition	2,145
Impairment	0
Cost Basis Adjustment	0
Cost at the end of the period
Land	3,500
Buildings, Improvements & Equipment	15,324
Total	18,824
Accumulated Depreciation	3,185
2801 N. Decatur Road, Decatur, GA
Real Estate And Accumulated Depreciation
Encumbrances	0
Initial Cost to Company
Land	3,100
Buildings, Improvements & Equipment	4,436
Cost Capitalized Subsequent to Acquisition	2,533
Impairment	0
Cost Basis Adjustment	0
Cost at the end of the period
Land	3,260
Buildings, Improvements & Equipment	6,809
Total	10,069
Accumulated Depreciation	2,148
114 Penland Street, Ellijay, GA
Real Estate And Accumulated Depreciation
Encumbrances	0
Initial Cost to Company
Land	496
Buildings, Improvements & Equipment	7,107
Cost Capitalized Subsequent to Acquisition	1,455
Impairment	0
Cost Basis Adjustment	(157)
Cost at the end of the period
Land	496
Buildings, Improvements & Equipment	8,405
Total	8,901
Accumulated Depreciation	1,765
353 North Belair Road, Evans, GA
Real Estate And Accumulated Depreciation
Encumbrances	0
Initial Cost to Company
Land	230
Buildings, Improvements & Equipment	2,663
Cost Capitalized Subsequent to Acquisition	1,326
Impairment	0
Cost Basis Adjustment	(244)
Cost at the end of the period
Land	230
Buildings, Improvements & Equipment	3,745
Total	3,975
Accumulated Depreciation	1,333
1294 Highway 54 West, Fayetteville, GA
Real Estate And Accumulated Depreciation
Encumbrances	0
Initial Cost to Company
Land	853
Buildings, Improvements & Equipment	9,903
Cost Capitalized Subsequent to Acquisition	1,324
Impairment	0
Cost Basis Adjustment	0
Cost at the end of the period
Land	943
Buildings, Improvements & Equipment	11,137
Total	12,080
Accumulated Depreciation	2,170
2435 Limestone Parkway, Gainesville, GA
Real Estate And Accumulated Depreciation
Encumbrances	0
Initial Cost to Company
Land	268
Buildings, Improvements & Equipment	3,186
Cost Capitalized Subsequent to Acquisition	1,621
Impairment	0
Cost Basis Adjustment	(224)
Cost at the end of the period
Land	268
Buildings, Improvements & Equipment	4,583
Total	4,851
Accumulated Depreciation	1,585
3315 Thompson Bridge Road, Gainesville, GA
Real Estate And Accumulated Depreciation
Encumbrances	0
Initial Cost to Company
Land	934
Buildings, Improvements & Equipment	30,962
Cost Capitalized Subsequent to Acquisition	1,937
Impairment	0
Cost Basis Adjustment	0
Cost at the end of the period
Land	956
Buildings, Improvements & Equipment	32,877
Total	33,833
Accumulated Depreciation	6,319
5373 Thompson Mill Road, Hoschton, GA
Real Estate And Accumulated Depreciation
Encumbrances	0
Initial Cost to Company
Land	944
Buildings, Improvements & Equipment	12,171
Cost Capitalized Subsequent to Acquisition	216
Impairment	0
Cost Basis Adjustment	0
Cost at the end of the period
Land	959
Buildings, Improvements & Equipment	12,372
Total	13,331
Accumulated Depreciation	2,404
8080 Summit Business Parkway, Jonesboro, GA
Real Estate And Accumulated Depreciation
Encumbrances	0
Initial Cost to Company
Land	1,800
Buildings, Improvements & Equipment	20,664
Cost Capitalized Subsequent to Acquisition	4,460
Impairment	0
Cost Basis Adjustment	(456)
Cost at the end of the period
Land	1,800
Buildings, Improvements & Equipment	24,668
Total	26,468
Accumulated Depreciation	7,010
Peake Road 6191 Macon GA 1 [Member]
Real Estate And Accumulated Depreciation
Encumbrances	0
Initial Cost to Company
Land	183
Buildings, Improvements & Equipment	2,179
Cost Capitalized Subsequent to Acquisition	1,329
Impairment	(848)
Cost Basis Adjustment	(1,142)
Cost at the end of the period
Land	110
Buildings, Improvements & Equipment	1,591
Total	1,701
Accumulated Depreciation	47
1360 Upper Hembree Road, Roswell, GA
Real Estate And Accumulated Depreciation
Encumbrances	0
Initial Cost to Company
Land	1,080
Buildings, Improvements & Equipment	6,138
Cost Capitalized Subsequent to Acquisition	752
Impairment	0
Cost Basis Adjustment	0
Cost at the end of the period
Land	1,067
Buildings, Improvements & Equipment	6,903
Total	7,970
Accumulated Depreciation	1,555
1 Savannah Square Drive 1 [Member]
Real Estate And Accumulated Depreciation
Encumbrances	0
Initial Cost to Company
Land	1,200
Buildings, Improvements & Equipment	19,090
Cost Capitalized Subsequent to Acquisition	7,990
Impairment	(6,993)
Cost Basis Adjustment	(8,926)
Cost at the end of the period
Land	835
Buildings, Improvements & Equipment	11,526
Total	12,361
Accumulated Depreciation	510
5200 Habersham Street, Savannah, GA
Real Estate And Accumulated Depreciation
Encumbrances	0
Initial Cost to Company
Land	800
Buildings, Improvements & Equipment	7,800
Cost Capitalized Subsequent to Acquisition	2,096
Impairment	(3,082)
Cost Basis Adjustment	(2,627)
Cost at the end of the period
Land	476
Buildings, Improvements & Equipment	4,511
Total	4,987
Accumulated Depreciation	100
Skidaway Road7410 Savannah G A 1 [Member]
Real Estate And Accumulated Depreciation
Encumbrances	0
Initial Cost to Company
Land	400
Buildings, Improvements & Equipment	5,670
Cost Capitalized Subsequent to Acquisition	1,957
Impairment	(1,870)
Cost Basis Adjustment	(2,626)
Cost at the end of the period
Land	252
Buildings, Improvements & Equipment	3,279
Total	3,531
Accumulated Depreciation	106
2078 Scenic Highway North, Snellville, GA
Real Estate And Accumulated Depreciation
Encumbrances	0
Initial Cost to Company
Land	870
Buildings, Improvements & Equipment	4,030
Cost Capitalized Subsequent to Acquisition	1,517
Impairment	0
Cost Basis Adjustment	(256)
Cost at the end of the period
Land	870
Buildings, Improvements & Equipment	5,291
Total	6,161
Accumulated Depreciation	1,318
475 Country Club Drive, Stockbridge, GA
Real Estate And Accumulated Depreciation
Encumbrances	0
Initial Cost to Company
Land	512
Buildings, Improvements & Equipment	9,560
Cost Capitalized Subsequent to Acquisition	1,047
Impairment	0
Cost Basis Adjustment	0
Cost at the end of the period
Land	551
Buildings, Improvements & Equipment	10,568
Total	11,119
Accumulated Depreciation	2,097
1300 Montreal Road, Tucker, GA
Real Estate And Accumulated Depreciation
Encumbrances	0
Initial Cost to Company
Land	690
Buildings, Improvements & Equipment	6,210
Cost Capitalized Subsequent to Acquisition	2,142
Impairment	0
Cost Basis Adjustment	(469)
Cost at the end of the period
Land	694
Buildings, Improvements & Equipment	7,879
Total	8,573
Accumulated Depreciation	2,776
1100 Ward Avenue, Honolulu, HI
Real Estate And Accumulated Depreciation
Encumbrances	0
Initial Cost to Company
Land	11,200
Buildings, Improvements & Equipment	55,618
Cost Capitalized Subsequent to Acquisition	7,232
Impairment	0
Cost Basis Adjustment	(71)
Cost at the end of the period
Land	11,247
Buildings, Improvements & Equipment	62,732
Total	73,979
Accumulated Depreciation	15,341
2340 West Seltice Way, Coeur d'Alene, ID
Real Estate And Accumulated Depreciation
Encumbrances	0
Initial Cost to Company
Land	910
Buildings, Improvements & Equipment	7,170
Cost Capitalized Subsequent to Acquisition	3,360
Impairment	0
Cost Basis Adjustment	0
Cost at the end of the period
Land	1,052
Buildings, Improvements & Equipment	10,388
Total	11,440
Accumulated Depreciation	2,826
850 Lincoln Drive, Idaho Falls, ID
Real Estate And Accumulated Depreciation
Encumbrances	0
Initial Cost to Company
Land	510
Buildings, Improvements & Equipment	6,640
Cost Capitalized Subsequent to Acquisition	2,970
Impairment	0
Cost Basis Adjustment	0
Cost at the end of the period
Land	760
Buildings, Improvements & Equipment	9,360
Total	10,120
Accumulated Depreciation	2,484
1250 West Central Road, Arlington Heights, IL
Real Estate And Accumulated Depreciation
Encumbrances	0
Initial Cost to Company
Land	3,665
Buildings, Improvements & Equipment	32,587
Cost Capitalized Subsequent to Acquisition	10,441
Impairment	0
Cost Basis Adjustment	(385)
Cost at the end of the period
Land	3,781
Buildings, Improvements & Equipment	42,527
Total	46,308
Accumulated Depreciation	26,487
1450 Busch Parkway, Buffalo Grove, IL
Real Estate And Accumulated Depreciation
Encumbrances	0
Initial Cost to Company
Land	3,800
Buildings, Improvements & Equipment	11,456
Cost Capitalized Subsequent to Acquisition	929
Impairment	0
Cost Basis Adjustment	0
Cost at the end of the period
Land	3,815
Buildings, Improvements & Equipment	12,370
Total	16,185
Accumulated Depreciation	3,548
2601 Patriot Boulevard, Glenview, IL
Real Estate And Accumulated Depreciation
Encumbrances	0
Initial Cost to Company
Land	2,285
Buildings, Improvements & Equipment	9,593
Cost Capitalized Subsequent to Acquisition	0
Impairment	0
Cost Basis Adjustment	0
Cost at the end of the period
Land	2,285
Buildings, Improvements & Equipment	9,593
Total	11,878
Accumulated Depreciation	1,659
1373 D'Ardian Professional Park, Godfrey, IL
Real Estate And Accumulated Depreciation
Encumbrances	0
Initial Cost to Company
Land	281
Buildings, Improvements & Equipment	15,088
Cost Capitalized Subsequent to Acquisition	731
Impairment	0
Cost Basis Adjustment	(135)
Cost at the end of the period
Land	281
Buildings, Improvements & Equipment	15,684
Total	15,965
Accumulated Depreciation	3,020
900 43rd Avenue, Moline, IL
Real Estate And Accumulated Depreciation
Encumbrances	0
Initial Cost to Company
Land	482
Buildings, Improvements & Equipment	7,651
Cost Capitalized Subsequent to Acquisition	573
Impairment	0
Cost Basis Adjustment	(76)
Cost at the end of the period
Land	482
Buildings, Improvements & Equipment	8,148
Total	8,630
Accumulated Depreciation	1,515
221 11th Avenue, Moline, IL
Real Estate And Accumulated Depreciation
Encumbrances	0
Initial Cost to Company
Land	161
Buildings, Improvements & Equipment	7,244
Cost Capitalized Subsequent to Acquisition	1,513
Impairment	0
Cost Basis Adjustment	0
Cost at the end of the period
Land	161
Buildings, Improvements & Equipment	8,757
Total	8,918
Accumulated Depreciation	1,713
2700 14th Street, Pekin, IL
Real Estate And Accumulated Depreciation
Encumbrances	0
Initial Cost to Company
Land	171
Buildings, Improvements & Equipment	11,475
Cost Capitalized Subsequent to Acquisition	554
Impairment	0
Cost Basis Adjustment	(159)
Cost at the end of the period
Land	172
Buildings, Improvements & Equipment	11,869
Total	12,041
Accumulated Depreciation	2,277
7130 Crimson Ridge Drive, Rockford, IL
Real Estate And Accumulated Depreciation
Encumbrances	0
Initial Cost to Company
Land	200
Buildings, Improvements & Equipment	7,300
Cost Capitalized Subsequent to Acquisition	2,336
Impairment	0
Cost Basis Adjustment	0
Cost at the end of the period
Land	1,596
Buildings, Improvements & Equipment	8,240
Total	9,836
Accumulated Depreciation	2,352
1220 Lakeview Drive, Romeoville, IL
Real Estate And Accumulated Depreciation
Encumbrances	0
Initial Cost to Company
Land	1,120
Buildings, Improvements & Equipment	19,582
Cost Capitalized Subsequent to Acquisition	(61)
Impairment	0
Cost Basis Adjustment	0
Cost at the end of the period
Land	1,058
Buildings, Improvements & Equipment	19,583
Total	20,641
Accumulated Depreciation	6,547
1201 Hartman Lane, Shiloh, IL
Real Estate And Accumulated Depreciation
Encumbrances	0
Initial Cost to Company
Land	743
Buildings, Improvements & Equipment	7,232
Cost Capitalized Subsequent to Acquisition	2,113
Impairment	0
Cost Basis Adjustment	0
Cost at the end of the period
Land	1,237
Buildings, Improvements & Equipment	8,851
Total	10,088
Accumulated Depreciation	1,461
900 Southwind Road, Springfield, IL
Real Estate And Accumulated Depreciation
Encumbrances	0
Initial Cost to Company
Land	300
Buildings, Improvements & Equipment	6,744
Cost Capitalized Subsequent to Acquisition	2,304
Impairment	0
Cost Basis Adjustment	(403)
Cost at the end of the period
Land	300
Buildings, Improvements & Equipment	8,645
Total	8,945
Accumulated Depreciation	3,052
2705 Avenue E, Sterling, IL
Real Estate And Accumulated Depreciation
Encumbrances	0
Initial Cost to Company
Land	341
Buildings, Improvements & Equipment	14,331
Cost Capitalized Subsequent to Acquisition	638
Impairment	0
Cost Basis Adjustment	0
Cost at the end of the period
Land	343
Buildings, Improvements & Equipment	14,967
Total	15,310
Accumulated Depreciation	2,951
39 Dorothy Drive, Troy, IL
Real Estate And Accumulated Depreciation
Encumbrances	0
Initial Cost to Company
Land	1,002
Buildings, Improvements & Equipment	7,010
Cost Capitalized Subsequent to Acquisition	1,577
Impairment	0
Cost Basis Adjustment	0
Cost at the end of the period
Land	1,002
Buildings, Improvements & Equipment	8,587
Total	9,589
Accumulated Depreciation	1,416
100 Grand Victorian Place, Washington, IL
Real Estate And Accumulated Depreciation
Encumbrances	0
Initial Cost to Company
Land	241
Buildings, Improvements & Equipment	12,046
Cost Capitalized Subsequent to Acquisition	416
Impairment	0
Cost Basis Adjustment	0
Cost at the end of the period
Land	241
Buildings, Improvements & Equipment	12,462
Total	12,703
Accumulated Depreciation	2,360
1615 Lakeside Drive, Waukegan, IL
Real Estate And Accumulated Depreciation
Encumbrances	0
Initial Cost to Company
Land	2,700
Buildings, Improvements & Equipment	9,590
Cost Capitalized Subsequent to Acquisition	3,139
Impairment	0
Cost Basis Adjustment	(944)
Cost at the end of the period
Land	3,478
Buildings, Improvements & Equipment	11,007
Total	14,485
Accumulated Depreciation	2,967
1675 Lakeside Drive, Waukegan, IL
Real Estate And Accumulated Depreciation
Encumbrances	0
Initial Cost to Company
Land	2,420
Buildings, Improvements & Equipment	9,382
Cost Capitalized Subsequent to Acquisition	2,589
Impairment	0
Cost Basis Adjustment	(957)
Cost at the end of the period
Land	2,873
Buildings, Improvements & Equipment	10,561
Total	13,434
Accumulated Depreciation	2,785
406 Smith Drive, Auburn, IN
Real Estate And Accumulated Depreciation
Encumbrances	0
Initial Cost to Company
Land	380
Buildings, Improvements & Equipment	8,246
Cost Capitalized Subsequent to Acquisition	631
Impairment	0
Cost Basis Adjustment	(253)
Cost at the end of the period
Land	524
Buildings, Improvements & Equipment	8,480
Total	9,004
Accumulated Depreciation	2,766
6990 East County Road 100 North, Avon, IN
Real Estate And Accumulated Depreciation
Encumbrances	0
Initial Cost to Company
Land	850
Buildings, Improvements & Equipment	11,888
Cost Capitalized Subsequent to Acquisition	1,082
Impairment	0
Cost Basis Adjustment	(333)
Cost at the end of the period
Land	850
Buildings, Improvements & Equipment	12,637
Total	13,487
Accumulated Depreciation	4,082
2455 Tamarack Trail, Bloomington, IN
Real Estate And Accumulated Depreciation
Encumbrances	0
Initial Cost to Company
Land	5,400
Buildings, Improvements & Equipment	25,129
Cost Capitalized Subsequent to Acquisition	30,110
Impairment	0
Cost Basis Adjustment	(529)
Cost at the end of the period
Land	6,339
Buildings, Improvements & Equipment	53,771
Total	60,110
Accumulated Depreciation	13,131
2460 Glebe Street, Carmel IN
Real Estate And Accumulated Depreciation
Encumbrances	0
Initial Cost to Company
Land	2,108
Buildings, Improvements & Equipment	57,741
Cost Capitalized Subsequent to Acquisition	1,106
Impairment	0
Cost Basis Adjustment	0
Cost at the end of the period
Land	2,125
Buildings, Improvements & Equipment	58,830
Total	60,955
Accumulated Depreciation	10,932
701 East County Line Road, Greenwood, IN
Real Estate And Accumulated Depreciation
Encumbrances	0
Initial Cost to Company
Land	1,830
Buildings, Improvements & Equipment	14,303
Cost Capitalized Subsequent to Acquisition	1,304
Impairment	0
Cost Basis Adjustment	(61)
Cost at the end of the period
Land	1,875
Buildings, Improvements & Equipment	15,501
Total	17,376
Accumulated Depreciation	4,094
8505 Woodfield Crossing Boulevard, Indianapolis, IN
Real Estate And Accumulated Depreciation
Encumbrances	0
Initial Cost to Company
Land	2,785
Buildings, Improvements & Equipment	16,396
Cost Capitalized Subsequent to Acquisition	7,084
Impairment	0
Cost Basis Adjustment	(2,127)
Cost at the end of the period
Land	2,838
Buildings, Improvements & Equipment	21,300
Total	24,138
Accumulated Depreciation	9,651
2501 Friendship Boulevard, Kokomo, IN
Real Estate And Accumulated Depreciation
Encumbrances	0
Initial Cost to Company
Land	512
Buildings, Improvements & Equipment	13,009
Cost Capitalized Subsequent to Acquisition	1,081
Impairment	0
Cost Basis Adjustment	0
Cost at the end of the period
Land	512
Buildings, Improvements & Equipment	14,090
Total	14,602
Accumulated Depreciation	1,725
603 Saint Joseph Drive, Kokomo, IN
Real Estate And Accumulated Depreciation
Encumbrances	0
Initial Cost to Company
Land	220
Buildings, Improvements & Equipment	5,899
Cost Capitalized Subsequent to Acquisition	1,223
Impairment	0
Cost Basis Adjustment	(256)
Cost at the end of the period
Land	220
Buildings, Improvements & Equipment	6,866
Total	7,086
Accumulated Depreciation	2,139
1211 Longwood Drive, La Porte, IN
Real Estate And Accumulated Depreciation
Encumbrances	0
Initial Cost to Company
Land	770
Buildings, Improvements & Equipment	5,550
Cost Capitalized Subsequent to Acquisition	1,478
Impairment	0
Cost Basis Adjustment	(288)
Cost at the end of the period
Land	923
Buildings, Improvements & Equipment	6,587
Total	7,510
Accumulated Depreciation	2,026
1590 West Timberview Drive, Marion, IN
Real Estate And Accumulated Depreciation
Encumbrances	0
Initial Cost to Company
Land	410
Buildings, Improvements & Equipment	5,409
Cost Capitalized Subsequent to Acquisition	1,476
Impairment	0
Cost Basis Adjustment	(267)
Cost at the end of the period
Land	410
Buildings, Improvements & Equipment	6,618
Total	7,028
Accumulated Depreciation	1,915
1473 East McKay Road, Shelbyville, IN
Real Estate And Accumulated Depreciation
Encumbrances	0
Initial Cost to Company
Land	190
Buildings, Improvements & Equipment	5,328
Cost Capitalized Subsequent to Acquisition	635
Impairment	0
Cost Basis Adjustment	(236)
Cost at the end of the period
Land	190
Buildings, Improvements & Equipment	5,727
Total	5,917
Accumulated Depreciation	1,801
17441 State Rd. 23, South Bend, IN
Real Estate And Accumulated Depreciation
Encumbrances	0
Initial Cost to Company
Land	400
Buildings, Improvements & Equipment	3,107
Cost Capitalized Subsequent to Acquisition	(38)
Impairment	0
Cost Basis Adjustment	(182)
Cost at the end of the period
Land	363
Buildings, Improvements & Equipment	2,924
Total	3,287
Accumulated Depreciation	1,380
222 South 25th Street, Terra Haute, IN
Real Estate And Accumulated Depreciation
Encumbrances	0
Initial Cost to Company
Land	300
Buildings, Improvements & Equipment	13,115
Cost Capitalized Subsequent to Acquisition	1,157
Impairment	0
Cost Basis Adjustment	(492)
Cost at the end of the period
Land	300
Buildings, Improvements & Equipment	13,780
Total	14,080
Accumulated Depreciation	4,445
150 Fox Ridge Drive, Vincennes, IN
Real Estate And Accumulated Depreciation
Encumbrances	0
Initial Cost to Company
Land	110
Buildings, Improvements & Equipment	3,603
Cost Capitalized Subsequent to Acquisition	1,820
Impairment	0
Cost Basis Adjustment	(208)
Cost at the end of the period
Land	110
Buildings, Improvements & Equipment	5,215
Total	5,325
Accumulated Depreciation	1,722
1501 Inverness Drive, Lawrence, KS
Real Estate And Accumulated Depreciation
Encumbrances	0
Initial Cost to Company
Land	1,600
Buildings, Improvements & Equipment	18,565
Cost Capitalized Subsequent to Acquisition	3,457
Impairment	0
Cost Basis Adjustment	(1,232)
Cost at the end of the period
Land	1,758
Buildings, Improvements & Equipment	20,632
Total	22,390
Accumulated Depreciation	5,995
5799 Broadmoor Street, Mission, KS
Real Estate And Accumulated Depreciation
Encumbrances	0
Initial Cost to Company
Land	1,522
Buildings, Improvements & Equipment	7,246
Cost Capitalized Subsequent to Acquisition	1,882
Impairment	0
Cost Basis Adjustment	0
Cost at the end of the period
Land	1,530
Buildings, Improvements & Equipment	9,120
Total	10,650
Accumulated Depreciation	1,470
3501 West 95th Street, Overland Park, KS
Real Estate And Accumulated Depreciation
Encumbrances	0
Initial Cost to Company
Land	2,568
Buildings, Improvements & Equipment	15,140
Cost Capitalized Subsequent to Acquisition	7,587
Impairment	0
Cost Basis Adjustment	(2,141)
Cost at the end of the period
Land	2,580
Buildings, Improvements & Equipment	20,574
Total	23,154
Accumulated Depreciation	8,677
6555 West 75th Street , Overland Park, KS
Real Estate And Accumulated Depreciation
Encumbrances	0
Initial Cost to Company
Land	1,274
Buildings, Improvements & Equipment	1,126
Cost Capitalized Subsequent to Acquisition	15,505
Impairment	0
Cost Basis Adjustment	(1,102)
Cost at the end of the period
Land	1,487
Buildings, Improvements & Equipment	15,316
Total	16,803
Accumulated Depreciation	6,507
6700 W. 115th Street, Overland Park, KS
Real Estate And Accumulated Depreciation
Encumbrances	0
Initial Cost to Company
Land	4,503
Buildings, Improvements & Equipment	29,387
Cost Capitalized Subsequent to Acquisition	177
Impairment	0
Cost Basis Adjustment	0
Cost at the end of the period
Land	4,503
Buildings, Improvements & Equipment	29,564
Total	34,067
Accumulated Depreciation	2,977
981 Campbell Lane, Bowling Green, KY
Real Estate And Accumulated Depreciation
Encumbrances	0
Initial Cost to Company
Land	365
Buildings, Improvements & Equipment	4,345
Cost Capitalized Subsequent to Acquisition	1,844
Impairment	0
Cost Basis Adjustment	(203)
Cost at the end of the period
Land	365
Buildings, Improvements & Equipment	5,986
Total	6,351
Accumulated Depreciation	2,119
102 Leonardwood Drive Frankfort, KY
Real Estate And Accumulated Depreciation
Encumbrances	0
Initial Cost to Company
Land	560
Buildings, Improvements & Equipment	8,282
Cost Capitalized Subsequent to Acquisition	2,529
Impairment	0
Cost Basis Adjustment	(605)
Cost at the end of the period
Land	579
Buildings, Improvements & Equipment	10,187
Total	10,766
Accumulated Depreciation	3,702
4190 Lafayette Road Hopkinsville, KY
Real Estate And Accumulated Depreciation
Encumbrances	0
Initial Cost to Company
Land	316
Buildings, Improvements & Equipment	3,761
Cost Capitalized Subsequent to Acquisition	748
Impairment	0
Cost Basis Adjustment	(193)
Cost at the end of the period
Land	316
Buildings, Improvements & Equipment	4,316
Total	4,632
Accumulated Depreciation	1,718
690 Mason Headley Road Lexington, KY
Real Estate And Accumulated Depreciation
Encumbrances	5,355
Initial Cost to Company
Land	0
Buildings, Improvements & Equipment	10,848
Cost Capitalized Subsequent to Acquisition	13,419
Impairment	0
Cost Basis Adjustment	(1,389)
Cost at the end of the period
Land	42
Buildings, Improvements & Equipment	22,836
Total	22,878
Accumulated Depreciation	11,738
700 Mason Headley Road Lexington, KY
Real Estate And Accumulated Depreciation
Encumbrances	1,281
Initial Cost to Company
Land	0
Buildings, Improvements & Equipment	6,394
Cost Capitalized Subsequent to Acquisition	8,409
Impairment	0
Cost Basis Adjustment	(951)
Cost at the end of the period
Land	52
Buildings, Improvements & Equipment	13,800
Total	13,852
Accumulated Depreciation	6,465
200 Brookside Drive Louisville, KY
Real Estate And Accumulated Depreciation
Encumbrances	0
Initial Cost to Company
Land	3,524
Buildings, Improvements & Equipment	20,779
Cost Capitalized Subsequent to Acquisition	10,672
Impairment	0
Cost Basis Adjustment	(3,217)
Cost at the end of the period
Land	3,549
Buildings, Improvements & Equipment	28,209
Total	31,758
Accumulated Depreciation	12,173
1517 West Broadway Mayfield, KY
Real Estate And Accumulated Depreciation
Encumbrances	0
Initial Cost to Company
Land	268
Buildings, Improvements & Equipment	2,730
Cost Capitalized Subsequent to Acquisition	1,617
Impairment	0
Cost Basis Adjustment	(221)
Cost at the end of the period
Land	268
Buildings, Improvements & Equipment	4,126
Total	4,394
Accumulated Depreciation	1,567
1700 Elmdale Road, Paducah, KY
Real Estate And Accumulated Depreciation
Encumbrances	0
Initial Cost to Company
Land	450
Buildings, Improvements & Equipment	5,358
Cost Capitalized Subsequent to Acquisition	1,477
Impairment	0
Cost Basis Adjustment	(319)
Cost at the end of the period
Land	451
Buildings, Improvements & Equipment	6,515
Total	6,966
Accumulated Depreciation	2,646
100 Neighborly Way, Somerset, KY
Real Estate And Accumulated Depreciation
Encumbrances	0
Initial Cost to Company
Land	200
Buildings, Improvements & Equipment	4,919
Cost Capitalized Subsequent to Acquisition	701
Impairment	0
Cost Basis Adjustment	0
Cost at the end of the period
Land	200
Buildings, Improvements & Equipment	5,620
Total	5,820
Accumulated Depreciation	2,068
1295 Boylston Street, Boston, MA
Real Estate And Accumulated Depreciation
Encumbrances	0
Initial Cost to Company
Land	7,600
Buildings, Improvements & Equipment	18,140
Cost Capitalized Subsequent to Acquisition	3,187
Impairment	0
Cost Basis Adjustment	0
Cost at the end of the period
Land	7,625
Buildings, Improvements & Equipment	21,302
Total	28,927
Accumulated Depreciation	6,065
549 Albany Street, Boston, MA
Real Estate And Accumulated Depreciation
Encumbrances	0
Initial Cost to Company
Land	4,576
Buildings, Improvements & Equipment	45,029
Cost Capitalized Subsequent to Acquisition	0
Impairment	0
Cost Basis Adjustment	0
Cost at the end of the period
Land	4,569
Buildings, Improvements & Equipment	45,036
Total	49,605
Accumulated Depreciation	9,385
330 Baker Avenue, Concord, MA
Real Estate And Accumulated Depreciation
Encumbrances	0
Initial Cost to Company
Land	3,775
Buildings, Improvements & Equipment	19,906
Cost Capitalized Subsequent to Acquisition	0
Impairment	0
Cost Basis Adjustment	0
Cost at the end of the period
Land	3,775
Buildings, Improvements & Equipment	19,906
Total	23,681
Accumulated Depreciation	3,442
4 Maguire Road, Lexington, MA
Real Estate And Accumulated Depreciation
Encumbrances	0
Initial Cost to Company
Land	3,600
Buildings, Improvements & Equipment	15,555
Cost Capitalized Subsequent to Acquisition	19,813
Impairment	(7,255)
Cost Basis Adjustment	(1,003)
Cost at the end of the period
Land	3,884
Buildings, Improvements & Equipment	26,826
Total	30,710
Accumulated Depreciation	3,016
100 Hampshire Street, Mansfield, MA
Real Estate And Accumulated Depreciation
Encumbrances	0
Initial Cost to Company
Land	2,090
Buildings, Improvements & Equipment	8,215
Cost Capitalized Subsequent to Acquisition	1,664
Impairment	0
Cost Basis Adjustment	0
Cost at the end of the period
Land	2,486
Buildings, Improvements & Equipment	9,483
Total	11,969
Accumulated Depreciation	2,665
15 Hampshire Street, Mansfield, MA
Real Estate And Accumulated Depreciation
Encumbrances	0
Initial Cost to Company
Land	1,360
Buildings, Improvements & Equipment	7,326
Cost Capitalized Subsequent to Acquisition	507
Impairment	0
Cost Basis Adjustment	0
Cost at the end of the period
Land	1,748
Buildings, Improvements & Equipment	7,445
Total	9,193
Accumulated Depreciation	2,202
5 Hampshire Street, Mansfield, MA
Real Estate And Accumulated Depreciation
Encumbrances	0
Initial Cost to Company
Land	1,190
Buildings, Improvements & Equipment	5,737
Cost Capitalized Subsequent to Acquisition	1,831
Impairment	0
Cost Basis Adjustment	(143)
Cost at the end of the period
Land	1,465
Buildings, Improvements & Equipment	7,150
Total	8,615
Accumulated Depreciation	2,019
30 Newcrossing Road, Reading, MA
Real Estate And Accumulated Depreciation
Encumbrances	0
Initial Cost to Company
Land	1,443
Buildings, Improvements & Equipment	14,153
Cost Capitalized Subsequent to Acquisition	285
Impairment	0
Cost Basis Adjustment	0
Cost at the end of the period
Land	1,455
Buildings, Improvements & Equipment	14,426
Total	15,881
Accumulated Depreciation	3,338
299 Cambridge Street, Winchester, MA
Real Estate And Accumulated Depreciation
Encumbrances	0
Initial Cost to Company
Land	3,218
Buildings, Improvements & Equipment	18,988
Cost Capitalized Subsequent to Acquisition	12,424
Impairment	0
Cost Basis Adjustment	(1,855)
Cost at the end of the period
Land	3,218
Buildings, Improvements & Equipment	29,557
Total	32,775
Accumulated Depreciation	12,726
2717 Riva Road, Annapolis, MD
Real Estate And Accumulated Depreciation
Encumbrances	0
Initial Cost to Company
Land	1,290
Buildings, Improvements & Equipment	12,373
Cost Capitalized Subsequent to Acquisition	1,370
Impairment	0
Cost Basis Adjustment	0
Cost at the end of the period
Land	1,290
Buildings, Improvements & Equipment	13,743
Total	15,033
Accumulated Depreciation	4,594
658 Boulton Street, Bel Air, MD
Real Estate And Accumulated Depreciation
Encumbrances	0
Initial Cost to Company
Land	4,750
Buildings, Improvements & Equipment	16,504
Cost Capitalized Subsequent to Acquisition	2
Impairment	0
Cost Basis Adjustment	0
Cost at the end of the period
Land	4,750
Buildings, Improvements & Equipment	16,506
Total	21,256
Accumulated Depreciation	5,827
7600 Laurel Bowie Road, Bowie, MD
Real Estate And Accumulated Depreciation
Encumbrances	0
Initial Cost to Company
Land	408
Buildings, Improvements & Equipment	3,421
Cost Capitalized Subsequent to Acquisition	1,488
Impairment	0
Cost Basis Adjustment	(393)
Cost at the end of the period
Land	408
Buildings, Improvements & Equipment	4,516
Total	4,924
Accumulated Depreciation	1,841
8100 Connecticut Avenue Chevy Chase, MD
Real Estate And Accumulated Depreciation
Encumbrances	0
Initial Cost to Company
Land	15,170
Buildings, Improvements & Equipment	92,830
Cost Capitalized Subsequent to Acquisition	12,492
Impairment	0
Cost Basis Adjustment	(1,924)
Cost at the end of the period
Land	15,177
Buildings, Improvements & Equipment	103,391
Total	118,568
Accumulated Depreciation	26,915
8220 Snowden River Parkway, Columbia, MD
Real Estate And Accumulated Depreciation
Encumbrances	0
Initial Cost to Company
Land	1,390
Buildings, Improvements & Equipment	10,303
Cost Capitalized Subsequent to Acquisition	934
Impairment	0
Cost Basis Adjustment	0
Cost at the end of the period
Land	1,390
Buildings, Improvements & Equipment	11,237
Total	12,627
Accumulated Depreciation	3,811
700 Port Street , Easton, MD
Real Estate And Accumulated Depreciation
Encumbrances	0
Initial Cost to Company
Land	383
Buildings, Improvements & Equipment	4,555
Cost Capitalized Subsequent to Acquisition	4,042
Impairment	0
Cost Basis Adjustment	(473)
Cost at the end of the period
Land	394
Buildings, Improvements & Equipment	8,113
Total	8,507
Accumulated Depreciation	3,169
3004 North Ridge Road , Ellicott City, MD
Real Estate And Accumulated Depreciation
Encumbrances	0
Initial Cost to Company
Land	1,409
Buildings, Improvements & Equipment	22,691
Cost Capitalized Subsequent to Acquisition	11,847
Impairment	0
Cost Basis Adjustment	(2,505)
Cost at the end of the period
Land	1,613
Buildings, Improvements & Equipment	31,829
Total	33,442
Accumulated Depreciation	12,430
1820 Latham Drive , Frederick, MD
Real Estate And Accumulated Depreciation
Encumbrances	0
Initial Cost to Company
Land	385
Buildings, Improvements & Equipment	3,444
Cost Capitalized Subsequent to Acquisition	1,319
Impairment	0
Cost Basis Adjustment	(444)
Cost at the end of the period
Land	385
Buildings, Improvements & Equipment	4,319
Total	4,704
Accumulated Depreciation	1,818
2100 Whittier Drive, Frederick, MD
Real Estate And Accumulated Depreciation
Encumbrances	0
Initial Cost to Company
Land	1,260
Buildings, Improvements & Equipment	9,464
Cost Capitalized Subsequent to Acquisition	2,444
Impairment	0
Cost Basis Adjustment	0
Cost at the end of the period
Land	1,260
Buildings, Improvements & Equipment	11,908
Total	13,168
Accumulated Depreciation	3,871
10116 Sharpsburg Pike, Hagerstown, MD
Real Estate And Accumulated Depreciation
Encumbrances	0
Initial Cost to Company
Land	1,040
Buildings, Improvements & Equipment	7,471
Cost Capitalized Subsequent to Acquisition	5,273
Impairment	0
Cost Basis Adjustment	0
Cost at the end of the period
Land	1,044
Buildings, Improvements & Equipment	12,740
Total	13,784
Accumulated Depreciation	4,317
4000 Old Court Road, Pikesville, MD
Real Estate And Accumulated Depreciation
Encumbrances	0
Initial Cost to Company
Land	2,000
Buildings, Improvements & Equipment	4,974
Cost Capitalized Subsequent to Acquisition	914
Impairment	0
Cost Basis Adjustment	(82)
Cost at the end of the period
Land	2,000
Buildings, Improvements & Equipment	5,806
Total	7,806
Accumulated Depreciation	1,947
12725 Twinbrook Parkway Rockville, MD
Real Estate And Accumulated Depreciation
Encumbrances	0
Initial Cost to Company
Land	6,138
Buildings, Improvements & Equipment	6,526
Cost Capitalized Subsequent to Acquisition	683
Impairment	0
Cost Basis Adjustment	(148)
Cost at the end of the period
Land	6,218
Buildings, Improvements & Equipment	6,981
Total	13,199
Accumulated Depreciation	1,108
715 Benfield Road, Severna Park, MD
Real Estate And Accumulated Depreciation
Encumbrances	0
Initial Cost to Company
Land	229
Buildings, Improvements & Equipment	9,798
Cost Capitalized Subsequent to Acquisition	2,502
Impairment	0
Cost Basis Adjustment	(1,103)
Cost at the end of the period
Land	246
Buildings, Improvements & Equipment	11,180
Total	11,426
Accumulated Depreciation	5,112
14400 Homecrest Road , Silver Spring, MD
Real Estate And Accumulated Depreciation
Encumbrances	0
Initial Cost to Company
Land	1,200
Buildings, Improvements & Equipment	9,288
Cost Capitalized Subsequent to Acquisition	8,287
Impairment	0
Cost Basis Adjustment	(1,509)
Cost at the end of the period
Land	1,207
Buildings, Improvements & Equipment	16,059
Total	17,266
Accumulated Depreciation	6,477
801 Roeder Road, Silver Spring, MD
Real Estate And Accumulated Depreciation
Encumbrances	0
Initial Cost to Company
Land	1,900
Buildings, Improvements & Equipment	12,858
Cost Capitalized Subsequent to Acquisition	1,956
Impairment	0
Cost Basis Adjustment	(326)
Cost at the end of the period
Land	1,900
Buildings, Improvements & Equipment	14,488
Total	16,388
Accumulated Depreciation	3,560
720 & 734 N. Pine Road, Hampton, MI
Real Estate And Accumulated Depreciation
Encumbrances	0
Initial Cost to Company
Land	300
Buildings, Improvements & Equipment	2,406
Cost Capitalized Subsequent to Acquisition	0
Impairment	0
Cost Basis Adjustment	(142)
Cost at the end of the period
Land	300
Buildings, Improvements & Equipment	2,264
Total	2,564
Accumulated Depreciation	1,068
4004 & 4012 Waldo Road, Midland, MI
Real Estate And Accumulated Depreciation
Encumbrances	0
Initial Cost to Company
Land	400
Buildings, Improvements & Equipment	2,606
Cost Capitalized Subsequent to Acquisition	0
Impairment	0
Cost Basis Adjustment	(162)
Cost at the end of the period
Land	400
Buildings, Improvements & Equipment	2,444
Total	2,844
Accumulated Depreciation	1,153
1605 & 1615 Fredericks Drive, Monroe, MI
Real Estate And Accumulated Depreciation
Encumbrances	0
Initial Cost to Company
Land	300
Buildings, Improvements & Equipment	2,506
Cost Capitalized Subsequent to Acquisition	0
Impairment	0
Cost Basis Adjustment	(152)
Cost at the end of the period
Land	300
Buildings, Improvements & Equipment	2,354
Total	2,654
Accumulated Depreciation	1,110
3150 & 3100 Old Centre Road, Portage, MI
Real Estate And Accumulated Depreciation
Encumbrances	0
Initial Cost to Company
Land	300
Buildings, Improvements & Equipment	2,206
Cost Capitalized Subsequent to Acquisition	0
Impairment	0
Cost Basis Adjustment	(133)
Cost at the end of the period
Land	300
Buildings, Improvements & Equipment	2,073
Total	2,373
Accumulated Depreciation	978
2445 & 2485 Mc Carty Road, Saginaw, MI
Real Estate And Accumulated Depreciation
Encumbrances	0
Initial Cost to Company
Land	600
Buildings, Improvements & Equipment	5,212
Cost Capitalized Subsequent to Acquisition	0
Impairment	0
Cost Basis Adjustment	(305)
Cost at the end of the period
Land	600
Buildings, Improvements & Equipment	4,907
Total	5,507
Accumulated Depreciation	2,315
11855 Ulysses Street NE, Blaine, MN
Real Estate And Accumulated Depreciation
Encumbrances	0
Initial Cost to Company
Land	2,774
Buildings, Improvements & Equipment	9,276
Cost Capitalized Subsequent to Acquisition	389
Impairment	0
Cost Basis Adjustment	0
Cost at the end of the period
Land	2,781
Buildings, Improvements & Equipment	9,658
Total	12,439
Accumulated Depreciation	2,300
1305 Corporate Center Drive, Eagan, MN
Real Estate And Accumulated Depreciation
Encumbrances	0
Initial Cost to Company
Land	2,300
Buildings, Improvements & Equipment	13,105
Cost Capitalized Subsequent to Acquisition	10,691
Impairment	0
Cost Basis Adjustment	0
Cost at the end of the period
Land	2,735
Buildings, Improvements & Equipment	23,361
Total	26,096
Accumulated Depreciation	5,042
8301 Golden Valley Road, Golden Valley, MN
Real Estate And Accumulated Depreciation
Encumbrances	0
Initial Cost to Company
Land	1,256
Buildings, Improvements & Equipment	4,680
Cost Capitalized Subsequent to Acquisition	579
Impairment	0
Cost Basis Adjustment	0
Cost at the end of the period
Land	1,256
Buildings, Improvements & Equipment	5,259
Total	6,515
Accumulated Depreciation	803
8401 Golden Valley Road, Golden Valley, MN
Real Estate And Accumulated Depreciation
Encumbrances	0
Initial Cost to Company
Land	1,510
Buildings, Improvements & Equipment	5,742
Cost Capitalized Subsequent to Acquisition	2,297
Impairment	0
Cost Basis Adjustment	0
Cost at the end of the period
Land	1,510
Buildings, Improvements & Equipment	8,039
Total	9,549
Accumulated Depreciation	1,362
8501 Golden Valley Road, Golden Valley, MN
Real Estate And Accumulated Depreciation
Encumbrances	0
Initial Cost to Company
Land	1,263
Buildings, Improvements & Equipment	4,288
Cost Capitalized Subsequent to Acquisition	1,013
Impairment	0
Cost Basis Adjustment	0
Cost at the end of the period
Land	1,263
Buildings, Improvements & Equipment	5,301
Total	6,564
Accumulated Depreciation	840
1201 Northland Drive, Mendota Heights, MN
Real Estate And Accumulated Depreciation
Encumbrances	0
Initial Cost to Company
Land	1,220
Buildings, Improvements & Equipment	10,208
Cost Capitalized Subsequent to Acquisition	1,257
Impairment	0
Cost Basis Adjustment	0
Cost at the end of the period
Land	1,468
Buildings, Improvements & Equipment	11,217
Total	12,685
Accumulated Depreciation	3,516
12700 Whitewater Drive, Minnetonka, MN
Real Estate And Accumulated Depreciation
Encumbrances	0
Initial Cost to Company
Land	5,453
Buildings, Improvements & Equipment	8,108
Cost Capitalized Subsequent to Acquisition	8,415
Impairment	0
Cost Basis Adjustment	0
Cost at the end of the period
Land	5,453
Buildings, Improvements & Equipment	16,523
Total	21,976
Accumulated Depreciation	2,808
20600 South Diamond Lake Road, Rogers, MN
Real Estate And Accumulated Depreciation
Encumbrances	0
Initial Cost to Company
Land	2,760
Buildings, Improvements & Equipment	45,789
Cost Capitalized Subsequent to Acquisition	2,809
Impairment	(20,359)
Cost Basis Adjustment	(15,686)
Cost at the end of the period
Land	1,195
Buildings, Improvements & Equipment	14,118
Total	15,313
Accumulated Depreciation	1,663
2200 County Road C West, Roseville, MN
Real Estate And Accumulated Depreciation
Encumbrances	0
Initial Cost to Company
Land	590
Buildings, Improvements & Equipment	702
Cost Capitalized Subsequent to Acquisition	640
Impairment	0
Cost Basis Adjustment	(82)
Cost at the end of the period
Land	792
Buildings, Improvements & Equipment	1,058
Total	1,850
Accumulated Depreciation	306
4166 Lexington Avenue N, Shoreview, MN
Real Estate And Accumulated Depreciation
Encumbrances	0
Initial Cost to Company
Land	1,300
Buildings, Improvements & Equipment	4,547
Cost Capitalized Subsequent to Acquisition	1,285
Impairment	0
Cost Basis Adjustment	0
Cost at the end of the period
Land	1,507
Buildings, Improvements & Equipment	5,625
Total	7,132
Accumulated Depreciation	1,398
1365 Crestridge Lane, West St. Paul, MN
Real Estate And Accumulated Depreciation
Encumbrances	0
Initial Cost to Company
Land	400
Buildings, Improvements & Equipment	2,506
Cost Capitalized Subsequent to Acquisition	0
Impairment	0
Cost Basis Adjustment	(292)
Cost at the end of the period
Land	400
Buildings, Improvements & Equipment	2,214
Total	2,614
Accumulated Depreciation	1,044
305 & 315 Thompson Avenue, West St. Paul, MN
Real Estate And Accumulated Depreciation
Encumbrances	0
Initial Cost to Company
Land	400
Buildings, Improvements & Equipment	3,608
Cost Capitalized Subsequent to Acquisition	99
Impairment	0
Cost Basis Adjustment	(402)
Cost at the end of the period
Land	400
Buildings, Improvements & Equipment	3,305
Total	3,705
Accumulated Depreciation	1,559
5351 Gretna Road, Branson, MO
Real Estate And Accumulated Depreciation
Encumbrances	0
Initial Cost to Company
Land	743
Buildings, Improvements & Equipment	10,973
Cost Capitalized Subsequent to Acquisition	1,015
Impairment	0
Cost Basis Adjustment	(227)
Cost at the end of the period
Land	754
Buildings, Improvements & Equipment	11,750
Total	12,504
Accumulated Depreciation	2,212
845 N New Ballas Court, Creve Coeur, MO
Real Estate And Accumulated Depreciation
Encumbrances	0
Initial Cost to Company
Land	1,582
Buildings, Improvements & Equipment	16,328
Cost Capitalized Subsequent to Acquisition	1,230
Impairment	0
Cost Basis Adjustment	0
Cost at the end of the period
Land	1,582
Buildings, Improvements & Equipment	17,558
Total	19,140
Accumulated Depreciation	1,780
3828 College View Drive, Joplin, MO
Real Estate And Accumulated Depreciation
Encumbrances	0
Initial Cost to Company
Land	260
Buildings, Improvements & Equipment	11,382
Cost Capitalized Subsequent to Acquisition	820
Impairment	0
Cost Basis Adjustment	(14)
Cost at the end of the period
Land	260
Buildings, Improvements & Equipment	12,188
Total	12,448
Accumulated Depreciation	3,271
14100 Magellan Plaza, Maryland Heights, MO
Real Estate And Accumulated Depreciation
Encumbrances	0
Initial Cost to Company
Land	3,719
Buildings, Improvements & Equipment	37,304
Cost Capitalized Subsequent to Acquisition	4,836
Impairment	0
Cost Basis Adjustment	0
Cost at the end of the period
Land	3,179
Buildings, Improvements & Equipment	42,680
Total	45,859
Accumulated Depreciation	9,271
640 E Highland Avenue, Nevada, MO
Real Estate And Accumulated Depreciation
Encumbrances	0
Initial Cost to Company
Land	311
Buildings, Improvements & Equipment	5,703
Cost Capitalized Subsequent to Acquisition	509
Impairment	0
Cost Basis Adjustment	0
Cost at the end of the period
Land	311
Buildings, Improvements & Equipment	6,212
Total	6,523
Accumulated Depreciation	1,172
2410 W. Chesterfield Blvd, Springfield, MO
Real Estate And Accumulated Depreciation
Encumbrances	0
Initial Cost to Company
Land	924
Buildings, Improvements & Equipment	12,772
Cost Capitalized Subsequent to Acquisition	608
Impairment	0
Cost Basis Adjustment	0
Cost at the end of the period
Land	924
Buildings, Improvements & Equipment	13,380
Total	14,304
Accumulated Depreciation	2,452
3540 East Cherokee Street, Springfield, MO
Real Estate And Accumulated Depreciation
Encumbrances	0
Initial Cost to Company
Land	1,084
Buildings, Improvements & Equipment	11,339
Cost Capitalized Subsequent to Acquisition	1,160
Impairment	0
Cost Basis Adjustment	0
Cost at the end of the period
Land	1,129
Buildings, Improvements & Equipment	12,454
Total	13,583
Accumulated Depreciation	2,353
4700 North Hanley Road, St Louis, MO
Real Estate And Accumulated Depreciation
Encumbrances	0
Initial Cost to Company
Land	5,166
Buildings, Improvements & Equipment	41,587
Cost Capitalized Subsequent to Acquisition	131
Impairment	0
Cost Basis Adjustment	0
Cost at the end of the period
Land	5,166
Buildings, Improvements & Equipment	41,718
Total	46,884
Accumulated Depreciation	7,268
118 Alamance Road, Burlington, NC
Real Estate And Accumulated Depreciation
Encumbrances	0
Initial Cost to Company
Land	575
Buildings, Improvements & Equipment	9,697
Cost Capitalized Subsequent to Acquisition	1,359
Impairment	0
Cost Basis Adjustment	(190)
Cost at the end of the period
Land	575
Buildings, Improvements & Equipment	10,866
Total	11,441
Accumulated Depreciation	3,048
1050 Crescent Green Drive, Cary, NC
Real Estate And Accumulated Depreciation
Encumbrances	0
Initial Cost to Company
Land	713
Buildings, Improvements & Equipment	4,628
Cost Capitalized Subsequent to Acquisition	3,066
Impairment	0
Cost Basis Adjustment	(922)
Cost at the end of the period
Land	713
Buildings, Improvements & Equipment	6,772
Total	7,485
Accumulated Depreciation	2,991
2220 & 2230 Farmington Drive, Chapel Hill, NC
Real Estate And Accumulated Depreciation
Encumbrances	0
Initial Cost to Company
Land	800
Buildings, Improvements & Equipment	6,414
Cost Capitalized Subsequent to Acquisition	0
Impairment	0
Cost Basis Adjustment	(375)
Cost at the end of the period
Land	800
Buildings, Improvements & Equipment	6,039
Total	6,839
Accumulated Depreciation	2,849
2101 Runnymede Lane, Charlotte, NC
Real Estate And Accumulated Depreciation
Encumbrances	0
Initial Cost to Company
Land	2,475
Buildings, Improvements & Equipment	11,451
Cost Capitalized Subsequent to Acquisition	1,318
Impairment	0
Cost Basis Adjustment	(301)
Cost at the end of the period
Land	2,458
Buildings, Improvements & Equipment	12,485
Total	14,943
Accumulated Depreciation	3,823
5920 McChesney Drive & 6101 Clarke Creek Parkway, Charlotte, NC
Real Estate And Accumulated Depreciation
Encumbrances	0
Initial Cost to Company
Land	1,320
Buildings, Improvements & Equipment	21,750
Cost Capitalized Subsequent to Acquisition	2,350
Impairment	0
Cost Basis Adjustment	(1,175)
Cost at the end of the period
Land	1,320
Buildings, Improvements & Equipment	22,925
Total	24,245
Accumulated Depreciation	6,847
500 Penny Lane, Concord, NC
Real Estate And Accumulated Depreciation
Encumbrances	0
Initial Cost to Company
Land	1,687
Buildings, Improvements & Equipment	17,603
Cost Capitalized Subsequent to Acquisition	783
Impairment	0
Cost Basis Adjustment	0
Cost at the end of the period
Land	1,687
Buildings, Improvements & Equipment	18,386
Total	20,073
Accumulated Depreciation	3,226
1002 State Highway 54, Durham, NC
Real Estate And Accumulated Depreciation
Encumbrances	0
Initial Cost to Company
Land	595
Buildings, Improvements & Equipment	5,200
Cost Capitalized Subsequent to Acquisition	554
Impairment	0
Cost Basis Adjustment	(114)
Cost at the end of the period
Land	595
Buildings, Improvements & Equipment	5,640
Total	6,235
Accumulated Depreciation	1,504
4505 Emperor Boulevard, Durham, NC
Real Estate And Accumulated Depreciation
Encumbrances	0
Initial Cost to Company
Land	1,285
Buildings, Improvements & Equipment	16,932
Cost Capitalized Subsequent to Acquisition	687
Impairment	0
Cost Basis Adjustment	0
Cost at the end of the period
Land	1,285
Buildings, Improvements & Equipment	17,619
Total	18,904
Accumulated Depreciation	1,990
5213 South Alston Avenue, Durham, NC
Real Estate And Accumulated Depreciation
Encumbrances	0
Initial Cost to Company
Land	1,093
Buildings, Improvements & Equipment	31,377
Cost Capitalized Subsequent to Acquisition	393
Impairment	0
Cost Basis Adjustment	0
Cost at the end of the period
Land	1,093
Buildings, Improvements & Equipment	31,770
Total	32,863
Accumulated Depreciation	5,452
2755 Union Road, Gastonia, NC
Real Estate And Accumulated Depreciation
Encumbrances	0
Initial Cost to Company
Land	1,104
Buildings, Improvements & Equipment	17,834
Cost Capitalized Subsequent to Acquisition	1,058
Impairment	0
Cost Basis Adjustment	(1,133)
Cost at the end of the period
Land	1,104
Buildings, Improvements & Equipment	17,759
Total	18,863
Accumulated Depreciation	2,551
1001 Phifer Road, Kings Mountain, NC
Real Estate And Accumulated Depreciation
Encumbrances	0
Initial Cost to Company
Land	655
Buildings, Improvements & Equipment	8,283
Cost Capitalized Subsequent to Acquisition	1,179
Impairment	0
Cost Basis Adjustment	(308)
Cost at the end of the period
Land	657
Buildings, Improvements & Equipment	9,152
Total	9,809
Accumulated Depreciation	2,496
128 Brawley School, Mooresville, NC
Real Estate And Accumulated Depreciation
Encumbrances	0
Initial Cost to Company
Land	595
Buildings, Improvements & Equipment	7,305
Cost Capitalized Subsequent to Acquisition	1,379
Impairment	0
Cost Basis Adjustment	(369)
Cost at the end of the period
Land	601
Buildings, Improvements & Equipment	8,309
Total	8,910
Accumulated Depreciation	2,219
1309 , 1321 and 1325 McCarthy Boulevard, New Bern, NC
Real Estate And Accumulated Depreciation
Encumbrances	0
Initial Cost to Company
Land	1,245
Buildings, Improvements & Equipment	20,898
Cost Capitalized Subsequent to Acquisition	2,886
Impairment	0
Cost Basis Adjustment	(159)
Cost at the end of the period
Land	1,245
Buildings, Improvements & Equipment	23,625
Total	24,870
Accumulated Depreciation	6,091
13150 & 13180 Dorman Road, Pineville, NC
Real Estate And Accumulated Depreciation
Encumbrances	0
Initial Cost to Company
Land	1,180
Buildings, Improvements & Equipment	22,800
Cost Capitalized Subsequent to Acquisition	3,030
Impairment	0
Cost Basis Adjustment	(1,234)
Cost at the end of the period
Land	1,180
Buildings, Improvements & Equipment	24,596
Total	25,776
Accumulated Depreciation	7,187
801 Dixie Trail, Raleigh, NC
Real Estate And Accumulated Depreciation
Encumbrances	0
Initial Cost to Company
Land	3,233
Buildings, Improvements & Equipment	17,788
Cost Capitalized Subsequent to Acquisition	1,166
Impairment	0
Cost Basis Adjustment	(1,114)
Cost at the end of the period
Land	3,236
Buildings, Improvements & Equipment	17,837
Total	21,073
Accumulated Depreciation	2,492
2744 South 17th Street, Wilmington, NC
Real Estate And Accumulated Depreciation
Encumbrances	0
Initial Cost to Company
Land	1,134
Buildings, Improvements & Equipment	14,771
Cost Capitalized Subsequent to Acquisition	1,881
Impairment	0
Cost Basis Adjustment	0
Cost at the end of the period
Land	1,139
Buildings, Improvements & Equipment	16,647
Total	17,786
Accumulated Depreciation	3,554
1730 Parkwood Boulevard West, Wilson, NC
Real Estate And Accumulated Depreciation
Encumbrances	0
Initial Cost to Company
Land	610
Buildings, Improvements & Equipment	14,787
Cost Capitalized Subsequent to Acquisition	1,296
Impairment	0
Cost Basis Adjustment	(163)
Cost at the end of the period
Land	610
Buildings, Improvements & Equipment	15,920
Total	16,530
Accumulated Depreciation	4,278
17007 Elm Plaza, Omaha, NE
Real Estate And Accumulated Depreciation
Encumbrances	0
Initial Cost to Company
Land	4,680
Buildings, Improvements & Equipment	22,022
Cost Capitalized Subsequent to Acquisition	0
Impairment	0
Cost Basis Adjustment	0
Cost at the end of the period
Land	4,680
Buildings, Improvements & Equipment	22,022
Total	26,702
Accumulated Depreciation	7,363
3030 South 80th Street, Omaha, NE
Real Estate And Accumulated Depreciation
Encumbrances	0
Initial Cost to Company
Land	650
Buildings, Improvements & Equipment	5,850
Cost Capitalized Subsequent to Acquisition	2,224
Impairment	0
Cost Basis Adjustment	(419)
Cost at the end of the period
Land	650
Buildings, Improvements & Equipment	7,655
Total	8,305
Accumulated Depreciation	2,729
490 Cooper Landing Road, Cherry Hill, NJ
Real Estate And Accumulated Depreciation
Encumbrances	0
Initial Cost to Company
Land	1,001
Buildings, Improvements & Equipment	8,175
Cost Capitalized Subsequent to Acquisition	3,307
Impairment	(6,080)
Cost Basis Adjustment	(4,163)
Cost at the end of the period
Land	2,240
Buildings, Improvements & Equipment	0
Total	2,240
Accumulated Depreciation	0
1400 Route 70, Lakewood, NJ
Real Estate And Accumulated Depreciation
Encumbrances	0
Initial Cost to Company
Land	4,885
Buildings, Improvements & Equipment	28,803
Cost Capitalized Subsequent to Acquisition	8,222
Impairment	0
Cost Basis Adjustment	(2,881)
Cost at the end of the period
Land	4,905
Buildings, Improvements & Equipment	34,124
Total	39,029
Accumulated Depreciation	14,951
2 Hillside Drive, Mt. Arlington, NJ
Real Estate And Accumulated Depreciation
Encumbrances	0
Initial Cost to Company
Land	1,375
Buildings, Improvements & Equipment	11,232
Cost Capitalized Subsequent to Acquisition	1,529
Impairment	0
Cost Basis Adjustment	(399)
Cost at the end of the period
Land	1,393
Buildings, Improvements & Equipment	12,344
Total	13,737
Accumulated Depreciation	5,366
655 Pomander Walk, Teaneck, NJ
Real Estate And Accumulated Depreciation
Encumbrances	0
Initial Cost to Company
Land	4,950
Buildings, Improvements & Equipment	44,550
Cost Capitalized Subsequent to Acquisition	5,842
Impairment	0
Cost Basis Adjustment	(1,884)
Cost at the end of the period
Land	4,984
Buildings, Improvements & Equipment	48,474
Total	53,458
Accumulated Depreciation	13,437
10500 Academy Road NE, Albuquerque, NM
Real Estate And Accumulated Depreciation
Encumbrances	0
Initial Cost to Company
Land	3,828
Buildings, Improvements & Equipment	22,572
Cost Capitalized Subsequent to Acquisition	9,313
Impairment	0
Cost Basis Adjustment	(2,228)
Cost at the end of the period
Land	3,828
Buildings, Improvements & Equipment	29,657
Total	33,485
Accumulated Depreciation	12,968
4100 Prospect Avenue NE, Albuquerque, NM
Real Estate And Accumulated Depreciation
Encumbrances	0
Initial Cost to Company
Land	540
Buildings, Improvements & Equipment	10,105
Cost Capitalized Subsequent to Acquisition	8
Impairment	0
Cost Basis Adjustment	0
Cost at the end of the period
Land	540
Buildings, Improvements & Equipment	10,113
Total	10,653
Accumulated Depreciation	3,591
4300 Landau Street NE, Albuquerque, NM
Real Estate And Accumulated Depreciation
Encumbrances	0
Initial Cost to Company
Land	1,060
Buildings, Improvements & Equipment	9,875
Cost Capitalized Subsequent to Acquisition	8
Impairment	0
Cost Basis Adjustment	0
Cost at the end of the period
Land	1,060
Buildings, Improvements & Equipment	9,883
Total	10,943
Accumulated Depreciation	3,510
4411 The 25 Way, Albuquerque, NM
Real Estate And Accumulated Depreciation
Encumbrances	0
Initial Cost to Company
Land	3,480
Buildings, Improvements & Equipment	25,245
Cost Capitalized Subsequent to Acquisition	4,677
Impairment	0
Cost Basis Adjustment	(1,061)
Cost at the end of the period
Land	3,978
Buildings, Improvements & Equipment	28,363
Total	32,341
Accumulated Depreciation	8,449
4420 The 25 Way, Albuquerque, NM
Real Estate And Accumulated Depreciation
Encumbrances	0
Initial Cost to Company
Land	1,430
Buildings, Improvements & Equipment	2,609
Cost Capitalized Subsequent to Acquisition	1,018
Impairment	0
Cost Basis Adjustment	(152)
Cost at the end of the period
Land	1,614
Buildings, Improvements & Equipment	3,291
Total	4,905
Accumulated Depreciation	863
9190 Coors Boulevard NW, Albuquerque, NM
Real Estate And Accumulated Depreciation
Encumbrances	0
Initial Cost to Company
Land	1,660
Buildings, Improvements & Equipment	9,173
Cost Capitalized Subsequent to Acquisition	8
Impairment	0
Cost Basis Adjustment	0
Cost at the end of the period
Land	1,660
Buildings, Improvements & Equipment	9,181
Total	10,841
Accumulated Depreciation	3,260
2200 East Long Street, Carson City, NV
Real Estate And Accumulated Depreciation
Encumbrances	0
Initial Cost to Company
Land	622
Buildings, Improvements & Equipment	17,900
Cost Capitalized Subsequent to Acquisition	752
Impairment	0
Cost Basis Adjustment	0
Cost at the end of the period
Land	622
Buildings, Improvements & Equipment	18,652
Total	19,274
Accumulated Depreciation	3,645
3201 Plumas Street, Reno, NV
Real Estate And Accumulated Depreciation
Encumbrances	0
Initial Cost to Company
Land	2,420
Buildings, Improvements & Equipment	49,580
Cost Capitalized Subsequent to Acquisition	7,657
Impairment	0
Cost Basis Adjustment	(1,004)
Cost at the end of the period
Land	2,420
Buildings, Improvements & Equipment	56,233
Total	58,653
Accumulated Depreciation	14,353
6300 Eighth Avenue, Brooklyn, NY
Real Estate And Accumulated Depreciation
Encumbrances	0
Initial Cost to Company
Land	3,870
Buildings, Improvements & Equipment	8,545
Cost Capitalized Subsequent to Acquisition	460
Impairment	0
Cost Basis Adjustment	0
Cost at the end of the period
Land	3,870
Buildings, Improvements & Equipment	9,005
Total	12,875
Accumulated Depreciation	2,877
4939 Brittonfield Parkway, East Syracuse, NY
Real Estate And Accumulated Depreciation
Encumbrances	0
Initial Cost to Company
Land	720
Buildings, Improvements & Equipment	17,084
Cost Capitalized Subsequent to Acquisition	1,721
Impairment	(2,826)
Cost Basis Adjustment	(5,312)
Cost at the end of the period
Land	900
Buildings, Improvements & Equipment	10,487
Total	11,387
Accumulated Depreciation	725
5008 Brittonfield Parkway, East Syracuse, NY
Real Estate And Accumulated Depreciation
Encumbrances	0
Initial Cost to Company
Land	420
Buildings, Improvements & Equipment	18,407
Cost Capitalized Subsequent to Acquisition	1,670
Impairment	(3,144)
Cost Basis Adjustment	(5,393)
Cost at the end of the period
Land	586
Buildings, Improvements & Equipment	11,374
Total	11,960
Accumulated Depreciation	700
200 Old County Road, Mineola, NY
Real Estate And Accumulated Depreciation
Encumbrances	0
Initial Cost to Company
Land	4,920
Buildings, Improvements & Equipment	24,056
Cost Capitalized Subsequent to Acquisition	15,557
Impairment	0
Cost Basis Adjustment	(153)
Cost at the end of the period
Land	4,920
Buildings, Improvements & Equipment	39,460
Total	44,380
Accumulated Depreciation	10,007
15 North Broadway, White Plains, NY
Real Estate And Accumulated Depreciation
Encumbrances	0
Initial Cost to Company
Land	4,900
Buildings, Improvements & Equipment	13,594
Cost Capitalized Subsequent to Acquisition	5,056
Impairment	0
Cost Basis Adjustment	0
Cost at the end of the period
Land	4,900
Buildings, Improvements & Equipment	18,650
Total	23,550
Accumulated Depreciation	5,000
537 Riverdale Avenue, Yonkers, NY
Real Estate And Accumulated Depreciation
Encumbrances	0
Initial Cost to Company
Land	8,460
Buildings, Improvements & Equipment	90,561
Cost Capitalized Subsequent to Acquisition	12,905
Impairment	0
Cost Basis Adjustment	(392)
Cost at the end of the period
Land	8,465
Buildings, Improvements & Equipment	103,069
Total	111,534
Accumulated Depreciation	27,467
4590 Knightsbridge Boulevard, Columbus, OH
Real Estate And Accumulated Depreciation
Encumbrances	0
Initial Cost to Company
Land	3,623
Buildings, Improvements & Equipment	27,778
Cost Capitalized Subsequent to Acquisition	17,430
Impairment	0
Cost Basis Adjustment	(3,682)
Cost at the end of the period
Land	3,732
Buildings, Improvements & Equipment	41,417
Total	45,149
Accumulated Depreciation	17,487
3929 Hoover Road, Grove City, OH
Real Estate And Accumulated Depreciation
Encumbrances	0
Initial Cost to Company
Land	332
Buildings, Improvements & Equipment	3,081
Cost Capitalized Subsequent to Acquisition	1,015
Impairment	0
Cost Basis Adjustment	0
Cost at the end of the period
Land	332
Buildings, Improvements & Equipment	4,096
Total	4,428
Accumulated Depreciation	2,561
7555 Innovation Way, Mason, OH
Real Estate And Accumulated Depreciation
Encumbrances	0
Initial Cost to Company
Land	1,025
Buildings, Improvements & Equipment	12,883
Cost Capitalized Subsequent to Acquisition	0
Impairment	0
Cost Basis Adjustment	0
Cost at the end of the period
Land	1,025
Buildings, Improvements & Equipment	12,883
Total	13,908
Accumulated Depreciation	1,691
8709 S.E. Causey Avenue, Portland, OR
Real Estate And Accumulated Depreciation
Encumbrances	0
Initial Cost to Company
Land	3,303
Buildings, Improvements & Equipment	77,428
Cost Capitalized Subsequent to Acquisition	1,738
Impairment	(26,073)
Cost Basis Adjustment	(9,749)
Cost at the end of the period
Land	2,201
Buildings, Improvements & Equipment	44,446
Total	46,647
Accumulated Depreciation	2,998
71 Darlington Road, Beaver Falls, PA
Real Estate And Accumulated Depreciation
Encumbrances	0
Initial Cost to Company
Land	1,500
Buildings, Improvements & Equipment	13,500
Cost Capitalized Subsequent to Acquisition	1,041
Impairment	0
Cost Basis Adjustment	(879)
Cost at the end of the period
Land	1,523
Buildings, Improvements & Equipment	13,639
Total	15,162
Accumulated Depreciation	5,391
950 Morgan Highway, Clarks Summit, PA
Real Estate And Accumulated Depreciation
Encumbrances	0
Initial Cost to Company
Land	1,001
Buildings, Improvements & Equipment	8,233
Cost Capitalized Subsequent to Acquisition	1,192
Impairment	0
Cost Basis Adjustment	(277)
Cost at the end of the period
Land	1,017
Buildings, Improvements & Equipment	9,132
Total	10,149
Accumulated Depreciation	3,850
145 Broadlawn Drive, Elizabeth, PA
Real Estate And Accumulated Depreciation
Encumbrances	0
Initial Cost to Company
Land	696
Buildings, Improvements & Equipment	6,304
Cost Capitalized Subsequent to Acquisition	672
Impairment	(4,280)
Cost Basis Adjustment	(3,017)
Cost at the end of the period
Land	375
Buildings, Improvements & Equipment	0
Total	375
Accumulated Depreciation	0
600 N. Pottstown Pike, Exton, PA
Real Estate And Accumulated Depreciation
Encumbrances	0
Initial Cost to Company
Land	1,001
Buildings, Improvements & Equipment	8,233
Cost Capitalized Subsequent to Acquisition	2,368
Impairment	0
Cost Basis Adjustment	(308)
Cost at the end of the period
Land	1,001
Buildings, Improvements & Equipment	10,293
Total	11,294
Accumulated Depreciation	4,199
242 Baltimore Pike, Glen Mills, PA
Real Estate And Accumulated Depreciation
Encumbrances	0
Initial Cost to Company
Land	1,001
Buildings, Improvements & Equipment	8,233
Cost Capitalized Subsequent to Acquisition	1,046
Impairment	0
Cost Basis Adjustment	(382)
Cost at the end of the period
Land	1,001
Buildings, Improvements & Equipment	8,897
Total	9,898
Accumulated Depreciation	3,844
20 Capital Drive, Harrisburg, PA
Real Estate And Accumulated Depreciation
Encumbrances	0
Initial Cost to Company
Land	397
Buildings, Improvements & Equipment	9,333
Cost Capitalized Subsequent to Acquisition	10
Impairment	0
Cost Basis Adjustment	0
Cost at the end of the period
Land	397
Buildings, Improvements & Equipment	9,343
Total	9,740
Accumulated Depreciation	1,614
210 Mall Boulevard, King of Prussia, PA
Real Estate And Accumulated Depreciation
Encumbrances	0
Initial Cost to Company
Land	1,540
Buildings, Improvements & Equipment	4,743
Cost Capitalized Subsequent to Acquisition	2,698
Impairment	0
Cost Basis Adjustment	0
Cost at the end of the period
Land	1,934
Buildings, Improvements & Equipment	7,047
Total	8,981
Accumulated Depreciation	2,255
216 Mall Boulevard, King of Prussia, PA
Real Estate And Accumulated Depreciation
Encumbrances	0
Initial Cost to Company
Land	880
Buildings, Improvements & Equipment	2,871
Cost Capitalized Subsequent to Acquisition	2,378
Impairment	0
Cost Basis Adjustment	0
Cost at the end of the period
Land	978
Buildings, Improvements & Equipment	5,151
Total	6,129
Accumulated Depreciation	1,241
5300 Old William Penn Highway, Murrysville, PA
Real Estate And Accumulated Depreciation
Encumbrances	0
Initial Cost to Company
Land	300
Buildings, Improvements & Equipment	2,506
Cost Capitalized Subsequent to Acquisition	0
Impairment	0
Cost Basis Adjustment	(272)
Cost at the end of the period
Land	300
Buildings, Improvements & Equipment	2,234
Total	2,534
Accumulated Depreciation	1,054
800 Manor Drive, New Britain (Chalfont), PA
Real Estate And Accumulated Depreciation
Encumbrances	0
Initial Cost to Company
Land	979
Buildings, Improvements & Equipment	8,052
Cost Capitalized Subsequent to Acquisition	1,713
Impairment	0
Cost Basis Adjustment	(440)
Cost at the end of the period
Land	981
Buildings, Improvements & Equipment	9,323
Total	10,304
Accumulated Depreciation	3,902
7151 Saltsburg Road, Penn Hills, PA
Real Estate And Accumulated Depreciation
Encumbrances	0
Initial Cost to Company
Land	200
Buildings, Improvements & Equipment	904
Cost Capitalized Subsequent to Acquisition	0
Impairment	0
Cost Basis Adjustment	(103)
Cost at the end of the period
Land	200
Buildings, Improvements & Equipment	801
Total	1,001
Accumulated Depreciation	378
5750 Centre Avenue, Pittsburgh, PA
Real Estate And Accumulated Depreciation
Encumbrances	0
Initial Cost to Company
Land	3,000
Buildings, Improvements & Equipment	11,828
Cost Capitalized Subsequent to Acquisition	4,477
Impairment	0
Cost Basis Adjustment	(259)
Cost at the end of the period
Land	3,788
Buildings, Improvements & Equipment	15,258
Total	19,046
Accumulated Depreciation	5,189
730 Holiday Drive, Pittsburgh, PA
Real Estate And Accumulated Depreciation
Encumbrances	0
Initial Cost to Company
Land	2,480
Buildings, Improvements & Equipment	6,395
Cost Capitalized Subsequent to Acquisition	5,835
Impairment	0
Cost Basis Adjustment	(936)
Cost at the end of the period
Land	2,711
Buildings, Improvements & Equipment	11,063
Total	13,774
Accumulated Depreciation	2,971
1400 Riggs Road, South Park, PA
Real Estate And Accumulated Depreciation
Encumbrances	0
Initial Cost to Company
Land	898
Buildings, Improvements & Equipment	8,102
Cost Capitalized Subsequent to Acquisition	1,361
Impairment	(5,192)
Cost Basis Adjustment	(3,499)
Cost at the end of the period
Land	1,670
Buildings, Improvements & Equipment	0
Total	1,670
Accumulated Depreciation	0
700 Northampton Street, Tiffany Court (Kingston), PA
Real Estate And Accumulated Depreciation
Encumbrances	0
Initial Cost to Company
Land	0
Buildings, Improvements & Equipment	5,682
Cost Capitalized Subsequent to Acquisition	2,246
Impairment	0
Cost Basis Adjustment	(359)
Cost at the end of the period
Land	0
Buildings, Improvements & Equipment	7,569
Total	7,569
Accumulated Depreciation	3,036
5250 Meadowgreen Drive, Whitehall, PA
Real Estate And Accumulated Depreciation
Encumbrances	0
Initial Cost to Company
Land	1,599
Buildings, Improvements & Equipment	14,401
Cost Capitalized Subsequent to Acquisition	4,007
Impairment	0
Cost Basis Adjustment	(1,106)
Cost at the end of the period
Land	1,599
Buildings, Improvements & Equipment	17,302
Total	18,901
Accumulated Depreciation	6,365
1304 McLees Road, Anderson, SC
Real Estate And Accumulated Depreciation
Encumbrances	0
Initial Cost to Company
Land	295
Buildings, Improvements & Equipment	3,509
Cost Capitalized Subsequent to Acquisition	1,224
Impairment	0
Cost Basis Adjustment	(253)
Cost at the end of the period
Land	295
Buildings, Improvements & Equipment	4,480
Total	4,775
Accumulated Depreciation	1,572
109 Old Salem Road, Beaufort, SC
Real Estate And Accumulated Depreciation
Encumbrances	0
Initial Cost to Company
Land	188
Buildings, Improvements & Equipment	2,234
Cost Capitalized Subsequent to Acquisition	1,625
Impairment	(807)
Cost Basis Adjustment	(1,514)
Cost at the end of the period
Land	104
Buildings, Improvements & Equipment	1,622
Total	1,726
Accumulated Depreciation	96
Pick Pocket Plantation Drive1119 Beaufort S C 1 [Member]
Real Estate And Accumulated Depreciation
Encumbrances	0
Initial Cost to Company
Land	1,200
Buildings, Improvements & Equipment	10,810
Cost Capitalized Subsequent to Acquisition	1,531
Impairment	(3,927)
Cost Basis Adjustment	(3,270)
Cost at the end of the period
Land	733
Buildings, Improvements & Equipment	5,611
Total	6,344
Accumulated Depreciation	30
719 Kershaw Highway, Camden, SC
Real Estate And Accumulated Depreciation
Encumbrances	0
Initial Cost to Company
Land	322
Buildings, Improvements & Equipment	3,697
Cost Capitalized Subsequent to Acquisition	1,777
Impairment	0
Cost Basis Adjustment	(376)
Cost at the end of the period
Land	322
Buildings, Improvements & Equipment	5,098
Total	5,420
Accumulated Depreciation	1,972
2333 Ashley River Road, Charleston, SC
Real Estate And Accumulated Depreciation
Encumbrances	0
Initial Cost to Company
Land	848
Buildings, Improvements & Equipment	14,000
Cost Capitalized Subsequent to Acquisition	2,849
Impairment	(7,118)
Cost Basis Adjustment	(4,415)
Cost at the end of the period
Land	377
Buildings, Improvements & Equipment	5,787
Total	6,164
Accumulated Depreciation	565
320 Seven Farms Drive, Charleston, SC
Real Estate And Accumulated Depreciation
Encumbrances	0
Initial Cost to Company
Land	1,092
Buildings, Improvements & Equipment	6,605
Cost Capitalized Subsequent to Acquisition	1,760
Impairment	0
Cost Basis Adjustment	(274)
Cost at the end of the period
Land	1,092
Buildings, Improvements & Equipment	8,091
Total	9,183
Accumulated Depreciation	2,008
251 Springtree Drive, Columbia, SC
Real Estate And Accumulated Depreciation
Encumbrances	0
Initial Cost to Company
Land	300
Buildings, Improvements & Equipment	1,905
Cost Capitalized Subsequent to Acquisition	0
Impairment	0
Cost Basis Adjustment	(112)
Cost at the end of the period
Land	300
Buildings, Improvements & Equipment	1,793
Total	2,093
Accumulated Depreciation	846
3 Summit Terrace, Columbia, SC
Real Estate And Accumulated Depreciation
Encumbrances	0
Initial Cost to Company
Land	610
Buildings, Improvements & Equipment	7,900
Cost Capitalized Subsequent to Acquisition	887
Impairment	(6,314)
Cost Basis Adjustment	(2,698)
Cost at the end of the period
Land	385
Buildings, Improvements & Equipment	0
Total	385
Accumulated Depreciation	0
7909 Parklane Road, Columbia, SC
Real Estate And Accumulated Depreciation
Encumbrances	0
Initial Cost to Company
Land	1,580
Buildings, Improvements & Equipment	4,520
Cost Capitalized Subsequent to Acquisition	2,323
Impairment	0
Cost Basis Adjustment	(314)
Cost at the end of the period
Land	1,725
Buildings, Improvements & Equipment	6,384
Total	8,109
Accumulated Depreciation	1,423
Berkmans Lane355 Greenville S C 1 [Member]
Real Estate And Accumulated Depreciation
Encumbrances	0
Initial Cost to Company
Land	700
Buildings, Improvements & Equipment	7,240
Cost Capitalized Subsequent to Acquisition	1,725
Impairment	(2,593)
Cost Basis Adjustment	(2,387)
Cost at the end of the period
Land	417
Buildings, Improvements & Equipment	4,268
Total	4,685
Accumulated Depreciation	131
116 Enterprise Court, Greenwood, SC
Real Estate And Accumulated Depreciation
Encumbrances	0
Initial Cost to Company
Land	310
Buildings, Improvements & Equipment	2,790
Cost Capitalized Subsequent to Acquisition	1,283
Impairment	0
Cost Basis Adjustment	(213)
Cost at the end of the period
Land	310
Buildings, Improvements & Equipment	3,860
Total	4,170
Accumulated Depreciation	1,324
1901 West Carolina, Hartsville, SC
Real Estate And Accumulated Depreciation
Encumbrances	0
Initial Cost to Company
Land	401
Buildings, Improvements & Equipment	4,775
Cost Capitalized Subsequent to Acquisition	1,068
Impairment	0
Cost Basis Adjustment	(302)
Cost at the end of the period
Land	401
Buildings, Improvements & Equipment	5,541
Total	5,942
Accumulated Depreciation	2,237
218 Old Chapin Road, Lexington, SC
Real Estate And Accumulated Depreciation
Encumbrances	0
Initial Cost to Company
Land	363
Buildings, Improvements & Equipment	4,322
Cost Capitalized Subsequent to Acquisition	979
Impairment	0
Cost Basis Adjustment	(400)
Cost at the end of the period
Land	363
Buildings, Improvements & Equipment	4,901
Total	5,264
Accumulated Depreciation	2,004
491 Highway 17, Little River, SC
Real Estate And Accumulated Depreciation
Encumbrances	0
Initial Cost to Company
Land	750
Buildings, Improvements & Equipment	9,018
Cost Capitalized Subsequent to Acquisition	1,349
Impairment	0
Cost Basis Adjustment	(314)
Cost at the end of the period
Land	750
Buildings, Improvements & Equipment	10,053
Total	10,803
Accumulated Depreciation	2,821
1010 Anna Knapp Boulevard, Mt. Pleasant, SC
Real Estate And Accumulated Depreciation
Encumbrances	0
Initial Cost to Company
Land	1,797
Buildings, Improvements & Equipment	6,132
Cost Capitalized Subsequent to Acquisition	624
Impairment	0
Cost Basis Adjustment	(458)
Cost at the end of the period
Land	1,797
Buildings, Improvements & Equipment	6,298
Total	8,095
Accumulated Depreciation	842
601 Mathis Ferry Road, Mt. Pleasant, SC
Real Estate And Accumulated Depreciation
Encumbrances	0
Initial Cost to Company
Land	1,687
Buildings, Improvements & Equipment	12,612
Cost Capitalized Subsequent to Acquisition	706
Impairment	(10,794)
Cost Basis Adjustment	(2,021)
Cost at the end of the period
Land	2,190
Buildings, Improvements & Equipment	0
Total	2,190
Accumulated Depreciation	0
937 Bowman road, Mt. Pleasant, SC
Real Estate And Accumulated Depreciation
Encumbrances	0
Initial Cost to Company
Land	3,898
Buildings, Improvements & Equipment	31,613
Cost Capitalized Subsequent to Acquisition	7,988
Impairment	0
Cost Basis Adjustment	(997)
Cost at the end of the period
Land	3,830
Buildings, Improvements & Equipment	38,672
Total	42,502
Accumulated Depreciation	10,603
Highway17 North9547 Myrtle Beach S C 1 [Member]
Real Estate And Accumulated Depreciation
Encumbrances	0
Initial Cost to Company
Land	543
Buildings, Improvements & Equipment	3,202
Cost Capitalized Subsequent to Acquisition	9,360
Impairment	(3,192)
Cost Basis Adjustment	(4,437)
Cost at the end of the period
Land	333
Buildings, Improvements & Equipment	5,143
Total	5,476
Accumulated Depreciation	218
2306 Riverbank Drive, Orangeburg, SC
Real Estate And Accumulated Depreciation
Encumbrances	0
Initial Cost to Company
Land	303
Buildings, Improvements & Equipment	3,607
Cost Capitalized Subsequent to Acquisition	1,043
Impairment	0
Cost Basis Adjustment	(358)
Cost at the end of the period
Land	303
Buildings, Improvements & Equipment	4,292
Total	4,595
Accumulated Depreciation	1,748
1920 Ebenezer Road, Rock Hill, SC
Real Estate And Accumulated Depreciation
Encumbrances	0
Initial Cost to Company
Land	300
Buildings, Improvements & Equipment	1,705
Cost Capitalized Subsequent to Acquisition	0
Impairment	0
Cost Basis Adjustment	(162)
Cost at the end of the period
Land	300
Buildings, Improvements & Equipment	1,543
Total	1,843
Accumulated Depreciation	728
15855 Wells Highway, Seneca, SC
Real Estate And Accumulated Depreciation
Encumbrances	0
Initial Cost to Company
Land	396
Buildings, Improvements & Equipment	4,714
Cost Capitalized Subsequent to Acquisition	1,416
Impairment	0
Cost Basis Adjustment	(353)
Cost at the end of the period
Land	396
Buildings, Improvements & Equipment	5,777
Total	6,173
Accumulated Depreciation	2,198
One Southern Court, West Columbia, SC
Real Estate And Accumulated Depreciation
Encumbrances	0
Initial Cost to Company
Land	520
Buildings, Improvements & Equipment	3,831
Cost Capitalized Subsequent to Acquisition	612
Impairment	0
Cost Basis Adjustment	0
Cost at the end of the period
Land	557
Buildings, Improvements & Equipment	4,406
Total	4,963
Accumulated Depreciation	1,545
6716 Nolensville Road, Brentwood, TN
Real Estate And Accumulated Depreciation
Encumbrances	0
Initial Cost to Company
Land	1,528
Buildings, Improvements & Equipment	6,037
Cost Capitalized Subsequent to Acquisition	223
Impairment	0
Cost Basis Adjustment	0
Cost at the end of the period
Land	1,528
Buildings, Improvements & Equipment	6,260
Total	7,788
Accumulated Depreciation	1,468
207 Uffelman Drive, Clarksville, TN
Real Estate And Accumulated Depreciation
Encumbrances	0
Initial Cost to Company
Land	320
Buildings, Improvements & Equipment	2,994
Cost Capitalized Subsequent to Acquisition	2,133
Impairment	0
Cost Basis Adjustment	(161)
Cost at the end of the period
Land	320
Buildings, Improvements & Equipment	4,966
Total	5,286
Accumulated Depreciation	1,425
51 Patel Way, Clarksville, TN
Real Estate And Accumulated Depreciation
Encumbrances	0
Initial Cost to Company
Land	800
Buildings, Improvements & Equipment	10,322
Cost Capitalized Subsequent to Acquisition	6,990
Impairment	0
Cost Basis Adjustment	(318)
Cost at the end of the period
Land	833
Buildings, Improvements & Equipment	16,961
Total	17,794
Accumulated Depreciation	3,840
2900 Westside Drive, Cleveland, TN
Real Estate And Accumulated Depreciation
Encumbrances	0
Initial Cost to Company
Land	305
Buildings, Improvements & Equipment	3,627
Cost Capitalized Subsequent to Acquisition	1,544
Impairment	0
Cost Basis Adjustment	(284)
Cost at the end of the period
Land	305
Buildings, Improvements & Equipment	4,887
Total	5,192
Accumulated Depreciation	1,830
1010 East Spring Street, Cookeville, TN
Real Estate And Accumulated Depreciation
Encumbrances	0
Initial Cost to Company
Land	322
Buildings, Improvements & Equipment	3,828
Cost Capitalized Subsequent to Acquisition	1,777
Impairment	0
Cost Basis Adjustment	(230)
Cost at the end of the period
Land	322
Buildings, Improvements & Equipment	5,375
Total	5,697
Accumulated Depreciation	1,968
105 Sunrise Circle, Franklin, TN
Real Estate And Accumulated Depreciation
Encumbrances	0
Initial Cost to Company
Land	322
Buildings, Improvements & Equipment	3,833
Cost Capitalized Subsequent to Acquisition	1,312
Impairment	0
Cost Basis Adjustment	(268)
Cost at the end of the period
Land	329
Buildings, Improvements & Equipment	4,870
Total	5,199
Accumulated Depreciation	1,877
1085 Hartsville Pike, Gallatin, TN
Real Estate And Accumulated Depreciation
Encumbrances	0
Initial Cost to Company
Land	280
Buildings, Improvements & Equipment	3,327
Cost Capitalized Subsequent to Acquisition	1,840
Impairment	0
Cost Basis Adjustment	(212)
Cost at the end of the period
Land	280
Buildings, Improvements & Equipment	4,955
Total	5,235
Accumulated Depreciation	1,589
2025 Caldwell Drive, Goodlettsville, TN
Real Estate And Accumulated Depreciation
Encumbrances	0
Initial Cost to Company
Land	400
Buildings, Improvements & Equipment	3,507
Cost Capitalized Subsequent to Acquisition	8,547
Impairment	0
Cost Basis Adjustment	(202)
Cost at the end of the period
Land	400
Buildings, Improvements & Equipment	11,852
Total	12,252
Accumulated Depreciation	3,324
1200 North Parkway, Jackson, TN
Real Estate And Accumulated Depreciation
Encumbrances	0
Initial Cost to Company
Land	295
Buildings, Improvements & Equipment	3,506
Cost Capitalized Subsequent to Acquisition	968
Impairment	0
Cost Basis Adjustment	(300)
Cost at the end of the period
Land	299
Buildings, Improvements & Equipment	4,170
Total	4,469
Accumulated Depreciation	1,567
550 Deer View Way, Jefferson City, TN
Real Estate And Accumulated Depreciation
Encumbrances	0
Initial Cost to Company
Land	940
Buildings, Improvements & Equipment	8,057
Cost Capitalized Subsequent to Acquisition	2,297
Impairment	0
Cost Basis Adjustment	(94)
Cost at the end of the period
Land	948
Buildings, Improvements & Equipment	10,252
Total	11,200
Accumulated Depreciation	2,166
10914 Kingston Pike, Knoxville, TN
Real Estate And Accumulated Depreciation
Encumbrances	9,817
Initial Cost to Company
Land	613
Buildings, Improvements & Equipment	12,410
Cost Capitalized Subsequent to Acquisition	370
Impairment	0
Cost Basis Adjustment	0
Cost at the end of the period
Land	613
Buildings, Improvements & Equipment	12,780
Total	13,393
Accumulated Depreciation	1,630
3020 Heatherton Way, Knoxville, TN
Real Estate And Accumulated Depreciation
Encumbrances	0
Initial Cost to Company
Land	304
Buildings, Improvements & Equipment	3,618
Cost Capitalized Subsequent to Acquisition	3,199
Impairment	(2,697)
Cost Basis Adjustment	(2,357)
Cost at the end of the period
Land	1,440
Buildings, Improvements & Equipment	627
Total	2,067
Accumulated Depreciation	29
3030 Holbrook Drive, Knoxville, TN
Real Estate And Accumulated Depreciation
Encumbrances	5,639
Initial Cost to Company
Land	352
Buildings, Improvements & Equipment	7,128
Cost Capitalized Subsequent to Acquisition	852
Impairment	0
Cost Basis Adjustment	0
Cost at the end of the period
Land	360
Buildings, Improvements & Equipment	7,972
Total	8,332
Accumulated Depreciation	996
100 Chatuga Drive West, Loudon, TN
Real Estate And Accumulated Depreciation
Encumbrances	0
Initial Cost to Company
Land	580
Buildings, Improvements & Equipment	16,093
Cost Capitalized Subsequent to Acquisition	31,831
Impairment	0
Cost Basis Adjustment	0
Cost at the end of the period
Land	580
Buildings, Improvements & Equipment	47,924
Total	48,504
Accumulated Depreciation	3,015
511 Pearson Springs Road, Maryville, TN
Real Estate And Accumulated Depreciation
Encumbrances	0
Initial Cost to Company
Land	300
Buildings, Improvements & Equipment	3,207
Cost Capitalized Subsequent to Acquisition	100
Impairment	0
Cost Basis Adjustment	(192)
Cost at the end of the period
Land	300
Buildings, Improvements & Equipment	3,115
Total	3,415
Accumulated Depreciation	1,469
1710 Magnolia Blvd, Nashville, TN
Real Estate And Accumulated Depreciation
Encumbrances	0
Initial Cost to Company
Land	750
Buildings, Improvements & Equipment	6,750
Cost Capitalized Subsequent to Acquisition	17,521
Impairment	0
Cost Basis Adjustment	(1,023)
Cost at the end of the period
Land	750
Buildings, Improvements & Equipment	23,248
Total	23,998
Accumulated Depreciation	4,413
350 Volunteer Drive, Paris, TN
Real Estate And Accumulated Depreciation
Encumbrances	0
Initial Cost to Company
Land	110
Buildings, Improvements & Equipment	12,100
Cost Capitalized Subsequent to Acquisition	720
Impairment	0
Cost Basis Adjustment	(905)
Cost at the end of the period
Land	110
Buildings, Improvements & Equipment	11,915
Total	12,025
Accumulated Depreciation	1,676
971 State Hwy 121, Allen, TX
Real Estate And Accumulated Depreciation
Encumbrances	0
Initial Cost to Company
Land	2,590
Buildings, Improvements & Equipment	17,912
Cost Capitalized Subsequent to Acquisition	0
Impairment	0
Cost Basis Adjustment	0
Cost at the end of the period
Land	2,590
Buildings, Improvements & Equipment	17,912
Total	20,502
Accumulated Depreciation	5,989
1111 W. 34th Street, Austin, TX
Real Estate And Accumulated Depreciation
Encumbrances	0
Initial Cost to Company
Land	400
Buildings, Improvements & Equipment	21,021
Cost Capitalized Subsequent to Acquisition	2,108
Impairment	0
Cost Basis Adjustment	0
Cost at the end of the period
Land	694
Buildings, Improvements & Equipment	22,835
Total	23,529
Accumulated Depreciation	7,664
6818 Austin Center Blvd, Austin, TX
Real Estate And Accumulated Depreciation
Encumbrances	0
Initial Cost to Company
Land	1,540
Buildings, Improvements & Equipment	27,467
Cost Capitalized Subsequent to Acquisition	2,977
Impairment	0
Cost Basis Adjustment	(558)
Cost at the end of the period
Land	1,585
Buildings, Improvements & Equipment	29,841
Total	31,426
Accumulated Depreciation	9,757
7600 Capital Texas Highway, Austin, TX
Real Estate And Accumulated Depreciation
Encumbrances	0
Initial Cost to Company
Land	300
Buildings, Improvements & Equipment	4,557
Cost Capitalized Subsequent to Acquisition	1,608
Impairment	0
Cost Basis Adjustment	0
Cost at the end of the period
Land	300
Buildings, Improvements & Equipment	6,165
Total	6,465
Accumulated Depreciation	1,460
4620 Bellaire Boulevard, Bellaire, TX
Real Estate And Accumulated Depreciation
Encumbrances	0
Initial Cost to Company
Land	1,238
Buildings, Improvements & Equipment	11,010
Cost Capitalized Subsequent to Acquisition	4,948
Impairment	0
Cost Basis Adjustment	(243)
Cost at the end of the period
Land	1,325
Buildings, Improvements & Equipment	15,628
Total	16,953
Accumulated Depreciation	9,547
120 Crosspoint Drive, Boerne, TX
Real Estate And Accumulated Depreciation
Encumbrances	0
Initial Cost to Company
Land	220
Buildings, Improvements & Equipment	4,926
Cost Capitalized Subsequent to Acquisition	960
Impairment	0
Cost Basis Adjustment	0
Cost at the end of the period
Land	227
Buildings, Improvements & Equipment	5,879
Total	6,106
Accumulated Depreciation	1,864
4015 Interstate 45, Conroe , TX
Real Estate And Accumulated Depreciation
Encumbrances	0
Initial Cost to Company
Land	620
Buildings, Improvements & Equipment	14,074
Cost Capitalized Subsequent to Acquisition	1,270
Impairment	0
Cost Basis Adjustment	(373)
Cost at the end of the period
Land	620
Buildings, Improvements & Equipment	14,971
Total	15,591
Accumulated Depreciation	4,115
5455 La Sierra Drive, Dallas, TX
Real Estate And Accumulated Depreciation
Encumbrances	0
Initial Cost to Company
Land	2,300
Buildings, Improvements & Equipment	25,200
Cost Capitalized Subsequent to Acquisition	8,177
Impairment	0
Cost Basis Adjustment	(902)
Cost at the end of the period
Land	2,324
Buildings, Improvements & Equipment	32,451
Total	34,775
Accumulated Depreciation	8,645
7831 Park Lane, Dallas, TX
Real Estate And Accumulated Depreciation
Encumbrances	0
Initial Cost to Company
Land	4,709
Buildings, Improvements & Equipment	27,768
Cost Capitalized Subsequent to Acquisition	23,525
Impairment	0
Cost Basis Adjustment	(2,998)
Cost at the end of the period
Land	5,432
Buildings, Improvements & Equipment	47,572
Total	53,004
Accumulated Depreciation	18,453
1575 Belvidere, El Paso, TX
Real Estate And Accumulated Depreciation
Encumbrances	0
Initial Cost to Company
Land	2,301
Buildings, Improvements & Equipment	13,567
Cost Capitalized Subsequent to Acquisition	7,482
Impairment	0
Cost Basis Adjustment	(1,537)
Cost at the end of the period
Land	2,316
Buildings, Improvements & Equipment	19,497
Total	21,813
Accumulated Depreciation	7,713
96 Frederick Road, Fredericksburg, TX
Real Estate And Accumulated Depreciation
Encumbrances	0
Initial Cost to Company
Land	280
Buildings, Improvements & Equipment	4,866
Cost Capitalized Subsequent to Acquisition	6,770
Impairment	0
Cost Basis Adjustment	0
Cost at the end of the period
Land	280
Buildings, Improvements & Equipment	11,636
Total	11,916
Accumulated Depreciation	2,871
6435 S.F.M. 549, Heath, TX
Real Estate And Accumulated Depreciation
Encumbrances	0
Initial Cost to Company
Land	1,135
Buildings, Improvements & Equipment	7,892
Cost Capitalized Subsequent to Acquisition	998
Impairment	(288)
Cost Basis Adjustment	(1,493)
Cost at the end of the period
Land	1,192
Buildings, Improvements & Equipment	7,052
Total	8,244
Accumulated Depreciation	426
13215 Dotson Road, Houston, TX
Real Estate And Accumulated Depreciation
Encumbrances	0
Initial Cost to Company
Land	990
Buildings, Improvements & Equipment	13,887
Cost Capitalized Subsequent to Acquisition	1,458
Impairment	0
Cost Basis Adjustment	0
Cost at the end of the period
Land	990
Buildings, Improvements & Equipment	15,345
Total	16,335
Accumulated Depreciation	3,994
777 North Post Oak Road, Houston, TX
Real Estate And Accumulated Depreciation
Encumbrances	0
Initial Cost to Company
Land	5,537
Buildings, Improvements & Equipment	32,647
Cost Capitalized Subsequent to Acquisition	27,154
Impairment	0
Cost Basis Adjustment	(4,460)
Cost at the end of the period
Land	5,540
Buildings, Improvements & Equipment	55,338
Total	60,878
Accumulated Depreciation	21,503
10030 North MacArthur Boulevard, Irving, TX
Real Estate And Accumulated Depreciation
Encumbrances	0
Initial Cost to Company
Land	2,186
Buildings, Improvements & Equipment	15,869
Cost Capitalized Subsequent to Acquisition	755
Impairment	0
Cost Basis Adjustment	0
Cost at the end of the period
Land	2,186
Buildings, Improvements & Equipment	16,624
Total	18,810
Accumulated Depreciation	2,848
4770 Regent Blvd, Irving, TX
Real Estate And Accumulated Depreciation
Encumbrances	0
Initial Cost to Company
Land	2,830
Buildings, Improvements & Equipment	15,082
Cost Capitalized Subsequent to Acquisition	4,467
Impairment	0
Cost Basis Adjustment	0
Cost at the end of the period
Land	2,830
Buildings, Improvements & Equipment	19,549
Total	22,379
Accumulated Depreciation	6,835
9812 Slide Road, Lubbock, TX
Real Estate And Accumulated Depreciation
Encumbrances	0
Initial Cost to Company
Land	1,110
Buildings, Improvements & Equipment	9,798
Cost Capitalized Subsequent to Acquisition	665
Impairment	0
Cost Basis Adjustment	0
Cost at the end of the period
Land	1,110
Buildings, Improvements & Equipment	10,463
Total	11,573
Accumulated Depreciation	2,882
605 Gateway Central, Marbel Falls, TX
Real Estate And Accumulated Depreciation
Encumbrances	0
Initial Cost to Company
Land	1,440
Buildings, Improvements & Equipment	7,125
Cost Capitalized Subsequent to Acquisition	1,380
Impairment	0
Cost Basis Adjustment	(34)
Cost at the end of the period
Land	1,440
Buildings, Improvements & Equipment	8,471
Total	9,911
Accumulated Depreciation	2,332
7150 N. President George Bush Turnpike, North Garland, TX
Real Estate And Accumulated Depreciation
Encumbrances	0
Initial Cost to Company
Land	1,981
Buildings, Improvements & Equipment	8,548
Cost Capitalized Subsequent to Acquisition	1,147
Impairment	(346)
Cost Basis Adjustment	(1,557)
Cost at the end of the period
Land	1,941
Buildings, Improvements & Equipment	7,832
Total	9,773
Accumulated Depreciation	485
500 Coit Road, Plano, TX
Real Estate And Accumulated Depreciation
Encumbrances	0
Initial Cost to Company
Land	3,463
Buildings, Improvements & Equipment	44,841
Cost Capitalized Subsequent to Acquisition	67
Impairment	0
Cost Basis Adjustment	0
Cost at the end of the period
Land	3,468
Buildings, Improvements & Equipment	44,903
Total	48,371
Accumulated Depreciation	2,436
2265 North Lakeshore Drive Rockwall, TX
Real Estate And Accumulated Depreciation
Encumbrances	0
Initial Cost to Company
Land	497
Buildings, Improvements & Equipment	3,582
Cost Capitalized Subsequent to Acquisition	0
Impairment	0
Cost Basis Adjustment	0
Cost at the end of the period
Land	497
Buildings, Improvements & Equipment	3,582
Total	4,079
Accumulated Depreciation	619
18302 Talavera Ridge San Antonio, TX
Real Estate And Accumulated Depreciation
Encumbrances	0
Initial Cost to Company
Land	6,855
Buildings, Improvements & Equipment	30,630
Cost Capitalized Subsequent to Acquisition	0
Impairment	0
Cost Basis Adjustment	0
Cost at the end of the period
Land	6,855
Buildings, Improvements & Equipment	30,630
Total	37,485
Accumulated Depreciation	5,297
21 Spurs Lane, Antonio, TX
Real Estate And Accumulated Depreciation
Encumbrances	11,120
Initial Cost to Company
Land	3,141
Buildings, Improvements & Equipment	23,142
Cost Capitalized Subsequent to Acquisition	2,199
Impairment	0
Cost Basis Adjustment	0
Cost at the end of the period
Land	3,192
Buildings, Improvements & Equipment	25,290
Total	28,482
Accumulated Depreciation	4,957
311 Nottingham West Place, San Antonio, TX
Real Estate And Accumulated Depreciation
Encumbrances	0
Initial Cost to Company
Land	4,283
Buildings, Improvements & Equipment	25,256
Cost Capitalized Subsequent to Acquisition	13,831
Impairment	0
Cost Basis Adjustment	(3,063)
Cost at the end of the period
Land	4,359
Buildings, Improvements & Equipment	35,948
Total	40,307
Accumulated Depreciation	15,661
511 & 575 Knights Cross Drive, San Antonio, TX
Real Estate And Accumulated Depreciation
Encumbrances	0
Initial Cost to Company
Land	2,300
Buildings, Improvements & Equipment	20,400
Cost Capitalized Subsequent to Acquisition	2,307
Impairment	0
Cost Basis Adjustment	(1,150)
Cost at the end of the period
Land	2,306
Buildings, Improvements & Equipment	21,551
Total	23,857
Accumulated Depreciation	6,484
5055 West Panther Creek Drive, Woodlands, TX
Real Estate And Accumulated Depreciation
Encumbrances	0
Initial Cost to Company
Land	3,694
Buildings, Improvements & Equipment	21,782
Cost Capitalized Subsequent to Acquisition	7,488
Impairment	0
Cost Basis Adjustment	(3,490)
Cost at the end of the period
Land	3,706
Buildings, Improvements & Equipment	25,768
Total	29,474
Accumulated Depreciation	11,746
491 Crestwood Drive, Charlottesville, VA
Real Estate And Accumulated Depreciation
Encumbrances	0
Initial Cost to Company
Land	641
Buildings, Improvements & Equipment	7,633
Cost Capitalized Subsequent to Acquisition	2,711
Impairment	0
Cost Basis Adjustment	(585)
Cost at the end of the period
Land	646
Buildings, Improvements & Equipment	9,754
Total	10,400
Accumulated Depreciation	3,844
1005 Elysian Place, Chesapeake, VA
Real Estate And Accumulated Depreciation
Encumbrances	0
Initial Cost to Company
Land	2,370
Buildings, Improvements & Equipment	23,705
Cost Capitalized Subsequent to Acquisition	2,291
Impairment	0
Cost Basis Adjustment	(153)
Cost at the end of the period
Land	2,381
Buildings, Improvements & Equipment	25,832
Total	28,213
Accumulated Depreciation	7,035
2856 Forehand Drive, Chesapeake, VA
Real Estate And Accumulated Depreciation
Encumbrances	0
Initial Cost to Company
Land	160
Buildings, Improvements & Equipment	1,498
Cost Capitalized Subsequent to Acquisition	2,398
Impairment	(1,427)
Cost Basis Adjustment	(1,159)
Cost at the end of the period
Land	1,470
Buildings, Improvements & Equipment	0
Total	1,470
Accumulated Depreciation	0
4027 Martinsburg Pike Clear brook VA
Real Estate And Accumulated Depreciation
Encumbrances	0
Initial Cost to Company
Land	3,775
Buildings, Improvements & Equipment	21,768
Cost Capitalized Subsequent to Acquisition	0
Impairment	0
Cost Basis Adjustment	0
Cost at the end of the period
Land	3,775
Buildings, Improvements & Equipment	21,768
Total	25,543
Accumulated Depreciation	3,764
4001 Fair Ridge Drive, Fairfax, VA
Real Estate And Accumulated Depreciation
Encumbrances	0
Initial Cost to Company
Land	2,500
Buildings, Improvements & Equipment	7,147
Cost Capitalized Subsequent to Acquisition	3,129
Impairment	0
Cost Basis Adjustment	(222)
Cost at the end of the period
Land	2,646
Buildings, Improvements & Equipment	9,908
Total	12,554
Accumulated Depreciation	3,099
20 HeartFields Lane , Fredericksburg, VA
Real Estate And Accumulated Depreciation
Encumbrances	0
Initial Cost to Company
Land	287
Buildings, Improvements & Equipment	8,480
Cost Capitalized Subsequent to Acquisition	1,864
Impairment	0
Cost Basis Adjustment	(781)
Cost at the end of the period
Land	287
Buildings, Improvements & Equipment	9,563
Total	9,850
Accumulated Depreciation	4,493
2800 Polo Parkway, Midlothian, VA
Real Estate And Accumulated Depreciation
Encumbrances	0
Initial Cost to Company
Land	1,103
Buildings, Improvements & Equipment	13,126
Cost Capitalized Subsequent to Acquisition	4,986
Impairment	0
Cost Basis Adjustment	(920)
Cost at the end of the period
Land	1,108
Buildings, Improvements & Equipment	17,187
Total	18,295
Accumulated Depreciation	6,502
655 Denbigh Boulevard, Newport News, VA
Real Estate And Accumulated Depreciation
Encumbrances	0
Initial Cost to Company
Land	581
Buildings, Improvements & Equipment	6,921
Cost Capitalized Subsequent to Acquisition	2,170
Impairment	0
Cost Basis Adjustment	(438)
Cost at the end of the period
Land	584
Buildings, Improvements & Equipment	8,650
Total	9,234
Accumulated Depreciation	3,373
6160 Kempsville Circle, Norfolk, VA
Real Estate And Accumulated Depreciation
Encumbrances	0
Initial Cost to Company
Land	3,263
Buildings, Improvements & Equipment	7,615
Cost Capitalized Subsequent to Acquisition	4,016
Impairment	0
Cost Basis Adjustment	(115)
Cost at the end of the period
Land	3,372
Buildings, Improvements & Equipment	11,407
Total	14,779
Accumulated Depreciation	1,458
6161 Kempsville Road, Norfolk, VA
Real Estate And Accumulated Depreciation
Encumbrances	0
Initial Cost to Company
Land	1,530
Buildings, Improvements & Equipment	9,531
Cost Capitalized Subsequent to Acquisition	2,984
Impairment	0
Cost Basis Adjustment	(323)
Cost at the end of the period
Land	1,530
Buildings, Improvements & Equipment	12,192
Total	13,722
Accumulated Depreciation	3,628
6311 Granby Street, Norfolk, VA
Real Estate And Accumulated Depreciation
Encumbrances	0
Initial Cost to Company
Land	1,920
Buildings, Improvements & Equipment	16,538
Cost Capitalized Subsequent to Acquisition	3,078
Impairment	0
Cost Basis Adjustment	(188)
Cost at the end of the period
Land	1,932
Buildings, Improvements & Equipment	19,416
Total	21,348
Accumulated Depreciation	5,116
885 Kempsville Road, Norfolk, VA
Real Estate And Accumulated Depreciation
Encumbrances	0
Initial Cost to Company
Land	1,780
Buildings, Improvements & Equipment	8,354
Cost Capitalized Subsequent to Acquisition	2,823
Impairment	0
Cost Basis Adjustment	(865)
Cost at the end of the period
Land	1,798
Buildings, Improvements & Equipment	10,294
Total	12,092
Accumulated Depreciation	3,070
531 Wythe Creek Road, Poquoson, VA
Real Estate And Accumulated Depreciation
Encumbrances	0
Initial Cost to Company
Land	220
Buildings, Improvements & Equipment	2,041
Cost Capitalized Subsequent to Acquisition	1,031
Impairment	0
Cost Basis Adjustment	(275)
Cost at the end of the period
Land	220
Buildings, Improvements & Equipment	2,797
Total	3,017
Accumulated Depreciation	1,132
10800 Nuckols Road, Glen Allen, VA
Real Estate And Accumulated Depreciation
Encumbrances	10,240
Initial Cost to Company
Land	2,863
Buildings, Improvements & Equipment	11,105
Cost Capitalized Subsequent to Acquisition	698
Impairment	0
Cost Basis Adjustment	0
Cost at the end of the period
Land	2,863
Buildings, Improvements & Equipment	11,803
Total	14,666
Accumulated Depreciation	1,278
3000 Skipwith Road, Richmond, VA
Real Estate And Accumulated Depreciation
Encumbrances	0
Initial Cost to Company
Land	732
Buildings, Improvements & Equipment	8,717
Cost Capitalized Subsequent to Acquisition	1,434
Impairment	0
Cost Basis Adjustment	(519)
Cost at the end of the period
Land	732
Buildings, Improvements & Equipment	9,632
Total	10,364
Accumulated Depreciation	3,951
9900 Independence Park Drive, Richmond, VA
Real Estate And Accumulated Depreciation
Encumbrances	0
Initial Cost to Company
Land	326
Buildings, Improvements & Equipment	3,166
Cost Capitalized Subsequent to Acquisition	272
Impairment	0
Cost Basis Adjustment	(92)
Cost at the end of the period
Land	326
Buildings, Improvements & Equipment	3,346
Total	3,672
Accumulated Depreciation	882
9930 Independence Park Drive, Richmond, VA
Real Estate And Accumulated Depreciation
Encumbrances	0
Initial Cost to Company
Land	604
Buildings, Improvements & Equipment	4,975
Cost Capitalized Subsequent to Acquisition	1,160
Impairment	0
Cost Basis Adjustment	0
Cost at the end of the period
Land	700
Buildings, Improvements & Equipment	6,039
Total	6,739
Accumulated Depreciation	1,340
5620 Wesleyan Drive, Virginia Beach, VA
Real Estate And Accumulated Depreciation
Encumbrances	0
Initial Cost to Company
Land	893
Buildings, Improvements & Equipment	7,926
Cost Capitalized Subsequent to Acquisition	2,685
Impairment	0
Cost Basis Adjustment	(124)
Cost at the end of the period
Land	893
Buildings, Improvements & Equipment	10,487
Total	11,380
Accumulated Depreciation	6,309
Longhill Road4132 Williamsburg V A 1 [Member]
Real Estate And Accumulated Depreciation
Encumbrances	0
Initial Cost to Company
Land	270
Buildings, Improvements & Equipment	2,468
Cost Capitalized Subsequent to Acquisition	1,392
Impairment	(945)
Cost Basis Adjustment	(1,583)
Cost at the end of the period
Land	162
Buildings, Improvements & Equipment	1,440
Total	1,602
Accumulated Depreciation	53
440 McLaws Circle, Williamsburg, VA
Real Estate And Accumulated Depreciation
Encumbrances	0
Initial Cost to Company
Land	1,466
Buildings, Improvements & Equipment	17,340
Cost Capitalized Subsequent to Acquisition	713
Impairment	0
Cost Basis Adjustment	(1,040)
Cost at the end of the period
Land	1,466
Buildings, Improvements & Equipment	17,013
Total	18,479
Accumulated Depreciation	2,339
21717 30th Drive SE, Bothell, WA
Real Estate And Accumulated Depreciation
Encumbrances	0
Initial Cost to Company
Land	3,012
Buildings, Improvements & Equipment	12,582
Cost Capitalized Subsequent to Acquisition	69
Impairment	0
Cost Basis Adjustment	0
Cost at the end of the period
Land	3,081
Buildings, Improvements & Equipment	12,582
Total	15,663
Accumulated Depreciation	2,807
21823 30th Drive SE, Bothell, WA
Real Estate And Accumulated Depreciation
Encumbrances	0
Initial Cost to Company
Land	2,627
Buildings, Improvements & Equipment	12,657
Cost Capitalized Subsequent to Acquisition	55
Impairment	0
Cost Basis Adjustment	0
Cost at the end of the period
Land	2,682
Buildings, Improvements & Equipment	12,657
Total	15,339
Accumulated Depreciation	2,823
516 Kenosia Avenue South, Kent, WA
Real Estate And Accumulated Depreciation
Encumbrances	0
Initial Cost to Company
Land	1,300
Buildings, Improvements & Equipment	8,458
Cost Capitalized Subsequent to Acquisition	3,728
Impairment	0
Cost Basis Adjustment	0
Cost at the end of the period
Land	1,368
Buildings, Improvements & Equipment	12,118
Total	13,486
Accumulated Depreciation	3,228
555 16th Avenue, Seattle, WA
Real Estate And Accumulated Depreciation
Encumbrances	0
Initial Cost to Company
Land	256
Buildings, Improvements & Equipment	4,869
Cost Capitalized Subsequent to Acquisition	68
Impairment	0
Cost Basis Adjustment	(513)
Cost at the end of the period
Land	256
Buildings, Improvements & Equipment	4,424
Total	4,680
Accumulated Depreciation	3,111
3003 West Good Hope Road, Glendale, WI
Real Estate And Accumulated Depreciation
Encumbrances	0
Initial Cost to Company
Land	1,500
Buildings, Improvements & Equipment	33,747
Cost Capitalized Subsequent to Acquisition	0
Impairment	0
Cost Basis Adjustment	0
Cost at the end of the period
Land	1,500
Buildings, Improvements & Equipment	33,747
Total	35,247
Accumulated Depreciation	10,335
7007 North Range Line Road, Glendale, WI
Real Estate And Accumulated Depreciation
Encumbrances	0
Initial Cost to Company
Land	250
Buildings, Improvements & Equipment	3,797
Cost Capitalized Subsequent to Acquisition	0
Impairment	0
Cost Basis Adjustment	0
Cost at the end of the period
Land	250
Buildings, Improvements & Equipment	3,797
Total	4,047
Accumulated Depreciation	1,163
215 Washington Street, Grafton, WI
Real Estate And Accumulated Depreciation
Encumbrances	0
Initial Cost to Company
Land	500
Buildings, Improvements & Equipment	10,058
Cost Capitalized Subsequent to Acquisition	0
Impairment	0
Cost Basis Adjustment	0
Cost at the end of the period
Land	500
Buildings, Improvements & Equipment	10,058
Total	10,558
Accumulated Depreciation	3,080
N168W22022 Main Street, Jackson, WI
Real Estate And Accumulated Depreciation
Encumbrances	0
Initial Cost to Company
Land	188
Buildings, Improvements & Equipment	5,962
Cost Capitalized Subsequent to Acquisition	912
Impairment	0
Cost Basis Adjustment	(101)
Cost at the end of the period
Land	192
Buildings, Improvements & Equipment	6,769
Total	6,961
Accumulated Depreciation	1,352
8351 Sheridan Road, Kenosha, WI
Real Estate And Accumulated Depreciation
Encumbrances	0
Initial Cost to Company
Land	750
Buildings, Improvements & Equipment	7,669
Cost Capitalized Subsequent to Acquisition	386
Impairment	0
Cost Basis Adjustment	0
Cost at the end of the period
Land	758
Buildings, Improvements & Equipment	8,047
Total	8,805
Accumulated Depreciation	2,817
5601 Burke Road, Madison, WI
Real Estate And Accumulated Depreciation
Encumbrances	0
Initial Cost to Company
Land	700
Buildings, Improvements & Equipment	7,461
Cost Capitalized Subsequent to Acquisition	922
Impairment	0
Cost Basis Adjustment	0
Cost at the end of the period
Land	712
Buildings, Improvements & Equipment	8,371
Total	9,083
Accumulated Depreciation	2,767
7707 N. Brookline Drive, Madison, WI
Real Estate And Accumulated Depreciation
Encumbrances	0
Initial Cost to Company
Land	2,615
Buildings, Improvements & Equipment	35,545
Cost Capitalized Subsequent to Acquisition	3,584
Impairment	0
Cost Basis Adjustment	(51)
Cost at the end of the period
Land	2,631
Buildings, Improvements & Equipment	39,062
Total	41,693
Accumulated Depreciation	7,676
10803 N. Port Washington Rd, Mequon, WI
Real Estate And Accumulated Depreciation
Encumbrances	0
Initial Cost to Company
Land	800
Buildings, Improvements & Equipment	8,388
Cost Capitalized Subsequent to Acquisition	900
Impairment	0
Cost Basis Adjustment	(25)
Cost at the end of the period
Land	805
Buildings, Improvements & Equipment	9,258
Total	10,063
Accumulated Depreciation	3,232
701 East Puetz Rd, Oak Creek, WI
Real Estate And Accumulated Depreciation
Encumbrances	0
Initial Cost to Company
Land	650
Buildings, Improvements & Equipment	18,396
Cost Capitalized Subsequent to Acquisition	2,522
Impairment	0
Cost Basis Adjustment	(105)
Cost at the end of the period
Land	1,376
Buildings, Improvements & Equipment	20,087
Total	21,463
Accumulated Depreciation	6,874
W231 N1440 Corporate Court, Pewaukee, WI
Real Estate And Accumulated Depreciation
Encumbrances	0
Initial Cost to Company
Land	3,900
Buildings, Improvements & Equipment	41,140
Cost Capitalized Subsequent to Acquisition	0
Impairment	0
Cost Basis Adjustment	0
Cost at the end of the period
Land	3,900
Buildings, Improvements & Equipment	41,140
Total	45,040
Accumulated Depreciation	12,599
8348 & 8400 Washington Avenue, Racine, WI
Real Estate And Accumulated Depreciation
Encumbrances	0
Initial Cost to Company
Land	1,150
Buildings, Improvements & Equipment	22,436
Cost Capitalized Subsequent to Acquisition	0
Impairment	0
Cost Basis Adjustment	0
Cost at the end of the period
Land	1,150
Buildings, Improvements & Equipment	22,436
Total	23,586
Accumulated Depreciation	6,871
1221 North 26th Street, Sheboygan, WI
Real Estate And Accumulated Depreciation
Encumbrances	0
Initial Cost to Company
Land	300
Buildings, Improvements & Equipment	975
Cost Capitalized Subsequent to Acquisition	0
Impairment	0
Cost Basis Adjustment	0
Cost at the end of the period
Land	300
Buildings, Improvements & Equipment	975
Total	1,275
Accumulated Depreciation	299
1222 North 23rd Street, Sheboygan, WI
Real Estate And Accumulated Depreciation
Encumbrances	0
Initial Cost to Company
Land	120
Buildings, Improvements & Equipment	4,014
Cost Capitalized Subsequent to Acquisition	0
Impairment	0
Cost Basis Adjustment	0
Cost at the end of the period
Land	120
Buildings, Improvements & Equipment	4,014
Total	4,134
Accumulated Depreciation	1,229
2414 Kohler Memorial Drive, Sheboygan, WI
Real Estate And Accumulated Depreciation
Encumbrances	0
Initial Cost to Company
Land	1,400
Buildings, Improvements & Equipment	35,168
Cost Capitalized Subsequent to Acquisition	0
Impairment	0
Cost Basis Adjustment	0
Cost at the end of the period
Land	1,400
Buildings, Improvements & Equipment	35,168
Total	36,568
Accumulated Depreciation	10,770
1125 N Edge Trail, Verona, WI
Real Estate And Accumulated Depreciation
Encumbrances	0
Initial Cost to Company
Land	1,365
Buildings, Improvements & Equipment	9,581
Cost Capitalized Subsequent to Acquisition	1,721
Impairment	0
Cost Basis Adjustment	(340)
Cost at the end of the period
Land	1,372
Buildings, Improvements & Equipment	10,955
Total	12,327
Accumulated Depreciation	2,524
3289 North Mayfair Road, Wauwatosa, WI
Real Estate And Accumulated Depreciation
Encumbrances	0
Initial Cost to Company
Land	2,300
Buildings, Improvements & Equipment	6,245
Cost Capitalized Subsequent to Acquisition	0
Impairment	0
Cost Basis Adjustment	0
Cost at the end of the period
Land	2,300
Buildings, Improvements & Equipment	6,245
Total	8,545
Accumulated Depreciation	1,913
503 South 18th Street, Laramie, WY
Real Estate And Accumulated Depreciation
Encumbrances	0
Initial Cost to Company
Land	191
Buildings, Improvements & Equipment	3,632
Cost Capitalized Subsequent to Acquisition	2,846
Impairment	0
Cost Basis Adjustment	(884)
Cost at the end of the period
Land	202
Buildings, Improvements & Equipment	5,583
Total	5,785
Accumulated Depreciation	2,651
1901 Howell Avenue, Worland, WY
Real Estate And Accumulated Depreciation
Encumbrances	0
Initial Cost to Company
Land	132
Buildings, Improvements & Equipment	2,508
Cost Capitalized Subsequent to Acquisition	2,293
Impairment	0
Cost Basis Adjustment	(571)
Cost at the end of the period
Land	132
Buildings, Improvements & Equipment	4,230
Total	4,362
Accumulated Depreciation	$ 2,313

XML

SCHEDULE III REAL ESTATE AND ACCUMULATED DEPRECIATION - Footnotes (Details) - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2021	Dec. 31, 2020
Real Estate And Accumulated Depreciation
Aggregate cost for federal income tax purposes	$ 7,405,729
Finance leases	$ 6,636
Finance Lease, Liability, Statement of Financial Position [Extensible Enumeration]	Secured debt and finance leases, net	Secured debt and finance leases, net
Continuing Operations
Real Estate And Accumulated Depreciation
Unamortized discount (premium), net	$ (578)
Buildings and Improvements | Maximum
Real Estate And Accumulated Depreciation
Period over which real estate assets are depreciated	40 years
Equipment | Maximum
Real Estate And Accumulated Depreciation
Period over which real estate assets are depreciated	12 years
Mortgages
Real Estate And Accumulated Depreciation
Mortgage debts	$ 62,499

XML

SCHEDULE III REAL ESTATE AND ACCUMULATED DEPRECIATION - Schedule of Real Estate and Accumulated Depreciation (Details) - Continuing Operations - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2021	Dec. 31, 2020	Dec. 31, 2019
Real Estate and Equipment
Balance at the beginning of the period	$ 7,410,730	$ 7,461,586	$ 7,876,300
Additions	229,735	192,124	277,350
Disposals	(910,372)	(145,430)	(250,996)
Impairment	174	(106,972)	(114,786)
Cost basis adjustment	(29,762)	(126,127)	(77,642)
Reclassification of assets held for sale, net	113,051	135,549	(248,640)
Balance at the end of the period	6,813,556	7,410,730	7,461,586
Accumulated Depreciation
Balance at the beginning of the period	1,694,901	1,570,801	1,534,392
Additions	223,039	216,418	221,165
Disposals	(158,523)	(10,228)	(54,816)
Impairment	0	0	0
Cost basis adjustment	(29,762)	(126,127)	(77,642)
Reclassification of assets held for sale, net	8,152	44,037	(52,298)
Balance at the end of the period	$ 1,737,807	$ 1,694,901	$ 1,570,801